{"data_date":"2026-11-08","library_size":29380,"matched_against":"each record's title and abstract (summary field), case-insensitive","n":3061,"page":"https://alzhub.org/answers/alzheimers-clinical-trials","query":"title or abstract mentions \"clinical trial\", \"phase 1/2/3/4\" (or I/II/III/IV), \"randomised controlled\", \"placebo-controlled\" or \"double-blind\"","studies":[{"alzhub_score":15,"alzhub_url":"https://alzhub.org/study/fda-approves-leqembi-lecanemab-irmb-under-the-accelerated-approval-149a0541","doi":null,"journal":"U.S. Food and Drug Administration (announced via Biogen press release)","n_participants":null,"pmid":null,"source_url":"https://investors.biogen.com/news-releases/news-release-details/fda-approves-leqembitm-lecanemab-irmb-under-accelerated-approval","study_design":"regulatory decision","title":"FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":14,"alzhub_url":"https://alzhub.org/study/fda-converts-novel-alzheimer-s-disease-treatment-to-traditional-826d45e8","doi":null,"journal":"U.S. Food and Drug Administration","n_participants":null,"pmid":null,"source_url":"https://www.fda.gov/news-events/press-announcements/fda-converts-novel-alzheimers-disease-treatment-traditional-approval","study_design":"regulatory decision","title":"FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval","title_match":false,"year":2023},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/lecanemab-in-early-alzheimer-s-disease-22dd8fce","doi":null,"journal":"New England Journal of Medicine","n_participants":1795,"pmid":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36449413/","study_design":"phase-3-trial","title":"Lecanemab in Early Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/donanemab-in-early-symptomatic-alzheimer-disease-the-trailblazer-alz-9857475c","doi":null,"journal":"JAMA","n_participants":1736,"pmid":null,"source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10352931/","study_design":"phase-3-trial","title":"Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/two-randomized-phase-3-studies-of-aducanumab-in-early-alzheimer-s-35542991","doi":"10.14283/jpad.2022.30","journal":"The journal of prevention of Alzheimer's disease","n_participants":1638,"pmid":"35542991","source_url":"https://pubmed.ncbi.nlm.nih.gov/35542991/","study_design":"clinical trial","title":"Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease","title_match":true,"year":2022},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-oral-semaglutide-14-mg-flexible-dose-in-early-c800c391","doi":null,"journal":"The Lancet","n_participants":3808,"pmid":null,"source_url":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00459-9/fulltext","study_design":"phase-3-trial","title":"Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (EVOKE and EVOKE+): two phase 3, randomised, placebo-controlled trials","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/ucb-presents-data-on-bepranemab-anti-tau-antibody-in-early-alzheimer-c943abc5","doi":null,"journal":"UCB press release (data presented at CTAD 2024)","n_participants":466,"pmid":null,"source_url":"https://www.ucb.com/newsroom/press-releases/article/ucb-presents-encouraging-data-on-bepranemab-in-early-alzheimer-s-disease-in-phase-2a-study-at-ctad-2024","study_design":"phase-2-trial","title":"UCB Presents Data on Bepranemab (anti-tau antibody) in Early Alzheimer's Disease: Phase 2a TOGETHER Study","title_match":true,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-aria-in-anti-amyloid-therapies-912127c4","doi":null,"journal":"Alzheimer's & Dementia","n_participants":null,"pmid":null,"source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13099593/","study_design":"systematic-review","title":"Amyloid-Related Imaging Abnormalities (ARIA) in Anti-Amyloid Therapies for Alzheimer's Disease: An Update from the Alzheimer's Association ARIA Workgroup","title_match":false,"year":2026},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/structured-vs-self-guided-multidomain-lifestyle-interventions-for-f1551689","doi":null,"journal":"JAMA","n_participants":2111,"pmid":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40720610/","study_design":"RCT","title":"Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-2-year-multidomain-intervention-of-diet-exercise-cognitive-training-18edebfe","doi":null,"journal":"The Lancet","n_participants":1260,"pmid":null,"source_url":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60461-5/abstract","study_design":"RCT","title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","title_match":true,"year":2015},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/hearing-intervention-versus-health-education-control-to-reduce-4ecff333","doi":null,"journal":"The Lancet","n_participants":977,"pmid":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/37478886/","study_design":"RCT","title":"Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial","title_match":true,"year":2023},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/the-glymphatic-system-clears-amyloid-beta-and-tau-from-brain-to-c3d280c0","doi":null,"journal":"Nature Communications","n_participants":48,"pmid":null,"source_url":"https://www.nature.com/articles/s41467-026-68374-8","study_design":"RCT","title":"The glymphatic system clears amyloid beta and tau from brain to plasma in humans","title_match":false,"year":2026},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/enhancing-the-quality-of-life-of-dementia-caregivers-from-different-46801c00","doi":null,"journal":"Annals of Internal Medicine","n_participants":642,"pmid":null,"source_url":"https://www.acpjournals.org/doi/10.7326/0003-4819-145-10-200611210-00005","study_design":"RCT","title":"Enhancing the Quality of Life of Dementia Caregivers From Different Ethnic or Racial Groups: A Randomized, Controlled Trial","title_match":true,"year":2006},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/interim-phase-1-multiple-ascending-dose-results-for-remternetug-955fa2a8","doi":null,"journal":"Presented at AD/PD 2023 Conference (Gothenburg, Sweden); covered by ALZFORUM and NeurologyLive","n_participants":41,"pmid":null,"source_url":"https://www.alzforum.org/therapeutics/remternetug","study_design":"RCT","title":"Interim Phase 1 multiple ascending dose results for remternetug (LY3372993) in Alzheimer's disease","title_match":true,"year":2023},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/randomized-phase-ii-study-of-the-safety-and-efficacy-of-semorinemab-1c8f9366","doi":null,"journal":"Neurology","n_participants":272,"pmid":null,"source_url":"https://www.neurology.org/doi/10.1212/WNL.0000000000207663","study_design":"phase-2-trial","title":"Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet","title_match":true,"year":2023},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/multiple-dose-results-from-an-ongoing-phase-1-study-of-mivelsiran-an-acc6d80e","doi":null,"journal":"Alzheimer's & Dementia (AAIC 2025 conference abstract)","n_participants":19,"pmid":null,"source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12739694/","study_design":"phase-1-trial","title":"Multiple-Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid-Beta Precursor Protein for Alzheimer's Disease","title_match":true,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/cassava-sciences-topline-phase-3-data-did-not-meet-co-primary-e69e4b94","doi":null,"journal":"GlobeNewswire (company press release); trial registered as NCT04994483","n_participants":804,"pmid":null,"source_url":"https://www.globenewswire.com/news-release/2024/11/25/2986578/8339/en/Cassava-Sciences-Topline-Phase-3-Data-Did-Not-Meet-Co-Primary-Endpoints.html","study_design":"phase-3-trial","title":"Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints (ReThink-ALZ)","title_match":true,"year":2024},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/sec-charges-cassava-sciences-and-former-top-executives-with-91a12b9f","doi":null,"journal":"SEC Press Release / Administrative Order (Securities Act of 1933 Release No. 11311)","n_participants":null,"pmid":null,"source_url":"https://www.sec.gov/newsroom/press-releases/2024-151","study_design":null,"title":"SEC Charges Cassava Sciences and Former Top Executives with Securities Fraud Related to Alzheimer's Drug Clinical Trial","title_match":true,"year":2024},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/clinical-effectiveness-of-dreams-start-dementia-related-manual-for-39366393","doi":"10.1016/j.lanhl.2024.08.004","journal":"The Lancet Healthy Longevity","n_participants":377,"pmid":"39366393","source_url":"https://doi.org/10.1016/j.lanhl.2024.08.004","study_design":"RCT","title":"Clinical effectiveness of DREAMS START (Dementia Related Manual for Sleep; Strategies for Relatives) versus usual care for people with dementia and their carers: a single-masked, phase 3, parallel-arm, superiority randomised controlled trial","title_match":true,"year":2024},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/palliative-care-program-for-community-dwelling-individuals-with-39878993","doi":"10.1001/jama.2024.25845","journal":"JAMA","n_participants":201,"pmid":"39878993","source_url":"https://pubmed.ncbi.nlm.nih.gov/39878993/","study_design":"RCT","title":"Palliative Care Program for Community-Dwelling Individuals With Dementia and Caregivers: The IN-PEACE Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/health-system-community-based-or-usual-dementia-care-for-persons-with-39878968","doi":"10.1001/jama.2024.25056","journal":"JAMA","n_participants":2176,"pmid":"39878968","source_url":"https://pubmed.ncbi.nlm.nih.gov/39878968/","study_design":"RCT","title":"Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers: The D-CARE Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/multicomponent-intervention-for-distressed-informal-caregivers-of-40094667","doi":"10.1001/jamanetworkopen.2025.0069","journal":"JAMA Network Open","n_participants":250,"pmid":"40094667","source_url":"https://pubmed.ncbi.nlm.nih.gov/40094667/","study_design":"RCT","title":"Multicomponent Intervention for Distressed Informal Caregivers of People With Dementia: A Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/a-randomized-trial-of-two-online-platforms-for-dementia-family-41085219","doi":"10.1002/alz.70690","journal":"Alzheimer's & Dementia","n_participants":240,"pmid":"41085219","source_url":"https://pubmed.ncbi.nlm.nih.gov/41085219/","study_design":"RCT","title":"A randomized trial of two online platforms for dementia family caregivers: GamePlan4Care and Resources4Care","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/benefits-and-harms-of-dementia-screening-for-family-members-of-older-42008257","doi":"10.1001/jamainternmed.2026.0844","journal":"JAMA Internal Medicine","n_participants":1808,"pmid":"42008257","source_url":"https://pubmed.ncbi.nlm.nih.gov/42008257/","study_design":"RCT","title":"Benefits and Harms of Dementia Screening for Family Members of Older Adults: A Randomized Clinical Trial","title_match":true,"year":2026},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/clinical-effectiveness-of-music-interventions-for-dementia-and-41380710","doi":"10.1016/j.lanhl.2025.100783","journal":"The Lancet Healthy Longevity","n_participants":1021,"pmid":"41380710","source_url":"https://pubmed.ncbi.nlm.nih.gov/41380710/","study_design":"RCT","title":"Clinical effectiveness of music interventions for dementia and depression in older people (MIDDEL): a multinational, cluster-randomised controlled trial","title_match":true,"year":2025},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/digital-reminiscence-for-predeath-grief-among-family-caregivers-of-42018322","doi":"10.1001/jamanetworkopen.2026.8278","journal":"JAMA Network Open","n_participants":68,"pmid":"42018322","source_url":"https://pubmed.ncbi.nlm.nih.gov/42018322/","study_design":"RCT","title":"Digital Reminiscence for Predeath Grief Among Family Caregivers of Patients With Dementia: A Pilot Randomized Clinical Trial","title_match":true,"year":2026},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/escitalopram-for-agitation-in-alzheimer-s-dementia-a-randomized-40133524","doi":"10.1038/s41591-025-03569-y","journal":"Nature Medicine","n_participants":173,"pmid":"40133524","source_url":"https://pubmed.ncbi.nlm.nih.gov/40133524/","study_design":"phase-3-trial","title":"Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial","title_match":true,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/brexpiprazole-treatment-for-agitation-in-alzheimer-s-dementia-a-39369280","doi":"10.1002/alz.14282","journal":"Alzheimer's & Dementia","n_participants":null,"pmid":"39369280","source_url":"https://pubmed.ncbi.nlm.nih.gov/39369280/","study_design":"phase-3-trial","title":"Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study","title_match":false,"year":2024},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-with-donanemab-in-early-40063015","doi":"10.1001/jamaneurol.2025.0065","journal":"JAMA Neurology","n_participants":3030,"pmid":"40063015","source_url":"https://pubmed.ncbi.nlm.nih.gov/40063015/","study_design":"phase-3-trial","title":"Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials","title_match":true,"year":2025},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/modified-titration-of-donanemab-reduces-aria-risk-and-maintains-40172303","doi":"10.1002/alz.70062","journal":"Alzheimer's & Dementia","n_participants":843,"pmid":"40172303","source_url":"https://pubmed.ncbi.nlm.nih.gov/40172303/","study_design":"phase-3-trial","title":"Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction","title_match":false,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/long-term-safety-and-efficacy-of-lecanemab-in-early-alzheimer-s-41355080","doi":"10.1002/alz.70905","journal":"Alzheimer's & Dementia","n_participants":null,"pmid":"41355080","source_url":"https://pubmed.ncbi.nlm.nih.gov/41355080/","study_design":"phase-3-trial","title":"Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the Clarity AD open-label extension study","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/sativex-nabiximols-for-the-treatment-of-agitation-aggression-in-40479610","doi":"10.1093/ageing/afaf149","journal":"Age and Ageing","n_participants":29,"pmid":"40479610","source_url":"https://pubmed.ncbi.nlm.nih.gov/40479610/","study_design":"RCT","title":"Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer's dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial","title_match":true,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-the-safety-and-efficacy-of-41350162","doi":"10.1016/j.jagp.2025.10.011","journal":"The American Journal of Geriatric Psychiatry","n_participants":75,"pmid":"41350162","source_url":"https://pubmed.ncbi.nlm.nih.gov/41350162/","study_design":"phase-2-trial","title":"A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease","title_match":true,"year":2025},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/liraglutide-in-mild-to-moderate-alzheimer-s-disease-a-phase-2b-41326666","doi":"10.1038/s41591-025-04106-7","journal":"Nature Medicine","n_participants":204,"pmid":"41326666","source_url":"https://pubmed.ncbi.nlm.nih.gov/41326666/","study_design":"phase-2-trial","title":"Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial","title_match":true,"year":2025},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/intranasal-oxytocin-for-apathy-in-people-with-frontotemporal-dementia-39862881","doi":"10.1016/S1474-4422(24)00456-3","journal":"The Lancet Neurology","n_participants":94,"pmid":"39862881","source_url":"https://pubmed.ncbi.nlm.nih.gov/39862881/","study_design":"phase-2-trial","title":"Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial","title_match":true,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-pimavanserin-in-patients-with-lewy-body-41286676","doi":"10.1186/s12883-025-04496-8","journal":"BMC Neurology","n_participants":76,"pmid":"41286676","source_url":"https://pubmed.ncbi.nlm.nih.gov/41286676/","study_design":"phase-3-trial","title":"Safety and efficacy of pimavanserin in patients with Lewy body dementia experiencing dementia-related psychosis in the HARMONY study","title_match":false,"year":2025},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/effects-of-exercise-on-cognition-and-alzheimer-s-biomarkers-in-a-40271888","doi":"10.1002/alz.14586","journal":"Alzheimer's & Dementia","n_participants":296,"pmid":"40271888","source_url":"https://pubmed.ncbi.nlm.nih.gov/40271888/","study_design":"phase-3-trial","title":"Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study","title_match":true,"year":2025},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/multidomain-lifestyle-intervention-for-the-prevention-of-cognitive-42442374","doi":"10.1016/S0140-6736(26)01278-X","journal":"The Lancet","n_participants":1065,"pmid":"42442374","source_url":"https://pubmed.ncbi.nlm.nih.gov/42442374/","study_design":"RCT","title":"Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial","title_match":true,"year":2026},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/remote-lower-intensity-multidomain-lifestyle-intervention-for-41130254","doi":"10.1016/j.lanhl.2025.100777","journal":"The Lancet Healthy Longevity","n_participants":746,"pmid":"41130254","source_url":"https://pubmed.ncbi.nlm.nih.gov/41130254/","study_design":"RCT","title":"Remote, lower-intensity, multidomain lifestyle intervention for subjective cognitive decline or mild cognitive impairment (APPLE-Tree): a multicentre, single-masked, randomised controlled trial","title_match":true,"year":2025},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/digital-detection-of-dementia-in-primary-care-a-randomized-clinical-41212562","doi":"10.1001/jamanetworkopen.2025.42222","journal":"JAMA Network Open","n_participants":5325,"pmid":"41212562","source_url":"https://pubmed.ncbi.nlm.nih.gov/41212562/","study_design":"RCT","title":"Digital Detection of Dementia in Primary Care: A Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/combined-mind-body-physical-exercise-cognitive-training-and-nurse-led-40294622","doi":"10.1016/j.lanhl.2025.100706","journal":"The Lancet Healthy Longevity","n_participants":456,"pmid":"40294622","source_url":"https://pubmed.ncbi.nlm.nih.gov/40294622/","study_design":"RCT","title":"Combined mind-body physical exercise, cognitive training, and nurse-led risk factor modification to enhance cognition among older adults with mild cognitive impairment in primary care: a three-arm randomised controlled trial","title_match":true,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/clinical-meaningfulness-of-donanemab-in-early-symptomatic-alzheimer-42128444","doi":"10.1212/CPJ.0000000000200621","journal":"Neurology: Clinical Practice","n_participants":null,"pmid":"42128444","source_url":"https://pubmed.ncbi.nlm.nih.gov/42128444/","study_design":"phase-3-trial","title":"Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial","title_match":true,"year":2026},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/clinical-imaging-and-blood-biomarker-outcomes-in-a-phase-3-clinical-41570392","doi":"10.1016/j.tjpad.2026.100480","journal":"The Journal of Prevention of Alzheimer's Disease","n_participants":598,"pmid":"41570392","source_url":"https://pubmed.ncbi.nlm.nih.gov/41570392/","study_design":"phase-3-trial","title":"Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease","title_match":true,"year":2026},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-for-detecting-amyloid-clearance-after-donanemab-in-42565262","doi":"10.1002/alz.71740","journal":"Alzheimer's & Dementia","n_participants":830,"pmid":"42565262","source_url":"https://pubmed.ncbi.nlm.nih.gov/42565262/","study_design":"phase-3-trial","title":"Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/statin-initiation-and-risk-of-incident-alzheimer-disease-and-38447103","doi":"10.1212/WNL.0000000000209168","journal":"Neurology","n_participants":4807,"pmid":"38447103","source_url":"https://pubmed.ncbi.nlm.nih.gov/38447103/","study_design":"cohort","title":"Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults","title_match":false,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/effectiveness-of-advance-care-planning-for-end-of-life-outcomes-in-41198038","doi":"10.1016/j.jamda.2025.105974","journal":"Journal of the American Medical Directors Association","n_participants":null,"pmid":"41198038","source_url":"https://pubmed.ncbi.nlm.nih.gov/41198038/","study_design":"meta-analysis","title":"Effectiveness of Advance Care Planning for End-of-Life Outcomes in Nursing Home Residents With Dementia: A Systematic Review and Meta-Analysis","title_match":false,"year":2025},{"alzhub_score":87,"alzhub_url":"https://alzhub.org/study/trial-of-the-mind-diet-for-prevention-of-cognitive-decline-in-older-37466280","doi":"10.1056/NEJMoa2302368","journal":"New England Journal of Medicine","n_participants":604,"pmid":"37466280","source_url":"https://pubmed.ncbi.nlm.nih.gov/37466280/","study_design":"RCT","title":"Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons","title_match":false,"year":2023},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-and-age-related-cognitive-decline-a-randomized-25961184","doi":"10.1001/jamainternmed.2015.1668","journal":"JAMA Internal Medicine","n_participants":447,"pmid":"25961184","source_url":"https://pubmed.ncbi.nlm.nih.gov/25961184/","study_design":"RCT","title":"Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial","title_match":true,"year":2015},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/meta-analysis-resistance-training-improves-cognition-in-mild-32599643","doi":"10.1055/a-1186-1272","journal":"International Journal of Sports Medicine","n_participants":null,"pmid":"32599643","source_url":"https://pubmed.ncbi.nlm.nih.gov/32599643/","study_design":"meta-analysis","title":"Meta-analysis: Resistance Training Improves Cognition in Mild Cognitive Impairment","title_match":false,"year":2020},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effect-of-a-24-week-resistance-exercise-intervention-on-cognitive-41562376","doi":"10.1002/alz.71019","journal":"Alzheimer's & Dementia","n_participants":90,"pmid":"41562376","source_url":"https://pubmed.ncbi.nlm.nih.gov/41562376/","study_design":"RCT","title":"Effect of a 24-week resistance exercise intervention on cognitive function in cognitively normal older adults: The AGUEDA randomized controlled trial","title_match":true,"year":2026},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/resistance-training-and-subcortical-vascular-cognitive-impairment-a-41795685","doi":"10.1002/alz.71245","journal":"Alzheimer's & Dementia","n_participants":91,"pmid":"41795685","source_url":"https://pubmed.ncbi.nlm.nih.gov/41795685/","study_design":"RCT","title":"Resistance training and subcortical vascular cognitive impairment: A 12-month randomized trial","title_match":false,"year":2026},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/dementia-and-physical-activity-dapa-trial-of-moderate-to-high-29769247","doi":"10.1136/bmj.k1675","journal":"BMJ","n_participants":494,"pmid":"29769247","source_url":"https://pubmed.ncbi.nlm.nih.gov/29769247/","study_design":"RCT","title":"Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial","title_match":true,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/effective-dosage-and-mode-of-exercise-for-enhancing-cognitive-38824515","doi":"10.1186/s12877-024-05060-8","journal":"BMC Geriatrics","n_participants":2242,"pmid":"38824515","source_url":"https://pubmed.ncbi.nlm.nih.gov/38824515/","study_design":"meta-analysis","title":"Effective dosage and mode of exercise for enhancing cognitive function in Alzheimer's disease and dementia: a systematic review and Bayesian Model-Based Network Meta-analysis of RCTs","title_match":false,"year":2024},{"alzhub_score":85,"alzhub_url":"https://alzhub.org/study/association-of-blood-pressure-lowering-with-incident-dementia-or-32427305","doi":"10.1001/jama.2020.4249","journal":"JAMA","n_participants":96158,"pmid":"32427305","source_url":"https://pubmed.ncbi.nlm.nih.gov/32427305/","study_design":"meta-analysis","title":"Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis","title_match":false,"year":2020},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/blood-pressure-lowering-and-prevention-of-dementia-an-individual-36282295","doi":"10.1093/eurheartj/ehac584","journal":"European Heart Journal","n_participants":28008,"pmid":"36282295","source_url":"https://pubmed.ncbi.nlm.nih.gov/36282295/","study_design":"meta-analysis","title":"Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis","title_match":false,"year":2022},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/blood-pressure-antihypertensive-use-and-late-life-alzheimer-and-non-39141884","doi":"10.1212/WNL.0000000000209715","journal":"Neurology","n_participants":31250,"pmid":"39141884","source_url":"https://pubmed.ncbi.nlm.nih.gov/39141884/","study_design":"meta-analysis","title":"Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk: An Individual Participant Data Meta-Analysis","title_match":false,"year":2024},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/anti-diabetic-agents-and-the-risks-of-dementia-in-patients-with-type-39716328","doi":"10.1186/s13195-024-01645-y","journal":"Alzheimer's Research & Therapy","n_participants":3462926,"pmid":"39716328","source_url":"https://pubmed.ncbi.nlm.nih.gov/39716328/","study_design":"meta-analysis","title":"Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials","title_match":true,"year":2024},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/clinically-important-benefits-and-harms-of-monoclonal-antibodies-38253509","doi":"10.1370/afm.3050","journal":"Annals of Family Medicine","n_participants":23202,"pmid":"38253509","source_url":"https://pubmed.ncbi.nlm.nih.gov/38253509/","study_design":"meta-analysis","title":"Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis","title_match":false,"year":2024},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/valacyclovir-treatment-of-early-symptomatic-alzheimer-disease-the-41405855","doi":"10.1001/jama.2025.21738","journal":"JAMA","n_participants":120,"pmid":"41405855","source_url":"https://pubmed.ncbi.nlm.nih.gov/41405855/","study_design":"phase-2-trial","title":"Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial","title_match":true,"year":2026},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/ceperognastat-in-early-symptomatic-alzheimer-disease-a-randomized-42441396","doi":"10.1001/jama.2026.12768","journal":"JAMA","n_participants":327,"pmid":"42441396","source_url":"https://pubmed.ncbi.nlm.nih.gov/42441396/","study_design":"phase-2-trial","title":"Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2026},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/cns-target-engagement-of-high-dose-dha-supplementation-in-older-42315445","doi":"10.1016/j.ebiom.2026.106316","journal":"EBioMedicine","n_participants":365,"pmid":"42315445","source_url":"https://pubmed.ncbi.nlm.nih.gov/42315445/","study_design":"phase-2-trial","title":"CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial","title_match":true,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/a-randomised-double-blind-placebo-controlled-crossover-trial-on-42613673","doi":"10.1093/ageing/afag239","journal":"Age and ageing","n_participants":25,"pmid":"42613673","source_url":"https://pubmed.ncbi.nlm.nih.gov/42613673/","study_design":"RCT","title":"A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results","title_match":true,"year":2026},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/predicting-onset-of-symptomatic-alzheimer-s-disease-with-plasma-p-41714746","doi":"10.1038/s41591-026-04206-y","journal":"Nature medicine","n_participants":603,"pmid":"41714746","source_url":"https://pubmed.ncbi.nlm.nih.gov/41714746/","study_design":"cohort","title":"Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocks","title_match":false,"year":2026},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/impact-of-different-antihypertensive-drug-classes-on-incident-41962914","doi":"10.1016/j.jamda.2026.106185","journal":"Journal of the American Medical Directors Association","n_participants":16823,"pmid":"41962914","source_url":"https://pubmed.ncbi.nlm.nih.gov/41962914/","study_design":"meta-analysis","title":"Impact of Different Antihypertensive Drug Classes on Incident Dementia in Older Adults: A Systematic Review and Meta-Analysis","title_match":false,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/effects-of-digital-psychological-interventions-for-family-caregivers-41505195","doi":"10.1093/ageing/afaf373","journal":"Age and ageing","n_participants":750,"pmid":"41505195","source_url":"https://pubmed.ncbi.nlm.nih.gov/41505195/","study_design":"meta-analysis","title":"Effects of digital psychological interventions for family caregivers of people with dementia: a systematic review and meta-analysis","title_match":false,"year":2026},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/evaluating-the-effects-of-the-world-health-organisation-s-online-41719424","doi":"10.1093/ageing/afag030","journal":"Age and ageing","n_participants":93,"pmid":"41719424","source_url":"https://pubmed.ncbi.nlm.nih.gov/41719424/","study_design":"RCT","title":"Evaluating the effects of the World Health Organisation's online intervention 'iSupport lite' to reduce burden in multilingual dementia carers: results from the Australian Draw-Care randomised clinical trial","title_match":true,"year":2026},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/effects-of-peer-support-interventions-for-family-caregivers-of-41690252","doi":"10.1016/j.archger.2026.106168","journal":"Archives of gerontology and geriatrics","n_participants":1680,"pmid":"41690252","source_url":"https://pubmed.ncbi.nlm.nih.gov/41690252/","study_design":"meta-analysis","title":"Effects of peer support interventions for family caregivers of persons with dementia: A systematic review and meta-analysis","title_match":false,"year":2026},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/cost-utility-and-cost-effectiveness-of-the-apple-tree-programme-42328805","doi":"10.1093/ageing/afag176","journal":"Age and ageing","n_participants":746,"pmid":"42328805","source_url":"https://pubmed.ncbi.nlm.nih.gov/42328805/","study_design":"RCT","title":"Cost utility and cost-effectiveness of the APPLE-Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce: economic evaluation embedded within a randomised controlled trial","title_match":true,"year":2026},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/alzheimer-and-cardiovascular-genetic-scores-and-cognition-the-finger-40747850","doi":"10.1093/brain/awaf277","journal":"Brain : a journal of neurology","n_participants":1177,"pmid":"40747850","source_url":"https://pubmed.ncbi.nlm.nih.gov/40747850/","study_design":"RCT","title":"Alzheimer and cardiovascular genetic scores and cognition: the FINGER randomized controlled trial","title_match":true,"year":2026},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/polygenic-score-integrating-neurodegenerative-and-vascular-risk-40042447","doi":"10.1002/alz.70014","journal":"Alzheimer's & Dementia","n_participants":241935,"pmid":"40042447","source_url":"https://pubmed.ncbi.nlm.nih.gov/40042447/","study_design":"cohort","title":"Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification","title_match":false,"year":2025},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/tau-targeting-antisense-oligonucleotide-maptrx-in-mild-alzheimer-s-37095250","doi":"10.1038/s41591-023-02326-3","journal":"Nature Medicine","n_participants":46,"pmid":"37095250","source_url":"https://pubmed.ncbi.nlm.nih.gov/37095250/","study_design":"phase-1-trial","title":"Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial","title_match":true,"year":2023},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau-217-and-a42-40-to-predict-early-brain-a-39068669","doi":"10.1001/jamaneurol.2024.2619","journal":"JAMA Neurology","n_participants":983,"pmid":"39068669","source_url":"https://pubmed.ncbi.nlm.nih.gov/39068669/","study_design":"cohort","title":"Plasma Phosphorylated Tau 217 and A\u03b242/40 to Predict Early Brain A\u03b2 Accumulation in People Without Cognitive Impairment","title_match":false,"year":2024},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-and-tau-pet-predict-future-cognitive-decline-among-40155777","doi":"10.1038/s43587-025-00835-z","journal":"Nature Aging","n_participants":1474,"pmid":"40155777","source_url":"https://pubmed.ncbi.nlm.nih.gov/40155777/","study_design":"cohort","title":"Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials","title_match":true,"year":2025},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/clinical-outcomes-and-cost-effectiveness-of-collaborative-dementia-38967926","doi":"10.1001/jamanetworkopen.2024.19282","journal":"JAMA Network Open","n_participants":428,"pmid":"38967926","source_url":"https://pubmed.ncbi.nlm.nih.gov/38967926/","study_design":"RCT","title":"Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care: A Secondary Analysis of a Cluster Randomized Clinical Trial","title_match":true,"year":2024},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/cost-effectiveness-of-a-digitally-supported-care-management-program-39922302","doi":"10.1016/j.jval.2025.01.011","journal":"Value in Health","n_participants":192,"pmid":"39922302","source_url":"https://pubmed.ncbi.nlm.nih.gov/39922302/","study_design":"RCT","title":"Cost-Effectiveness of a Digitally Supported Care Management Program for Caregivers of People With Dementia","title_match":false,"year":2025},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/cost-utility-of-a-new-psychosocial-goal-setting-and-manualised-39978389","doi":"10.1016/j.lanhl.2024.100676","journal":"The Lancet Healthy Longevity","n_participants":302,"pmid":"39978389","source_url":"https://pubmed.ncbi.nlm.nih.gov/39978389/","study_design":"RCT","title":"Cost-utility of a new psychosocial goal-setting and manualised support intervention for independence in dementia (NIDUS-Family) versus goal setting and routine care: an economic evaluation embedded within a randomised controlled trial","title_match":true,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/the-social-value-of-lecanemab-for-patients-with-early-alzheimer-s-42108615","doi":"10.1177/13872877261447312","journal":"Journal of Alzheimer's Disease","n_participants":null,"pmid":"42108615","source_url":"https://pubmed.ncbi.nlm.nih.gov/42108615/","study_design":"modelling","title":"The social value of lecanemab for patients with early Alzheimer's disease in Japan","title_match":false,"year":2026},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/microglial-mechanisms-drive-amyloid-clearance-in-immunized-patients-40050704","doi":"10.1038/s41591-025-03574-1","journal":"Nature Medicine","n_participants":null,"pmid":"40050704","source_url":"https://pubmed.ncbi.nlm.nih.gov/40050704/","study_design":"case-control","title":"Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/the-trem2-agonistic-antibody-al002-in-early-alzheimer-s-disease-a-41787076","doi":"10.1038/s41591-026-04273-1","journal":"Nature Medicine","n_participants":381,"pmid":"41787076","source_url":"https://pubmed.ncbi.nlm.nih.gov/41787076/","study_design":"phase-2-trial","title":"The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial","title_match":true,"year":2026},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/astrocyte-reactivity-influences-amyloid-effects-on-tau-pathology-in-37248300","doi":"10.1038/s41591-023-02380-x","journal":"Nature Medicine","n_participants":1016,"pmid":"37248300","source_url":"https://pubmed.ncbi.nlm.nih.gov/37248300/","study_design":"cohort","title":"Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/apoe-stratified-genome-wide-association-analyses-provide-insights-42736378","doi":"10.1038/s41588-026-02713-9","journal":"Nature genetics","n_participants":null,"pmid":"42736378","source_url":"https://pubmed.ncbi.nlm.nih.gov/42736378/","study_design":"case-control","title":"APOE-stratified genome-wide association analyses provide insights into the genetic etiology of Alzheimers's disease","title_match":false,"year":2026},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/measurement-of-longitudinal-amyloid-change-with-18f-florbetapir-pet-25745095","doi":"10.2967/jnumed.114.148981","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":14,"pmid":"25745095","source_url":"https://pubmed.ncbi.nlm.nih.gov/25745095/","study_design":"longitudinal study","title":"Measurement of longitudinal \u03b2-amyloid change with 18F-florbetapir PET and standardized uptake value ratios","title_match":false,"year":2015},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/prediction-of-longitudinal-cognitive-decline-in-preclinical-alzheimer-36745413","doi":"10.1001/jamaneurol.2022.5272","journal":"JAMA neurology","n_participants":564,"pmid":"36745413","source_url":"https://pubmed.ncbi.nlm.nih.gov/36745413/","study_design":"cohort study","title":"Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers","title_match":false,"year":2023},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/accuracy-of-tau-positron-emission-tomography-as-a-prognostic-marker-34180956","doi":"10.1001/jamaneurol.2021.1858","journal":"JAMA neurology","n_participants":1135,"pmid":"34180956","source_url":"https://pubmed.ncbi.nlm.nih.gov/34180956/","study_design":"cohort study","title":"Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging","title_match":false,"year":2021},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/prevalence-estimates-of-amyloid-abnormality-across-the-alzheimer-35099509","doi":"10.1001/jamaneurol.2021.5216","journal":"JAMA neurology","n_participants":97,"pmid":"35099509","source_url":"https://pubmed.ncbi.nlm.nih.gov/35099509/","study_design":"cross-sectional","title":"Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum","title_match":false,"year":2022},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/reasons-for-failed-trials-of-disease-modifying-treatments-for-31835422","doi":"10.3390/biomedicines7040097","journal":"Biomedicines","n_participants":null,"pmid":"31835422","source_url":"https://pubmed.ncbi.nlm.nih.gov/31835422/","study_design":null,"title":"Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research","title_match":false,"year":2019},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/association-of-donanemab-treatment-with-exploratory-plasma-biomarkers-36251300","doi":"10.1001/jamaneurol.2022.3392","journal":"JAMA neurology","n_participants":1955,"pmid":"36251300","source_url":"https://pubmed.ncbi.nlm.nih.gov/36251300/","study_design":null,"title":"Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial","title_match":true,"year":2022},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-neurofilament-concentration-reflects-disease-24242746","doi":"10.1002/ana.24052","journal":"Annals of neurology","n_participants":null,"pmid":"24242746","source_url":"https://pubmed.ncbi.nlm.nih.gov/24242746/","study_design":"longitudinal study","title":"Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration","title_match":false,"year":2014},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/the-role-of-amyloid-pet-in-imaging-neurodegenerative-disorders-a-35649652","doi":"10.2967/jnumed.121.263195","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"35649652","source_url":"https://pubmed.ncbi.nlm.nih.gov/35649652/","study_design":null,"title":"The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review","title_match":false,"year":2022},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/validation-of-plasma-amyloid-42-40-for-detecting-alzheimer-disease-34906975","doi":"10.1212/wnl.0000000000013211","journal":"Neurology","n_participants":465,"pmid":"34906975","source_url":"https://pubmed.ncbi.nlm.nih.gov/34906975/","study_design":null,"title":"Validation of Plasma Amyloid-\u03b2 42/40 for Detecting Alzheimer Disease Amyloid Plaques","title_match":false,"year":2022},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/plasma-and-csf-biomarkers-for-the-diagnosis-of-alzheimer-s-disease-in-30172624","doi":"10.1016/s1474-4422(18)30285-0","journal":"The Lancet. Neurology","n_participants":282,"pmid":"30172624","source_url":"https://pubmed.ncbi.nlm.nih.gov/30172624/","study_design":"cross-sectional","title":"Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study","title_match":false,"year":2018},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/an-update-on-blood-based-biomarkers-for-non-alzheimer-32322100","doi":"10.1038/s41582-020-0348-0","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"32322100","source_url":"https://pubmed.ncbi.nlm.nih.gov/32322100/","study_design":null,"title":"An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders","title_match":false,"year":2020},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/defining-the-lowest-threshold-for-amyloid-pet-to-predict-future-33199430","doi":"10.1212/wnl.0000000000011214","journal":"Neurology","n_participants":342,"pmid":"33199430","source_url":"https://pubmed.ncbi.nlm.nih.gov/33199430/","study_design":null,"title":"Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation","title_match":false,"year":2021},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/amyloid-and-tau-prediction-of-cognitive-and-functional-decline-in-39044488","doi":"10.14283/jpad.2024.122","journal":"The journal of prevention of Alzheimer's disease","n_participants":583,"pmid":"39044488","source_url":"https://pubmed.ncbi.nlm.nih.gov/39044488/","study_design":"longitudinal study","title":"Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies","title_match":false,"year":2024},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/serum-neurofilament-light-chain-in-behavioral-variant-frontotemporal-30209235","doi":"10.1212/wnl.0000000000006318","journal":"Neurology","n_participants":74,"pmid":"30209235","source_url":"https://pubmed.ncbi.nlm.nih.gov/30209235/","study_design":null,"title":"Serum neurofilament light chain in behavioral variant frontotemporal dementia","title_match":false,"year":2018},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/amyloid-pet-screening-for-enrichment-of-early-stage-alzheimer-disease-26885819","doi":"10.1097/wad.0000000000000144","journal":"Alzheimer disease and associated disorders","n_participants":278,"pmid":"26885819","source_url":"https://pubmed.ncbi.nlm.nih.gov/26885819/","study_design":null,"title":"Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical Trial","title_match":true,"year":2016},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/finding-treatment-effects-in-alzheimer-trials-in-the-face-of-disease-34550903","doi":"10.1212/wnl.0000000000012022","journal":"Neurology","n_participants":302,"pmid":"34550903","source_url":"https://pubmed.ncbi.nlm.nih.gov/34550903/","study_design":null,"title":"Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity","title_match":false,"year":2021},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/amyloid-pet-in-clinical-practice-its-place-in-the-multidimensional-24179802","doi":"10.1016/j.nicl.2013.03.014","journal":"NeuroImage. Clinical","n_participants":null,"pmid":"24179802","source_url":"https://pubmed.ncbi.nlm.nih.gov/24179802/","study_design":"cross-sectional","title":"Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/clinical-use-and-utility-of-amyloid-imaging-28818990","doi":"10.2967/jnumed.116.185017","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"28818990","source_url":"https://pubmed.ncbi.nlm.nih.gov/28818990/","study_design":null,"title":"Clinical Use and Utility of Amyloid Imaging","title_match":false,"year":2017},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/association-of-apolipoprotein-e-4-allele-with-clinical-and-multimodal-34228042","doi":"10.1001/jamaneurol.2021.1893","journal":"JAMA neurology","n_participants":null,"pmid":"34228042","source_url":"https://pubmed.ncbi.nlm.nih.gov/34228042/","study_design":"cohort study","title":"Association of Apolipoprotein E \u025b4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome","title_match":false,"year":2021},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/detection-of-brain-tau-pathology-in-down-syndrome-using-plasma-35789365","doi":"10.1001/jamaneurol.2022.1740","journal":"JAMA neurology","n_participants":300,"pmid":"35789365","source_url":"https://pubmed.ncbi.nlm.nih.gov/35789365/","study_design":"cross-sectional","title":"Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers","title_match":false,"year":2022},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/large-multi-ethnic-genetic-analyses-of-amyloid-imaging-identify-new-37101235","doi":"10.1186/s40478-023-01563-4","journal":"Acta neuropathologica communications","n_participants":13409,"pmid":"37101235","source_url":"https://pubmed.ncbi.nlm.nih.gov/37101235/","study_design":null,"title":"Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease","title_match":false,"year":2023},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/autosomal-dominant-and-sporadic-late-onset-alzheimer-s-disease-share-35580594","doi":"10.1093/brain/awac181","journal":"Brain : a journal of neurology","n_participants":559,"pmid":"35580594","source_url":"https://pubmed.ncbi.nlm.nih.gov/35580594/","study_design":null,"title":"Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology","title_match":false,"year":2022},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/confidentiality-in-preclinical-alzheimer-disease-studies-when-24477112","doi":"10.1212/wnl.0000000000000153","journal":"Neurology","n_participants":null,"pmid":"24477112","source_url":"https://pubmed.ncbi.nlm.nih.gov/24477112/","study_design":null,"title":"Confidentiality in preclinical Alzheimer disease studies: when research and medical records meet","title_match":false,"year":2014},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-neuropathology-in-a-patient-previously-treated-with-35581440","doi":"10.1007/s00401-022-02433-4","journal":"Acta neuropathologica","n_participants":null,"pmid":"35581440","source_url":"https://pubmed.ncbi.nlm.nih.gov/35581440/","study_design":"case report","title":"Alzheimer disease neuropathology in a patient previously treated with aducanumab","title_match":false,"year":2022},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/impact-of-reference-and-target-region-selection-on-amyloid-pet-suv-29777003","doi":"10.2967/jnumed.118.209130","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"29777003","source_url":"https://pubmed.ncbi.nlm.nih.gov/29777003/","study_design":null,"title":"Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab","title_match":true,"year":2019},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/predictive-value-of-sup-18-sup-f-florbetapir-and-sup-18-sup-f-fdg-pet-31628215","doi":"10.2967/jnumed.119.230797","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":159,"pmid":"31628215","source_url":"https://pubmed.ncbi.nlm.nih.gov/31628215/","study_design":null,"title":"Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia","title_match":false,"year":2020},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/antibody-based-in-vivo-pet-imaging-detects-amyloid-reduction-in-29853653","doi":"10.2967/jnumed.118.213140","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"29853653","source_url":"https://pubmed.ncbi.nlm.nih.gov/29853653/","study_design":"clinical trial","title":"Antibody-Based In Vivo PET Imaging Detects Amyloid-\u03b2 Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition","title_match":false,"year":2018},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/a-survey-of-knowledge-and-views-concerning-genetic-and-amyloid-pet-27019867","doi":"10.1016/j.trci.2015.12.001","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":207,"pmid":"27019867","source_url":"https://pubmed.ncbi.nlm.nih.gov/27019867/","study_design":null,"title":"A Survey of Knowledge and Views Concerning Genetic and Amyloid PET Status Disclosure","title_match":false,"year":2016},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/comparative-neurofilament-light-chain-trajectories-in-csf-and-plasma-39557867","doi":"10.1038/s41467-024-52937-8","journal":"Nature communications","n_participants":567,"pmid":"39557867","source_url":"https://pubmed.ncbi.nlm.nih.gov/39557867/","study_design":"cross-sectional","title":"Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effectiveness-of-florbetapir-pet-imaging-in-changing-patient-28787712","doi":"10.1159/000478007","journal":"Dementia and geriatric cognitive disorders","n_participants":618,"pmid":"28787712","source_url":"https://pubmed.ncbi.nlm.nih.gov/28787712/","study_design":null,"title":"Effectiveness of Florbetapir PET Imaging in Changing Patient Management","title_match":false,"year":2017},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/clinical-effect-of-early-vs-late-amyloid-positron-emission-tomography-37155177","doi":"10.1001/jamaneurol.2023.0997","journal":"JAMA neurology","n_participants":844,"pmid":"37155177","source_url":"https://pubmed.ncbi.nlm.nih.gov/37155177/","study_design":null,"title":"Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/biomarker-pattern-of-aria-e-participants-in-phase-3-randomized-29429971","doi":"10.1212/wnl.0000000000005060","journal":"Neurology","n_participants":1512,"pmid":"29429971","source_url":"https://pubmed.ncbi.nlm.nih.gov/29429971/","study_design":"longitudinal study","title":"Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab","title_match":true,"year":2018},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/evaluation-of-plasma-phosphorylated-tau217-for-differentiation-37010841","doi":"10.1001/jamaneurol.2023.0488","journal":"JAMA neurology","n_participants":113,"pmid":"37010841","source_url":"https://pubmed.ncbi.nlm.nih.gov/37010841/","study_design":"cohort study","title":"Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/using-alzheimer-s-disease-blood-tests-to-accelerate-clinical-trial-35934777","doi":"10.1002/alz.12754","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"35934777","source_url":"https://pubmed.ncbi.nlm.nih.gov/35934777/","study_design":null,"title":"Using Alzheimer's disease blood tests to accelerate clinical trial enrollment","title_match":true,"year":2023},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/downstream-biomarker-effects-of-gantenerumab-or-solanezumab-in-38683602","doi":"10.1001/jamaneurol.2024.0991","journal":"JAMA neurology","n_participants":142,"pmid":"38683602","source_url":"https://pubmed.ncbi.nlm.nih.gov/38683602/","study_design":"longitudinal study","title":"Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial","title_match":true,"year":2024},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/assessment-of-efficacy-and-safety-of-zagotenemab-results-from-38386949","doi":"10.1212/wnl.0000000000208061","journal":"Neurology","n_participants":360,"pmid":"38386949","source_url":"https://pubmed.ncbi.nlm.nih.gov/38386949/","study_design":"clinical trial","title":"Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease","title_match":true,"year":2024},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-dynamics-disorders-relationship-to-alzheimer-31719134","doi":"10.1212/wnl.0000000000008616","journal":"Neurology","n_participants":684,"pmid":"31719134","source_url":"https://pubmed.ncbi.nlm.nih.gov/31719134/","study_design":null,"title":"Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition","title_match":false,"year":2019},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/amyloid-positron-emission-tomography-candidates-may-focus-more-on-30094328","doi":"10.1016/j.dadm.2018.05.003","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":59,"pmid":"30094328","source_url":"https://pubmed.ncbi.nlm.nih.gov/30094328/","study_design":"randomized controlled trial","title":"Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure","title_match":false,"year":2018},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/posttreatment-amyloid-levels-and-clinical-outcomes-following-41082199","doi":"10.1001/jamaneurol.2025.3869","journal":"JAMA neurology","n_participants":1582,"pmid":"41082199","source_url":"https://pubmed.ncbi.nlm.nih.gov/41082199/","study_design":"clinical trial","title":"Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/csf-synuclein-seed-amplification-assay-in-patients-with-atypical-39208367","doi":"10.1212/wnl.0000000000209818","journal":"Neurology","n_participants":50,"pmid":"39208367","source_url":"https://pubmed.ncbi.nlm.nih.gov/39208367/","study_design":"cross-sectional","title":"CSF \u03b1-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders","title_match":false,"year":2024},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/association-of-plasma-biomarkers-with-longitudinal-atrophy-and-40063856","doi":"10.1212/wnl.0000000000213438","journal":"Neurology","n_participants":1240,"pmid":"40063856","source_url":"https://pubmed.ncbi.nlm.nih.gov/40063856/","study_design":"cohort study","title":"Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/assessing-amyloid-pet-positivity-and-cognitive-function-in-down-38940611","doi":"10.1002/alz.14068","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38940611","source_url":"https://pubmed.ncbi.nlm.nih.gov/38940611/","study_design":"cross-sectional","title":"Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid","title_match":true,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/amyloid-pet-fdg-pet-or-mri-the-power-of-different-imaging-biomarkers-31672138","doi":"10.1186/s12883-019-1498-9","journal":"BMC neurology","n_participants":null,"pmid":"31672138","source_url":"https://pubmed.ncbi.nlm.nih.gov/31672138/","study_design":"longitudinal study","title":"Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/current-role-for-biomarkers-in-clinical-diagnosis-of-alzheimer-29134465","doi":"10.1007/s11940-017-0484-z","journal":"Current treatment options in neurology","n_participants":null,"pmid":"29134465","source_url":"https://pubmed.ncbi.nlm.nih.gov/29134465/","study_design":null,"title":"Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia","title_match":false,"year":2017},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/simultaneously-evaluating-the-effect-of-baseline-levels-and-30569014","doi":"10.1016/j.trci.2018.10.009","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":262,"pmid":"30569014","source_url":"https://pubmed.ncbi.nlm.nih.gov/30569014/","study_design":"longitudinal study","title":"Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/predicting-regional-pattern-of-longitudinal-amyloid-accumulation-by-27754901","doi":"10.2967/jnumed.116.176115","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":58,"pmid":"27754901","source_url":"https://pubmed.ncbi.nlm.nih.gov/27754901/","study_design":"longitudinal study","title":"Predicting Regional Pattern of Longitudinal \u03b2-Amyloid Accumulation by Baseline PET","title_match":false,"year":2017},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/aerobic-exercise-does-not-affect-serum-neurofilament-light-in-36761410","doi":"10.3389/fnins.2023.1108191","journal":"Frontiers in neuroscience","n_participants":136,"pmid":"36761410","source_url":"https://pubmed.ncbi.nlm.nih.gov/36761410/","study_design":null,"title":"Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/dimebon-alters-hippocampal-amyloid-pathology-in-3xtg-ad-mice-23071869","doi":null,"journal":"International journal of physiology, pathophysiology and pharmacology","n_participants":null,"pmid":"23071869","source_url":"https://pubmed.ncbi.nlm.nih.gov/23071869/","study_design":null,"title":"Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice","title_match":false,"year":2012},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/tnfr-1-and-gdf-15-are-associated-with-plasma-neurofilament-light-36508390","doi":"10.1093/gerona/glac244","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":116,"pmid":"36508390","source_url":"https://pubmed.ncbi.nlm.nih.gov/36508390/","study_design":"cross-sectional","title":"TNFR-1 and GDF-15 Are Associated With Plasma Neurofilament Light Chain and Progranulin Among Community-Dwelling Older Adults: A Secondary Analysis of the MAPT Study","title_match":false,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/molecular-imaging-of-alzheimer-disease-pathology-24503555","doi":"10.3174/ajnr.a3847","journal":"AJNR. American journal of neuroradiology","n_participants":null,"pmid":"24503555","source_url":"https://pubmed.ncbi.nlm.nih.gov/24503555/","study_design":"cohort study","title":"Molecular imaging of Alzheimer disease pathology","title_match":false,"year":2014},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/home-based-gamma-transcranial-alternating-current-stimulation-in-41359335","doi":"10.1001/jamanetworkopen.2025.46556","journal":"JAMA network open","n_participants":null,"pmid":"41359335","source_url":"https://pubmed.ncbi.nlm.nih.gov/41359335/","study_design":"open-label trial","title":"Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/deconstructing-pathological-tau-by-biological-process-in-early-stages-38552342","doi":"10.1016/j.ebiom.2024.105080","journal":"EBioMedicine","n_participants":null,"pmid":"38552342","source_url":"https://pubmed.ncbi.nlm.nih.gov/38552342/","study_design":"cross-sectional","title":"Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging","title_match":false,"year":2024},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/cognitive-impact-of-multidomain-intervention-and-omega-3-according-to-37872582","doi":"10.1186/s13195-023-01325-3","journal":"Alzheimer's research & therapy","n_participants":483,"pmid":"37872582","source_url":"https://pubmed.ncbi.nlm.nih.gov/37872582/","study_design":null,"title":"Cognitive impact of multidomain intervention and omega 3 according to blood A\u03b242/40 ratio: a subgroup analysis from the randomized MAPT trial","title_match":false,"year":2023},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/advanced-brain-imaging-for-the-diagnosis-of-alzheimer-disease-37639461","doi":"10.1097/wco.0000000000001198","journal":"Current opinion in neurology","n_participants":null,"pmid":"37639461","source_url":"https://pubmed.ncbi.nlm.nih.gov/37639461/","study_design":null,"title":"Advanced brain imaging for the diagnosis of Alzheimer disease","title_match":false,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/proteomic-clusters-underlie-heterogeneity-in-preclinical-alzheimer-s-36542469","doi":"10.1093/brain/awac484","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"36542469","source_url":"https://pubmed.ncbi.nlm.nih.gov/36542469/","study_design":"longitudinal study","title":"Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression","title_match":false,"year":2023},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/neuropsychological-assessment-and-cerebral-vascular-disease-the-new-23999023","doi":"10.1016/j.neurol.2013.07.009","journal":"Revue neurologique","n_participants":null,"pmid":"23999023","source_url":"https://pubmed.ncbi.nlm.nih.gov/23999023/","study_design":null,"title":"Neuropsychological assessment and cerebral vascular disease: the new standards","title_match":false,"year":2013},{"alzhub_score":85,"alzhub_url":"https://alzhub.org/study/two-phase-3-trials-of-bapineuzumab-in-mild-to-moderate-alzheimer-s-24450891","doi":"10.1056/nejmoa1304839","journal":"The New England journal of medicine","n_participants":1090,"pmid":"24450891","source_url":"https://pubmed.ncbi.nlm.nih.gov/24450891/","study_design":"clinical trial","title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","title_match":true,"year":2014},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/the-genetic-landscape-of-alzheimer-disease-clinical-implications-and-26312828","doi":"10.1038/gim.2015.117","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","n_participants":null,"pmid":"26312828","source_url":"https://pubmed.ncbi.nlm.nih.gov/26312828/","study_design":null,"title":"The genetic landscape of Alzheimer disease: clinical implications and perspectives","title_match":false,"year":2016},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-phase-2-multiple-ascending-dose-trial-of-bapineuzumab-in-mild-to-19923550","doi":"10.1212/wnl.0b013e3181c67808","journal":"Neurology","n_participants":234,"pmid":"19923550","source_url":"https://pubmed.ncbi.nlm.nih.gov/19923550/","study_design":"clinical trial","title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","title_match":true,"year":2009},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/comparing-predictors-of-conversion-and-decline-in-mild-cognitive-20592257","doi":"10.1212/wnl.0b013e3181e8e8b8","journal":"Neurology","n_participants":85,"pmid":"20592257","source_url":"https://pubmed.ncbi.nlm.nih.gov/20592257/","study_design":"longitudinal study","title":"Comparing predictors of conversion and decline in mild cognitive impairment","title_match":false,"year":2010},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/apolipoprotein-e4-allele-as-a-predictor-of-cholinergic-deficits-and-8618881","doi":"10.1073/pnas.92.26.12260","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":40,"pmid":"8618881","source_url":"https://pubmed.ncbi.nlm.nih.gov/8618881/","study_design":null,"title":"Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease","title_match":false,"year":1995},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/safety-and-tolerability-of-the-secretase-inhibitor-avagacestat-in-a-22892585","doi":"10.1001/archneurol.2012.2194","journal":"Archives of neurology","n_participants":209,"pmid":"22892585","source_url":"https://pubmed.ncbi.nlm.nih.gov/22892585/","study_design":"clinical trial","title":"Safety and tolerability of the \u03b3-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease","title_match":true,"year":2012},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/ginkgo-biloba-for-preventing-cognitive-decline-in-older-adults-a-20040554","doi":"10.1001/jama.2009.1913","journal":"JAMA","n_participants":1545,"pmid":"20040554","source_url":"https://pubmed.ncbi.nlm.nih.gov/20040554/","study_design":null,"title":"Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial","title_match":false,"year":2009},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/sex-apolipoprotein-e-epsilon-4-status-and-hippocampal-volume-in-mild-15956166","doi":"10.1001/archneur.62.6.953","journal":"Archives of neurology","n_participants":193,"pmid":"15956166","source_url":"https://pubmed.ncbi.nlm.nih.gov/15956166/","study_design":null,"title":"Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment","title_match":false,"year":2005},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/health-behavior-changes-after-genetic-risk-assessment-for-alzheimer-18317253","doi":"10.1097/wad.0b013e31815a9dcc","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"18317253","source_url":"https://pubmed.ncbi.nlm.nih.gov/18317253/","study_design":null,"title":"Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study","title_match":false,"year":2008},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/association-of-amyloid-reduction-after-donanemab-treatment-with-tau-36094645","doi":"10.1001/jamaneurol.2022.2793","journal":"JAMA neurology","n_participants":272,"pmid":"36094645","source_url":"https://pubmed.ncbi.nlm.nih.gov/36094645/","study_design":"clinical trial","title":"Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial","title_match":true,"year":2022},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/updated-safety-results-from-phase-3-lecanemab-study-in-early-38730496","doi":"10.1186/s13195-024-01441-8","journal":"Alzheimer's research & therapy","n_participants":1795,"pmid":"38730496","source_url":"https://pubmed.ncbi.nlm.nih.gov/38730496/","study_design":"open-label trial","title":"Updated safety results from phase 3 lecanemab study in early Alzheimer's disease","title_match":true,"year":2024},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/incidence-of-cerebral-microbleeds-in-preclinical-alzheimer-disease-24623839","doi":"10.1212/wnl.0000000000000285","journal":"Neurology","n_participants":null,"pmid":"24623839","source_url":"https://pubmed.ncbi.nlm.nih.gov/24623839/","study_design":"longitudinal study","title":"Incidence of cerebral microbleeds in preclinical Alzheimer disease","title_match":false,"year":2014},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-study-on-effects-of-ibuprofen-on-cognitive-19448381","doi":"10.1007/bf03325217","journal":"Aging clinical and experimental research","n_participants":27,"pmid":"19448381","source_url":"https://pubmed.ncbi.nlm.nih.gov/19448381/","study_design":null,"title":"A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease","title_match":true,"year":2009},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/volumetric-mri-vs-clinical-predictors-of-alzheimer-disease-in-mild-18195264","doi":"10.1212/01.wnl.0000287091.57376.65","journal":"Neurology","n_participants":129,"pmid":"18195264","source_url":"https://pubmed.ncbi.nlm.nih.gov/18195264/","study_design":null,"title":"Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment","title_match":false,"year":2008},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/association-of-docosahexaenoic-acid-supplementation-with-alzheimer-28114437","doi":"10.1001/jamaneurol.2016.4899","journal":"JAMA neurology","n_participants":null,"pmid":"28114437","source_url":"https://pubmed.ncbi.nlm.nih.gov/28114437/","study_design":null,"title":"Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E \u03b54 Carriers: A Review","title_match":false,"year":2017},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/amyloid-11c-pib-pet-imaging-results-from-2-randomized-bapineuzumab-26208959","doi":"10.1212/wnl.0000000000001877","journal":"Neurology","n_participants":115,"pmid":"26208959","source_url":"https://pubmed.ncbi.nlm.nih.gov/26208959/","study_design":"clinical trial","title":"Amyloid-\u03b2 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials","title_match":true,"year":2015},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/increased-brain-atrophy-rates-in-cognitively-normal-older-adults-with-21181717","doi":"10.1002/ana.22315","journal":"Annals of neurology","n_participants":null,"pmid":"21181717","source_url":"https://pubmed.ncbi.nlm.nih.gov/21181717/","study_design":null,"title":"Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid A\u03b21-42","title_match":false,"year":2010},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/amyloid-and-tau-biomarkers-and-clinical-phenotype-in-dementia-with-32989106","doi":"10.1212/wnl.0000000000010943","journal":"Neurology","n_participants":417,"pmid":"32989106","source_url":"https://pubmed.ncbi.nlm.nih.gov/32989106/","study_design":null,"title":"\u03b2-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies","title_match":false,"year":2020},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/apoe-by-sex-interactions-on-brain-structure-and-metabolism-in-healthy-26397226","doi":"10.18632/oncotarget.5185","journal":"Oncotarget","n_participants":274,"pmid":"26397226","source_url":"https://pubmed.ncbi.nlm.nih.gov/26397226/","study_design":"cross-sectional","title":"APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls","title_match":false,"year":2015},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/serial-mri-and-csf-biomarkers-in-normal-aging-mci-and-ad-20625167","doi":"10.1212/wnl.0b013e3181e7ca82","journal":"Neurology","n_participants":312,"pmid":"20625167","source_url":"https://pubmed.ncbi.nlm.nih.gov/20625167/","study_design":null,"title":"Serial MRI and CSF biomarkers in normal aging, MCI, and AD","title_match":false,"year":2010},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/hypothetical-preclinical-alzheimer-disease-groups-and-longitudinal-27064267","doi":"10.1001/jamaneurol.2016.0194","journal":"JAMA neurology","n_participants":null,"pmid":"27064267","source_url":"https://pubmed.ncbi.nlm.nih.gov/27064267/","study_design":"cohort study","title":"Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change","title_match":false,"year":2016},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/validation-of-olfactory-deficit-as-a-biomarker-of-alzheimer-disease-28243501","doi":"10.1212/cpj.0000000000000293","journal":"Neurology. Clinical practice","n_participants":96,"pmid":"28243501","source_url":"https://pubmed.ncbi.nlm.nih.gov/28243501/","study_design":"cross-sectional","title":"Validation of olfactory deficit as a biomarker of Alzheimer disease","title_match":false,"year":2017},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/does-nsaid-use-modify-cognitive-trajectories-in-the-elderly-the-cache-17636065","doi":"10.1212/01.wnl.0000265223.25679.2a","journal":"Neurology","n_participants":3383,"pmid":"17636065","source_url":"https://pubmed.ncbi.nlm.nih.gov/17636065/","study_design":null,"title":"Does NSAID use modify cognitive trajectories in the elderly? The Cache County study","title_match":false,"year":2007},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/genetically-decreased-vitamin-d-and-risk-of-alzheimer-disease-27856775","doi":"10.1212/wnl.0000000000003430","journal":"Neurology","n_participants":33996,"pmid":"27856775","source_url":"https://pubmed.ncbi.nlm.nih.gov/27856775/","study_design":null,"title":"Genetically decreased vitamin D and risk of Alzheimer disease","title_match":false,"year":2016},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effect-of-apolipoprotein-e-genotype-and-diet-on-apolipoprotein-e-23779114","doi":"10.1001/jamaneurol.2013.396","journal":"JAMA neurology","n_participants":null,"pmid":"23779114","source_url":"https://pubmed.ncbi.nlm.nih.gov/23779114/","study_design":null,"title":"Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial","title_match":true,"year":2013},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/genetic-heterogeneity-in-alzheimer-disease-and-implications-for-25217249","doi":"10.1007/s11910-014-0499-8","journal":"Current neurology and neuroscience reports","n_participants":null,"pmid":"25217249","source_url":"https://pubmed.ncbi.nlm.nih.gov/25217249/","study_design":null,"title":"Genetic heterogeneity in Alzheimer disease and implications for treatment strategies","title_match":false,"year":2014},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/dissociable-influences-of-i-apoe-i-4-and-polygenic-risk-of-ad-29592889","doi":"10.1212/wnl.0000000000005415","journal":"Neurology","n_participants":702,"pmid":"29592889","source_url":"https://pubmed.ncbi.nlm.nih.gov/29592889/","study_design":"longitudinal study","title":"Dissociable influences of APOE \u03b54 and polygenic risk of AD dementia on amyloid and cognition","title_match":false,"year":2018},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/donanemab-in-early-symptomatic-alzheimer-disease-the-trailblazer-alz-37459141","doi":"10.1001/jama.2023.13239","journal":"JAMA","n_participants":860,"pmid":"37459141","source_url":"https://pubmed.ncbi.nlm.nih.gov/37459141/","study_design":"clinical trial","title":"Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/estrogen-plus-progestin-and-the-incidence-of-dementia-and-mild-12771112","doi":"10.1001/jama.289.20.2651","journal":"JAMA","n_participants":2229,"pmid":"12771112","source_url":"https://pubmed.ncbi.nlm.nih.gov/12771112/","study_design":null,"title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","title_match":true,"year":2003},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/effect-of-physical-activity-on-cognitive-function-in-older-adults-at-18768414","doi":"10.1001/jama.300.9.1027","journal":"JAMA","n_participants":170,"pmid":"18768414","source_url":"https://pubmed.ncbi.nlm.nih.gov/18768414/","study_design":"randomized controlled trial","title":"Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial","title_match":false,"year":2008},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/risk-of-death-with-atypical-antipsychotic-drug-treatment-for-dementia-16234500","doi":"10.1001/jama.294.15.1934","journal":"JAMA","n_participants":3353,"pmid":"16234500","source_url":"https://pubmed.ncbi.nlm.nih.gov/16234500/","study_design":"meta-analysis","title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","title_match":true,"year":2005},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/intranasal-insulin-therapy-for-alzheimer-disease-and-amnestic-mild-21911655","doi":"10.1001/archneurol.2011.233","journal":"Archives of neurology","n_participants":64,"pmid":"21911655","source_url":"https://pubmed.ncbi.nlm.nih.gov/21911655/","study_design":null,"title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","title_match":true,"year":2012},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/clinical-effects-of-abeta-immunization-an1792-in-patients-with-ad-in-15883316","doi":"10.1212/01.wnl.0000159740.16984.3c","journal":"Neurology","n_participants":300,"pmid":"15883316","source_url":"https://pubmed.ncbi.nlm.nih.gov/15883316/","study_design":null,"title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","title_match":false,"year":2005},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/lifestyle-interventions-to-prevent-cognitive-impairment-dementia-and-30291317","doi":"10.1038/s41582-018-0070-3","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"30291317","source_url":"https://pubmed.ncbi.nlm.nih.gov/30291317/","study_design":null,"title":"Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease","title_match":false,"year":2018},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/memantine-treatment-in-patients-with-moderate-to-severe-alzheimer-14734594","doi":"10.1001/jama.291.3.317","journal":"JAMA","n_participants":203,"pmid":"14734594","source_url":"https://pubmed.ncbi.nlm.nih.gov/14734594/","study_design":null,"title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","title_match":true,"year":2004},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/metal-protein-attenuation-with-iodochlorhydroxyquin-clioquinol-14676042","doi":"10.1001/archneur.60.12.1685","journal":"Archives of neurology","n_participants":null,"pmid":"14676042","source_url":"https://pubmed.ncbi.nlm.nih.gov/14676042/","study_design":"clinical trial","title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","title_match":true,"year":2003},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/effects-of-rofecoxib-or-naproxen-vs-placebo-on-alzheimer-disease-12783912","doi":"10.1001/jama.289.21.2819","journal":"JAMA","n_participants":474,"pmid":"12783912","source_url":"https://pubmed.ncbi.nlm.nih.gov/12783912/","study_design":null,"title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial","title_match":true,"year":2003},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/estrogen-replacement-therapy-for-treatment-of-mild-to-moderate-10697060","doi":"10.1001/jama.283.8.1007","journal":"JAMA","n_participants":42,"pmid":"10697060","source_url":"https://pubmed.ncbi.nlm.nih.gov/10697060/","study_design":null,"title":"Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study","title_match":true,"year":2000},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-trial-of-resveratrol-for-26362286","doi":"10.1212/wnl.0000000000002035","journal":"Neurology","n_participants":119,"pmid":"26362286","source_url":"https://pubmed.ncbi.nlm.nih.gov/26362286/","study_design":"clinical trial","title":"A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease","title_match":true,"year":2015},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/the-prevention-of-dementia-with-antihypertensive-treatment-new-12374512","doi":"10.1001/archinte.162.18.2046","journal":"Archives of internal medicine","n_participants":1485,"pmid":"12374512","source_url":"https://pubmed.ncbi.nlm.nih.gov/12374512/","study_design":null,"title":"The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study","title_match":false,"year":2002},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/effectiveness-of-collaborative-care-for-older-adults-with-alzheimer-16684985","doi":"10.1001/jama.295.18.2148","journal":"JAMA","n_participants":84,"pmid":"16684985","source_url":"https://pubmed.ncbi.nlm.nih.gov/16684985/","study_design":null,"title":"Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial","title_match":true,"year":2006},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/donepezil-improves-cognition-and-global-function-in-alzheimer-disease-9588436","doi":"10.1001/archinte.158.9.1021","journal":"Archives of internal medicine","n_participants":468,"pmid":"9588436","source_url":"https://pubmed.ncbi.nlm.nih.gov/9588436/","study_design":"clinical trial","title":"Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group","title_match":true,"year":1998},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-in-2-phase-3-studies-evaluating-34807243","doi":"10.1001/jamaneurol.2021.4161","journal":"JAMA neurology","n_participants":1087,"pmid":"34807243","source_url":"https://pubmed.ncbi.nlm.nih.gov/34807243/","study_design":"clinical trial","title":"Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease","title_match":true,"year":2022},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effects-of-xanomeline-a-selective-muscarinic-receptor-agonist-on-9109749","doi":"10.1001/archneur.1997.00550160091022","journal":"Archives of neurology","n_participants":343,"pmid":"9109749","source_url":"https://pubmed.ncbi.nlm.nih.gov/9109749/","study_design":null,"title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","title_match":false,"year":1997},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/omega-3-fatty-acid-treatment-in-174-patients-with-mild-to-moderate-17030655","doi":"10.1001/archneur.63.10.1402","journal":"Archives of neurology","n_participants":32,"pmid":"17030655","source_url":"https://pubmed.ncbi.nlm.nih.gov/17030655/","study_design":null,"title":"Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial","title_match":true,"year":2006},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/enhancing-the-quality-of-life-of-dementia-caregivers-from-different-17116917","doi":"10.7326/0003-4819-145-10-200611210-00005","journal":"Annals of internal medicine","n_participants":null,"pmid":"17116917","source_url":"https://pubmed.ncbi.nlm.nih.gov/17116917/","study_design":null,"title":"Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial","title_match":true,"year":2006},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/exercise-plus-behavioral-management-in-patients-with-alzheimer-14559955","doi":"10.1001/jama.290.15.2015","journal":"JAMA","n_participants":null,"pmid":"14559955","source_url":"https://pubmed.ncbi.nlm.nih.gov/14559955/","study_design":"randomized controlled trial","title":"Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial","title_match":true,"year":2003},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/effect-of-tarenflurbil-on-cognitive-decline-and-activities-of-daily-20009055","doi":"10.1001/jama.2009.1866","journal":"JAMA","n_participants":1684,"pmid":"20009055","source_url":"https://pubmed.ncbi.nlm.nih.gov/20009055/","study_design":"clinical trial","title":"Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial","title_match":true,"year":2009},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/a-family-intervention-to-delay-nursing-home-placement-of-patients-8940320","doi":"10.1001/jama.1996.03540210033030","journal":"JAMA","n_participants":null,"pmid":"8940320","source_url":"https://pubmed.ncbi.nlm.nih.gov/8940320/","study_design":null,"title":"A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial","title_match":true,"year":1996},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/ginkgo-biloba-for-prevention-of-dementia-a-randomized-controlled-trial-19017911","doi":"10.1001/jama.2008.683","journal":"JAMA","n_participants":2587,"pmid":"19017911","source_url":"https://pubmed.ncbi.nlm.nih.gov/19017911/","study_design":null,"title":"Ginkgo biloba for prevention of dementia: a randomized controlled trial","title_match":true,"year":2008},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/effects-of-abeta-immunization-an1792-on-mri-measures-of-cerebral-15883317","doi":"10.1212/01.wnl.0000159743.08996.99","journal":"Neurology","n_participants":45,"pmid":"15883317","source_url":"https://pubmed.ncbi.nlm.nih.gov/15883317/","study_design":null,"title":"Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease","title_match":false,"year":2005},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effect-of-vitamin-e-and-memantine-on-functional-decline-in-alzheimer-24381967","doi":"10.1001/jama.2013.282834","journal":"JAMA","n_participants":152,"pmid":"24381967","source_url":"https://pubmed.ncbi.nlm.nih.gov/24381967/","study_design":null,"title":"Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial","title_match":false,"year":2014},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/olanzapine-treatment-of-psychotic-and-behavioral-symptoms-in-patients-11015815","doi":"10.1001/archpsyc.57.10.968","journal":"Archives of general psychiatry","n_participants":null,"pmid":"11015815","source_url":"https://pubmed.ncbi.nlm.nih.gov/11015815/","study_design":null,"title":"Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group","title_match":true,"year":2000},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/effect-of-citalopram-on-agitation-in-alzheimer-disease-the-citad-24549548","doi":"10.1001/jama.2014.93","journal":"JAMA","n_participants":186,"pmid":"24549548","source_url":"https://pubmed.ncbi.nlm.nih.gov/24549548/","study_design":null,"title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","title_match":true,"year":2014},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/high-dose-b-vitamin-supplementation-and-cognitive-decline-in-18854539","doi":"10.1001/jama.300.15.1774","journal":"JAMA","n_participants":340,"pmid":"18854539","source_url":"https://pubmed.ncbi.nlm.nih.gov/18854539/","study_design":null,"title":"High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial","title_match":true,"year":2008},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/improving-caregiver-well-being-delays-nursing-home-placement-of-17101889","doi":"10.1212/01.wnl.0000242727.81172.91","journal":"Neurology","n_participants":null,"pmid":"17101889","source_url":"https://pubmed.ncbi.nlm.nih.gov/17101889/","study_design":"randomized controlled trial","title":"Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease","title_match":false,"year":2006},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/effect-of-1-night-of-total-sleep-deprivation-on-cerebrospinal-fluid-24887018","doi":"10.1001/jamaneurol.2014.1173","journal":"JAMA neurology","n_participants":26,"pmid":"24887018","source_url":"https://pubmed.ncbi.nlm.nih.gov/24887018/","study_design":null,"title":"Effect of 1 night of total sleep deprivation on cerebrospinal fluid \u03b2-amyloid 42 in healthy middle-aged men: a randomized clinical trial","title_match":true,"year":2014},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/screening-for-dementia-in-primary-care-a-summary-of-the-evidence-for-12779304","doi":"10.7326/0003-4819-138-11-200306030-00015","journal":"Annals of internal medicine","n_participants":null,"pmid":"12779304","source_url":"https://pubmed.ncbi.nlm.nih.gov/12779304/","study_design":null,"title":"Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force","title_match":false,"year":2003},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-cognitive-function-and-dementia-a-systematic-review-23680940","doi":"10.1097/ede.0b013e3182944410","journal":"Epidemiology (Cambridge, Mass.)","n_participants":null,"pmid":"23680940","source_url":"https://pubmed.ncbi.nlm.nih.gov/23680940/","study_design":"randomized controlled trial","title":"Mediterranean diet, cognitive function, and dementia: a systematic review","title_match":false,"year":2013},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/randomized-controlled-trial-of-atorvastatin-in-mild-to-moderate-20200346","doi":"10.1212/wnl.0b013e3181d6476a","journal":"Neurology","n_participants":640,"pmid":"20200346","source_url":"https://pubmed.ncbi.nlm.nih.gov/20200346/","study_design":"randomized controlled trial","title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","title_match":true,"year":2010},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/mechanism-of-amyloid-removal-in-patients-with-alzheimer-disease-21987394","doi":"10.1001/archneurol.2011.1538","journal":"Archives of neurology","n_participants":null,"pmid":"21987394","source_url":"https://pubmed.ncbi.nlm.nih.gov/21987394/","study_design":null,"title":"Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab","title_match":false,"year":2012},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/a-placebo-controlled-double-blind-randomized-trial-of-an-extract-of-9343463","doi":"10.1001/jama.278.16.1327","journal":"JAMA","n_participants":309,"pmid":"9343463","source_url":"https://pubmed.ncbi.nlm.nih.gov/9343463/","study_design":null,"title":"A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group","title_match":true,"year":1997},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/safety-efficacy-and-feasibility-of-intranasal-insulin-for-the-32568367","doi":"10.1001/jamaneurol.2020.1840","journal":"JAMA neurology","n_participants":432,"pmid":"32568367","source_url":"https://pubmed.ncbi.nlm.nih.gov/32568367/","study_design":"clinical trial","title":"Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/emerging-diagnostics-and-therapeutics-for-alzheimer-disease-37667136","doi":"10.1038/s41591-023-02505-2","journal":"Nature medicine","n_participants":null,"pmid":"37667136","source_url":"https://pubmed.ncbi.nlm.nih.gov/37667136/","study_design":null,"title":"Emerging diagnostics and therapeutics for Alzheimer disease","title_match":false,"year":2023},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/atorvastatin-for-the-treatment-of-mild-to-moderate-alzheimer-disease-15883262","doi":"10.1001/archneur.62.5.753","journal":"Archives of neurology","n_participants":98,"pmid":"15883262","source_url":"https://pubmed.ncbi.nlm.nih.gov/15883262/","study_design":null,"title":"Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results","title_match":false,"year":2005},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/antioxidants-for-alzheimer-disease-a-randomized-clinical-trial-with-22431837","doi":"10.1001/archneurol.2012.85","journal":"Archives of neurology","n_participants":null,"pmid":"22431837","source_url":"https://pubmed.ncbi.nlm.nih.gov/22431837/","study_design":null,"title":"Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures","title_match":true,"year":2012},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/cognitive-function-over-time-in-the-alzheimer-s-disease-anti-18474729","doi":"10.1001/archneur.2008.65.7.nct70006","journal":"Archives of neurology","n_participants":null,"pmid":"18474729","source_url":"https://pubmed.ncbi.nlm.nih.gov/18474729/","study_design":"longitudinal study","title":"Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib","title_match":true,"year":2008},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/naproxen-and-celecoxib-do-not-prevent-ad-in-early-results-from-a-17460158","doi":"10.1212/01.wnl.0000260269.93245.d2","journal":"Neurology","n_participants":null,"pmid":"17460158","source_url":"https://pubmed.ncbi.nlm.nih.gov/17460158/","study_design":null,"title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","title_match":true,"year":2007},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effect-of-levetiracetam-on-cognition-in-patients-with-alzheimer-34570177","doi":"10.1001/jamaneurol.2021.3310","journal":"JAMA neurology","n_participants":34,"pmid":"34570177","source_url":"https://pubmed.ncbi.nlm.nih.gov/34570177/","study_design":null,"title":"Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial","title_match":true,"year":2021},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-trial-of-simvastatin-to-21795660","doi":"10.1212/wnl.0b013e318228bf11","journal":"Neurology","n_participants":406,"pmid":"21795660","source_url":"https://pubmed.ncbi.nlm.nih.gov/21795660/","study_design":null,"title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","title_match":true,"year":2011},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/phase-2-safety-trial-targeting-amyloid-beta-production-with-a-gamma-18695053","doi":"10.1001/archneur.65.8.1031","journal":"Archives of neurology","n_participants":15,"pmid":"18695053","source_url":"https://pubmed.ncbi.nlm.nih.gov/18695053/","study_design":null,"title":"Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease","title_match":true,"year":2008},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/efficacy-of-donepezil-in-mild-cognitive-impairment-a-randomized-15326237","doi":"10.1212/01.wnl.0000134664.80320.92","journal":"Neurology","n_participants":133,"pmid":"15326237","source_url":"https://pubmed.ncbi.nlm.nih.gov/15326237/","study_design":null,"title":"Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial","title_match":true,"year":2004},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/screening-for-cognitive-impairment-in-older-adults-updated-evidence-32096857","doi":"10.1001/jama.2019.22258","journal":"JAMA","n_participants":4005,"pmid":"32096857","source_url":"https://pubmed.ncbi.nlm.nih.gov/32096857/","study_design":"meta-analysis","title":"Screening for Cognitive Impairment in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","title_match":false,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/etanercept-in-alzheimer-disease-a-randomized-placebo-controlled-25934853","doi":"10.1212/wnl.0000000000001617","journal":"Neurology","n_participants":20,"pmid":"25934853","source_url":"https://pubmed.ncbi.nlm.nih.gov/25934853/","study_design":null,"title":"Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial","title_match":true,"year":2015},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/a-randomized-placebo-controlled-pilot-trial-of-omega-3-fatty-acids-24077434","doi":"10.3233/jad-130722","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"24077434","source_url":"https://pubmed.ncbi.nlm.nih.gov/24077434/","study_design":null,"title":"A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease","title_match":true,"year":2014},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/effects-of-the-finnish-alzheimer-disease-exercise-trial-finalex-a-23589097","doi":"10.1001/jamainternmed.2013.359","journal":"JAMA internal medicine","n_participants":210,"pmid":"23589097","source_url":"https://pubmed.ncbi.nlm.nih.gov/23589097/","study_design":"randomized controlled trial","title":"Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial","title_match":true,"year":2013},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/memantine-treatment-in-mild-to-moderate-alzheimer-disease-a-24-week-16861375","doi":"10.1097/01.jgp.0000224350.82719.83","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":201,"pmid":"16861375","source_url":"https://pubmed.ncbi.nlm.nih.gov/16861375/","study_design":null,"title":"Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial","title_match":true,"year":2006},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/tramiprosate-in-mild-to-moderate-alzheimer-s-disease-a-randomized-22291741","doi":"10.5114/aoms.2011.20612","journal":"Archives of medical science : AMS","n_participants":1052,"pmid":"22291741","source_url":"https://pubmed.ncbi.nlm.nih.gov/22291741/","study_design":"randomized controlled trial","title":"Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)","title_match":true,"year":2011},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/effects-of-a-gamma-secretase-inhibitor-in-a-randomized-study-of-16505324","doi":"10.1212/01.wnl.0000198762.41312.e1","journal":"Neurology","n_participants":70,"pmid":"16505324","source_url":"https://pubmed.ncbi.nlm.nih.gov/16505324/","study_design":null,"title":"Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease","title_match":false,"year":2006},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/abby-a-phase-2-randomized-trial-of-crenezumab-in-mild-to-moderate-29695589","doi":"10.1212/wnl.0000000000005550","journal":"Neurology","n_participants":184,"pmid":"29695589","source_url":"https://pubmed.ncbi.nlm.nih.gov/29695589/","study_design":"clinical trial","title":"ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease","title_match":true,"year":2018},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effect-of-person-centered-showering-and-the-towel-bath-on-bathing-15507054","doi":"10.1111/j.1532-5415.2004.52501.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"15507054","source_url":"https://pubmed.ncbi.nlm.nih.gov/15507054/","study_design":null,"title":"Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia: a randomized, controlled trial","title_match":true,"year":2004},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/a-phase-2-randomized-trial-of-elnd005-scyllo-inositol-in-mild-to-21917766","doi":"10.1212/wnl.0b013e3182309fa5","journal":"Neurology","n_participants":84,"pmid":"21917766","source_url":"https://pubmed.ncbi.nlm.nih.gov/21917766/","study_design":"clinical trial","title":"A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease","title_match":true,"year":2011},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/donepezil-treatment-of-patients-with-mci-a-48-week-randomized-placebo-19176895","doi":"10.1212/01.wnl.0000344650.95823.03","journal":"Neurology","n_participants":null,"pmid":"19176895","source_url":"https://pubmed.ncbi.nlm.nih.gov/19176895/","study_design":null,"title":"Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","title_match":true,"year":2009},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/targeting-prodromal-alzheimer-disease-with-avagacestat-a-randomized-26414022","doi":"10.1001/jamaneurol.2015.0607","journal":"JAMA neurology","n_participants":263,"pmid":"26414022","source_url":"https://pubmed.ncbi.nlm.nih.gov/26414022/","study_design":"randomized controlled trial","title":"Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial","title_match":true,"year":2015},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/evaluating-the-safety-and-efficacy-of-crenezumab-vs-placebo-in-adults-36121669","doi":"10.1001/jamaneurol.2022.2909","journal":"JAMA neurology","n_participants":3664,"pmid":"36121669","source_url":"https://pubmed.ncbi.nlm.nih.gov/36121669/","study_design":"clinical trial","title":"Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials","title_match":true,"year":2022},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/interactive-wearable-systems-for-upper-body-rehabilitation-a-28284228","doi":"10.1186/s12984-017-0229-y","journal":"Journal of neuroengineering and rehabilitation","n_participants":21,"pmid":"28284228","source_url":"https://pubmed.ncbi.nlm.nih.gov/28284228/","study_design":null,"title":"Interactive wearable systems for upper body rehabilitation: a systematic review","title_match":false,"year":2017},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/goal-oriented-cognitive-rehabilitation-for-people-with-early-stage-20808145","doi":"10.1097/jgp.0b013e3181d5792a","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"20808145","source_url":"https://pubmed.ncbi.nlm.nih.gov/20808145/","study_design":"randomized controlled trial","title":"Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: a single-blind randomized controlled trial of clinical efficacy","title_match":true,"year":2010},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/a-randomized-pilot-clinical-trial-of-the-safety-of-pioglitazone-in-20837824","doi":"10.1001/archneurol.2010.229","journal":"Archives of neurology","n_participants":29,"pmid":"20837824","source_url":"https://pubmed.ncbi.nlm.nih.gov/20837824/","study_design":"randomized controlled trial","title":"A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease","title_match":true,"year":2011},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/accelerated-brain-volume-loss-caused-by-anti-amyloid-drugs-a-36973044","doi":"10.1212/wnl.0000000000207156","journal":"Neurology","n_participants":8062,"pmid":"36973044","source_url":"https://pubmed.ncbi.nlm.nih.gov/36973044/","study_design":"systematic review","title":"Accelerated Brain Volume Loss Caused by Anti-\u03b2-Amyloid Drugs: A Systematic Review and Meta-analysis","title_match":false,"year":2023},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-lanabecestat-for-treatment-of-early-and-mild-31764959","doi":"10.1001/jamaneurol.2019.3988","journal":"JAMA neurology","n_participants":6871,"pmid":"31764959","source_url":"https://pubmed.ncbi.nlm.nih.gov/31764959/","study_design":"clinical trial","title":"Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials","title_match":true,"year":2020},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/effect-of-immunotherapy-with-bapineuzumab-on-cerebrospinal-fluid-22473769","doi":"10.1001/archneurol.2012.90","journal":"Archives of neurology","n_participants":19,"pmid":"22473769","source_url":"https://pubmed.ncbi.nlm.nih.gov/22473769/","study_design":"clinical trial","title":"Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/memantine-treatment-in-patients-with-mild-to-moderate-alzheimer-s-18288936","doi":"10.2174/156720508783884576","journal":"Current Alzheimer research","n_participants":433,"pmid":"18288936","source_url":"https://pubmed.ncbi.nlm.nih.gov/18288936/","study_design":null,"title":"Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial","title_match":true,"year":2008},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/adeno-associated-viral-vector-serotype-2-nerve-growth-factor-for-29582053","doi":"10.1001/jamaneurol.2018.0233","journal":"JAMA neurology","n_participants":49,"pmid":"29582053","source_url":"https://pubmed.ncbi.nlm.nih.gov/29582053/","study_design":"clinical trial","title":"Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2018},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/clinical-trial-of-an-inhibitor-of-rage-a-interactions-in-alzheimer-24696507","doi":"10.1212/wnl.0000000000000364","journal":"Neurology","n_participants":399,"pmid":"24696507","source_url":"https://pubmed.ncbi.nlm.nih.gov/24696507/","study_design":null,"title":"Clinical trial of an inhibitor of RAGE-A\u03b2 interactions in Alzheimer disease","title_match":true,"year":2014},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-neuropsychological-test-battery-for-use-in-alzheimer-disease-17846273","doi":"10.1001/archneur.64.9.1323","journal":"Archives of neurology","n_participants":300,"pmid":"17846273","source_url":"https://pubmed.ncbi.nlm.nih.gov/17846273/","study_design":null,"title":"A neuropsychological test battery for use in Alzheimer disease clinical trials","title_match":true,"year":2007},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-semorinemab-in-individuals-with-prodromal-to-35696185","doi":"10.1001/jamaneurol.2022.1375","journal":"JAMA neurology","n_participants":422,"pmid":"35696185","source_url":"https://pubmed.ncbi.nlm.nih.gov/35696185/","study_design":"clinical trial","title":"Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2022},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/randomized-placebo-controlled-trial-of-the-effects-of-aspirin-on-32213642","doi":"10.1212/wnl.0000000000009277","journal":"Neurology","n_participants":19114,"pmid":"32213642","source_url":"https://pubmed.ncbi.nlm.nih.gov/32213642/","study_design":null,"title":"Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline","title_match":true,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/donepezil-preserves-cognition-and-global-function-in-patients-with-17664405","doi":"10.1212/01.wnl.0000266627.96040.5a","journal":"Neurology","n_participants":176,"pmid":"17664405","source_url":"https://pubmed.ncbi.nlm.nih.gov/17664405/","study_design":null,"title":"Donepezil preserves cognition and global function in patients with severe Alzheimer disease","title_match":false,"year":2007},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/efficacy-of-donepezil-in-early-stage-alzheimer-disease-a-randomized-15596605","doi":"10.1001/archneur.61.12.1852","journal":"Archives of neurology","n_participants":96,"pmid":"15596605","source_url":"https://pubmed.ncbi.nlm.nih.gov/15596605/","study_design":null,"title":"Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial","title_match":true,"year":2004},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/effect-of-omega-3-fatty-acids-lutein-zeaxanthin-or-other-nutrient-26305649","doi":"10.1001/jama.2015.9677","journal":"JAMA","n_participants":89,"pmid":"26305649","source_url":"https://pubmed.ncbi.nlm.nih.gov/26305649/","study_design":null,"title":"Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial","title_match":true,"year":2015},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/minocycline-at-2-different-dosages-vs-placebo-for-patients-with-mild-31738372","doi":"10.1001/jamaneurol.2019.3762","journal":"JAMA neurology","n_participants":554,"pmid":"31738372","source_url":"https://pubmed.ncbi.nlm.nih.gov/31738372/","study_design":null,"title":"Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/sertraline-for-the-treatment-of-depression-in-alzheimer-disease-20087081","doi":"10.1097/jgp.0b013e3181c796eb","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":67,"pmid":"20087081","source_url":"https://pubmed.ncbi.nlm.nih.gov/20087081/","study_design":null,"title":"Sertraline for the treatment of depression in Alzheimer disease","title_match":false,"year":2010},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/dementia-prevention-and-treatment-a-narrative-review-38436963","doi":"10.1001/jamainternmed.2023.8522","journal":"JAMA internal medicine","n_participants":null,"pmid":"38436963","source_url":"https://pubmed.ncbi.nlm.nih.gov/38436963/","study_design":null,"title":"Dementia Prevention and Treatment: A Narrative Review","title_match":false,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/a-phase-ii-trial-of-huperzine-a-in-mild-to-moderate-alzheimer-disease-21502597","doi":"10.1212/wnl.0b013e318216eb7b","journal":"Neurology","n_participants":70,"pmid":"21502597","source_url":"https://pubmed.ncbi.nlm.nih.gov/21502597/","study_design":null,"title":"A phase II trial of huperzine A in mild to moderate Alzheimer disease","title_match":true,"year":2011},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/chronic-divalproex-sodium-to-attenuate-agitation-and-clinical-21810649","doi":"10.1001/archgenpsychiatry.2011.72","journal":"Archives of general psychiatry","n_participants":122,"pmid":"21810649","source_url":"https://pubmed.ncbi.nlm.nih.gov/21810649/","study_design":null,"title":"Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/quetiapine-for-agitation-or-psychosis-in-patients-with-dementia-and-17452579","doi":"10.1212/01.wnl.0000260060.60870.89","journal":"Neurology","n_participants":23,"pmid":"17452579","source_url":"https://pubmed.ncbi.nlm.nih.gov/17452579/","study_design":null,"title":"Quetiapine for agitation or psychosis in patients with dementia and parkinsonism","title_match":false,"year":2007},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/ginkgo-biloba-and-donepezil-a-comparison-in-the-treatment-of-16930364","doi":"10.1111/j.1468-1331.2006.01409.x","journal":"European journal of neurology","n_participants":null,"pmid":"16930364","source_url":"https://pubmed.ncbi.nlm.nih.gov/16930364/","study_design":null,"title":"Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study","title_match":true,"year":2006},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/effect-of-dextromethorphan-quinidine-on-agitation-in-patients-with-26393847","doi":"10.1001/jama.2015.10214","journal":"JAMA","n_participants":93,"pmid":"26393847","source_url":"https://pubmed.ncbi.nlm.nih.gov/26393847/","study_design":"clinical trial","title":"Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial","title_match":true,"year":2015},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/a-single-ascending-dose-study-of-bapineuzumab-in-patients-with-20505438","doi":"10.1097/wad.0b013e3181c53b00","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"20505438","source_url":"https://pubmed.ncbi.nlm.nih.gov/20505438/","study_design":"clinical trial","title":"A single ascending dose study of bapineuzumab in patients with Alzheimer disease","title_match":false,"year":2010},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/comparison-of-integrated-outpatient-palliative-care-with-standard-32040141","doi":"10.1001/jamaneurol.2019.4992","journal":"JAMA neurology","n_participants":584,"pmid":"32040141","source_url":"https://pubmed.ncbi.nlm.nih.gov/32040141/","study_design":null,"title":"Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/brain-atrophy-in-cognitively-impaired-elderly-the-importance-of-long-25877495","doi":"10.3945/ajcn.114.103283","journal":"The American journal of clinical nutrition","n_participants":83,"pmid":"25877495","source_url":"https://pubmed.ncbi.nlm.nih.gov/25877495/","study_design":null,"title":"Brain atrophy in cognitively impaired elderly: the importance of long-chain \u03c9-3 fatty acids and B vitamin status in a randomized controlled trial","title_match":true,"year":2015},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/pf-04494700-an-oral-inhibitor-of-receptor-for-advanced-glycation-end-21192237","doi":"10.1097/wad.0b013e318204b550","journal":"Alzheimer disease and associated disorders","n_participants":28,"pmid":"21192237","source_url":"https://pubmed.ncbi.nlm.nih.gov/21192237/","study_design":null,"title":"PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-24-week-randomized-controlled-trial-of-memantine-in-patients-with-17545739","doi":"10.1097/wad.0b013e318065c495","journal":"Alzheimer disease and associated disorders","n_participants":350,"pmid":"17545739","source_url":"https://pubmed.ncbi.nlm.nih.gov/17545739/","study_design":null,"title":"A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease","title_match":true,"year":2007},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/effect-of-idalopirdine-as-adjunct-to-cholinesterase-inhibitors-on-29318278","doi":"10.1001/jama.2017.20373","journal":"JAMA","n_participants":933,"pmid":"29318278","source_url":"https://pubmed.ncbi.nlm.nih.gov/29318278/","study_design":null,"title":"Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials","title_match":true,"year":2018},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/trazodone-improves-sleep-parameters-in-alzheimer-disease-patients-a-24495406","doi":"10.1016/j.jagp.2013.12.174","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":15,"pmid":"24495406","source_url":"https://pubmed.ncbi.nlm.nih.gov/24495406/","study_design":null,"title":"Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study","title_match":true,"year":2014},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/melatonin-fails-to-improve-sleep-or-agitation-in-double-blind-19155748","doi":"10.1097/jgp.0b013e318187de18","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":24,"pmid":"19155748","source_url":"https://pubmed.ncbi.nlm.nih.gov/19155748/","study_design":null,"title":"Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease","title_match":true,"year":2009},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/persistence-of-contradicted-claims-in-the-literature-18056905","doi":"10.1001/jama.298.21.2517","journal":"JAMA","n_participants":null,"pmid":"18056905","source_url":"https://pubmed.ncbi.nlm.nih.gov/18056905/","study_design":null,"title":"Persistence of contradicted claims in the literature","title_match":false,"year":2007},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/effect-of-azd0530-on-cerebral-metabolic-decline-in-alzheimer-disease-31329216","doi":"10.1001/jamaneurol.2019.2050","journal":"JAMA neurology","n_participants":159,"pmid":"31329216","source_url":"https://pubmed.ncbi.nlm.nih.gov/31329216/","study_design":null,"title":"Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/effects-of-docosahexaenoic-acid-rich-n-3-fatty-acid-supplementation-18541548","doi":"10.1093/ajcn/87.6.1616","journal":"The American journal of clinical nutrition","n_participants":null,"pmid":"18541548","source_url":"https://pubmed.ncbi.nlm.nih.gov/18541548/","study_design":null,"title":"Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study","title_match":false,"year":2008},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-trial-of-two-doses-of-16375657","doi":"10.2174/156720505774932287","journal":"Current Alzheimer research","n_participants":null,"pmid":"16375657","source_url":"https://pubmed.ncbi.nlm.nih.gov/16375657/","study_design":null,"title":"A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type","title_match":true,"year":2005},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-bright-light-therapy-for-agitated-10440971","doi":"10.1002/(sici)1099-1166(199907)14:7<520::aid-gps983>3.0.co;2-m","journal":"International journal of geriatric psychiatry","n_participants":15,"pmid":"10440971","source_url":"https://pubmed.ncbi.nlm.nih.gov/10440971/","study_design":null,"title":"A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care","title_match":true,"year":1999},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effects-of-exercise-on-cognition-the-finnish-alzheimer-disease-27037872","doi":"10.1111/jgs.14059","journal":"Journal of the American Geriatrics Society","n_participants":210,"pmid":"27037872","source_url":"https://pubmed.ncbi.nlm.nih.gov/27037872/","study_design":null,"title":"Effects of Exercise on Cognition: The Finnish Alzheimer Disease Exercise Trial: A Randomized, Controlled Trial","title_match":true,"year":2016},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/diet-intervention-and-cerebrospinal-fluid-biomarkers-in-amnestic-mild-21670398","doi":"10.1001/archneurol.2011.125","journal":"Archives of neurology","n_participants":29,"pmid":"21670398","source_url":"https://pubmed.ncbi.nlm.nih.gov/21670398/","study_design":"randomized controlled trial","title":"Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment","title_match":false,"year":2011},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-review-of-hormone-therapy-trials-and-implications-23727128","doi":"10.1016/j.jsbmb.2013.05.010","journal":"The Journal of steroid biochemistry and molecular biology","n_participants":null,"pmid":"23727128","source_url":"https://pubmed.ncbi.nlm.nih.gov/23727128/","study_design":"cohort study","title":"Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause","title_match":false,"year":2014},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/a-24-week-open-label-extension-study-of-memantine-in-moderate-to-16401736","doi":"10.1001/archneur.63.1.49","journal":"Archives of neurology","n_participants":175,"pmid":"16401736","source_url":"https://pubmed.ncbi.nlm.nih.gov/16401736/","study_design":"open-label trial","title":"A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease","title_match":false,"year":2006},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/run-in-periods-in-randomized-trials-implications-for-the-application-9438743","doi":"10.1001/jama.279.3.222","journal":"JAMA","n_participants":null,"pmid":"9438743","source_url":"https://pubmed.ncbi.nlm.nih.gov/9438743/","study_design":null,"title":"Run-in periods in randomized trials: implications for the application of results in clinical practice","title_match":false,"year":1998},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/brexpiprazole-for-the-treatment-of-agitation-in-alzheimer-dementia-a-37930669","doi":"10.1001/jamaneurol.2023.3810","journal":"JAMA neurology","n_participants":228,"pmid":"37930669","source_url":"https://pubmed.ncbi.nlm.nih.gov/37930669/","study_design":null,"title":"Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/preserving-health-of-alzheimer-caregivers-impact-of-a-spouse-17804831","doi":"10.1097/jgp.0b013e31805d858a","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"17804831","source_url":"https://pubmed.ncbi.nlm.nih.gov/17804831/","study_design":"randomized controlled trial","title":"Preserving health of Alzheimer caregivers: impact of a spouse caregiver intervention","title_match":false,"year":2007},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/cognitive-improvement-in-mild-to-moderate-alzheimer-s-dementia-after-12637119","doi":"10.1016/s0149-2918(03)90023-3","journal":"Clinical therapeutics","n_participants":261,"pmid":"12637119","source_url":"https://pubmed.ncbi.nlm.nih.gov/12637119/","study_design":null,"title":"Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial","title_match":true,"year":2003},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/randomized-placebo-controlled-clinical-trial-of-donepezil-in-vascular-20395618","doi":"10.1161/strokeaha.109.570077","journal":"Stroke","n_participants":974,"pmid":"20395618","source_url":"https://pubmed.ncbi.nlm.nih.gov/20395618/","study_design":null,"title":"Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size","title_match":true,"year":2010},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/the-cognitive-benefits-of-galantamine-are-sustained-for-at-least-36-14967774","doi":"10.1001/archneur.61.2.252","journal":"Archives of neurology","n_participants":119,"pmid":"14967774","source_url":"https://pubmed.ncbi.nlm.nih.gov/14967774/","study_design":"open-label trial","title":"The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial","title_match":false,"year":2004},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/effect-of-milk-and-other-dairy-products-on-the-risk-of-frailty-31089731","doi":"10.1093/advances/nmy105","journal":"Advances in nutrition (Bethesda, Md.)","n_participants":661,"pmid":"31089731","source_url":"https://pubmed.ncbi.nlm.nih.gov/31089731/","study_design":"randomized controlled trial","title":"Effect of Milk and Other Dairy Products on the Risk of Frailty, Sarcopenia, and Cognitive Performance Decline in the Elderly: A Systematic Review","title_match":false,"year":2019},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/benzoate-a-d-amino-acid-oxidase-inhibitor-for-the-treatment-of-early-24074637","doi":"10.1016/j.biopsych.2013.08.010","journal":"Biological psychiatry","n_participants":null,"pmid":"24074637","source_url":"https://pubmed.ncbi.nlm.nih.gov/24074637/","study_design":null,"title":"Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial","title_match":true,"year":2014},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/effect-of-personalized-risk-reduction-strategies-on-cognition-and-38010725","doi":"10.1001/jamainternmed.2023.6279","journal":"JAMA internal medicine","n_participants":172,"pmid":"38010725","source_url":"https://pubmed.ncbi.nlm.nih.gov/38010725/","study_design":null,"title":"Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical Trial","title_match":true,"year":2024},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/reactions-to-multiple-ascending-doses-of-the-microtubule-stabilizer-31710340","doi":"10.1001/jamaneurol.2019.3812","journal":"JAMA neurology","n_participants":39,"pmid":"31710340","source_url":"https://pubmed.ncbi.nlm.nih.gov/31710340/","study_design":"clinical trial","title":"Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/safety-tolerability-and-feasibility-of-young-plasma-infusion-in-the-30383097","doi":"10.1001/jamaneurol.2018.3288","journal":"JAMA neurology","n_participants":null,"pmid":"30383097","source_url":"https://pubmed.ncbi.nlm.nih.gov/30383097/","study_design":"open-label trial","title":"Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/methylphenidate-for-the-treatment-of-apathy-in-alzheimer-disease-18480686","doi":"10.1097/jcp.0b013e318172b479","journal":"Journal of clinical psychopharmacology","n_participants":null,"pmid":"18480686","source_url":"https://pubmed.ncbi.nlm.nih.gov/18480686/","study_design":null,"title":"Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge","title_match":false,"year":2008},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/association-of-sleep-disordered-breathing-with-alzheimer-disease-32202593","doi":"10.1001/jamaneurol.2020.0311","journal":"JAMA neurology","n_participants":157,"pmid":"32202593","source_url":"https://pubmed.ncbi.nlm.nih.gov/32202593/","study_design":"cross-sectional","title":"Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/exploratory-tau-biomarker-results-from-a-multiple-ascending-dose-37902726","doi":"10.1001/jamaneurol.2023.3861","journal":"JAMA neurology","n_participants":13,"pmid":"37902726","source_url":"https://pubmed.ncbi.nlm.nih.gov/37902726/","study_design":"clinical trial","title":"Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/findings-of-efficacy-safety-and-biomarker-outcomes-of-atabecestat-in-33464300","doi":"10.1001/jamaneurol.2020.4857","journal":"JAMA neurology","n_participants":189,"pmid":"33464300","source_url":"https://pubmed.ncbi.nlm.nih.gov/33464300/","study_design":null,"title":"Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial","title_match":true,"year":2021},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/quetiapine-treatment-of-psychosis-associated-with-dementia-a-double-16905684","doi":"10.1097/01.jgp.0000196628.12010.35","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"16905684","source_url":"https://pubmed.ncbi.nlm.nih.gov/16905684/","study_design":"randomized controlled trial","title":"Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial","title_match":true,"year":2006},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/effect-of-methylphenidate-on-apathy-in-patients-with-alzheimer-34570180","doi":"10.1001/jamaneurol.2021.3356","journal":"JAMA neurology","n_participants":200,"pmid":"34570180","source_url":"https://pubmed.ncbi.nlm.nih.gov/34570180/","study_design":"longitudinal study","title":"Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial","title_match":true,"year":2021},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/the-effect-of-reminiscence-therapy-on-cognitive-functions-depression-30246408","doi":"10.1002/gps.4980","journal":"International journal of geriatric psychiatry","n_participants":60,"pmid":"30246408","source_url":"https://pubmed.ncbi.nlm.nih.gov/30246408/","study_design":null,"title":"The effect of reminiscence therapy on cognitive functions, depression, and quality of life in Alzheimer patients: Randomized controlled trial","title_match":true,"year":2019},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-effect-of-integrated-emotion-oriented-care-versus-usual-care-on-15799079","doi":"10.1002/gps.1286","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"15799079","source_url":"https://pubmed.ncbi.nlm.nih.gov/15799079/","study_design":null,"title":"The effect of integrated emotion-oriented care versus usual care on elderly persons with dementia in the nursing home and on nursing assistants: a randomized clinical trial","title_match":true,"year":2005},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/down-syndrome-and-dementia-a-randomized-controlled-trial-of-21739598","doi":"10.1002/ajmg.a.34114","journal":"American journal of medical genetics. Part A","n_participants":53,"pmid":"21739598","source_url":"https://pubmed.ncbi.nlm.nih.gov/21739598/","study_design":null,"title":"Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation","title_match":true,"year":2011},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/randomized-phase-ii-study-of-the-safety-and-efficacy-of-semorinemab-37643887","doi":"10.1212/wnl.0000000000207663","journal":"Neurology","n_participants":624,"pmid":"37643887","source_url":"https://pubmed.ncbi.nlm.nih.gov/37643887/","study_design":"clinical trial","title":"Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet","title_match":true,"year":2023},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-action-to-control-cardiovascular-risk-in-diabetes-memory-in-17599421","doi":"10.1016/j.amjcard.2007.03.029","journal":"The American journal of cardiology","n_participants":2977,"pmid":"17599421","source_url":"https://pubmed.ncbi.nlm.nih.gov/17599421/","study_design":null,"title":"The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods","title_match":false,"year":2007},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/deferiprone-in-alzheimer-disease-a-randomized-clinical-trial-39495531","doi":"10.1001/jamaneurol.2024.3733","journal":"JAMA neurology","n_participants":167,"pmid":"39495531","source_url":"https://pubmed.ncbi.nlm.nih.gov/39495531/","study_design":"longitudinal study","title":"Deferiprone in Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/ginkgo-biloba-extract-egb-761-in-dementia-intent-to-treat-analyses-of-14663654","doi":"10.1055/s-2003-45117","journal":"Pharmacopsychiatry","n_participants":null,"pmid":"14663654","source_url":"https://pubmed.ncbi.nlm.nih.gov/14663654/","study_design":null,"title":"Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial","title_match":true,"year":2003},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/circulating-cholesterol-levels-apolipoprotein-e-genotype-and-dementia-16866904","doi":"10.1111/j.1600-0404.2006.00690.x","journal":"Acta neurologica Scandinavica. Supplementum","n_participants":null,"pmid":"16866904","source_url":"https://pubmed.ncbi.nlm.nih.gov/16866904/","study_design":null,"title":"Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial","title_match":false,"year":2006},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/sb-742457-and-donepezil-in-alzheimer-disease-a-randomized-placebo-20872778","doi":"10.1002/gps.2562","journal":"International journal of geriatric psychiatry","n_participants":61,"pmid":"20872778","source_url":"https://pubmed.ncbi.nlm.nih.gov/20872778/","study_design":null,"title":"SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study","title_match":true,"year":2011},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/effects-of-a-tailored-lighting-intervention-on-sleep-quality-rest-31855161","doi":"10.5664/jcsm.8078","journal":"Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine","n_participants":46,"pmid":"31855161","source_url":"https://pubmed.ncbi.nlm.nih.gov/31855161/","study_design":null,"title":"Effects of a Tailored Lighting Intervention on Sleep Quality, Rest-Activity, Mood, and Behavior in Older Adults With Alzheimer Disease and Related Dementias: A Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/is-high-homocysteine-level-a-risk-factor-for-cognitive-decline-in-21705865","doi":"10.1097/jgp.0b013e3181f17eed","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":6122,"pmid":"21705865","source_url":"https://pubmed.ncbi.nlm.nih.gov/21705865/","study_design":"meta-analysis","title":"Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression","title_match":false,"year":2011},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-clinical-trial-of-activity-therapy-for-apathy-15481065","doi":"10.1002/gps.1215","journal":"International journal of geriatric psychiatry","n_participants":37,"pmid":"15481065","source_url":"https://pubmed.ncbi.nlm.nih.gov/15481065/","study_design":null,"title":"A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care","title_match":true,"year":2004},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/long-term-multivitamin-supplementation-and-cognitive-function-in-men-24490265","doi":"10.7326/0003-4819-159-12-201312170-00006","journal":"Annals of internal medicine","n_participants":null,"pmid":"24490265","source_url":"https://pubmed.ncbi.nlm.nih.gov/24490265/","study_design":null,"title":"Long-term multivitamin supplementation and cognitive function in men: a randomized trial","title_match":false,"year":2013},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/cordial-cognitive-rehabilitation-and-cognitive-behavioral-treatment-21986341","doi":"10.1097/wad.0b013e318231e46e","journal":"Alzheimer disease and associated disorders","n_participants":201,"pmid":"21986341","source_url":"https://pubmed.ncbi.nlm.nih.gov/21986341/","study_design":null,"title":"CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial","title_match":true,"year":2012},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/donepezil-improves-obstructive-sleep-apnea-in-alzheimer-disease-a-18198262","doi":"10.1378/chest.07-1446","journal":"Chest","n_participants":null,"pmid":"18198262","source_url":"https://pubmed.ncbi.nlm.nih.gov/18198262/","study_design":null,"title":"Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study","title_match":true,"year":2008},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/blood-pressure-variability-and-progression-of-clinical-alzheimer-31542965","doi":"10.1161/hypertensionaha.119.13664","journal":"Hypertension (Dallas, Tex. : 1979)","n_participants":460,"pmid":"31542965","source_url":"https://pubmed.ncbi.nlm.nih.gov/31542965/","study_design":"randomized controlled trial","title":"Blood Pressure Variability and Progression of Clinical Alzheimer Disease","title_match":false,"year":2019},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/divalproex-sodium-in-nursing-home-residents-with-possible-or-probable-16286437","doi":"10.1176/appi.ajgp.13.11.942","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":75,"pmid":"16286437","source_url":"https://pubmed.ncbi.nlm.nih.gov/16286437/","study_design":null,"title":"Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial","title_match":true,"year":2005},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/effect-of-cerebellum-stimulation-on-cognitive-recovery-in-patients-35700915","doi":"10.1016/j.brs.2022.06.004","journal":"Brain stimulation","n_participants":27,"pmid":"35700915","source_url":"https://pubmed.ncbi.nlm.nih.gov/35700915/","study_design":null,"title":"Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial","title_match":true,"year":2022},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/celecoxib-or-naproxen-treatment-does-not-benefit-depressive-symptoms-21775876","doi":"10.1097/jgp.0b013e318227f4da","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":2528,"pmid":"21775876","source_url":"https://pubmed.ncbi.nlm.nih.gov/21775876/","study_design":"longitudinal study","title":"Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older:  findings from a randomized controlled trial","title_match":true,"year":2012},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/growth-hormone-secretagogue-mk-677-no-clinical-effect-on-ad-19015485","doi":"10.1212/01.wnl.0000335163.88054.e7","journal":"Neurology","n_participants":563,"pmid":"19015485","source_url":"https://pubmed.ncbi.nlm.nih.gov/19015485/","study_design":null,"title":"Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial","title_match":false,"year":2008},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/a-three-country-randomized-controlled-trial-of-a-psychosocial-18978250","doi":"10.1097/jgp.0b013e3181898095","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"18978250","source_url":"https://pubmed.ncbi.nlm.nih.gov/18978250/","study_design":"randomized controlled trial","title":"A three-country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: effects on caregiver depression","title_match":true,"year":2008},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-study-of-aripiprazole-18591574","doi":"10.1097/jgp.0b013e318165db77","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":131,"pmid":"18591574","source_url":"https://pubmed.ncbi.nlm.nih.gov/18591574/","study_design":null,"title":"A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease","title_match":true,"year":2008},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/a-pilot-randomized-trial-of-carbamazepine-for-behavioral-symptoms-in-11739066","doi":"10.1176/appi.ajgp.9.4.400","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"11739066","source_url":"https://pubmed.ncbi.nlm.nih.gov/11739066/","study_design":null,"title":"A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease","title_match":false,"year":2001},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/technology-enhanced-multi-domain-at-home-continuum-of-care-program-27887597","doi":"10.1186/s12888-016-1132-y","journal":"BMC psychiatry","n_participants":30,"pmid":"27887597","source_url":"https://pubmed.ncbi.nlm.nih.gov/27887597/","study_design":"randomized controlled trial","title":"Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial","title_match":true,"year":2016},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/effects-of-non-steroidal-anti-inflammatory-drug-treatments-on-21560159","doi":"10.1002/gps.2723","journal":"International journal of geriatric psychiatry","n_participants":2388,"pmid":"21560159","source_url":"https://pubmed.ncbi.nlm.nih.gov/21560159/","study_design":null,"title":"Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial","title_match":true,"year":2012},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/ginkgo-for-elderly-people-with-dementia-and-age-associated-memory-12767414","doi":"10.1016/s0895-4356(03)00003-9","journal":"Journal of clinical epidemiology","n_participants":79,"pmid":"12767414","source_url":"https://pubmed.ncbi.nlm.nih.gov/12767414/","study_design":null,"title":"Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial","title_match":true,"year":2003},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/deep-brain-stimulation-targeting-the-fornix-for-mild-alzheimer-29914028","doi":"10.3233/jad-180121","journal":"Journal of Alzheimer's disease : JAD","n_participants":42,"pmid":"29914028","source_url":"https://pubmed.ncbi.nlm.nih.gov/29914028/","study_design":"post-hoc analysis","title":"Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation","title_match":false,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/healthy-brain-aging-role-of-exercise-and-physical-activity-20176294","doi":"10.1016/j.cger.2009.11.002","journal":"Clinics in geriatric medicine","n_participants":null,"pmid":"20176294","source_url":"https://pubmed.ncbi.nlm.nih.gov/20176294/","study_design":"randomized controlled trial","title":"Healthy brain aging: role of exercise and physical activity","title_match":false,"year":2010},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-anti-inflammatory-prevention-trial-design-methods-19328435","doi":"10.1016/j.jalz.2008.09.004","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"19328435","source_url":"https://pubmed.ncbi.nlm.nih.gov/19328435/","study_design":null,"title":"Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results","title_match":false,"year":2009},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-assessment-scale-evaluation-of-psychometric-11723368","doi":"10.1097/00002093-200110000-00003","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"11723368","source_url":"https://pubmed.ncbi.nlm.nih.gov/11723368/","study_design":null,"title":"The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease","title_match":true,"year":2001},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/response-of-patients-with-alzheimer-disease-to-rivastigmine-treatment-11255445","doi":"10.1001/archneur.58.3.417","journal":"Archives of neurology","n_participants":187,"pmid":"11255445","source_url":"https://pubmed.ncbi.nlm.nih.gov/11255445/","study_design":"open-label trial","title":"Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression","title_match":false,"year":2001},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/benefit-finding-and-effect-on-caregiver-depression-a-double-blind-28287803","doi":"10.1037/ccp0000176","journal":"Journal of consulting and clinical psychology","n_participants":null,"pmid":"28287803","source_url":"https://pubmed.ncbi.nlm.nih.gov/28287803/","study_design":null,"title":"Benefit-finding and effect on caregiver depression: A double-blind randomized controlled trial","title_match":true,"year":2017},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/commentary-on-a-roadmap-for-the-prevention-of-dementia-ii-leon-thal-19328438","doi":"10.1016/j.jalz.2009.01.008","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":300,"pmid":"19328438","source_url":"https://pubmed.ncbi.nlm.nih.gov/19328438/","study_design":null,"title":"Commentary on \"A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.\" The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease","title_match":false,"year":2009},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/double-blind-placebo-controlled-study-with-citicoline-in-apoe-10669911","doi":"10.1358/mf.1999.21.9.795632","journal":"Methods and findings in experimental and clinical pharmacology","n_participants":17,"pmid":"10669911","source_url":"https://pubmed.ncbi.nlm.nih.gov/10669911/","study_design":null,"title":"Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion","title_match":true,"year":1999},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/cardioprotective-glucose-lowering-agents-and-dementia-risk-a-40193122","doi":"10.1001/jamaneurol.2025.0360","journal":"JAMA neurology","n_participants":164,"pmid":"40193122","source_url":"https://pubmed.ncbi.nlm.nih.gov/40193122/","study_design":"meta-analysis","title":"Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/safety-and-pharmacology-of-a-single-intravenous-dose-of-ponezumab-in-23334070","doi":"10.1097/wnf.0b013e31827db49b","journal":"Clinical neuropharmacology","n_participants":null,"pmid":"23334070","source_url":"https://pubmed.ncbi.nlm.nih.gov/23334070/","study_design":null,"title":"Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study","title_match":true,"year":2013},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/efficacy-safety-and-tolerability-of-rivastigmine-capsules-in-patients-18674411","doi":"10.1185/03007990802328142","journal":"Current medical research and opinion","n_participants":710,"pmid":"18674411","source_url":"https://pubmed.ncbi.nlm.nih.gov/18674411/","study_design":null,"title":"Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study","title_match":false,"year":2008},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/p75-neurotrophin-receptor-modulation-in-mild-to-moderate-alzheimer-38760589","doi":"10.1038/s41591-024-02977-w","journal":"Nature medicine","n_participants":242,"pmid":"38760589","source_url":"https://pubmed.ncbi.nlm.nih.gov/38760589/","study_design":null,"title":"p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial","title_match":true,"year":2024},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/effect-of-study-partner-on-the-conduct-of-alzheimer-disease-clinical-23255824","doi":"10.1212/wnl.0b013e31827debfe","journal":"Neurology","n_participants":null,"pmid":"23255824","source_url":"https://pubmed.ncbi.nlm.nih.gov/23255824/","study_design":null,"title":"Effect of study partner on the conduct of Alzheimer disease clinical trials","title_match":true,"year":2013},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/association-of-intensive-vs-standard-blood-pressure-control-with-33683313","doi":"10.1001/jamaneurol.2021.0178","journal":"JAMA neurology","n_participants":1267,"pmid":"33683313","source_url":"https://pubmed.ncbi.nlm.nih.gov/33683313/","study_design":"meta-analysis","title":"Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial","title_match":false,"year":2021},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/neuron-derived-extracellular-vesicles-in-blood-reveal-effects-of-37730689","doi":"10.1186/s13195-023-01303-9","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"37730689","source_url":"https://pubmed.ncbi.nlm.nih.gov/37730689/","study_design":"randomized controlled trial","title":"Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/a-novel-abeta-isoform-pattern-in-csf-reflects-gamma-secretase-20350302","doi":"10.1186/alzrt30","journal":"Alzheimer's research & therapy","n_participants":35,"pmid":"20350302","source_url":"https://pubmed.ncbi.nlm.nih.gov/20350302/","study_design":null,"title":"A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease","title_match":false,"year":2010},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/a-randomized-placebo-controlled-trial-of-latrepirdine-in-huntington-20142523","doi":"10.1001/archneurol.2009.334","journal":"Archives of neurology","n_participants":46,"pmid":"20142523","source_url":"https://pubmed.ncbi.nlm.nih.gov/20142523/","study_design":null,"title":"A randomized, placebo-controlled trial of latrepirdine in Huntington disease","title_match":true,"year":2010},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/vascular-care-in-patients-with-alzheimer-disease-with-cerebrovascular-20056923","doi":"10.1161/strokeaha.109.571281","journal":"Stroke","n_participants":123,"pmid":"20056923","source_url":"https://pubmed.ncbi.nlm.nih.gov/20056923/","study_design":null,"title":"Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study","title_match":false,"year":2010},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/effect-of-tacrine-on-language-praxis-and-noncognitive-behavioral-9236571","doi":"10.1001/archneur.1997.00550190026010","journal":"Archives of neurology","n_participants":181,"pmid":"9236571","source_url":"https://pubmed.ncbi.nlm.nih.gov/9236571/","study_design":null,"title":"Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease","title_match":false,"year":1997},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/comparing-the-effects-of-multisensory-stimulation-and-individualized-27060958","doi":"10.3233/jad-151150","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"27060958","source_url":"https://pubmed.ncbi.nlm.nih.gov/27060958/","study_design":null,"title":"Comparing the Effects of Multisensory Stimulation and Individualized Music Sessions on Elderly People with Severe Dementia: A Randomized Controlled Trial","title_match":true,"year":2016},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/i-know-what-you-told-me-but-this-is-what-i-think-perceived-risk-of-20139767","doi":"10.1097/gim.0b013e3181cef9e1","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","n_participants":158,"pmid":"20139767","source_url":"https://pubmed.ncbi.nlm.nih.gov/20139767/","study_design":"randomized controlled trial","title":"\"I know what you told me, but this is what I think:\" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate","title_match":false,"year":2010},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/the-peaceful-mind-program-a-pilot-test-of-a-cognitive-behavioral-23567399","doi":"10.1016/j.jagp.2013.01.007","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"23567399","source_url":"https://pubmed.ncbi.nlm.nih.gov/23567399/","study_design":"randomized controlled trial","title":"The peaceful mind program: a pilot test of a cognitive-behavioral therapy-based intervention for anxious patients with dementia","title_match":false,"year":2013},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/brief-psychosocial-therapy-for-the-treatment-of-agitation-in-19700946","doi":"10.1097/jgp.0b013e3181b0f8c0","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":318,"pmid":"19700946","source_url":"https://pubmed.ncbi.nlm.nih.gov/19700946/","study_design":"randomized controlled trial","title":"Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)","title_match":false,"year":2009},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/continuous-csf-drainage-in-ad-results-of-a-double-blind-randomized-18525029","doi":"10.1212/01.wnl.0000316197.04157.6f","journal":"Neurology","n_participants":215,"pmid":"18525029","source_url":"https://pubmed.ncbi.nlm.nih.gov/18525029/","study_design":"longitudinal study","title":"Continuous CSF drainage in AD: results of a double-blind, randomized, placebo-controlled study","title_match":true,"year":2008},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/ampa-potentiator-treatment-of-cognitive-deficits-in-alzheimer-disease-17389305","doi":"10.1212/01.wnl.0000260240.46070.7c","journal":"Neurology","n_participants":90,"pmid":"17389305","source_url":"https://pubmed.ncbi.nlm.nih.gov/17389305/","study_design":null,"title":"AMPA potentiator treatment of cognitive deficits in Alzheimer disease","title_match":false,"year":2007},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/risperidone-in-the-treatment-of-psychosis-of-alzheimer-disease-16505133","doi":"10.1097/01.jgp.0000194643.63245.8c","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":238,"pmid":"16505133","source_url":"https://pubmed.ncbi.nlm.nih.gov/16505133/","study_design":null,"title":"Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial","title_match":true,"year":2006},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/effects-of-dha-rich-n-3-fatty-acid-supplementation-on-gene-expression-22545106","doi":"10.1371/journal.pone.0035425","journal":"PloS one","n_participants":16,"pmid":"22545106","source_url":"https://pubmed.ncbi.nlm.nih.gov/22545106/","study_design":null,"title":"Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study","title_match":false,"year":2012},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/treatment-of-cardiovascular-risk-factors-to-prevent-cognitive-decline-20859546","doi":"10.2147/vhrm.s7343","journal":"Vascular health and risk management","n_participants":null,"pmid":"20859546","source_url":"https://pubmed.ncbi.nlm.nih.gov/20859546/","study_design":null,"title":"Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review","title_match":false,"year":2010},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/neuroprotective-effect-of-trans-resveratrol-in-mild-to-moderate-34402024","doi":"10.1007/s40120-021-00271-2","journal":"Neurology and therapy","n_participants":15,"pmid":"34402024","source_url":"https://pubmed.ncbi.nlm.nih.gov/34402024/","study_design":"case-control study","title":"Neuroprotective Effect of Trans-Resveratrol in Mild to Moderate Alzheimer Disease: A Randomized, Double-Blind Trial","title_match":true,"year":2021},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/low-dose-ladostigil-for-mild-cognitive-impairment-a-phase-2-placebo-31492718","doi":"10.1212/wnl.0000000000008239","journal":"Neurology","n_participants":107,"pmid":"31492718","source_url":"https://pubmed.ncbi.nlm.nih.gov/31492718/","study_design":"clinical trial","title":"Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial","title_match":true,"year":2019},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/effects-of-nilvadipine-on-cerebral-blood-flow-in-patients-with-31203725","doi":"10.1161/hypertensionaha.119.12892","journal":"Hypertension (Dallas, Tex. : 1979)","n_participants":null,"pmid":"31203725","source_url":"https://pubmed.ncbi.nlm.nih.gov/31203725/","study_design":null,"title":"Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease","title_match":false,"year":2019},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/economic-evaluation-of-donepezil-in-moderate-to-severe-alzheimer-15326236","doi":"10.1212/01.wnl.0000134663.79663.6e","journal":"Neurology","n_participants":144,"pmid":"15326236","source_url":"https://pubmed.ncbi.nlm.nih.gov/15326236/","study_design":null,"title":"Economic evaluation of donepezil in moderate to severe Alzheimer disease","title_match":false,"year":2004},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/what-do-people-at-risk-for-alzheimer-disease-think-about-surrogate-16275826","doi":"10.1212/01.wnl.0000183144.61428.73","journal":"Neurology","n_participants":null,"pmid":"16275826","source_url":"https://pubmed.ncbi.nlm.nih.gov/16275826/","study_design":null,"title":"What do people at risk for Alzheimer disease think about surrogate consent for research?","title_match":false,"year":2005},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/effect-of-rotigotine-vs-placebo-on-cognitive-functions-among-patients-32667654","doi":"10.1001/jamanetworkopen.2020.10372","journal":"JAMA network open","n_participants":47,"pmid":"32667654","source_url":"https://pubmed.ncbi.nlm.nih.gov/32667654/","study_design":"longitudinal study","title":"Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/hmg-coa-reductase-inhibitors-statins-in-the-treatment-of-alzheimer-s-12474023","doi":null,"journal":"The journal of nutrition, health & aging","n_participants":null,"pmid":"12474023","source_url":"https://pubmed.ncbi.nlm.nih.gov/12474023/","study_design":null,"title":"HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier","title_match":false,"year":2002},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/effect-of-exercise-training-or-complex-mental-and-social-activities-36227593","doi":"10.1001/jamanetworkopen.2022.36510","journal":"JAMA network open","n_participants":34,"pmid":"36227593","source_url":"https://pubmed.ncbi.nlm.nih.gov/36227593/","study_design":null,"title":"Effect of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic Stroke: A Randomized Clinical Trial","title_match":true,"year":2022},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/magnetic-resonance-imaging-predictors-of-cognition-in-mild-cognitive-17620494","doi":"10.1001/archneur.64.7.1023","journal":"Archives of neurology","n_participants":896,"pmid":"17620494","source_url":"https://pubmed.ncbi.nlm.nih.gov/17620494/","study_design":"cohort study","title":"Magnetic resonance imaging predictors of cognition in mild cognitive impairment","title_match":false,"year":2007},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/clinical-efficacy-and-safety-of-huperzine-alpha-in-treatment-of-mild-12181083","doi":null,"journal":"Zhonghua yi xue za zhi","n_participants":100,"pmid":"12181083","source_url":"https://pubmed.ncbi.nlm.nih.gov/12181083/","study_design":null,"title":"[Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]","title_match":true,"year":2002},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/selegiline-in-the-treatment-of-alzheimer-s-disease-a-long-term-10354658","doi":null,"journal":"Journal of psychiatry & neuroscience : JPN","n_participants":143,"pmid":"10354658","source_url":"https://pubmed.ncbi.nlm.nih.gov/10354658/","study_design":null,"title":"Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group","title_match":true,"year":1999},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/multidomain-lifestyle-interventions-for-the-prevention-of-cognitive-26374482","doi":"10.1161/strokeaha.115.009992","journal":"Stroke","n_participants":101,"pmid":"26374482","source_url":"https://pubmed.ncbi.nlm.nih.gov/26374482/","study_design":null,"title":"Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke: Randomized Trial","title_match":false,"year":2015},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/effectiveness-of-personalized-hippocampal-network-targeted-38709534","doi":"10.1001/jamanetworkopen.2024.9220","journal":"JAMA network open","n_participants":30,"pmid":"38709534","source_url":"https://pubmed.ncbi.nlm.nih.gov/38709534/","study_design":null,"title":"Effectiveness of Personalized Hippocampal Network-Targeted Stimulation in Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2024},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/treating-neuropsychiatric-symptoms-in-dementia-with-lewy-bodies-a-20625270","doi":"10.1097/wad.0b013e3181e6a4d7","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"20625270","source_url":"https://pubmed.ncbi.nlm.nih.gov/20625270/","study_design":null,"title":"Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial","title_match":true,"year":2010},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/double-blind-placebo-controlled-study-of-acetyl-l-carnitine-in-2178869","doi":"10.1185/03007999009112690","journal":"Current medical research and opinion","n_participants":36,"pmid":"2178869","source_url":"https://pubmed.ncbi.nlm.nih.gov/2178869/","study_design":null,"title":"Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia","title_match":true,"year":1990},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effect-of-long-term-omega-3-supplementation-and-a-lifestyle-33036701","doi":"10.1016/j.maturitas.2020.06.012","journal":"Maturitas","n_participants":1445,"pmid":"33036701","source_url":"https://pubmed.ncbi.nlm.nih.gov/33036701/","study_design":null,"title":"Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study)","title_match":true,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/heterogeneity-of-treatment-response-to-citalopram-for-patients-with-26771737","doi":"10.1176/appi.ajp.2015.15050648","journal":"The American journal of psychiatry","n_participants":186,"pmid":"26771737","source_url":"https://pubmed.ncbi.nlm.nih.gov/26771737/","study_design":null,"title":"Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial","title_match":true,"year":2016},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/comparison-of-sertraline-venlafaxine-and-desipramine-effects-on-24955552","doi":"10.1055/s-0034-1377041","journal":"Pharmacopsychiatry","n_participants":null,"pmid":"24955552","source_url":"https://pubmed.ncbi.nlm.nih.gov/24955552/","study_design":null,"title":"Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients","title_match":false,"year":2014},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-an-activity-specific-exercise-21937893","doi":"10.1519/jpt.0b013e31820aab9c","journal":"Journal of geriatric physical therapy (2001)","n_participants":null,"pmid":"21937893","source_url":"https://pubmed.ncbi.nlm.nih.gov/21937893/","study_design":null,"title":"A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings","title_match":true,"year":2011},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/risks-and-benefits-of-screening-for-dementia-in-primary-care-the-31792940","doi":"10.1111/jgs.16247","journal":"Journal of the American Geriatrics Society","n_participants":2008,"pmid":"31792940","source_url":"https://pubmed.ncbi.nlm.nih.gov/31792940/","study_design":"randomized controlled trial","title":"Risks and Benefits of Screening for Dementia in Primary Care: The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of Dementia Screening (IU CHOICE)Trial","title_match":false,"year":2020},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/effect-of-sodium-benzoate-on-cognitive-function-among-patients-with-33881530","doi":"10.1001/jamanetworkopen.2021.6156","journal":"JAMA network open","n_participants":97,"pmid":"33881530","source_url":"https://pubmed.ncbi.nlm.nih.gov/33881530/","study_design":null,"title":"Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial","title_match":true,"year":2021},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/preservation-of-the-capacity-to-appoint-a-proxy-decision-maker-21300949","doi":"10.1001/archgenpsychiatry.2010.191","journal":"Archives of general psychiatry","n_participants":null,"pmid":"21300949","source_url":"https://pubmed.ncbi.nlm.nih.gov/21300949/","study_design":null,"title":"Preservation of the capacity to appoint a proxy decision maker: implications for dementia research","title_match":false,"year":2011},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-views-of-alzheimer-disease-patients-and-their-study-partners-on-18310554","doi":"10.1097/jgp.0b013e318162992d","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"18310554","source_url":"https://pubmed.ncbi.nlm.nih.gov/18310554/","study_design":"randomized controlled trial","title":"The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment","title_match":true,"year":2008},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-aria-in-clinical-trials-of-39556389","doi":"10.1001/jamaneurol.2024.3937","journal":"JAMA neurology","n_participants":985,"pmid":"39556389","source_url":"https://pubmed.ncbi.nlm.nih.gov/39556389/","study_design":"clinical trial","title":"Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease","title_match":true,"year":2025},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-disclosing-genetic-risk-information-28726810","doi":"10.1038/gim.2017.103","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","n_participants":257,"pmid":"28726810","source_url":"https://pubmed.ncbi.nlm.nih.gov/28726810/","study_design":null,"title":"A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone","title_match":true,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/growth-hormone-releasing-hormone-effects-on-brain-aminobutyric-acid-23689947","doi":"10.1001/jamaneurol.2013.1425","journal":"JAMA neurology","n_participants":null,"pmid":"23689947","source_url":"https://pubmed.ncbi.nlm.nih.gov/23689947/","study_design":null,"title":"Growth hormone-releasing hormone effects on brain \u03b3-aminobutyric acid levels in mild cognitive impairment and healthy aging","title_match":false,"year":2013},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-trial-of-triflusal-in-18317243","doi":"10.1097/wad.0b013e3181611024","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"18317243","source_url":"https://pubmed.ncbi.nlm.nih.gov/18317243/","study_design":null,"title":"A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study","title_match":true,"year":2008},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/proportion-of-women-and-reporting-of-outcomes-by-sex-in-clinical-34515784","doi":"10.1001/jamanetworkopen.2021.24124","journal":"JAMA network open","n_participants":100,"pmid":"34515784","source_url":"https://pubmed.ncbi.nlm.nih.gov/34515784/","study_design":"systematic review","title":"Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis","title_match":true,"year":2021},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/caregiver-preference-for-rivastigmine-patches-versus-capsules-for-the-17646620","doi":"10.1212/01.wnl.0000281848.25142.11","journal":"Neurology","n_participants":1059,"pmid":"17646620","source_url":"https://pubmed.ncbi.nlm.nih.gov/17646620/","study_design":null,"title":"Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease","title_match":false,"year":2007},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effects-of-transcranial-pulse-stimulation-tps-on-adults-with-symptoms-36767702","doi":"10.3390/ijerph20032333","journal":"International journal of environmental research and public health","n_participants":30,"pmid":"36767702","source_url":"https://pubmed.ncbi.nlm.nih.gov/36767702/","study_design":"randomized controlled trial","title":"Effects of Transcranial Pulse Stimulation (TPS) on Adults with Symptoms of Depression-A Pilot Randomized Controlled Trial","title_match":true,"year":2023},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/cognitive-changes-with-omega-3-polyunsaturated-fatty-acids-in-non-29083439","doi":"10.1007/s12603-017-0957-5","journal":"The journal of nutrition, health & aging","n_participants":183,"pmid":"29083439","source_url":"https://pubmed.ncbi.nlm.nih.gov/29083439/","study_design":"randomized controlled trial","title":"Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index","title_match":false,"year":2017},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/atomoxetine-augmentation-of-cholinesterase-inhibitor-therapy-in-19700948","doi":"10.1097/jgp.0b013e3181aad585","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":92,"pmid":"19700948","source_url":"https://pubmed.ncbi.nlm.nih.gov/19700948/","study_design":null,"title":"Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study","title_match":true,"year":2009},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/telehealth-rehabilitation-for-cognitive-impairment-randomized-29422453","doi":"10.2196/resprot.9420","journal":"JMIR research protocols","n_participants":null,"pmid":"29422453","source_url":"https://pubmed.ncbi.nlm.nih.gov/29422453/","study_design":null,"title":"Telehealth Rehabilitation for Cognitive Impairment: Randomized Controlled Feasibility Trial","title_match":true,"year":2018},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/aerobic-exercise-sustains-performance-of-instrumental-activities-of-29286983","doi":"10.1519/jpt.0000000000000172","journal":"Journal of geriatric physical therapy (2001)","n_participants":null,"pmid":"29286983","source_url":"https://pubmed.ncbi.nlm.nih.gov/29286983/","study_design":"randomized controlled trial","title":"Aerobic Exercise Sustains Performance of Instrumental Activities of Daily Living in Early-Stage Alzheimer Disease","title_match":false,"year":2019},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-efficacy-safety-and-tolerability-of-donepezil-for-the-treatment-19606472","doi":"10.1002/ajmg.a.32953","journal":"American journal of medical genetics. Part A","n_participants":123,"pmid":"19606472","source_url":"https://pubmed.ncbi.nlm.nih.gov/19606472/","study_design":"open-label trial","title":"The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome","title_match":false,"year":2009},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/activities-of-daily-living-in-moderate-to-severe-alzheimer-disease-an-17132971","doi":"10.1097/01.wad.0000213859.35355.59","journal":"Alzheimer disease and associated disorders","n_participants":404,"pmid":"17132971","source_url":"https://pubmed.ncbi.nlm.nih.gov/17132971/","study_design":null,"title":"Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment","title_match":false,"year":2006},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/slowing-the-progression-of-alzheimer-disease-methodologic-issues-9348423","doi":null,"journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"9348423","source_url":"https://pubmed.ncbi.nlm.nih.gov/9348423/","study_design":null,"title":"Slowing the progression of Alzheimer disease: methodologic issues","title_match":false,"year":1997},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/short-term-effects-of-a-gain-focused-reappraisal-intervention-for-27401052","doi":"10.1016/j.jagp.2016.04.012","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"27401052","source_url":"https://pubmed.ncbi.nlm.nih.gov/27401052/","study_design":null,"title":"Short-Term Effects of a Gain-Focused Reappraisal Intervention for Dementia Caregivers: A Double-Blind Cluster-Randomized Controlled Trial","title_match":true,"year":2016},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/raloxifene-for-women-with-alzheimer-disease-a-randomized-controlled-26537053","doi":"10.1212/wnl.0000000000002171","journal":"Neurology","n_participants":null,"pmid":"26537053","source_url":"https://pubmed.ncbi.nlm.nih.gov/26537053/","study_design":null,"title":"Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial","title_match":true,"year":2015},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/action-of-estrogens-in-the-aging-brain-dementia-and-cognitive-aging-19913598","doi":"10.1016/j.bbagen.2009.11.005","journal":"Biochimica et biophysica acta","n_participants":null,"pmid":"19913598","source_url":"https://pubmed.ncbi.nlm.nih.gov/19913598/","study_design":null,"title":"Action of estrogens in the aging brain: dementia and cognitive aging","title_match":false,"year":2010},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/genetic-susceptibility-testing-versus-family-history-based-risk-15654228","doi":"10.1097/01.gim.0000151157.13716.6c","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","n_participants":30,"pmid":"15654228","source_url":"https://pubmed.ncbi.nlm.nih.gov/15654228/","study_design":null,"title":"Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease","title_match":false,"year":2005},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/huperzine-a-in-capsules-and-tablets-for-treating-patients-with-10678137","doi":null,"journal":"Zhongguo yao li xue bao = Acta pharmacologica Sinica","n_participants":60,"pmid":"10678137","source_url":"https://pubmed.ncbi.nlm.nih.gov/10678137/","study_design":null,"title":"Huperzine-A in capsules and tablets for treating patients with Alzheimer disease","title_match":false,"year":1999},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/a-phase-i-study-to-assess-the-effect-of-speed-of-injection-on-pain-31883703","doi":"10.1016/j.clinthera.2019.11.015","journal":"Clinical therapeutics","n_participants":null,"pmid":"31883703","source_url":"https://pubmed.ncbi.nlm.nih.gov/31883703/","study_design":"open-label trial","title":"A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers","title_match":true,"year":2020},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/effect-of-copper-intake-on-csf-parameters-in-patients-with-mild-18972062","doi":"10.1007/s00702-008-0136-2","journal":"Journal of neural transmission (Vienna, Austria : 1996)","n_participants":null,"pmid":"18972062","source_url":"https://pubmed.ncbi.nlm.nih.gov/18972062/","study_design":"clinical trial","title":"Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial","title_match":true,"year":2008},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/cost-benefit-analysis-of-second-generation-antipsychotics-and-placebo-17984395","doi":"10.1001/archpsyc.64.11.1259","journal":"Archives of general psychiatry","n_participants":421,"pmid":"17984395","source_url":"https://pubmed.ncbi.nlm.nih.gov/17984395/","study_design":"clinical trial","title":"Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease","title_match":false,"year":2007},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/a-pilot-study-of-vitamins-to-lower-plasma-homocysteine-levels-in-12611755","doi":"10.1176/appi.ajgp.11.2.246","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":69,"pmid":"12611755","source_url":"https://pubmed.ncbi.nlm.nih.gov/12611755/","study_design":"open-label trial","title":"A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease","title_match":false,"year":2003},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/safety-tolerability-and-immunogenicity-of-the-aci-24-vaccine-in-35532913","doi":"10.1001/jamaneurol.2022.0983","journal":"JAMA neurology","n_participants":20,"pmid":"35532913","source_url":"https://pubmed.ncbi.nlm.nih.gov/35532913/","study_design":null,"title":"Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial","title_match":true,"year":2022},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/results-from-a-phase-ii-study-to-assess-the-clinical-and-29231230","doi":"10.14283/jpad.2015.63","journal":"The journal of prevention of Alzheimer's disease","n_participants":332,"pmid":"29231230","source_url":"https://pubmed.ncbi.nlm.nih.gov/29231230/","study_design":null,"title":"Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE\u00ae AD02 in Patients with Early Alzheimer's Disease","title_match":true,"year":2015},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/improving-depression-and-enhancing-resilience-in-family-dementia-20104071","doi":"10.1097/jgp.0b013e3181beab1e","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"20104071","source_url":"https://pubmed.ncbi.nlm.nih.gov/20104071/","study_design":"randomized controlled trial","title":"Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram","title_match":true,"year":2010},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/the-effects-of-counseling-spouse-caregivers-of-people-with-alzheimer-19705519","doi":"10.1097/jgp.0b013e3181a65187","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"19705519","source_url":"https://pubmed.ncbi.nlm.nih.gov/19705519/","study_design":"randomized controlled trial","title":"The effects of counseling spouse caregivers of people with Alzheimer disease taking donepezil and of country of residence on rates of admission to nursing homes and mortality","title_match":false,"year":2009},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/is-more-always-better-dose-effect-in-a-multidomain-intervention-in-35049127","doi":"10.1002/alz.12544","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":749,"pmid":"35049127","source_url":"https://pubmed.ncbi.nlm.nih.gov/35049127/","study_design":"randomized controlled trial","title":"Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia","title_match":false,"year":2022},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/do-hearing-aids-influence-behavioral-and-psychological-symptoms-of-28269769","doi":"10.3233/jad-160792","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"28269769","source_url":"https://pubmed.ncbi.nlm.nih.gov/28269769/","study_design":null,"title":"Do Hearing Aids Influence Behavioral and Psychological Symptoms of Dementia and Quality of Life in Hearing Impaired Alzheimer's Disease Patients and Their Caregivers?","title_match":false,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/multisensory-stimulation-as-an-intervention-strategy-for-elderly-26631687","doi":"10.1177/1533317515618801","journal":"American journal of Alzheimer's disease and other dementias","n_participants":null,"pmid":"26631687","source_url":"https://pubmed.ncbi.nlm.nih.gov/26631687/","study_design":null,"title":"Multisensory Stimulation as an Intervention Strategy for Elderly Patients With Severe Dementia: A Pilot Randomized Controlled Trial","title_match":true,"year":2016},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/cognitive-outcomes-after-sertaline-treatment-in-patients-with-23032478","doi":"10.1097/jgp.0b013e31826ce4c5","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":67,"pmid":"23032478","source_url":"https://pubmed.ncbi.nlm.nih.gov/23032478/","study_design":null,"title":"Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/a-benefit-finding-intervention-for-family-caregivers-of-persons-with-22747914","doi":"10.1186/1745-6215-13-98","journal":"Trials","n_participants":null,"pmid":"22747914","source_url":"https://pubmed.ncbi.nlm.nih.gov/22747914/","study_design":null,"title":"A benefit-finding intervention for family caregivers of persons with Alzheimer disease: study protocol of a randomized controlled trial","title_match":true,"year":2012},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/a-memory-and-organizational-aid-improves-alzheimer-disease-research-20808101","doi":"10.1097/jgp.0b013e3181dd1c3b","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"20808101","source_url":"https://pubmed.ncbi.nlm.nih.gov/20808101/","study_design":null,"title":"A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial","title_match":true,"year":2010},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/the-guidage-study-methodological-issues-a-5-year-double-blind-17101932","doi":"10.1212/wnl.67.9_suppl_3.s6","journal":"Neurology","n_participants":2854,"pmid":"17101932","source_url":"https://pubmed.ncbi.nlm.nih.gov/17101932/","study_design":"randomized controlled trial","title":"The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint","title_match":true,"year":2006},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-prevention-of-hip-fracture-with-risedronate-and-ergocalciferol-16087821","doi":"10.1001/archinte.165.15.1737","journal":"Archives of internal medicine","n_participants":29,"pmid":"16087821","source_url":"https://pubmed.ncbi.nlm.nih.gov/16087821/","study_design":null,"title":"The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial","title_match":true,"year":2005},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/a-multicenter-double-blind-study-of-controlled-release-physostigmine-8960716","doi":"10.1212/wnl.47.6.1389","journal":"Neurology","n_participants":366,"pmid":"8960716","source_url":"https://pubmed.ncbi.nlm.nih.gov/8960716/","study_design":null,"title":"A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group","title_match":true,"year":1996},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/estrogens-episodic-memory-and-alzheimer-s-disease-a-critical-update-19401959","doi":"10.1055/s-0029-1216281","journal":"Seminars in reproductive medicine","n_participants":null,"pmid":"19401959","source_url":"https://pubmed.ncbi.nlm.nih.gov/19401959/","study_design":"cohort study","title":"Estrogens, episodic memory, and Alzheimer's disease: a critical update","title_match":false,"year":2009},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/maxcog-maximizing-cognition-a-randomized-controlled-trial-of-the-28034509","doi":"10.1016/j.jagp.2016.11.008","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":55,"pmid":"28034509","source_url":"https://pubmed.ncbi.nlm.nih.gov/28034509/","study_design":"randomized controlled trial","title":"MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease","title_match":true,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/is-there-evidence-for-cognitive-intervention-in-alzheimer-disease-a-23314062","doi":"10.1097/wad.0b013e31827bda55","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"23314062","source_url":"https://pubmed.ncbi.nlm.nih.gov/23314062/","study_design":"randomized controlled trial","title":"Is there evidence for cognitive intervention in Alzheimer disease? A systematic review of efficacy, feasibility, and cost-effectiveness","title_match":false,"year":2013},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/cognitive-response-to-memantine-in-moderate-to-severe-alzheimer-17132970","doi":"10.1097/01.wad.0000213860.35355.d4","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"17132970","source_url":"https://pubmed.ncbi.nlm.nih.gov/17132970/","study_design":"post-hoc analysis","title":"Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis","title_match":false,"year":2006},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/psychosis-of-alzheimer-disease-validity-of-the-construct-and-response-12837670","doi":"10.1176/appi.ajgp.11.4.414","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"12837670","source_url":"https://pubmed.ncbi.nlm.nih.gov/12837670/","study_design":null,"title":"Psychosis of Alzheimer disease: validity of the construct and response to risperidone","title_match":false,"year":2003},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/the-empowering-role-of-mobile-apps-in-behavior-change-interventions-27485822","doi":"10.2196/mhealth.4878","journal":"JMIR mHealth and uHealth","n_participants":102,"pmid":"27485822","source_url":"https://pubmed.ncbi.nlm.nih.gov/27485822/","study_design":"randomized controlled trial","title":"The Empowering Role of Mobile Apps in Behavior Change Interventions: The Gray Matters Randomized Controlled Trial","title_match":true,"year":2016},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/effects-of-liraglutide-on-neurodegeneration-blood-flow-and-cognition-23158895","doi":null,"journal":"Danish medical journal","n_participants":20,"pmid":"23158895","source_url":"https://pubmed.ncbi.nlm.nih.gov/23158895/","study_design":null,"title":"Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer\u00b4s disease - protocol for a controlled, randomized double-blinded trial","title_match":false,"year":2012},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/effect-of-galantamine-on-verbal-repetition-in-ad-a-secondary-analysis-17404193","doi":"10.1212/01.wnl.0000258661.61577.b7","journal":"Neurology","n_participants":57,"pmid":"17404193","source_url":"https://pubmed.ncbi.nlm.nih.gov/17404193/","study_design":null,"title":"Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial","title_match":false,"year":2007},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/a-responder-analysis-of-memantine-treatment-in-patients-with-16670247","doi":"10.1097/01.jgp.0000203151.17311.38","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":404,"pmid":"16670247","source_url":"https://pubmed.ncbi.nlm.nih.gov/16670247/","study_design":null,"title":"A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil","title_match":false,"year":2006},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/slowing-cognitive-decline-in-major-depressive-disorder-and-mild-39476073","doi":"10.1001/jamapsychiatry.2024.3241","journal":"JAMA psychiatry","n_participants":null,"pmid":"39476073","source_url":"https://pubmed.ncbi.nlm.nih.gov/39476073/","study_design":null,"title":"Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/eligibility-rates-among-racially-and-ethnically-diverse-us-37830926","doi":"10.1002/ana.26819","journal":"Annals of neurology","n_participants":156,"pmid":"37830926","source_url":"https://pubmed.ncbi.nlm.nih.gov/37830926/","study_design":null,"title":"Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease","title_match":true,"year":2024},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/bupropion-for-the-treatment-of-apathy-in-alzheimer-disease-a-32463470","doi":"10.1001/jamanetworkopen.2020.6027","journal":"JAMA network open","n_participants":108,"pmid":"32463470","source_url":"https://pubmed.ncbi.nlm.nih.gov/32463470/","study_design":null,"title":"Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/benefit-finding-intervention-delivered-individually-to-alzheimer-31556447","doi":"10.1093/geronb/gbz118","journal":"The journals of gerontology. Series B, Psychological sciences and social sciences","n_participants":null,"pmid":"31556447","source_url":"https://pubmed.ncbi.nlm.nih.gov/31556447/","study_design":null,"title":"Benefit-Finding Intervention Delivered Individually to Alzheimer Family Caregivers: Longer-Term Outcomes of a Randomized Double-Blind Controlled Trial","title_match":true,"year":2020},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/disclosing-pleiotropic-effects-during-genetic-risk-assessment-for-26810768","doi":"10.7326/m15-0187","journal":"Annals of internal medicine","n_participants":null,"pmid":"26810768","source_url":"https://pubmed.ncbi.nlm.nih.gov/26810768/","study_design":null,"title":"Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial","title_match":false,"year":2016},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/donepezil-significantly-improves-abilities-in-daily-lives-of-female-21495523","doi":"10.2190/pm.41.1.g","journal":"International journal of psychiatry in medicine","n_participants":null,"pmid":"21495523","source_url":"https://pubmed.ncbi.nlm.nih.gov/21495523/","study_design":null,"title":"Donepezil significantly improves abilities in daily lives of female Down syndrome patients with severe cognitive impairment: a 24-week randomized, double-blind, placebo-controlled trial","title_match":true,"year":2011},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/rationale-and-design-of-a-multicenter-study-of-selegiline-and-alpha-8876776","doi":"10.1097/00002093-199601030-00004","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"8876776","source_url":"https://pubmed.ncbi.nlm.nih.gov/8876776/","study_design":null,"title":"Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study","title_match":false,"year":1996},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/ultrasound-neuromodulation-with-transcranial-pulse-stimulation-in-40009384","doi":"10.1001/jamanetworkopen.2024.59170","journal":"JAMA network open","n_participants":30,"pmid":"40009384","source_url":"https://pubmed.ncbi.nlm.nih.gov/40009384/","study_design":null,"title":"Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease: A Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/targeting-functional-decline-in-alzheimer-disease-a-randomized-trial-27893087","doi":"10.7326/m16-0830","journal":"Annals of internal medicine","n_participants":null,"pmid":"27893087","source_url":"https://pubmed.ncbi.nlm.nih.gov/27893087/","study_design":null,"title":"Targeting Functional Decline in Alzheimer Disease: A Randomized Trial","title_match":false,"year":2017},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/effects-of-lexical-semantic-treatment-on-memory-in-early-alzheimer-22460609","doi":"10.1177/1545968312440146","journal":"Neurorehabilitation and neural repair","n_participants":null,"pmid":"22460609","source_url":"https://pubmed.ncbi.nlm.nih.gov/22460609/","study_design":null,"title":"Effects of lexical-semantic treatment on memory in early Alzheimer disease: an observer-blinded randomized controlled trial","title_match":true,"year":2012},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/potential-cognitive-enhancing-and-disease-modification-effects-of-19300592","doi":null,"journal":"Neuropsychiatric disease and treatment","n_participants":null,"pmid":"19300592","source_url":"https://pubmed.ncbi.nlm.nih.gov/19300592/","study_design":"randomized controlled trial","title":"Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease","title_match":false,"year":2007},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-presence-of-a-caregiver-is-associated-with-patient-outcomes-in-32736164","doi":"10.1016/j.parkreldis.2020.07.003","journal":"Parkinsonism & related disorders","n_participants":210,"pmid":"32736164","source_url":"https://pubmed.ncbi.nlm.nih.gov/32736164/","study_design":"randomized controlled trial","title":"The presence of a caregiver is associated with patient outcomes in patients with Parkinson's disease and atypical parkinsonisms","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/cerebrolysin-in-alzheimer-s-disease-a-randomized-double-blind-placebo-12111446","doi":"10.1007/s007020200092","journal":"Journal of neural transmission (Vienna, Austria : 1996)","n_participants":192,"pmid":"12111446","source_url":"https://pubmed.ncbi.nlm.nih.gov/12111446/","study_design":null,"title":"Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent","title_match":true,"year":2002},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/lecanemab-reduces-brain-amyloid-and-delays-cognitive-worsening-36948153","doi":"10.1016/j.xcrm.2023.100982","journal":"Cell reports. Medicine","n_participants":null,"pmid":"36948153","source_url":"https://pubmed.ncbi.nlm.nih.gov/36948153/","study_design":null,"title":"Lecanemab reduces brain amyloid-\u03b2 and delays cognitive worsening","title_match":false,"year":2023},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-edonerpic-maleate-for-patients-with-mild-to-31282954","doi":"10.1001/jamaneurol.2019.1868","journal":"JAMA neurology","n_participants":482,"pmid":"31282954","source_url":"https://pubmed.ncbi.nlm.nih.gov/31282954/","study_design":"clinical trial","title":"Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/long-term-outcomes-of-the-benefit-finding-group-intervention-for-31076215","doi":"10.1016/j.jagp.2019.03.013","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":129,"pmid":"31076215","source_url":"https://pubmed.ncbi.nlm.nih.gov/31076215/","study_design":null,"title":"Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers: A Cluster-Randomized Double-Blind Controlled Trial","title_match":true,"year":2019},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/personality-factors-moderate-the-associations-between-apolipoprotein-23079898","doi":"10.1097/jgp.0b013e318267016b","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"23079898","source_url":"https://pubmed.ncbi.nlm.nih.gov/23079898/","study_design":null,"title":"Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/effect-of-an-antioxidant-drink-on-homocysteine-levels-in-alzheimer-s-20850133","doi":"10.1016/j.jns.2010.08.050","journal":"Journal of the neurological sciences","n_participants":100,"pmid":"20850133","source_url":"https://pubmed.ncbi.nlm.nih.gov/20850133/","study_design":null,"title":"Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients","title_match":false,"year":2010},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/l-deprenyl-in-the-treatment-of-mild-dementia-of-the-alzheimer-type-8227897","doi":"10.1111/j.1532-5415.1993.tb07306.x","journal":"Journal of the American Geriatrics Society","n_participants":39,"pmid":"8227897","source_url":"https://pubmed.ncbi.nlm.nih.gov/8227897/","study_design":null,"title":"L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial","title_match":false,"year":1993},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/effect-of-cholinesterase-inhibitors-on-mortality-in-patients-with-36096687","doi":"10.1212/wnl.0000000000201161","journal":"Neurology","n_participants":79153,"pmid":"36096687","source_url":"https://pubmed.ncbi.nlm.nih.gov/36096687/","study_design":"systematic review","title":"Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials","title_match":false,"year":2022},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/a-phase-ii-randomized-double-blind-placebo-controlled-study-of-safety-27589523","doi":"10.3233/jad-160369","journal":"Journal of Alzheimer's disease : JAD","n_participants":146,"pmid":"27589523","source_url":"https://pubmed.ncbi.nlm.nih.gov/27589523/","study_design":null,"title":"A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease","title_match":true,"year":2016},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/incorporating-ethnicity-into-genetic-risk-assessment-for-alzheimer-18344711","doi":"10.1097/gim.0b013e318164e4cf","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","n_participants":null,"pmid":"18344711","source_url":"https://pubmed.ncbi.nlm.nih.gov/18344711/","study_design":null,"title":"Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience","title_match":false,"year":2008},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/milacemide-a-placebo-controlled-study-in-senile-dementia-of-the-1634705","doi":"10.1111/j.1532-5415.1992.tb02019.x","journal":"Journal of the American Geriatrics Society","n_participants":113,"pmid":"1634705","source_url":"https://pubmed.ncbi.nlm.nih.gov/1634705/","study_design":null,"title":"Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type","title_match":true,"year":1992},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/phosphodiesterase-type-5-inhibitors-in-men-with-erectile-dysfunction-38324745","doi":"10.1212/wnl.0000000000209131","journal":"Neurology","n_participants":269725,"pmid":"38324745","source_url":"https://pubmed.ncbi.nlm.nih.gov/38324745/","study_design":"randomized controlled trial","title":"Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease: A Cohort Study","title_match":false,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/patterns-of-regional-brain-atrophy-and-brain-aging-in-middle-and-37261829","doi":"10.1001/jamanetworkopen.2023.16182","journal":"JAMA network open","n_participants":416,"pmid":"37261829","source_url":"https://pubmed.ncbi.nlm.nih.gov/37261829/","study_design":"cohort study","title":"Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes","title_match":false,"year":2023},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/prevention-of-cognitive-decline-in-subjective-cognitive-decline-apoe-33816762","doi":"10.1002/trc2.12155","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":200,"pmid":"33816762","source_url":"https://pubmed.ncbi.nlm.nih.gov/33816762/","study_design":null,"title":"Prevention of cognitive decline in subjective cognitive decline APOE \u03b54 carriers after EGCG and a multimodal intervention (PENSA): Study design","title_match":false,"year":2021},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effect-of-simvastatin-on-csf-alzheimer-disease-biomarkers-in-28821686","doi":"10.1212/wnl.0000000000004392","journal":"Neurology","n_participants":null,"pmid":"28821686","source_url":"https://pubmed.ncbi.nlm.nih.gov/28821686/","study_design":null,"title":"Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults","title_match":false,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/thinking-about-it-for-somebody-else-alzheimer-s-disease-research-and-23498380","doi":"10.1016/j.jagp.2012.11.014","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":40,"pmid":"23498380","source_url":"https://pubmed.ncbi.nlm.nih.gov/23498380/","study_design":null,"title":"\"Thinking about it for somebody else\": Alzheimer's disease research and proxy decision makers' translation of ethical principles into practice","title_match":false,"year":2013},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/effectiveness-of-a-condensed-protocol-for-disclosing-apoe-genotype-22498844","doi":"10.1038/gim.2012.37","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","n_participants":280,"pmid":"22498844","source_url":"https://pubmed.ncbi.nlm.nih.gov/22498844/","study_design":null,"title":"Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/interpreting-the-clinical-significance-of-capacity-scores-for-18556397","doi":"10.1097/jgp.0b013e318172b406","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"18556397","source_url":"https://pubmed.ncbi.nlm.nih.gov/18556397/","study_design":"cross-sectional","title":"Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials","title_match":true,"year":2008},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/comparison-of-three-rating-scales-as-outcome-measures-for-treatment-16955427","doi":"10.1002/gps.1583","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"16955427","source_url":"https://pubmed.ncbi.nlm.nih.gov/16955427/","study_design":null,"title":"Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS","title_match":false,"year":2006},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/effects-of-multisite-anodal-transcranial-direct-current-stimulation-35339351","doi":"10.1016/j.neucli.2022.02.003","journal":"Neurophysiologie clinique = Clinical neurophysiology","n_participants":18,"pmid":"35339351","source_url":"https://pubmed.ncbi.nlm.nih.gov/35339351/","study_design":null,"title":"Effects of multisite anodal transcranial direct current stimulation combined with cognitive stimulation in patients with Alzheimer's disease and its neurophysiological correlates: A double-blind randomized clinical trial","title_match":true,"year":2022},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/screening-for-deficits-on-intrinsic-capacity-domains-and-associated-35193041","doi":"10.1016/j.archger.2022.104654","journal":"Archives of gerontology and geriatrics","n_participants":442,"pmid":"35193041","source_url":"https://pubmed.ncbi.nlm.nih.gov/35193041/","study_design":"randomized controlled trial","title":"Screening for deficits on intrinsic capacity domains and associated healthcare costs","title_match":false,"year":2022},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/mindfulness-training-improves-cognition-and-strengthens-intrinsic-34512305","doi":"10.3389/fnagi.2021.702796","journal":"Frontiers in aging neuroscience","n_participants":72,"pmid":"34512305","source_url":"https://pubmed.ncbi.nlm.nih.gov/34512305/","study_design":"randomized controlled trial","title":"Mindfulness Training Improves Cognition and Strengthens Intrinsic Connectivity Between the Hippocampus and Posteromedial Cortex in Healthy Older Adults","title_match":false,"year":2021},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/risks-and-benefits-of-unapproved-disease-modifying-treatments-for-31792092","doi":"10.1212/wnl.0000000000008699","journal":"Neurology","n_participants":39875,"pmid":"31792092","source_url":"https://pubmed.ncbi.nlm.nih.gov/31792092/","study_design":"systematic review","title":"Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/test-retest-reliability-of-memory-task-functional-magnetic-resonance-21555634","doi":"10.1001/archneurol.2011.94","journal":"Archives of neurology","n_participants":24,"pmid":"21555634","source_url":"https://pubmed.ncbi.nlm.nih.gov/21555634/","study_design":"randomized controlled trial","title":"Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials","title_match":true,"year":2011},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/memantine-treatment-of-cognitive-symptoms-in-mild-to-moderate-17334274","doi":"10.1097/wad.0b013e318032cf29","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"17334274","source_url":"https://pubmed.ncbi.nlm.nih.gov/17334274/","study_design":null,"title":"Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial","title_match":true,"year":2007},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/cognitive-outcomes-of-long-term-benzodiazepine-and-related-drug-bdzr-31604674","doi":"10.1016/j.jamda.2019.08.006","journal":"Journal of the American Medical Directors Association","n_participants":448,"pmid":"31604674","source_url":"https://pubmed.ncbi.nlm.nih.gov/31604674/","study_design":"randomized controlled trial","title":"Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD","title_match":false,"year":2020},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/design-of-depression-in-alzheimer-s-disease-study-2-17068314","doi":"10.1097/01.jgp.0000240977.71305.ee","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"17068314","source_url":"https://pubmed.ncbi.nlm.nih.gov/17068314/","study_design":null,"title":"Design of Depression in Alzheimer's Disease Study-2","title_match":false,"year":2006},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/prospective-associations-between-diffusion-tensor-imaging-parameters-31981370","doi":"10.1111/jgs.16343","journal":"Journal of the American Geriatrics Society","n_participants":227,"pmid":"31981370","source_url":"https://pubmed.ncbi.nlm.nih.gov/31981370/","study_design":"cross-sectional","title":"Prospective Associations Between Diffusion Tensor Imaging Parameters and Frailty in Older Adults","title_match":false,"year":2020},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/idebenone-a-new-drug-in-the-treatment-of-cognitive-impairment-in-7988944","doi":null,"journal":"Functional neurology","n_participants":null,"pmid":"7988944","source_url":"https://pubmed.ncbi.nlm.nih.gov/7988944/","study_design":null,"title":"Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type","title_match":false,"year":1994},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/an-internet-based-intervention-augmented-with-a-diet-and-physical-32969833","doi":"10.2196/19431","journal":"Journal of medical Internet research","n_participants":125,"pmid":"32969833","source_url":"https://pubmed.ncbi.nlm.nih.gov/32969833/","study_design":"randomized controlled trial","title":"An Internet-Based Intervention Augmented With a Diet and Physical Activity Consultation to Decrease the Risk of Dementia in At-Risk Adults in a Primary Care Setting: Pragmatic Randomized Controlled Trial","title_match":true,"year":2020},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/danggui-shaoyao-san-for-dementia-a-prisma-compliant-systematic-review-31977846","doi":"10.1097/md.0000000000018507","journal":"Medicine","n_participants":567,"pmid":"31977846","source_url":"https://pubmed.ncbi.nlm.nih.gov/31977846/","study_design":"systematic review","title":"Danggui-Shaoyao-San for dementia: A PRISMA-compliant systematic review and meta-analysis","title_match":false,"year":2020},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-memantine-on-clinical-ratings-fluorodeoxyglucose-positron-23948786","doi":"10.1097/jcp.0b013e31829a876a","journal":"Journal of clinical psychopharmacology","n_participants":null,"pmid":"23948786","source_url":"https://pubmed.ncbi.nlm.nih.gov/23948786/","study_design":null,"title":"Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial","title_match":true,"year":2013},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/plasma-abeta-homocysteine-and-cognition-the-vitamin-intervention-for-19153374","doi":"10.1212/01.wnl.0000339486.63862.db","journal":"Neurology","n_participants":150,"pmid":"19153374","source_url":"https://pubmed.ncbi.nlm.nih.gov/19153374/","study_design":"randomized controlled trial","title":"Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial","title_match":false,"year":2009},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/mirtazapine-for-treatment-of-depression-and-comorbidities-in-11573849","doi":"10.1345/aph.10371","journal":"The Annals of pharmacotherapy","n_participants":null,"pmid":"11573849","source_url":"https://pubmed.ncbi.nlm.nih.gov/11573849/","study_design":null,"title":"Mirtazapine for treatment of depression and comorbidities in Alzheimer disease","title_match":false,"year":2001},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/association-of-plasma-phosphorylated-tau-with-the-response-to-37657939","doi":"10.1212/wnl.0000000000207755","journal":"Neurology","n_participants":45,"pmid":"37657939","source_url":"https://pubmed.ncbi.nlm.nih.gov/37657939/","study_design":null,"title":"Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies","title_match":false,"year":2023},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/the-beneficial-effect-on-cognition-of-noninvasive-brain-stimulation-36698219","doi":"10.1186/s13195-023-01164-2","journal":"Alzheimer's research & therapy","n_participants":12,"pmid":"36698219","source_url":"https://pubmed.ncbi.nlm.nih.gov/36698219/","study_design":"meta-analysis","title":"The beneficial effect on cognition of noninvasive brain stimulation intervention in patients with dementia: a network meta-analysis of randomized controlled trials","title_match":true,"year":2023},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/the-trial-to-reduce-antimicrobial-use-in-nursing-home-residents-with-34251396","doi":"10.1001/jamainternmed.2021.3098","journal":"JAMA internal medicine","n_participants":null,"pmid":"34251396","source_url":"https://pubmed.ncbi.nlm.nih.gov/34251396/","study_design":null,"title":"The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial","title_match":true,"year":2021},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/kidney-function-and-cognitive-decline-in-older-adults-examining-the-33217785","doi":"10.1111/jgs.16954","journal":"Journal of the American Geriatrics Society","n_participants":1334,"pmid":"33217785","source_url":"https://pubmed.ncbi.nlm.nih.gov/33217785/","study_design":"longitudinal study","title":"Kidney Function and Cognitive Decline in Older Adults: Examining the Role of Neurodegeneration","title_match":false,"year":2021},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/psychosocial-behaviour-management-programme-for-home-dwelling-people-28857263","doi":"10.1002/gps.4784","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"28857263","source_url":"https://pubmed.ncbi.nlm.nih.gov/28857263/","study_design":"randomized controlled trial","title":"Psychosocial behaviour management programme for home-dwelling people with dementia: A cluster-randomized controlled trial","title_match":true,"year":2018},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/comparison-of-topiramate-and-risperidone-for-the-treatment-of-20075646","doi":"10.1097/jcp.0b013e3181ca0c59","journal":"Journal of clinical psychopharmacology","n_participants":41,"pmid":"20075646","source_url":"https://pubmed.ncbi.nlm.nih.gov/20075646/","study_design":null,"title":"Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial","title_match":true,"year":2010},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-donepezil-on-verbal-memory-after-semantic-processing-in-18541979","doi":"10.1097/wnn.0b013e3181799df1","journal":"Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology","n_participants":null,"pmid":"18541979","source_url":"https://pubmed.ncbi.nlm.nih.gov/18541979/","study_design":null,"title":"Effects of donepezil on verbal memory after semantic processing in healthy older adults","title_match":false,"year":2008},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/potential-neuroregenerative-and-neuroprotective-effects-of-uridine-33368017","doi":"10.1007/s40120-020-00227-y","journal":"Neurology and therapy","n_participants":null,"pmid":"33368017","source_url":"https://pubmed.ncbi.nlm.nih.gov/33368017/","study_design":"randomized controlled trial","title":"Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review","title_match":false,"year":2021},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/findings-of-a-pilot-study-investigating-the-effects-of-mediterranean-32440639","doi":"10.1093/cdn/nzaa077","journal":"Current developments in nutrition","n_participants":102,"pmid":"32440639","source_url":"https://pubmed.ncbi.nlm.nih.gov/32440639/","study_design":null,"title":"Findings of a Pilot Study Investigating the Effects of Mediterranean Diet and Aerobic Exercise on Cognition in Cognitively Healthy Older People Living Independently within Aged-Care Facilities: The Lifestyle Intervention in Independent Living Aged Care (LIILAC) Study","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/association-of-3-year-multidomain-intervention-and-omega-3-31169912","doi":"10.1111/jgs.15994","journal":"Journal of the American Geriatrics Society","n_participants":53,"pmid":"31169912","source_url":"https://pubmed.ncbi.nlm.nih.gov/31169912/","study_design":null,"title":"Association of 3-Year Multidomain Intervention and Omega-3 Supplementation with Frailty Incidence","title_match":false,"year":2019},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/adaptive-dose-finding-phase-2-trial-evaluating-the-safety-and-25973909","doi":"10.1097/wad.0000000000000093","journal":"Alzheimer disease and associated disorders","n_participants":337,"pmid":"25973909","source_url":"https://pubmed.ncbi.nlm.nih.gov/25973909/","study_design":"longitudinal study","title":"Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease","title_match":true,"year":2015},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/a-double-blind-randomized-placebo-controlled-withdrawal-trial-25523285","doi":"10.1016/j.jamda.2014.11.002","journal":"Journal of the American Medical Directors Association","n_participants":199,"pmid":"25523285","source_url":"https://pubmed.ncbi.nlm.nih.gov/25523285/","study_design":null,"title":"A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)","title_match":true,"year":2015},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-danish-alzheimer-intervention-study-rationale-study-design-and-21196773","doi":"10.1159/000322942","journal":"Neuroepidemiology","n_participants":330,"pmid":"21196773","source_url":"https://pubmed.ncbi.nlm.nih.gov/21196773/","study_design":null,"title":"The Danish Alzheimer intervention study: rationale, study design and baseline characteristics of the cohort","title_match":false,"year":2011},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/clinical-studies-with-oxiracetam-in-patients-with-dementia-of-1603291","doi":"10.1159/000118805","journal":"Neuropsychobiology","n_participants":30,"pmid":"1603291","source_url":"https://pubmed.ncbi.nlm.nih.gov/1603291/","study_design":"randomized controlled trial","title":"Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree","title_match":false,"year":1992},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/video-intervention-and-goals-of-care-documentation-in-hospitalized-37695586","doi":"10.1001/jamanetworkopen.2023.32556","journal":"JAMA network open","n_participants":802,"pmid":"37695586","source_url":"https://pubmed.ncbi.nlm.nih.gov/37695586/","study_design":null,"title":"Video Intervention and Goals-of-Care Documentation in Hospitalized Older Adults: The VIDEO-PCE Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/association-of-sleep-disordered-breathing-and-medial-temporal-lobe-37258299","doi":"10.1212/wnl.0000000000207421","journal":"Neurology","n_participants":122,"pmid":"37258299","source_url":"https://pubmed.ncbi.nlm.nih.gov/37258299/","study_design":"randomized controlled trial","title":"Association of Sleep-Disordered Breathing and Medial Temporal Lobe Atrophy in Cognitively Unimpaired Amyloid-Positive Older Adults","title_match":false,"year":2023},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/study-protocol-for-the-alzheimer-and-music-therapy-study-an-rct-to-35771851","doi":"10.1371/journal.pone.0270682","journal":"PloS one","n_participants":84,"pmid":"35771851","source_url":"https://pubmed.ncbi.nlm.nih.gov/35771851/","study_design":"randomized controlled trial","title":"Study protocol for the Alzheimer and music therapy study: An RCT to compare the efficacy of music therapy and physical activity on brain plasticity, depressive symptoms, and cognitive decline, in a population with and at risk for Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/impact-of-combined-photo-biomodulation-and-aerobic-exercise-on-33469351","doi":"10.2147/ijgm.s280559","journal":"International journal of general medicine","n_participants":null,"pmid":"33469351","source_url":"https://pubmed.ncbi.nlm.nih.gov/33469351/","study_design":null,"title":"Impact of Combined Photo-Biomodulation and Aerobic Exercise on Cognitive Function and Quality-of-Life in Elderly Alzheimer Patients with Anemia: A Randomized Clinical Trial","title_match":true,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/medication-development-for-agitation-and-aggression-in-alzheimer-25226218","doi":"10.1017/s1041610214001720","journal":"International psychogeriatrics","n_participants":18,"pmid":"25226218","source_url":"https://pubmed.ncbi.nlm.nih.gov/25226218/","study_design":null,"title":"Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design","title_match":true,"year":2015},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/lecanemab-for-patients-with-early-alzheimer-disease-bayesian-analysis-37040116","doi":"10.1001/jamanetworkopen.2023.7230","journal":"JAMA network open","n_participants":854,"pmid":"37040116","source_url":"https://pubmed.ncbi.nlm.nih.gov/37040116/","study_design":"clinical trial","title":"Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/cost-effectiveness-of-the-namaste-care-family-program-for-nursing-32887591","doi":"10.1186/s12913-020-05570-2","journal":"BMC health services research","n_participants":null,"pmid":"32887591","source_url":"https://pubmed.ncbi.nlm.nih.gov/32887591/","study_design":"randomized controlled trial","title":"Cost-effectiveness of the Namaste care family program for nursing home residents with advanced dementia in comparison with usual care: a cluster-randomized controlled trial","title_match":true,"year":2020},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/towards-early-disease-modification-of-parkinson-s-disease-a-review-of-32809153","doi":"10.1007/s00415-020-10162-5","journal":"Journal of neurology","n_participants":null,"pmid":"32809153","source_url":"https://pubmed.ncbi.nlm.nih.gov/32809153/","study_design":"clinical trial","title":"Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field","title_match":false,"year":2021},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/vascular-function-is-improved-after-an-environmental-enrichment-29632101","doi":"10.1161/hypertensionaha.117.10066","journal":"Hypertension (Dallas, Tex. : 1979)","n_participants":55,"pmid":"29632101","source_url":"https://pubmed.ncbi.nlm.nih.gov/29632101/","study_design":null,"title":"Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study","title_match":false,"year":2018},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/effect-of-public-deliberation-on-attitudes-toward-surrogate-consent-21975207","doi":"10.1212/wnl.0b013e31823648cb","journal":"Neurology","n_participants":503,"pmid":"21975207","source_url":"https://pubmed.ncbi.nlm.nih.gov/21975207/","study_design":"randomized controlled trial","title":"Effect of public deliberation on attitudes toward surrogate consent for dementia research","title_match":false,"year":2011},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/recording-care-time-in-nursing-homes-development-and-validation-of-20478097","doi":"10.1017/s1041610210000487","journal":"International psychogeriatrics","n_participants":null,"pmid":"20478097","source_url":"https://pubmed.ncbi.nlm.nih.gov/20478097/","study_design":"randomized controlled trial","title":"Recording care time in nursing homes: development and validation of the \"RUD-FOCA\" (Resource Utilization in Dementia-Formal Care)","title_match":false,"year":2010},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/psychoeducational-program-for-the-family-member-caregivers-of-people-33971764","doi":"10.1177/21501327211014088","journal":"Journal of primary care & community health","n_participants":null,"pmid":"33971764","source_url":"https://pubmed.ncbi.nlm.nih.gov/33971764/","study_design":"randomized controlled trial","title":"Psychoeducational Program for the Family Member Caregivers of People with Dementia to Reduce Perceived Burden and Increase Patient's Quality of Life: A Randomized Controlled Trial","title_match":true,"year":2021},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/effect-of-1-year-of-qigong-exercise-on-cognitive-function-among-older-33192794","doi":"10.3389/fpsyg.2020.546834","journal":"Frontiers in psychology","n_participants":33,"pmid":"33192794","source_url":"https://pubmed.ncbi.nlm.nih.gov/33192794/","study_design":null,"title":"Effect of 1 Year of Qigong Exercise on Cognitive Function Among Older Chinese Adults at Risk of Cognitive Decline: A Cluster Randomized Controlled Trial","title_match":true,"year":2020},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/designing-a-trial-to-evaluate-potential-treatments-for-apathy-in-23567407","doi":"10.1016/j.jagp.2012.12.018","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"23567407","source_url":"https://pubmed.ncbi.nlm.nih.gov/23567407/","study_design":null,"title":"Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET)","title_match":false,"year":2013},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/chinese-herbal-medicine-for-patients-with-mild-to-moderate-alzheimer-22805083","doi":"10.3736/jcim20120707","journal":"Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine","n_participants":131,"pmid":"22805083","source_url":"https://pubmed.ncbi.nlm.nih.gov/22805083/","study_design":null,"title":"[Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial]","title_match":true,"year":2012},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/effects-of-chinese-medicine-for-tonifying-the-kidney-and-resolving-22500712","doi":"10.3736/jcim20120407","journal":"Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine","n_participants":null,"pmid":"22500712","source_url":"https://pubmed.ncbi.nlm.nih.gov/22500712/","study_design":null,"title":"Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial","title_match":true,"year":2012},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/characteristics-and-performance-of-a-modified-version-of-the-adcs-19812469","doi":"10.1097/wad.0b013e31819cb760","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"19812469","source_url":"https://pubmed.ncbi.nlm.nih.gov/19812469/","study_design":null,"title":"Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials","title_match":true,"year":2009},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-indiana-alzheimer-disease-center-s-symposium-on-mild-cognitive-19689237","doi":"10.2174/156720509788929345","journal":"Current Alzheimer research","n_participants":3000,"pmid":"19689237","source_url":"https://pubmed.ncbi.nlm.nih.gov/19689237/","study_design":null,"title":"The Indiana Alzheimer Disease Center's Symposium on Mild Cognitive Impairment. Cognitive training in older adults: lessons from the ACTIVE Study","title_match":false,"year":2009},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/outcome-measures-in-clinical-trials-on-medicinal-products-for-the-17433121","doi":"10.1017/s1041610207005273","journal":"International psychogeriatrics","n_participants":null,"pmid":"17433121","source_url":"https://pubmed.ncbi.nlm.nih.gov/17433121/","study_design":null,"title":"Outcome measures in clinical trials on medicinal products for the treatment of dementia: a European regulatory perspective","title_match":true,"year":2007},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/extended-release-physostigmine-in-alzheimer-disease-a-multicenter-10665618","doi":"10.1001/archpsyc.57.2.157","journal":"Archives of general psychiatry","n_participants":850,"pmid":"10665618","source_url":"https://pubmed.ncbi.nlm.nih.gov/10665618/","study_design":null,"title":"Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group","title_match":true,"year":2000},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/does-therapeutic-exercise-support-improvement-in-cognitive-function-37509042","doi":"10.3390/brainsci13071112","journal":"Brain sciences","n_participants":57,"pmid":"37509042","source_url":"https://pubmed.ncbi.nlm.nih.gov/37509042/","study_design":"randomized controlled trial","title":"Does Therapeutic Exercise Support Improvement in Cognitive Function and Instrumental Activities of Daily Living in Patients with Mild Alzheimer's Disease? A Randomized Controlled Trial","title_match":true,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/home-based-electronic-cognitive-therapy-in-patients-with-alzheimer-36094804","doi":"10.2196/34450","journal":"JMIR formative research","n_participants":null,"pmid":"36094804","source_url":"https://pubmed.ncbi.nlm.nih.gov/36094804/","study_design":null,"title":"Home-Based Electronic Cognitive Therapy in Patients With Alzheimer Disease: Feasibility Randomized Controlled Trial","title_match":true,"year":2022},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/a-cluster-randomized-controlled-trial-to-test-the-feasibility-and-30334942","doi":"10.1097/md.0000000000012553","journal":"Medicine","n_participants":null,"pmid":"30334942","source_url":"https://pubmed.ncbi.nlm.nih.gov/30334942/","study_design":"randomized controlled trial","title":"A cluster randomized controlled trial to test the feasibility and preliminary effectiveness of a family dementia caregiver intervention in Vietnam: The REACH VN study protocol","title_match":true,"year":2018},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/procedural-framework-to-facilitate-hospital-based-informed-consent-30246863","doi":"10.1111/jgs.15525","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"30246863","source_url":"https://pubmed.ncbi.nlm.nih.gov/30246863/","study_design":"randomized controlled trial","title":"Procedural Framework to Facilitate Hospital-Based Informed Consent for Dementia Research","title_match":false,"year":2018},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/limitations-of-sacubitril-valsartan-in-the-management-of-heart-failure-27574931","doi":"10.1097/mjt.0000000000000473","journal":"American journal of therapeutics","n_participants":8442,"pmid":"27574931","source_url":"https://pubmed.ncbi.nlm.nih.gov/27574931/","study_design":null,"title":"Limitations of Sacubitril/Valsartan in the Management of Heart Failure","title_match":false,"year":2017},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/mental-exercises-for-cognitive-function-clinical-evidence-23412645","doi":"10.3961/jpmph.2013.46.s.s22","journal":"Journal of preventive medicine and public health = Yebang Uihakhoe chi","n_participants":16,"pmid":"23412645","source_url":"https://pubmed.ncbi.nlm.nih.gov/23412645/","study_design":"randomized controlled trial","title":"Mental exercises for cognitive function: clinical evidence","title_match":false,"year":2013},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/pilot-study-to-show-the-feasibility-of-a-multicenter-trial-of-home-20592583","doi":"10.1097/wad.0b013e3181d7109f","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"20592583","source_url":"https://pubmed.ncbi.nlm.nih.gov/20592583/","study_design":null,"title":"Pilot study to show the feasibility of a multicenter trial of home-based assessment of people over 75 years old","title_match":false,"year":2010},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/donepezil-treatment-and-alzheimer-disease-can-the-results-of-17974866","doi":"10.1097/jgp.0b013e3180986138","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":91,"pmid":"17974866","source_url":"https://pubmed.ncbi.nlm.nih.gov/17974866/","study_design":null,"title":"Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?","title_match":true,"year":2007},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/incidence-of-amyloid-related-imaging-abnormalities-in-phase-iii-40112274","doi":"10.1212/wnl.0000000000213483","journal":"Neurology","n_participants":6315,"pmid":"40112274","source_url":"https://pubmed.ncbi.nlm.nih.gov/40112274/","study_design":"meta-analysis","title":"Incidence of Amyloid-Related Imaging Abnormalities in Phase III Clinical Trials of Anti-Amyloid-\u03b2 Immunotherapy: An Updated Meta-Analysis","title_match":true,"year":2025},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/tango-therapy-vs-physical-exercise-in-older-people-with-dementia-a-37875856","doi":"10.1186/s12877-023-04342-x","journal":"BMC geriatrics","n_participants":31,"pmid":"37875856","source_url":"https://pubmed.ncbi.nlm.nih.gov/37875856/","study_design":"randomized controlled trial","title":"Tango-therapy vs physical exercise in older people with dementia; a randomized controlled trial","title_match":true,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/impact-of-hypertension-on-cognitive-decline-and-dementia-32743317","doi":"10.4235/agmr.19.0048","journal":"Annals of geriatric medicine and research","n_participants":null,"pmid":"32743317","source_url":"https://pubmed.ncbi.nlm.nih.gov/32743317/","study_design":"cohort study","title":"Impact of Hypertension on Cognitive Decline and Dementia","title_match":false,"year":2020},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/rates-of-cognitive-change-in-alzheimer-disease-observations-across-a-19561444","doi":"10.1097/wad.0b013e31819cd4be","journal":"Alzheimer disease and associated disorders","n_participants":3403,"pmid":"19561444","source_url":"https://pubmed.ncbi.nlm.nih.gov/19561444/","study_design":null,"title":"Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezil","title_match":true,"year":2009},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/an-anti-tau-therapeutic-antibody-etalanetug-e2814-a-phase-1-first-in-40673737","doi":"10.1097/wad.0000000000000680","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"40673737","source_url":"https://pubmed.ncbi.nlm.nih.gov/40673737/","study_design":null,"title":"An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy Subjects","title_match":true,"year":2025},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/high-risk-medications-in-persons-living-with-dementia-a-randomized-39432286","doi":"10.1001/jamainternmed.2024.5632","journal":"JAMA internal medicine","n_participants":787,"pmid":"39432286","source_url":"https://pubmed.ncbi.nlm.nih.gov/39432286/","study_design":"open-label trial","title":"High-Risk Medications in Persons Living With Dementia: A Randomized Clinical Trial","title_match":true,"year":2024},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/3-pufa-for-secondary-prevention-of-white-matter-lesions-and-neuronal-39088212","doi":"10.1001/jamanetworkopen.2024.26872","journal":"JAMA network open","n_participants":102,"pmid":"39088212","source_url":"https://pubmed.ncbi.nlm.nih.gov/39088212/","study_design":null,"title":"\u03c9-3 PUFA for Secondary Prevention of White Matter Lesions and Neuronal Integrity Breakdown in Older Adults: A Randomized Clinical Trial","title_match":true,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/use-of-bacopa-monnieri-in-the-treatment-of-dementia-due-to-alzheimer-35612544","doi":"10.2196/38542","journal":"Interactive journal of medical research","n_participants":null,"pmid":"35612544","source_url":"https://pubmed.ncbi.nlm.nih.gov/35612544/","study_design":null,"title":"Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials","title_match":true,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/naturally-occurring-monoclonal-antibodies-and-their-therapeutic-26389734","doi":"10.1001/jamaneurol.2015.2188","journal":"JAMA neurology","n_participants":null,"pmid":"26389734","source_url":"https://pubmed.ncbi.nlm.nih.gov/26389734/","study_design":"clinical trial","title":"Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases","title_match":false,"year":2015},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/nutritional-treatment-of-aged-individuals-with-alzheimer-disease-22624652","doi":"10.1186/1745-6215-13-66","journal":"Trials","n_participants":202,"pmid":"22624652","source_url":"https://pubmed.ncbi.nlm.nih.gov/22624652/","study_design":null,"title":"Nutritional treatment of aged individuals with Alzheimer disease living at home with their spouses: study protocol for a randomized controlled trial","title_match":true,"year":2012},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/protocols-to-demonstrate-slowing-of-alzheimer-disease-progression-9305517","doi":null,"journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"9305517","source_url":"https://pubmed.ncbi.nlm.nih.gov/9305517/","study_design":null,"title":"Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group","title_match":false,"year":1997},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/effectiveness-of-brief-infusions-with-ginkgo-biloba-special-extract-8974721","doi":null,"journal":"Zeitschrift fur Gerontologie und Geriatrie","n_participants":40,"pmid":"8974721","source_url":"https://pubmed.ncbi.nlm.nih.gov/8974721/","study_design":null,"title":"[Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type]","title_match":false,"year":1996},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/double-blind-randomized-placebo-controlled-clinical-trial-on-the-10463377","doi":"10.1055/s-2007-979202","journal":"Pharmacopsychiatry","n_participants":204,"pmid":"10463377","source_url":"https://pubmed.ncbi.nlm.nih.gov/10463377/","study_design":null,"title":"Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type","title_match":true,"year":1999},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/herbal-medicine-treatment-for-alzheimer-disease-a-protocol-for-a-32872063","doi":"10.1097/md.0000000000021745","journal":"Medicine","n_participants":null,"pmid":"32872063","source_url":"https://pubmed.ncbi.nlm.nih.gov/32872063/","study_design":"meta-analysis","title":"Herbal medicine treatment for Alzheimer disease: A protocol for a systematic review and meta-analysis","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-clinical-studies-on-the-effect-of-psychoactive-32118591","doi":"10.1097/mjt.0000000000001120","journal":"American journal of therapeutics","n_participants":422,"pmid":"32118591","source_url":"https://pubmed.ncbi.nlm.nih.gov/32118591/","study_design":"randomized controlled trial","title":"A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer Dementia","title_match":false,"year":2020},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/under-reporting-of-cardiovascular-events-in-the-rofecoxib-alzheimer-22877803","doi":"10.1016/j.ahj.2012.05.002","journal":"American heart journal","n_participants":null,"pmid":"22877803","source_url":"https://pubmed.ncbi.nlm.nih.gov/22877803/","study_design":null,"title":"Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies","title_match":false,"year":2012},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/effects-of-the-association-of-sulbutiamine-with-an-17675917","doi":"10.1016/s0013-7006(07)91552-3","journal":"L'Encephale","n_participants":null,"pmid":"17675917","source_url":"https://pubmed.ncbi.nlm.nih.gov/17675917/","study_design":null,"title":"[Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease]","title_match":false,"year":2007},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/lecanemab-a-humanized-monoclonal-antibody-for-the-treatment-of-early-38095619","doi":"10.1177/10600280231218253","journal":"The Annals of pharmacotherapy","n_participants":null,"pmid":"38095619","source_url":"https://pubmed.ncbi.nlm.nih.gov/38095619/","study_design":null,"title":"Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease","title_match":false,"year":2024},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/impact-of-donepezil-and-memantine-on-behavioral-and-psychological-34851866","doi":"10.1097/wnn.0000000000000285","journal":"Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology","n_participants":42,"pmid":"34851866","source_url":"https://pubmed.ncbi.nlm.nih.gov/34851866/","study_design":null,"title":"Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study","title_match":false,"year":2021},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/self-efficacy-in-controlling-upsetting-thoughts-but-not-positive-34843329","doi":"10.1037/pag0000654","journal":"Psychology and aging","n_participants":null,"pmid":"34843329","source_url":"https://pubmed.ncbi.nlm.nih.gov/34843329/","study_design":"randomized controlled trial","title":"Self-efficacy in controlling upsetting thoughts, but not positive gains, mediates the effects of benefit-finding group intervention for Alzheimer family caregivers","title_match":false,"year":2022},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/the-impact-of-a-multi-domain-intervention-on-cerebral-glucose-33076983","doi":"10.1186/s13195-020-00683-6","journal":"Alzheimer's research & therapy","n_participants":67,"pmid":"33076983","source_url":"https://pubmed.ncbi.nlm.nih.gov/33076983/","study_design":null,"title":"The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial","title_match":false,"year":2020},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/dietary-interventions-and-cognition-of-alzheimer-s-disease-patients-a-32973980","doi":"10.1590/1980-57642020dn14-030008","journal":"Dementia & neuropsychologia","n_participants":null,"pmid":"32973980","source_url":"https://pubmed.ncbi.nlm.nih.gov/32973980/","study_design":"systematic review","title":"Dietary interventions and cognition of Alzheimer's disease patients: a systematic review of randomized controlled trial","title_match":true,"year":2020},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/improving-recovery-and-outcomes-every-day-after-the-icu-improve-study-29580264","doi":"10.1186/s13063-018-2569-8","journal":"Trials","n_participants":null,"pmid":"29580264","source_url":"https://pubmed.ncbi.nlm.nih.gov/29580264/","study_design":"randomized controlled trial","title":"Improving Recovery and Outcomes Every Day after the ICU (IMPROVE): study protocol for a randomized controlled trial","title_match":true,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-and-chinese-medicine-as-a-useful-alternative-28124587","doi":"10.2174/1567205014666170117103656","journal":"Current Alzheimer research","n_participants":null,"pmid":"28124587","source_url":"https://pubmed.ncbi.nlm.nih.gov/28124587/","study_design":null,"title":"Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review","title_match":false,"year":2017},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/toward-onset-prevention-of-cognitive-decline-in-adults-with-down-24888381","doi":"10.1186/1745-6215-15-202","journal":"Trials","n_participants":null,"pmid":"24888381","source_url":"https://pubmed.ncbi.nlm.nih.gov/24888381/","study_design":"randomized controlled trial","title":"Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial","title_match":true,"year":2014},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/effect-of-second-generation-antipsychotics-on-caregiver-burden-in-21939611","doi":"10.4088/jcp.10m06574","journal":"The Journal of clinical psychiatry","n_participants":361,"pmid":"21939611","source_url":"https://pubmed.ncbi.nlm.nih.gov/21939611/","study_design":"clinical trial","title":"Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease","title_match":false,"year":2012},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/efficacy-of-naftidrofuryl-in-patients-with-vascular-or-mixed-dementia-10945510","doi":"10.1016/s0149-2918(00)80056-9","journal":"Clinical therapeutics","n_participants":null,"pmid":"10945510","source_url":"https://pubmed.ncbi.nlm.nih.gov/10945510/","study_design":null,"title":"Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial","title_match":true,"year":2000},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/propentofylline-in-the-treatment-of-vascular-dementia-and-alzheimer-9769027","doi":null,"journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"9769027","source_url":"https://pubmed.ncbi.nlm.nih.gov/9769027/","study_design":null,"title":"Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials","title_match":true,"year":1998},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/l-deprenyl-in-the-treatment-of-mild-dementia-of-the-alzheimer-type-8463521","doi":"10.1111/j.1532-5415.1993.tb06942.x","journal":"Journal of the American Geriatrics Society","n_participants":39,"pmid":"8463521","source_url":"https://pubmed.ncbi.nlm.nih.gov/8463521/","study_design":null,"title":"L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results","title_match":false,"year":1993},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/observational-studies-in-alzheimer-disease-bridging-preclinical-36316487","doi":"10.1038/s41582-022-00733-7","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"36316487","source_url":"https://pubmed.ncbi.nlm.nih.gov/36316487/","study_design":null,"title":"Observational studies in Alzheimer disease: bridging preclinical studies and clinical trials","title_match":true,"year":2022},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/closing-the-gap-between-observational-research-and-randomized-35442427","doi":"10.1093/epirev/mxac002","journal":"Epidemiologic reviews","n_participants":null,"pmid":"35442427","source_url":"https://pubmed.ncbi.nlm.nih.gov/35442427/","study_design":null,"title":"Closing the Gap Between Observational Research and Randomized Controlled Trials for Prevention of Alzheimer Disease and Dementia","title_match":true,"year":2022},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/repeated-transcranial-magnetic-stimulation-for-improving-cognition-in-33416500","doi":"10.2196/25144","journal":"JMIR research protocols","n_participants":523,"pmid":"33416500","source_url":"https://pubmed.ncbi.nlm.nih.gov/33416500/","study_design":null,"title":"Repeated Transcranial Magnetic Stimulation for Improving Cognition in Patients With Alzheimer Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial","title_match":true,"year":2021},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/blood-pressure-lowering-with-nilvadipine-in-patients-with-mild-to-31088188","doi":"10.1161/jaha.119.011938","journal":"Journal of the American Heart Association","n_participants":255,"pmid":"31088188","source_url":"https://pubmed.ncbi.nlm.nih.gov/31088188/","study_design":"randomized controlled trial","title":"Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension","title_match":false,"year":2019},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/trajectory-of-the-mapt-pacc-preclinical-alzheimer-cognitive-composite-29405230","doi":"10.14283/jpad.2017.21","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"29405230","source_url":"https://pubmed.ncbi.nlm.nih.gov/29405230/","study_design":"randomized controlled trial","title":"Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials","title_match":false,"year":2018},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/electroacupuncture-for-older-adults-with-mild-cognitive-impairment-26012577","doi":"10.1186/s13063-015-0740-z","journal":"Trials","n_participants":75,"pmid":"26012577","source_url":"https://pubmed.ncbi.nlm.nih.gov/26012577/","study_design":null,"title":"Electroacupuncture for older adults with mild cognitive impairment: study protocol for a randomized controlled trial","title_match":true,"year":2015},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-galantamine-and-galantamine-combined-with-nimodipine-on-24964105","doi":"10.1590/0004-282x20140055","journal":"Arquivos de neuro-psiquiatria","n_participants":null,"pmid":"24964105","source_url":"https://pubmed.ncbi.nlm.nih.gov/24964105/","study_design":null,"title":"Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study)","title_match":true,"year":2014},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/aluminium-and-the-pathogenesis-of-alzheimer-s-disease-a-summary-of-1490430","doi":"10.1002/9780470514306.ch6","journal":"Ciba Foundation symposium","n_participants":null,"pmid":"1490430","source_url":"https://pubmed.ncbi.nlm.nih.gov/1490430/","study_design":"randomized controlled trial","title":"Aluminium and the pathogenesis of Alzheimer's disease: a summary of evidence","title_match":false,"year":1992},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/lecanemab-questions-38484213","doi":"10.1212/wnl.0000000000209320","journal":"Neurology","n_participants":null,"pmid":"38484213","source_url":"https://pubmed.ncbi.nlm.nih.gov/38484213/","study_design":"randomized controlled trial","title":"Lecanemab Questions","title_match":false,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-cilostazol-in-mild-cognitive-impairment-a-38048134","doi":"10.1001/jamanetworkopen.2023.44938","journal":"JAMA network open","n_participants":159,"pmid":"38048134","source_url":"https://pubmed.ncbi.nlm.nih.gov/38048134/","study_design":"clinical trial","title":"Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/effects-of-meditation-training-and-non-native-language-training-on-37450303","doi":"10.1001/jamanetworkopen.2023.17848","journal":"JAMA network open","n_participants":null,"pmid":"37450303","source_url":"https://pubmed.ncbi.nlm.nih.gov/37450303/","study_design":"randomized controlled trial","title":"Effects of Meditation Training and Non-Native Language Training on Cognition in Older Adults: A Secondary Analysis of a Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/development-and-validation-of-a-cutoff-for-the-chair-stand-test-as-a-35226732","doi":"10.1093/gerona/glac055","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":null,"pmid":"35226732","source_url":"https://pubmed.ncbi.nlm.nih.gov/35226732/","study_design":"randomized controlled trial","title":"Development and Validation of a Cutoff for the Chair Stand Test as a Screening for Mobility Impairment in the Context of the Integrated Care for Older People Program","title_match":false,"year":2023},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-comprehensive-intervention-on-life-quality-among-the-33988909","doi":"10.1002/nop2.917","journal":"Nursing open","n_participants":null,"pmid":"33988909","source_url":"https://pubmed.ncbi.nlm.nih.gov/33988909/","study_design":"randomized controlled trial","title":"Effects of comprehensive intervention on life quality among the elderly with Alzheimer Disease and their caregivers based on mixed models","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/using-historical-data-to-facilitate-clinical-prevention-trials-in-33962665","doi":"10.1186/s13195-021-00832-5","journal":"Alzheimer's research & therapy","n_participants":395,"pmid":"33962665","source_url":"https://pubmed.ncbi.nlm.nih.gov/33962665/","study_design":"cohort study","title":"Using historical data to facilitate clinical prevention trials in Alzheimer disease? An analysis of longitudinal MCI (mild cognitive impairment) data sets","title_match":false,"year":2021},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/effect-of-fresh-pomegranate-juice-on-the-level-of-melatonin-insulin-31993180","doi":"10.1002/fsn3.1344","journal":"Food science & nutrition","n_participants":28,"pmid":"31993180","source_url":"https://pubmed.ncbi.nlm.nih.gov/31993180/","study_design":null,"title":"Effect of fresh pomegranate juice on the level of melatonin, insulin, and fasting serum glucose in healthy individuals and people with impaired fasting glucose","title_match":false,"year":2020},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/semantic-memory-in-the-clinical-progression-of-alzheimer-disease-28926415","doi":"10.1097/wnn.0000000000000131","journal":"Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology","n_participants":null,"pmid":"28926415","source_url":"https://pubmed.ncbi.nlm.nih.gov/28926415/","study_design":null,"title":"Semantic Memory in the Clinical Progression of Alzheimer Disease","title_match":false,"year":2017},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/study-protocol-pragmatic-randomized-control-trial-of-an-internet-28806917","doi":"10.1186/s12877-017-0581-6","journal":"BMC geriatrics","n_participants":null,"pmid":"28806917","source_url":"https://pubmed.ncbi.nlm.nih.gov/28806917/","study_design":"randomized controlled trial","title":"Study protocol: pragmatic randomized control trial of an internet-based intervention (My tools 4 care) for family carers","title_match":false,"year":2017},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/comprehensive-individualized-person-centered-management-of-community-28122366","doi":"10.1159/000455397","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"28122366","source_url":"https://pubmed.ncbi.nlm.nih.gov/28122366/","study_design":null,"title":"Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled Trial","title_match":true,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/oxidative-stress-hypothesis-for-alzheimer-s-disease-and-its-potential-24291874","doi":"10.5692/clinicalneurol.53.1043","journal":"Rinsho shinkeigaku = Clinical neurology","n_participants":null,"pmid":"24291874","source_url":"https://pubmed.ncbi.nlm.nih.gov/24291874/","study_design":"randomized controlled trial","title":"[Oxidative stress hypothesis for Alzheimer's disease and its potential therapeutic implications]","title_match":false,"year":2013},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/neuropsychological-correlates-of-capacity-determinations-in-alzheimer-23498384","doi":"10.1016/j.jagp.2012.11.008","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":77,"pmid":"23498384","source_url":"https://pubmed.ncbi.nlm.nih.gov/23498384/","study_design":null,"title":"Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment","title_match":false,"year":2013},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/rivastigmine-treatment-for-the-prevention-of-electroconvulsive-22751086","doi":"10.1097/wnf.0b013e31825e7945","journal":"Clinical neuropharmacology","n_participants":null,"pmid":"22751086","source_url":"https://pubmed.ncbi.nlm.nih.gov/22751086/","study_design":null,"title":"Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia","title_match":false,"year":2012},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-role-of-copper-in-the-pathophysiology-of-alzheimer-s-disease-15905983","doi":"10.1007/s00115-004-1849-6","journal":"Der Nervenarzt","n_participants":null,"pmid":"15905983","source_url":"https://pubmed.ncbi.nlm.nih.gov/15905983/","study_design":"longitudinal study","title":"[The role of copper in the pathophysiology of Alzheimer's disease]","title_match":false,"year":2005},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/h2-histamine-receptor-blockade-in-the-treatment-of-alzheimer-disease-11882746","doi":"10.1097/00002093-200201000-00004","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"11882746","source_url":"https://pubmed.ncbi.nlm.nih.gov/11882746/","study_design":null,"title":"H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine","title_match":true,"year":2002},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/ambroxol-as-a-treatment-for-parkinson-disease-dementia-a-randomized-40587145","doi":"10.1001/jamaneurol.2025.1687","journal":"JAMA neurology","n_participants":75,"pmid":"40587145","source_url":"https://pubmed.ncbi.nlm.nih.gov/40587145/","study_design":"clinical trial","title":"Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/modulation-of-cortical-and-hippocampal-functional-mri-connectivity-40552996","doi":"10.1148/radiol.241463","journal":"Radiology","n_participants":23,"pmid":"40552996","source_url":"https://pubmed.ncbi.nlm.nih.gov/40552996/","study_design":"randomized controlled trial","title":"Modulation of Cortical and Hippocampal Functional MRI Connectivity Following Transcranial Alternating Current Stimulation in Mild Alzheimer Disease","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/serious-games-for-learning-among-older-adults-with-cognitive-37043277","doi":"10.2196/43607","journal":"Journal of medical Internet research","n_participants":null,"pmid":"37043277","source_url":"https://pubmed.ncbi.nlm.nih.gov/37043277/","study_design":"systematic review","title":"Serious Games for Learning Among Older Adults With Cognitive Impairment: Systematic Review and Meta-analysis","title_match":false,"year":2023},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/intervention-for-a-digital-cognitive-multi-domain-alzheimer-risk-35119374","doi":"10.2196/31841","journal":"JMIR research protocols","n_participants":null,"pmid":"35119374","source_url":"https://pubmed.ncbi.nlm.nih.gov/35119374/","study_design":null,"title":"Intervention for a Digital, Cognitive, Multi-Domain Alzheimer Risk Velocity Study: Protocol for a Randomized Controlled Trial","title_match":true,"year":2022},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/the-effect-of-multidomain-interventions-on-global-cognition-symptoms-35098979","doi":"10.14283/jpad.2021.53","journal":"The journal of prevention of Alzheimer's disease","n_participants":4162,"pmid":"35098979","source_url":"https://pubmed.ncbi.nlm.nih.gov/35098979/","study_design":null,"title":"The Effect of Multidomain Interventions on Global Cognition, Symptoms of Depression and Apathy - A Pooled Analysis of Two Randomized Controlled Trials","title_match":true,"year":2022},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/short-and-medium-term-effects-of-a-multicomponent-physical-exercise-32957420","doi":"10.1097/md.0000000000022385","journal":"Medicine","n_participants":null,"pmid":"32957420","source_url":"https://pubmed.ncbi.nlm.nih.gov/32957420/","study_design":null,"title":"Short and medium-term effects of a multicomponent physical exercise program with a Mediterranean diet on bone mineral density, gait, balance, and fall risk for patients with Alzheimer disease: Randomized controlled clinical trial study protocol","title_match":true,"year":2020},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/effects-of-integrated-yoga-intervention-on-psychopathologies-and-31370033","doi":null,"journal":"Advances in mind-body medicine","n_participants":30,"pmid":"31370033","source_url":"https://pubmed.ncbi.nlm.nih.gov/31370033/","study_design":"randomized controlled trial","title":"Effects of Integrated Yoga Intervention on Psychopathologies and Sleep Quality Among Professional Caregivers of Older Adults With Alzheimer's Disease: A Controlled Pilot Study","title_match":false,"year":2018},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/sertraline-and-mirtazapine-versus-placebo-in-subgroups-of-depression-31084994","doi":"10.1016/j.jagp.2019.03.021","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":111,"pmid":"31084994","source_url":"https://pubmed.ncbi.nlm.nih.gov/31084994/","study_design":null,"title":"Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial","title_match":true,"year":2019},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/relationship-between-brain-amyloid-deposition-and-instrumental-30207586","doi":"10.1111/jgs.15497","journal":"Journal of the American Geriatrics Society","n_participants":269,"pmid":"30207586","source_url":"https://pubmed.ncbi.nlm.nih.gov/30207586/","study_design":"randomized controlled trial","title":"Relationship Between Brain Amyloid Deposition and Instrumental Activities of Daily Living in Older Adults: A Longitudinal Study from the Multidomain Alzheimer Prevention Trial","title_match":false,"year":2018},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/poor-self-rated-health-did-not-increase-risk-of-permanent-nursing-27094158","doi":"10.1186/s12877-016-0262-x","journal":"BMC geriatrics","n_participants":null,"pmid":"27094158","source_url":"https://pubmed.ncbi.nlm.nih.gov/27094158/","study_design":"randomized controlled trial","title":"Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/assessing-the-effectiveness-of-ehealth-interventions-to-manage-39083787","doi":"10.2196/58174","journal":"Journal of medical Internet research","n_participants":34,"pmid":"39083787","source_url":"https://pubmed.ncbi.nlm.nih.gov/39083787/","study_design":null,"title":"Assessing the Effectiveness of eHealth Interventions to Manage Multiple Lifestyle Risk Behaviors Among Older Adults: Systematic Review and Meta-Analysis","title_match":false,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-effects-of-low-dose-radiation-therapy-in-patients-with-mild-to-37403351","doi":"10.3857/roj.2023.00052","journal":"Radiation oncology journal","n_participants":null,"pmid":"37403351","source_url":"https://pubmed.ncbi.nlm.nih.gov/37403351/","study_design":"randomized controlled trial","title":"The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study","title_match":false,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/transcranial-magnetic-stimulation-intervention-in-alzheimer-s-disease-30185210","doi":"10.1186/s13104-018-3757-z","journal":"BMC research notes","n_participants":null,"pmid":"30185210","source_url":"https://pubmed.ncbi.nlm.nih.gov/30185210/","study_design":"randomized controlled trial","title":"Transcranial magnetic stimulation intervention in Alzheimer's disease: a research proposal for a randomized controlled trial","title_match":true,"year":2018},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/relearning-of-activities-of-daily-living-a-comparison-of-the-26728933","doi":"10.1007/s12603-016-0675-4","journal":"The journal of nutrition, health & aging","n_participants":52,"pmid":"26728933","source_url":"https://pubmed.ncbi.nlm.nih.gov/26728933/","study_design":"randomized controlled trial","title":"Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type","title_match":false,"year":2016},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/a-randomized-trial-of-the-impact-of-a-specific-care-plan-in-1120-18373036","doi":"10.1007/bf02982632","journal":"The journal of nutrition, health & aging","n_participants":null,"pmid":"18373036","source_url":"https://pubmed.ncbi.nlm.nih.gov/18373036/","study_design":"randomized controlled trial","title":"A randomized trial of the impact of a specific care plan in 1120 Alzheimer's patients (PLASA Study) over a two-year period: design and baseline data","title_match":false,"year":2008},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/treatments-for-alzheimer-disease-16004170","doi":"10.1097/01.smj.0000166671.86815.c1","journal":"Southern medical journal","n_participants":null,"pmid":"16004170","source_url":"https://pubmed.ncbi.nlm.nih.gov/16004170/","study_design":"randomized controlled trial","title":"Treatments for Alzheimer disease","title_match":false,"year":2005},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/thiamine-for-alzheimer-s-disease-11405995","doi":"10.1002/14651858.cd001498","journal":"The Cochrane database of systematic reviews","n_participants":null,"pmid":"11405995","source_url":"https://pubmed.ncbi.nlm.nih.gov/11405995/","study_design":"systematic review","title":"Thiamine for Alzheimer's disease","title_match":false,"year":2001},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/phase-2a-proof-of-concept-double-blind-randomized-placebo-controlled-39671543","doi":"10.1212/wnl.0000000000210152","journal":"Neurology","n_participants":47,"pmid":"39671543","source_url":"https://pubmed.ncbi.nlm.nih.gov/39671543/","study_design":null,"title":"Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease","title_match":true,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/addressing-the-chronic-pain-early-cognitive-decline-comorbidity-among-37768713","doi":"10.2196/47319","journal":"JMIR research protocols","n_participants":37,"pmid":"37768713","source_url":"https://pubmed.ncbi.nlm.nih.gov/37768713/","study_design":null,"title":"Addressing the Chronic Pain-Early Cognitive Decline Comorbidity Among Older Adults: Protocol for the Active Brains Remote Efficacy Trial","title_match":false,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/the-effect-of-transcranial-alternating-current-stimulation-with-35475789","doi":"10.2196/37282","journal":"JMIR research protocols","n_participants":75,"pmid":"35475789","source_url":"https://pubmed.ncbi.nlm.nih.gov/35475789/","study_design":null,"title":"The Effect of Transcranial Alternating Current Stimulation With Cognitive Training on Executive Brain Function in Individuals With Dementia: Protocol for a Crossover Randomized Controlled Trial","title_match":true,"year":2022},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/effects-of-risperidone-and-galantamine-treatment-on-alzheimer-s-28269767","doi":"10.3233/jad-160758","journal":"Journal of Alzheimer's disease : JAD","n_participants":44,"pmid":"28269767","source_url":"https://pubmed.ncbi.nlm.nih.gov/28269767/","study_design":null,"title":"Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid","title_match":false,"year":2017},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/rationale-and-design-of-a-multicenter-phase-2-clinical-trial-to-25294055","doi":"10.1016/j.jstrokecerebrovasdis.2014.06.005","journal":"Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","n_participants":372,"pmid":"25294055","source_url":"https://pubmed.ncbi.nlm.nih.gov/25294055/","study_design":"clinical trial","title":"Rationale and design of a multicenter, phase 2 clinical trial to investigate the efficacy of traditional Chinese medicine SaiLuoTong in vascular dementia","title_match":true,"year":2014},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/effects-of-rivastigmine-transdermal-patch-and-capsule-on-aspects-of-20502014","doi":"10.1159/000296073","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"20502014","source_url":"https://pubmed.ncbi.nlm.nih.gov/20502014/","study_design":null,"title":"Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis","title_match":false,"year":2010},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/nicotine-for-alzheimer-s-disease-10796667","doi":"10.1002/14651858.cd001749","journal":"The Cochrane database of systematic reviews","n_participants":null,"pmid":"10796667","source_url":"https://pubmed.ncbi.nlm.nih.gov/10796667/","study_design":"systematic review","title":"Nicotine for Alzheimer's disease","title_match":false,"year":2000},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/clinical-trials-of-propentofylline-in-vascular-dementia-european-10609697","doi":null,"journal":"Alzheimer disease and associated disorders","n_participants":800,"pmid":"10609697","source_url":"https://pubmed.ncbi.nlm.nih.gov/10609697/","study_design":null,"title":"Clinical trials of propentofylline in vascular dementia. European/Canadian Propentofylline Study Group","title_match":true,"year":1999},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/effect-of-individual-virtual-reality-cognitive-training-programs-on-37878378","doi":"10.2196/48912","journal":"JMIR mental health","n_participants":30,"pmid":"37878378","source_url":"https://pubmed.ncbi.nlm.nih.gov/37878378/","study_design":null,"title":"Effect of Individual Virtual Reality Cognitive Training Programs on Cognitive Function and Depression in Middle-Aged Women: Randomized Controlled Trial","title_match":true,"year":2023},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/simulated-electroconvulsive-therapy-a-novel-approach-to-a-control-35220356","doi":"10.1097/yct.0000000000000832","journal":"The journal of ECT","n_participants":null,"pmid":"35220356","source_url":"https://pubmed.ncbi.nlm.nih.gov/35220356/","study_design":"randomized controlled trial","title":"Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials","title_match":true,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/feasibility-and-acceptability-of-a-web-based-caregiver-decision-aid-34550082","doi":"10.2196/30990","journal":"JMIR formative research","n_participants":203,"pmid":"34550082","source_url":"https://pubmed.ncbi.nlm.nih.gov/34550082/","study_design":"clinical trial","title":"Feasibility and Acceptability of a Web-Based Caregiver Decision Aid (Safety in Dementia) for Firearm Access: Pilot Randomized Controlled Trial","title_match":true,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/potentially-inappropriate-prescribing-in-australian-nursing-home-30106321","doi":"10.1089/jpm.2018.0070","journal":"Journal of palliative medicine","n_participants":65,"pmid":"30106321","source_url":"https://pubmed.ncbi.nlm.nih.gov/30106321/","study_design":"randomized controlled trial","title":"Potentially Inappropriate Prescribing in Australian Nursing Home Residents with Advanced Dementia: A Substudy of the IDEAL Study","title_match":false,"year":2018},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/change-in-depression-confidence-and-physical-function-among-older-29059120","doi":"10.1519/jpt.0000000000000143","journal":"Journal of geriatric physical therapy (2001)","n_participants":20,"pmid":"29059120","source_url":"https://pubmed.ncbi.nlm.nih.gov/29059120/","study_design":"randomized controlled trial","title":"Change in Depression, Confidence, and Physical Function Among Older Adults With Mild Cognitive Impairment","title_match":false,"year":2019},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/systematic-review-of-atorvastatin-for-the-treatment-of-alzheimer-s-25657666","doi":"10.3969/j.issn.1673-5374.2012.17.010","journal":"Neural regeneration research","n_participants":710,"pmid":"25657666","source_url":"https://pubmed.ncbi.nlm.nih.gov/25657666/","study_design":"systematic review","title":"Systematic review of atorvastatin for the treatment of Alzheimer's disease","title_match":false,"year":2012},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/usefulness-of-plasma-haloperidol-levels-for-monitoring-clinical-12611748","doi":"10.1176/appi.ajgp.11.2.186","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":40,"pmid":"12611748","source_url":"https://pubmed.ncbi.nlm.nih.gov/12611748/","study_design":null,"title":"Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol","title_match":false,"year":2003},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/double-blind-randomized-placebo-controlled-pilot-study-with-anapsos-11196347","doi":"10.1358/mf.2000.22.7.802270","journal":"Methods and findings in experimental and clinical pharmacology","n_participants":22,"pmid":"11196347","source_url":"https://pubmed.ncbi.nlm.nih.gov/11196347/","study_design":null,"title":"Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics","title_match":true,"year":2000},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/targeting-amyloid-pathology-in-early-alzheimer-s-the-promise-of-39998021","doi":"10.3390/pharmacy13010023","journal":"Pharmacy (Basel, Switzerland)","n_participants":null,"pmid":"39998021","source_url":"https://pubmed.ncbi.nlm.nih.gov/39998021/","study_design":"clinical trial","title":"Targeting Amyloid Pathology in Early Alzheimer's: The Promise of Donanemab-Azbt","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/mindfulness-based-app-to-reduce-stress-in-caregivers-of-persons-with-37831492","doi":"10.2196/50108","journal":"JMIR research protocols","n_participants":14,"pmid":"37831492","source_url":"https://pubmed.ncbi.nlm.nih.gov/37831492/","study_design":"randomized controlled trial","title":"Mindfulness-Based App to Reduce Stress in Caregivers of Persons With Alzheimer Disease and Related Dementias: Protocol for a Single-Blind Feasibility Proof-of-Concept Randomized Controlled Trial","title_match":true,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/repeated-transcranial-magnetic-stimulation-for-improving-cognition-in-34383681","doi":"10.2196/31183","journal":"JMIR research protocols","n_participants":150,"pmid":"34383681","source_url":"https://pubmed.ncbi.nlm.nih.gov/34383681/","study_design":null,"title":"Repeated Transcranial Magnetic Stimulation for Improving Cognition in Alzheimer Disease: Protocol for an Interim Analysis of a Randomized Controlled Trial","title_match":true,"year":2021},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/investigation-of-the-effects-of-interventions-made-according-to-the-34233376","doi":"10.1111/psyg.12734","journal":"Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society","n_participants":29,"pmid":"34233376","source_url":"https://pubmed.ncbi.nlm.nih.gov/34233376/","study_design":null,"title":"Investigation of the effects of interventions made according to the Progressively Lowered Stress Threshold Model on the care outcomes of Alzheimer patients and their families: a randomized clinical trial","title_match":true,"year":2021},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/home-based-multimodal-exercise-program-in-older-people-with-alzheimer-33586858","doi":"10.1002/pri.1899","journal":"Physiotherapy research international : the journal for researchers and clinicians in physical therapy","n_participants":null,"pmid":"33586858","source_url":"https://pubmed.ncbi.nlm.nih.gov/33586858/","study_design":null,"title":"Home-based multimodal exercise program in older people with Alzheimer disease: Randomized controlled trial protocol","title_match":true,"year":2021},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/validity-and-power-of-minimization-algorithm-in-longitudinal-analysis-29250611","doi":"10.1080/24709360.2017.1331822","journal":"Biostatistics & epidemiology","n_participants":null,"pmid":"29250611","source_url":"https://pubmed.ncbi.nlm.nih.gov/29250611/","study_design":"longitudinal study","title":"Validity and power of minimization algorithm in longitudinal analysis of clinical trials","title_match":true,"year":2017},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/citalopram-for-the-treatment-of-agitation-in-alzheimer-dementia-26303700","doi":"10.1177/0891988715601735","journal":"Journal of geriatric psychiatry and neurology","n_participants":null,"pmid":"26303700","source_url":"https://pubmed.ncbi.nlm.nih.gov/26303700/","study_design":null,"title":"Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences","title_match":false,"year":2016},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/efficacy-of-rivastigmine-for-cognitive-symptoms-in-parkinson-disease-19590387","doi":"10.1097/nrl.0b013e3181a968df","journal":"The neurologist","n_participants":541,"pmid":"19590387","source_url":"https://pubmed.ncbi.nlm.nih.gov/19590387/","study_design":"randomized controlled trial","title":"Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia","title_match":false,"year":2009},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/effects-of-medication-on-parotid-salivary-flow-rates-in-an-individual-7716695","doi":"10.1111/j.1754-4505.1993.tb01499.x","journal":"Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry","n_participants":null,"pmid":"7716695","source_url":"https://pubmed.ncbi.nlm.nih.gov/7716695/","study_design":"randomized controlled trial","title":"Effects of medication on parotid salivary flow rates in an individual with dementia of the Alzheimer type","title_match":false,"year":1993},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/pulse-pressure-as-a-predictor-of-alzheimer-s-disease-biomarkers-and-40908201","doi":"10.1016/j.tjpad.2025.100363","journal":"The journal of prevention of Alzheimer's disease","n_participants":1690,"pmid":"40908201","source_url":"https://pubmed.ncbi.nlm.nih.gov/40908201/","study_design":"cohort study","title":"Pulse pressure as a predictor of Alzheimer's disease biomarkers and cognitive decline: The moderating role of APOE \u03b54","title_match":false,"year":2025},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/changes-in-daily-functioning-in-association-with-tau-and-amyloid-40440591","doi":"10.1212/wnl.0000000000213775","journal":"Neurology","n_participants":434,"pmid":"40440591","source_url":"https://pubmed.ncbi.nlm.nih.gov/40440591/","study_design":"randomized controlled trial","title":"Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/protocol-for-a-randomized-phase-ii-iii-double-blind-placebo-40434891","doi":"10.1097/wad.0000000000000677","journal":"Alzheimer disease and associated disorders","n_participants":326,"pmid":"40434891","source_url":"https://pubmed.ncbi.nlm.nih.gov/40434891/","study_design":null,"title":"Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)","title_match":true,"year":2025},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/designing-and-implementing-the-ideal-study-a-randomized-clinical-39748836","doi":"10.1002/trc2.70016","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":374,"pmid":"39748836","source_url":"https://pubmed.ncbi.nlm.nih.gov/39748836/","study_design":"randomized controlled trial","title":"Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late-onset Alzheimer's disease in an urban Latino population","title_match":true,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/comparison-of-the-efficacy-of-updated-drugs-for-the-treatment-on-the-39550061","doi":"10.1016/j.neuroscience.2024.11.029","journal":"Neuroscience","n_participants":null,"pmid":"39550061","source_url":"https://pubmed.ncbi.nlm.nih.gov/39550061/","study_design":"meta-analysis","title":"Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer 's disease: A systematic review and network meta- analysis","title_match":false,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/reminiscence-and-digital-storytelling-to-improve-the-social-and-37676706","doi":"10.2196/49752","journal":"JMIR research protocols","n_participants":null,"pmid":"37676706","source_url":"https://pubmed.ncbi.nlm.nih.gov/37676706/","study_design":"randomized controlled trial","title":"Reminiscence and Digital Storytelling to Improve the Social and Emotional Well-Being of Older Adults With Alzheimer's Disease and Related Dementias: Protocol for a Mixed Methods Study Design and a Randomized Controlled Trial","title_match":true,"year":2023},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/a-web-based-decision-aid-for-caregivers-of-persons-with-dementia-with-36719721","doi":"10.2196/43702","journal":"JMIR research protocols","n_participants":117,"pmid":"36719721","source_url":"https://pubmed.ncbi.nlm.nih.gov/36719721/","study_design":"randomized controlled trial","title":"A Web-Based Decision Aid for Caregivers of Persons With Dementia With Firearm Access (Safe at Home Study): Protocol for a Randomized Controlled Trial","title_match":true,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/the-cost-effectiveness-of-three-prevention-strategies-in-alzheimer-s-34585216","doi":"10.14283/jpad.2021.47","journal":"The journal of prevention of Alzheimer's disease","n_participants":1525,"pmid":"34585216","source_url":"https://pubmed.ncbi.nlm.nih.gov/34585216/","study_design":null,"title":"The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT)","title_match":false,"year":2021},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-an-herbal-therapy-in-patients-with-amnestic-28596794","doi":"10.1155/2017/4251747","journal":"Evidence-based complementary and alternative medicine : eCAM","n_participants":216,"pmid":"28596794","source_url":"https://pubmed.ncbi.nlm.nih.gov/28596794/","study_design":null,"title":"Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial","title_match":true,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/effects-of-a-neuropsychology-program-based-on-mindfulness-on-24880524","doi":"10.1016/j.regg.2014.03.002","journal":"Revista espanola de geriatria y gerontologia","n_participants":null,"pmid":"24880524","source_url":"https://pubmed.ncbi.nlm.nih.gov/24880524/","study_design":null,"title":"[Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study]","title_match":true,"year":2014},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/effectiveness-of-a-modified-continuum-curriculum-for-medical-students-21220718","doi":"10.1212/wnl.0b013e318205d4fa","journal":"Neurology","n_participants":null,"pmid":"21220718","source_url":"https://pubmed.ncbi.nlm.nih.gov/21220718/","study_design":"longitudinal study","title":"Effectiveness of a modified Continuum curriculum for medical students: a randomized trial","title_match":false,"year":2011},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/finding-potent-drugs-for-alzheimer-s-disease-is-more-important-than-19595873","doi":"10.1016/j.jalz.2006.03.010","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"19595873","source_url":"https://pubmed.ncbi.nlm.nih.gov/19595873/","study_design":null,"title":"Finding potent drugs for Alzheimer's disease is more important than proving the drugs are disease modifying","title_match":false,"year":2006},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/cardiovascular-risk-and-memory-in-non-demented-elderly-women-18805604","doi":"10.1016/j.neurobiolaging.2008.08.007","journal":"Neurobiology of aging","n_participants":375,"pmid":"18805604","source_url":"https://pubmed.ncbi.nlm.nih.gov/18805604/","study_design":null,"title":"Cardiovascular risk and memory in non-demented elderly women","title_match":false,"year":2010},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/lecithin-for-dementia-and-cognitive-impairment-11034695","doi":"10.1002/14651858.cd001015","journal":"The Cochrane database of systematic reviews","n_participants":265,"pmid":"11034695","source_url":"https://pubmed.ncbi.nlm.nih.gov/11034695/","study_design":"randomized controlled trial","title":"Lecithin for dementia and cognitive impairment","title_match":false,"year":2000},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/comparative-study-of-choline-alfoscerate-as-a-combination-therapy-38875437","doi":"10.1097/md.0000000000038067","journal":"Medicine","n_participants":119,"pmid":"38875437","source_url":"https://pubmed.ncbi.nlm.nih.gov/38875437/","study_design":null,"title":"Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial","title_match":true,"year":2024},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/effects-of-exercise-on-urinary-ad7c-ntp-alzheimer-associated-neuronal-38669527","doi":"10.3233/jad-230946","journal":"Journal of Alzheimer's disease : JAD","n_participants":12,"pmid":"38669527","source_url":"https://pubmed.ncbi.nlm.nih.gov/38669527/","study_design":null,"title":"Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial","title_match":true,"year":2024},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-study-to-assess-the-skin-irritation-and-37695107","doi":"10.1097/wad.0000000000000578","journal":"Alzheimer disease and associated disorders","n_participants":198,"pmid":"37695107","source_url":"https://pubmed.ncbi.nlm.nih.gov/37695107/","study_design":"clinical trial","title":"A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers","title_match":true,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/study-protocol-pragmatic-randomized-control-trial-of-my-tools-4-care-32778059","doi":"10.1186/s12877-020-01690-w","journal":"BMC geriatrics","n_participants":null,"pmid":"32778059","source_url":"https://pubmed.ncbi.nlm.nih.gov/32778059/","study_design":"randomized controlled trial","title":"Study protocol: pragmatic randomized control trial of my tools 4 care- in care (MT4C-in care) a web-based tool for family Carers of persons with dementia residing in long term care","title_match":false,"year":2020},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-programmable-compared-with-fixed-anti-siphon-30333067","doi":"10.1186/s13063-018-2951-6","journal":"Trials","n_participants":306,"pmid":"30333067","source_url":"https://pubmed.ncbi.nlm.nih.gov/30333067/","study_design":"randomized controlled trial","title":"Efficacy and safety of programmable compared with fixed anti-siphon devices for treating idiopathic normal-pressure hydrocephalus (iNPH) in adults - SYGRAVA: study protocol for a randomized trial","title_match":false,"year":2018},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/the-clinical-efficacy-of-reminiscence-therapy-in-patients-with-mild-29390538","doi":"10.1097/md.0000000000009381","journal":"Medicine","n_participants":45,"pmid":"29390538","source_url":"https://pubmed.ncbi.nlm.nih.gov/29390538/","study_design":null,"title":"The clinical efficacy of reminiscence therapy in patients with mild-to-moderate Alzheimer disease: Study protocol for a randomized parallel-design controlled trial","title_match":false,"year":2017},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/is-sertraline-treatment-or-depression-remission-in-depressed-24314887","doi":"10.1016/j.jagp.2013.02.014","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":131,"pmid":"24314887","source_url":"https://pubmed.ncbi.nlm.nih.gov/24314887/","study_design":null,"title":"Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2","title_match":false,"year":2014},{"alzhub_score":29,"alzhub_url":"https://alzhub.org/study/antagonic-stress-superiority-versus-meclofenoxate-in-18649860","doi":"10.1016/s0167-4943(05)80065-2","journal":"Archives of gerontology and geriatrics","n_participants":null,"pmid":"18649860","source_url":"https://pubmed.ncbi.nlm.nih.gov/18649860/","study_design":null,"title":"Antagonic-stress superiority versus meclofenoxate in gerontopsychiatry (alzheimer type dementia)","title_match":false,"year":1994},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/low-dose-lithium-for-mild-cognitive-impairment-a-pilot-randomized-41770546","doi":"10.1001/jamaneurol.2026.0072","journal":"JAMA neurology","n_participants":170,"pmid":"41770546","source_url":"https://pubmed.ncbi.nlm.nih.gov/41770546/","study_design":null,"title":"Low-Dose Lithium for Mild Cognitive Impairment: A Pilot Randomized Clinical Trial","title_match":true,"year":2026},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/efficacy-of-lt-i-gt-bacopa-monnieri-lt-i-gt-linn-on-cognitive-41740144","doi":"10.2196/82891","journal":"JMIR research protocols","n_participants":76,"pmid":"41740144","source_url":"https://pubmed.ncbi.nlm.nih.gov/41740144/","study_design":null,"title":"Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial","title_match":true,"year":2026},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-multimodal-lifestyle-intervention-complemented-with-40664536","doi":"10.1016/j.tjpad.2025.100271","journal":"The journal of prevention of Alzheimer's disease","n_participants":129,"pmid":"40664536","source_url":"https://pubmed.ncbi.nlm.nih.gov/40664536/","study_design":null,"title":"A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- \u025b4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study)","title_match":true,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/sodium-benzoate-a-d-amino-acid-oxidase-inhibitor-improved-short-term-40405827","doi":"10.1111/pcn.13841","journal":"Psychiatry and clinical neurosciences","n_participants":null,"pmid":"40405827","source_url":"https://pubmed.ncbi.nlm.nih.gov/40405827/","study_design":null,"title":"Sodium benzoate, a D-amino acid oxidase inhibitor, improved short-term memory in patients with mild cognitive impairment in a randomized, double-blind, placebo-controlled clinical trial","title_match":true,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/structural-and-metabolic-topological-alterations-associated-with-40159989","doi":"10.1111/pcn.13812","journal":"Psychiatry and clinical neurosciences","n_participants":270,"pmid":"40159989","source_url":"https://pubmed.ncbi.nlm.nih.gov/40159989/","study_design":null,"title":"Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trial","title_match":true,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/intervention-development-for-tailored-education-for-aging-and-39412840","doi":"10.2196/60395","journal":"JMIR research protocols","n_participants":20,"pmid":"39412840","source_url":"https://pubmed.ncbi.nlm.nih.gov/39412840/","study_design":"randomized controlled trial","title":"Intervention Development for Tailored Education for Aging and Cognitive Health (TEACH) for Dementia Prevention in Midlife Adults: Protocol for a Randomized Controlled Trial","title_match":true,"year":2024},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/intervention-for-the-management-of-neuropsychiatric-symptoms-to-39392675","doi":"10.2196/58356","journal":"JMIR research protocols","n_participants":28,"pmid":"39392675","source_url":"https://pubmed.ncbi.nlm.nih.gov/39392675/","study_design":"randomized controlled trial","title":"Intervention for the Management of Neuropsychiatric Symptoms to Reduce Caregiver Stress: Protocol for the Mindful and Self-Compassion Care Intervention for Caregivers of Persons Living With Dementia","title_match":false,"year":2024},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/design-and-methods-of-the-early-age-related-hearing-loss-38728564","doi":"10.1097/mao.0000000000004093","journal":"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology","n_participants":null,"pmid":"38728564","source_url":"https://pubmed.ncbi.nlm.nih.gov/38728564/","study_design":null,"title":"Design and Methods of the Early Age-Related Hearing Loss Investigation Randomized Controlled Trial","title_match":true,"year":2024},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-clinical-efficacy-of-olibanum-gum-chewing-in-patients-with-mild-38069542","doi":"10.1002/npr2.12398","journal":"Neuropsychopharmacology reports","n_participants":36,"pmid":"38069542","source_url":"https://pubmed.ncbi.nlm.nih.gov/38069542/","study_design":null,"title":"The clinical efficacy of Olibanum gum chewing in patients with\u00a0Mild-to-Moderate Alzheimer disease: A randomized Parallel-Design controlled trial","title_match":false,"year":2024},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/association-between-urate-lowering-therapies-and-cognitive-decline-in-36097005","doi":"10.1038/s41598-022-17808-6","journal":"Scientific reports","n_participants":51,"pmid":"36097005","source_url":"https://pubmed.ncbi.nlm.nih.gov/36097005/","study_design":"randomized controlled trial","title":"Association between urate-lowering therapies and cognitive decline in community-dwelling older adults","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/the-atencion-plena-en-enfermedad-de-alzheimer-atenea-mindfulness-in-35327020","doi":"10.3390/healthcare10030542","journal":"Healthcare (Basel, Switzerland)","n_participants":null,"pmid":"35327020","source_url":"https://pubmed.ncbi.nlm.nih.gov/35327020/","study_design":null,"title":"The ATENci\u00f3n Plena en Enfermedad de Alzheimer (ATENEA-Mindfulness in Alzheimer's Disease) Program for Caregivers: Study Protocol for a Randomized Controlled Trial","title_match":true,"year":2022},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/acupuncture-for-amnestic-mild-cognitive-impairment-a-pilot-34797294","doi":"10.1097/md.0000000000027686","journal":"Medicine","n_participants":25,"pmid":"34797294","source_url":"https://pubmed.ncbi.nlm.nih.gov/34797294/","study_design":null,"title":"Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-shenmayizhi-decoction-as-an-adjuvant-treatment-31852125","doi":"10.1097/md.0000000000018326","journal":"Medicine","n_participants":196,"pmid":"31852125","source_url":"https://pubmed.ncbi.nlm.nih.gov/31852125/","study_design":null,"title":"Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia: Study protocol for a randomized controlled trial","title_match":true,"year":2019},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/practical-lessons-from-amyloid-immunotherapy-trials-in-alzheimer-22631442","doi":"10.2174/156720512804142958","journal":"Current Alzheimer research","n_participants":20,"pmid":"22631442","source_url":"https://pubmed.ncbi.nlm.nih.gov/22631442/","study_design":null,"title":"Practical lessons from amyloid immunotherapy trials in Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effects-of-exercise-and-intensive-vascular-risk-reduction-on-41870419","doi":"10.1001/jamaneurol.2026.0359","journal":"JAMA neurology","n_participants":3290,"pmid":"41870419","source_url":"https://pubmed.ncbi.nlm.nih.gov/41870419/","study_design":null,"title":"Effects of Exercise and Intensive Vascular Risk Reduction on Cognitive Function in Older Adults: A Randomized Clinical Trial","title_match":true,"year":2026},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-evolution-of-randomized-clinical-trial-designs-to-assess-40880087","doi":"10.1001/jamanetworkopen.2025.29665","journal":"JAMA network open","n_participants":203,"pmid":"40880087","source_url":"https://pubmed.ncbi.nlm.nih.gov/40880087/","study_design":"clinical trial","title":"The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer Disease","title_match":true,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/stress-and-hypertension-among-african-american-female-family-40146982","doi":"10.2196/66975","journal":"JMIR research protocols","n_participants":null,"pmid":"40146982","source_url":"https://pubmed.ncbi.nlm.nih.gov/40146982/","study_design":"randomized controlled trial","title":"Stress and Hypertension Among African American Female Family Caregivers of Persons Living With Alzheimer Disease and Related Dementias: Protocol for a Pilot Internet-Based Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/association-between-lifestyle-at-different-life-periods-and-brain-39919257","doi":"10.1212/wnl.0000000000213347","journal":"Neurology","n_participants":null,"pmid":"39919257","source_url":"https://pubmed.ncbi.nlm.nih.gov/39919257/","study_design":"randomized controlled trial","title":"Association Between Lifestyle at Different Life Periods and Brain Integrity in Older Adults","title_match":false,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-mental-imagery-on-quality-of-life-cognitive-and-emotional-39766459","doi":"10.3390/brainsci14121260","journal":"Brain sciences","n_participants":55,"pmid":"39766459","source_url":"https://pubmed.ncbi.nlm.nih.gov/39766459/","study_design":"randomized controlled trial","title":"Effects of Mental Imagery on Quality of Life, Cognitive, and Emotional Status in Older Adults with Early-Stage Alzheimer's Disease Dementia: A Randomized Controlled Trial","title_match":true,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-mindfulness-based-lifestyle-intervention-for-dementia-risk-39571150","doi":"10.2196/64149","journal":"JMIR research protocols","n_participants":225,"pmid":"39571150","source_url":"https://pubmed.ncbi.nlm.nih.gov/39571150/","study_design":"randomized controlled trial","title":"A Mindfulness-Based Lifestyle Intervention for Dementia Risk Reduction: Protocol for the My Healthy Brain Feasibility Randomized Controlled Trial","title_match":true,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/nutritional-interventions-for-the-prevention-of-cognitive-decline-in-38416536","doi":"10.2196/47196","journal":"JMIR research protocols","n_participants":51,"pmid":"38416536","source_url":"https://pubmed.ncbi.nlm.nih.gov/38416536/","study_design":"systematic review","title":"Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled Trials","title_match":true,"year":2024},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/neurochemical-ameliorating-of-the-hippocampus-in-dyslipidemic-38318412","doi":"10.47176/mjiri.37.123","journal":"Medical journal of the Islamic Republic of Iran","n_participants":12,"pmid":"38318412","source_url":"https://pubmed.ncbi.nlm.nih.gov/38318412/","study_design":null,"title":"Neurochemical Ameliorating of the Hippocampus in Dyslipidemic Alzheimer Patients Following Silymarin; a Double-Blind Placebo-Controlled Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/asure-clinical-trial-protocol-a-randomized-placebo-controlled-proof-37874087","doi":"10.14283/jpad.2023.107","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"37874087","source_url":"https://pubmed.ncbi.nlm.nih.gov/37874087/","study_design":null,"title":"ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients","title_match":true,"year":2023},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/personalized-integrated-care-promoting-quality-of-life-for-older-37486732","doi":"10.2196/47916","journal":"JMIR research protocols","n_participants":558,"pmid":"37486732","source_url":"https://pubmed.ncbi.nlm.nih.gov/37486732/","study_design":null,"title":"Personalized Integrated Care Promoting Quality of Life for Older People: Protocol for a Multicenter Randomized Controlled Trial","title_match":true,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/transcranial-color-coded-doppler-cerebral-hemodynamics-following-36714789","doi":"10.1177/15443167221099274","journal":"Journal for vascular ultrasound : JVU","n_participants":12,"pmid":"36714789","source_url":"https://pubmed.ncbi.nlm.nih.gov/36714789/","study_design":null,"title":"Transcranial Color-Coded Doppler Cerebral Hemodynamics Following Aerobic Exercise Training: Outcomes From a Pilot Randomized Clinical Trial","title_match":true,"year":2022},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/a-psychosocial-intervention-for-supporting-informal-caregivers-of-36367770","doi":"10.2196/37496","journal":"JMIR research protocols","n_participants":null,"pmid":"36367770","source_url":"https://pubmed.ncbi.nlm.nih.gov/36367770/","study_design":"randomized controlled trial","title":"A Psychosocial Intervention for Supporting Informal Caregivers of Older People With Alzheimer Disease: Protocol for the InnFamiglia Randomized Controlled Trial","title_match":true,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-investigating-the-feasibility-of-a-low-34328428","doi":"10.2196/30514","journal":"JMIR research protocols","n_participants":null,"pmid":"34328428","source_url":"https://pubmed.ncbi.nlm.nih.gov/34328428/","study_design":"randomized controlled trial","title":"A Randomized Controlled Trial Investigating the Feasibility of a Low-Intensity Psychological Intervention for Fear of Memory Loss and Quality of Life in Older Adults: Protocol for the Reducing Fear and Avoidance of Memory Loss (REFRAME) Study","title_match":true,"year":2021},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-efficacy-and-safety-of-hachimijiogan-for-mild-alzheimer-disease-32957414","doi":"10.1097/md.0000000000022370","journal":"Medicine","n_participants":null,"pmid":"32957414","source_url":"https://pubmed.ncbi.nlm.nih.gov/32957414/","study_design":null,"title":"The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/education-research-online-alzheimer-education-for-high-school-and-32665410","doi":"10.1212/wnl.0000000000009859","journal":"Neurology","n_participants":721,"pmid":"32665410","source_url":"https://pubmed.ncbi.nlm.nih.gov/32665410/","study_design":"randomized controlled trial","title":"Education Research: Online Alzheimer education for high school and college students: A randomized controlled trial","title_match":true,"year":2020},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/taking-care-of-the-dyad-frequency-of-caregiver-assessment-among-31002403","doi":"10.1111/jgs.15882","journal":"Journal of the American Geriatrics Society","n_participants":211,"pmid":"31002403","source_url":"https://pubmed.ncbi.nlm.nih.gov/31002403/","study_design":"randomized controlled trial","title":"Taking Care of the Dyad: Frequency of Caregiver Assessment Among Veterans with Dementia","title_match":false,"year":2019},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-prevention-of-hip-fracture-with-menatetrenone-and-risedronate-21778673","doi":"10.2739/kurumemedj.57.117","journal":"The Kurume medical journal","n_participants":15,"pmid":"21778673","source_url":"https://pubmed.ncbi.nlm.nih.gov/21778673/","study_design":null,"title":"The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial","title_match":true,"year":2011},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/mri-substudy-participation-in-alzheimer-disease-ad-clinical-trials-19571733","doi":"10.1097/wad.0b013e3181aba588","journal":"Alzheimer disease and associated disorders","n_participants":166,"pmid":"19571733","source_url":"https://pubmed.ncbi.nlm.nih.gov/19571733/","study_design":null,"title":"MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population","title_match":true,"year":2009},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/digital-memory-assessments-and-plasma-ptau217-enable-efficient-41653883","doi":"10.1016/j.tjpad.2026.100503","journal":"The journal of prevention of Alzheimer's disease","n_participants":818,"pmid":"41653883","source_url":"https://pubmed.ncbi.nlm.nih.gov/41653883/","study_design":null,"title":"Digital memory assessments and plasma pTau217 enable efficient preclinical Alzheimer's trials","title_match":false,"year":2026},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/apolipoprotein-e-4-dependent-associations-between-carotenoids-and-40876538","doi":"10.1016/j.ajcnut.2025.08.012","journal":"The American journal of clinical nutrition","n_participants":442,"pmid":"40876538","source_url":"https://pubmed.ncbi.nlm.nih.gov/40876538/","study_design":"randomized controlled trial","title":"Apolipoprotein E \u03b54-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/financial-incentives-to-increase-diversity-of-older-participants-in-a-40844772","doi":"10.1001/jamahealthforum.2025.2273","journal":"JAMA health forum","n_participants":844,"pmid":"40844772","source_url":"https://pubmed.ncbi.nlm.nih.gov/40844772/","study_design":null,"title":"Financial Incentives to Increase Diversity of Older Participants in a Memory Concerns Registry: A Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-rotigotine-in-patients-with-frontotemporal-40809903","doi":"10.1016/j.lanepe.2025.101409","journal":"The Lancet regional health. Europe","n_participants":128,"pmid":"40809903","source_url":"https://pubmed.ncbi.nlm.nih.gov/40809903/","study_design":null,"title":"Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial","title_match":true,"year":2025},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-33667416","doi":"10.1016/s0140-6736(20)32205-4","journal":"Lancet (London, England)","n_participants":null,"pmid":"33667416","source_url":"https://pubmed.ncbi.nlm.nih.gov/33667416/","study_design":null,"title":"Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/exercise-training-increases-size-of-hippocampus-and-improves-memory-21282661","doi":"10.1073/pnas.1015950108","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"21282661","source_url":"https://pubmed.ncbi.nlm.nih.gov/21282661/","study_design":"randomized controlled trial","title":"Exercise training increases size of hippocampus and improves memory","title_match":false,"year":2011},{"alzhub_score":85,"alzhub_url":"https://alzhub.org/study/a-2-year-multidomain-intervention-of-diet-exercise-cognitive-training-25771249","doi":"10.1016/s0140-6736(15)60461-5","journal":"Lancet (London, England)","n_participants":631,"pmid":"25771249","source_url":"https://pubmed.ncbi.nlm.nih.gov/25771249/","study_design":"randomized controlled trial","title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","title_match":true,"year":2015},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/prevalence-incidence-and-factors-associated-with-pre-stroke-and-post-19782001","doi":"10.1016/s1474-4422(09)70236-4","journal":"The Lancet. Neurology","n_participants":7511,"pmid":"19782001","source_url":"https://pubmed.ncbi.nlm.nih.gov/19782001/","study_design":"systematic review","title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis","title_match":false,"year":2009},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/high-blood-pressure-and-cardiovascular-disease-31865786","doi":"10.1161/hypertensionaha.119.14240","journal":"Hypertension (Dallas, Tex. : 1979)","n_participants":null,"pmid":"31865786","source_url":"https://pubmed.ncbi.nlm.nih.gov/31865786/","study_design":"meta-analysis","title":"High Blood Pressure and Cardiovascular Disease","title_match":false,"year":2020},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/late-life-depression-and-risk-of-vascular-dementia-and-alzheimer-s-23637108","doi":"10.1192/bjp.bp.112.118307","journal":"The British journal of psychiatry : the journal of mental science","n_participants":23,"pmid":"23637108","source_url":"https://pubmed.ncbi.nlm.nih.gov/23637108/","study_design":"systematic review","title":"Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies","title_match":false,"year":2013},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/the-study-on-cognition-and-prognosis-in-the-elderly-scope-principal-12714861","doi":"10.1097/00004872-200305000-00011","journal":"Journal of hypertension","n_participants":4964,"pmid":"12714861","source_url":"https://pubmed.ncbi.nlm.nih.gov/12714861/","study_design":"open-label trial","title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial","title_match":true,"year":2003},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/prevention-of-dementia-in-randomised-double-blind-placebo-controlled-9802273","doi":"10.1016/s0140-6736(98)03086-4","journal":"Lancet (London, England)","n_participants":1180,"pmid":"9802273","source_url":"https://pubmed.ncbi.nlm.nih.gov/9802273/","study_design":null,"title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","title_match":true,"year":1998},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/physical-activity-cognition-and-brain-outcomes-a-review-of-the-2018-31095081","doi":"10.1249/mss.0000000000001936","journal":"Medicine and science in sports and exercise","n_participants":null,"pmid":"31095081","source_url":"https://pubmed.ncbi.nlm.nih.gov/31095081/","study_design":"meta-analysis","title":"Physical Activity, Cognition, and Brain Outcomes: A Review of the 2018 Physical Activity Guidelines","title_match":false,"year":2019},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/effects-of-blood-pressure-lowering-with-perindopril-and-indapamide-12742805","doi":"10.1001/archinte.163.9.1069","journal":"Archives of internal medicine","n_participants":6105,"pmid":"12742805","source_url":"https://pubmed.ncbi.nlm.nih.gov/12742805/","study_design":null,"title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","title_match":false,"year":2003},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/post-stroke-cognitive-impairment-and-dementia-35420911","doi":"10.1161/circresaha.122.319951","journal":"Circulation research","n_participants":null,"pmid":"35420911","source_url":"https://pubmed.ncbi.nlm.nih.gov/35420911/","study_design":null,"title":"Post-Stroke Cognitive Impairment and Dementia","title_match":false,"year":2022},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/physical-exercise-as-a-preventive-or-disease-modifying-treatment-of-21878600","doi":"10.4065/mcp.2011.0252","journal":"Mayo Clinic proceedings","n_participants":null,"pmid":"21878600","source_url":"https://pubmed.ncbi.nlm.nih.gov/21878600/","study_design":"meta-analysis","title":"Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging","title_match":false,"year":2011},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-prevention-from-risk-factors-to-early-intervention-28899416","doi":"10.1186/s13195-017-0297-z","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"28899416","source_url":"https://pubmed.ncbi.nlm.nih.gov/28899416/","study_design":null,"title":"Alzheimer's disease prevention: from risk factors to early intervention","title_match":false,"year":2017},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/nutrition-and-prevention-of-cognitive-impairment-30244829","doi":"10.1016/s1474-4422(18)30338-7","journal":"The Lancet. Neurology","n_participants":null,"pmid":"30244829","source_url":"https://pubmed.ncbi.nlm.nih.gov/30244829/","study_design":null,"title":"Nutrition and prevention of cognitive impairment","title_match":false,"year":2018},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/association-of-mediterranean-diet-with-mild-cognitive-impairment-and-24164735","doi":"10.3233/jad-130830","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"24164735","source_url":"https://pubmed.ncbi.nlm.nih.gov/24164735/","study_design":"systematic review","title":"Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis","title_match":false,"year":2014},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/association-of-proton-pump-inhibitors-with-risk-of-dementia-a-26882076","doi":"10.1001/jamaneurol.2015.4791","journal":"JAMA neurology","n_participants":2950,"pmid":"26882076","source_url":"https://pubmed.ncbi.nlm.nih.gov/26882076/","study_design":"cohort study","title":"Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis","title_match":false,"year":2016},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/the-finnish-geriatric-intervention-study-to-prevent-cognitive-23332672","doi":"10.1016/j.jalz.2012.09.012","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1200,"pmid":"23332672","source_url":"https://pubmed.ncbi.nlm.nih.gov/23332672/","study_design":null,"title":"The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress","title_match":false,"year":2013},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/an-update-on-genetic-frontotemporal-dementia-31119452","doi":"10.1007/s00415-019-09363-4","journal":"Journal of neurology","n_participants":null,"pmid":"31119452","source_url":"https://pubmed.ncbi.nlm.nih.gov/31119452/","study_design":null,"title":"An update on genetic frontotemporal dementia","title_match":false,"year":2019},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/incidence-and-prediction-of-falls-in-dementia-a-prospective-study-in-19436724","doi":"10.1371/journal.pone.0005521","journal":"PloS one","n_participants":179,"pmid":"19436724","source_url":"https://pubmed.ncbi.nlm.nih.gov/19436724/","study_design":null,"title":"Incidence and prediction of falls in dementia: a prospective study in older people","title_match":false,"year":2009},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/update-on-alzheimer-s-disease-therapy-and-prevention-strategies-28099083","doi":"10.1146/annurev-med-042915-103753","journal":"Annual review of medicine","n_participants":null,"pmid":"28099083","source_url":"https://pubmed.ncbi.nlm.nih.gov/28099083/","study_design":null,"title":"Update on Alzheimer's Disease Therapy and Prevention Strategies","title_match":false,"year":2017},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-cognitive-function-and-dementia-a-systematic-27633105","doi":"10.3945/an.116.012138","journal":"Advances in nutrition (Bethesda, Md.)","n_participants":null,"pmid":"27633105","source_url":"https://pubmed.ncbi.nlm.nih.gov/27633105/","study_design":"systematic review","title":"Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence","title_match":false,"year":2016},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/hearing-intervention-versus-health-education-control-to-reduce-37478886","doi":"10.1016/s0140-6736(23)01406-x","journal":"Lancet (London, England)","n_participants":858,"pmid":"37478886","source_url":"https://pubmed.ncbi.nlm.nih.gov/37478886/","study_design":"randomized controlled trial","title":"Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial","title_match":true,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/prevention-of-stroke-in-patients-with-silent-cerebrovascular-disease-27980126","doi":"10.1161/str.0000000000000116","journal":"Stroke","n_participants":null,"pmid":"27980126","source_url":"https://pubmed.ncbi.nlm.nih.gov/27980126/","study_design":null,"title":"Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association","title_match":false,"year":2017},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/effect-of-tai-chi-on-cognitive-performance-in-older-adults-systematic-24383523","doi":"10.1111/jgs.12611","journal":"Journal of the American Geriatrics Society","n_participants":2553,"pmid":"24383523","source_url":"https://pubmed.ncbi.nlm.nih.gov/24383523/","study_design":"systematic review","title":"Effect of tai chi on cognitive performance in older adults: systematic review and meta-analysis","title_match":false,"year":2014},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/physical-exercise-and-cognitive-performance-in-the-elderly-current-24379659","doi":"10.2147/cia.s39506","journal":"Clinical interventions in aging","n_participants":null,"pmid":"24379659","source_url":"https://pubmed.ncbi.nlm.nih.gov/24379659/","study_design":null,"title":"Physical exercise and cognitive performance in the elderly: current perspectives","title_match":false,"year":2014},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/aerobic-exercise-increases-hippocampal-volume-in-older-women-with-24711660","doi":"10.1136/bjsports-2013-093184","journal":"British journal of sports medicine","n_participants":null,"pmid":"24711660","source_url":"https://pubmed.ncbi.nlm.nih.gov/24711660/","study_design":null,"title":"Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial","title_match":true,"year":2015},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/dexmedetomidine-versus-propofol-sedation-reduces-delirium-after-26575144","doi":"10.1097/aln.0000000000000951","journal":"Anesthesiology","n_participants":null,"pmid":"26575144","source_url":"https://pubmed.ncbi.nlm.nih.gov/26575144/","study_design":"randomized controlled trial","title":"Dexmedetomidine versus Propofol Sedation Reduces Delirium after Cardiac Surgery: A Randomized Controlled Trial","title_match":true,"year":2016},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/study-design-of-aspirin-in-reducing-events-in-the-elderly-aspree-a-24113028","doi":"10.1016/j.cct.2013.09.014","journal":"Contemporary clinical trials","n_participants":14383,"pmid":"24113028","source_url":"https://pubmed.ncbi.nlm.nih.gov/24113028/","study_design":null,"title":"Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial","title_match":true,"year":2013},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/exergaming-and-older-adult-cognition-a-cluster-randomized-clinical-22261206","doi":"10.1016/j.amepre.2011.10.016","journal":"American journal of preventive medicine","n_participants":null,"pmid":"22261206","source_url":"https://pubmed.ncbi.nlm.nih.gov/22261206/","study_design":null,"title":"Exergaming and older adult cognition: a cluster randomized clinical trial","title_match":true,"year":2012},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/modifiable-factors-that-alter-the-size-of-the-hippocampus-with-ageing-22410582","doi":"10.1038/nrneurol.2012.27","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"22410582","source_url":"https://pubmed.ncbi.nlm.nih.gov/22410582/","study_design":null,"title":"Modifiable factors that alter the size of the hippocampus with ageing","title_match":false,"year":2012},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/depression-an-underrecognized-target-for-prevention-of-dementia-in-32433512","doi":"10.1038/s41398-020-0839-1","journal":"Translational psychiatry","n_participants":null,"pmid":"32433512","source_url":"https://pubmed.ncbi.nlm.nih.gov/32433512/","study_design":null,"title":"Depression-an underrecognized target for prevention of dementia in Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/the-risk-benefit-profile-of-commonly-used-herbal-therapies-ginkgo-st-11777363","doi":"10.7326/0003-4819-136-1-200201010-00010","journal":"Annals of internal medicine","n_participants":null,"pmid":"11777363","source_url":"https://pubmed.ncbi.nlm.nih.gov/11777363/","study_design":null,"title":"The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava","title_match":false,"year":2002},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/vascular-risk-factors-cognitive-decline-and-dementia-18561512","doi":"10.2147/vhrm.s1839","journal":"Vascular health and risk management","n_participants":null,"pmid":"18561512","source_url":"https://pubmed.ncbi.nlm.nih.gov/18561512/","study_design":"longitudinal study","title":"Vascular risk factors, cognitive decline, and dementia","title_match":false,"year":2008},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/multidomain-interventions-to-prevent-cognitive-impairment-alzheimer-s-32010923","doi":"10.14283/jpad.2019.41","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"32010923","source_url":"https://pubmed.ncbi.nlm.nih.gov/32010923/","study_design":null,"title":"Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS","title_match":false,"year":2020},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/can-cognitive-exercise-prevent-the-onset-of-dementia-systematic-19225276","doi":"10.1097/jgp.0b013e3181953b57","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":54,"pmid":"19225276","source_url":"https://pubmed.ncbi.nlm.nih.gov/19225276/","study_design":"longitudinal study","title":"Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up","title_match":true,"year":2009},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/prevention-of-sporadic-alzheimer-s-disease-lessons-learned-from-26213339","doi":"10.1016/s1474-4422(15)00153-2","journal":"The Lancet. Neurology","n_participants":null,"pmid":"26213339","source_url":"https://pubmed.ncbi.nlm.nih.gov/26213339/","study_design":null,"title":"Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions","title_match":true,"year":2015},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/the-benefits-associated-with-volunteering-among-seniors-a-critical-25150681","doi":"10.1037/a0037610","journal":"Psychological bulletin","n_participants":null,"pmid":"25150681","source_url":"https://pubmed.ncbi.nlm.nih.gov/25150681/","study_design":"randomized controlled trial","title":"The benefits associated with volunteering among seniors: a critical review and recommendations for future research","title_match":false,"year":2014},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/fish-consumption-long-chain-omega-3-fatty-acids-and-risk-of-cognitive-19262590","doi":"10.1038/ncpneuro1044","journal":"Nature clinical practice. Neurology","n_participants":null,"pmid":"19262590","source_url":"https://pubmed.ncbi.nlm.nih.gov/19262590/","study_design":"systematic review","title":"Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association","title_match":false,"year":2009},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/the-treatment-of-hyperhomocysteinemia-18729731","doi":"10.1146/annurev.med.60.041807.123308","journal":"Annual review of medicine","n_participants":null,"pmid":"18729731","source_url":"https://pubmed.ncbi.nlm.nih.gov/18729731/","study_design":null,"title":"The treatment of hyperhomocysteinemia","title_match":false,"year":2009},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/effects-of-n-3-fatty-acids-epa-v-dha-on-depressive-symptoms-quality-21929835","doi":"10.1017/s0007114511004788","journal":"The British journal of nutrition","n_participants":null,"pmid":"21929835","source_url":"https://pubmed.ncbi.nlm.nih.gov/21929835/","study_design":"randomized controlled trial","title":"Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial","title_match":true,"year":2012},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/improved-exercise-tolerance-and-quality-of-life-with-cardiac-12707240","doi":"10.1161/01.cir.0000066322.21016.4a","journal":"Circulation","n_participants":90,"pmid":"12707240","source_url":"https://pubmed.ncbi.nlm.nih.gov/12707240/","study_design":"randomized controlled trial","title":"Improved exercise tolerance and quality of life with cardiac rehabilitation of older patients after myocardial infarction: results of a randomized, controlled trial","title_match":true,"year":2003},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/aerobic-exercise-improves-cognition-for-older-adults-with-glucose-20847403","doi":"10.3233/jad-2010-100768","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"20847403","source_url":"https://pubmed.ncbi.nlm.nih.gov/20847403/","study_design":null,"title":"Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/changes-in-brain-volume-and-cognition-in-a-randomized-trial-of-22451320","doi":"10.3233/jad-2012-120079","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"22451320","source_url":"https://pubmed.ncbi.nlm.nih.gov/22451320/","study_design":null,"title":"Changes in brain volume and cognition in a randomized trial of exercise and social interaction in a community-based sample of non-demented Chinese elders","title_match":false,"year":2012},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/mixed-dementia-emerging-concepts-and-therapeutic-implications-15598922","doi":"10.1001/jama.292.23.2901","journal":"JAMA","n_participants":null,"pmid":"15598922","source_url":"https://pubmed.ncbi.nlm.nih.gov/15598922/","study_design":null,"title":"Mixed dementia: emerging concepts and therapeutic implications","title_match":false,"year":2004},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/contributions-of-brain-insulin-resistance-and-deficiency-in-amyloid-22191795","doi":"10.2165/11597760-000000000-00000","journal":"Drugs","n_participants":null,"pmid":"22191795","source_url":"https://pubmed.ncbi.nlm.nih.gov/22191795/","study_design":null,"title":"Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease","title_match":false,"year":2012},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/age-related-hearing-impairment-a-risk-factor-and-frailty-marker-for-25686757","doi":"10.1038/nrneurol.2015.12","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"25686757","source_url":"https://pubmed.ncbi.nlm.nih.gov/25686757/","study_design":null,"title":"Age-related hearing impairment-a risk factor and frailty marker for dementia and AD","title_match":false,"year":2015},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/anti-inflammatory-drugs-and-risk-of-alzheimer-s-disease-an-updated-25227314","doi":"10.3233/jad-141506","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"25227314","source_url":"https://pubmed.ncbi.nlm.nih.gov/25227314/","study_design":"randomized controlled trial","title":"Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis","title_match":false,"year":2015},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/psychiatric-complications-of-treatment-with-corticosteroids-review-22003987","doi":"10.1111/j.1440-1819.2011.02260.x","journal":"Psychiatry and clinical neurosciences","n_participants":null,"pmid":"22003987","source_url":"https://pubmed.ncbi.nlm.nih.gov/22003987/","study_design":"case report","title":"Psychiatric complications of treatment with corticosteroids: review with case report","title_match":false,"year":2011},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/randomized-crossover-trial-of-a-modified-ketogenic-diet-in-alzheimer-33622392","doi":"10.1186/s13195-021-00783-x","journal":"Alzheimer's research & therapy","n_participants":26,"pmid":"33622392","source_url":"https://pubmed.ncbi.nlm.nih.gov/33622392/","study_design":"randomized controlled trial","title":"Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/critical-window-hypothesis-of-hormone-therapy-and-cognition-a-23715379","doi":"10.1097/gme.0b013e3182960cf8","journal":"Menopause (New York, N.Y.)","n_participants":null,"pmid":"23715379","source_url":"https://pubmed.ncbi.nlm.nih.gov/23715379/","study_design":null,"title":"Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies","title_match":false,"year":2013},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/prevention-of-diseases-after-menopause-24969415","doi":"10.3109/13697137.2014.933411","journal":"Climacteric : the journal of the International Menopause Society","n_participants":null,"pmid":"24969415","source_url":"https://pubmed.ncbi.nlm.nih.gov/24969415/","study_design":null,"title":"Prevention of diseases after menopause","title_match":false,"year":2014},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effect-of-the-apolipoprotein-e-genotype-on-cognitive-change-during-a-29356827","doi":"10.1001/jamaneurol.2017.4365","journal":"JAMA neurology","n_participants":1260,"pmid":"29356827","source_url":"https://pubmed.ncbi.nlm.nih.gov/29356827/","study_design":null,"title":"Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial","title_match":true,"year":2018},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/physical-activity-and-exercise-in-mild-cognitive-impairment-and-32981668","doi":"10.1016/j.jamda.2020.08.031","journal":"Journal of the American Medical Directors Association","n_participants":28205,"pmid":"32981668","source_url":"https://pubmed.ncbi.nlm.nih.gov/32981668/","study_design":"meta-analysis","title":"Physical Activity and Exercise in Mild Cognitive Impairment and Dementia: An Umbrella Review of Intervention and Observational Studies","title_match":false,"year":2020},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/angiotensin-converting-enzyme-inhibitors-and-cognitive-decline-in-19597068","doi":"10.1001/archinternmed.2009.175","journal":"Archives of internal medicine","n_participants":1054,"pmid":"19597068","source_url":"https://pubmed.ncbi.nlm.nih.gov/19597068/","study_design":null,"title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study","title_match":false,"year":2009},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/cardiovascular-risk-factors-and-dementia-18675769","doi":"10.1016/j.amjopharm.2008.06.004","journal":"The American journal of geriatric pharmacotherapy","n_participants":null,"pmid":"18675769","source_url":"https://pubmed.ncbi.nlm.nih.gov/18675769/","study_design":"open-label trial","title":"Cardiovascular risk factors and dementia","title_match":false,"year":2008},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/mild-behavioral-impairment-as-a-marker-of-cognitive-decline-in-30902566","doi":"10.1016/j.jagp.2019.01.215","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":9931,"pmid":"30902566","source_url":"https://pubmed.ncbi.nlm.nih.gov/30902566/","study_design":null,"title":"Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults","title_match":false,"year":2019},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/dietary-patterns-and-cognitive-health-in-older-adults-a-systematic-30689586","doi":"10.3233/jad-180468","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30689586","source_url":"https://pubmed.ncbi.nlm.nih.gov/30689586/","study_design":"cohort study","title":"Dietary Patterns and Cognitive Health in Older Adults: A Systematic Review","title_match":false,"year":2019},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/a-1-year-randomized-controlled-trial-comparing-mind-body-exercise-tai-22579072","doi":"10.1016/j.jamda.2012.03.008","journal":"Journal of the American Medical Directors Association","n_participants":389,"pmid":"22579072","source_url":"https://pubmed.ncbi.nlm.nih.gov/22579072/","study_design":"randomized controlled trial","title":"A 1-year randomized controlled trial comparing mind body exercise (Tai Chi) with stretching and toning exercise on cognitive function in older Chinese adults at risk of cognitive decline","title_match":true,"year":2012},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/affective-and-emotional-dysregulation-as-pre-dementia-risk-markers-28899446","doi":"10.1017/s1041610217001880","journal":"International psychogeriatrics","n_participants":null,"pmid":"28899446","source_url":"https://pubmed.ncbi.nlm.nih.gov/28899446/","study_design":null,"title":"Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria","title_match":false,"year":2018},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/main-morbidities-recorded-in-the-women-s-international-study-of-long-17626056","doi":"10.1136/bmj.39266.425069.ad","journal":"BMJ (Clinical research ed.)","n_participants":2196,"pmid":"17626056","source_url":"https://pubmed.ncbi.nlm.nih.gov/17626056/","study_design":null,"title":"Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women","title_match":true,"year":2007},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/antihypertensive-drugs-prevention-of-cognitive-decline-and-dementia-a-25700645","doi":"10.1007/s40263-015-0230-6","journal":"CNS drugs","n_participants":1346176,"pmid":"25700645","source_url":"https://pubmed.ncbi.nlm.nih.gov/25700645/","study_design":"systematic review","title":"Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","title_match":true,"year":2015},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/dual-task-performances-can-be-improved-in-patients-with-dementia-a-20445152","doi":"10.1212/wnl.0b013e3181e39696","journal":"Neurology","n_participants":null,"pmid":"20445152","source_url":"https://pubmed.ncbi.nlm.nih.gov/20445152/","study_design":null,"title":"Dual-task performances can be improved in patients with dementia: a randomized controlled trial","title_match":true,"year":2010},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/diet-cognition-and-alzheimer-s-disease-food-for-thought-23892520","doi":"10.1007/s00394-013-0561-3","journal":"European journal of nutrition","n_participants":null,"pmid":"23892520","source_url":"https://pubmed.ncbi.nlm.nih.gov/23892520/","study_design":null,"title":"Diet, cognition, and Alzheimer's disease: food for thought","title_match":false,"year":2014},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/future-directions-in-alzheimer-s-disease-from-risk-factors-to-24418410","doi":"10.1016/j.bcp.2014.01.003","journal":"Biochemical pharmacology","n_participants":null,"pmid":"24418410","source_url":"https://pubmed.ncbi.nlm.nih.gov/24418410/","study_design":null,"title":"Future directions in Alzheimer's disease from risk factors to prevention","title_match":false,"year":2014},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/omega-3-fatty-acids-and-dementia-19523795","doi":"10.1016/j.plefa.2009.05.015","journal":"Prostaglandins, leukotrienes, and essential fatty acids","n_participants":null,"pmid":"19523795","source_url":"https://pubmed.ncbi.nlm.nih.gov/19523795/","study_design":null,"title":"Omega-3 fatty acids and dementia","title_match":false,"year":2009},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/effects-of-a-moderate-intensity-aerobic-exercise-programme-on-the-30901716","doi":"10.1016/j.ijnurstu.2019.02.019","journal":"International journal of nursing studies","n_participants":120,"pmid":"30901716","source_url":"https://pubmed.ncbi.nlm.nih.gov/30901716/","study_design":"randomized controlled trial","title":"Effects of a moderate-intensity aerobic exercise programme on the cognitive function and quality of life of community-dwelling elderly people with mild cognitive impairment: A randomised controlled trial","title_match":true,"year":2019},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/statin-use-and-risk-of-dementia-or-alzheimer-s-disease-a-systematic-34871380","doi":"10.1093/eurjpc/zwab208","journal":"European journal of preventive cardiology","n_participants":null,"pmid":"34871380","source_url":"https://pubmed.ncbi.nlm.nih.gov/34871380/","study_design":"meta-analysis","title":"Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies","title_match":false,"year":2022},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-multidisciplinary-multifactorial-intervention-program-reduces-17061151","doi":"10.1007/s00198-006-0226-7","journal":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","n_participants":199,"pmid":"17061151","source_url":"https://pubmed.ncbi.nlm.nih.gov/17061151/","study_design":null,"title":"A multidisciplinary, multifactorial intervention program reduces postoperative falls and injuries after femoral neck fracture","title_match":false,"year":2007},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/estrogen-replacement-therapy-and-alzheimer-s-disease-in-the-italian-9566385","doi":"10.1212/wnl.50.4.996","journal":"Neurology","n_participants":null,"pmid":"9566385","source_url":"https://pubmed.ncbi.nlm.nih.gov/9566385/","study_design":null,"title":"Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging","title_match":false,"year":1998},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/effects-of-physical-exercise-on-cognitive-function-of-older-adults-32460123","doi":"10.1016/j.archger.2020.104048","journal":"Archives of gerontology and geriatrics","n_participants":2077,"pmid":"32460123","source_url":"https://pubmed.ncbi.nlm.nih.gov/32460123/","study_design":"meta-analysis","title":"Effects of physical exercise on cognitive function of older adults with mild cognitive impairment: A systematic review and meta-analysis","title_match":false,"year":2020},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/a-nationwide-survey-on-the-prevalence-of-dementia-and-mild-cognitive-21178286","doi":"10.3233/jad-2010-101221","journal":"Journal of Alzheimer's disease : JAD","n_participants":6141,"pmid":"21178286","source_url":"https://pubmed.ncbi.nlm.nih.gov/21178286/","study_design":null,"title":"A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea","title_match":false,"year":2011},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/current-developments-in-dementia-risk-prediction-modelling-an-updated-26334524","doi":"10.1371/journal.pone.0136181","journal":"PloS one","n_participants":null,"pmid":"26334524","source_url":"https://pubmed.ncbi.nlm.nih.gov/26334524/","study_design":"systematic review","title":"Current Developments in Dementia Risk Prediction Modelling: An Updated Systematic Review","title_match":false,"year":2015},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/hypertension-and-dementia-19927134","doi":"10.1038/ajh.2009.212","journal":"American journal of hypertension","n_participants":null,"pmid":"19927134","source_url":"https://pubmed.ncbi.nlm.nih.gov/19927134/","study_design":null,"title":"Hypertension and dementia","title_match":false,"year":2010},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/effect-of-raloxifene-on-prevention-of-dementia-and-cognitive-15800139","doi":"10.1176/appi.ajp.162.4.683","journal":"The American journal of psychiatry","n_participants":null,"pmid":"15800139","source_url":"https://pubmed.ncbi.nlm.nih.gov/15800139/","study_design":null,"title":"Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial","title_match":false,"year":2005},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/hormonal-and-metabolic-changes-of-aging-and-the-influence-of-33673927","doi":"10.1016/j.mayocp.2020.07.033","journal":"Mayo Clinic proceedings","n_participants":null,"pmid":"33673927","source_url":"https://pubmed.ncbi.nlm.nih.gov/33673927/","study_design":null,"title":"Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications","title_match":false,"year":2021},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/the-association-between-the-mediterranean-dietary-pattern-and-28657600","doi":"10.3390/nu9070674","journal":"Nutrients","n_participants":null,"pmid":"28657600","source_url":"https://pubmed.ncbi.nlm.nih.gov/28657600/","study_design":"cohort study","title":"The Association between the Mediterranean Dietary Pattern and Cognitive Health: A Systematic Review","title_match":false,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/dementia-prevention-current-epidemiological-evidence-and-future-22339927","doi":"10.1186/alzrt104","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"22339927","source_url":"https://pubmed.ncbi.nlm.nih.gov/22339927/","study_design":null,"title":"Dementia prevention: current epidemiological evidence and future perspective","title_match":false,"year":2012},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pet-amyloid-beta-imaging-in-preclinical-alzheimer-s-disease-22108203","doi":"10.1016/j.bbadis.2011.11.005","journal":"Biochimica et biophysica acta","n_participants":null,"pmid":"22108203","source_url":"https://pubmed.ncbi.nlm.nih.gov/22108203/","study_design":null,"title":"PET amyloid-beta imaging in preclinical Alzheimer's disease","title_match":false,"year":2012},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/cardiovascular-and-cerebrovascular-events-in-the-randomized-17111043","doi":"10.1371/journal.pctr.0010033","journal":"PLoS clinical trials","n_participants":2528,"pmid":"17111043","source_url":"https://pubmed.ncbi.nlm.nih.gov/17111043/","study_design":null,"title":"Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)","title_match":true,"year":2006},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/treatment-of-protein-energy-malnutrition-in-chronic-nonmalignant-11451713","doi":"10.1093/ajcn/74.1.6","journal":"The American journal of clinical nutrition","n_participants":null,"pmid":"11451713","source_url":"https://pubmed.ncbi.nlm.nih.gov/11451713/","study_design":null,"title":"Treatment of protein-energy malnutrition in chronic nonmalignant disorders","title_match":false,"year":2001},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/a-deep-learning-model-for-early-prediction-of-alzheimer-s-disease-31201098","doi":"10.1016/j.jalz.2019.02.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":2146,"pmid":"31201098","source_url":"https://pubmed.ncbi.nlm.nih.gov/31201098/","study_design":null,"title":"A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data","title_match":false,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/early-onset-and-delayed-onset-poststroke-dementia-revisiting-the-28211452","doi":"10.1038/nrneurol.2017.16","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"28211452","source_url":"https://pubmed.ncbi.nlm.nih.gov/28211452/","study_design":null,"title":"Early-onset and delayed-onset poststroke dementia - revisiting the mechanisms","title_match":false,"year":2017},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/structured-vs-self-guided-multidomain-lifestyle-interventions-for-40720610","doi":"10.1001/jama.2025.12923","journal":"JAMA","n_participants":1056,"pmid":"40720610","source_url":"https://pubmed.ncbi.nlm.nih.gov/40720610/","study_design":null,"title":"Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/eso-guideline-on-covert-cerebral-small-vessel-disease-34414301","doi":"10.1177/23969873211012132","journal":"European stroke journal","n_participants":null,"pmid":"34414301","source_url":"https://pubmed.ncbi.nlm.nih.gov/34414301/","study_design":null,"title":"ESO Guideline on covert cerebral small vessel disease","title_match":false,"year":2021},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/how-can-dementia-and-disability-be-prevented-in-older-adults-where-33314384","doi":"10.1111/joim.13227","journal":"Journal of internal medicine","n_participants":null,"pmid":"33314384","source_url":"https://pubmed.ncbi.nlm.nih.gov/33314384/","study_design":"randomized controlled trial","title":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","title_match":false,"year":2021},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/the-epidemiology-of-estrogen-replacement-therapy-and-alzheimer-s-9153164","doi":"10.1212/wnl.48.5_suppl_7.27s","journal":"Neurology","n_participants":null,"pmid":"9153164","source_url":"https://pubmed.ncbi.nlm.nih.gov/9153164/","study_design":"cross-sectional","title":"The epidemiology of estrogen replacement therapy and Alzheimer's disease","title_match":false,"year":1997},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/the-effect-of-a-pre-and-postoperative-orthogeriatric-service-on-24735588","doi":"10.1186/1741-7015-12-63","journal":"BMC medicine","n_participants":329,"pmid":"24735588","source_url":"https://pubmed.ncbi.nlm.nih.gov/24735588/","study_design":"randomized controlled trial","title":"The effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial)","title_match":true,"year":2014},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/hiiting-the-brain-with-exercise-mechanisms-consequences-and-practical-32347544","doi":"10.1113/jp275021","journal":"The Journal of physiology","n_participants":null,"pmid":"32347544","source_url":"https://pubmed.ncbi.nlm.nih.gov/32347544/","study_design":null,"title":"HIITing the brain with exercise: mechanisms, consequences and practical recommendations","title_match":false,"year":2020},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/the-effect-of-an-online-cognitive-training-package-in-healthy-older-26543007","doi":"10.1016/j.jamda.2015.06.014","journal":"Journal of the American Medical Directors Association","n_participants":2912,"pmid":"26543007","source_url":"https://pubmed.ncbi.nlm.nih.gov/26543007/","study_design":"randomized controlled trial","title":"The Effect of an Online Cognitive Training Package in Healthy Older Adults: An Online Randomized Controlled Trial","title_match":true,"year":2015},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/interim-follow-up-of-a-randomized-controlled-trial-comparing-chinese-21495078","doi":"10.1002/gps.2602","journal":"International journal of geriatric psychiatry","n_participants":171,"pmid":"21495078","source_url":"https://pubmed.ncbi.nlm.nih.gov/21495078/","study_design":"randomized controlled trial","title":"Interim follow-up of a randomized controlled trial comparing Chinese style mind body (Tai Chi) and stretching exercises on cognitive function in subjects at risk of progressive cognitive decline","title_match":true,"year":2011},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/promoting-successful-cognitive-aging-a-ten-year-update-33935078","doi":"10.3233/jad-201462","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"33935078","source_url":"https://pubmed.ncbi.nlm.nih.gov/33935078/","study_design":"cohort study","title":"Promoting Successful Cognitive Aging: A Ten-Year Update","title_match":false,"year":2021},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/enhanced-neural-activation-with-blueberry-supplementation-in-mild-28221821","doi":"10.1080/1028415x.2017.1287833","journal":"Nutritional neuroscience","n_participants":null,"pmid":"28221821","source_url":"https://pubmed.ncbi.nlm.nih.gov/28221821/","study_design":null,"title":"Enhanced neural activation with blueberry supplementation in mild cognitive impairment","title_match":false,"year":2018},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/folic-acid-with-or-without-vitamin-b12-for-the-prevention-and-18843658","doi":"10.1002/14651858.cd004514.pub2","journal":"The Cochrane database of systematic reviews","n_participants":null,"pmid":"18843658","source_url":"https://pubmed.ncbi.nlm.nih.gov/18843658/","study_design":null,"title":"Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people","title_match":false,"year":2008},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/effect-of-the-mediterranean-diet-on-cognition-and-brain-morphology-29566197","doi":"10.1093/ajcn/nqx070","journal":"The American journal of clinical nutrition","n_participants":1888,"pmid":"29566197","source_url":"https://pubmed.ncbi.nlm.nih.gov/29566197/","study_design":"meta-analysis","title":"Effect of the Mediterranean diet on cognition and brain morphology and function: a systematic review of randomized controlled trials","title_match":true,"year":2018},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/effects-of-physical-exercise-on-health-and-well-being-of-individuals-26432622","doi":"10.1016/j.jamda.2015.08.016","journal":"Journal of the American Medical Directors Association","n_participants":901,"pmid":"26432622","source_url":"https://pubmed.ncbi.nlm.nih.gov/26432622/","study_design":null,"title":"Effects of Physical Exercise on Health and Well-Being of Individuals Living With a Dementia in Nursing Homes: A Systematic Review","title_match":false,"year":2016},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/cognitive-leisure-activities-and-their-role-in-preventing-dementia-a-20923507","doi":"10.1111/j.1744-1609.2010.00150.x","journal":"International journal of evidence-based healthcare","n_participants":null,"pmid":"20923507","source_url":"https://pubmed.ncbi.nlm.nih.gov/20923507/","study_design":"meta-analysis","title":"Cognitive leisure activities and their role in preventing dementia: a systematic review","title_match":false,"year":2010},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/vegetarian-and-vegan-diets-benefits-and-drawbacks-37450568","doi":"10.1093/eurheartj/ehad436","journal":"European heart journal","n_participants":null,"pmid":"37450568","source_url":"https://pubmed.ncbi.nlm.nih.gov/37450568/","study_design":null,"title":"Vegetarian and vegan diets: benefits and drawbacks","title_match":false,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/sex-and-gender-differences-in-alzheimer-s-disease-current-challenges-32056347","doi":"10.1111/ene.14174","journal":"European journal of neurology","n_participants":null,"pmid":"32056347","source_url":"https://pubmed.ncbi.nlm.nih.gov/32056347/","study_design":null,"title":"Sex and gender differences in Alzheimer's disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology","title_match":false,"year":2020},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/efficacy-of-cognitive-rehabilitation-therapies-for-mild-cognitive-23471631","doi":"10.1007/s11065-013-9230-9","journal":"Neuropsychology review","n_participants":null,"pmid":"23471631","source_url":"https://pubmed.ncbi.nlm.nih.gov/23471631/","study_design":null,"title":"Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions","title_match":false,"year":2013},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-diagnosis-of-dementia-due-to-alzheimer-s-disease-recommendations-21514250","doi":"10.1016/j.jalz.2011.03.005","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"21514250","source_url":"https://pubmed.ncbi.nlm.nih.gov/21514250/","study_design":null,"title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","title_match":false,"year":2011},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-as-a-diagnostic-entity-15324362","doi":"10.1111/j.1365-2796.2004.01388.x","journal":"Journal of internal medicine","n_participants":null,"pmid":"15324362","source_url":"https://pubmed.ncbi.nlm.nih.gov/15324362/","study_design":null,"title":"Mild cognitive impairment as a diagnostic entity","title_match":false,"year":2004},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/diagnosis-and-management-of-dementia-with-lewy-bodies-fourth-28592453","doi":"10.1212/wnl.0000000000004058","journal":"Neurology","n_participants":null,"pmid":"28592453","source_url":"https://pubmed.ncbi.nlm.nih.gov/28592453/","study_design":null,"title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","title_match":false,"year":2017},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/current-concepts-in-mild-cognitive-impairment-11735772","doi":"10.1001/archneur.58.12.1985","journal":"Archives of neurology","n_participants":null,"pmid":"11735772","source_url":"https://pubmed.ncbi.nlm.nih.gov/11735772/","study_design":null,"title":"Current concepts in mild cognitive impairment","title_match":false,"year":2001},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/2022-alzheimer-s-disease-facts-and-figures-35289055","doi":"10.1002/alz.12638","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"35289055","source_url":"https://pubmed.ncbi.nlm.nih.gov/35289055/","study_design":null,"title":"2022 Alzheimer's disease facts and figures","title_match":false,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/national-institute-of-neurological-disorders-and-stroke-canadian-16917086","doi":"10.1161/01.str.0000237236.88823.47","journal":"Stroke","n_participants":null,"pmid":"16917086","source_url":"https://pubmed.ncbi.nlm.nih.gov/16917086/","study_design":null,"title":"National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards","title_match":false,"year":2006},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/effect-of-intensive-vs-standard-blood-pressure-control-on-probable-30688979","doi":"10.1001/jama.2018.21442","journal":"JAMA","n_participants":4678,"pmid":"30688979","source_url":"https://pubmed.ncbi.nlm.nih.gov/30688979/","study_design":null,"title":"Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-clinical-trials-and-drug-development-20610346","doi":"10.1016/s1474-4422(10)70119-8","journal":"The Lancet. Neurology","n_participants":null,"pmid":"20610346","source_url":"https://pubmed.ncbi.nlm.nih.gov/20610346/","study_design":null,"title":"Alzheimer's disease: clinical trials and drug development","title_match":true,"year":2010},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/accuracy-of-the-clinical-diagnosis-of-alzheimer-disease-at-national-22437338","doi":"10.1097/nen.0b013e31824b211b","journal":"Journal of neuropathology and experimental neurology","n_participants":1198,"pmid":"22437338","source_url":"https://pubmed.ncbi.nlm.nih.gov/22437338/","study_design":null,"title":"Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010","title_match":false,"year":2012},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-dementia-associated-with-parkinson-s-disease-15590953","doi":"10.1056/nejmoa041470","journal":"The New England journal of medicine","n_participants":541,"pmid":"15590953","source_url":"https://pubmed.ncbi.nlm.nih.gov/15590953/","study_design":null,"title":"Rivastigmine for dementia associated with Parkinson's disease","title_match":false,"year":2004},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-can-be-distinguished-from-alzheimer-disease-14732621","doi":"10.1001/archneur.61.1.59","journal":"Archives of neurology","n_participants":769,"pmid":"14732621","source_url":"https://pubmed.ncbi.nlm.nih.gov/14732621/","study_design":null,"title":"Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials","title_match":true,"year":2004},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/dementia-in-china-epidemiology-clinical-management-and-research-31494009","doi":"10.1016/s1474-4422(19)30290-x","journal":"The Lancet. Neurology","n_participants":null,"pmid":"31494009","source_url":"https://pubmed.ncbi.nlm.nih.gov/31494009/","study_design":null,"title":"Dementia in China: epidemiology, clinical management, and research advances","title_match":false,"year":2020},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/efficacy-of-rivastigmine-in-dementia-with-lewy-bodies-a-randomised-11145488","doi":"10.1016/s0140-6736(00)03399-7","journal":"Lancet (London, England)","n_participants":120,"pmid":"11145488","source_url":"https://pubmed.ncbi.nlm.nih.gov/11145488/","study_design":null,"title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","title_match":true,"year":2000},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/current-understanding-of-alzheimer-s-disease-diagnosis-and-treatment-30135715","doi":"10.12688/f1000research.14506.1","journal":"F1000Research","n_participants":null,"pmid":"30135715","source_url":"https://pubmed.ncbi.nlm.nih.gov/30135715/","study_design":null,"title":"Current understanding of Alzheimer's disease diagnosis and treatment","title_match":false,"year":2018},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/randomized-trial-of-verubecestat-for-mild-to-moderate-alzheimer-s-29719179","doi":"10.1056/nejmoa1706441","journal":"The New England journal of medicine","n_participants":1958,"pmid":"29719179","source_url":"https://pubmed.ncbi.nlm.nih.gov/29719179/","study_design":null,"title":"Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease","title_match":false,"year":2018},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/the-campaign-study-of-parkinson-s-disease-10-year-outlook-in-an-23781007","doi":"10.1136/jnnp-2013-305277","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":142,"pmid":"23781007","source_url":"https://pubmed.ncbi.nlm.nih.gov/23781007/","study_design":null,"title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","title_match":false,"year":2013},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/synuclein-and-tau-concentrations-in-cerebrospinal-fluid-of-patients-21317042","doi":"10.1016/s1474-4422(11)70014-x","journal":"The Lancet. Neurology","n_participants":null,"pmid":"21317042","source_url":"https://pubmed.ncbi.nlm.nih.gov/21317042/","study_design":"cross-sectional","title":"\u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","title_match":false,"year":2011},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/multimodal-techniques-for-diagnosis-and-prognosis-of-alzheimer-s-19829371","doi":"10.1038/nature08538","journal":"Nature","n_participants":null,"pmid":"19829371","source_url":"https://pubmed.ncbi.nlm.nih.gov/19829371/","study_design":null,"title":"Multimodal techniques for diagnosis and prognosis of Alzheimer's disease","title_match":false,"year":2009},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/incident-dementia-and-blood-pressure-lowering-in-the-hypertension-in-18614402","doi":"10.1016/s1474-4422(08)70143-1","journal":"The Lancet. Neurology","n_participants":1687,"pmid":"18614402","source_url":"https://pubmed.ncbi.nlm.nih.gov/18614402/","study_design":"meta-analysis","title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","title_match":true,"year":2008},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/effectiveness-of-cholinesterase-inhibitors-and-memantine-for-treating-18316756","doi":"10.7326/0003-4819-148-5-200803040-00009","journal":"Annals of internal medicine","n_participants":null,"pmid":"18316756","source_url":"https://pubmed.ncbi.nlm.nih.gov/18316756/","study_design":null,"title":"Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline","title_match":false,"year":2008},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/cerebral-amyloid-pet-with-florbetaben-18f-in-patients-with-alzheimer-21481640","doi":"10.1016/s1474-4422(11)70077-1","journal":"The Lancet. Neurology","n_participants":81,"pmid":"21481640","source_url":"https://pubmed.ncbi.nlm.nih.gov/21481640/","study_design":"clinical trial","title":"Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study","title_match":true,"year":2011},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/blood-biomarkers-for-alzheimer-s-disease-in-clinical-practice-and-37202517","doi":"10.1038/s43587-023-00403-3","journal":"Nature aging","n_participants":null,"pmid":"37202517","source_url":"https://pubmed.ncbi.nlm.nih.gov/37202517/","study_design":"longitudinal study","title":"Blood biomarkers for Alzheimer's disease in clinical practice and trials","title_match":false,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/clinical-diagnosis-and-management-of-amyotrophic-lateral-sclerosis-21989247","doi":"10.1038/nrneurol.2011.153","journal":"Nature reviews. Neurology","n_participants":100000,"pmid":"21989247","source_url":"https://pubmed.ncbi.nlm.nih.gov/21989247/","study_design":null,"title":"Clinical diagnosis and management of amyotrophic lateral sclerosis","title_match":false,"year":2011},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/tau-biomarkers-in-alzheimer-s-disease-towards-implementation-in-35643092","doi":"10.1016/s1474-4422(22)00168-5","journal":"The Lancet. Neurology","n_participants":null,"pmid":"35643092","source_url":"https://pubmed.ncbi.nlm.nih.gov/35643092/","study_design":"clinical trial","title":"Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials","title_match":false,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2018-29955663","doi":"10.1016/j.trci.2018.03.009","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29955663","source_url":"https://pubmed.ncbi.nlm.nih.gov/29955663/","study_design":null,"title":"Alzheimer's disease drug development pipeline: 2018","title_match":false,"year":2018},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/cognitive-impairment-after-ischemic-and-hemorrhagic-stroke-a-37125534","doi":"10.1161/str.0000000000000430","journal":"Stroke","n_participants":null,"pmid":"37125534","source_url":"https://pubmed.ncbi.nlm.nih.gov/37125534/","study_design":"cohort study","title":"Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association","title_match":false,"year":2023},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/posterior-cortical-atrophy-22265212","doi":"10.1016/s1474-4422(11)70289-7","journal":"The Lancet. Neurology","n_participants":null,"pmid":"22265212","source_url":"https://pubmed.ncbi.nlm.nih.gov/22265212/","study_design":null,"title":"Posterior cortical atrophy","title_match":false,"year":2012},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/efficacy-of-galantamine-in-probable-vascular-dementia-and-alzheimer-s-11965273","doi":"10.1016/s0140-6736(02)08267-3","journal":"Lancet (London, England)","n_participants":396,"pmid":"11965273","source_url":"https://pubmed.ncbi.nlm.nih.gov/11965273/","study_design":null,"title":"Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial","title_match":false,"year":2002},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/drug-treatments-in-alzheimer-s-disease-27251914","doi":"10.7861/clinmedicine.16-3-247","journal":"Clinical medicine (London, England)","n_participants":null,"pmid":"27251914","source_url":"https://pubmed.ncbi.nlm.nih.gov/27251914/","study_design":null,"title":"Drug treatments in Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/sensitivity-and-specificity-of-dopamine-transporter-imaging-with-123i-17362834","doi":"10.1016/s1474-4422(07)70057-1","journal":"The Lancet. Neurology","n_participants":94,"pmid":"17362834","source_url":"https://pubmed.ncbi.nlm.nih.gov/17362834/","study_design":null,"title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","title_match":true,"year":2007},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/development-of-cognitive-instruments-for-use-in-clinical-trials-of-9236948","doi":null,"journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"9236948","source_url":"https://pubmed.ncbi.nlm.nih.gov/9236948/","study_design":null,"title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study","title_match":true,"year":1997},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/baseline-mri-predictors-of-conversion-from-mci-to-probable-ad-in-the-19689234","doi":"10.2174/156720509788929273","journal":"Current Alzheimer research","n_participants":339,"pmid":"19689234","source_url":"https://pubmed.ncbi.nlm.nih.gov/19689234/","study_design":"longitudinal study","title":"Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort","title_match":false,"year":2009},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/olfactory-and-other-sensory-impairments-in-alzheimer-disease-30532084","doi":"10.1038/s41582-018-0097-5","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"30532084","source_url":"https://pubmed.ncbi.nlm.nih.gov/30532084/","study_design":null,"title":"Olfactory and other sensory impairments in Alzheimer disease","title_match":false,"year":2019},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-1-year-placebo-controlled-preservation-of-function-survival-study-11502917","doi":"10.1212/wnl.57.3.481","journal":"Neurology","n_participants":null,"pmid":"11502917","source_url":"https://pubmed.ncbi.nlm.nih.gov/11502917/","study_design":null,"title":"A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients","title_match":true,"year":2001},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/clinical-utility-of-cerebrospinal-fluid-biomarkers-in-the-diagnosis-24795085","doi":"10.1016/j.jalz.2014.02.004","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"24795085","source_url":"https://pubmed.ncbi.nlm.nih.gov/24795085/","study_design":null,"title":"Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/behavioral-treatment-of-depression-in-dementia-patients-a-controlled-9224439","doi":"10.1093/geronb/52b.4.p159","journal":"The journals of gerontology. Series B, Psychological sciences and social sciences","n_participants":null,"pmid":"9224439","source_url":"https://pubmed.ncbi.nlm.nih.gov/9224439/","study_design":null,"title":"Behavioral treatment of depression in dementia patients: a controlled clinical trial","title_match":true,"year":1997},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/the-efficacy-of-ginkgo-biloba-on-cognitive-function-in-alzheimer-9823823","doi":"10.1001/archneur.55.11.1409","journal":"Archives of neurology","n_participants":212,"pmid":"9823823","source_url":"https://pubmed.ncbi.nlm.nih.gov/9823823/","study_design":"meta-analysis","title":"The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease","title_match":false,"year":1998},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/plasma-p-tau181-accurately-predicts-alzheimer-s-disease-pathology-at-32720099","doi":"10.1007/s00401-020-02195-x","journal":"Acta neuropathologica","n_participants":115,"pmid":"32720099","source_url":"https://pubmed.ncbi.nlm.nih.gov/32720099/","study_design":"longitudinal study","title":"Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8\u00a0years prior to post-mortem and improves the clinical characterisation of cognitive decline","title_match":false,"year":2020},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/diagnostic-performance-and-prediction-of-clinical-progression-of-33106600","doi":"10.1038/s41380-020-00923-z","journal":"Molecular psychiatry","n_participants":1000,"pmid":"33106600","source_url":"https://pubmed.ncbi.nlm.nih.gov/33106600/","study_design":"longitudinal study","title":"Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative","title_match":false,"year":2021},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-study-of-rofecoxib-in-patients-with-mild-15742005","doi":"10.1038/sj.npp.1300690","journal":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","n_participants":725,"pmid":"15742005","source_url":"https://pubmed.ncbi.nlm.nih.gov/15742005/","study_design":null,"title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","title_match":true,"year":2005},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/a-randomized-placebo-controlled-trial-of-risperidone-for-the-12633121","doi":"10.4088/jcp.v64n0205","journal":"The Journal of clinical psychiatry","n_participants":345,"pmid":"12633121","source_url":"https://pubmed.ncbi.nlm.nih.gov/12633121/","study_design":null,"title":"A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia","title_match":true,"year":2003},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/glial-fibrillary-acidic-protein-in-serum-is-increased-in-alzheimer-s-30594925","doi":"10.3233/jad-180325","journal":"Journal of Alzheimer's disease : JAD","n_participants":28,"pmid":"30594925","source_url":"https://pubmed.ncbi.nlm.nih.gov/30594925/","study_design":null,"title":"Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment","title_match":false,"year":2019},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/idiopathic-normal-pressure-hydrocephalus-a-systematic-review-of-11846911","doi":"10.1097/00006123-200111000-00028","journal":"Neurosurgery","n_participants":null,"pmid":"11846911","source_url":"https://pubmed.ncbi.nlm.nih.gov/11846911/","study_design":null,"title":"Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome","title_match":false,"year":2001},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/postoperative-cognitive-dysfunction-24622758","doi":"10.3238/arztebl.2014.0119","journal":"Deutsches Arzteblatt international","n_participants":null,"pmid":"24622758","source_url":"https://pubmed.ncbi.nlm.nih.gov/24622758/","study_design":null,"title":"Postoperative cognitive dysfunction","title_match":false,"year":2014},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2017-29067343","doi":"10.1016/j.trci.2017.05.002","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":54073,"pmid":"29067343","source_url":"https://pubmed.ncbi.nlm.nih.gov/29067343/","study_design":null,"title":"Alzheimer's disease drug development pipeline: 2017","title_match":false,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/primary-progressive-aphasia-clinicopathological-correlations-20139998","doi":"10.1038/nrneurol.2009.216","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"20139998","source_url":"https://pubmed.ncbi.nlm.nih.gov/20139998/","study_design":null,"title":"Primary progressive aphasia: clinicopathological correlations","title_match":false,"year":2010},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/phase-3-trial-of-flutemetamol-labeled-with-radioactive-fluorine-18-25622185","doi":"10.1001/jamaneurol.2014.4144","journal":"JAMA neurology","n_participants":176,"pmid":"25622185","source_url":"https://pubmed.ncbi.nlm.nih.gov/25622185/","study_design":"open-label trial","title":"Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density","title_match":true,"year":2015},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/screening-for-cognitive-impairment-in-older-adults-a-systematic-24145578","doi":"10.7326/0003-4819-159-9-201311050-00730","journal":"Annals of internal medicine","n_participants":null,"pmid":"24145578","source_url":"https://pubmed.ncbi.nlm.nih.gov/24145578/","study_design":null,"title":"Screening for cognitive impairment in older adults: A systematic review for the U.S. Preventive Services Task Force","title_match":false,"year":2013},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/report-of-the-second-dementia-with-lewy-body-international-workshop-10496243","doi":"10.1212/wnl.53.5.902","journal":"Neurology","n_participants":null,"pmid":"10496243","source_url":"https://pubmed.ncbi.nlm.nih.gov/10496243/","study_design":null,"title":"Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies","title_match":false,"year":1999},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/understanding-neurodegeneration-after-traumatic-brain-injury-from-31542723","doi":"10.1136/jnnp-2017-317557","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"31542723","source_url":"https://pubmed.ncbi.nlm.nih.gov/31542723/","study_design":null,"title":"Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia","title_match":true,"year":2019},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/18f-flutemetamol-amyloid-imaging-in-alzheimer-disease-and-mild-20687209","doi":"10.1002/ana.22068","journal":"Annals of neurology","n_participants":null,"pmid":"20687209","source_url":"https://pubmed.ncbi.nlm.nih.gov/20687209/","study_design":null,"title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","title_match":true,"year":2010},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/the-amyloid-cascade-inflammatory-hypothesis-of-alzheimer-disease-24052108","doi":"10.1007/s00401-013-1177-7","journal":"Acta neuropathologica","n_participants":null,"pmid":"24052108","source_url":"https://pubmed.ncbi.nlm.nih.gov/24052108/","study_design":"clinical trial","title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy","title_match":false,"year":2013},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/longitudinal-change-in-csf-biomarkers-in-autosomal-dominant-alzheimer-24598588","doi":"10.1126/scitranslmed.3007901","journal":"Science translational medicine","n_participants":null,"pmid":"24598588","source_url":"https://pubmed.ncbi.nlm.nih.gov/24598588/","study_design":"cross-sectional","title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/effects-of-the-insulin-sensitizer-metformin-in-alzheimer-disease-28538088","doi":"10.1097/wad.0000000000000202","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"28538088","source_url":"https://pubmed.ncbi.nlm.nih.gov/28538088/","study_design":null,"title":"Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study","title_match":true,"year":2017},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-cortical-signature-of-prodromal-ad-regional-thinning-predicts-19109536","doi":"10.1212/01.wnl.0000340981.97664.2f","journal":"Neurology","n_participants":49,"pmid":"19109536","source_url":"https://pubmed.ncbi.nlm.nih.gov/19109536/","study_design":"longitudinal study","title":"The cortical signature of prodromal AD: regional thinning predicts mild AD dementia","title_match":false,"year":2009},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/using-serial-registered-brain-magnetic-resonance-imaging-to-measure-10714659","doi":"10.1001/archneur.57.3.339","journal":"Archives of neurology","n_participants":207,"pmid":"10714659","source_url":"https://pubmed.ncbi.nlm.nih.gov/10714659/","study_design":null,"title":"Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects","title_match":false,"year":2000},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/longitudinal-changes-in-white-matter-disease-and-cognition-in-the-21060014","doi":"10.1001/archneurol.2010.284","journal":"Archives of neurology","n_participants":804,"pmid":"21060014","source_url":"https://pubmed.ncbi.nlm.nih.gov/21060014/","study_design":null,"title":"Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative","title_match":false,"year":2010},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/disease-modifying-therapies-for-alzheimer-disease-challenges-to-early-17938373","doi":"10.1212/01.wnl.0000295996.54210.69","journal":"Neurology","n_participants":null,"pmid":"17938373","source_url":"https://pubmed.ncbi.nlm.nih.gov/17938373/","study_design":null,"title":"Disease-modifying therapies for Alzheimer disease: challenges to early intervention","title_match":false,"year":2007},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/changes-in-premorbid-brain-volume-predict-alzheimer-s-disease-12939422","doi":"10.1212/01.wnl.0000079053.77227.14","journal":"Neurology","n_participants":null,"pmid":"12939422","source_url":"https://pubmed.ncbi.nlm.nih.gov/12939422/","study_design":"cross-sectional","title":"Changes in premorbid brain volume predict Alzheimer's disease pathology","title_match":false,"year":2003},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/physical-activity-attenuates-age-related-biomarker-alterations-in-25298312","doi":"10.1212/wnl.0000000000000964","journal":"Neurology","n_participants":186,"pmid":"25298312","source_url":"https://pubmed.ncbi.nlm.nih.gov/25298312/","study_design":"cross-sectional","title":"Physical activity attenuates age-related biomarker alterations in preclinical AD","title_match":false,"year":2014},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/impaired-default-network-functional-connectivity-in-autosomal-23884042","doi":"10.1212/wnl.0b013e3182a1aafe","journal":"Neurology","n_participants":null,"pmid":"23884042","source_url":"https://pubmed.ncbi.nlm.nih.gov/23884042/","study_design":"cross-sectional","title":"Impaired default network functional connectivity in autosomal dominant Alzheimer disease","title_match":false,"year":2013},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/increased-cerebral-metabolism-after-1-year-of-deep-brain-stimulation-22566505","doi":"10.1001/archneurol.2012.590","journal":"Archives of neurology","n_participants":null,"pmid":"22566505","source_url":"https://pubmed.ncbi.nlm.nih.gov/22566505/","study_design":"open-label trial","title":"Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-amyloid-and-phospho-tau-biomarker-interactions-24852682","doi":"10.1002/ana.24186","journal":"Annals of neurology","n_participants":145,"pmid":"24852682","source_url":"https://pubmed.ncbi.nlm.nih.gov/24852682/","study_design":"cross-sectional","title":"Cerebrospinal fluid \u03b2-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease","title_match":false,"year":2014},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/measuring-atrophy-in-alzheimer-disease-a-serial-mri-study-over-6-and-16009896","doi":"10.1212/01.wnl.0000167542.89697.0f","journal":"Neurology","n_participants":null,"pmid":"16009896","source_url":"https://pubmed.ncbi.nlm.nih.gov/16009896/","study_design":null,"title":"Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months","title_match":false,"year":2005},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-addneuromed-framework-for-multi-centre-mri-assessment-of-21157852","doi":"10.1002/gps.2491","journal":"International journal of geriatric psychiatry","n_participants":378,"pmid":"21157852","source_url":"https://pubmed.ncbi.nlm.nih.gov/21157852/","study_design":"longitudinal study","title":"The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months","title_match":false,"year":2011},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/disease-staging-of-alzheimer-s-disease-using-a-csf-based-biomarker-38514824","doi":"10.1038/s43587-024-00599-y","journal":"Nature aging","n_participants":426,"pmid":"38514824","source_url":"https://pubmed.ncbi.nlm.nih.gov/38514824/","study_design":"longitudinal study","title":"Disease staging of Alzheimer's disease using a CSF-based biomarker model","title_match":false,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/vitamin-d-and-the-nervous-system-31142227","doi":"10.1080/01616412.2019.1622872","journal":"Neurological research","n_participants":null,"pmid":"31142227","source_url":"https://pubmed.ncbi.nlm.nih.gov/31142227/","study_design":null,"title":"Vitamin D and the nervous system","title_match":false,"year":2019},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/tau-pet-imaging-in-neurodegenerative-disorders-35649647","doi":"10.2967/jnumed.121.263196","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"35649647","source_url":"https://pubmed.ncbi.nlm.nih.gov/35649647/","study_design":"cross-sectional","title":"Tau PET Imaging in Neurodegenerative Disorders","title_match":false,"year":2022},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/volumetric-mri-and-cognitive-measures-in-alzheimer-disease-comparison-18274807","doi":"10.1007/s00415-008-0750-9","journal":"Journal of neurology","n_participants":null,"pmid":"18274807","source_url":"https://pubmed.ncbi.nlm.nih.gov/18274807/","study_design":"longitudinal study","title":"Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression","title_match":false,"year":2008},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-as-a-biomarker-for-cerebral-amyloidosis-and-risk-22078170","doi":"10.1016/j.neurobiolaging.2011.09.006","journal":"Neurobiology of aging","n_participants":null,"pmid":"22078170","source_url":"https://pubmed.ncbi.nlm.nih.gov/22078170/","study_design":"longitudinal study","title":"Amyloid imaging as a biomarker for cerebral \u03b2-amyloidosis and risk prediction for Alzheimer dementia","title_match":false,"year":2011},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/targeted-delivery-of-nerve-growth-factor-via-encapsulated-cell-22655593","doi":"10.3171/2012.2.jns11714","journal":"Journal of neurosurgery","n_participants":null,"pmid":"22655593","source_url":"https://pubmed.ncbi.nlm.nih.gov/22655593/","study_design":"open-label trial","title":"Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery","title_match":false,"year":2012},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/periventricular-white-matter-hyperintensities-increase-the-likelihood-18825439","doi":"10.1007/s00415-008-0874-y","journal":"Journal of neurology","n_participants":null,"pmid":"18825439","source_url":"https://pubmed.ncbi.nlm.nih.gov/18825439/","study_design":null,"title":"Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia","title_match":false,"year":2008},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-an-update-36321981","doi":"10.2214/ajr.22.28461","journal":"AJR. American journal of roentgenology","n_participants":null,"pmid":"36321981","source_url":"https://pubmed.ncbi.nlm.nih.gov/36321981/","study_design":null,"title":"Amyloid-Related Imaging Abnormalities: An Update","title_match":false,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/rates-of-decline-in-alzheimer-disease-decrease-with-age-22876315","doi":"10.1371/journal.pone.0042325","journal":"PloS one","n_participants":723,"pmid":"22876315","source_url":"https://pubmed.ncbi.nlm.nih.gov/22876315/","study_design":"longitudinal study","title":"Rates of decline in Alzheimer disease decrease with age","title_match":false,"year":2012},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/baseline-predictors-of-rates-of-hippocampal-atrophy-in-mild-cognitive-17923611","doi":"10.1212/01.wnl.0000277458.26846.96","journal":"Neurology","n_participants":323,"pmid":"17923611","source_url":"https://pubmed.ncbi.nlm.nih.gov/17923611/","study_design":null,"title":"Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment","title_match":false,"year":2007},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/aphasic-variant-of-alzheimer-disease-clinical-anatomic-and-genetic-27566743","doi":"10.1212/wnl.0000000000003165","journal":"Neurology","n_participants":19,"pmid":"27566743","source_url":"https://pubmed.ncbi.nlm.nih.gov/27566743/","study_design":null,"title":"Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features","title_match":false,"year":2016},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/cortical-microstructural-correlates-of-astrocytosis-in-autosomal-32291295","doi":"10.1212/wnl.0000000000009405","journal":"Neurology","n_participants":31,"pmid":"32291295","source_url":"https://pubmed.ncbi.nlm.nih.gov/32291295/","study_design":null,"title":"Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease","title_match":false,"year":2020},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/association-of-microglial-activation-with-spontaneous-aria-e-and-csf-35940900","doi":"10.1212/wnl.0000000000200892","journal":"Neurology","n_participants":null,"pmid":"35940900","source_url":"https://pubmed.ncbi.nlm.nih.gov/35940900/","study_design":"longitudinal study","title":"Association of Microglial Activation With Spontaneous ARIA-E and CSF Levels of Anti-A\u03b2 Autoantibodies","title_match":false,"year":2022},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/lecanemab-in-early-alzheimer-s-disease-36449413","doi":"10.1056/nejmoa2212948","journal":"The New England journal of medicine","n_participants":1795,"pmid":"36449413","source_url":"https://pubmed.ncbi.nlm.nih.gov/36449413/","study_design":"clinical trial","title":"Lecanemab in Early Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/2021-alzheimer-s-disease-facts-and-figures-33756057","doi":"10.1002/alz.12328","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"33756057","source_url":"https://pubmed.ncbi.nlm.nih.gov/33756057/","study_design":null,"title":"2021 Alzheimer's disease facts and figures","title_match":false,"year":2021},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/donanemab-in-early-alzheimer-s-disease-33720637","doi":"10.1056/nejmoa2100708","journal":"The New England journal of medicine","n_participants":257,"pmid":"33720637","source_url":"https://pubmed.ncbi.nlm.nih.gov/33720637/","study_design":"clinical trial","title":"Donanemab in Early Alzheimer's Disease","title_match":false,"year":2021},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/the-hawthorne-effect-a-randomised-controlled-trial-17608932","doi":"10.1186/1471-2288-7-30","journal":"BMC medical research methodology","n_participants":140,"pmid":"17608932","source_url":"https://pubmed.ncbi.nlm.nih.gov/17608932/","study_design":null,"title":"The Hawthorne Effect: a randomised, controlled trial","title_match":true,"year":2007},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/vascular-cognitive-impairment-12849265","doi":"10.1016/s1474-4422(03)00305-3","journal":"The Lancet. Neurology","n_participants":null,"pmid":"12849265","source_url":"https://pubmed.ncbi.nlm.nih.gov/12849265/","study_design":null,"title":"Vascular cognitive impairment","title_match":false,"year":2003},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/galantamine-in-ad-a-6-month-randomized-placebo-controlled-trial-with-10881250","doi":"10.1212/wnl.54.12.2261","journal":"Neurology","n_participants":636,"pmid":"10881250","source_url":"https://pubmed.ncbi.nlm.nih.gov/10881250/","study_design":"open-label trial","title":"Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group","title_match":true,"year":2000},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/nonpharmacological-therapies-in-alzheimer-s-disease-a-systematic-20838046","doi":"10.1159/000316119","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"20838046","source_url":"https://pubmed.ncbi.nlm.nih.gov/20838046/","study_design":"systematic review","title":"Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy","title_match":false,"year":2010},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/effect-of-bright-light-and-melatonin-on-cognitive-and-noncognitive-18544724","doi":"10.1001/jama.299.22.2642","journal":"JAMA","n_participants":null,"pmid":"18544724","source_url":"https://pubmed.ncbi.nlm.nih.gov/18544724/","study_design":"randomized controlled trial","title":"Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial","title_match":true,"year":2008},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-24-week-randomized-double-blind-study-of-donepezil-in-moderate-to-11524468","doi":"10.1212/wnl.57.4.613","journal":"Neurology","n_participants":144,"pmid":"11524468","source_url":"https://pubmed.ncbi.nlm.nih.gov/11524468/","study_design":null,"title":"A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease","title_match":true,"year":2001},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/the-effects-of-donepezil-in-alzheimer-s-disease-results-from-a-10325453","doi":"10.1159/000017126","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"10325453","source_url":"https://pubmed.ncbi.nlm.nih.gov/10325453/","study_design":null,"title":"The effects of donepezil in Alzheimer's disease - results from a multinational trial","title_match":false,"year":1999},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-galantamine-in-patients-with-mild-to-moderate-11110737","doi":"10.1136/bmj.321.7274.1445","journal":"BMJ (Clinical research ed.)","n_participants":653,"pmid":"11110737","source_url":"https://pubmed.ncbi.nlm.nih.gov/11110737/","study_design":null,"title":"Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group","title_match":true,"year":2000},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/estrogen-for-alzheimer-s-disease-in-women-randomized-double-blind-10668686","doi":"10.1212/wnl.54.2.295","journal":"Neurology","n_participants":null,"pmid":"10668686","source_url":"https://pubmed.ncbi.nlm.nih.gov/10668686/","study_design":null,"title":"Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial","title_match":true,"year":2000},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/the-wisconsin-registry-for-alzheimer-s-prevention-a-review-of-29322089","doi":"10.1016/j.dadm.2017.11.007","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":1561,"pmid":"29322089","source_url":"https://pubmed.ncbi.nlm.nih.gov/29322089/","study_design":"cohort study","title":"The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions","title_match":false,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/sertraline-or-mirtazapine-for-depression-in-dementia-hta-sadd-a-21764118","doi":"10.1016/s0140-6736(11)60830-1","journal":"Lancet (London, England)","n_participants":107,"pmid":"21764118","source_url":"https://pubmed.ncbi.nlm.nih.gov/21764118/","study_design":null,"title":"Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial","title_match":true,"year":2011},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/the-effect-of-a-disease-management-intervention-on-quality-and-17116916","doi":"10.7326/0003-4819-145-10-200611210-00004","journal":"Annals of internal medicine","n_participants":408,"pmid":"17116916","source_url":"https://pubmed.ncbi.nlm.nih.gov/17116916/","study_design":null,"title":"The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial","title_match":true,"year":2006},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/the-silent-epidemic-of-chronic-pain-in-older-adults-31004724","doi":"10.1016/j.pnpbp.2019.04.006","journal":"Progress in neuro-psychopharmacology & biological psychiatry","n_participants":null,"pmid":"31004724","source_url":"https://pubmed.ncbi.nlm.nih.gov/31004724/","study_design":null,"title":"The silent epidemic of chronic pain in older adults","title_match":false,"year":2019},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-internet-based-supportive-interventions-for-23963684","doi":"10.1002/gps.4016","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"23963684","source_url":"https://pubmed.ncbi.nlm.nih.gov/23963684/","study_design":null,"title":"A systematic review of Internet-based supportive interventions for caregivers of patients with dementia","title_match":false,"year":2014},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/effects-of-physical-activity-and-exercise-on-the-cognitive-function-31266451","doi":"10.1186/s12877-019-1175-2","journal":"BMC geriatrics","n_participants":673,"pmid":"31266451","source_url":"https://pubmed.ncbi.nlm.nih.gov/31266451/","study_design":"meta-analysis","title":"Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis","title_match":false,"year":2019},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/community-based-occupational-therapy-for-patients-with-dementia-and-17114212","doi":"10.1136/bmj.39001.688843.be","journal":"BMJ (Clinical research ed.)","n_participants":135,"pmid":"17114212","source_url":"https://pubmed.ncbi.nlm.nih.gov/17114212/","study_design":"randomized controlled trial","title":"Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial","title_match":true,"year":2006},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/two-phase-3-trials-of-gantenerumab-in-early-alzheimer-s-disease-37966285","doi":"10.1056/nejmoa2304430","journal":"The New England journal of medicine","n_participants":980,"pmid":"37966285","source_url":"https://pubmed.ncbi.nlm.nih.gov/37966285/","study_design":"clinical trial","title":"Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease","title_match":true,"year":2023},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/memantine-for-patients-with-parkinson-s-disease-dementia-or-dementia-20729148","doi":"10.1016/s1474-4422(10)70194-0","journal":"The Lancet. Neurology","n_participants":199,"pmid":"20729148","source_url":"https://pubmed.ncbi.nlm.nih.gov/20729148/","study_design":null,"title":"Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","title_match":true,"year":2010},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/blood-brain-barrier-opening-with-focused-ultrasound-in-parkinson-s-33536430","doi":"10.1038/s41467-021-21022-9","journal":"Nature communications","n_participants":null,"pmid":"33536430","source_url":"https://pubmed.ncbi.nlm.nih.gov/33536430/","study_design":null,"title":"Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia","title_match":false,"year":2021},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/evaluation-of-the-safety-and-immunogenicity-of-synthetic-abeta42-15642910","doi":"10.1212/01.wnl.0000148604.77591.67","journal":"Neurology","n_participants":null,"pmid":"15642910","source_url":"https://pubmed.ncbi.nlm.nih.gov/15642910/","study_design":"clinical trial","title":"Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD","title_match":false,"year":2005},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/cognitive-emotional-and-social-benefits-of-regular-musical-activities-24009169","doi":"10.1093/geront/gnt100","journal":"The Gerontologist","n_participants":30,"pmid":"24009169","source_url":"https://pubmed.ncbi.nlm.nih.gov/24009169/","study_design":null,"title":"Cognitive, emotional, and social benefits of regular musical activities in early dementia: randomized controlled study","title_match":true,"year":2014},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/repurposed-drugs-targeting-eif2-p-mediated-translational-repression-28430857","doi":"10.1093/brain/awx074","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"28430857","source_url":"https://pubmed.ncbi.nlm.nih.gov/28430857/","study_design":null,"title":"Repurposed drugs targeting eIF2\u03b1-P-mediated translational repression prevent neurodegeneration in mice","title_match":false,"year":2017},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-protocols-for-the-10-66-dementia-research-group-population-based-17659078","doi":"10.1186/1471-2458-7-165","journal":"BMC public health","n_participants":null,"pmid":"17659078","source_url":"https://pubmed.ncbi.nlm.nih.gov/17659078/","study_design":"randomized controlled trial","title":"The protocols for the 10/66 dementia research group population-based research programme","title_match":false,"year":2007},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/general-practitioners-knowledge-confidence-and-attitudes-in-the-15271637","doi":"10.1093/ageing/afh140","journal":"Age and ageing","n_participants":null,"pmid":"15271637","source_url":"https://pubmed.ncbi.nlm.nih.gov/15271637/","study_design":"randomized controlled trial","title":"General practitioners' knowledge, confidence and attitudes in the diagnosis and management of dementia","title_match":false,"year":2004},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/translating-evidence-based-dementia-caregiving-interventions-into-26035597","doi":"10.1093/geront/gnu123","journal":"The Gerontologist","n_participants":null,"pmid":"26035597","source_url":"https://pubmed.ncbi.nlm.nih.gov/26035597/","study_design":null,"title":"Translating Evidence-Based Dementia Caregiving Interventions into Practice: State-of-the-Science and Next Steps","title_match":false,"year":2015},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/tailored-activities-to-manage-neuropsychiatric-behaviors-in-persons-18310553","doi":"10.1097/jgp.0b013e318160da72","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"18310553","source_url":"https://pubmed.ncbi.nlm.nih.gov/18310553/","study_design":null,"title":"Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot study","title_match":false,"year":2008},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-a-home-environmental-intervention-11220813","doi":"10.1093/geront/41.1.4","journal":"The Gerontologist","n_participants":171,"pmid":"11220813","source_url":"https://pubmed.ncbi.nlm.nih.gov/11220813/","study_design":null,"title":"A randomized, controlled trial of a home environmental intervention: effect on efficacy and upset in caregivers and on daily function of persons with dementia","title_match":true,"year":2001},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/acnp-white-paper-update-on-use-of-antipsychotic-drugs-in-elderly-17637610","doi":"10.1038/sj.npp.1301492","journal":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","n_participants":null,"pmid":"17637610","source_url":"https://pubmed.ncbi.nlm.nih.gov/17637610/","study_design":"meta-analysis","title":"ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia","title_match":false,"year":2008},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/effect-of-collaborative-dementia-care-via-telephone-and-internet-on-31566651","doi":"10.1001/jamainternmed.2019.4101","journal":"JAMA internal medicine","n_participants":452,"pmid":"31566651","source_url":"https://pubmed.ncbi.nlm.nih.gov/31566651/","study_design":null,"title":"Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/a-community-based-exercise-programme-to-improve-functional-ability-in-21564154","doi":"10.1111/j.1471-6712.2011.00895.x","journal":"Scandinavian journal of caring sciences","n_participants":null,"pmid":"21564154","source_url":"https://pubmed.ncbi.nlm.nih.gov/21564154/","study_design":"randomized controlled trial","title":"A community-based exercise programme to improve functional ability in people with Alzheimer's disease: a randomized controlled trial","title_match":true,"year":2012},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/plasma-phospho-tau-in-alzheimer-s-disease-towards-diagnostic-and-36927491","doi":"10.1186/s13024-023-00605-8","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"36927491","source_url":"https://pubmed.ncbi.nlm.nih.gov/36927491/","study_design":null,"title":"Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications","title_match":false,"year":2023},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/florbetapir-f18-av-45-pet-to-assess-amyloid-burden-in-alzheimer-s-23375563","doi":"10.1016/j.jalz.2012.10.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":184,"pmid":"23375563","source_url":"https://pubmed.ncbi.nlm.nih.gov/23375563/","study_design":"clinical trial","title":"Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging","title_match":false,"year":2013},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/donepezil-is-associated-with-delayed-nursing-home-placement-in-12834513","doi":"10.1046/j.1365-2389.2003.51306.x","journal":"Journal of the American Geriatrics Society","n_participants":1115,"pmid":"12834513","source_url":"https://pubmed.ncbi.nlm.nih.gov/12834513/","study_design":"open-label trial","title":"Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease","title_match":false,"year":2003},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/quantification-of-amyloid-pet-for-future-clinical-use-a-state-of-the-35389071","doi":"10.1007/s00259-022-05784-y","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"35389071","source_url":"https://pubmed.ncbi.nlm.nih.gov/35389071/","study_design":null,"title":"Quantification of amyloid PET for future clinical use: a state-of-the-art review","title_match":false,"year":2022},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/nighttime-insomnia-treatment-and-education-for-alzheimer-s-disease-a-15877554","doi":"10.1111/j.1532-5415.2005.53252.x","journal":"Journal of the American Geriatrics Society","n_participants":17,"pmid":"15877554","source_url":"https://pubmed.ncbi.nlm.nih.gov/15877554/","study_design":null,"title":"Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial","title_match":true,"year":2005},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/cognitive-training-for-people-with-mild-to-moderate-dementia-30909318","doi":"10.1002/14651858.cd013069.pub2","journal":"The Cochrane database of systematic reviews","n_participants":653,"pmid":"30909318","source_url":"https://pubmed.ncbi.nlm.nih.gov/30909318/","study_design":"meta-analysis","title":"Cognitive training for people with mild to moderate dementia","title_match":false,"year":2019},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-effectiveness-of-nonpharmacological-interventions-for-informal-31985249","doi":"10.1037/pag0000401","journal":"Psychology and aging","n_participants":null,"pmid":"31985249","source_url":"https://pubmed.ncbi.nlm.nih.gov/31985249/","study_design":"systematic review","title":"The effectiveness of nonpharmacological interventions for informal dementia caregivers: An updated systematic review and meta-analysis","title_match":false,"year":2020},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/galantamine-a-novel-cholinergic-drug-with-a-unique-dual-mode-of-12177686","doi":"10.1111/j.1527-3458.2002.tb00221.x","journal":"CNS drug reviews","n_participants":null,"pmid":"12177686","source_url":"https://pubmed.ncbi.nlm.nih.gov/12177686/","study_design":null,"title":"Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease","title_match":false,"year":2002},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-with-lewy-bodies-a-randomized-placebo-22829268","doi":"10.1002/ana.23557","journal":"Annals of neurology","n_participants":35,"pmid":"22829268","source_url":"https://pubmed.ncbi.nlm.nih.gov/22829268/","study_design":"clinical trial","title":"Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial","title_match":true,"year":2012},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/yogic-meditation-reverses-nf-b-and-irf-related-transcriptome-dynamics-22795617","doi":"10.1016/j.psyneuen.2012.06.011","journal":"Psychoneuroendocrinology","n_participants":null,"pmid":"22795617","source_url":"https://pubmed.ncbi.nlm.nih.gov/22795617/","study_design":null,"title":"Yogic meditation reverses NF-\u03baB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial","title_match":true,"year":2013},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/cognitive-dysfunction-and-dementia-in-parkinson-s-disease-15480840","doi":"10.1007/s00702-004-0168-1","journal":"Journal of neural transmission (Vienna, Austria : 1996)","n_participants":null,"pmid":"15480840","source_url":"https://pubmed.ncbi.nlm.nih.gov/15480840/","study_design":null,"title":"Cognitive dysfunction and dementia in Parkinson's disease","title_match":false,"year":2004},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/salvia-for-dementia-therapy-review-of-pharmacological-activity-and-12895683","doi":"10.1016/s0091-3057(03)00108-4","journal":"Pharmacology, biochemistry, and behavior","n_participants":null,"pmid":"12895683","source_url":"https://pubmed.ncbi.nlm.nih.gov/12895683/","study_design":"open-label trial","title":"Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial","title_match":true,"year":2003},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/double-blind-placebo-controlled-proof-of-concept-trial-of-bexarotene-26822146","doi":"10.1186/s13195-016-0173-2","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"26822146","source_url":"https://pubmed.ncbi.nlm.nih.gov/26822146/","study_design":null,"title":"Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease","title_match":true,"year":2016},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/gradual-disturbances-of-the-amplitude-of-low-frequency-fluctuations-30618593","doi":"10.3389/fnins.2018.00975","journal":"Frontiers in neuroscience","n_participants":44,"pmid":"30618593","source_url":"https://pubmed.ncbi.nlm.nih.gov/30618593/","study_design":null,"title":"Gradual Disturbances of the Amplitude of Low-Frequency Fluctuations (ALFF) and Fractional ALFF in Alzheimer Spectrum","title_match":false,"year":2018},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/the-link-between-oxidative-stress-mitochondrial-dysfunction-and-36358538","doi":"10.3390/antiox11112167","journal":"Antioxidants (Basel, Switzerland)","n_participants":null,"pmid":"36358538","source_url":"https://pubmed.ncbi.nlm.nih.gov/36358538/","study_design":null,"title":"The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer's Disease: Therapeutic Implications and Future Perspectives","title_match":false,"year":2022},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/metrifonate-benefits-cognitive-behavioral-and-global-function-in-9595967","doi":"10.1212/wnl.50.5.1222","journal":"Neurology","n_participants":24,"pmid":"9595967","source_url":"https://pubmed.ncbi.nlm.nih.gov/9595967/","study_design":null,"title":"Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease","title_match":false,"year":1998},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-36-week-multicenter-randomized-double-blind-placebo-controlled-33731209","doi":"10.1186/s13195-021-00795-7","journal":"Alzheimer's research & therapy","n_participants":818,"pmid":"33731209","source_url":"https://pubmed.ncbi.nlm.nih.gov/33731209/","study_design":"clinical trial","title":"A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia","title_match":true,"year":2021},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/the-multidisciplinary-approach-to-alzheimer-s-disease-and-dementia-a-30619031","doi":"10.3389/fneur.2018.01058","journal":"Frontiers in neurology","n_participants":null,"pmid":"30619031","source_url":"https://pubmed.ncbi.nlm.nih.gov/30619031/","study_design":null,"title":"The Multidisciplinary Approach to Alzheimer's Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment","title_match":false,"year":2018},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/a-web-based-psychoeducational-program-for-informal-caregivers-of-25967983","doi":"10.2196/jmir.3717","journal":"Journal of medical Internet research","n_participants":25,"pmid":"25967983","source_url":"https://pubmed.ncbi.nlm.nih.gov/25967983/","study_design":"randomized controlled trial","title":"A web-based psychoeducational program for informal caregivers of patients with Alzheimer's disease: a pilot randomized controlled trial","title_match":true,"year":2015},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/association-of-receipt-of-palliative-care-interventions-with-health-33048152","doi":"10.1001/jama.2020.14205","journal":"JAMA","n_participants":4068,"pmid":"33048152","source_url":"https://pubmed.ncbi.nlm.nih.gov/33048152/","study_design":"systematic review","title":"Association of Receipt of Palliative Care Interventions With Health Care Use, Quality of Life, and Symptom Burden Among Adults With Chronic Noncancer Illness: A Systematic Review and Meta-analysis","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/ecology-of-the-aging-human-brain-21825242","doi":"10.1001/archneurol.2011.157","journal":"Archives of neurology","n_participants":1672,"pmid":"21825242","source_url":"https://pubmed.ncbi.nlm.nih.gov/21825242/","study_design":null,"title":"Ecology of the aging human brain","title_match":false,"year":2011},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/enhancing-caregiver-health-findings-from-the-resources-for-enhancing-20122038","doi":"10.1111/j.1532-5415.2009.02631.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"20122038","source_url":"https://pubmed.ncbi.nlm.nih.gov/20122038/","study_design":null,"title":"Enhancing caregiver health: findings from the resources for enhancing Alzheimer's caregiver health II intervention","title_match":false,"year":2010},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/reducing-caregiver-burden-a-randomized-psychoeducational-intervention-10396888","doi":"10.1093/geront/39.3.299","journal":"The Gerontologist","n_participants":null,"pmid":"10396888","source_url":"https://pubmed.ncbi.nlm.nih.gov/10396888/","study_design":null,"title":"Reducing caregiver burden: a randomized psychoeducational intervention for caregivers of persons with dementia","title_match":false,"year":1999},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/a-double-blind-comparison-of-citalopram-and-risperidone-for-the-17846102","doi":"10.1097/jgp.0b013e3180cc1ff5","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":103,"pmid":"17846102","source_url":"https://pubmed.ncbi.nlm.nih.gov/17846102/","study_design":null,"title":"A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia","title_match":true,"year":2007},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/worksite-based-internet-multimedia-program-for-family-caregivers-of-16326661","doi":"10.1093/geront/45.6.793","journal":"The Gerontologist","n_participants":null,"pmid":"16326661","source_url":"https://pubmed.ncbi.nlm.nih.gov/16326661/","study_design":null,"title":"Worksite-based internet multimedia program for family caregivers of persons with dementia","title_match":false,"year":2005},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/progressive-multifocal-leukoencephalopathy-the-evolution-of-a-disease-9222338","doi":"10.3109/13550289509111006","journal":"Journal of neurovirology","n_participants":null,"pmid":"9222338","source_url":"https://pubmed.ncbi.nlm.nih.gov/9222338/","study_design":null,"title":"Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare","title_match":false,"year":1995},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effectiveness-of-an-internet-intervention-for-family-caregivers-of-25679228","doi":"10.1371/journal.pone.0116622","journal":"PloS one","n_participants":149,"pmid":"25679228","source_url":"https://pubmed.ncbi.nlm.nih.gov/25679228/","study_design":null,"title":"Effectiveness of an Internet intervention for family caregivers of people with dementia: results of a randomized controlled trial","title_match":true,"year":2015},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/application-of-resource-utilization-in-dementia-rud-instrument-in-a-23142433","doi":"10.1016/j.jalz.2012.06.008","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"23142433","source_url":"https://pubmed.ncbi.nlm.nih.gov/23142433/","study_design":null,"title":"Application of Resource Utilization in Dementia (RUD) instrument in a global setting","title_match":false,"year":2013},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/molecular-mechanisms-for-alzheimer-s-disease-implications-for-16805778","doi":"10.1111/j.1471-4159.2006.03989.x","journal":"Journal of neurochemistry","n_participants":null,"pmid":"16805778","source_url":"https://pubmed.ncbi.nlm.nih.gov/16805778/","study_design":null,"title":"Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics","title_match":false,"year":2006},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/the-clinician-interview-based-impression-cibi-a-clinician-s-global-7991118","doi":"10.1212/wnl.44.12.2315","journal":"Neurology","n_participants":null,"pmid":"7991118","source_url":"https://pubmed.ncbi.nlm.nih.gov/7991118/","study_design":null,"title":"The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease","title_match":false,"year":1994},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effectiveness-and-safety-of-dementia-care-management-in-primary-care-28746708","doi":"10.1001/jamapsychiatry.2017.2124","journal":"JAMA psychiatry","n_participants":6838,"pmid":"28746708","source_url":"https://pubmed.ncbi.nlm.nih.gov/28746708/","study_design":null,"title":"Effectiveness and Safety of Dementia Care Management in Primary Care: A Randomized Clinical Trial","title_match":true,"year":2017},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/retracted-internet-based-supportive-interventions-for-family-32902388","doi":"10.2196/19468","journal":"Journal of medical Internet research","n_participants":null,"pmid":"32902388","source_url":"https://pubmed.ncbi.nlm.nih.gov/32902388/","study_design":"systematic review","title":"Retracted: Internet-Based Supportive Interventions for Family Caregivers of People With Dementia: Systematic Review and Meta-Analysis","title_match":false,"year":2020},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/the-effectiveness-of-a-home-care-program-for-supporting-caregivers-of-18523642","doi":"10.1371/journal.pone.0002333","journal":"PloS one","n_participants":null,"pmid":"18523642","source_url":"https://pubmed.ncbi.nlm.nih.gov/18523642/","study_design":"randomized controlled trial","title":"The effectiveness of a home care program for supporting caregivers of persons with dementia in developing countries: a randomised controlled trial from Goa, India","title_match":true,"year":2008},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/efficacy-of-donepezil-on-maintenance-of-activities-of-daily-living-in-12757558","doi":"10.1046/j.1365-2389.2003.51260.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"12757558","source_url":"https://pubmed.ncbi.nlm.nih.gov/12757558/","study_design":null,"title":"Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden","title_match":false,"year":2003},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/comorbidities-associated-with-mortality-in-31-461-adults-with-covid-32911500","doi":"10.1371/journal.pmed.1003321","journal":"PLoS medicine","n_participants":null,"pmid":"32911500","source_url":"https://pubmed.ncbi.nlm.nih.gov/32911500/","study_design":"cohort study","title":"Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis","title_match":false,"year":2020},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/the-mental-activity-and-exercise-max-trial-a-randomized-controlled-23545598","doi":"10.1001/jamainternmed.2013.189","journal":"JAMA internal medicine","n_participants":126,"pmid":"23545598","source_url":"https://pubmed.ncbi.nlm.nih.gov/23545598/","study_design":"randomized controlled trial","title":"The Mental Activity and eXercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults","title_match":true,"year":2013},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/baseline-characteristics-of-participants-in-the-aspree-aspirin-in-28329340","doi":"10.1093/gerona/glw342","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":null,"pmid":"28329340","source_url":"https://pubmed.ncbi.nlm.nih.gov/28329340/","study_design":null,"title":"Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study","title_match":false,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/elderly-patients-with-dementia-related-symptoms-of-severe-agitation-18494535","doi":"10.4088/jcp.v69n0602","journal":"The Journal of clinical psychiatry","n_participants":null,"pmid":"18494535","source_url":"https://pubmed.ncbi.nlm.nih.gov/18494535/","study_design":null,"title":"Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy","title_match":true,"year":2008},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/mindfulness-based-stress-reduction-for-family-caregivers-a-randomized-23070934","doi":"10.1093/geront/gns126","journal":"The Gerontologist","n_participants":null,"pmid":"23070934","source_url":"https://pubmed.ncbi.nlm.nih.gov/23070934/","study_design":null,"title":"Mindfulness-based stress reduction for family caregivers: a randomized controlled trial","title_match":true,"year":2013},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/effectiveness-of-nonpharmacological-interventions-for-the-management-17101935","doi":"10.1001/archinte.166.20.2182","journal":"Archives of internal medicine","n_participants":null,"pmid":"17101935","source_url":"https://pubmed.ncbi.nlm.nih.gov/17101935/","study_design":null,"title":"Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review","title_match":false,"year":2006},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/prevalence-and-subtypes-of-dementia-in-taiwan-a-community-survey-of-7836638","doi":"10.1111/j.1532-5415.1995.tb06379.x","journal":"Journal of the American Geriatrics Society","n_participants":1521,"pmid":"7836638","source_url":"https://pubmed.ncbi.nlm.nih.gov/7836638/","study_design":null,"title":"Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individuals","title_match":false,"year":1995},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/dementia-in-latin-america-paving-the-way-toward-a-regional-action-plan-33634602","doi":"10.1002/alz.12202","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"33634602","source_url":"https://pubmed.ncbi.nlm.nih.gov/33634602/","study_design":null,"title":"Dementia in Latin America: Paving the way toward a regional action plan","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-prevalence-of-dementia-and-depression-in-the-elderly-community-in-7771920","doi":"10.1001/archpsyc.1995.03950180083011","journal":"Archives of general psychiatry","n_participants":null,"pmid":"7771920","source_url":"https://pubmed.ncbi.nlm.nih.gov/7771920/","study_design":"clinical trial","title":"The prevalence of dementia and depression in the elderly community in a southern European population. The Zaragoza study","title_match":false,"year":1995},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-link-between-obstructive-sleep-apnea-and-neurocognitive-35913462","doi":"10.1513/annalsats.202205-380st","journal":"Annals of the American Thoracic Society","n_participants":null,"pmid":"35913462","source_url":"https://pubmed.ncbi.nlm.nih.gov/35913462/","study_design":"longitudinal study","title":"The Link between Obstructive Sleep Apnea and Neurocognitive Impairment: An Official American Thoracic Society Workshop Report","title_match":false,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/use-of-an-alzheimer-s-disease-polygenic-risk-score-to-identify-mild-29487403","doi":"10.1038/s41380-018-0030-8","journal":"Molecular psychiatry","n_participants":null,"pmid":"29487403","source_url":"https://pubmed.ncbi.nlm.nih.gov/29487403/","study_design":null,"title":"Use of an Alzheimer's disease polygenic risk score to identify mild cognitive impairment in adults in their 50s","title_match":false,"year":2019},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/methods-and-demographic-findings-of-the-baseline-survey-of-the-15313596","doi":"10.1016/j.puhe.2003.10.007","journal":"Public health","n_participants":null,"pmid":"15313596","source_url":"https://pubmed.ncbi.nlm.nih.gov/15313596/","study_design":"longitudinal study","title":"Methods and demographic findings of the baseline survey of the NEDICES cohort: a door-to-door survey of neurological disorders in three communities from Central Spain","title_match":false,"year":2004},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/effectiveness-of-supporting-informal-caregivers-of-people-with-27079704","doi":"10.3233/jad-151011","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"27079704","source_url":"https://pubmed.ncbi.nlm.nih.gov/27079704/","study_design":"systematic review","title":"Effectiveness of Supporting Informal Caregivers of People with Dementia: A Systematic Review of Randomized and Non-Randomized Controlled Trials","title_match":true,"year":2016},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-neuropathological-comorbidities-are-common-in-the-33285640","doi":"10.3233/jad-201213","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"33285640","source_url":"https://pubmed.ncbi.nlm.nih.gov/33285640/","study_design":null,"title":"Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old","title_match":false,"year":2021},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/assessing-end-of-life-preferences-for-advanced-dementia-in-rural-21254815","doi":"10.1089/jpm.2010.0299","journal":"Journal of palliative medicine","n_participants":43,"pmid":"21254815","source_url":"https://pubmed.ncbi.nlm.nih.gov/21254815/","study_design":"randomized controlled trial","title":"Assessing end-of-life preferences for advanced dementia in rural patients using an educational video: a randomized controlled trial","title_match":true,"year":2011},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/addressing-the-disparities-in-dementia-risk-early-detection-and-care-35199931","doi":"10.1002/alz.12589","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"35199931","source_url":"https://pubmed.ncbi.nlm.nih.gov/35199931/","study_design":null,"title":"Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium","title_match":false,"year":2022},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/effects-of-exercise-on-neurobehavioral-function-in-community-dwelling-8617907","doi":"10.1111/j.1532-5415.1996.tb01444.x","journal":"Journal of the American Geriatrics Society","n_participants":42,"pmid":"8617907","source_url":"https://pubmed.ncbi.nlm.nih.gov/8617907/","study_design":"randomized controlled trial","title":"Effects of exercise on neurobehavioral function in community-dwelling older people more than 75 years of age","title_match":false,"year":1996},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/cognitive-training-interventions-for-dementia-and-mild-cognitive-32101639","doi":"10.1002/14651858.cd011961.pub2","journal":"The Cochrane database of systematic reviews","n_participants":225,"pmid":"32101639","source_url":"https://pubmed.ncbi.nlm.nih.gov/32101639/","study_design":null,"title":"Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease","title_match":false,"year":2020},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-cost-effectiveness-of-a-behavior-intervention-with-caregivers-of-18179480","doi":"10.1111/j.1532-5415.2007.01569.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"18179480","source_url":"https://pubmed.ncbi.nlm.nih.gov/18179480/","study_design":null,"title":"The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease","title_match":false,"year":2008},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/intervention-to-promote-communication-about-goals-of-care-for-37210665","doi":"10.1001/jama.2023.8812","journal":"JAMA","n_participants":3918,"pmid":"37210665","source_url":"https://pubmed.ncbi.nlm.nih.gov/37210665/","study_design":null,"title":"Intervention to Promote Communication About Goals of Care for Hospitalized Patients With Serious Illness: A Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/cerebral-amyloid-angiopathy-interacts-with-neuritic-amyloid-plaques-35759327","doi":"10.1093/brain/awac178","journal":"Brain : a journal of neurology","n_participants":1722,"pmid":"35759327","source_url":"https://pubmed.ncbi.nlm.nih.gov/35759327/","study_design":"cohort study","title":"Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline","title_match":false,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/modifiable-barriers-for-recruitment-and-retention-of-older-adults-33612540","doi":"10.3233/jad-201081","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"33612540","source_url":"https://pubmed.ncbi.nlm.nih.gov/33612540/","study_design":"narrative review","title":"Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer's Disease Research","title_match":false,"year":2021},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/walking-stabilizes-cognitive-functioning-in-alzheimer-s-disease-ad-22959822","doi":"10.1016/j.archger.2012.06.016","journal":"Archives of gerontology and geriatrics","n_participants":104,"pmid":"22959822","source_url":"https://pubmed.ncbi.nlm.nih.gov/22959822/","study_design":null,"title":"Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year","title_match":false,"year":2013},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/geriatric-telepsychiatry-systematic-review-and-policy-considerations-30416025","doi":"10.1016/j.jagp.2018.10.009","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"30416025","source_url":"https://pubmed.ncbi.nlm.nih.gov/30416025/","study_design":"randomized controlled trial","title":"Geriatric Telepsychiatry: Systematic Review and Policy Considerations","title_match":false,"year":2019},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/effect-of-a-herbal-extract-containing-curcumin-and-piperine-on-22725836","doi":"10.1111/j.1365-2125.2012.04364.x","journal":"British journal of clinical pharmacology","n_participants":null,"pmid":"22725836","source_url":"https://pubmed.ncbi.nlm.nih.gov/22725836/","study_design":null,"title":"Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers","title_match":false,"year":2013},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/health-status-and-risk-profiles-for-brain-aging-of-rural-dwelling-35441085","doi":"10.1002/trc2.12254","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":5765,"pmid":"35441085","source_url":"https://pubmed.ncbi.nlm.nih.gov/35441085/","study_design":null,"title":"Health status and risk profiles for brain aging of rural-dwelling older adults: Data from the interdisciplinary baseline assessments in MIND-China","title_match":false,"year":2022},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/effect-of-aspirin-vs-placebo-on-the-prevention-of-depression-in-older-32492080","doi":"10.1001/jamapsychiatry.2020.1214","journal":"JAMA psychiatry","n_participants":114,"pmid":"32492080","source_url":"https://pubmed.ncbi.nlm.nih.gov/32492080/","study_design":null,"title":"Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/effect-of-a-lay-counselor-intervention-on-prevention-of-major-30422259","doi":"10.1001/jamapsychiatry.2018.3048","journal":"JAMA psychiatry","n_participants":181,"pmid":"30422259","source_url":"https://pubmed.ncbi.nlm.nih.gov/30422259/","study_design":null,"title":"Effect of a Lay Counselor Intervention on Prevention of Major Depression in Older Adults Living in Low- and Middle-Income Countries: A Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/herbs-commonly-used-by-women-an-evidence-based-review-12748451","doi":"10.1067/mob.2003.402","journal":"American journal of obstetrics and gynecology","n_participants":null,"pmid":"12748451","source_url":"https://pubmed.ncbi.nlm.nih.gov/12748451/","study_design":null,"title":"Herbs commonly used by women: an evidence-based review","title_match":false,"year":2003},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/interventions-for-hispanic-caregivers-of-patients-with-dementia-a-22467412","doi":"10.1177/1533317512439794","journal":"American journal of Alzheimer's disease and other dementias","n_participants":null,"pmid":"22467412","source_url":"https://pubmed.ncbi.nlm.nih.gov/22467412/","study_design":null,"title":"Interventions for Hispanic caregivers of patients with dementia: a review of the literature","title_match":false,"year":2012},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/evaluation-of-technology-based-interventions-for-informal-caregivers-30642650","doi":"10.1016/j.jagp.2018.12.003","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"30642650","source_url":"https://pubmed.ncbi.nlm.nih.gov/30642650/","study_design":"meta-analysis","title":"Evaluation of Technology-Based Interventions for Informal Caregivers of Patients With Dementia-A Meta-Analysis of Randomized Controlled Trials","title_match":true,"year":2019},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/the-prevalence-of-dementia-in-rural-tanzania-a-cross-sectional-22996739","doi":"10.1002/gps.3880","journal":"International journal of geriatric psychiatry","n_participants":1198,"pmid":"22996739","source_url":"https://pubmed.ncbi.nlm.nih.gov/22996739/","study_design":"cross-sectional","title":"The prevalence of dementia in rural Tanzania: a cross-sectional community-based study","title_match":false,"year":2013},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/co-morbidity-and-drug-treatment-in-alzheimer-s-disease-a-cross-21970467","doi":"10.1186/1471-2318-11-58","journal":"BMC geriatrics","n_participants":187,"pmid":"21970467","source_url":"https://pubmed.ncbi.nlm.nih.gov/21970467/","study_design":null,"title":"Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway","title_match":false,"year":2011},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-mini-mental-state-examination-as-a-selected-diagnostic-test-for-10775968","doi":"10.33588/rn.3005.99125","journal":"Revista de neurologia","n_participants":1611,"pmid":"10775968","source_url":"https://pubmed.ncbi.nlm.nih.gov/10775968/","study_design":"clinical trial","title":"[The Mini-Mental State Examination as a selected diagnostic test for dementia: a Colombian population study. GENECO]","title_match":false,"year":2000},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/pharmacologic-treatment-of-agitation-associated-with-dementia-2870097","doi":"10.1111/j.1532-5415.1986.tb04320.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"2870097","source_url":"https://pubmed.ncbi.nlm.nih.gov/2870097/","study_design":null,"title":"Pharmacologic treatment of agitation associated with dementia","title_match":false,"year":1986},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/preserving-identity-and-planning-for-advance-care-pipac-preliminary-24359036","doi":"10.1080/13607863.2013.868403","journal":"Aging & mental health","n_participants":18,"pmid":"24359036","source_url":"https://pubmed.ncbi.nlm.nih.gov/24359036/","study_design":null,"title":"Preserving Identity and Planning for Advance Care (PIPAC): preliminary outcomes from a patient-centered intervention for individuals with mild dementia","title_match":false,"year":2014},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/the-neuroinflammatory-biomarker-ykl-40-for-neurodegenerative-diseases-31195846","doi":"10.1080/14789450.2019.1628643","journal":"Expert review of proteomics","n_participants":null,"pmid":"31195846","source_url":"https://pubmed.ncbi.nlm.nih.gov/31195846/","study_design":null,"title":"The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development","title_match":false,"year":2019},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/rate-of-progression-of-mild-cognitive-impairment-to-dementia-meta-19236314","doi":"10.1111/j.1600-0447.2008.01326.x","journal":"Acta psychiatrica Scandinavica","n_participants":null,"pmid":"19236314","source_url":"https://pubmed.ncbi.nlm.nih.gov/19236314/","study_design":"meta-analysis","title":"Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies","title_match":false,"year":2009},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/long-term-effects-of-abeta42-immunisation-in-alzheimer-s-disease-18640458","doi":"10.1016/s0140-6736(08)61075-2","journal":"Lancet (London, England)","n_participants":80,"pmid":"18640458","source_url":"https://pubmed.ncbi.nlm.nih.gov/18640458/","study_design":null,"title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","title_match":true,"year":2008},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/long-term-persistence-in-use-of-statin-therapy-in-elderly-patients-12132975","doi":"10.1001/jama.288.4.455","journal":"JAMA","n_participants":null,"pmid":"12132975","source_url":"https://pubmed.ncbi.nlm.nih.gov/12132975/","study_design":"cohort study","title":"Long-term persistence in use of statin therapy in elderly patients","title_match":false,"year":2002},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-age-dependent-relation-of-blood-pressure-to-cognitive-function-16033691","doi":"10.1016/s1474-4422(05)70141-1","journal":"The Lancet. Neurology","n_participants":null,"pmid":"16033691","source_url":"https://pubmed.ncbi.nlm.nih.gov/16033691/","study_design":"cross-sectional","title":"The age-dependent relation of blood pressure to cognitive function and dementia","title_match":false,"year":2005},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-phase-2b-proof-of-concept-clinical-trial-in-33865446","doi":"10.1186/s13195-021-00813-8","journal":"Alzheimer's research & therapy","n_participants":18,"pmid":"33865446","source_url":"https://pubmed.ncbi.nlm.nih.gov/33865446/","study_design":"clinical trial","title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-A\u03b2 protofibril antibody","title_match":true,"year":2021},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-27042901","doi":"10.1212/con.0000000000000313","journal":"Continuum (Minneapolis, Minn.)","n_participants":null,"pmid":"27042901","source_url":"https://pubmed.ncbi.nlm.nih.gov/27042901/","study_design":null,"title":"Mild Cognitive Impairment","title_match":false,"year":2016},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/update-on-treatments-for-nonmotor-symptoms-of-parkinson-s-disease-an-30653247","doi":"10.1002/mds.27602","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":37,"pmid":"30653247","source_url":"https://pubmed.ncbi.nlm.nih.gov/30653247/","study_design":null,"title":"Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review","title_match":false,"year":2019},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/down-syndrome-32029743","doi":"10.1038/s41572-019-0143-7","journal":"Nature reviews. Disease primers","n_participants":null,"pmid":"32029743","source_url":"https://pubmed.ncbi.nlm.nih.gov/32029743/","study_design":null,"title":"Down syndrome","title_match":false,"year":2020},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/conjugated-equine-estrogens-and-global-cognitive-function-in-15213207","doi":"10.1001/jama.291.24.2959","journal":"JAMA","n_participants":1387,"pmid":"15213207","source_url":"https://pubmed.ncbi.nlm.nih.gov/15213207/","study_design":null,"title":"Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study","title_match":false,"year":2004},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effectiveness-of-a-6-year-multidomain-vascular-care-intervention-to-27474376","doi":"10.1016/s0140-6736(16)30950-3","journal":"Lancet (London, England)","n_participants":3526,"pmid":"27474376","source_url":"https://pubmed.ncbi.nlm.nih.gov/27474376/","study_design":"randomized controlled trial","title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial","title_match":true,"year":2016},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/a-phase-iii-randomized-trial-of-gantenerumab-in-prodromal-alzheimer-s-29221491","doi":"10.1186/s13195-017-0318-y","journal":"Alzheimer's research & therapy","n_participants":3089,"pmid":"29221491","source_url":"https://pubmed.ncbi.nlm.nih.gov/29221491/","study_design":null,"title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease","title_match":true,"year":2017},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-neuroimaging-initiative-positron-emission-20451870","doi":"10.1016/j.jalz.2010.03.003","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":100,"pmid":"20451870","source_url":"https://pubmed.ncbi.nlm.nih.gov/20451870/","study_design":"longitudinal study","title":"The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core","title_match":false,"year":2010},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/ykl-40-a-novel-prognostic-fluid-biomarker-for-preclinical-alzheimer-s-21035623","doi":"10.1016/j.biopsych.2010.08.025","journal":"Biological psychiatry","n_participants":47,"pmid":"21035623","source_url":"https://pubmed.ncbi.nlm.nih.gov/21035623/","study_design":null,"title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/hormone-replacement-therapy-and-cognition-systematic-review-and-meta-11255426","doi":"10.1001/jama.285.11.1489","journal":"JAMA","n_participants":null,"pmid":"11255426","source_url":"https://pubmed.ncbi.nlm.nih.gov/11255426/","study_design":"meta-analysis","title":"Hormone replacement therapy and cognition: systematic review and meta-analysis","title_match":false,"year":2001},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/omega-3-fatty-acids-evidence-basis-for-treatment-and-future-research-17194275","doi":"10.4088/jcp.v67n1217","journal":"The Journal of clinical psychiatry","n_participants":null,"pmid":"17194275","source_url":"https://pubmed.ncbi.nlm.nih.gov/17194275/","study_design":"meta-analysis","title":"Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry","title_match":false,"year":2006},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/delirium-superimposed-on-dementia-a-systematic-review-12366629","doi":"10.1046/j.1532-5415.2002.50468.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"12366629","source_url":"https://pubmed.ncbi.nlm.nih.gov/12366629/","study_design":"systematic review","title":"Delirium superimposed on dementia: a systematic review","title_match":false,"year":2002},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/a-randomized-trial-of-risperidone-placebo-and-haloperidol-for-10496251","doi":"10.1212/wnl.53.5.946","journal":"Neurology","n_participants":344,"pmid":"10496251","source_url":"https://pubmed.ncbi.nlm.nih.gov/10496251/","study_design":null,"title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","title_match":false,"year":1999},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/research-criteria-for-subcortical-vascular-dementia-in-clinical-trials-10961414","doi":"10.1007/978-3-7091-6781-6_4","journal":"Journal of neural transmission. Supplementum","n_participants":null,"pmid":"10961414","source_url":"https://pubmed.ncbi.nlm.nih.gov/10961414/","study_design":null,"title":"Research criteria for subcortical vascular dementia in clinical trials","title_match":true,"year":2000},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/apoe4-homozygozity-represents-a-distinct-genetic-form-of-alzheimer-s-38710950","doi":"10.1038/s41591-024-02931-w","journal":"Nature medicine","n_participants":3297,"pmid":"38710950","source_url":"https://pubmed.ncbi.nlm.nih.gov/38710950/","study_design":null,"title":"APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/strategies-to-prevent-falls-and-fractures-in-hospitals-and-care-homes-17158580","doi":"10.1136/bmj.39049.706493.55","journal":"BMJ (Clinical research ed.)","n_participants":null,"pmid":"17158580","source_url":"https://pubmed.ncbi.nlm.nih.gov/17158580/","study_design":"systematic review","title":"Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses","title_match":false,"year":2007},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/neuro-inflammation-and-anti-inflammatory-treatment-options-for-30954437","doi":"10.1016/j.clinbiochem.2019.04.001","journal":"Clinical biochemistry","n_participants":null,"pmid":"30954437","source_url":"https://pubmed.ncbi.nlm.nih.gov/30954437/","study_design":null,"title":"Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/multiplexed-immunoassay-panel-identifies-novel-csf-biomarkers-for-21526197","doi":"10.1371/journal.pone.0018850","journal":"PloS one","n_participants":null,"pmid":"21526197","source_url":"https://pubmed.ncbi.nlm.nih.gov/21526197/","study_design":null,"title":"Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis","title_match":false,"year":2011},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-comparison-of-machine-learning-methods-for-survival-analysis-of-33230128","doi":"10.1038/s41598-020-77220-w","journal":"Scientific reports","n_participants":1037,"pmid":"33230128","source_url":"https://pubmed.ncbi.nlm.nih.gov/33230128/","study_design":"cohort study","title":"A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction","title_match":false,"year":2020},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/digital-technologies-as-biomarkers-clinical-outcomes-assessment-and-29955666","doi":"10.1016/j.trci.2018.04.003","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29955666","source_url":"https://pubmed.ncbi.nlm.nih.gov/29955666/","study_design":null,"title":"Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials","title_match":true,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-the-effects-of-multi-sensory-11317951","doi":"10.1348/014466501163508","journal":"The British journal of clinical psychology","n_participants":null,"pmid":"11317951","source_url":"https://pubmed.ncbi.nlm.nih.gov/11317951/","study_design":"randomized controlled trial","title":"A randomized controlled trial of the effects of multi-sensory stimulation (MSS) for people with dementia","title_match":true,"year":2001},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-the-treatment-of-dementia-and-visual-hallucinations-12240787","doi":"10.1185/030079902125000813","journal":"Current medical research and opinion","n_participants":null,"pmid":"12240787","source_url":"https://pubmed.ncbi.nlm.nih.gov/12240787/","study_design":null,"title":"Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series","title_match":false,"year":2002},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/cardiometabolic-risk-factors-associated-with-brain-age-and-accelerate-34626047","doi":"10.1002/hbm.25680","journal":"Human brain mapping","n_participants":null,"pmid":"34626047","source_url":"https://pubmed.ncbi.nlm.nih.gov/34626047/","study_design":"cross-sectional","title":"Cardiometabolic risk factors associated with brain age and accelerate brain ageing","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/amyloid-and-tau-drive-early-alzheimer-s-disease-decline-while-glucose-32632135","doi":"10.1038/s42003-020-1079-x","journal":"Communications biology","n_participants":null,"pmid":"32632135","source_url":"https://pubmed.ncbi.nlm.nih.gov/32632135/","study_design":null,"title":"\u03b2-amyloid and tau drive early Alzheimer's disease decline while glucose hypometabolism drives late decline","title_match":false,"year":2020},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/machine-learning-prediction-of-incidence-of-alzheimer-s-disease-using-32258428","doi":"10.1038/s41746-020-0256-0","journal":"NPJ digital medicine","n_participants":40736,"pmid":"32258428","source_url":"https://pubmed.ncbi.nlm.nih.gov/32258428/","study_design":null,"title":"Machine learning prediction of incidence of Alzheimer's disease using large-scale administrative health data","title_match":false,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-coach-prompting-system-to-assist-older-adults-with-dementia-18992135","doi":"10.1186/1471-2318-8-28","journal":"BMC geriatrics","n_participants":null,"pmid":"18992135","source_url":"https://pubmed.ncbi.nlm.nih.gov/18992135/","study_design":null,"title":"The COACH prompting system to assist older adults with dementia through handwashing: an efficacy study","title_match":false,"year":2008},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/speech-in-alzheimer-s-disease-can-temporal-and-acoustic-parameters-24481220","doi":"10.1159/000356726","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"24481220","source_url":"https://pubmed.ncbi.nlm.nih.gov/24481220/","study_design":null,"title":"Speech in Alzheimer's disease: can temporal and acoustic parameters discriminate dementia?","title_match":false,"year":2014},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/mri-predictors-of-amyloid-pathology-results-from-the-emif-ad-30261928","doi":"10.1186/s13195-018-0428-1","journal":"Alzheimer's research & therapy","n_participants":337,"pmid":"30261928","source_url":"https://pubmed.ncbi.nlm.nih.gov/30261928/","study_design":null,"title":"MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study","title_match":false,"year":2018},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/a-novel-ensemble-based-machine-learning-algorithm-to-predict-the-31379711","doi":"10.3389/fneur.2019.00756","journal":"Frontiers in neurology","n_participants":null,"pmid":"31379711","source_url":"https://pubmed.ncbi.nlm.nih.gov/31379711/","study_design":null,"title":"A Novel Ensemble-Based Machine Learning Algorithm to Predict the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Socio-Demographic Characteristics, Clinical Information, and Neuropsychological Measures","title_match":false,"year":2019},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/identifying-incipient-dementia-individuals-using-machine-learning-and-28756942","doi":"10.1016/j.neurobiolaging.2017.06.027","journal":"Neurobiology of aging","n_participants":null,"pmid":"28756942","source_url":"https://pubmed.ncbi.nlm.nih.gov/28756942/","study_design":null,"title":"Identifying incipient dementia individuals using machine learning and amyloid imaging","title_match":false,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/predictors-of-survival-in-a-series-of-clinically-diagnosed-23968651","doi":"10.1016/j.parkreldis.2013.06.014","journal":"Parkinsonism & related disorders","n_participants":null,"pmid":"23968651","source_url":"https://pubmed.ncbi.nlm.nih.gov/23968651/","study_design":null,"title":"Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients","title_match":false,"year":2013},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/effect-of-a-robotic-seal-on-the-motor-activity-and-sleep-patterns-of-29563027","doi":"10.1016/j.maturitas.2018.01.007","journal":"Maturitas","n_participants":null,"pmid":"29563027","source_url":"https://pubmed.ncbi.nlm.nih.gov/29563027/","study_design":"randomized controlled trial","title":"Effect of a robotic seal on the motor activity and sleep patterns of older people with dementia, as measured by wearable technology: A cluster-randomised controlled trial","title_match":true,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/eyetracking-metrics-in-young-onset-alzheimer-s-disease-a-window-into-28824534","doi":"10.3389/fneur.2017.00377","journal":"Frontiers in neurology","n_participants":26,"pmid":"28824534","source_url":"https://pubmed.ncbi.nlm.nih.gov/28824534/","study_design":null,"title":"Eyetracking Metrics in Young Onset Alzheimer's Disease: A Window into Cognitive Visual Functions","title_match":false,"year":2017},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/early-diagnosis-of-alzheimer-s-disease-using-machine-learning-a-multi-35922851","doi":"10.1186/s13195-022-01047-y","journal":"Alzheimer's research & therapy","n_participants":570,"pmid":"35922851","source_url":"https://pubmed.ncbi.nlm.nih.gov/35922851/","study_design":null,"title":"Early diagnosis of Alzheimer's disease using machine learning: a multi-diagnostic, generalizable approach","title_match":false,"year":2022},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/pet-robot-intervention-for-people-with-dementia-a-systematic-review-30553098","doi":"10.1016/j.psychres.2018.12.032","journal":"Psychiatry research","n_participants":null,"pmid":"30553098","source_url":"https://pubmed.ncbi.nlm.nih.gov/30553098/","study_design":"systematic review","title":"Pet robot intervention for people with dementia: A systematic review and meta-analysis of randomized controlled trials","title_match":true,"year":2019},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/maintain-your-brain-protocol-of-a-3-year-randomized-controlled-trial-30475762","doi":"10.3233/jad-180572","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30475762","source_url":"https://pubmed.ncbi.nlm.nih.gov/30475762/","study_design":"randomized controlled trial","title":"Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds","title_match":true,"year":2019},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/new-directions-in-clinical-trials-for-frontotemporal-lobar-31668596","doi":"10.1016/j.jalz.2019.06.4956","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"31668596","source_url":"https://pubmed.ncbi.nlm.nih.gov/31668596/","study_design":null,"title":"New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures","title_match":true,"year":2020},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/the-effect-of-digital-reminiscence-therapy-on-people-with-dementia-a-32375661","doi":"10.1186/s12877-020-01563-2","journal":"BMC geriatrics","n_participants":25,"pmid":"32375661","source_url":"https://pubmed.ncbi.nlm.nih.gov/32375661/","study_design":null,"title":"The effect of digital reminiscence therapy on people with dementia: a pilot randomized controlled trial","title_match":true,"year":2020},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/sensing-technology-to-monitor-behavioral-and-psychological-symptoms-32116687","doi":"10.3389/fphar.2019.01699","journal":"Frontiers in pharmacology","n_participants":1337,"pmid":"32116687","source_url":"https://pubmed.ncbi.nlm.nih.gov/32116687/","study_design":"systematic review","title":"Sensing Technology to Monitor Behavioral and Psychological Symptoms and to Assess Treatment Response in People With Dementia. A Systematic Review","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/novel-mri-techniques-in-the-assessment-of-dementia-18205002","doi":"10.1007/s00259-007-0703-z","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"18205002","source_url":"https://pubmed.ncbi.nlm.nih.gov/18205002/","study_design":null,"title":"Novel MRI techniques in the assessment of dementia","title_match":false,"year":2008},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/huntington-s-disease-present-treatments-and-future-therapeutic-15076012","doi":"10.1097/00004850-200403000-00001","journal":"International clinical psychopharmacology","n_participants":null,"pmid":"15076012","source_url":"https://pubmed.ncbi.nlm.nih.gov/15076012/","study_design":"open-label trial","title":"Huntington's disease: present treatments and future therapeutic modalities","title_match":false,"year":2004},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/using-smartphone-technology-to-improve-prospective-memory-functioning-34786698","doi":"10.1111/jgs.17551","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"34786698","source_url":"https://pubmed.ncbi.nlm.nih.gov/34786698/","study_design":"randomized controlled trial","title":"Using smartphone technology to improve prospective memory functioning: A randomized controlled trial","title_match":true,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/artificial-intelligence-and-open-science-in-discovery-of-disease-38382465","doi":"10.1016/j.xcrm.2023.101379","journal":"Cell reports. Medicine","n_participants":null,"pmid":"38382465","source_url":"https://pubmed.ncbi.nlm.nih.gov/38382465/","study_design":null,"title":"Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/hearing-loss-treatment-in-older-adults-with-cognitive-impairment-a-30304320","doi":"10.1044/2018_jslhr-h-18-0077","journal":"Journal of speech, language, and hearing research : JSLHR","n_participants":null,"pmid":"30304320","source_url":"https://pubmed.ncbi.nlm.nih.gov/30304320/","study_design":"randomized controlled trial","title":"Hearing Loss Treatment in Older Adults With Cognitive Impairment: A Systematic Review","title_match":false,"year":2018},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/mri-characterizes-the-progressive-course-of-ad-and-predicts-29881340","doi":"10.3389/fnagi.2018.00135","journal":"Frontiers in aging neuroscience","n_participants":200,"pmid":"29881340","source_url":"https://pubmed.ncbi.nlm.nih.gov/29881340/","study_design":null,"title":"MRI Characterizes the Progressive Course of AD and Predicts Conversion to Alzheimer's Dementia 24 Months Before Probable Diagnosis","title_match":false,"year":2018},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/dissociation-of-down-syndrome-and-alzheimer-s-disease-effects-with-28642933","doi":"10.1016/j.trci.2016.02.004","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"28642933","source_url":"https://pubmed.ncbi.nlm.nih.gov/28642933/","study_design":null,"title":"Dissociation of Down syndrome and Alzheimer's disease effects with imaging","title_match":false,"year":2016},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-cost-effectiveness-of-using-paro-a-therapeutic-robotic-seal-to-29325922","doi":"10.1016/j.jamda.2017.10.008","journal":"Journal of the American Medical Directors Association","n_participants":415,"pmid":"29325922","source_url":"https://pubmed.ncbi.nlm.nih.gov/29325922/","study_design":"randomized controlled trial","title":"The Cost-Effectiveness of Using PARO, a Therapeutic Robotic Seal, to Reduce Agitation and Medication Use in Dementia: Findings from a Cluster-Randomized Controlled Trial","title_match":true,"year":2018},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/comparison-of-trained-clinician-ratings-with-expert-ratings-of-18953607","doi":"10.1007/s00455-008-9196-6","journal":"Dysphagia","n_participants":669,"pmid":"18953607","source_url":"https://pubmed.ncbi.nlm.nih.gov/18953607/","study_design":null,"title":"Comparison of trained clinician ratings with expert ratings of aspiration on videofluoroscopic images from a randomized clinical trial","title_match":true,"year":2009},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/cognitive-improvement-effects-of-electro-acupuncture-for-the-30621676","doi":"10.1186/s12906-018-2407-2","journal":"BMC complementary and alternative medicine","n_participants":103,"pmid":"30621676","source_url":"https://pubmed.ncbi.nlm.nih.gov/30621676/","study_design":"meta-analysis","title":"Cognitive improvement effects of electro-acupuncture for the treatment of MCI compared with Western medications: a systematic review and Meta-analysis","title_match":false,"year":2019},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/developing-a-machine-learning-model-for-detecting-depression-anxiety-37531702","doi":"10.1016/j.ijnurstu.2023.104562","journal":"International journal of nursing studies","n_participants":null,"pmid":"37531702","source_url":"https://pubmed.ncbi.nlm.nih.gov/37531702/","study_design":"cross-sectional","title":"Developing a machine learning model for detecting depression, anxiety, and apathy in older adults with mild cognitive impairment using speech and facial expressions: A cross-sectional observational study","title_match":false,"year":2023},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/management-of-cognitive-determinants-in-senile-dementia-of-alzheimer-25316430","doi":"10.1007/s40261-014-0235-9","journal":"Clinical drug investigation","n_participants":null,"pmid":"25316430","source_url":"https://pubmed.ncbi.nlm.nih.gov/25316430/","study_design":null,"title":"Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product","title_match":false,"year":2014},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/prediction-of-alzheimer-s-disease-progression-within-6-years-using-38924662","doi":"10.1002/alz.13886","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":166,"pmid":"38924662","source_url":"https://pubmed.ncbi.nlm.nih.gov/38924662/","study_design":null,"title":"Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models","title_match":false,"year":2024},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/inflammageing-chronic-inflammation-in-ageing-cardiovascular-disease-30065258","doi":"10.1038/s41569-018-0064-2","journal":"Nature reviews. Cardiology","n_participants":null,"pmid":"30065258","source_url":"https://pubmed.ncbi.nlm.nih.gov/30065258/","study_design":null,"title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and\u00a0frailty","title_match":false,"year":2018},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/impact-of-hypertension-on-cognitive-function-a-scientific-statement-27977393","doi":"10.1161/hyp.0000000000000053","journal":"Hypertension (Dallas, Tex. : 1979)","n_participants":null,"pmid":"27977393","source_url":"https://pubmed.ncbi.nlm.nih.gov/27977393/","study_design":null,"title":"Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association","title_match":false,"year":2016},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/vitamin-d-effects-on-musculoskeletal-health-immunity-autoimmunity-23542507","doi":"10.1016/j.autrev.2013.02.004","journal":"Autoimmunity reviews","n_participants":null,"pmid":"23542507","source_url":"https://pubmed.ncbi.nlm.nih.gov/23542507/","study_design":"meta-analysis","title":"Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence","title_match":false,"year":2013},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/homocysteine-lowering-by-b-vitamins-slows-the-rate-of-accelerated-20838622","doi":"10.1371/journal.pone.0012244","journal":"PloS one","n_participants":271,"pmid":"20838622","source_url":"https://pubmed.ncbi.nlm.nih.gov/20838622/","study_design":"randomized controlled trial","title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","title_match":true,"year":2010},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-design-and-rationale-of-a-multicenter-clinical-trial-comparing-24902920","doi":"10.1177/1740774514537404","journal":"Clinical trials (London, England)","n_participants":9361,"pmid":"24902920","source_url":"https://pubmed.ncbi.nlm.nih.gov/24902920/","study_design":null,"title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","title_match":true,"year":2014},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/a-systemic-review-of-the-roles-of-n-3-fatty-acids-in-health-and-19328262","doi":"10.1016/j.jada.2008.12.022","journal":"Journal of the American Dietetic Association","n_participants":null,"pmid":"19328262","source_url":"https://pubmed.ncbi.nlm.nih.gov/19328262/","study_design":null,"title":"A systemic review of the roles of n-3 fatty acids in health and disease","title_match":false,"year":2009},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-31152740","doi":"10.1053/j.gastro.2019.05.056","journal":"Gastroenterology","n_participants":8791,"pmid":"31152740","source_url":"https://pubmed.ncbi.nlm.nih.gov/31152740/","study_design":"randomized controlled trial","title":"Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin","title_match":false,"year":2019},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/cognitive-and-clinical-outcomes-of-homocysteine-lowering-b-vitamin-21780182","doi":"10.1002/gps.2758","journal":"International journal of geriatric psychiatry","n_participants":133,"pmid":"21780182","source_url":"https://pubmed.ncbi.nlm.nih.gov/21780182/","study_design":null,"title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial","title_match":true,"year":2012},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/defining-the-relationship-between-hypertension-cognitive-decline-and-28299725","doi":"10.1007/s11906-017-0724-3","journal":"Current hypertension reports","n_participants":null,"pmid":"28299725","source_url":"https://pubmed.ncbi.nlm.nih.gov/28299725/","study_design":null,"title":"Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review","title_match":false,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-the-role-of-long-chain-3-fatty-acids-in-fish-31521398","doi":"10.1016/j.neurol.2019.08.005","journal":"Revue neurologique","n_participants":null,"pmid":"31521398","source_url":"https://pubmed.ncbi.nlm.nih.gov/31521398/","study_design":null,"title":"Mediterranean diet: The role of long-chain \u03c9-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer disease","title_match":false,"year":2019},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/the-2015-dutch-food-based-dietary-guidelines-27049034","doi":"10.1038/ejcn.2016.52","journal":"European journal of clinical nutrition","n_participants":null,"pmid":"27049034","source_url":"https://pubmed.ncbi.nlm.nih.gov/27049034/","study_design":"meta-analysis","title":"The 2015 Dutch food-based dietary guidelines","title_match":false,"year":2016},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/glucose-regulation-cognition-and-brain-mri-in-type-2-diabetes-a-25163604","doi":"10.1016/s2213-8587(14)70148-2","journal":"The lancet. Diabetes & endocrinology","n_participants":null,"pmid":"25163604","source_url":"https://pubmed.ncbi.nlm.nih.gov/25163604/","study_design":null,"title":"Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review","title_match":false,"year":2015},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/neuropsychiatric-signs-and-symptoms-of-alzheimer-s-disease-new-29067350","doi":"10.1016/j.trci.2017.07.001","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29067350","source_url":"https://pubmed.ncbi.nlm.nih.gov/29067350/","study_design":null,"title":"Neuropsychiatric signs and symptoms of Alzheimer's disease: New\u00a0treatment paradigms","title_match":false,"year":2017},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/long-term-metformin-usage-and-cognitive-function-among-older-adults-24577463","doi":"10.3233/jad-131901","journal":"Journal of Alzheimer's disease : JAD","n_participants":204,"pmid":"24577463","source_url":"https://pubmed.ncbi.nlm.nih.gov/24577463/","study_design":"cross-sectional","title":"Long-term metformin usage and cognitive function among older adults with diabetes","title_match":false,"year":2014},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/the-effects-of-light-therapy-on-sleep-problems-a-systematic-review-26606319","doi":"10.1016/j.smrv.2015.08.009","journal":"Sleep medicine reviews","n_participants":1154,"pmid":"26606319","source_url":"https://pubmed.ncbi.nlm.nih.gov/26606319/","study_design":"meta-analysis","title":"The effects of light therapy on sleep problems: A systematic review and meta-analysis","title_match":false,"year":2016},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/cognitive-effects-of-treating-obstructive-sleep-apnea-in-alzheimer-s-18795985","doi":"10.1111/j.1532-5415.2008.01934.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"18795985","source_url":"https://pubmed.ncbi.nlm.nih.gov/18795985/","study_design":null,"title":"Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study","title_match":true,"year":2008},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/prognosis-and-neuropathologic-correlation-of-clinical-subtypes-of-30640364","doi":"10.1001/jamaneurol.2018.4377","journal":"JAMA neurology","n_participants":146,"pmid":"30640364","source_url":"https://pubmed.ncbi.nlm.nih.gov/30640364/","study_design":"cohort study","title":"Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease","title_match":false,"year":2019},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/new-evidence-on-the-management-of-lewy-body-dementia-31519472","doi":"10.1016/s1474-4422(19)30153-x","journal":"The Lancet. Neurology","n_participants":null,"pmid":"31519472","source_url":"https://pubmed.ncbi.nlm.nih.gov/31519472/","study_design":"meta-analysis","title":"New evidence on the management of Lewy body dementia","title_match":false,"year":2020},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/cognitive-function-trajectories-and-their-determinants-in-older-29691286","doi":"10.1136/jech-2017-210116","journal":"Journal of epidemiology and community health","n_participants":626,"pmid":"29691286","source_url":"https://pubmed.ncbi.nlm.nih.gov/29691286/","study_design":"longitudinal study","title":"Cognitive function trajectories and their determinants in older people: 8 years of follow-up in the English Longitudinal Study of Ageing","title_match":false,"year":2018},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/obstructive-sleep-apnea-is-linked-to-depression-and-cognitive-27139243","doi":"10.1016/j.jagp.2016.01.134","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"27139243","source_url":"https://pubmed.ncbi.nlm.nih.gov/27139243/","study_design":null,"title":"Obstructive Sleep Apnea is Linked to Depression and Cognitive Impairment: Evidence and Potential Mechanisms","title_match":false,"year":2016},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/evidence-of-oxidative-stress-in-alzheimer-s-disease-brain-and-19076432","doi":"10.1196/annals.1427.010","journal":"Annals of the New York Academy of Sciences","n_participants":null,"pmid":"19076432","source_url":"https://pubmed.ncbi.nlm.nih.gov/19076432/","study_design":null,"title":"Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows","title_match":false,"year":2008},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/pi3-kinase-akt-mtor-signaling-impaired-on-off-switches-in-aging-23470275","doi":"10.1016/j.exger.2013.02.025","journal":"Experimental gerontology","n_participants":null,"pmid":"23470275","source_url":"https://pubmed.ncbi.nlm.nih.gov/23470275/","study_design":null,"title":"PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/cerebrovascular-pathology-in-down-syndrome-and-alzheimer-disease-29195510","doi":"10.1186/s40478-017-0499-4","journal":"Acta neuropathologica communications","n_participants":32,"pmid":"29195510","source_url":"https://pubmed.ncbi.nlm.nih.gov/29195510/","study_design":null,"title":"Cerebrovascular pathology in Down syndrome and Alzheimer disease","title_match":false,"year":2017},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitor-therapy-stabilizes-symptoms-of-alzheimer-10850724","doi":"10.1097/00002093-200000001-00002","journal":"Alzheimer disease and associated disorders","n_participants":8000,"pmid":"10850724","source_url":"https://pubmed.ncbi.nlm.nih.gov/10850724/","study_design":null,"title":"Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease","title_match":false,"year":2000},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/cryo-em-structures-of-amyloid-and-tau-filaments-in-down-syndrome-38553642","doi":"10.1038/s41594-024-01252-3","journal":"Nature structural & molecular biology","n_participants":null,"pmid":"38553642","source_url":"https://pubmed.ncbi.nlm.nih.gov/38553642/","study_design":null,"title":"Cryo-EM structures of amyloid-\u03b2 and tau filaments in Down syndrome","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/microbleeds-and-cerebral-amyloid-angiopathy-in-the-brains-of-people-30452414","doi":"10.3233/jad-180589","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30452414","source_url":"https://pubmed.ncbi.nlm.nih.gov/30452414/","study_design":null,"title":"Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/therapeutic-approaches-in-the-improvement-of-cognitive-performance-in-22541285","doi":"10.1016/b978-0-444-54299-1.00001-7","journal":"Progress in brain research","n_participants":null,"pmid":"22541285","source_url":"https://pubmed.ncbi.nlm.nih.gov/22541285/","study_design":null,"title":"Therapeutic approaches in the improvement of cognitive performance in Down syndrome: past, present, and future","title_match":false,"year":2012},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/longitudinal-clinical-and-cognitive-changes-along-the-alzheimer-35930282","doi":"10.1001/jamanetworkopen.2022.25573","journal":"JAMA network open","n_participants":632,"pmid":"35930282","source_url":"https://pubmed.ncbi.nlm.nih.gov/35930282/","study_design":"cohort study","title":"Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome","title_match":false,"year":2022},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/lecanemab-and-vascular-amyloid-deposition-in-brains-of-people-with-39158850","doi":"10.1001/jamaneurol.2024.2579","journal":"JAMA neurology","n_participants":15,"pmid":"39158850","source_url":"https://pubmed.ncbi.nlm.nih.gov/39158850/","study_design":null,"title":"Lecanemab and Vascular-Amyloid Deposition in Brains of People With Down Syndrome","title_match":false,"year":2024},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/beyond-amyloid-immune-cerebrovascular-and-metabolic-contributions-to-35472307","doi":"10.1016/j.neuron.2022.04.001","journal":"Neuron","n_participants":null,"pmid":"35472307","source_url":"https://pubmed.ncbi.nlm.nih.gov/35472307/","study_design":null,"title":"Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome","title_match":false,"year":2022},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/discoveries-in-down-syndrome-moving-basic-science-to-clinical-care-22541294","doi":"10.1016/b978-0-444-54299-1.00010-8","journal":"Progress in brain research","n_participants":null,"pmid":"22541294","source_url":"https://pubmed.ncbi.nlm.nih.gov/22541294/","study_design":null,"title":"Discoveries in Down syndrome: moving basic science to clinical care","title_match":false,"year":2012},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/the-amyloid-cascade-hypothesis-a-conclusion-in-search-of-support-39532243","doi":"10.1016/j.ajpath.2024.10.014","journal":"The American journal of pathology","n_participants":null,"pmid":"39532243","source_url":"https://pubmed.ncbi.nlm.nih.gov/39532243/","study_design":null,"title":"The Amyloid Cascade Hypothesis: A Conclusion in Search of Support","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cognitive-enhancement-by-pharmacological-and-behavioral-interventions-22898099","doi":"10.1016/j.bcp.2012.06.028","journal":"Biochemical pharmacology","n_participants":null,"pmid":"22898099","source_url":"https://pubmed.ncbi.nlm.nih.gov/22898099/","study_design":null,"title":"Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model","title_match":false,"year":2012},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/plasma-p-tau212-as-a-biomarker-of-sporadic-and-down-syndrome-40275833","doi":"10.1002/alz.70172","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":245,"pmid":"40275833","source_url":"https://pubmed.ncbi.nlm.nih.gov/40275833/","study_design":null,"title":"Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/telemedicine-dementia-and-down-syndrome-implications-for-alzheimer-19595881","doi":"10.1016/j.jalz.2006.04.001","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":90,"pmid":"19595881","source_url":"https://pubmed.ncbi.nlm.nih.gov/19595881/","study_design":null,"title":"Telemedicine, dementia and Down syndrome: implications for Alzheimer disease","title_match":false,"year":2006},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/the-effect-of-acetyl-l-carnitine-administration-on-persons-with-down-16621446","doi":"10.1016/j.ridd.2004.07.009","journal":"Research in developmental disabilities","n_participants":40,"pmid":"16621446","source_url":"https://pubmed.ncbi.nlm.nih.gov/16621446/","study_design":null,"title":"The effect of acetyl-L-carnitine administration on persons with Down syndrome","title_match":false,"year":2006},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/towards-onset-prevention-of-cognition-decline-in-adults-with-down-27473843","doi":"10.1186/s13063-016-1370-9","journal":"Trials","n_participants":21,"pmid":"27473843","source_url":"https://pubmed.ncbi.nlm.nih.gov/27473843/","study_design":"cohort study","title":"Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial","title_match":true,"year":2016},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/the-glutamatergic-hypothesis-for-down-syndrome-the-potential-use-of-n-24152324","doi":"10.2174/18715273113126660183","journal":"CNS & neurological disorders drug targets","n_participants":null,"pmid":"24152324","source_url":"https://pubmed.ncbi.nlm.nih.gov/24152324/","study_design":null,"title":"The glutamatergic hypothesis for Down syndrome: the potential use of N-methyl-D-aspartate receptor antagonists to enhance cognition and decelerate neurodegeneration","title_match":false,"year":2014},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-down-alzheimer-barcelona-neuroimaging-initiative-dabni-and-its-40528282","doi":"10.1002/alz.70259","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1135,"pmid":"40528282","source_url":"https://pubmed.ncbi.nlm.nih.gov/40528282/","study_design":"cohort study","title":"The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery","title_match":false,"year":2025},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/early-diagnosis-of-alzheimer-disease-with-positron-emission-tomography-10850738","doi":"10.1097/00002093-200000001-00016","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"10850738","source_url":"https://pubmed.ncbi.nlm.nih.gov/10850738/","study_design":null,"title":"Early diagnosis of Alzheimer disease with positron emission tomography","title_match":false,"year":2000},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/state-of-the-art-therapy-for-down-syndrome-36692980","doi":"10.1111/dmcn.15517","journal":"Developmental medicine and child neurology","n_participants":null,"pmid":"36692980","source_url":"https://pubmed.ncbi.nlm.nih.gov/36692980/","study_design":null,"title":"State-of-the-art therapy for Down syndrome","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/research-attitudes-in-families-of-individuals-with-down-syndrome-36419175","doi":"10.1186/s13195-022-01120-6","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"36419175","source_url":"https://pubmed.ncbi.nlm.nih.gov/36419175/","study_design":null,"title":"Research attitudes in families of individuals with Down syndrome: importance for clinical trials","title_match":true,"year":2022},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/novel-monoclonal-antibody-3b8-specifically-recognizes-pyroglutamate-32114116","doi":"10.1016/j.neulet.2020.134876","journal":"Neuroscience letters","n_participants":null,"pmid":"32114116","source_url":"https://pubmed.ncbi.nlm.nih.gov/32114116/","study_design":null,"title":"Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid \u03b2 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice","title_match":false,"year":2020},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/the-tau-biomarker-cascade-is-condensed-in-down-syndrome-compared-with-41240365","doi":"10.1093/brain/awaf428","journal":"Brain : a journal of neurology","n_participants":198,"pmid":"41240365","source_url":"https://pubmed.ncbi.nlm.nih.gov/41240365/","study_design":"longitudinal study","title":"The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/present-and-future-of-alzheimer-therapy-10961434","doi":"10.1007/978-3-7091-6781-6_24","journal":"Journal of neural transmission. Supplementum","n_participants":8000,"pmid":"10961434","source_url":"https://pubmed.ncbi.nlm.nih.gov/10961434/","study_design":null,"title":"Present and future of Alzheimer therapy","title_match":false,"year":2000},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/imaging-and-plasma-biomarkers-for-pathological-accumulation-in-down-41205623","doi":"10.1093/brain/awaf418","journal":"Brain : a journal of neurology","n_participants":328,"pmid":"41205623","source_url":"https://pubmed.ncbi.nlm.nih.gov/41205623/","study_design":"longitudinal study","title":"Imaging and plasma biomarkers for pathological accumulation in Down syndrome","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/a-head-to-head-comparison-of-multiple-amyloid-pet-radiotracers-for-8ec63439","doi":"10.1101/2025.03.18.25324200","journal":"medRxiv","n_participants":237,"pmid":null,"source_url":"https://doi.org/10.1101/2025.03.18.25324200","study_design":"longitudinal study","title":"A head-to-head comparison of multiple amyloid PET radiotracers for Down syndrome clinical trials","title_match":true,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/microglia-in-neurodegenerative-diseases-mechanism-and-potential-37735487","doi":"10.1038/s41392-023-01588-0","journal":"Signal transduction and targeted therapy","n_participants":null,"pmid":"37735487","source_url":"https://pubmed.ncbi.nlm.nih.gov/37735487/","study_design":null,"title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","title_match":false,"year":2023},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/neurodegenerative-disease-concomitant-proteinopathies-are-prevalent-29878075","doi":"10.1093/brain/awy146","journal":"Brain : a journal of neurology","n_participants":247,"pmid":"29878075","source_url":"https://pubmed.ncbi.nlm.nih.gov/29878075/","study_design":null,"title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","title_match":false,"year":2018},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/tau-and-neurodegenerative-disease-the-story-so-far-26635213","doi":"10.1038/nrneurol.2015.225","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"26635213","source_url":"https://pubmed.ncbi.nlm.nih.gov/26635213/","study_design":null,"title":"Tau and neurodegenerative disease: the story so far","title_match":false,"year":2016},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/comparison-of-risperidone-and-placebo-for-psychosis-and-behavioral-10084637","doi":"10.4088/jcp.v60n0207","journal":"The Journal of clinical psychiatry","n_participants":625,"pmid":"10084637","source_url":"https://pubmed.ncbi.nlm.nih.gov/10084637/","study_design":null,"title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group","title_match":true,"year":1999},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/development-of-methodology-for-conducting-clinical-trials-in-18829698","doi":"10.1093/brain/awn234","journal":"Brain : a journal of neurology","n_participants":107,"pmid":"18829698","source_url":"https://pubmed.ncbi.nlm.nih.gov/18829698/","study_design":null,"title":"Development of methodology for conducting clinical trials in frontotemporal lobar degeneration","title_match":true,"year":2008},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/recent-developments-of-hdac-inhibitors-emerging-indications-and-novel-33971031","doi":"10.1111/bcp.14889","journal":"British journal of clinical pharmacology","n_participants":null,"pmid":"33971031","source_url":"https://pubmed.ncbi.nlm.nih.gov/33971031/","study_design":null,"title":"Recent developments of HDAC inhibitors: Emerging indications and novel molecules","title_match":false,"year":2021},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-neuroimaging-initiative-adni-clinical-20042704","doi":"10.1212/wnl.0b013e3181cb3e25","journal":"Neurology","n_participants":819,"pmid":"20042704","source_url":"https://pubmed.ncbi.nlm.nih.gov/20042704/","study_design":null,"title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","title_match":false,"year":2010},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/vitamin-e-and-donepezil-for-the-treatment-of-mild-cognitive-impairment-15829527","doi":"10.1056/nejmoa050151","journal":"The New England journal of medicine","n_participants":769,"pmid":"15829527","source_url":"https://pubmed.ncbi.nlm.nih.gov/15829527/","study_design":null,"title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","title_match":false,"year":2005},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/sodium-oligomannate-therapeutically-remodels-gut-microbiota-and-31488882","doi":"10.1038/s41422-019-0216-x","journal":"Cell research","n_participants":null,"pmid":"31488882","source_url":"https://pubmed.ncbi.nlm.nih.gov/31488882/","study_design":"clinical trial","title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression","title_match":false,"year":2019},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/neuropsychological-criteria-for-mild-cognitive-impairment-improves-24844687","doi":"10.3233/jad-140276","journal":"Journal of Alzheimer's disease : JAD","n_participants":846,"pmid":"24844687","source_url":"https://pubmed.ncbi.nlm.nih.gov/24844687/","study_design":null,"title":"Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates","title_match":false,"year":2014},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-an-overview-18204414","doi":"10.1017/s1092852900016151","journal":"CNS spectrums","n_participants":null,"pmid":"18204414","source_url":"https://pubmed.ncbi.nlm.nih.gov/18204414/","study_design":null,"title":"Mild cognitive impairment: an overview","title_match":false,"year":2008},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/preserved-cognition-in-patients-with-early-alzheimer-disease-and-16286438","doi":"10.1176/appi.ajgp.13.11.950","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":20,"pmid":"16286438","source_url":"https://pubmed.ncbi.nlm.nih.gov/16286438/","study_design":null,"title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study","title_match":false,"year":2005},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-neuroimaging-initiative-progress-report-and-20451868","doi":"10.1016/j.jalz.2010.03.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"20451868","source_url":"https://pubmed.ncbi.nlm.nih.gov/20451868/","study_design":null,"title":"The Alzheimer's disease neuroimaging initiative: progress report and future plans","title_match":false,"year":2010},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2023-37251912","doi":"10.1002/trc2.12385","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":36,"pmid":"37251912","source_url":"https://pubmed.ncbi.nlm.nih.gov/37251912/","study_design":"clinical trial","title":"Alzheimer's disease drug development pipeline: 2023","title_match":false,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-neuroimaging-initiative-3-continued-27931796","doi":"10.1016/j.jalz.2016.10.006","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"27931796","source_url":"https://pubmed.ncbi.nlm.nih.gov/27931796/","study_design":null,"title":"The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement","title_match":true,"year":2017},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/preventing-alzheimer-s-disease-related-gray-matter-atrophy-by-b-23690582","doi":"10.1073/pnas.1301816110","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"23690582","source_url":"https://pubmed.ncbi.nlm.nih.gov/23690582/","study_design":null,"title":"Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment","title_match":false,"year":2013},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/addition-of-a-non-immersive-virtual-reality-component-to-treadmill-27524393","doi":"10.1016/s0140-6736(16)31325-3","journal":"Lancet (London, England)","n_participants":154,"pmid":"27524393","source_url":"https://pubmed.ncbi.nlm.nih.gov/27524393/","study_design":"randomized controlled trial","title":"Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial","title_match":true,"year":2016},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/increased-soluble-trem2-in-cerebrospinal-fluid-is-associated-with-31462511","doi":"10.1126/scitranslmed.aav6221","journal":"Science translational medicine","n_participants":null,"pmid":"31462511","source_url":"https://pubmed.ncbi.nlm.nih.gov/31462511/","study_design":null,"title":"Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/recent-publications-from-the-alzheimer-s-disease-neuroimaging-28342697","doi":"10.1016/j.jalz.2016.11.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"28342697","source_url":"https://pubmed.ncbi.nlm.nih.gov/28342697/","study_design":"longitudinal study","title":"Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials","title_match":true,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/update-on-the-biomarker-core-of-the-alzheimer-s-disease-neuroimaging-20451871","doi":"10.1016/j.jalz.2010.03.008","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"20451871","source_url":"https://pubmed.ncbi.nlm.nih.gov/20451871/","study_design":null,"title":"Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects","title_match":false,"year":2010},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-quantitative-structural-neuroimaging-for-detection-19201945","doi":"10.1148/radiol.2511080924","journal":"Radiology","n_participants":84,"pmid":"19201945","source_url":"https://pubmed.ncbi.nlm.nih.gov/19201945/","study_design":null,"title":"Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment","title_match":false,"year":2009},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/effect-of-rivastigmine-on-delay-to-diagnosis-of-alzheimer-s-disease-17509485","doi":"10.1016/s1474-4422(07)70109-6","journal":"The Lancet. Neurology","n_participants":null,"pmid":"17509485","source_url":"https://pubmed.ncbi.nlm.nih.gov/17509485/","study_design":null,"title":"Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study","title_match":false,"year":2007},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-due-to-alzheimer-disease-in-the-community-23686697","doi":"10.1002/ana.23931","journal":"Annals of neurology","n_participants":null,"pmid":"23686697","source_url":"https://pubmed.ncbi.nlm.nih.gov/23686697/","study_design":"longitudinal study","title":"Mild cognitive impairment due to Alzheimer disease in the community","title_match":false,"year":2013},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/sex-and-age-differences-in-atrophic-rates-an-adni-study-with-n-1368-20620666","doi":"10.1016/j.neurobiolaging.2010.04.033","journal":"Neurobiology of aging","n_participants":363,"pmid":"20620666","source_url":"https://pubmed.ncbi.nlm.nih.gov/20620666/","study_design":"longitudinal study","title":"Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans","title_match":false,"year":2010},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/predicting-alzheimer-s-disease-progression-using-multi-modal-deep-30760848","doi":"10.1038/s41598-018-37769-z","journal":"Scientific reports","n_participants":null,"pmid":"30760848","source_url":"https://pubmed.ncbi.nlm.nih.gov/30760848/","study_design":"cross-sectional","title":"Predicting Alzheimer's disease progression using multi-modal deep learning approach","title_match":false,"year":2019},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/diffusion-imaging-changes-in-grey-matter-in-alzheimer-s-disease-a-26136857","doi":"10.1186/s13195-015-0132-3","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"26136857","source_url":"https://pubmed.ncbi.nlm.nih.gov/26136857/","study_design":null,"title":"Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegeneration","title_match":false,"year":2015},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/antioxidant-clinical-trials-in-mild-cognitive-impairment-and-22019723","doi":"10.1016/j.bbadis.2011.10.006","journal":"Biochimica et biophysica acta","n_participants":null,"pmid":"22019723","source_url":"https://pubmed.ncbi.nlm.nih.gov/22019723/","study_design":null,"title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease","title_match":true,"year":2012},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/early-diagnosis-of-alzheimer-s-disease-is-mci-too-late-19689230","doi":"10.2174/156720509788929237","journal":"Current Alzheimer research","n_participants":null,"pmid":"19689230","source_url":"https://pubmed.ncbi.nlm.nih.gov/19689230/","study_design":null,"title":"Early diagnosis of Alzheimer's disease: is MCI too late?","title_match":false,"year":2009},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/cognitive-and-memory-training-in-adults-at-risk-of-dementia-a-21942932","doi":"10.1186/1471-2318-11-55","journal":"BMC geriatrics","n_participants":305,"pmid":"21942932","source_url":"https://pubmed.ncbi.nlm.nih.gov/21942932/","study_design":"systematic review","title":"Cognitive and memory training in adults at risk of dementia: a systematic review","title_match":false,"year":2011},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/measures-of-resting-state-eeg-rhythms-for-clinical-trials-in-33860614","doi":"10.1002/alz.12311","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"33860614","source_url":"https://pubmed.ncbi.nlm.nih.gov/33860614/","study_design":null,"title":"Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel","title_match":true,"year":2021},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/association-of-elevated-amyloid-levels-with-cognition-and-biomarkers-26595683","doi":"10.1001/jamaneurol.2015.3098","journal":"JAMA neurology","n_participants":286,"pmid":"26595683","source_url":"https://pubmed.ncbi.nlm.nih.gov/26595683/","study_design":"longitudinal study","title":"Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community","title_match":false,"year":2016},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/plasma-proteins-predict-conversion-to-dementia-from-prodromal-disease-25012867","doi":"10.1016/j.jalz.2014.05.1749","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1148,"pmid":"25012867","source_url":"https://pubmed.ncbi.nlm.nih.gov/25012867/","study_design":null,"title":"Plasma proteins predict conversion to dementia from prodromal disease","title_match":false,"year":2014},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/plasma-microrna-biomarkers-for-detection-of-mild-cognitive-impairment-23001356","doi":"10.18632/aging.100486","journal":"Aging","n_participants":null,"pmid":"23001356","source_url":"https://pubmed.ncbi.nlm.nih.gov/23001356/","study_design":"longitudinal study","title":"Plasma microRNA biomarkers for detection of mild cognitive impairment","title_match":false,"year":2012},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/preventive-and-therapeutic-strategies-in-alzheimer-s-disease-focus-on-32486897","doi":"10.1089/ars.2020.8134","journal":"Antioxidants & redox signaling","n_participants":null,"pmid":"32486897","source_url":"https://pubmed.ncbi.nlm.nih.gov/32486897/","study_design":null,"title":"Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis","title_match":false,"year":2021},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/evidence-of-demyelination-in-mild-cognitive-impairment-and-dementia-29679574","doi":"10.1016/j.jalz.2018.03.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"29679574","source_url":"https://pubmed.ncbi.nlm.nih.gov/29679574/","study_design":null,"title":"Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content","title_match":false,"year":2018},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/docosahexaenoic-acid-concentrated-fish-oil-supplementation-in-22932777","doi":"10.1007/s00213-012-2848-0","journal":"Psychopharmacology","n_participants":18,"pmid":"22932777","source_url":"https://pubmed.ncbi.nlm.nih.gov/22932777/","study_design":null,"title":"Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial","title_match":true,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-redox-dysregulation-as-a-common-denominator-for-22122400","doi":"10.1089/ars.2011.4082","journal":"Antioxidants & redox signaling","n_participants":null,"pmid":"22122400","source_url":"https://pubmed.ncbi.nlm.nih.gov/22122400/","study_design":null,"title":"Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms","title_match":false,"year":2012},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/neuropsychological-predictors-of-conversion-from-mild-cognitive-24002185","doi":"10.3233/jad-130881","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"24002185","source_url":"https://pubmed.ncbi.nlm.nih.gov/24002185/","study_design":null,"title":"Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/mild-behavioral-impairment-and-subjective-cognitive-decline-predict-33554909","doi":"10.3233/jad-201184","journal":"Journal of Alzheimer's disease : JAD","n_participants":2769,"pmid":"33554909","source_url":"https://pubmed.ncbi.nlm.nih.gov/33554909/","study_design":null,"title":"Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/predicting-progression-from-mild-cognitive-impairment-to-alzheimer-s-26901338","doi":"10.1371/journal.pone.0138866","journal":"PloS one","n_participants":139,"pmid":"26901338","source_url":"https://pubmed.ncbi.nlm.nih.gov/26901338/","study_design":null,"title":"Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification","title_match":false,"year":2016},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/clinical-aspects-of-melatonin-intervention-in-alzheimer-s-disease-21358972","doi":"10.2174/157015910792246209","journal":"Current neuropharmacology","n_participants":null,"pmid":"21358972","source_url":"https://pubmed.ncbi.nlm.nih.gov/21358972/","study_design":null,"title":"Clinical aspects of melatonin intervention in Alzheimer's disease progression","title_match":false,"year":2010},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/adcoms-a-composite-clinical-outcome-for-prodromal-alzheimer-s-disease-27010616","doi":"10.1136/jnnp-2015-312383","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"27010616","source_url":"https://pubmed.ncbi.nlm.nih.gov/27010616/","study_design":"longitudinal study","title":"ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials","title_match":false,"year":2016},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/magnetic-resonance-imaging-biomarkers-for-the-early-diagnosis-of-26388719","doi":"10.3389/fnins.2015.00307","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"26388719","source_url":"https://pubmed.ncbi.nlm.nih.gov/26388719/","study_design":null,"title":"Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach","title_match":false,"year":2015},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-current-research-and-clinical-implications-17226738","doi":"10.1055/s-2006-956752","journal":"Seminars in neurology","n_participants":null,"pmid":"17226738","source_url":"https://pubmed.ncbi.nlm.nih.gov/17226738/","study_design":null,"title":"Mild cognitive impairment: current research and clinical implications","title_match":false,"year":2007},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/qualitative-estimates-of-medial-temporal-atrophy-as-a-predictor-of-17210817","doi":"10.1001/archneur.64.1.108","journal":"Archives of neurology","n_participants":190,"pmid":"17210817","source_url":"https://pubmed.ncbi.nlm.nih.gov/17210817/","study_design":null,"title":"Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia","title_match":false,"year":2007},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/identification-and-validation-of-novel-cerebrospinal-fluid-biomarkers-21264269","doi":"10.1371/journal.pone.0016032","journal":"PloS one","n_participants":24,"pmid":"21264269","source_url":"https://pubmed.ncbi.nlm.nih.gov/21264269/","study_design":null,"title":"Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease","title_match":false,"year":2011},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/sex-differences-in-progression-to-mild-cognitive-impairment-and-29478836","doi":"10.1016/j.parkreldis.2018.02.007","journal":"Parkinsonism & related disorders","n_participants":418,"pmid":"29478836","source_url":"https://pubmed.ncbi.nlm.nih.gov/29478836/","study_design":"longitudinal study","title":"Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease","title_match":false,"year":2018},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/antioxidant-strategies-for-alzheimer-s-disease-12133201","doi":"10.1079/pns2002146","journal":"The Proceedings of the Nutrition Society","n_participants":null,"pmid":"12133201","source_url":"https://pubmed.ncbi.nlm.nih.gov/12133201/","study_design":null,"title":"Antioxidant strategies for Alzheimer's disease","title_match":false,"year":2002},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/the-accumulation-rate-of-tau-aggregates-is-higher-in-females-and-33439987","doi":"10.1093/brain/awaa327","journal":"Brain : a journal of neurology","n_participants":157,"pmid":"33439987","source_url":"https://pubmed.ncbi.nlm.nih.gov/33439987/","study_design":"cohort study","title":"The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects","title_match":false,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-an-opportunity-to-identify-patients-at-high-16990077","doi":"10.1016/j.clinthera.2006.07.006","journal":"Clinical therapeutics","n_participants":769,"pmid":"16990077","source_url":"https://pubmed.ncbi.nlm.nih.gov/16990077/","study_design":null,"title":"Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/maintenance-treatment-of-depression-in-old-age-a-randomized-double-21199965","doi":"10.1001/archgenpsychiatry.2010.184","journal":"Archives of general psychiatry","n_participants":73,"pmid":"21199965","source_url":"https://pubmed.ncbi.nlm.nih.gov/21199965/","study_design":null,"title":"Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy","title_match":true,"year":2011},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/synaptic-biomarkers-in-csf-aid-in-diagnosis-correlate-with-cognition-31853477","doi":"10.1016/j.trci.2019.11.002","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"31853477","source_url":"https://pubmed.ncbi.nlm.nih.gov/31853477/","study_design":null,"title":"Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/cognitive-frailty-a-systematic-review-of-epidemiological-and-25808052","doi":"10.1089/rej.2014.1637","journal":"Rejuvenation research","n_participants":null,"pmid":"25808052","source_url":"https://pubmed.ncbi.nlm.nih.gov/25808052/","study_design":"systematic review","title":"Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/assessing-the-preparedness-of-the-health-care-system-infrastructure-31205802","doi":"10.7249/rr2503","journal":"Rand health quarterly","n_participants":null,"pmid":"31205802","source_url":"https://pubmed.ncbi.nlm.nih.gov/31205802/","study_design":null,"title":"Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment","title_match":false,"year":2019},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/from-mild-cognitive-impairment-to-subjective-cognitive-decline-28243102","doi":"10.2147/ndt.s123428","journal":"Neuropsychiatric disease and treatment","n_participants":null,"pmid":"28243102","source_url":"https://pubmed.ncbi.nlm.nih.gov/28243102/","study_design":"cross-sectional","title":"From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution","title_match":false,"year":2017},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/effect-of-probiotic-bifidobacterium-breve-in-improving-cognitive-35570493","doi":"10.3233/jad-220148","journal":"Journal of Alzheimer's disease : JAD","n_participants":130,"pmid":"35570493","source_url":"https://pubmed.ncbi.nlm.nih.gov/35570493/","study_design":null,"title":"Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial","title_match":true,"year":2022},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-prevention-initiative-autosomal-dominant-alzheimer-s-29955659","doi":"10.1016/j.trci.2018.02.002","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":300,"pmid":"29955659","source_url":"https://pubmed.ncbi.nlm.nih.gov/29955659/","study_design":"clinical trial","title":"The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort","title_match":false,"year":2018},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/progression-to-dementia-or-reversion-to-normal-cognition-in-mild-35351783","doi":"10.1212/wnl.0000000000200256","journal":"Neurology","n_participants":409,"pmid":"35351783","source_url":"https://pubmed.ncbi.nlm.nih.gov/35351783/","study_design":null,"title":"Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms","title_match":false,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/japanese-and-north-american-alzheimer-s-disease-neuroimaging-29753531","doi":"10.1016/j.jalz.2018.03.009","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":75,"pmid":"29753531","source_url":"https://pubmed.ncbi.nlm.nih.gov/29753531/","study_design":null,"title":"Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials","title_match":false,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/nih-state-of-the-science-conference-statement-preventing-alzheimer-s-20445638","doi":null,"journal":"NIH consensus and state-of-the-science statements","n_participants":null,"pmid":"20445638","source_url":"https://pubmed.ncbi.nlm.nih.gov/20445638/","study_design":"systematic review","title":"NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline","title_match":false,"year":2010},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effects-of-intensive-lifestyle-changes-on-the-progression-of-mild-38849944","doi":"10.1186/s13195-024-01482-z","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"38849944","source_url":"https://pubmed.ncbi.nlm.nih.gov/38849944/","study_design":"clinical trial","title":"Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial","title_match":true,"year":2024},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/donepezil-delays-progression-to-ad-in-mci-subjects-with-depressive-19528519","doi":"10.1212/wnl.0b013e3181aa52d3","journal":"Neurology","n_participants":208,"pmid":"19528519","source_url":"https://pubmed.ncbi.nlm.nih.gov/19528519/","study_design":null,"title":"Donepezil delays progression to AD in MCI subjects with depressive symptoms","title_match":false,"year":2009},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/computerised-cognitive-training-for-preventing-dementia-in-people-30864747","doi":"10.1002/14651858.cd012279.pub2","journal":"The Cochrane database of systematic reviews","n_participants":660,"pmid":"30864747","source_url":"https://pubmed.ncbi.nlm.nih.gov/30864747/","study_design":null,"title":"Computerised cognitive training for preventing dementia in people with mild cognitive impairment","title_match":false,"year":2019},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/predicting-the-risk-of-mild-cognitive-impairment-in-the-mayo-clinic-25788555","doi":"10.1212/wnl.0000000000001437","journal":"Neurology","n_participants":null,"pmid":"25788555","source_url":"https://pubmed.ncbi.nlm.nih.gov/25788555/","study_design":"cohort study","title":"Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging","title_match":false,"year":2015},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/why-do-so-many-drugs-for-alzheimer-s-disease-fail-in-development-time-18953116","doi":"10.3233/jad-2008-15213","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"18953116","source_url":"https://pubmed.ncbi.nlm.nih.gov/18953116/","study_design":null,"title":"Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?","title_match":false,"year":2008},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/does-lithium-prevent-alzheimer-s-disease-22500970","doi":"10.2165/11599180-000000000-00000","journal":"Drugs & aging","n_participants":null,"pmid":"22500970","source_url":"https://pubmed.ncbi.nlm.nih.gov/22500970/","study_design":null,"title":"Does lithium prevent Alzheimer's disease?","title_match":false,"year":2012},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/deciphering-the-mechanism-underlying-late-onset-alzheimer-disease-23183882","doi":"10.1038/nrneurol.2012.236","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"23183882","source_url":"https://pubmed.ncbi.nlm.nih.gov/23183882/","study_design":null,"title":"Deciphering the mechanism underlying late-onset Alzheimer disease","title_match":false,"year":2013},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/preclinical-properties-of-18f-av-45-a-pet-agent-for-abeta-plaques-in-19837759","doi":"10.2967/jnumed.109.065284","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"19837759","source_url":"https://pubmed.ncbi.nlm.nih.gov/19837759/","study_design":null,"title":"Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain","title_match":false,"year":2009},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/degradation-of-the-alzheimer-disease-amyloid-beta-peptide-by-metal-16648635","doi":"10.1074/jbc.m602487200","journal":"The Journal of biological chemistry","n_participants":null,"pmid":"16648635","source_url":"https://pubmed.ncbi.nlm.nih.gov/16648635/","study_design":null,"title":"Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity","title_match":false,"year":2006},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/generation-of-antibodies-specific-for-beta-amyloid-by-vaccination-of-12379846","doi":"10.1038/nm783","journal":"Nature medicine","n_participants":null,"pmid":"12379846","source_url":"https://pubmed.ncbi.nlm.nih.gov/12379846/","study_design":null,"title":"Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease","title_match":false,"year":2002},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/increased-csf-apps-levels-in-patients-with-alzheimer-disease-treated-25344383","doi":"10.1212/wnl.0000000000001017","journal":"Neurology","n_participants":null,"pmid":"25344383","source_url":"https://pubmed.ncbi.nlm.nih.gov/25344383/","study_design":null,"title":"Increased CSF APPs-\u03b1 levels in patients with Alzheimer disease treated with acitretin","title_match":false,"year":2014},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/why-alzheimer-trials-fail-removing-soluble-oligomeric-beta-amyloid-is-24210593","doi":"10.1016/j.neurobiolaging.2013.10.085","journal":"Neurobiology of aging","n_participants":null,"pmid":"24210593","source_url":"https://pubmed.ncbi.nlm.nih.gov/24210593/","study_design":null,"title":"Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult","title_match":false,"year":2014},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/autoantibodies-to-amyloid-beta-peptide-abeta-are-increased-in-12665674","doi":"10.1385/nmm:3:1:29","journal":"Neuromolecular medicine","n_participants":null,"pmid":"12665674","source_url":"https://pubmed.ncbi.nlm.nih.gov/12665674/","study_design":null,"title":"Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development","title_match":false,"year":2003},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/plasma-gfap-is-an-early-marker-of-amyloid-but-not-tau-pathology-in-34259835","doi":"10.1093/brain/awab223","journal":"Brain : a journal of neurology","n_participants":75,"pmid":"34259835","source_url":"https://pubmed.ncbi.nlm.nih.gov/34259835/","study_design":"longitudinal study","title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/current-state-of-alzheimer-s-fluid-biomarkers-30488277","doi":"10.1007/s00401-018-1932-x","journal":"Acta neuropathologica","n_participants":null,"pmid":"30488277","source_url":"https://pubmed.ncbi.nlm.nih.gov/30488277/","study_design":null,"title":"Current state of Alzheimer's fluid biomarkers","title_match":false,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-and-plasma-biomarkers-in-alzheimer-disease-20157306","doi":"10.1038/nrneurol.2010.4","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"20157306","source_url":"https://pubmed.ncbi.nlm.nih.gov/20157306/","study_design":null,"title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","title_match":false,"year":2010},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/fluid-biomarkers-in-alzheimer-disease-22951438","doi":"10.1101/cshperspect.a006221","journal":"Cold Spring Harbor perspectives in medicine","n_participants":null,"pmid":"22951438","source_url":"https://pubmed.ncbi.nlm.nih.gov/22951438/","study_design":null,"title":"Fluid biomarkers in Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-phase-ii-study-targeting-amyloid-beta-with-3aps-in-mild-to-moderate-17082468","doi":"10.1212/01.wnl.0000244346.08950.64","journal":"Neurology","n_participants":58,"pmid":"17082468","source_url":"https://pubmed.ncbi.nlm.nih.gov/17082468/","study_design":"open-label trial","title":"A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease","title_match":true,"year":2006},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/sod1-in-cerebral-spinal-fluid-as-a-pharmacodynamic-marker-for-23147550","doi":"10.1001/jamaneurol.2013.593","journal":"JAMA neurology","n_participants":null,"pmid":"23147550","source_url":"https://pubmed.ncbi.nlm.nih.gov/23147550/","study_design":null,"title":"SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy","title_match":false,"year":2013},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-markers-of-neurodegeneration-and-rates-of-brain-25867677","doi":"10.1001/jamaneurol.2015.0202","journal":"JAMA neurology","n_participants":23,"pmid":"25867677","source_url":"https://pubmed.ncbi.nlm.nih.gov/25867677/","study_design":"longitudinal study","title":"Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease","title_match":false,"year":2015},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/longitudinal-assessment-of-tau-and-amyloid-beta-in-cerebrospinal-23644819","doi":"10.1007/s00401-013-1121-x","journal":"Acta neuropathologica","n_participants":null,"pmid":"23644819","source_url":"https://pubmed.ncbi.nlm.nih.gov/23644819/","study_design":null,"title":"Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease","title_match":false,"year":2013},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/update-on-the-core-and-developing-cerebrospinal-fluid-biomarkers-for-25165049","doi":"10.3325/cmj.2014.55.347","journal":"Croatian medical journal","n_participants":null,"pmid":"25165049","source_url":"https://pubmed.ncbi.nlm.nih.gov/25165049/","study_design":null,"title":"Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease","title_match":false,"year":2014},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/requiring-an-amyloid-beta1-42-biomarker-for-prodromal-alzheimer-s-20813339","doi":"10.1016/j.jalz.2010.07.004","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":400,"pmid":"20813339","source_url":"https://pubmed.ncbi.nlm.nih.gov/20813339/","study_design":null,"title":"Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials","title_match":true,"year":2010},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/testing-a-multitep-based-combination-vaccine-to-reduce-a-and-tau-31847886","doi":"10.1186/s13195-019-0556-2","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"31847886","source_url":"https://pubmed.ncbi.nlm.nih.gov/31847886/","study_design":"clinical trial","title":"Testing a MultiTEP-based combination vaccine to reduce A\u03b2 and tau pathology in Tau22/5xFAD bigenic mice","title_match":false,"year":2019},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/fluid-biomarkers-for-diagnosing-dementia-rationale-and-the-canadian-24565514","doi":"10.1186/alzrt223","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"24565514","source_url":"https://pubmed.ncbi.nlm.nih.gov/24565514/","study_design":null,"title":"Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians","title_match":false,"year":2013},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-amyloid-and-tau-biomarker-changes-across-the-40638114","doi":"10.1001/jamanetworkopen.2025.19919","journal":"JAMA network open","n_participants":197,"pmid":"40638114","source_url":"https://pubmed.ncbi.nlm.nih.gov/40638114/","study_design":"cohort study","title":"Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum","title_match":false,"year":2025},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/plasma-p-tau181-as-an-outcome-and-predictor-of-multidomain-38310892","doi":"10.1016/s2666-7568(23)00255-6","journal":"The lancet. Healthy longevity","n_participants":527,"pmid":"38310892","source_url":"https://pubmed.ncbi.nlm.nih.gov/38310892/","study_design":null,"title":"Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial","title_match":true,"year":2024},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/onset-of-alzheimer-disease-in-apolipoprotein-4-carriers-is-earlier-in-38594621","doi":"10.1186/s12883-024-03611-5","journal":"BMC neurology","n_participants":33,"pmid":"38594621","source_url":"https://pubmed.ncbi.nlm.nih.gov/38594621/","study_design":"post-hoc analysis","title":"Onset of Alzheimer disease in apolipoprotein \u025b4 carriers is earlier in butyrylcholinesterase K variant carriers","title_match":false,"year":2024},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/sample-size-estimates-for-biomarker-based-outcome-measures-in-40118731","doi":"10.1016/j.tjpad.2025.100133","journal":"The journal of prevention of Alzheimer's disease","n_participants":200,"pmid":"40118731","source_url":"https://pubmed.ncbi.nlm.nih.gov/40118731/","study_design":null,"title":"Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/a-cross-sectional-study-in-healthy-elderly-subjects-aimed-at-34274005","doi":"10.1186/s13195-021-00874-9","journal":"Alzheimer's research & therapy","n_participants":200,"pmid":"34274005","source_url":"https://pubmed.ncbi.nlm.nih.gov/34274005/","study_design":null,"title":"A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial participation","title_match":true,"year":2021},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/csf-synuclein-seed-amplification-assays-and-alzheimer-disease-41248454","doi":"10.1212/wnl.0000000000214346","journal":"Neurology","n_participants":null,"pmid":"41248454","source_url":"https://pubmed.ncbi.nlm.nih.gov/41248454/","study_design":"cohort study","title":"CSF \u03b1-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/a-phase-2b-randomized-clinical-trial-of-the-oral-p38-inhibitor-9c23dcf2","doi":"10.21203/rs.3.rs-10623740/v1","journal":"Research Square","n_participants":159,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10623740/v1","study_design":null,"title":"A Phase 2b randomized clinical trial of the oral p38\u03b1 inhibitor neflamapimod in dementia with Lewy bodies (DLB)","title_match":true,"year":2026},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/clinical-trials-of-new-drugs-for-alzheimer-disease-a-2020-2023-update-37784171","doi":"10.1186/s12929-023-00976-6","journal":"Journal of biomedical science","n_participants":null,"pmid":"37784171","source_url":"https://pubmed.ncbi.nlm.nih.gov/37784171/","study_design":null,"title":"Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update","title_match":true,"year":2023},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/lecanemab-ban2401-an-anti-beta-amyloid-monoclonal-antibody-for-the-36749830","doi":"10.1080/13543784.2023.2178414","journal":"Expert opinion on investigational drugs","n_participants":null,"pmid":"36749830","source_url":"https://pubmed.ncbi.nlm.nih.gov/36749830/","study_design":"clinical trial","title":"Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease","title_match":false,"year":2023},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/a-comparative-study-of-the-effects-of-aducanumab-and-scanning-33836798","doi":"10.1186/s13195-021-00809-4","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"33836798","source_url":"https://pubmed.ncbi.nlm.nih.gov/33836798/","study_design":null,"title":"A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease","title_match":false,"year":2021},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/glucagon-like-peptide-1-class-drugs-show-clear-protective-effects-in-38677445","doi":"10.1016/j.neuropharm.2024.109952","journal":"Neuropharmacology","n_participants":null,"pmid":"38677445","source_url":"https://pubmed.ncbi.nlm.nih.gov/38677445/","study_design":null,"title":"Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?","title_match":true,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/vessels-sing-their-arias-the-role-of-vascular-amyloid-in-the-age-of-34905943","doi":"10.1161/strokeaha.121.036873","journal":"Stroke","n_participants":null,"pmid":"34905943","source_url":"https://pubmed.ncbi.nlm.nih.gov/34905943/","study_design":null,"title":"Vessels Sing Their ARIAs: The Role of Vascular Amyloid in the Age of Aducanumab","title_match":false,"year":2022},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/an-intranasally-delivered-peptide-drug-ameliorates-cognitive-decline-28356312","doi":"10.15252/emmm.201606666","journal":"EMBO molecular medicine","n_participants":null,"pmid":"28356312","source_url":"https://pubmed.ncbi.nlm.nih.gov/28356312/","study_design":null,"title":"An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice","title_match":false,"year":2017},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/lessons-learnt-from-the-second-generation-of-anti-amyloid-monoclonal-33321511","doi":"10.1159/000511506","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"33321511","source_url":"https://pubmed.ncbi.nlm.nih.gov/33321511/","study_design":"clinical trial","title":"Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials","title_match":true,"year":2020},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/genome-wide-association-studies-of-aria-from-the-aducanumab-phase-3-38165296","doi":"10.1212/wnl.0000000000207919","journal":"Neurology","n_participants":1691,"pmid":"38165296","source_url":"https://pubmed.ncbi.nlm.nih.gov/38165296/","study_design":"clinical trial","title":"Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies","title_match":true,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/incidence-of-amyloid-related-imaging-abnormalities-in-patients-with-36038268","doi":"10.1212/wnl.0000000000201019","journal":"Neurology","n_participants":9429,"pmid":"36038268","source_url":"https://pubmed.ncbi.nlm.nih.gov/36038268/","study_design":"clinical trial","title":"Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-\u03b2-Amyloid Immunotherapy: A Meta-analysis","title_match":false,"year":2022},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/aducanumab-use-in-symptomatic-alzheimer-disease-evidence-in-focus-35197360","doi":"10.1212/wnl.0000000000200176","journal":"Neurology","n_participants":null,"pmid":"35197360","source_url":"https://pubmed.ncbi.nlm.nih.gov/35197360/","study_design":"clinical trial","title":"Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus [RETIRED]: A Report of the AAN Guidelines Subcommittee","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/lessons-from-anti-amyloid-immunotherapies-in-alzheimer-disease-aiming-28787714","doi":"10.1159/000478741","journal":"Neuro-degenerative diseases","n_participants":null,"pmid":"28787714","source_url":"https://pubmed.ncbi.nlm.nih.gov/28787714/","study_design":null,"title":"Lessons from Anti-Amyloid-\u03b2 Immunotherapies in Alzheimer Disease: Aiming at a Moving Target","title_match":false,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/therapeutic-anti-amyloid-antibodies-cause-neuronal-disturbances-36515320","doi":"10.1002/alz.12833","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"36515320","source_url":"https://pubmed.ncbi.nlm.nih.gov/36515320/","study_design":null,"title":"Therapeutic anti-amyloid \u03b2 antibodies cause neuronal disturbances","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/new-and-emerging-drug-therapies-for-alzheimer-disease-38962384","doi":"10.18773/austprescr.2024.021","journal":"Australian prescriber","n_participants":null,"pmid":"38962384","source_url":"https://pubmed.ncbi.nlm.nih.gov/38962384/","study_design":null,"title":"New and emerging drug therapies for Alzheimer disease","title_match":false,"year":2024},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/clinical-benefits-and-risks-of-antiamyloid-antibodies-in-sporadic-40194268","doi":"10.2196/68454","journal":"Journal of medical Internet research","n_participants":21236,"pmid":"40194268","source_url":"https://pubmed.ncbi.nlm.nih.gov/40194268/","study_design":"meta-analysis","title":"Clinical Benefits and Risks of Antiamyloid Antibodies in Sporadic Alzheimer Disease: Systematic Review and Network Meta-Analysis With a Web Application","title_match":false,"year":2025},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/biomarkers-as-endpoints-in-clinical-trials-for-alzheimer-s-disease-38669547","doi":"10.3233/jad-240008","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"38669547","source_url":"https://pubmed.ncbi.nlm.nih.gov/38669547/","study_design":"clinical trial","title":"Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease","title_match":true,"year":2024},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/practical-considerations-in-the-administration-of-aducanumab-for-the-35733944","doi":"10.1212/cpj.0000000000001144","journal":"Neurology. Clinical practice","n_participants":null,"pmid":"35733944","source_url":"https://pubmed.ncbi.nlm.nih.gov/35733944/","study_design":null,"title":"Practical Considerations in the Administration of Aducanumab for the Neurologist","title_match":false,"year":2022},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/a-time-to-event-exposure-response-model-for-amyloid-related-imaging-35285968","doi":"10.1002/jcph.2047","journal":"Journal of clinical pharmacology","n_participants":3251,"pmid":"35285968","source_url":"https://pubmed.ncbi.nlm.nih.gov/35285968/","study_design":"clinical trial","title":"A Time-to-Event Exposure-Response Model for Amyloid-Related Imaging Abnormalities Following Administration of Aducanumab to Subjects With Early Alzheimer Disease","title_match":false,"year":2022},{"alzhub_score":30,"alzhub_url":"https://alzhub.org/study/alzheimer-s-trials-a-cul-de-sac-with-no-end-in-sight-34313409","doi":"10.17219/acem/139501","journal":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","n_participants":null,"pmid":"34313409","source_url":"https://pubmed.ncbi.nlm.nih.gov/34313409/","study_design":null,"title":"Alzheimer's trials: A cul-de-sac with no end in sight","title_match":false,"year":2021},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/increasing-the-cognitive-screening-efficiency-of-global-phase-iii-35622461","doi":"10.1097/wad.0000000000000508","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"35622461","source_url":"https://pubmed.ncbi.nlm.nih.gov/35622461/","study_design":"clinical trial","title":"Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease: The Cognitive Task Force","title_match":true,"year":2022},{"alzhub_score":27,"alzhub_url":"https://alzhub.org/study/etiology-risk-factors-treatments-and-current-status-of-alzheimer-s-36256566","doi":"10.24875/gmm.m22000681","journal":"Gaceta medica de Mexico","n_participants":null,"pmid":"36256566","source_url":"https://pubmed.ncbi.nlm.nih.gov/36256566/","study_design":null,"title":"Etiology, risk factors, treatments and current status of Alzheimer's disease in Mexico","title_match":false,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/clinicopathologic-evaluation-of-amyloid-clearance-in-alzheimer-disease-42437499","doi":"10.1001/jama.2026.13058","journal":"JAMA","n_participants":null,"pmid":"42437499","source_url":"https://pubmed.ncbi.nlm.nih.gov/42437499/","study_design":"longitudinal study","title":"Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease","title_match":false,"year":2026},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/incidence-of-amyloid-related-imaging-abnormalities-and-health-41885326","doi":"10.18553/jmcp.2026.32.4.470","journal":"Journal of managed care & specialty pharmacy","n_participants":240,"pmid":"41885326","source_url":"https://pubmed.ncbi.nlm.nih.gov/41885326/","study_design":null,"title":"Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study","title_match":false,"year":2026},{"alzhub_score":27,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-which-substances-are-at-present-in-phase-iii-35288774","doi":"10.1007/s00115-022-01275-5","journal":"Der Nervenarzt","n_participants":null,"pmid":"35288774","source_url":"https://pubmed.ncbi.nlm.nih.gov/35288774/","study_design":null,"title":"[Alzheimer's disease-Which substances are at present in phase III studies?]","title_match":true,"year":2022},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/a-24-week-double-blind-placebo-controlled-trial-of-donepezil-in-9443470","doi":"10.1212/wnl.50.1.136","journal":"Neurology","n_participants":162,"pmid":"9443470","source_url":"https://pubmed.ncbi.nlm.nih.gov/9443470/","study_design":null,"title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group","title_match":true,"year":1998},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/trial-of-solanezumab-for-mild-dementia-due-to-alzheimer-s-disease-29365294","doi":"10.1056/nejmoa1705971","journal":"The New England journal of medicine","n_participants":2129,"pmid":"29365294","source_url":"https://pubmed.ncbi.nlm.nih.gov/29365294/","study_design":"clinical trial","title":"Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease","title_match":false,"year":2018},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/an-inventory-to-assess-activities-of-daily-living-for-clinical-trials-9236950","doi":null,"journal":"Alzheimer disease and associated disorders","n_participants":45,"pmid":"9236950","source_url":"https://pubmed.ncbi.nlm.nih.gov/9236950/","study_design":null,"title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","title_match":true,"year":1997},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/efficacy-of-an-evidence-based-cognitive-stimulation-therapy-programme-12948999","doi":"10.1192/bjp.183.3.248","journal":"The British journal of psychiatry : the journal of mental science","n_participants":201,"pmid":"12948999","source_url":"https://pubmed.ncbi.nlm.nih.gov/12948999/","study_design":"randomized controlled trial","title":"Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial","title_match":true,"year":2003},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-memantine-in-patients-with-mild-to-moderate-12105362","doi":"10.1161/01.str.0000020094.08790.49","journal":"Stroke","n_participants":321,"pmid":"12105362","source_url":"https://pubmed.ncbi.nlm.nih.gov/12105362/","study_design":null,"title":"Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)","title_match":true,"year":2002},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/the-study-of-mental-and-resistance-training-smart-studyresistance-25444575","doi":"10.1016/j.jamda.2014.09.010","journal":"Journal of the American Medical Directors Association","n_participants":null,"pmid":"25444575","source_url":"https://pubmed.ncbi.nlm.nih.gov/25444575/","study_design":null,"title":"The Study of Mental and Resistance Training (SMART) study\u2014resistance training and/or cognitive training in mild cognitive impairment: a randomized, double-blind, double-sham controlled trial","title_match":true,"year":2014},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/a-phase-ii-study-of-fornix-deep-brain-stimulation-in-mild-alzheimer-s-27567810","doi":"10.3233/jad-160017","journal":"Journal of Alzheimer's disease : JAD","n_participants":42,"pmid":"27567810","source_url":"https://pubmed.ncbi.nlm.nih.gov/27567810/","study_design":"post-hoc analysis","title":"A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease","title_match":true,"year":2016},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-study-of-the-efficacy-11843990","doi":"10.1111/j.1532-5415.2001.49266.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"11843990","source_url":"https://pubmed.ncbi.nlm.nih.gov/11843990/","study_design":null,"title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting","title_match":true,"year":2001},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/effects-of-aspirin-plus-extended-release-dipyridamole-versus-18757238","doi":"10.1016/s1474-4422(08)70198-4","journal":"The Lancet. Neurology","n_participants":20332,"pmid":"18757238","source_url":"https://pubmed.ncbi.nlm.nih.gov/18757238/","study_design":null,"title":"Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study","title_match":true,"year":2008},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/tau-aggregation-inhibitor-therapy-an-exploratory-phase-2-study-in-25550228","doi":"10.3233/jad-142874","journal":"Journal of Alzheimer's disease : JAD","n_participants":135,"pmid":"25550228","source_url":"https://pubmed.ncbi.nlm.nih.gov/25550228/","study_design":null,"title":"Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease","title_match":true,"year":2015},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/a-double-blind-placebo-controlled-multicentre-study-of-memantine-in-12409683","doi":"10.1097/00004850-200211000-00005","journal":"International clinical psychopharmacology","n_participants":579,"pmid":"12409683","source_url":"https://pubmed.ncbi.nlm.nih.gov/12409683/","study_design":"randomized controlled trial","title":"A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)","title_match":true,"year":2002},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-tarenflurbil-in-mild-to-moderate-alzheimer-s-18450517","doi":"10.1016/s1474-4422(08)70090-5","journal":"The Lancet. Neurology","n_participants":69,"pmid":"18450517","source_url":"https://pubmed.ncbi.nlm.nih.gov/18450517/","study_design":null,"title":"Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial","title_match":true,"year":2008},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/increased-risk-of-cognitive-and-functional-decline-in-patients-with-22371515","doi":"10.1503/cmaj.111173","journal":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","n_participants":31506,"pmid":"22371515","source_url":"https://pubmed.ncbi.nlm.nih.gov/22371515/","study_design":"post-hoc analysis","title":"Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies","title_match":false,"year":2012},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/long-term-efficacy-and-safety-of-donepezil-in-the-treatment-of-10793322","doi":"10.1016/s0924-977x(00)00067-5","journal":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","n_participants":133,"pmid":"10793322","source_url":"https://pubmed.ncbi.nlm.nih.gov/10793322/","study_design":"open-label trial","title":"Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study","title_match":false,"year":2000},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-cholinesterase-inhibitors-and-memantine-in-24828899","doi":"10.1136/jnnp-2014-307659","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"24828899","source_url":"https://pubmed.ncbi.nlm.nih.gov/24828899/","study_design":"meta-analysis","title":"Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis","title_match":false,"year":2015},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/effects-of-3-fatty-acids-on-cognitive-performance-a-meta-analysis-22305186","doi":"10.1016/j.neurobiolaging.2011.12.014","journal":"Neurobiology of aging","n_participants":934,"pmid":"22305186","source_url":"https://pubmed.ncbi.nlm.nih.gov/22305186/","study_design":"meta-analysis","title":"Effects of \u03c9-3 fatty acids on cognitive performance: a meta-analysis","title_match":false,"year":2012},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/long-term-efficacy-and-safety-of-donepezil-in-the-treatment-of-9452942","doi":"10.1016/s0924-977x(97)00079-5","journal":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","n_participants":133,"pmid":"9452942","source_url":"https://pubmed.ncbi.nlm.nih.gov/9452942/","study_design":"open-label trial","title":"Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study","title_match":false,"year":1998},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/salvia-officinalis-extract-in-the-treatment-of-patients-with-mild-to-12605619","doi":"10.1046/j.1365-2710.2003.00463.x","journal":"Journal of clinical pharmacy and therapeutics","n_participants":42,"pmid":"12605619","source_url":"https://pubmed.ncbi.nlm.nih.gov/12605619/","study_design":null,"title":"Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial","title_match":true,"year":2003},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/effects-of-rivastigmine-in-patients-with-and-without-visual-16960863","doi":"10.1002/mds.21077","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":188,"pmid":"16960863","source_url":"https://pubmed.ncbi.nlm.nih.gov/16960863/","study_design":null,"title":"Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease","title_match":false,"year":2006},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/donepezil-in-patients-with-subcortical-vascular-cognitive-impairment-18296124","doi":"10.1016/s1474-4422(08)70046-2","journal":"The Lancet. Neurology","n_participants":86,"pmid":"18296124","source_url":"https://pubmed.ncbi.nlm.nih.gov/18296124/","study_design":null,"title":"Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL","title_match":true,"year":2008},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/renin-angiotensin-system-blockade-and-cognitive-function-in-patients-20980201","doi":"10.1016/s1474-4422(10)70250-7","journal":"The Lancet. Neurology","n_participants":620,"pmid":"20980201","source_url":"https://pubmed.ncbi.nlm.nih.gov/20980201/","study_design":"randomized controlled trial","title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies","title_match":false,"year":2011},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/rosiglitazone-does-not-improve-cognition-or-global-function-when-used-21592048","doi":"10.2174/156720511796391935","journal":"Current Alzheimer research","n_participants":1496,"pmid":"21592048","source_url":"https://pubmed.ncbi.nlm.nih.gov/21592048/","study_design":"clinical trial","title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies","title_match":true,"year":2011},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/saffron-in-the-treatment-of-patients-with-mild-to-moderate-alzheimer-20831681","doi":"10.1111/j.1365-2710.2009.01133.x","journal":"Journal of clinical pharmacy and therapeutics","n_participants":null,"pmid":"20831681","source_url":"https://pubmed.ncbi.nlm.nih.gov/20831681/","study_design":null,"title":"Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial","title_match":true,"year":2010},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-methylphenidate-for-apathy-in-alzheimer-s-24021498","doi":"10.4088/jcp.12m08099","journal":"The Journal of clinical psychiatry","n_participants":37,"pmid":"24021498","source_url":"https://pubmed.ncbi.nlm.nih.gov/24021498/","study_design":null,"title":"Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial","title_match":true,"year":2013},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-effect-of-a-virtual-reality-based-intervention-program-on-32365533","doi":"10.3390/jcm9051283","journal":"Journal of clinical medicine","n_participants":68,"pmid":"32365533","source_url":"https://pubmed.ncbi.nlm.nih.gov/32365533/","study_design":"randomized controlled trial","title":"The Effect of a Virtual Reality-Based Intervention Program on Cognition in Older Adults with Mild Cognitive Impairment: A Randomized Control Trial","title_match":false,"year":2020},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/nilvadipine-in-mild-to-moderate-alzheimer-disease-a-randomised-30248105","doi":"10.1371/journal.pmed.1002660","journal":"PLoS medicine","n_participants":577,"pmid":"30248105","source_url":"https://pubmed.ncbi.nlm.nih.gov/30248105/","study_design":null,"title":"Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial","title_match":true,"year":2018},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/would-older-adults-with-mild-cognitive-impairment-adhere-to-and-25826620","doi":"10.1371/journal.pone.0118173","journal":"PloS one","n_participants":null,"pmid":"25826620","source_url":"https://pubmed.ncbi.nlm.nih.gov/25826620/","study_design":"randomized controlled trial","title":"Would older adults with mild cognitive impairment adhere to and benefit from a structured lifestyle activity intervention to enhance cognition?: a cluster randomized controlled trial","title_match":true,"year":2015},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/a-recommended-scale-for-cognitive-screening-in-clinical-trials-of-20878991","doi":"10.1002/mds.23362","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":null,"pmid":"20878991","source_url":"https://pubmed.ncbi.nlm.nih.gov/20878991/","study_design":null,"title":"A recommended scale for cognitive screening in clinical trials of Parkinson's disease","title_match":true,"year":2010},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/a-phase-ib-multiple-ascending-dose-study-of-the-safety-tolerability-25874001","doi":"10.1186/s13195-015-0119-0","journal":"Alzheimer's research & therapy","n_participants":24,"pmid":"25874001","source_url":"https://pubmed.ncbi.nlm.nih.gov/25874001/","study_design":null,"title":"A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease","title_match":true,"year":2015},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/clinical-prediction-of-alzheimer-disease-dementia-across-the-spectrum-18056553","doi":"10.1001/archpsyc.64.12.1443","journal":"Archives of general psychiatry","n_participants":77,"pmid":"18056553","source_url":"https://pubmed.ncbi.nlm.nih.gov/18056553/","study_design":"longitudinal study","title":"Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment","title_match":false,"year":2007},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/huperzine-a-for-alzheimer-s-disease-a-systematic-review-and-meta-24086396","doi":"10.1371/journal.pone.0074916","journal":"PloS one","n_participants":1823,"pmid":"24086396","source_url":"https://pubmed.ncbi.nlm.nih.gov/24086396/","study_design":"meta-analysis","title":"Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials","title_match":true,"year":2013},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/effects-of-a-combined-transcranial-magnetic-stimulation-tms-and-31879235","doi":"10.1016/j.jalz.2019.08.197","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":131,"pmid":"31879235","source_url":"https://pubmed.ncbi.nlm.nih.gov/31879235/","study_design":null,"title":"Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/galantamine-treatment-of-vascular-dementia-a-randomized-trial-17664404","doi":"10.1212/01.wnl.0000266625.31615.f6","journal":"Neurology","n_participants":788,"pmid":"17664404","source_url":"https://pubmed.ncbi.nlm.nih.gov/17664404/","study_design":null,"title":"Galantamine treatment of vascular dementia: a randomized trial","title_match":false,"year":2007},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/amyloid-positron-emission-tomography-and-cerebrospinal-fluid-results-30231896","doi":"10.1186/s13195-018-0424-5","journal":"Alzheimer's research & therapy","n_participants":26,"pmid":"30231896","source_url":"https://pubmed.ncbi.nlm.nih.gov/30231896/","study_design":null,"title":"Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)","title_match":true,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/efficacy-of-flupirtine-on-cognitive-function-in-patients-with-cjd-a-15007119","doi":"10.1212/01.wnl.0000113764.35026.ef","journal":"Neurology","n_participants":13,"pmid":"15007119","source_url":"https://pubmed.ncbi.nlm.nih.gov/15007119/","study_design":null,"title":"Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study","title_match":true,"year":2004},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/donepezil-in-parkinson-s-disease-dementia-a-randomized-double-blind-22915447","doi":"10.1002/mds.25098","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":550,"pmid":"22915447","source_url":"https://pubmed.ncbi.nlm.nih.gov/22915447/","study_design":null,"title":"Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study","title_match":true,"year":2012},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/clinical-efficacy-and-safety-of-donepezil-on-cognitive-and-global-11044775","doi":"10.1159/000017259","journal":"Dementia and geriatric cognitive disorders","n_participants":228,"pmid":"11044775","source_url":"https://pubmed.ncbi.nlm.nih.gov/11044775/","study_design":null,"title":"Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group","title_match":true,"year":2000},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/rationale-for-use-of-the-clinical-dementia-rating-sum-of-boxes-as-a-22658286","doi":"10.1016/j.jalz.2011.11.002","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":382,"pmid":"22658286","source_url":"https://pubmed.ncbi.nlm.nih.gov/22658286/","study_design":null,"title":"Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials","title_match":true,"year":2013},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/cognitive-effects-of-aerobic-exercise-in-alzheimer-s-disease-a-pilot-33523004","doi":"10.3233/jad-201100","journal":"Journal of Alzheimer's disease : JAD","n_participants":96,"pmid":"33523004","source_url":"https://pubmed.ncbi.nlm.nih.gov/33523004/","study_design":"randomized controlled trial","title":"Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial","title_match":true,"year":2021},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/effect-of-baseline-cognitive-function-and-antihypertensive-treatment-16109319","doi":"10.1016/j.amjhyper.2005.02.013","journal":"American journal of hypertension","n_participants":2070,"pmid":"16109319","source_url":"https://pubmed.ncbi.nlm.nih.gov/16109319/","study_design":"open-label trial","title":"Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)","title_match":false,"year":2005},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/ub-311-a-novel-ubith-sup-sup-amyloid-peptide-vaccine-for-mild-29067332","doi":"10.1016/j.trci.2017.03.005","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29067332","source_url":"https://pubmed.ncbi.nlm.nih.gov/29067332/","study_design":null,"title":"UB-311, a novel UBITh\u00ae amyloid \u03b2 peptide vaccine for mild Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-clinical-trial-of-plasma-exchange-with-32715623","doi":"10.1002/alz.12137","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"32715623","source_url":"https://pubmed.ncbi.nlm.nih.gov/32715623/","study_design":null,"title":"A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study","title_match":true,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/social-robots-in-advanced-dementia-26388764","doi":"10.3389/fnagi.2015.00133","journal":"Frontiers in aging neuroscience","n_participants":101,"pmid":"26388764","source_url":"https://pubmed.ncbi.nlm.nih.gov/26388764/","study_design":"clinical trial","title":"Social robots in advanced dementia","title_match":false,"year":2015},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/tilavonemab-in-early-alzheimer-s-disease-results-from-a-phase-2-36730056","doi":"10.1093/brain/awad024","journal":"Brain : a journal of neurology","n_participants":108,"pmid":"36730056","source_url":"https://pubmed.ncbi.nlm.nih.gov/36730056/","study_design":"clinical trial","title":"Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study","title_match":true,"year":2023},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/the-efficacy-and-safety-of-transcutaneous-auricular-vagus-nerve-36150665","doi":"10.1016/j.brs.2022.09.003","journal":"Brain stimulation","n_participants":52,"pmid":"36150665","source_url":"https://pubmed.ncbi.nlm.nih.gov/36150665/","study_design":"randomized controlled trial","title":"The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial","title_match":true,"year":2022},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/do-cognitive-interventions-improve-general-cognition-in-dementia-a-25838501","doi":"10.1136/bmjopen-2014-005247","journal":"BMJ open","n_participants":null,"pmid":"25838501","source_url":"https://pubmed.ncbi.nlm.nih.gov/25838501/","study_design":"systematic review","title":"Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression","title_match":false,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/mini-mental-state-examination-and-logical-memory-scores-for-entry-26899835","doi":"10.1186/s13195-016-0176-z","journal":"Alzheimer's research & therapy","n_participants":23438,"pmid":"26899835","source_url":"https://pubmed.ncbi.nlm.nih.gov/26899835/","study_design":null,"title":"Mini Mental State Examination and Logical Memory scores for entry into Alzheimer's disease trials","title_match":false,"year":2016},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/attainment-of-treatment-goals-by-people-with-alzheimer-s-disease-16554498","doi":"10.1503/cmaj.051432","journal":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","n_participants":159,"pmid":"16554498","source_url":"https://pubmed.ncbi.nlm.nih.gov/16554498/","study_design":"randomized controlled trial","title":"Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial","title_match":true,"year":2006},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/vitamin-c-status-and-cognitive-function-a-systematic-review-28867798","doi":"10.3390/nu9090960","journal":"Nutrients","n_participants":null,"pmid":"28867798","source_url":"https://pubmed.ncbi.nlm.nih.gov/28867798/","study_design":"case-control study","title":"Vitamin C Status and Cognitive Function: A Systematic Review","title_match":false,"year":2017},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-high-dose-vitamin-d2-followed-by-21694461","doi":"10.3233/jad-2011-110149","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"21694461","source_url":"https://pubmed.ncbi.nlm.nih.gov/21694461/","study_design":"randomized controlled trial","title":"A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease","title_match":true,"year":2011},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/acupuncture-for-patients-with-mild-to-moderate-alzheimer-s-disease-a-29284465","doi":"10.1186/s12906-017-2064-x","journal":"BMC complementary and alternative medicine","n_participants":87,"pmid":"29284465","source_url":"https://pubmed.ncbi.nlm.nih.gov/29284465/","study_design":"systematic review","title":"Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial","title_match":true,"year":2017},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/the-impact-of-individual-cognitive-stimulation-therapy-icst-on-28350796","doi":"10.1371/journal.pmed.1002269","journal":"PLoS medicine","n_participants":null,"pmid":"28350796","source_url":"https://pubmed.ncbi.nlm.nih.gov/28350796/","study_design":"randomized controlled trial","title":"The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: A randomised controlled trial","title_match":true,"year":2017},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/ambroxol-as-a-novel-disease-modifying-treatment-for-parkinson-s-30738426","doi":"10.1186/s12883-019-1252-3","journal":"BMC neurology","n_participants":75,"pmid":"30738426","source_url":"https://pubmed.ncbi.nlm.nih.gov/30738426/","study_design":null,"title":"Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial","title_match":true,"year":2019},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-effects-of-dl-3-n-butylphthalide-in-patients-with-vascular-26086183","doi":"10.1016/j.jalz.2015.04.010","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":281,"pmid":"26086183","source_url":"https://pubmed.ncbi.nlm.nih.gov/26086183/","study_design":null,"title":"The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial","title_match":true,"year":2016},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/no-effect-of-one-year-treatment-with-indomethacin-on-alzheimer-s-18213383","doi":"10.1371/journal.pone.0001475","journal":"PloS one","n_participants":51,"pmid":"18213383","source_url":"https://pubmed.ncbi.nlm.nih.gov/18213383/","study_design":null,"title":"No effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trial","title_match":true,"year":2008},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/systematic-detection-and-multidisciplinary-care-of-delirium-in-older-12389836","doi":null,"journal":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","n_participants":1925,"pmid":"12389836","source_url":"https://pubmed.ncbi.nlm.nih.gov/12389836/","study_design":null,"title":"Systematic detection and multidisciplinary care of delirium in older medical inpatients: a randomized trial","title_match":false,"year":2002},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/effect-of-tramiprosate-in-patients-with-mild-to-moderate-alzheimer-s-19536424","doi":"10.1007/s12603-009-0106-x","journal":"The journal of nutrition, health & aging","n_participants":109,"pmid":"19536424","source_url":"https://pubmed.ncbi.nlm.nih.gov/19536424/","study_design":"longitudinal study","title":"Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study","title_match":false,"year":2009},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/reality-orientation-therapy-combined-with-cholinesterase-inhibitors-16260821","doi":"10.1192/bjp.187.5.450","journal":"The British journal of psychiatry : the journal of mental science","n_participants":156,"pmid":"16260821","source_url":"https://pubmed.ncbi.nlm.nih.gov/16260821/","study_design":null,"title":"Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial","title_match":true,"year":2005},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/individual-goal-oriented-cognitive-rehabilitation-to-improve-everyday-30724405","doi":"10.1002/gps.5076","journal":"International journal of geriatric psychiatry","n_participants":475,"pmid":"30724405","source_url":"https://pubmed.ncbi.nlm.nih.gov/30724405/","study_design":"randomized controlled trial","title":"Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: A multicentre randomised controlled trial (the GREAT trial)","title_match":true,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/treatment-of-cognitive-impairment-after-poststroke-depression-a-10884441","doi":"10.1161/01.str.31.7.1482","journal":"Stroke","n_participants":33,"pmid":"10884441","source_url":"https://pubmed.ncbi.nlm.nih.gov/10884441/","study_design":null,"title":"Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial","title_match":true,"year":2000},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/a-26-week-analysis-of-a-double-blind-placebo-controlled-trial-of-the-10867450","doi":"10.1159/000017242","journal":"Dementia and geriatric cognitive disorders","n_participants":309,"pmid":"10867450","source_url":"https://pubmed.ncbi.nlm.nih.gov/10867450/","study_design":null,"title":"A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia","title_match":true,"year":2000},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/masitinib-for-mild-to-moderate-alzheimer-s-disease-results-from-a-36849969","doi":"10.1186/s13195-023-01169-x","journal":"Alzheimer's research & therapy","n_participants":182,"pmid":"36849969","source_url":"https://pubmed.ncbi.nlm.nih.gov/36849969/","study_design":null,"title":"Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial","title_match":true,"year":2023},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/utility-of-the-global-cdr-sup-sup-plus-nacc-ftld-rating-and-31914218","doi":"10.1002/alz.12033","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":40,"pmid":"31914218","source_url":"https://pubmed.ncbi.nlm.nih.gov/31914218/","study_design":"longitudinal study","title":"Utility of the global CDR\u00ae plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/identification-of-clusters-of-rapid-and-slow-decliners-among-subjects-28755001","doi":"10.1038/s41598-017-06624-y","journal":"Scientific reports","n_participants":562,"pmid":"28755001","source_url":"https://pubmed.ncbi.nlm.nih.gov/28755001/","study_design":"longitudinal study","title":"Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/evaluation-of-a-calibrated-18-f-fdg-pet-score-as-a-biomarker-for-21764801","doi":"10.2967/jnumed.111.090902","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":44,"pmid":"21764801","source_url":"https://pubmed.ncbi.nlm.nih.gov/21764801/","study_design":null,"title":"Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment","title_match":false,"year":2011},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/high-blood-pressure-and-risk-of-dementia-a-two-sample-mendelian-33766239","doi":"10.1016/j.biopsych.2020.12.015","journal":"Biological psychiatry","n_participants":299024,"pmid":"33766239","source_url":"https://pubmed.ncbi.nlm.nih.gov/33766239/","study_design":"meta-analysis","title":"High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank","title_match":false,"year":2021},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/cognitive-impairment-precedes-and-predicts-functional-impairment-in-26402769","doi":"10.3233/jad-142508","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"26402769","source_url":"https://pubmed.ncbi.nlm.nih.gov/26402769/","study_design":"clinical trial","title":"Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease","title_match":false,"year":2015},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/tau-pet-is-superior-to-phospho-tau-when-predicting-cognitive-decline-36516028","doi":"10.1002/alz.12875","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"36516028","source_url":"https://pubmed.ncbi.nlm.nih.gov/36516028/","study_design":null,"title":"Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients","title_match":false,"year":2023},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/rpop-robust-pet-only-processing-of-community-acquired-heterogeneous-34890793","doi":"10.1016/j.neuroimage.2021.118775","journal":"NeuroImage","n_participants":740,"pmid":"34890793","source_url":"https://pubmed.ncbi.nlm.nih.gov/34890793/","study_design":null,"title":"rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data","title_match":false,"year":2022},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/association-of-peripheral-blood-dna-methylation-level-with-alzheimer-34654479","doi":"10.1186/s13148-021-01179-2","journal":"Clinical epigenetics","n_participants":19,"pmid":"34654479","source_url":"https://pubmed.ncbi.nlm.nih.gov/34654479/","study_design":null,"title":"Association of peripheral blood DNA methylation level with Alzheimer's disease progression","title_match":false,"year":2021},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/progranulin-aav-gene-therapy-for-frontotemporal-dementia-38745011","doi":"10.1038/s41591-024-02973-0","journal":"Nature medicine","n_participants":null,"pmid":"38745011","source_url":"https://pubmed.ncbi.nlm.nih.gov/38745011/","study_design":"clinical trial","title":"Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results","title_match":true,"year":2024},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/joint-genetic-inhibition-of-pcsk9-and-cetp-and-the-association-with-35921096","doi":"10.1001/jamacardio.2022.2333","journal":"JAMA cardiology","n_participants":null,"pmid":"35921096","source_url":"https://pubmed.ncbi.nlm.nih.gov/35921096/","study_design":"clinical trial","title":"Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/cerebral-microbleeds-and-risk-of-incident-dementia-the-framingham-28347929","doi":"10.1016/j.neurobiolaging.2017.02.018","journal":"Neurobiology of aging","n_participants":85,"pmid":"28347929","source_url":"https://pubmed.ncbi.nlm.nih.gov/28347929/","study_design":null,"title":"Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study","title_match":false,"year":2017},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/generalizable-deep-learning-model-for-early-alzheimer-s-disease-36253382","doi":"10.1038/s41598-022-20674-x","journal":"Scientific reports","n_participants":null,"pmid":"36253382","source_url":"https://pubmed.ncbi.nlm.nih.gov/36253382/","study_design":null,"title":"Generalizable deep learning model for early Alzheimer's disease detection from structural MRIs","title_match":false,"year":2022},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/deep-brain-stimulation-of-frontal-lobe-networks-to-treat-alzheimer-s-29400666","doi":"10.3233/jad-170082","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"29400666","source_url":"https://pubmed.ncbi.nlm.nih.gov/29400666/","study_design":null,"title":"Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease","title_match":false,"year":2018},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/combined-plasma-and-cerebrospinal-fluid-signature-for-the-prediction-26659895","doi":"10.1001/jamaneurol.2015.3135","journal":"JAMA neurology","n_participants":928,"pmid":"26659895","source_url":"https://pubmed.ncbi.nlm.nih.gov/26659895/","study_design":"cohort study","title":"Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease","title_match":false,"year":2016},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/comparison-of-group-level-and-individualized-brain-regions-for-37155176","doi":"10.1001/jamaneurol.2023.1067","journal":"JAMA neurology","n_participants":215,"pmid":"37155176","source_url":"https://pubmed.ncbi.nlm.nih.gov/37155176/","study_design":"cohort study","title":"Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease","title_match":false,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/enrichment-through-biomarkers-in-clinical-trials-of-alzheimer-s-drugs-20541287","doi":"10.1016/j.neurobiolaging.2010.04.036","journal":"Neurobiology of aging","n_participants":null,"pmid":"20541287","source_url":"https://pubmed.ncbi.nlm.nih.gov/20541287/","study_design":null,"title":"Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment","title_match":true,"year":2010},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/rates-of-brain-atrophy-across-disease-stages-in-familial-33112398","doi":"10.1001/jamanetworkopen.2020.22847","journal":"JAMA network open","n_participants":100,"pmid":"33112398","source_url":"https://pubmed.ncbi.nlm.nih.gov/33112398/","study_design":"case-control study","title":"Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/circulating-vitamin-d-levels-and-alzheimer-s-disease-a-mendelian-31815694","doi":"10.3233/jad-190713","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"31815694","source_url":"https://pubmed.ncbi.nlm.nih.gov/31815694/","study_design":null,"title":"Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank","title_match":false,"year":2020},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/assessment-of-executive-function-declines-in-presymptomatic-and-31914230","doi":"10.1016/j.jalz.2019.01.012","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":31,"pmid":"31914230","source_url":"https://pubmed.ncbi.nlm.nih.gov/31914230/","study_design":null,"title":"Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint","title_match":true,"year":2020},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/in-vivo-imaging-of-amyloid-deposition-in-alzheimer-disease-using-the-20501908","doi":"10.2967/jnumed.109.069088","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":16,"pmid":"20501908","source_url":"https://pubmed.ncbi.nlm.nih.gov/20501908/","study_design":"open-label trial","title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","title_match":false,"year":2010},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/clinical-trials-and-late-stage-drug-development-for-alzheimer-s-24605808","doi":"10.1111/joim.12191","journal":"Journal of internal medicine","n_participants":null,"pmid":"24605808","source_url":"https://pubmed.ncbi.nlm.nih.gov/24605808/","study_design":"meta-analysis","title":"Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014","title_match":true,"year":2014},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-as-homeostatic-responses-to-age-related-myelin-19775776","doi":"10.1016/j.neurobiolaging.2009.08.007","journal":"Neurobiology of aging","n_participants":null,"pmid":"19775776","source_url":"https://pubmed.ncbi.nlm.nih.gov/19775776/","study_design":null,"title":"Alzheimer's disease as homeostatic responses to age-related myelin breakdown","title_match":false,"year":2011},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/long-term-respiratory-and-neurological-sequelae-of-covid-19-33177481","doi":"10.12659/msm.928996","journal":"Medical science monitor : international medical journal of experimental and clinical research","n_participants":null,"pmid":"33177481","source_url":"https://pubmed.ncbi.nlm.nih.gov/33177481/","study_design":null,"title":"Long-Term Respiratory and Neurological Sequelae of COVID-19","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/truncated-stathmin-2-is-a-marker-of-tdp-43-pathology-in-32790644","doi":"10.1172/jci139741","journal":"The Journal of clinical investigation","n_participants":null,"pmid":"32790644","source_url":"https://pubmed.ncbi.nlm.nih.gov/32790644/","study_design":null,"title":"Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia","title_match":false,"year":2020},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/18f-mk-6240-pet-for-early-and-late-detection-of-neurofibrillary-32671408","doi":"10.1093/brain/awaa180","journal":"Brain : a journal of neurology","n_participants":301,"pmid":"32671408","source_url":"https://pubmed.ncbi.nlm.nih.gov/32671408/","study_design":null,"title":"18F-MK-6240 PET for early and late detection of neurofibrillary tangles","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/large-femoral-heads-decrease-the-incidence-of-dislocation-after-total-22717828","doi":"10.2106/jbjs.k.00570","journal":"The Journal of bone and joint surgery. American volume","n_participants":null,"pmid":"22717828","source_url":"https://pubmed.ncbi.nlm.nih.gov/22717828/","study_design":"randomized controlled trial","title":"Large femoral heads decrease the incidence of dislocation after total hip arthroplasty: a randomized controlled trial","title_match":true,"year":2012},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/clinical-trials-of-new-drugs-for-alzheimer-disease-31906949","doi":"10.1186/s12929-019-0609-7","journal":"Journal of biomedical science","n_participants":null,"pmid":"31906949","source_url":"https://pubmed.ncbi.nlm.nih.gov/31906949/","study_design":null,"title":"Clinical trials of new drugs for Alzheimer disease","title_match":true,"year":2020},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/nsaids-and-alzheimer-disease-epidemiological-animal-model-and-16697488","doi":"10.1016/j.neurobiolaging.2006.03.013","journal":"Neurobiology of aging","n_participants":null,"pmid":"16697488","source_url":"https://pubmed.ncbi.nlm.nih.gov/16697488/","study_design":null,"title":"NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies","title_match":false,"year":2007},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/drug-candidates-in-clinical-trials-for-alzheimer-s-disease-28720101","doi":"10.1186/s12929-017-0355-7","journal":"Journal of biomedical science","n_participants":null,"pmid":"28720101","source_url":"https://pubmed.ncbi.nlm.nih.gov/28720101/","study_design":null,"title":"Drug candidates in clinical trials for Alzheimer's disease","title_match":true,"year":2017},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/regulatory-t-cells-delay-disease-progression-in-alzheimer-like-26912648","doi":"10.1093/brain/awv408","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"26912648","source_url":"https://pubmed.ncbi.nlm.nih.gov/26912648/","study_design":null,"title":"Regulatory T cells delay disease progression in Alzheimer-like pathology","title_match":false,"year":2016},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/next-generation-active-immunization-approach-for-synucleinopathies-24525765","doi":"10.1007/s00401-014-1256-4","journal":"Acta neuropathologica","n_participants":null,"pmid":"24525765","source_url":"https://pubmed.ncbi.nlm.nih.gov/24525765/","study_design":null,"title":"Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials","title_match":true,"year":2014},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/nadph-oxidases-novel-therapeutic-targets-for-neurodegenerative-22503440","doi":"10.1016/j.tips.2012.03.008","journal":"Trends in pharmacological sciences","n_participants":null,"pmid":"22503440","source_url":"https://pubmed.ncbi.nlm.nih.gov/22503440/","study_design":null,"title":"NADPH oxidases: novel therapeutic targets for neurodegenerative diseases","title_match":false,"year":2012},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/neuroinflammatory-processes-a1-astrocyte-activation-and-protein-31551688","doi":"10.3389/fnins.2019.00925","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"31551688","source_url":"https://pubmed.ncbi.nlm.nih.gov/31551688/","study_design":null,"title":"Neuroinflammatory Processes, A1 Astrocyte Activation and Protein Aggregation in the Retina of Alzheimer's Disease Patients, Possible Biomarkers for Early Diagnosis","title_match":false,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/the-metal-ion-hypothesis-of-alzheimer-s-disease-and-the-anti-36455485","doi":"10.1016/j.bioorg.2022.106301","journal":"Bioorganic chemistry","n_participants":null,"pmid":"36455485","source_url":"https://pubmed.ncbi.nlm.nih.gov/36455485/","study_design":null,"title":"The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators","title_match":false,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/a-randomized-control-trial-for-redesign-a-dementia-friendly-mobile-36508394","doi":"10.1093/geront/gnac182","journal":"The Gerontologist","n_participants":150,"pmid":"36508394","source_url":"https://pubmed.ncbi.nlm.nih.gov/36508394/","study_design":null,"title":"A Randomized Control Trial for ReDeSign: A Dementia-Friendly Mobile Microlearning Training for Store Workers in Japan","title_match":false,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/relational-design-for-dementia-and-job-significance-redesign-study-35112011","doi":"10.1016/j.conctc.2022.100896","journal":"Contemporary Clinical Trials Communications","n_participants":62,"pmid":"35112011","source_url":"https://pubmed.ncbi.nlm.nih.gov/35112011/","study_design":"randomized controlled trial","title":"Relational Design for Dementia and Job Significance (ReDeSign): Study protocol for a randomized controlled trial of an online dementia training for retail workers","title_match":true,"year":2022},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/lifestyle-medicine-our-only-hope-against-the-ticking-non-communicable-bb73e4c1","doi":"10.4103/jcsr.jcsr_16_26","journal":"The Journal of Clinical and Scientific Research","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.4103/jcsr.jcsr_16_26","study_design":"meta-analysis","title":"Lifestyle medicine: Our only hope against the ticking non-communicable diseases time bomb","title_match":false,"year":2026},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/moving-elderly-inpatients-to-a-transitional-care-facility-reduced-16865841","doi":"10.1136/ebn.9.3.90","journal":"Evidence-Based Nursing","n_participants":320,"pmid":"16865841","source_url":"https://pubmed.ncbi.nlm.nih.gov/16865841/","study_design":"randomized controlled trial","title":"Moving elderly inpatients to a transitional care facility reduced hospital stay but increased time to transfer to long term care","title_match":false,"year":2006},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/cogchamps-impact-of-a-project-to-educate-nurses-about-delirium-and-29986686","doi":"10.1186/s12913-018-3286-4","journal":"BMC Health Services Research","n_participants":181,"pmid":"29986686","source_url":"https://pubmed.ncbi.nlm.nih.gov/29986686/","study_design":null,"title":"CogChamps: impact of a project to educate nurses about delirium and improve the quality of care for hospitalized patients with cognitive impairment","title_match":false,"year":2018},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/should-we-include-dementia-diagnosis-or-cognitive-impairment-to-41430206","doi":"10.1186/s12913-025-13868-2","journal":"BMC Health Services Research","n_participants":1035,"pmid":"41430206","source_url":"https://pubmed.ncbi.nlm.nih.gov/41430206/","study_design":null,"title":"Should we include dementia diagnosis or cognitive impairment to predict home care cost? An observational study using real-world data","title_match":false,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/back-to-the-future-feasibility-of-recruitment-and-retention-to-26491262","doi":"10.2147/ppa.s86922","journal":"Patient Preference and Adherence","n_participants":30,"pmid":"26491262","source_url":"https://pubmed.ncbi.nlm.nih.gov/26491262/","study_design":"randomized controlled trial","title":"Back to the future \u2013 feasibility of recruitment and retention to patient education and telephone follow-up after hip fracture: a pilot randomized controlled trial","title_match":true,"year":2015},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-linkage-to-real-world-evidence-ad-line-study-39350370","doi":"10.14283/jpad.2024.115","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":147,"pmid":"39350370","source_url":"https://pubmed.ncbi.nlm.nih.gov/39350370/","study_design":"cohort study","title":"Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab","title_match":true,"year":2024},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/assessment-of-vascular-event-prevention-and-cognitive-function-among-30821829","doi":"10.1001/jamanetworkopen.2019.0223","journal":"JAMA Network Open","n_participants":1197,"pmid":"30821829","source_url":"https://pubmed.ncbi.nlm.nih.gov/30821829/","study_design":null,"title":"Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes","title_match":false,"year":2019},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/physicians-in-supporting-roles-in-chronic-disease-care-the-caremore-21226686","doi":"10.1111/j.1532-5415.2010.03237.x","journal":"Journal of the American Geriatrics Society","n_participants":75,"pmid":"21226686","source_url":"https://pubmed.ncbi.nlm.nih.gov/21226686/","study_design":null,"title":"Physicians in Supporting Roles in Chronic Disease Care: The CareMore Model","title_match":false,"year":2011},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/characterize-demographics-comorbidities-and-comedications-in-newly-3c0c71b6","doi":"10.1002/alz.073825","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/alz.073825","study_design":null,"title":"Characterize demographics, comorbidities and co\u2010medications in newly diagnosed United States (US) Alzheimer\u2019s Disease patients using Medicare claims","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/patient-and-physician-adherence-in-hypertension-management-23815530","doi":"10.1111/jch.12105","journal":"Journal of Clinical Hypertension","n_participants":null,"pmid":"23815530","source_url":"https://pubmed.ncbi.nlm.nih.gov/23815530/","study_design":"randomized controlled trial","title":"Patient and Physician Adherence in Hypertension Management","title_match":false,"year":2013},{"alzhub_score":31,"alzhub_url":"https://alzhub.org/study/3d-team-care-management-trial-study-design-features-and-participant-6c04db48","doi":"10.1093/geroni/igaa057.2678","journal":"Innovation in Aging","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1093/geroni/igaa057.2678","study_design":null,"title":"3D Team Care Management Trial: Study Design Features and Participant Characteristics","title_match":false,"year":2020},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/oral-presentations-of-the-2018-annual-meeting-of-the-congress-of-31076780","doi":"10.1093/neuros/nyy303","journal":"Neurosurgery","n_participants":40,"pmid":"31076780","source_url":"https://pubmed.ncbi.nlm.nih.gov/31076780/","study_design":null,"title":"Oral Presentations of the 2018 Annual Meeting of the Congress of Neurological Surgeons","title_match":false,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/characterizing-neighborhood-vulnerabilities-in-mild-cognitive-38910939","doi":"10.3233/adr-240020","journal":"Journal of Alzheimer s Disease Reports","n_participants":null,"pmid":"38910939","source_url":"https://pubmed.ncbi.nlm.nih.gov/38910939/","study_design":null,"title":"Characterizing Neighborhood Vulnerabilities in Mild Cognitive Impairment using the Environmental Justice Index","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/does-the-area-deprivation-index-adi-influence-dementia-evaluation-and-8f88e7a1","doi":"10.1212/wnl.0000000000202532","journal":"Neurology","n_participants":4600,"pmid":null,"source_url":"https://doi.org/10.1212/wnl.0000000000202532","study_design":null,"title":"Does the Area Deprivation Index (ADI) influence dementia evaluation and diagnosis in Virginia? (S29.004)","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/impact-of-race-ethnicity-and-area-deprivation-index-on-alzheimers-32ecf47a","doi":"10.1002/alz.089954","journal":"Alzheimer s & Dementia","n_participants":644,"pmid":null,"source_url":"https://doi.org/10.1002/alz.089954","study_design":null,"title":"Impact of race/ethnicity and area deprivation index on Alzheimer\u2019s disease and related disorders biomarkers in the POINTER Cohort","title_match":false,"year":2024},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/cognitive-health-in-persons-with-human-immunodeficiency-virus-the-36930639","doi":"10.1093/infdis/jiac388","journal":"The Journal of Infectious Diseases","n_participants":154,"pmid":"36930639","source_url":"https://pubmed.ncbi.nlm.nih.gov/36930639/","study_design":"systematic review","title":"Cognitive Health in Persons With Human Immunodeficiency Virus: The Impact of Early Treatment, Comorbidities, and Aging","title_match":false,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-relationship-of-neighborhood-socioeconomic-disadvantage-and-42421660","doi":"10.1002/cncr.70506","journal":"Cancer","n_participants":100,"pmid":"42421660","source_url":"https://pubmed.ncbi.nlm.nih.gov/42421660/","study_design":"randomized controlled trial","title":"The relationship of neighborhood socioeconomic disadvantage and pretreatment cancer\u2010related cognitive impairment in women with breast cancer: A post hoc analysis of a randomized controlled trial","title_match":true,"year":2026},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/do-ecological-factors-influence-the-clinical-presentation-of-33563811","doi":"10.1136/jnnp-2020-325625","journal":"Journal of Neurology Neurosurgery & Psychiatry","n_participants":null,"pmid":"33563811","source_url":"https://pubmed.ncbi.nlm.nih.gov/33563811/","study_design":null,"title":"Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis?","title_match":false,"year":2021},{"alzhub_score":30,"alzhub_url":"https://alzhub.org/study/the-psychosocial-analyzation-of-alzheimers-disease-and-other-dementia-aa323b3e","doi":"10.1002/alz.090376","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/alz.090376","study_design":null,"title":"The Psychosocial Analyzation of Alzheimer\u2019s Disease and other Dementia among Black Ohioans","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/suggested-patient-selection-criteria-for-initial-clinical-trials-of-33481554","doi":"10.1097/tp.0000000000003632","journal":"Transplantation","n_participants":null,"pmid":"33481554","source_url":"https://pubmed.ncbi.nlm.nih.gov/33481554/","study_design":null,"title":"Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United States","title_match":true,"year":2021},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/higher-neighborhood-deprivation-is-associated-with-accelerated-41346478","doi":"10.1002/bsa3.70045","journal":"Alzheimer s & Dementia Behavior & Socioeconomics of Aging","n_participants":161,"pmid":"41346478","source_url":"https://pubmed.ncbi.nlm.nih.gov/41346478/","study_design":"longitudinal study","title":"Higher neighborhood deprivation is associated with accelerated disease progression in behavioral\u2010variant frontotemporal degeneration","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/factors-associated-with-incentive-redemption-among-participants-in-a-38940329","doi":"10.1111/acem.14979","journal":"Academic Emergency Medicine","n_participants":586,"pmid":"38940329","source_url":"https://pubmed.ncbi.nlm.nih.gov/38940329/","study_design":"cohort study","title":"Factors associated with incentive redemption among participants in a multicenter prospective syncope clinical study","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/p1243-biomarkerguided-stratification-approach-of-the-clinical-f3bd9fcb","doi":"10.1016/j.jalz.2019.06.798","journal":"Alzheimer s & Dementia","n_participants":20,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2019.06.798","study_design":null,"title":"P1\u2010243: BIOMARKER\u2010GUIDED STRATIFICATION APPROACH OF THE CLINICAL CONTINUUM OF ALZHEIMER'S DISEASE USING UNSUPERVISED CLUSTERING METHODS","title_match":false,"year":2019},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/evaluating-plasma-p-tau217-as-an-endpoint-for-alzheimer-disease-41364889","doi":"10.1212/wnl.0000000000214441","journal":"Neurology","n_participants":716,"pmid":"41364889","source_url":"https://pubmed.ncbi.nlm.nih.gov/41364889/","study_design":"longitudinal study","title":"Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials","title_match":true,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/can-longitudinal-measures-of-plasma-biomarkers-track-disease-5bc7b467","doi":"10.1002/alz70856_105473","journal":"Alzheimer s & Dementia","n_participants":718,"pmid":null,"source_url":"https://doi.org/10.1002/alz70856_105473","study_design":"longitudinal study","title":"Can longitudinal measures of plasma biomarkers track disease progression in early Alzheimer\u00b4s Disease?","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/plasma-hepcidin-as-a-potential-informative-biomarker-of-alzheimer-39948603","doi":"10.1186/s13195-025-01696-9","journal":"Alzheimer s Research & Therapy","n_participants":null,"pmid":"39948603","source_url":"https://pubmed.ncbi.nlm.nih.gov/39948603/","study_design":null,"title":"Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/brain-amyloid-plaque-levels-affect-clinical-progression-in-alzheimer-41543367","doi":"10.1002/psp4.70173","journal":"CPT Pharmacometrics & Systems Pharmacology","n_participants":null,"pmid":"41543367","source_url":"https://pubmed.ncbi.nlm.nih.gov/41543367/","study_design":"clinical trial","title":"Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR \u2010 SB Utilizing Semi\u2010Mechanistic Model","title_match":false,"year":2026},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/implication-for-clinical-trials-from-longitudinal-tau-pet-40986433","doi":"10.1212/wnl.0000000000214111","journal":"Neurology","n_participants":null,"pmid":"40986433","source_url":"https://pubmed.ncbi.nlm.nih.gov/40986433/","study_design":"longitudinal study","title":"Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease Stages","title_match":true,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/combination-of-amyloid-and-fdg-pet-for-the-prediction-of-short-term-40257609","doi":"10.1007/s00259-025-07275-2","journal":"European Journal of Nuclear Medicine and Molecular Imaging","n_participants":145,"pmid":"40257609","source_url":"https://pubmed.ncbi.nlm.nih.gov/40257609/","study_design":null,"title":"Combination of amyloid and FDG PET for the prediction of short-term conversion from MCI to Alzheimer\u00b4s disease in the clinical practice","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/lecanemab-in-diad-6month-amyloid-pet-results-from-the-diantu001-trial-41447716","doi":"10.1002/alz70859_105303","journal":"Alzheimer s & Dementia","n_participants":97,"pmid":"41447716","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12740335/","study_design":null,"title":"Lecanemab in DIAD: 6\u2010Month Amyloid PET Results from the DIAN\u2010TU\u2010001 Trial","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/immunohistochemical-evaluation-of-a-trial-of-gantenerumab-or-40459787","doi":"10.1007/s00401-025-02890-7","journal":"Acta Neuropathologica","n_participants":null,"pmid":"40459787","source_url":"https://pubmed.ncbi.nlm.nih.gov/40459787/","study_design":null,"title":"Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/quantitative-amyloid-brain-imaging-a-literature-review-of-the-41667284","doi":"10.2967/jnmt.125.271678","journal":"Journal of Nuclear Medicine Technology","n_participants":null,"pmid":"41667284","source_url":"https://pubmed.ncbi.nlm.nih.gov/41667284/","study_design":"longitudinal study","title":"Quantitative Amyloid Brain Imaging: A Literature Review of the Centiloid Scale in Alzheimer Disease Evaluation","title_match":false,"year":2026},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/trajectories-of-plasma-and-csf-mtbr-tau243-and-phosphorylated-tau-41957377","doi":"10.1038/s41467-026-71732-1","journal":"Nature Communications","n_participants":null,"pmid":"41957377","source_url":"https://pubmed.ncbi.nlm.nih.gov/41957377/","study_design":null,"title":"Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer\u2019s disease continuum","title_match":false,"year":2026},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/adaptation-of-a-protocol-for-disclosure-of-amyloid-pet-results-for-41448156","doi":"10.1002/alz70858_100947","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41448156","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12740482/","study_design":"longitudinal study","title":"Adaptation of a Protocol for Disclosure of Amyloid PET Results for Adults with Down Syndrome and Their Caregivers","title_match":false,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/plasma-biomarker-characterization-of-alzheimers-disease-psychosis-in-41451623","doi":"10.1002/alz70859_106556","journal":"Alzheimer s & Dementia","n_participants":322,"pmid":"41451623","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12741765/","study_design":"clinical trial","title":"Plasma Biomarker Characterization of Alzheimer\u2019s Disease Psychosis in Study ACP\u2010204\u2010006","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/early-behavioral-and-cognitive-changes-in-patients-with-41809433","doi":"10.1212/wn9.0000000000000055","journal":"Neurology Open Access","n_participants":1028,"pmid":"41809433","source_url":"https://pubmed.ncbi.nlm.nih.gov/41809433/","study_design":"cohort study","title":"Early Behavioral and Cognitive Changes in Patients With Pathologically Confirmed Alzheimer Disease, Lewy Body Dementia, and Mixed Dementia","title_match":false,"year":2026},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/cerebral-microbleeds-and-amyloid-pathology-estimates-from-the-amyloid-39841474","doi":"10.1001/jamanetworkopen.2024.55571","journal":"JAMA Network Open","n_participants":4080,"pmid":"39841474","source_url":"https://pubmed.ncbi.nlm.nih.gov/39841474/","study_design":"cross-sectional","title":"Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study","title_match":false,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/psychological-impacts-of-apoe-genotype-disclosure-among-latinos-in-42712082","doi":"10.1002/alz.71796","journal":"Alzheimer s & Dementia","n_participants":194,"pmid":"42712082","source_url":"https://pubmed.ncbi.nlm.nih.gov/42712082/","study_design":"randomized controlled trial","title":"Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial","title_match":true,"year":2026},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/lecanemab-aducanumab-and-donanemab-bind-the-same-human-alzheimer-41435407","doi":"10.1002/alz70855_099914","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41435407","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12726945/","study_design":null,"title":"Lecanemab, aducanumab, and donanemab bind the same human Alzheimer disease A\u03b2 aggregates at different epitopes","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/searching-for-responders-to-multidomain-dementia-prevention-in-late-39821948","doi":"10.1002/alz.14472","journal":"Alzheimer s & Dementia","n_participants":5205,"pmid":"39821948","source_url":"https://pubmed.ncbi.nlm.nih.gov/39821948/","study_design":null,"title":"Searching for responders to multidomain dementia prevention in late life: A pooled analysis of individual participant data from the MAPT and preDIVA trials","title_match":false,"year":2025},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/apolipoprotein-e-mimetic-peptide-cn-105-and-postoperative-delirium-in-41931297","doi":"10.1001/jamanetworkopen.2026.2289","journal":"JAMA Network Open","n_participants":null,"pmid":"41931297","source_url":"https://pubmed.ncbi.nlm.nih.gov/41931297/","study_design":"clinical trial","title":"Apolipoprotein E Mimetic Peptide CN-105 and Postoperative Delirium in Older Patients","title_match":false,"year":2026},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/how-to-efficiently-move-towards-primary-prevention-in-sporadic-ad-41450236","doi":"10.1002/alz70859_105951","journal":"Alzheimer s & Dementia","n_participants":1000,"pmid":"41450236","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12741627/","study_design":"longitudinal study","title":"How to efficiently move towards primary prevention in sporadic AD","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/use-of-lecanemab-and-donanemab-in-the-canadian-healthcare-system-39893139","doi":"10.1016/j.tjpad.2025.100068","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":null,"pmid":"39893139","source_url":"https://pubmed.ncbi.nlm.nih.gov/39893139/","study_design":null,"title":"Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-combination-therapies-overview-and-scenarios-41145337","doi":"10.1016/j.tjpad.2025.100328","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":null,"pmid":"41145337","source_url":"https://pubmed.ncbi.nlm.nih.gov/41145337/","study_design":"clinical trial","title":"Alzheimer Combination Therapies: Overview and Scenarios","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/treating-alzheimer-disease-with-antiamyloid-therapiesthe-real-world-40844810","doi":"10.1001/jama.2025.14180","journal":"JAMA","n_participants":null,"pmid":"40844810","source_url":"https://pubmed.ncbi.nlm.nih.gov/40844810/","study_design":null,"title":"Treating Alzheimer Disease With Antiamyloid Therapies\u2014The Real-World Experience Grows","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/a-new-era-in-neuropharmacology-assessing-the-efficacy-and-safety-of-42084750","doi":"10.1007/s00415-026-13829-7","journal":"Journal of Neurology","n_participants":null,"pmid":"42084750","source_url":"https://pubmed.ncbi.nlm.nih.gov/42084750/","study_design":null,"title":"A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/lecanemab-binds-to-transgenic-mouse-modelderived-amyloid-fibril-40495448","doi":"10.1111/nan.70022","journal":"Neuropathology and Applied Neurobiology","n_participants":null,"pmid":"40495448","source_url":"https://pubmed.ncbi.nlm.nih.gov/40495448/","study_design":null,"title":"Lecanemab Binds to Transgenic Mouse Model\u2010Derived Amyloid\u2010\u03b2 Fibril Structures Resembling Alzheimer's Disease Type I, Type II and Arctic Folds","title_match":false,"year":2025},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/both-amyloid-and-tau-assessments-are-desired-before-initiating-40108731","doi":"10.1097/rlu.0000000000005842","journal":"Clinical Nuclear Medicine","n_participants":null,"pmid":"40108731","source_url":"https://pubmed.ncbi.nlm.nih.gov/40108731/","study_design":"clinical trial","title":"Both Amyloid and Tau Assessments Are Desired Before Initiating Disease-modifying Therapy for Alzheimer Disease: Three Real-world Cases","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/monoclonal-antibodies-for-treatment-alzheimer-s-disease-12954b56","doi":"10.31393/reports-vnmedical-2025-29(4)-29","journal":"Reports of Vinnytsia National Medical University","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.31393/reports-vnmedical-2025-29(4)-29","study_design":"systematic review","title":"Monoclonal antibodies for treatment Alzheimer`s disease","title_match":false,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/anti-amyloid-treatment-in-alzheimer-disease-updated-implications-for-42688139","doi":"10.3389/fneur.2026.1889769","journal":"Frontiers in Neurology","n_participants":null,"pmid":"42688139","source_url":"https://pubmed.ncbi.nlm.nih.gov/42688139/","study_design":null,"title":"Anti-amyloid treatment in Alzheimer disease: updated implications for patients with cerebral amyloid angiopathy and other cerebrovascular conditions","title_match":false,"year":2026},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-neuroimaging-initiative-two-decades-of-pioneering-39760440","doi":"10.1002/alz.14186","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"39760440","source_url":"https://pubmed.ncbi.nlm.nih.gov/39760440/","study_design":"longitudinal study","title":"Alzheimer's Disease Neuroimaging Initiative: Two decades of pioneering Alzheimer's disease research and future directions","title_match":false,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/current-amyloid-inhibitors-therapeutic-applications-and-nanomaterial-40024279","doi":"10.1016/j.pneurobio.2025.102734","journal":"Progress in Neurobiology","n_participants":null,"pmid":"40024279","source_url":"https://pubmed.ncbi.nlm.nih.gov/40024279/","study_design":null,"title":"Current amyloid inhibitors: Therapeutic applications and nanomaterial-based innovations","title_match":false,"year":2025},{"alzhub_score":28,"alzhub_url":"https://alzhub.org/study/investigating-the-neuroprotective-role-of-curcumin-in-alzheimer-s-1b5cecc3","doi":"10.64062/jpgmb.vol1.issue4.13","journal":"Journal of Pharmacology Genetics and Molecular Biology","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64062/jpgmb.vol1.issue4.13","study_design":null,"title":"Investigating The Neuroprotective Role of Curcumin in Alzheimer's Disease Models","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/analisis-comparativo-del-efecto-de-las-dietas-mediterranea-cetogenica-0826d547","doi":"10.60134/mlshnr.v4i1.2902","journal":"MLS Health & Nutrition Research","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.60134/mlshnr.v4i1.2902","study_design":"meta-analysis","title":"An\u00e1lisis comparativo del efecto de las dietas mediterr\u00e1nea, cetog\u00e9nica, DASH y MIND en la prevenci\u00f3n del alzheimer","title_match":false,"year":2025},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/treating-dementia-with-brain-amyloid-medications-42128656","doi":"10.46747/cfp.7205330","journal":"Canadian Family Physician","n_participants":null,"pmid":"42128656","source_url":"https://pubmed.ncbi.nlm.nih.gov/42128656/","study_design":null,"title":"Treating dementia with brain amyloid medications","title_match":false,"year":2026},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/baseline-imaging-characteristics-of-participants-in-the-phase-ii-iii-41447186","doi":"10.1002/alz70859_105301","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41447186","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12739784/","study_design":null,"title":"Baseline Imaging Characteristics of Participants in the Phase II/III DIAN\u2010TU\u2010001 Tau NexGen Trial for Dominantly Inherited Alzheimer\u2019s Disease","title_match":true,"year":2025},{"alzhub_score":29,"alzhub_url":"https://alzhub.org/study/vascular-considerations-for-patients-receiving-amyloid-immunotherapy-74e40508","doi":"10.1093/geroni/igaf122.1009","journal":"Innovation in Aging","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1093/geroni/igaf122.1009","study_design":null,"title":"Vascular Considerations for Patients Receiving Amyloid Immunotherapy","title_match":false,"year":2025},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/diet-exercise-and-lifestyle-in-glaucoma-current-evidence-and-future-41228444","doi":"10.3390/nu17213369","journal":"Nutrients","n_participants":null,"pmid":"41228444","source_url":"https://pubmed.ncbi.nlm.nih.gov/41228444/","study_design":"cross-sectional","title":"Diet, Exercise, and Lifestyle in Glaucoma: Current Evidence and Future Perspectives","title_match":false,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/gut-microbiota-modulation-through-mediterranean-diet-foods-40289944","doi":"10.3390/nu17060948","journal":"Nutrients","n_participants":null,"pmid":"40289944","source_url":"https://pubmed.ncbi.nlm.nih.gov/40289944/","study_design":null,"title":"Gut Microbiota Modulation Through Mediterranean Diet Foods: Implications for Human Health","title_match":false,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/digital-gait-biomarkers-in-parkinsons-disease-susceptibility-risk-40118834","doi":"10.1038/s41531-025-00897-1","journal":"npj Parkinson s Disease","n_participants":null,"pmid":"40118834","source_url":"https://pubmed.ncbi.nlm.nih.gov/40118834/","study_design":"narrative review","title":"Digital gait biomarkers in Parkinson\u2019s disease: susceptibility/risk, progression, response to exercise, and prognosis","title_match":false,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/adherence-and-intensity-in-multimodal-lifestyle-based-interventions-40098201","doi":"10.1186/s13195-025-01691-0","journal":"Alzheimer s Research & Therapy","n_participants":null,"pmid":"40098201","source_url":"https://pubmed.ncbi.nlm.nih.gov/40098201/","study_design":"narrative review","title":"Adherence and intensity in multimodal lifestyle-based interventions for cognitive decline prevention: state-of-the-art and future directions","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/cardiovascular-biomarkers-for-risk-stratification-in-primary-40795138","doi":"10.1093/eurheartj/ehaf517","journal":"European Heart Journal","n_participants":null,"pmid":"40795138","source_url":"https://pubmed.ncbi.nlm.nih.gov/40795138/","study_design":null,"title":"Cardiovascular biomarkers for risk stratification in primary prevention","title_match":false,"year":2025},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/immune-and-metabolic-effects-of-african-heritage-diets-versus-western-40181181","doi":"10.1038/s41591-025-03602-0","journal":"Nature Medicine","n_participants":null,"pmid":"40181181","source_url":"https://pubmed.ncbi.nlm.nih.gov/40181181/","study_design":"randomized controlled trial","title":"Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/multimorbidity-in-dementia-current-perspectives-and-future-challenges-40755143","doi":"10.1002/alz.70546","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40755143","source_url":"https://pubmed.ncbi.nlm.nih.gov/40755143/","study_design":null,"title":"Multimorbidity in dementia: Current perspectives and future challenges","title_match":false,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-integration-of-lifestyle-modification-advice-and-diet-and-41252315","doi":"10.1159/000548370","journal":"Obesity Facts","n_participants":null,"pmid":"41252315","source_url":"https://pubmed.ncbi.nlm.nih.gov/41252315/","study_design":"meta-analysis","title":"The Integration of Lifestyle Modification Advice and Diet and Physical Exercise Interventions: Cornerstones in the Management of Obesity with Incretin Mimetics","title_match":false,"year":2025},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/ultraprocessed-or-minimally-processed-diets-following-healthy-dietary-40760353","doi":"10.1038/s41591-025-03842-0","journal":"Nature Medicine","n_participants":55,"pmid":"40760353","source_url":"https://pubmed.ncbi.nlm.nih.gov/40760353/","study_design":null,"title":"Ultraprocessed or minimally processed diets following healthy dietary guidelines on weight and cardiometabolic health: a randomized, crossover trial","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/effects-of-b-vitamins-on-homocysteine-lowering-and-thrombotic-risk-40218880","doi":"10.3390/nu17071122","journal":"Nutrients","n_participants":null,"pmid":"40218880","source_url":"https://pubmed.ncbi.nlm.nih.gov/40218880/","study_design":null,"title":"Effects of B Vitamins on Homocysteine Lowering and Thrombotic Risk Reduction\u2014A Review of Randomized Controlled Trials Published Since January 1996","title_match":true,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/cardiovascular-disease-management-and-prevention-in-saudi-arabia-d3c9feab","doi":"10.1155/ijcp/7233591","journal":"International Journal of Clinical Practice","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1155/ijcp/7233591","study_design":null,"title":"Cardiovascular Disease Management and Prevention in Saudi Arabia: Strategies, Risk Factors, and Targeted Interventions","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/fracture-prevention-with-infrequent-zoledronate-in-women-50-to-60-39813642","doi":"10.1056/nejmoa2407031","journal":"New England Journal of Medicine","n_participants":null,"pmid":"39813642","source_url":"https://pubmed.ncbi.nlm.nih.gov/39813642/","study_design":null,"title":"Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/interventions-that-support-lifestyle-behavior-change-for-secondary-40294167","doi":"10.1161/strokeaha.124.045888","journal":"Stroke","n_participants":null,"pmid":"40294167","source_url":"https://pubmed.ncbi.nlm.nih.gov/40294167/","study_design":"longitudinal study","title":"Interventions That Support Lifestyle Behavior Change for Secondary Prevention of Stroke: A Scoping Review","title_match":false,"year":2025},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/hearing-loss-and-falls-40111358","doi":"10.1001/jamaoto.2025.0056","journal":"JAMA Otolaryngology\u2013Head & Neck Surgery","n_participants":935,"pmid":"40111358","source_url":"https://pubmed.ncbi.nlm.nih.gov/40111358/","study_design":"systematic review","title":"Hearing Loss and Falls","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/multicomponent-exercise-and-functional-fitness-strategies-for-fall-40559671","doi":"10.3390/sports13060159","journal":"Sports","n_participants":40,"pmid":"40559671","source_url":"https://pubmed.ncbi.nlm.nih.gov/40559671/","study_design":"randomized controlled trial","title":"Multicomponent Exercise and Functional Fitness: Strategies for Fall Prevention in Aging Women","title_match":false,"year":2025},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/a-village-doctor-led-mobile-health-intervention-for-cardiovascular-40425261","doi":"10.1136/bmj-2024-082765","journal":"BMJ","n_participants":4533,"pmid":"40425261","source_url":"https://pubmed.ncbi.nlm.nih.gov/40425261/","study_design":"randomized controlled trial","title":"A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial","title_match":true,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/montreal-cognitive-assessment-vs-the-mini-mental-state-examination-as-39951678","doi":"10.1212/wnl.0000000000213401","journal":"Neurology","n_participants":null,"pmid":"39951678","source_url":"https://pubmed.ncbi.nlm.nih.gov/39951678/","study_design":"cohort study","title":"Montreal Cognitive Assessment vs the Mini-Mental State Examination as a Screening Tool for Patients With Genetic Frontotemporal Dementia","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/interpreter-communication-quality-in-cognitive-assessments-for-39937478","doi":"10.1001/jamanetworkopen.2024.58069","journal":"JAMA Network Open","n_participants":126,"pmid":"39937478","source_url":"https://pubmed.ncbi.nlm.nih.gov/39937478/","study_design":null,"title":"Interpreter Communication Quality in Cognitive Assessments for Dementia","title_match":false,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/long-term-effect-of-intensive-vs-standard-blood-pressure-control-on-39819096","doi":"10.1212/wnl.0000000000213334","journal":"Neurology","n_participants":248,"pmid":"39819096","source_url":"https://pubmed.ncbi.nlm.nih.gov/39819096/","study_design":null,"title":"Long-Term Effect of Intensive vs Standard Blood Pressure Control on Mild Cognitive Impairment and Probable Dementia in SPRINT","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/potential-role-of-lymphovenous-bypass-in-mitigating-alzheimer-s-40709010","doi":"10.1055/a-2627-9243","journal":"Archives of Plastic Surgery","n_participants":null,"pmid":"40709010","source_url":"https://pubmed.ncbi.nlm.nih.gov/40709010/","study_design":"case report","title":"Potential Role of Lymphovenous Bypass in Mitigating Alzheimer's Disease Dementia","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/speech-based-digital-cognitive-assessments-for-detection-of-mild-40415342","doi":"10.1177/13872877251343296","journal":"Journal of Alzheimer s Disease","n_participants":110,"pmid":"40415342","source_url":"https://pubmed.ncbi.nlm.nih.gov/40415342/","study_design":null,"title":"Speech-based digital cognitive assessments for detection of mild cognitive impairment: Validation against paper-based neurocognitive assessment scores","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/utility-of-combination-of-mini-mental-state-examination-and-montreal-40770950","doi":"10.1177/13872877251365629","journal":"Journal of Alzheimer s Disease","n_participants":940,"pmid":"40770950","source_url":"https://pubmed.ncbi.nlm.nih.gov/40770950/","study_design":"post-hoc analysis","title":"Utility of combination of Mini-Mental State Examination and Montreal Cognitive Assessment to predict incident Alzheimer's disease dementia in patients at high vascular risks","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/concurrent-validity-testretest-reliability-and-normative-properties-40193495","doi":"10.1037/neu0001005","journal":"Neuropsychology","n_participants":null,"pmid":"40193495","source_url":"https://pubmed.ncbi.nlm.nih.gov/40193495/","study_design":null,"title":"Concurrent validity, test\u2013retest reliability, and normative properties of the ignite app: A cognitive assessment for frontotemporal dementia","title_match":false,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/comorbid-pathologies-and-their-impact-on-dementia-with-lewy-40868991","doi":"10.3390/ijms26167674","journal":"International Journal of Molecular Sciences","n_participants":null,"pmid":"40868991","source_url":"https://pubmed.ncbi.nlm.nih.gov/40868991/","study_design":null,"title":"Comorbid Pathologies and Their Impact on Dementia with Lewy Bodies\u2014Current View","title_match":false,"year":2025},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/eye-tracking-based-tablet-application-for-enhanced-cognitive-41116086","doi":"10.1007/s11357-025-01941-x","journal":"GeroScience","n_participants":null,"pmid":"41116086","source_url":"https://pubmed.ncbi.nlm.nih.gov/41116086/","study_design":null,"title":"Eye-tracking-based tablet application for enhanced cognitive assessment: a clinical trial for software as a medical device (SaMD)","title_match":true,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/hearing-and-cognitive-scores-measured-with-the-montreal-cognitive-39846386","doi":"10.1002/alz.14514","journal":"Alzheimer s & Dementia","n_participants":6879,"pmid":"39846386","source_url":"https://pubmed.ncbi.nlm.nih.gov/39846386/","study_design":"cohort study","title":"Hearing and cognitive scores measured with the Montreal Cognitive Assessment Scale in The HUNT Study, Norway","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/machine-learningbased-cognitive-assessment-with-the-autonomous-40737611","doi":"10.2196/67446","journal":"Journal of Medical Internet Research","n_participants":35,"pmid":"40737611","source_url":"https://pubmed.ncbi.nlm.nih.gov/40737611/","study_design":null,"title":"Machine Learning\u2013Based Cognitive Assessment With The Autonomous Cognitive Examination: Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/neurodetector-eeg-based-cognitive-assessment-using-event-related-41008292","doi":"10.3390/brainsci15090931","journal":"Brain Sciences","n_participants":null,"pmid":"41008292","source_url":"https://pubmed.ncbi.nlm.nih.gov/41008292/","study_design":null,"title":"Neurodetector: EEG-Based Cognitive Assessment Using Event-Related Potentials as a Virtual Switch","title_match":false,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/speechbased-digital-cognitive-assessment-for-clinical-trials-42151661","doi":"10.1002/alz.71462","journal":"Alzheimer s & Dementia","n_participants":736,"pmid":"42151661","source_url":"https://pubmed.ncbi.nlm.nih.gov/42151661/","study_design":"longitudinal study","title":"Speech\u2010based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts","title_match":true,"year":2026},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/implications-and-opportunities-regarding-biological-frameworks-in-40684248","doi":"10.1002/alz.70470","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40684248","source_url":"https://pubmed.ncbi.nlm.nih.gov/40684248/","study_design":null,"title":"Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies","title_match":false,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/determinants-of-dementia-risk-among-older-adults-with-probable-40133853","doi":"10.1186/s12889-025-22065-z","journal":"BMC Public Health","n_participants":null,"pmid":"40133853","source_url":"https://pubmed.ncbi.nlm.nih.gov/40133853/","study_design":null,"title":"Determinants of dementia risk among older adults with probable sarcopenia and sarcopenia","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/assessing-cognition-remotely-expanding-the-reach-of-cognitive-testing-40051592","doi":"10.5770/cgj.28.790","journal":"Canadian Geriatrics Journal","n_participants":52,"pmid":"40051592","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051592/","study_design":null,"title":"Assessing Cognition Remotely: Expanding the Reach of Cognitive Testing for Older Adults at Risk for Dementia in a Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/cognitive-trajectories-from-preclinical-alzheimer-s-disease-to-41910174","doi":"10.1002/advs.202518124","journal":"Advanced Science","n_participants":1447,"pmid":"41910174","source_url":"https://pubmed.ncbi.nlm.nih.gov/41910174/","study_design":null,"title":"Cognitive Trajectories from Preclinical Alzheimer's Disease to Dementia","title_match":false,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/loneliness-trajectories-and-dementia-risk-insights-from-the-hunt-40735047","doi":"10.1002/dad2.70154","journal":"Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring","n_participants":9389,"pmid":"40735047","source_url":"https://pubmed.ncbi.nlm.nih.gov/40735047/","study_design":null,"title":"Loneliness trajectories and dementia risk: Insights from the HUNT cohort study","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/the-role-of-amyloid-and-tau-pet-in-the-new-era-of-alzheimer-disease-41290365","doi":"10.2967/jnumed.124.268339","journal":"Journal of Nuclear Medicine","n_participants":null,"pmid":"41290365","source_url":"https://pubmed.ncbi.nlm.nih.gov/41290365/","study_design":null,"title":"The Role of Amyloid- and Tau PET in the New Era of Alzheimer Disease Therapies","title_match":false,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/amyloid-and-tau-pathology-in-cognitively-unimpaired-individuals-with-40203224","doi":"10.1212/wnl.0000000000213507","journal":"Neurology","n_participants":243,"pmid":"40203224","source_url":"https://pubmed.ncbi.nlm.nih.gov/40203224/","study_design":"longitudinal study","title":"Amyloid and Tau Pathology in Cognitively Unimpaired Individuals With a Parental History of Alzheimer Disease","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/high-throughput-phenotyping-of-the-symptoms-of-alzheimer-disease-and-40460418","doi":"10.2196/66926","journal":"JMIR AI","n_participants":null,"pmid":"40460418","source_url":"https://pubmed.ncbi.nlm.nih.gov/40460418/","study_design":null,"title":"High-Throughput Phenotyping of the Symptoms of Alzheimer Disease and Related Dementias Using Large Language Models: Cross-Sectional Study","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/longitudinal-evaluation-of-18-f-mk-6240-along-the-alzheimer-disease-41927280","doi":"10.2967/jnumed.125.271127","journal":"Journal of Nuclear Medicine","n_participants":27,"pmid":"41927280","source_url":"https://pubmed.ncbi.nlm.nih.gov/41927280/","study_design":"longitudinal study","title":"Longitudinal Evaluation of 18 F-MK-6240 Along the Alzheimer Disease Continuum","title_match":false,"year":2026},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/a-harmonized-visual-reading-framework-for-tau-pet-staging-in-42766299","doi":"10.1001/jamaneurol.2026.3253","journal":"JAMA Neurology","n_participants":681,"pmid":"42766299","source_url":"https://pubmed.ncbi.nlm.nih.gov/42766299/","study_design":"cross-sectional","title":"A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease","title_match":false,"year":2026},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/cyclic-2-5d-perceptual-loss-for-crossmodal-3d-medical-image-synthesis-41968275","doi":"10.1002/hbm.70508","journal":"Human Brain Mapping","n_participants":null,"pmid":"41968275","source_url":"https://pubmed.ncbi.nlm.nih.gov/41968275/","study_design":null,"title":"Cyclic 2.5D Perceptual Loss for Cross\u2010Modal 3D Medical Image Synthesis: T1w MRI to Tau PET","title_match":false,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/the-clinical-prognosis-of-cognitively-unimpaired-individuals-with-41439799","doi":"10.1002/alz70856_096588","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41439799","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12729469/","study_design":"cohort study","title":"The clinical prognosis of cognitively unimpaired individuals with positive PET biomarkers","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/burden-and-care-time-for-dementia-caregivers-in-the-live-home-path-40042468","doi":"10.1002/alz.14622","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40042468","source_url":"https://pubmed.ncbi.nlm.nih.gov/40042468/","study_design":"randomized controlled trial","title":"Burden and care time for dementia caregivers in the LIVE@Home.Path trial","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/implementation-of-telemedicine-for-patients-with-dementia-and-their-40324768","doi":"10.2196/65667","journal":"Journal of Medical Internet Research","n_participants":54,"pmid":"40324768","source_url":"https://pubmed.ncbi.nlm.nih.gov/40324768/","study_design":"randomized controlled trial","title":"Implementation of Telemedicine for Patients With Dementia and Their Caregivers: Scoping Review","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/impact-of-neuropsychiatric-symptoms-on-caregiver-burden-of-people-40390335","doi":"10.1111/psyg.70051","journal":"Psychogeriatrics","n_participants":30,"pmid":"40390335","source_url":"https://pubmed.ncbi.nlm.nih.gov/40390335/","study_design":null,"title":"Impact of Neuropsychiatric Symptoms on Caregiver Burden of People With Dementia With Lewy Bodies: A Multicentre Prospective Longitudinal Study","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/videoconference-delivered-acceptance-and-commitment-therapy-for-40163859","doi":"10.2196/67545","journal":"JMIR Formative Research","n_participants":16,"pmid":"40163859","source_url":"https://pubmed.ncbi.nlm.nih.gov/40163859/","study_design":"randomized controlled trial","title":"Videoconference-Delivered Acceptance and Commitment Therapy for Family Caregivers of People With Dementia: Pilot Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/patient-and-caregiver-outcomes-of-health-system-community-based-and-40892399","doi":"10.1001/jamainternmed.2025.4247","journal":"JAMA Internal Medicine","n_participants":1271,"pmid":"40892399","source_url":"https://pubmed.ncbi.nlm.nih.gov/40892399/","study_design":null,"title":"Patient and Caregiver Outcomes of Health System, Community-Based, and Usual Dementia Care","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/supporting-informal-dementia-caregivers-through-an-isupport-web-based-40925598","doi":"10.2196/77688","journal":"Journal of Medical Internet Research","n_participants":60,"pmid":"40925598","source_url":"https://pubmed.ncbi.nlm.nih.gov/40925598/","study_design":"randomized controlled trial","title":"Supporting Informal Dementia Caregivers Through an iSupport Web-Based Primary Health Care Intervention: Hybrid Effectiveness-Implementation Mixed Methods Study","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/identifying-and-addressing-unmet-needs-in-dementia-the-role-of-care-40148225","doi":"10.1002/gps.70066","journal":"International Journal of Geriatric Psychiatry","n_participants":417,"pmid":"40148225","source_url":"https://pubmed.ncbi.nlm.nih.gov/40148225/","study_design":null,"title":"Identifying and Addressing Unmet Needs in Dementia: The Role of Care Access and Psychosocial Support","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/informal-caregivers-perspectives-on-participation-in-a-dementia-39950207","doi":"10.1080/11038128.2025.2463374","journal":"Scandinavian Journal of Occupational Therapy","n_participants":null,"pmid":"39950207","source_url":"https://pubmed.ncbi.nlm.nih.gov/39950207/","study_design":null,"title":"Informal caregivers\u2019 perspectives on participation in a dementia rehabilitation programme","title_match":false,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/effects-of-a-virtual-isupport-program-on-carers-and-people-with-41023309","doi":"10.1002/alz.70747","journal":"Alzheimer s & Dementia","n_participants":149,"pmid":"41023309","source_url":"https://pubmed.ncbi.nlm.nih.gov/41023309/","study_design":"randomized controlled trial","title":"Effects of a virtual iSupport Program on carers and people with dementia","title_match":false,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/smartphone-app-based-psychoeducation-for-caregivers-of-people-with-41000210","doi":"10.2147/cia.s551994","journal":"Clinical Interventions in Aging","n_participants":null,"pmid":"41000210","source_url":"https://pubmed.ncbi.nlm.nih.gov/41000210/","study_design":"randomized controlled trial","title":"Smartphone App-Based Psychoeducation for Caregivers of People with Dementia in Vietnam: A Pilot Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/the-effects-of-a-mobile-application-based-dementia-care-intelligent-41642176","doi":"10.1093/ageing/afag021","journal":"Age and Ageing","n_participants":125,"pmid":"41642176","source_url":"https://pubmed.ncbi.nlm.nih.gov/41642176/","study_design":null,"title":"The effects of a mobile application-based dementia care intelligent recommender system on caregivers of people with dementia: a randomized controlled trial","title_match":true,"year":2026},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/mobile-app-psychoeducation-for-dementia-caregivers-in-vietnam-a-41158517","doi":"10.2147/jmdh.s557573","journal":"Journal of Multidisciplinary Healthcare","n_participants":172,"pmid":"41158517","source_url":"https://pubmed.ncbi.nlm.nih.gov/41158517/","study_design":"randomized controlled trial","title":"Mobile App Psychoeducation for Dementia Caregivers In Vietnam: A Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/namaste-care-family-for-people-with-dementia-and-familya-randomized-40684251","doi":"10.1002/alz.70495","journal":"Alzheimer s & Dementia","n_participants":116,"pmid":"40684251","source_url":"https://pubmed.ncbi.nlm.nih.gov/40684251/","study_design":"randomized controlled trial","title":"Namaste Care Family for people with dementia and family\u2212A randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/predicting-psychological-distress-in-informal-caregivers-of-older-41126193","doi":"10.1186/s12912-025-03905-0","journal":"BMC Nursing","n_participants":null,"pmid":"41126193","source_url":"https://pubmed.ncbi.nlm.nih.gov/41126193/","study_design":"cross-sectional","title":"Predicting psychological distress in informal caregivers of older people with dementia: development and interpretation of a nomogram and XGBoost model","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/supporting-dementia-caregiving-with-a-mobile-care-ecosystem-41543360","doi":"10.2196/78759","journal":"JMIR Aging","n_participants":null,"pmid":"41543360","source_url":"https://pubmed.ncbi.nlm.nih.gov/41543360/","study_design":"clinical trial","title":"Supporting Dementia Caregiving With a Mobile Care Ecosystem: Development and Mixed Methods Study","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/process-evaluation-in-a-randomised-controlled-trial-of-dreams-start-40116618","doi":"10.1093/ageing/afaf053","journal":"Age and Ageing","n_participants":null,"pmid":"40116618","source_url":"https://pubmed.ncbi.nlm.nih.gov/40116618/","study_design":"randomized controlled trial","title":"Process evaluation in a randomised controlled trial of DREAMS-START (dementia related manual for sleep; strategies for relatives) for sleep disturbance in people with dementia and their carers","title_match":true,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/black-raspberry-supplementation-on-overweight-and-helicobacter-pylori-39939643","doi":"10.1038/s41538-024-00356-w","journal":"npj Science of Food","n_participants":null,"pmid":"39939643","source_url":"https://pubmed.ncbi.nlm.nih.gov/39939643/","study_design":null,"title":"Black raspberry supplementation on overweight and Helicobacter pylori infected mild dementia patients a pilot study","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/innovations-in-dementia-empowerment-and-action-rct-for-underserved-41387197","doi":"10.1111/jgs.70189","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"41387197","source_url":"https://pubmed.ncbi.nlm.nih.gov/41387197/","study_design":"randomized controlled trial","title":"Innovations in Dementia Empowerment and Action: RCT for Underserved Communities","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/convening-hispanic-latino-caregiving-advisors-for-inclusive-research-39874544","doi":"10.1089/jpm.2024.0335","journal":"Journal of Palliative Medicine","n_participants":null,"pmid":"39874544","source_url":"https://pubmed.ncbi.nlm.nih.gov/39874544/","study_design":null,"title":"Convening Hispanic/Latino Caregiving Advisors for Inclusive Research in Dementia Palliative Care","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/retracted-evaluating-the-clinical-efficacy-of-an-exergame-based-39969990","doi":"10.2196/69109","journal":"Journal of Medical Internet Research","n_participants":232,"pmid":"39969990","source_url":"https://pubmed.ncbi.nlm.nih.gov/39969990/","study_design":null,"title":"Retracted: Evaluating the Clinical Efficacy of an Exergame-Based Training Program for Enhancing Physical and Cognitive Functions in Older Adults With Mild Cognitive Impairment and Dementia Residing in Rural Long-Term Care Facilities: Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-holy-grail-highlighting-the-need-for-equitable-access-to-dementia-39995763","doi":"10.1016/j.lanwpc.2025.101492","journal":"The Lancet Regional Health - Western Pacific","n_participants":null,"pmid":"39995763","source_url":"https://pubmed.ncbi.nlm.nih.gov/39995763/","study_design":null,"title":"The Holy Grail: highlighting the need for equitable access to dementia treatments and clinical trials","title_match":true,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/creating-harmony-at-home-via-environmental-cueing-a-feasibility-trial-40621818","doi":"10.1002/alz.70405","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40621818","source_url":"https://pubmed.ncbi.nlm.nih.gov/40621818/","study_design":"open-label trial","title":"Creating harmony at home via environmental cueing: A feasibility trial of a non\u2010pharmacological intervention for rural caregivers of persons with dementia","title_match":false,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/disparities-in-clinical-trial-participation-for-hearing-loss-40285653","doi":"10.1002/lary.32213","journal":"The Laryngoscope","n_participants":null,"pmid":"40285653","source_url":"https://pubmed.ncbi.nlm.nih.gov/40285653/","study_design":null,"title":"Disparities in Clinical Trial Participation for Hearing Loss Treatment and Cognitive Outcomes in the United States: A Scoping Review","title_match":true,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/older-adults-living-with-alzheimers-disease-dementia-or-mild-40253707","doi":"10.1080/13607863.2025.2468893","journal":"Aging & Mental Health","n_participants":15,"pmid":"40253707","source_url":"https://pubmed.ncbi.nlm.nih.gov/40253707/","study_design":"randomized controlled trial","title":"Older adults living with Alzheimer\u2019s Disease, dementia or mild cognitive impairment with no informal caregiver or care partner: IDEA Caf\u00e9, the first pilot randomized trial intervention for this underserved populations","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/association-of-zinc-deficiency-and-risk-of-new-onset-dementia-a-41262731","doi":"10.3389/fnut.2025.1666887","journal":"Frontiers in Nutrition","n_participants":34249,"pmid":"41262731","source_url":"https://pubmed.ncbi.nlm.nih.gov/41262731/","study_design":"cohort study","title":"Association of zinc deficiency and risk of new-onset dementia: a retrospective cohort study","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/associations-of-semaglutide-with-alzheimer-s-disease-related-40552638","doi":"10.1177/13872877251351329","journal":"Journal of Alzheimer s Disease","n_participants":null,"pmid":"40552638","source_url":"https://pubmed.ncbi.nlm.nih.gov/40552638/","study_design":null,"title":"Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimers-disease-exploring-pathophysiological-hypotheses-and-the-39940772","doi":"10.3390/ijms26031004","journal":"International Journal of Molecular Sciences","n_participants":null,"pmid":"39940772","source_url":"https://pubmed.ncbi.nlm.nih.gov/39940772/","study_design":null,"title":"Alzheimer\u2019s Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/artificial-intelligence-in-drug-development-for-delirium-and-41049735","doi":"10.1016/j.apsb.2025.04.026","journal":"Acta Pharmaceutica Sinica B","n_participants":null,"pmid":"41049735","source_url":"https://pubmed.ncbi.nlm.nih.gov/41049735/","study_design":null,"title":"Artificial intelligence in drug development for delirium and Alzheimer\u2019s disease","title_match":false,"year":2025},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-european-multicenter-network-for-the-implementation-of-artificial-39855632","doi":"10.1055/a-2508-5708","journal":"Thrombosis and Haemostasis","n_participants":null,"pmid":"39855632","source_url":"https://pubmed.ncbi.nlm.nih.gov/39855632/","study_design":"meta-analysis","title":"A European-Multicenter Network for the Implementation of Artificial Intelligence to Manage Complexity and Comorbidities of Atrial Fibrillation Patients: The ARISTOTELES Consortium","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/machine-learning-models-for-dementia-screening-to-classify-brain-39838434","doi":"10.1186/s13195-024-01650-1","journal":"Alzheimer s Research & Therapy","n_participants":15,"pmid":"39838434","source_url":"https://pubmed.ncbi.nlm.nih.gov/39838434/","study_design":null,"title":"Machine learning models for dementia screening to classify brain amyloid positivity on positron emission tomography using blood markers and demographic characteristics: a retrospective observational study","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/the-role-for-artificial-intelligence-in-identifying-combination-41145341","doi":"10.1016/j.tjpad.2025.100366","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":null,"pmid":"41145341","source_url":"https://pubmed.ncbi.nlm.nih.gov/41145341/","study_design":null,"title":"The role for artificial intelligence in identifying combination therapies for Alzheimer\u2019s disease","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/acceptability-of-wearable-technology-for-the-early-detection-of-40893385","doi":"10.1186/s44247-025-00191-3","journal":"BMC Digital Health","n_participants":null,"pmid":"40893385","source_url":"https://pubmed.ncbi.nlm.nih.gov/40893385/","study_design":null,"title":"Acceptability of wearable technology for the early detection of dementia-causing diseases: perspectives from the CODEC II cohort","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-application-of-artificial-intelligence-to-older-adults-with-41556097","doi":"10.1177/07334648251408185","journal":"Journal of Applied Gerontology","n_participants":15,"pmid":"41556097","source_url":"https://pubmed.ncbi.nlm.nih.gov/41556097/","study_design":null,"title":"The Application of Artificial Intelligence to Older Adults With Disabilities: A Scoping Review","title_match":false,"year":2026},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/machine-learningenhanced-screening-funnel-for-clinical-trials-in-40276322","doi":"10.1002/trc2.70084","journal":"Alzheimer s & Dementia Translational Research & Clinical Interventions","n_participants":null,"pmid":"40276322","source_url":"https://pubmed.ncbi.nlm.nih.gov/40276322/","study_design":null,"title":"Machine learning\u2013enhanced screening funnel for clinical trials in Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/social-isolation-and-loneliness-as-modifiable-risk-factors-for-2107eb6a","doi":"10.36922/an025220067","journal":"Advanced Neurology","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.36922/an025220067","study_design":"meta-analysis","title":"Social isolation and loneliness as modifiable risk factors for dementia: Evidence-based interventions and public health implications","title_match":false,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/the-effect-of-hypertension-on-cognitive-decline-and-dementia-a-meta-9ee4e49b","doi":"10.26502/fccm.92920425","journal":"Cardiology and Cardiovascular Medicine","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.26502/fccm.92920425","study_design":"meta-analysis","title":"The Effect of Hypertension on Cognitive Decline and Dementia: A Meta- Analysis","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/bace1-as-an-early-biomarker-and-its-relevance-to-risk-factors-for-40706761","doi":"10.1016/j.brainresbull.2025.111475","journal":"Brain Research Bulletin","n_participants":null,"pmid":"40706761","source_url":"https://pubmed.ncbi.nlm.nih.gov/40706761/","study_design":null,"title":"BACE1 as an early biomarker and its relevance to risk factors for Alzheimer\u2019s disease","title_match":false,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-and-frontotemporal-dementia-a-review-of-40387258","doi":"10.1002/jnr.70046","journal":"Journal of Neuroscience Research","n_participants":null,"pmid":"40387258","source_url":"https://pubmed.ncbi.nlm.nih.gov/40387258/","study_design":null,"title":"Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/mechanisms-underlying-cognitive-impairment-and-management-strategies-41169480","doi":"10.3389/fendo.2025.1655768","journal":"Frontiers in Endocrinology","n_participants":null,"pmid":"41169480","source_url":"https://pubmed.ncbi.nlm.nih.gov/41169480/","study_design":null,"title":"Mechanisms underlying cognitive impairment and management strategies in type 2 diabetes","title_match":false,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/repetitive-transcranial-magnetic-stimulation-and-tai-chi-chuan-for-39792383","doi":"10.1001/jamanetworkopen.2024.54307","journal":"JAMA Network Open","n_participants":55,"pmid":"39792383","source_url":"https://pubmed.ncbi.nlm.nih.gov/39792383/","study_design":null,"title":"Repetitive Transcranial Magnetic Stimulation and Tai Chi Chuan for Older Adults With Sleep Disorders and Mild Cognitive Impairment","title_match":false,"year":2025},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/the-down-alzheimer-barcelona-neuroimaging-initiative-dabni-ten-years-41518664","doi":"10.1002/alz70856_106426","journal":"Alzheimer s & Dementia","n_participants":1135,"pmid":"41518664","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12790410/","study_design":"longitudinal study","title":"The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI): Ten Years of Progress in Understanding Alzheimer's in Down Syndrome","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/mild-premorbid-intellectual-impairment-as-a-resilience-factor-in-down-41442130","doi":"10.1002/alz70856_099392","journal":"Alzheimer s & Dementia","n_participants":455,"pmid":"41442130","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12732624/","study_design":"cross-sectional","title":"Mild premorbid intellectual impairment as a resilience factor in Down syndrome associated Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/distinct-sensitivity-of-mri-versus-18-f-fdgpet-to-detect-cerebral-294a9f95","doi":"10.1002/alz70856_107114","journal":"Alzheimer s & Dementia","n_participants":29,"pmid":null,"source_url":"https://doi.org/10.1002/alz70856_107114","study_design":null,"title":"Distinct Sensitivity of MRI Versus [ 18 F]FDG\u2010PET To Detect Cerebral Changes Across the Alzheimer's Continuum in Down Syndrome: A Multimodal Imaging Study","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/vascular-dementia-from-pathophysiology-to-therapeutic-frontiers-41010812","doi":"10.3390/jcm14186611","journal":"Journal of Clinical Medicine","n_participants":null,"pmid":"41010812","source_url":"https://pubmed.ncbi.nlm.nih.gov/41010812/","study_design":null,"title":"Vascular Dementia: From Pathophysiology to Therapeutic Frontiers","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/deconstructing-the-intercellular-interactome-in-vascular-dementia-40592323","doi":"10.1016/j.cell.2025.06.002","journal":"Cell","n_participants":null,"pmid":"40592323","source_url":"https://pubmed.ncbi.nlm.nih.gov/40592323/","study_design":null,"title":"Deconstructing the intercellular interactome in vascular dementia with focal ischemia for therapeutic applications","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/longitudinal-fdg-pet-metabolic-change-along-the-lewy-body-continuum-39804619","doi":"10.1001/jamaneurol.2024.4643","journal":"JAMA Neurology","n_participants":72,"pmid":"39804619","source_url":"https://pubmed.ncbi.nlm.nih.gov/39804619/","study_design":"case-control study","title":"Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/overlap-in-the-diagnostic-criteria-of-frontotemporal-dementia-39956963","doi":"10.1177/13872877251316804","journal":"Journal of Alzheimer s Disease","n_participants":2751,"pmid":"39956963","source_url":"https://pubmed.ncbi.nlm.nih.gov/39956963/","study_design":null,"title":"Overlap in the diagnostic criteria of frontotemporal dementia syndromes with parkinsonism","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/frontotemporal-dementia-as-a-consequence-of-grn-mutations-from-40972833","doi":"10.1016/j.phrs.2025.107957","journal":"Pharmacological Research","n_participants":null,"pmid":"40972833","source_url":"https://pubmed.ncbi.nlm.nih.gov/40972833/","study_design":null,"title":"Frontotemporal dementia as a consequence of GRN mutations: From disease cause to models to therapies","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/structural-and-functional-connectivity-in-tau-mutation-carriers-from-40673371","doi":"10.1002/alz.70367","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40673371","source_url":"https://pubmed.ncbi.nlm.nih.gov/40673371/","study_design":null,"title":"Structural and functional connectivity in tau mutation carriers: from presymptomatic to symptomatic frontotemporal dementia","title_match":false,"year":2025},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/phase-2-study-of-palmitoylethanolamide-combined-with-luteoline-in-40046339","doi":"10.1093/braincomms/fcaf080","journal":"Brain Communications","n_participants":25,"pmid":"40046339","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046339/","study_design":"clinical trial","title":"Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients","title_match":true,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/ethics-of-disclosure-of-onsetpredictive-biomarker-test-results-for-40502924","doi":"10.1002/dad2.70133","journal":"Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring","n_participants":null,"pmid":"40502924","source_url":"https://pubmed.ncbi.nlm.nih.gov/40502924/","study_design":null,"title":"Ethics of disclosure of onset\u2010predictive biomarker test results for genetic frontotemporal dementia in the research context","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/quantitative-susceptibility-mapping-reveals-differences-between-40904193","doi":"10.1093/brain/awaf325","journal":"Brain","n_participants":66,"pmid":"40904193","source_url":"https://pubmed.ncbi.nlm.nih.gov/40904193/","study_design":null,"title":"Quantitative susceptibility mapping reveals differences between subtypes of Lewy body dementia","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/lewy-body-dementia-research-in-latin-america-a-scoping-review-40256832","doi":"10.1002/mdc3.70059","journal":"Movement Disorders Clinical Practice","n_participants":null,"pmid":"40256832","source_url":"https://pubmed.ncbi.nlm.nih.gov/40256832/","study_design":"cohort study","title":"Lewy Body Dementia Research in Latin America: A Scoping Review","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/phase-2-study-of-zervimesine-ct1812-in-participants-with-41416579","doi":"10.1002/alz.71004","journal":"Alzheimer s & Dementia","n_participants":293,"pmid":"41416579","source_url":"https://pubmed.ncbi.nlm.nih.gov/41416579/","study_design":null,"title":"Phase 2 study of zervimesine (CT1812) in participants with mild\u2010to\u2010moderate dementia with Lewy bodies (DLB)","title_match":true,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/novel-approaches-for-the-treatment-of-frontotemporal-dementia-is-40804782","doi":"10.1080/14737175.2025.2546867","journal":"Expert Review of Neurotherapeutics","n_participants":null,"pmid":"40804782","source_url":"https://pubmed.ncbi.nlm.nih.gov/40804782/","study_design":null,"title":"Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?","title_match":false,"year":2025},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/fluid-biomarkers-in-familial-frontotemporal-dementia-progress-and-40901664","doi":"10.3389/fneur.2025.1663609","journal":"Frontiers in Neurology","n_participants":null,"pmid":"40901664","source_url":"https://pubmed.ncbi.nlm.nih.gov/40901664/","study_design":null,"title":"Fluid biomarkers in familial frontotemporal dementia: progress and prospects","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/brainderived-tau-to-measure-treatment-effect-in-alzheimer-s-disease-40487537","doi":"10.1002/dad2.70123","journal":"Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring","n_participants":null,"pmid":"40487537","source_url":"https://pubmed.ncbi.nlm.nih.gov/40487537/","study_design":null,"title":"Brain\u2010derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/the-role-of-quantitative-eeg-biomarkers-in-alzheimers-disease-and-40336944","doi":"10.3389/fnagi.2025.1522552","journal":"Frontiers in Aging Neuroscience","n_participants":null,"pmid":"40336944","source_url":"https://pubmed.ncbi.nlm.nih.gov/40336944/","study_design":null,"title":"The role of quantitative EEG biomarkers in Alzheimer\u2019s disease and mild cognitive impairment: applications and insights","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/effects-of-an-integrated-social-art-intervention-on-cognitive-and-40316979","doi":"10.1186/s12916-025-04085-z","journal":"BMC Medicine","n_participants":null,"pmid":"40316979","source_url":"https://pubmed.ncbi.nlm.nih.gov/40316979/","study_design":"randomized controlled trial","title":"Effects of an integrated social-art intervention on cognitive and psychosocial outcomes among older adults with mild cognitive impairment in nursing homes: a mixed methods study","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/oral-diadochokinesis-performance-correlates-with-mild-cognitive-40462097","doi":"10.1186/s12903-025-06289-4","journal":"BMC Oral Health","n_participants":null,"pmid":"40462097","source_url":"https://pubmed.ncbi.nlm.nih.gov/40462097/","study_design":"cohort study","title":"Oral diadochokinesis performance correlates with mild cognitive impairment: a cross-sectional study","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/a-fourarm-randomized-controlled-trial-on-the-effects-of-41433843","doi":"10.1002/alz70860_098518","journal":"Alzheimer s & Dementia","n_participants":65,"pmid":"41433843","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12725420/","study_design":"randomized controlled trial","title":"A Four\u2010Arm Randomized Controlled Trial on the Effects of Multi\u2010Dimensional Cognitive Intervention in Parkinson's Disease Patients with Mild Cognitive Impairment and Subjective Cognitive Decline (REMIND)","title_match":true,"year":2025},{"alzhub_score":31,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-due-to-cerebrovascular-disease-and-72d29644","doi":"10.14412/2074-2711-2025-3-77-83","journal":"Neurology neuropsychiatry Psychosomatics","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.14412/2074-2711-2025-3-77-83","study_design":null,"title":"Mild cognitive impairment due to cerebrovascular disease and Alzheimer\u2019s","title_match":false,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/probiotic-supplementation-improves-the-clinical-measures-of-cognition-40918855","doi":"10.7759/cureus.89302","journal":"Cureus","n_participants":null,"pmid":"40918855","source_url":"https://pubmed.ncbi.nlm.nih.gov/40918855/","study_design":null,"title":"Probiotic Supplementation Improves the Clinical Measures of Cognition in Patients With Mild Cognitive Impairment","title_match":false,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/csf-biomarkerbased-cognitive-trajectories-in-parkinson-s-40501082","doi":"10.1002/acn3.70075","journal":"Annals of Clinical and Translational Neurology","n_participants":50,"pmid":"40501082","source_url":"https://pubmed.ncbi.nlm.nih.gov/40501082/","study_design":"cohort study","title":"CSF Biomarker\u2010Based Cognitive Trajectories in Parkinson's Disease\u2010Subjective Cognitive Decline","title_match":false,"year":2025},{"alzhub_score":29,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-a-pre-dementia-syndrome-194e158e","doi":"10.48087/bjmsra.2025.12324","journal":"Batna Journal of Medical Sciences (BJMS)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.48087/bjmsra.2025.12324","study_design":null,"title":"Mild Cognitive Impairment: A Pre-Dementia Syndrome","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/comprehensive-anatomical-staging-predicts-clinical-progression-in-40564976","doi":"10.3390/ijms26125514","journal":"International Journal of Molecular Sciences","n_participants":504,"pmid":"40564976","source_url":"https://pubmed.ncbi.nlm.nih.gov/40564976/","study_design":null,"title":"Comprehensive Anatomical Staging Predicts Clinical Progression in Mild Cognitive Impairment: A Data-Driven Approach","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/a-mobile-based-multidomain-lifestyle-intervention-using-cognitive-39833671","doi":"10.1186/s12877-025-05684-4","journal":"BMC Geriatrics","n_participants":null,"pmid":"39833671","source_url":"https://pubmed.ncbi.nlm.nih.gov/39833671/","study_design":null,"title":"A mobile-based multidomain lifestyle intervention using Cognitive Evergreenland for older adults with subjective cognitive decline: a feasibility study","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/timedependent-biomarker-accuracy-in-forecasting-mild-cognitive-41433380","doi":"10.1002/alz70862_110285","journal":"Alzheimer s & Dementia","n_participants":102,"pmid":"41433380","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12725005/","study_design":"longitudinal study","title":"Time\u2010dependent biomarker accuracy in forecasting mild cognitive impairment","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/a-pilot-randomized-controlled-double-blind-trial-of-intermittent-40170189","doi":"10.1186/s40814-025-01625-5","journal":"Pilot and Feasibility Studies","n_participants":20,"pmid":"40170189","source_url":"https://pubmed.ncbi.nlm.nih.gov/40170189/","study_design":null,"title":"A pilot randomized controlled double-blind trial of intermittent theta burst stimulation (iTBS) repetitive transcranial magnetic stimulation (rTMS) to improve memory in mild cognitive impairment (MCI): a study protocol","title_match":true,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/identifying-exercise-interventions-that-may-slow-the-progression-of-40255800","doi":"10.7759/cureus.80895","journal":"Cureus","n_participants":1075,"pmid":"40255800","source_url":"https://pubmed.ncbi.nlm.nih.gov/40255800/","study_design":"meta-analysis","title":"Identifying Exercise Interventions That May Slow the Progression of Cognitive Decline in Older Adults With Mild Cognitive Impairment: A Scoping Review","title_match":false,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/effects-of-intensive-lifestyle-changes-on-the-progression-of-mild-39893378","doi":"10.1186/s13195-024-01621-6","journal":"Alzheimer s Research & Therapy","n_participants":null,"pmid":"39893378","source_url":"https://pubmed.ncbi.nlm.nih.gov/39893378/","study_design":null,"title":"Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer\u2019s disease: the need for rigor","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/improved-cognitive-function-efficiency-saccadic-eye-movement-and-40702818","doi":"10.1177/13872877251361033","journal":"Journal of Alzheimer s Disease","n_participants":25,"pmid":"40702818","source_url":"https://pubmed.ncbi.nlm.nih.gov/40702818/","study_design":null,"title":"Improved cognitive function, efficiency, saccadic eye movement, and depressive symptoms in mild cognitive impairment with transcranial photobiomodulation","title_match":false,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/repeated-plasma-ptau217-measurements-to-monitor-clinical-progression-40442871","doi":"10.1002/alz.70319","journal":"Alzheimer s & Dementia","n_participants":186,"pmid":"40442871","source_url":"https://pubmed.ncbi.nlm.nih.gov/40442871/","study_design":"longitudinal study","title":"Repeated plasma p\u2010tau217 measurements to monitor clinical progression heterogeneity","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/predicting-the-beneficial-effects-of-cognitive-stimulation-and-40004217","doi":"10.3390/ijms26041754","journal":"International Journal of Molecular Sciences","n_participants":null,"pmid":"40004217","source_url":"https://pubmed.ncbi.nlm.nih.gov/40004217/","study_design":null,"title":"Predicting the Beneficial Effects of Cognitive Stimulation and Transcranial Direct Current Stimulation in Amnestic Mild Cognitive Impairment with Clinical, Inflammation, and Human Microglia Exposed to Serum as Potential Markers: A Double-Blind Placebo-Controlled Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/family-caregiver-perspectives-on-administering-home-based-stimulation-41834385","doi":"10.1177/13872877261429857","journal":"Journal of Alzheimer s Disease","n_participants":null,"pmid":"41834385","source_url":"https://pubmed.ncbi.nlm.nih.gov/41834385/","study_design":null,"title":"Family caregiver perspectives on administering home-based stimulation in patients with mild cognitive impairment","title_match":false,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/nonpharmacological-multicomponent-intervention-for-mild-cognitive-12e6dfb4","doi":"10.1186/s40814-026-01871-1","journal":"PubMed Central","n_participants":40,"pmid":null,"source_url":"https://doi.org/10.1186/s40814-026-01871-1","study_design":null,"title":"Nonpharmacological multicomponent intervention for mild cognitive impairment with a family-patient approach: protocol for the pilot clinical trial\u2014INTERCOG study","title_match":true,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/evaluating-the-effects-of-liraglutide-empagliflozin-and-linagliptin-40840993","doi":"10.1136/bmjopen-2024-095382","journal":"BMJ Open","n_participants":396,"pmid":"40840993","source_url":"https://pubmed.ncbi.nlm.nih.gov/40840993/","study_design":"open-label trial","title":"Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase","title_match":true,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/sex-specific-effects-of-apolipoprotein-e-4-genotype-on-longitudinal-39924830","doi":"10.1177/13872877241313066","journal":"Journal of Alzheimer s Disease","n_participants":73,"pmid":"39924830","source_url":"https://pubmed.ncbi.nlm.nih.gov/39924830/","study_design":"longitudinal study","title":"Sex-specific effects of apolipoprotein E \u03b54 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/novel-fully-human-high-affinity-anti-trem2-antibody-shows-efficacy-in-40405265","doi":"10.1186/s13195-025-01759-x","journal":"Alzheimer s Research & Therapy","n_participants":null,"pmid":"40405265","source_url":"https://pubmed.ncbi.nlm.nih.gov/40405265/","study_design":null,"title":"Novel fully human high-affinity anti-TREM2 antibody shows efficacy in clinically relevant Alzheimer\u00b4s mouse model","title_match":false,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/developments-on-bace-1-inhibitors-as-antialzheimer-agents-a-41838033","doi":"10.1002/ardp.70220","journal":"Archiv der Pharmazie","n_participants":null,"pmid":"41838033","source_url":"https://pubmed.ncbi.nlm.nih.gov/41838033/","study_design":null,"title":"Developments on BACE 1 Inhibitors as Anti\u2010Alzheimer Agents: A Perspective on Medicinal Chemistry\u2010Based Advances","title_match":false,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-landscape-of-autosomal-dominant-alzheimers-disease-global-39903689","doi":"10.1093/brain/awaf038","journal":"Brain","n_participants":550,"pmid":"39903689","source_url":"https://pubmed.ncbi.nlm.nih.gov/39903689/","study_design":null,"title":"The landscape of autosomal-dominant Alzheimer\u2019s disease: global distribution and age of onset","title_match":false,"year":2025},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/evaluating-the-impact-of-age-and-treatment-on-neuroinflammation-40992617","doi":"10.1016/j.expneurol.2025.115475","journal":"Experimental Neurology","n_participants":null,"pmid":"40992617","source_url":"https://pubmed.ncbi.nlm.nih.gov/40992617/","study_design":null,"title":"Evaluating the impact of age and treatment on neuroinflammation-related proteins in mouse models of proteinopathies","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/phenotypic-characterization-of-recently-identified-psen1-genetic-41433957","doi":"10.1002/alz70861_108984","journal":"Alzheimer s & Dementia","n_participants":61,"pmid":"41433957","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12724748/","study_design":null,"title":"Phenotypic Characterization of Recently Identified PSEN1 Genetic Variants in ADAD in Colombia","title_match":false,"year":2025},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/the-evolving-roles-of-imaging-and-fluid-biomarkers-for-alzheimer-41447680","doi":"10.1002/alz70856_101336","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41447680","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12740309/","study_design":null,"title":"The evolving roles of imaging and fluid biomarkers for Alzheimer disease over the past quarter century","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/is-tau-acetylation-a-key-to-frontotemporal-lobar-degeneration-42504910","doi":"10.1093/clinchem/hvag090","journal":"Clinical Chemistry","n_participants":null,"pmid":"42504910","source_url":"https://pubmed.ncbi.nlm.nih.gov/42504910/","study_design":null,"title":"Is Tau Acetylation a Key to Frontotemporal Lobar Degeneration Diagnosis?","title_match":false,"year":2026},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/glp-1-receptor-agonists-beyond-glycemic-control-clinical-implications-d1c44bbc","doi":"10.55729/2000-9666.1651","journal":"Journal of Community Hospital Internal Medicine Perspectives","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.55729/2000-9666.1651","study_design":"clinical trial","title":"GLP-1 Receptor Agonists Beyond Glycemic Control: Clinical Implications in Neurodegenerative Disease and Substance Use Disorders","title_match":false,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/gamma-sensory-stimulation-in-mild-alzheimer-s-dementia-an-openlabel-41137616","doi":"10.1002/alz.70792","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41137616","source_url":"https://pubmed.ncbi.nlm.nih.gov/41137616/","study_design":"longitudinal study","title":"Gamma sensory stimulation in mild Alzheimer's dementia: An open\u2010label extension study","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/extension-and-external-validation-of-mapping-between-the-minimental-40538019","doi":"10.1002/alz.70163","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40538019","source_url":"https://pubmed.ncbi.nlm.nih.gov/40538019/","study_design":null,"title":"Extension and external validation of mapping between the Mini\u2010Mental State Examination and the Clinical Dementia Rating scale in patients with Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/cognitive-and-neuropsychiatric-effects-of-40-hz-tacs-simultaneously-40283048","doi":"10.3390/medicina61040757","journal":"Medicina","n_participants":42,"pmid":"40283048","source_url":"https://pubmed.ncbi.nlm.nih.gov/40283048/","study_design":null,"title":"Cognitive and Neuropsychiatric Effects of 40 Hz tACS Simultaneously with Cognitive Exercises for Dementia: A Randomized, Crossover, Double-Blind, Sham-Controlled Study","title_match":true,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/determination-of-balance-fall-risk-and-kinesiophobia-in-individuals-40134734","doi":"10.3389/fpsyg.2025.1535440","journal":"Frontiers in Psychology","n_participants":null,"pmid":"40134734","source_url":"https://pubmed.ncbi.nlm.nih.gov/40134734/","study_design":null,"title":"Determination of balance, fall risk, and kinesiophobia in individuals with Alzheimer\u2019s Dementia","title_match":false,"year":2025},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-oral-semaglutide-14-mg-flexible-dose-in-early-41865758","doi":"10.1016/s0140-6736(26)00459-9","journal":"The Lancet","n_participants":928,"pmid":"41865758","source_url":"https://pubmed.ncbi.nlm.nih.gov/41865758/","study_design":"clinical trial","title":"Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials","title_match":true,"year":2026},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/cognitive-and-psychosocial-effects-of-individual-cognitive-93926460","doi":"10.1007/s40737-025-00489-5","journal":"Journal of Psychosocial Rehabilitation and Mental Health","n_participants":18,"pmid":null,"source_url":"https://doi.org/10.1007/s40737-025-00489-5","study_design":"randomized controlled trial","title":"Cognitive and Psychosocial Effects of Individual Cognitive Stimulation in Dementia: A Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/clinical-efficacy-safety-and-imaging-effects-of-oral-41015981","doi":"10.1007/s40265-025-02250-5","journal":"Drugs","n_participants":320,"pmid":"41015981","source_url":"https://pubmed.ncbi.nlm.nih.gov/41015981/","study_design":null,"title":"Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOE\u03b54/\u03b54 Homozygotes with Early Alzheimer\u2019s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial","title_match":true,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/combination-of-intranasal-insulin-and-oral-semaglutide-for-cognition-41434629","doi":"10.1002/alz70860_102127","journal":"Alzheimer s & Dementia","n_participants":24,"pmid":"41434629","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12726504/","study_design":null,"title":"Combination of Intranasal insulin and oral semaglutide for cognition in older adults with metabolic syndrome at high dementia risk","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/reminder-program-a-randomized-controlled-trial-protocol-of-a-41366742","doi":"10.1186/s12877-025-06714-x","journal":"BMC Geriatrics","n_participants":270,"pmid":"41366742","source_url":"https://pubmed.ncbi.nlm.nih.gov/41366742/","study_design":null,"title":"REMINDER program: a randomized controlled trial protocol of a neuropsychological intervention for lifestyle modification in older adults at risk of dementia","title_match":true,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/clarity-ad-asian-regional-analysis-of-a-phase-iii-trial-of-lecanemab-40189473","doi":"10.1016/j.tjpad.2025.100160","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":294,"pmid":"40189473","source_url":"https://pubmed.ncbi.nlm.nih.gov/40189473/","study_design":"clinical trial","title":"Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/clinical-management-of-cerebral-amyloid-angiopathy-40566003","doi":"10.3390/jcm14124259","journal":"Journal of Clinical Medicine","n_participants":null,"pmid":"40566003","source_url":"https://pubmed.ncbi.nlm.nih.gov/40566003/","study_design":null,"title":"Clinical Management of Cerebral Amyloid Angiopathy","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-amyloid-peptide-controversies-and-challenges-of-40674941","doi":"10.1016/j.jpet.2025.103639","journal":"Journal of Pharmacology and Experimental Therapeutics","n_participants":null,"pmid":"40674941","source_url":"https://pubmed.ncbi.nlm.nih.gov/40674941/","study_design":null,"title":"Alzheimer disease: Amyloid peptide controversies and challenges of anti-A\u03b2 immunotherapy","title_match":false,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/an-acetylated-tau-174-csf-biomarker-discriminates-between-tdp-43-and-41986736","doi":"10.1038/s41591-026-04341-6","journal":"Nature Medicine","n_participants":513,"pmid":"41986736","source_url":"https://pubmed.ncbi.nlm.nih.gov/41986736/","study_design":null,"title":"An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration","title_match":false,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/tdp-43-proteinopathies-and-neurodegeneration-insights-from-40891506","doi":"10.1111/febs.70239","journal":"FEBS Journal","n_participants":null,"pmid":"40891506","source_url":"https://pubmed.ncbi.nlm.nih.gov/40891506/","study_design":null,"title":"TDP \u201043 proteinopathies and neurodegeneration: insights from Caenorhabditis elegans models","title_match":false,"year":2025},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/alzheimer-syndrome-or-age-related-dementiahistory-therapy-and-41227148","doi":"10.3390/jcm14217752","journal":"Journal of Clinical Medicine","n_participants":null,"pmid":"41227148","source_url":"https://pubmed.ncbi.nlm.nih.gov/41227148/","study_design":"narrative review","title":"Alzheimer Syndrome or Age-Related Dementia\u2014History, Therapy and Prevention","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/cognitive-impairment-dementia-and-depression-in-older-adults-41682879","doi":"10.3390/jcm15031198","journal":"Journal of Clinical Medicine","n_participants":null,"pmid":"41682879","source_url":"https://pubmed.ncbi.nlm.nih.gov/41682879/","study_design":"cohort study","title":"Cognitive Impairment, Dementia and Depression in Older Adults","title_match":false,"year":2026},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/neurofilament-biomarkers-in-neurology-from-neuroinflammation-to-41097004","doi":"10.3390/ijms26199739","journal":"International Journal of Molecular Sciences","n_participants":null,"pmid":"41097004","source_url":"https://pubmed.ncbi.nlm.nih.gov/41097004/","study_design":"narrative review","title":"Neurofilament Biomarkers in Neurology: From Neuroinflammation to Neurodegeneration, Bridging Established and Novel Analytical Advances with Clinical Practice","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/proteostasis-and-neuroinflammation-in-alzheimers-disease-41074409","doi":"10.31083/jin39826","journal":"Journal of Integrative Neuroscience","n_participants":null,"pmid":"41074409","source_url":"https://pubmed.ncbi.nlm.nih.gov/41074409/","study_design":null,"title":"Proteostasis and Neuroinflammation in Alzheimer\u2019s Disease","title_match":false,"year":2025},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/neuroinflammation-and-progress-in-clinical-trials-for-the-treatment-1ee39399","doi":"10.36922/imo025050007","journal":"Innovative Medicines & Omics","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.36922/imo025050007","study_design":null,"title":"Neuroinflammation and progress in clinical trials for the treatment of Alzheimer\u2019s disease and related dementias: An update","title_match":true,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/connexin43-hemichannel-blockade-turns-microglia-neuroprotective-and-40595567","doi":"10.1038/s41467-025-60746-w","journal":"Nature Communications","n_participants":null,"pmid":"40595567","source_url":"https://pubmed.ncbi.nlm.nih.gov/40595567/","study_design":null,"title":"Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/isobavachalcone-ameliorates-alzheimer-disease-pathology-by-autophagy-40183098","doi":"10.3389/fphar.2025.1525364","journal":"Frontiers in Pharmacology","n_participants":null,"pmid":"40183098","source_url":"https://pubmed.ncbi.nlm.nih.gov/40183098/","study_design":"post-hoc analysis","title":"Isobavachalcone ameliorates Alzheimer disease pathology by autophagy-mediated clearance of amyloid beta and inhibition of NLRP3 inflammasome in primary astrocytes and 5x-FAD mice","title_match":false,"year":2025},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/shp2-in-microglia-attenuates-neuroinflammation-and-cognitive-deficits-22fe2677","doi":"10.1186/s40001-026-04317-9","journal":"European journal of medical research","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1186/s40001-026-04317-9","study_design":null,"title":"SHP2 in microglia attenuates neuroinflammation and cognitive deficits in vascular dementia by modulating the FAK/Src/PU. 1/IRF8 pathway","title_match":false,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/can-the-herpes-zoster-vaccination-be-a-strategy-against-dementia-40350295","doi":"10.5582/ddt.2025.01032","journal":"Drug Discoveries & Therapeutics","n_participants":null,"pmid":"40350295","source_url":"https://pubmed.ncbi.nlm.nih.gov/40350295/","study_design":"cohort study","title":"Can the herpes zoster vaccination be a strategy against dementia?","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/targeting-nlrp3-signaling-with-a-novel-sulfonylurea-compound-for-the-40462117","doi":"10.1186/s12987-025-00665-6","journal":"Fluids and Barriers of the CNS","n_participants":null,"pmid":"40462117","source_url":"https://pubmed.ncbi.nlm.nih.gov/40462117/","study_design":null,"title":"Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/distinct-and-combined-interferon-receptor-1-loss-in-neurons-and-42226039","doi":"10.1186/s12929-026-01257-8","journal":"Journal of Biomedical Science","n_participants":null,"pmid":"42226039","source_url":"https://pubmed.ncbi.nlm.nih.gov/42226039/","study_design":null,"title":"Distinct and combined interferon-\u0251/\u03b2-receptor-1 loss in neurons and astrocytes disrupt brain energy metabolism and drive Parkinsonian dementia","title_match":false,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/twenty-years-of-therapeutic-development-in-tauopathy-mouse-models-a-40826256","doi":"10.1002/alz.70578","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40826256","source_url":"https://pubmed.ncbi.nlm.nih.gov/40826256/","study_design":null,"title":"Twenty years of therapeutic development in tauopathy mouse models: a scoping review","title_match":false,"year":2025},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/plasma-mtbr-tau243-biomarker-identifies-tau-tangle-pathology-in-40164726","doi":"10.1038/s41591-025-03617-7","journal":"Nature Medicine","n_participants":108,"pmid":"40164726","source_url":"https://pubmed.ncbi.nlm.nih.gov/40164726/","study_design":null,"title":"Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer\u2019s disease","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/charting-the-research-frontier-for-viral-infections-immunomodulation-41561087","doi":"10.3389/fcimb.2025.1701760","journal":"Frontiers in Cellular and Infection Microbiology","n_participants":null,"pmid":"41561087","source_url":"https://pubmed.ncbi.nlm.nih.gov/41561087/","study_design":"randomized controlled trial","title":"Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints","title_match":true,"year":2026},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/pathological-mechanisms-and-treatment-progression-of-alzheimers-40660381","doi":"10.1186/s40001-025-02886-9","journal":"European journal of medical research","n_participants":null,"pmid":"40660381","source_url":"https://pubmed.ncbi.nlm.nih.gov/40660381/","study_design":null,"title":"Pathological mechanisms and treatment progression of Alzheimer\u2019s disease","title_match":false,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/brain-organoids-in-alzheimer-disease-and-related-tauopathies-42624102","doi":"10.1016/j.stemcr.2026.103051","journal":"Stem Cell Reports","n_participants":null,"pmid":"42624102","source_url":"https://pubmed.ncbi.nlm.nih.gov/42624102/","study_design":null,"title":"Brain organoids in Alzheimer disease and related tauopathies: Challenges and opportunities for translational readiness","title_match":false,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/proteolytic-therapeutic-modalities-for-amyloidoses-insights-into-39939242","doi":"10.1016/j.neurot.2025.e00548","journal":"Neurotherapeutics","n_participants":null,"pmid":"39939242","source_url":"https://pubmed.ncbi.nlm.nih.gov/39939242/","study_design":null,"title":"Proteolytic therapeutic modalities for amyloidoses: Insights into immunotherapy, PROTAC, and photo-oxygenation","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/current-advances-and-unmet-needs-in-alzheimer-s-disease-trials-for-40528298","doi":"10.1002/alz.70258","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40528298","source_url":"https://pubmed.ncbi.nlm.nih.gov/40528298/","study_design":"longitudinal study","title":"Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/florzolotau-18f-retention-is-linked-to-neuropsychological-performance-41923154","doi":"10.1002/alz.71319","journal":"Alzheimer s & Dementia","n_participants":120,"pmid":"41923154","source_url":"https://pubmed.ncbi.nlm.nih.gov/41923154/","study_design":null,"title":"Florzolotau (18F) retention is linked to neuropsychological performance in tauopathy","title_match":false,"year":2026},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/repulsive-guidance-molecule-a-as-a-therapeutic-target-across-40244061","doi":"10.3390/ijms26073221","journal":"International Journal of Molecular Sciences","n_participants":null,"pmid":"40244061","source_url":"https://pubmed.ncbi.nlm.nih.gov/40244061/","study_design":null,"title":"Repulsive Guidance Molecule-A as a Therapeutic Target Across Neurological Disorders: An Update","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/tau-protein-physiological-functions-and-multifaceted-roles-in-41488807","doi":"10.61373/gp025i.0122","journal":"Genomic psychiatry :","n_participants":null,"pmid":"41488807","source_url":"https://pubmed.ncbi.nlm.nih.gov/41488807/","study_design":null,"title":"Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/biofluid-biomarker-changes-following-treatment-with-sabirnetug-acu193-39955261","doi":"10.1016/j.tjpad.2025.100082","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":null,"pmid":"39955261","source_url":"https://pubmed.ncbi.nlm.nih.gov/39955261/","study_design":"clinical trial","title":"Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-polyphenols-and-neuroprotection-mechanistic-41470875","doi":"10.3390/nu17243929","journal":"Nutrients","n_participants":null,"pmid":"41470875","source_url":"https://pubmed.ncbi.nlm.nih.gov/41470875/","study_design":"narrative review","title":"Mediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein","title_match":false,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/boosting-cognitive-training-through-social-engagement-impacts-on-40894462","doi":"10.1177/30495334251366575","journal":"Sage Open Aging","n_participants":50,"pmid":"40894462","source_url":"https://pubmed.ncbi.nlm.nih.gov/40894462/","study_design":"randomized controlled trial","title":"Boosting Cognitive Training through Social Engagement: Impacts on Older Adults With Subjective Cognitive Decline","title_match":false,"year":2025},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/south-korean-study-to-prevent-cognitive-impairment-and-protect-brain-39840755","doi":"10.1002/alz.14517","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"39840755","source_url":"https://pubmed.ncbi.nlm.nih.gov/39840755/","study_design":"randomized controlled trial","title":"South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face\u2010to\u2010face and video communication platforms in mild cognitive impairment (SUPERBRAIN\u2010MEET): A randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/impact-of-cognitive-training-on-claimsbased-diagnosed-dementia-over-41669119","doi":"10.1002/trc2.70197","journal":"Alzheimer s & Dementia Translational Research & Clinical Interventions","n_participants":2021,"pmid":"41669119","source_url":"https://pubmed.ncbi.nlm.nih.gov/41669119/","study_design":"randomized controlled trial","title":"Impact of cognitive training on claims\u2010based diagnosed dementia over 20 years: evidence from the ACTIVE study","title_match":false,"year":2026},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/the-role-of-phytochemicals-in-age-related-cognitive-decline-a-natural-a534c305","doi":"10.1177/1934578x251350761","journal":"Natural Product Communications","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1177/1934578x251350761","study_design":null,"title":"The Role of Phytochemicals in Age-Related Cognitive Decline: A Natural Solution for Brain Health","title_match":false,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/targeting-brain-health-in-subjective-cognitive-decline-insights-from-40366507","doi":"10.1007/s40520-025-03062-z","journal":"Aging Clinical and Experimental Research","n_participants":null,"pmid":"40366507","source_url":"https://pubmed.ncbi.nlm.nih.gov/40366507/","study_design":null,"title":"Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/multidomain-therapy-for-alzheimers-disease-a-scoping-review-of-41275266","doi":"10.1186/s13024-025-00912-2","journal":"Molecular Neurodegeneration","n_participants":null,"pmid":"41275266","source_url":"https://pubmed.ncbi.nlm.nih.gov/41275266/","study_design":"cohort study","title":"Multidomain therapy for Alzheimer\u2019s disease: a scoping review of cognitive decline trials","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/managing-cognitive-decline-through-a-social-robotbased-intervention-40896828","doi":"10.2196/67601","journal":"JMIR Research Protocols","n_participants":40,"pmid":"40896828","source_url":"https://pubmed.ncbi.nlm.nih.gov/40896828/","study_design":"randomized controlled trial","title":"Managing Cognitive Decline Through a Social Robot\u2013Based Intervention: Protocol for the engAGE Proof of Concept and Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/effects-of-a-mediterranean-diet-based-program-on-cognitive-decline-41978123","doi":"10.3390/nu18071073","journal":"Nutrients","n_participants":58,"pmid":"41978123","source_url":"https://pubmed.ncbi.nlm.nih.gov/41978123/","study_design":null,"title":"Effects of a Mediterranean Diet-Based Program on Cognitive Decline: Non-Blinded Non-Randomized Controlled Trial of the CESPORT Program","title_match":true,"year":2026},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/beneficial-effects-of-olive-oil-and-the-mediterranean-diet-on-42075568","doi":"10.3390/medicina62040696","journal":"Medicina","n_participants":null,"pmid":"42075568","source_url":"https://pubmed.ncbi.nlm.nih.gov/42075568/","study_design":"narrative review","title":"Beneficial Effects of Olive Oil and the Mediterranean Diet on Alzheimer\u2019s Disease and Vascular Dementia: A Review","title_match":false,"year":2026},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/factors-associated-with-adherence-to-tabletbased-cognitive-training-40065916","doi":"10.1002/trc2.70062","journal":"Alzheimer s & Dementia Translational Research & Clinical Interventions","n_participants":191,"pmid":"40065916","source_url":"https://pubmed.ncbi.nlm.nih.gov/40065916/","study_design":"randomized controlled trial","title":"Factors associated with adherence to tablet\u2010based cognitive training: J\u2010MINT study","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/efficacy-of-a-multidomain-intervention-in-older-adults-with-vascular-41222037","doi":"10.1002/alz.70822","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41222037","source_url":"https://pubmed.ncbi.nlm.nih.gov/41222037/","study_design":null,"title":"Efficacy of a multidomain intervention in older adults with vascular risks: The Japan\u2010Multimodal Intervention Trial for the Prevention of Dementia (J\u2010MINT)","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/effectiveness-of-a-52-week-multidomain-intervention-to-maintain-41266554","doi":"10.1038/s41598-025-24865-0","journal":"Scientific Reports","n_participants":84,"pmid":"41266554","source_url":"https://pubmed.ncbi.nlm.nih.gov/41266554/","study_design":"randomized controlled trial","title":"Effectiveness of a 52-week multidomain intervention to maintain cognitive function in patients with mild cognitive impairment: a randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/effect-of-a-protein-enriched-mediterranean-diet-and-exercise-promed-42680255","doi":"10.1016/j.ajcnut.2026.101383","journal":"American Journal of Clinical Nutrition","n_participants":105,"pmid":"42680255","source_url":"https://pubmed.ncbi.nlm.nih.gov/42680255/","study_design":null,"title":"Effect of a PROtein-enriched MEDiterranean diet and EXercise (PROMED-EX) on nutritional status and cognitive performance in older adults at risk of undernutrition and cognitive decline: the PROMED-EX randomized controlled trial","title_match":true,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-cost-of-a-mediterranean-diet-and-walking-intervention-to-reduce-41102970","doi":"10.1017/s0007114525105333","journal":"British Journal Of Nutrition","n_participants":null,"pmid":"41102970","source_url":"https://pubmed.ncbi.nlm.nih.gov/41102970/","study_design":null,"title":"The cost of a Mediterranean Diet and walking intervention to reduce risk of dementia and improve quality of life in independent living populations in Australia: The MedWalk randomised controlled trial","title_match":true,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/cognitive-training-gain-transfer-in-cognitively-healthy-aging-per-40933821","doi":"10.3389/fnagi.2025.1587395","journal":"Frontiers in Aging Neuroscience","n_participants":235,"pmid":"40933821","source_url":"https://pubmed.ncbi.nlm.nih.gov/40933821/","study_design":null,"title":"Cognitive training gain transfer in cognitively healthy aging: per protocol results of the German AgeGain study","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/mind-your-nose-a-randomized-controlled-trial-of-olfactorybased-memory-40636802","doi":"10.1002/trc2.70120","journal":"Alzheimer s & Dementia Translational Research & Clinical Interventions","n_participants":53,"pmid":"40636802","source_url":"https://pubmed.ncbi.nlm.nih.gov/40636802/","study_design":null,"title":"Mind your nose: A randomized controlled trial of olfactory\u2010based memory training for older people with subjective cognitive decline","title_match":true,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/the-efficacy-of-computerized-cognitive-training-in-patients-with-39985041","doi":"10.1186/s13063-025-08745-6","journal":"Trials","n_participants":null,"pmid":"39985041","source_url":"https://pubmed.ncbi.nlm.nih.gov/39985041/","study_design":"randomized controlled trial","title":"The efficacy of computerized cognitive training in patients with coronary heart disease and cognitive impairment, no dementia: study protocol for a randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/the-effects-of-an-immersive-virtual-reality-and-telemedicine-based-40718565","doi":"10.3389/fpsyg.2025.1591239","journal":"Frontiers in Psychology","n_participants":75,"pmid":"40718565","source_url":"https://pubmed.ncbi.nlm.nih.gov/40718565/","study_design":null,"title":"The effects of an immersive virtual reality and telemedicine-based multi-component intervention in individuals with subjective cognitive decline: study protocol of a randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/cita-go-on-study-a-community-based-multidomain-lifestyle-intervention-40589624","doi":"10.3389/fnagi.2025.1539711","journal":"Frontiers in Aging Neuroscience","n_participants":1051,"pmid":"40589624","source_url":"https://pubmed.ncbi.nlm.nih.gov/40589624/","study_design":"randomized controlled trial","title":"CITA GO-ON study. A community based multidomain lifestyle intervention to prevent cognitive decline. Protocol design and recruitment process","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/weight-loss-and-metabolic-improvements-dominate-the-microbiome-41958469","doi":"10.1002/trc2.70239","journal":"Alzheimer s & Dementia Translational Research & Clinical Interventions","n_participants":null,"pmid":"41958469","source_url":"https://pubmed.ncbi.nlm.nih.gov/41958469/","study_design":"randomized controlled trial","title":"Weight loss and metabolic improvements dominate the microbiome response in the MIND diet intervention: a randomized controlled trial","title_match":true,"year":2026},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/efficacy-of-a-group-based-8-week-multicomponent-cognitive-training-on-39863320","doi":"10.1016/j.tjpad.2024.100033","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":40,"pmid":"39863320","source_url":"https://pubmed.ncbi.nlm.nih.gov/39863320/","study_design":"longitudinal study","title":"Efficacy of a group-based 8-week multicomponent cognitive training on cognition, mood and activities of daily living among healthy older adults: A two-year follow-up of a randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/a-randomised-controlled-trial-of-physical-activity-and-cognitive-42098784","doi":"10.1186/s13063-026-09681-9","journal":"Trials","n_participants":126,"pmid":"42098784","source_url":"https://pubmed.ncbi.nlm.nih.gov/42098784/","study_design":"randomized controlled trial","title":"A randomised controlled trial of physical activity and cognitive training in older adults: the PhABHeaD study","title_match":true,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-and-neurodegenerative-diseases-recent-advances-42505396","doi":"10.3390/cells15141287","journal":"Cells","n_participants":null,"pmid":"42505396","source_url":"https://pubmed.ncbi.nlm.nih.gov/42505396/","study_design":null,"title":"Mediterranean Diet and Neurodegenerative Diseases: Recent Advances from the Gut\u2013Immune\u2013Brain Axis to Multi-Omics-Guided Precision Nutrition","title_match":false,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/the-effects-of-a-multidomain-lifestyle-intervention-on-brain-function-41252227","doi":"10.2196/69814","journal":"JMIR Research Protocols","n_participants":102,"pmid":"41252227","source_url":"https://pubmed.ncbi.nlm.nih.gov/41252227/","study_design":null,"title":"The Effects of a Multidomain Lifestyle Intervention on Brain Function and Its Relation With Immunometabolic Markers and Intestinal Health in Older Adults at Risk of Cognitive Decline: Study Design and Baseline Characteristics of the HELI Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/motor-imagery-based-neurofeedback-in-older-adults-neural-signatures-41742172","doi":"10.1186/s12984-026-01912-z","journal":"Journal of NeuroEngineering and Rehabilitation","n_participants":null,"pmid":"41742172","source_url":"https://pubmed.ncbi.nlm.nih.gov/41742172/","study_design":null,"title":"Motor imagery-based neurofeedback in older adults: neural signatures and feasibility in a randomized controlled trial targeting age-related cognitive decline","title_match":true,"year":2026},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/japan-multimodal-intervention-trial-for-the-prevention-of-dementia-in-40397393","doi":"10.1177/13872877251344222","journal":"Journal of Alzheimer s Disease","n_participants":null,"pmid":"40397393","source_url":"https://pubmed.ncbi.nlm.nih.gov/40397393/","study_design":"randomized controlled trial","title":"Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/beneficial-effects-of-water-based-exercise-alone-and-in-combination-40868843","doi":"10.3390/life15081195","journal":"Life","n_participants":null,"pmid":"40868843","source_url":"https://pubmed.ncbi.nlm.nih.gov/40868843/","study_design":null,"title":"Beneficial Effects of Water-Based Exercise Alone and in Combination with Cognitive Training on Cardiovascular Fitness and Arterial Stiffness in Older Adults with Mild Cognitive Impairment: A Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/effect-of-combined-transcranial-direct-current-stimulation-and-40995064","doi":"10.1016/j.jadr.2025.100973","journal":"Journal of Affective Disorders Reports","n_participants":null,"pmid":"40995064","source_url":"https://pubmed.ncbi.nlm.nih.gov/40995064/","study_design":null,"title":"Effect of combined transcranial direct current stimulation and cognitive training on brain microstructure and network homogeneity in late-life depression: a pilot study","title_match":false,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/a-2025-update-on-treatment-strategies-for-the-alzheimers-disease-40442885","doi":"10.1097/jcma.0000000000001252","journal":"Journal of the Chinese Medical Association","n_participants":null,"pmid":"40442885","source_url":"https://pubmed.ncbi.nlm.nih.gov/40442885/","study_design":null,"title":"A 2025 update on treatment strategies for the Alzheimer\u2019s disease spectrum","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/effects-of-a-12-week-hybrid-analogdigital-cognitive-training-on-41220868","doi":"10.12779/dnd.2025.24.4.301","journal":"Dementia and Neurocognitive Disorders","n_participants":33,"pmid":"41220868","source_url":"https://pubmed.ncbi.nlm.nih.gov/41220868/","study_design":"randomized controlled trial","title":"Effects of a 12-Week Hybrid Analog\u2013Digital Cognitive Training on Cognitively Unimpaired Older Adults: A Pilot Single-Blind Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/adherence-and-aerobic-exercise-intensity-in-live-online-exercise-40046640","doi":"10.1016/j.jarlif.2025.100003","journal":"Journal of Aging Research and Lifestyle","n_participants":null,"pmid":"40046640","source_url":"https://pubmed.ncbi.nlm.nih.gov/40046640/","study_design":"randomized controlled trial","title":"Adherence and aerobic exercise intensity in live online exercise sessions for older adults with mild cognitive impairment: Insights from the Japan-Multimodal Intervention Trial for the Prevention of Dementia","title_match":false,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-aerobic-exercise-and-computer-based-cognitive-training-on-41918619","doi":"10.3389/fnagi.2026.1776069","journal":"Frontiers in Aging Neuroscience","n_participants":28,"pmid":"41918619","source_url":"https://pubmed.ncbi.nlm.nih.gov/41918619/","study_design":"randomized controlled trial","title":"Effects of aerobic exercise and computer-based cognitive training on cognition, functional independence, quality of life, and salivary cortisol levels in older adults with mild cognitive impairment: a randomized trial","title_match":false,"year":2026},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/mediation-of-modifiable-risk-factors-in-two-multidomain-dementia-39868821","doi":"10.1002/alz.14557","journal":"Alzheimer s & Dementia","n_participants":1679,"pmid":"39868821","source_url":"https://pubmed.ncbi.nlm.nih.gov/39868821/","study_design":null,"title":"Mediation of modifiable risk factors in two multidomain dementia prevention trials","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/the-intricate-interplay-between-dietary-habits-and-cognitive-function-39944956","doi":"10.3389/fnut.2025.1539355","journal":"Frontiers in Nutrition","n_participants":null,"pmid":"39944956","source_url":"https://pubmed.ncbi.nlm.nih.gov/39944956/","study_design":null,"title":"The intricate interplay between dietary habits and cognitive function: insights from the gut-brain axis","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/can-a-mediterranean-diet-prevent-cognitive-decline-35a69624","doi":"10.5281/zenodo.17735068","journal":"Zenodo (CERN European Organization for Nuclear Research)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.5281/zenodo.17735068","study_design":null,"title":"Can a Mediterranean diet prevent cognitive decline?","title_match":false,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/can-a-mediterranean-diet-prevent-cognitive-decline-19d07aa5","doi":"10.5281/zenodo.17735067","journal":"Zenodo (CERN European Organization for Nuclear Research)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.5281/zenodo.17735067","study_design":null,"title":"Can a Mediterranean diet prevent cognitive decline?","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-lifestyle-intervention-in-memory-clinics-of-general-and-academic-41508135","doi":"10.1186/s13195-025-01947-9","journal":"Alzheimer s Research & Therapy","n_participants":null,"pmid":"41508135","source_url":"https://pubmed.ncbi.nlm.nih.gov/41508135/","study_design":"randomized controlled trial","title":"The Lifestyle Intervention in memory clinics of General and academic Hospitals Trial (LIGHT): Rationale and study design of a randomized controlled trial to reduce modifiable dementia risk","title_match":true,"year":2026},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/speed-of-processing-training-for-stress-adaptation-in-caregivers-of-a-40454426","doi":"10.1093/geroni/igaf033","journal":"Innovation in Aging","n_participants":null,"pmid":"40454426","source_url":"https://pubmed.ncbi.nlm.nih.gov/40454426/","study_design":"randomized controlled trial","title":"Speed of Processing Training for Stress Adaptation in Caregivers of a Family Member With Dementia: A Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/effects-of-computerized-cognitive-training-on-vesicular-acetylcholine-41084791","doi":"10.2196/75161","journal":"JMIR Serious Games","n_participants":92,"pmid":"41084791","source_url":"https://pubmed.ncbi.nlm.nih.gov/41084791/","study_design":"randomized controlled trial","title":"Effects of Computerized Cognitive Training on Vesicular Acetylcholine Transporter Levels using [18F]Fluoroethoxybenzovesamicol Positron Emission Tomography in Healthy Older Adults: Results from the Improving Neurological Health in Aging via Neuroplasticity-based Computerized Exercise (INHANCE) Randomized Clinical Trial","title_match":true,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/sinomaksprotocol-of-a-randomised-controlled-trial-to-evaluate-the-40306986","doi":"10.1136/bmjopen-2024-093618","journal":"BMJ Open","n_participants":200,"pmid":"40306986","source_url":"https://pubmed.ncbi.nlm.nih.gov/40306986/","study_design":"randomized controlled trial","title":"SinoMAKS\u2014protocol of a randomised controlled trial to evaluate the Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes","title_match":true,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-3-minute-diagnostic-confusion-assessment-method-severity-score-40331035","doi":"10.1016/j.bjao.2025.100398","journal":"BJA Open","n_participants":177,"pmid":"40331035","source_url":"https://pubmed.ncbi.nlm.nih.gov/40331035/","study_design":"cohort study","title":"The 3-Minute Diagnostic Confusion Assessment Method severity score correlates with the Delirium Rating Scale\u2013Revised\u201398 and with biomarkers of delirium","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/content-validity-practicality-and-testing-of-the-reliability-of-41448697","doi":"10.1136/bmjopen-2025-112357","journal":"BMJ Open","n_participants":70,"pmid":"41448697","source_url":"https://pubmed.ncbi.nlm.nih.gov/41448697/","study_design":null,"title":"Content validity, practicality and testing of the reliability of various tools for the detection and screening of delirium in residents with dementia in German nursing homes: a study protocol","title_match":false,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/prediction-and-risk-evaluation-of-delirium-after-surgery-in-older-41850989","doi":"10.1016/j.bja.2026.01.025","journal":"British Journal of Anaesthesia","n_participants":929,"pmid":"41850989","source_url":"https://pubmed.ncbi.nlm.nih.gov/41850989/","study_design":"cohort study","title":"Prediction and risk evaluation of delirium after surgery in older patients: development and internal validation of an algorithm from the prospective BioCog cohort study","title_match":false,"year":2026},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/effects-of-intermittent-theta-burst-stimulation-on-cognitive-and-39755599","doi":"10.1186/s12877-024-05625-7","journal":"BMC Geriatrics","n_participants":18,"pmid":"39755599","source_url":"https://pubmed.ncbi.nlm.nih.gov/39755599/","study_design":null,"title":"Effects of intermittent theta burst stimulation on cognitive and swallowing function in patients with MCI and dysphagia risk: a randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/efficacy-of-sodium-valproate-in-behavioral-and-psychological-symptoms-40530730","doi":"10.2174/0115672050383192250610115920","journal":"Current Alzheimer Research","n_participants":116,"pmid":"40530730","source_url":"https://pubmed.ncbi.nlm.nih.gov/40530730/","study_design":null,"title":"Efficacy of Sodium Valproate in Behavioral and Psychological Symptoms of Dementia: A Retrospective Observational Study from PUMCH Dementia Cohort","title_match":false,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/group-and-partnered-dance-for-people-living-with-dementia-an-overview-39950072","doi":"10.3389/fpsyg.2025.1500688","journal":"Frontiers in Psychology","n_participants":21,"pmid":"39950072","source_url":"https://pubmed.ncbi.nlm.nih.gov/39950072/","study_design":"randomized controlled trial","title":"Group and partnered dance for people living with dementia: an overview of intervention design and measurement considerations","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/weighted-blankets-for-agitation-in-hospitalized-patients-with-40009836","doi":"10.2196/57264","journal":"JMIR Research Protocols","n_participants":24,"pmid":"40009836","source_url":"https://pubmed.ncbi.nlm.nih.gov/40009836/","study_design":null,"title":"Weighted Blankets for Agitation in Hospitalized Patients with Dementia: Protocol for a Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/brexpiprazole-for-treating-agitation-in-different-groups-of-people-41689409","doi":"10.1080/17582024.2026.2623968","journal":"Neurodegenerative Disease Management","n_participants":null,"pmid":"41689409","source_url":"https://pubmed.ncbi.nlm.nih.gov/41689409/","study_design":null,"title":"Brexpiprazole for treating agitation in different groups of people with Alzheimer\u2019s dementia: a plain language summary","title_match":false,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/clinical-checklists-of-multicomponent-non-pharmacological-42366006","doi":"10.1136/bmjopen-2025-105740","journal":"BMJ Open","n_participants":12,"pmid":"42366006","source_url":"https://pubmed.ncbi.nlm.nih.gov/42366006/","study_design":null,"title":"Clinical checklists of multicomponent non-pharmacological interventions for delirium management in adult patients in non-ICU inpatient healthcare settings: a rapid review","title_match":false,"year":2026},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/palliative-care-needs-of-older-adults-with-and-without-dementia-40820287","doi":"10.1177/07334648251363646","journal":"Journal of Applied Gerontology","n_participants":52,"pmid":"40820287","source_url":"https://pubmed.ncbi.nlm.nih.gov/40820287/","study_design":"cross-sectional","title":"Palliative Care Needs of Older Adults With and Without Dementia During Post-Acute Care in Skilled Nursing Facilities","title_match":false,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/formal-caregivers-knowledge-attitudes-and-challenges-in-end-of-life-40598442","doi":"10.1186/s12912-025-03424-y","journal":"BMC Nursing","n_participants":null,"pmid":"40598442","source_url":"https://pubmed.ncbi.nlm.nih.gov/40598442/","study_design":null,"title":"Formal caregivers\u2019 knowledge, attitudes, and challenges in end-of-life care for people with advanced dementia: a qualitative study in Chinese nursing home","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/planning-ahead-protocol-for-a-randomised-trial-of-advance-care-40413042","doi":"10.1136/bmjopen-2025-102186","journal":"BMJ Open","n_participants":null,"pmid":"40413042","source_url":"https://pubmed.ncbi.nlm.nih.gov/40413042/","study_design":"randomized controlled trial","title":"Planning Ahead: protocol for a randomised trial of advance care planning for community dwelling older adults at increased mortality risk","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/virtual-nurse-led-early-primary-palliative-care-intervention-elicit-41442238","doi":"10.2196/75082","journal":"JMIR Research Protocols","n_participants":200,"pmid":"41442238","source_url":"https://pubmed.ncbi.nlm.nih.gov/41442238/","study_design":null,"title":"Virtual, Nurse-Led Early Primary Palliative Care Intervention (ELICIT) for Community-Dwelling Older Adults With Cognitive Impairment: Protocol for a Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/contrasting-approaches-in-advance-care-planning-in-dementia-as-644d01cf","doi":"10.1093/geroni/igaf122.2219","journal":"Innovation in Aging","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1093/geroni/igaf122.2219","study_design":"randomized controlled trial","title":"Contrasting Approaches in Advance Care Planning in Dementia as Perceived by General Practitioners","title_match":false,"year":2025},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/the-dementia-palliative-care-clinical-trials-training-program-5d919ce7","doi":"10.1093/geroni/igaf122.1510","journal":"Innovation in Aging","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1093/geroni/igaf122.1510","study_design":null,"title":"The Dementia Palliative Care Clinical Trials Training Program","title_match":true,"year":2025},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/end-of-life-and-palliative-care-in-dementia-an-overview-for-clinicians-24c01465","doi":"10.1007/s11940-026-00879-5","journal":"Current Treatment Options in Neurology","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1007/s11940-026-00879-5","study_design":null,"title":"End-of-life and Palliative Care in Dementia: An Overview for Clinicians","title_match":false,"year":2026},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/evaluating-the-pragmatic-characteristics-of-advance-care-planning-638a6122","doi":"10.17615/sjc8-m169","journal":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","n_participants":21,"pmid":null,"source_url":"https://doi.org/10.17615/sjc8-m169","study_design":null,"title":"Evaluating the pragmatic characteristics of advance care planning outcome measures in dementia clinical trials: A scoping review","title_match":true,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/developing-and-testing-a-program-to-strengthen-the-dementia-41478422","doi":"10.1016/j.jpainsymman.2025.12.020","journal":"Journal of Pain and Symptom Management","n_participants":53,"pmid":"41478422","source_url":"https://pubmed.ncbi.nlm.nih.gov/41478422/","study_design":"longitudinal study","title":"Developing and Testing a Program to Strengthen the Dementia Palliative Care Trial Workforce","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cerebral-small-vessel-disease-current-and-emerging-therapeutic-39965248","doi":"10.14336/ad.2024.1515","journal":"Aging and Disease","n_participants":null,"pmid":"39965248","source_url":"https://pubmed.ncbi.nlm.nih.gov/39965248/","study_design":null,"title":"Cerebral Small Vessel Disease: Current and Emerging Therapeutic Strategies","title_match":false,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/progressive-structural-alterations-in-the-cerebral-small-vessel-40899970","doi":"10.1177/13872877251372953","journal":"Journal of Alzheimer s Disease","n_participants":26,"pmid":"40899970","source_url":"https://pubmed.ncbi.nlm.nih.gov/40899970/","study_design":"longitudinal study","title":"Progressive structural alterations in the cerebral small vessel disease with cognitive impairment and vascular dementia","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/tongxinluo-capsule-in-the-treatment-of-cerebral-small-vessel-disease-40935402","doi":"10.1136/svn-2024-003929","journal":"Stroke and Vascular Neurology","n_participants":1052,"pmid":"40935402","source_url":"https://pubmed.ncbi.nlm.nih.gov/40935402/","study_design":null,"title":"Tongxinluo capsule in the treatment of cerebral small vessel disease: protocol of a randomised, double-blind, placebo-controlled, multicentre clinical study (TOPS-CSVD)","title_match":true,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/metabolic-and-vascular-contributions-to-dementia-soluble-epoxide-41059602","doi":"10.1002/alz.70718","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41059602","source_url":"https://pubmed.ncbi.nlm.nih.gov/41059602/","study_design":null,"title":"Metabolic and vascular contributions to dementia: Soluble epoxide hydrolase\u2010derived linoleic acid oxylipins and glycemic status are related to cerebral small vessel disease markers, atrophy, and cognitive performance","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/comparative-risk-of-dementia-in-diabetic-stroke-patients-prescribed-40049567","doi":"10.1016/j.jstrokecerebrovasdis.2025.108276","journal":"Journal of Stroke and Cerebrovascular Diseases","n_participants":15901,"pmid":"40049567","source_url":"https://pubmed.ncbi.nlm.nih.gov/40049567/","study_design":"cohort study","title":"Comparative risk of dementia in diabetic stroke patients prescribed SGLT2 vs. DPP-4 inhibitors: A propensity-matched retrospective cohort study","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/clinically-meaningful-outcomes-in-alzheimer-s-disease-and-alzheimer-s-39975465","doi":"10.1002/trc2.70058","journal":"Alzheimer s & Dementia Translational Research & Clinical Interventions","n_participants":null,"pmid":"39975465","source_url":"https://pubmed.ncbi.nlm.nih.gov/39975465/","study_design":null,"title":"Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-dementia-trials-accelerator-dta-a-uk-dementia-trials-ready-cohort-25fefcbf","doi":"10.64898/2026.08.14.26359869","journal":"medRxiv (preprint)","n_participants":10000,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.14.26359869","study_design":null,"title":"The Dementia Trials Accelerator (DTA): a UK dementia trials-ready cohort","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/deep-multimodal-clustering-identifies-biological-subtypes-of-normal-a064c939","doi":"10.64898/2026.08.18.26360683","journal":"medRxiv (preprint)","n_participants":1136,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.18.26360683","study_design":"prospective cohort","title":"Deep multimodal clustering identifies biological subtypes of normal aging with divergent cognitive decline risk","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/aspirin-and-healthy-longevity-within-racial-and-ethnic-minoritized-4c0acdbc","doi":"10.64898/2026.08.24.26361036","journal":"medRxiv (preprint)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.24.26361036","study_design":"randomized controlled trial","title":"Aspirin and healthy longevity within racial and ethnic minoritized older adults in the United States","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/treatment-response-biomarkers-in-early-alzheimers-disease-59d29669","doi":"10.64898/2026.08.27.26361425","journal":"medRxiv (preprint)","n_participants":65,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.27.26361425","study_design":"longitudinal study","title":"Treatment response biomarkers in early Alzheimers disease: longitudinal trajectories, sample size estimates, and the impact of progression variability","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/returning-apoe-and-ptau-217-results-the-esmarter-randomized-7a589453","doi":"10.64898/2026.08.27.26361535","journal":"medRxiv (preprint)","n_participants":216,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.27.26361535","study_design":null,"title":"Returning APOE and pTau-217 Results: the eSMARTER Randomized Noninferiority Clinical Trial","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/comparative-value-of-cognitive-and-functional-assessments-for-4acee6a6","doi":"10.64898/2026.09.01.26360561","journal":"medRxiv (preprint)","n_participants":2430,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.01.26360561","study_design":null,"title":"Comparative Value of Cognitive and Functional Assessments for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer's Disease: An ADNI Cohort Study","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/feasibility-safety-and-preliminary-efficacy-of-partnered-rhythmic-50b7bf22","doi":"10.64898/2026.09.11.26362767","journal":"medRxiv (preprint)","n_participants":68,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.11.26362767","study_design":"randomized controlled trial","title":"Feasibility, Safety, and Preliminary Efficacy of Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease: A 12-Month Pilot Randomized Controlled Trial","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/one-night-of-closed-loop-auditory-stimulation-during-sleep-enhances-5e962d7a","doi":"10.64898/2026.09.14.26360893","journal":"medRxiv (preprint)","n_participants":37,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.14.26360893","study_design":null,"title":"One night of closed-loop auditory stimulation during sleep enhances memory consolidation in patients with Alzheimer's Disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/physiological-variability-in-key-alzheimer-s-biomarkers-in-amyloid-281c7577","doi":"10.64898/2026.09.18.26363412","journal":"medRxiv (preprint)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.18.26363412","study_design":null,"title":"Physiological variability in key Alzheimer's biomarkers in amyloid-positive clinical trial cohorts and the mechanistic basis of biomarker ratios","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/smartphone-passive-digital-phenotyping-in-frontotemporal-lobar-7ef6cdb9","doi":"10.64898/2026.09.18.26363439","journal":"medRxiv (preprint)","n_participants":567,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.18.26363439","study_design":"longitudinal study","title":"Smartphone Passive Digital Phenotyping in Frontotemporal Lobar Degeneration","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/prevalence-of-dementia-among-community-dwelling-older-adults-in-rural-b0b8641c","doi":"10.64898/2026.09.18.26363378","journal":"medRxiv (preprint)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.18.26363378","study_design":"cross-sectional","title":"Prevalence of dementia among community-dwelling older adults in rural Uganda: findings from DEPEND Uganda (Dementia Epidemiology, unmet need and co-developing solutions in Uganda)","title_match":false,"year":2026},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/environmental-predictors-of-objectively-measured-out-of-home-time-30878823","doi":"10.1016/j.archger.2019.01.021","journal":"Archives of gerontology and geriatrics","n_participants":147,"pmid":"30878823","source_url":"https://pubmed.ncbi.nlm.nih.gov/30878823/","study_design":"randomized controlled trial","title":"Environmental predictors of objectively measured out-of-home time among older adults with cognitive decline","title_match":false,"year":2019},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/clinical-meaningfulness-of-anti-amyloid-therapies-in-early-alzheimer-41724687","doi":"10.1002/alz.71230","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"41724687","source_url":"https://pubmed.ncbi.nlm.nih.gov/41724687/","study_design":null,"title":"Clinical meaningfulness of anti-amyloid therapies in early Alzheimer's disease: Perspectives from the East and Southeast Asia region","title_match":false,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/long-term-value-of-lecanemab-to-individuals-and-families-40895811","doi":"10.1002/trc2.70151","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"40895811","source_url":"https://pubmed.ncbi.nlm.nih.gov/40895811/","study_design":null,"title":"Long-term value of lecanemab to individuals and families","title_match":false,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/practical-guide-of-the-korean-association-for-geriatric-psychiatry-to-40696527","doi":"10.3346/jkms.2025.40.e215","journal":"Journal of Korean medical science","n_participants":null,"pmid":"40696527","source_url":"https://pubmed.ncbi.nlm.nih.gov/40696527/","study_design":"randomized controlled trial","title":"Practical Guide of the Korean Association for Geriatric Psychiatry to Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer's Disease: Focused on Lecanemab","title_match":false,"year":2025},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/experiences-from-clinical-research-and-routine-use-of-florbetaben-39770490","doi":"10.3390/ph17121648","journal":"Pharmaceuticals (Basel, Switzerland)","n_participants":null,"pmid":"39770490","source_url":"https://pubmed.ncbi.nlm.nih.gov/39770490/","study_design":null,"title":"Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization Insights","title_match":false,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/clinical-meaningfulness-in-alzheimer-s-disease-clinical-trials-a-39350367","doi":"10.14283/jpad.2024.112","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"39350367","source_url":"https://pubmed.ncbi.nlm.nih.gov/39350367/","study_design":"longitudinal study","title":"Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force","title_match":true,"year":2024},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/precision-medicine-approach-to-alzheimer-s-disease-rationale-and-37807782","doi":"10.3233/jad-230467","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"37807782","source_url":"https://pubmed.ncbi.nlm.nih.gov/37807782/","study_design":null,"title":"Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications","title_match":false,"year":2023},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/care-ecosystem-collaborative-model-and-health-care-costs-in-medicare-37721734","doi":"10.1001/jamainternmed.2023.4764","journal":"JAMA internal medicine","n_participants":780,"pmid":"37721734","source_url":"https://pubmed.ncbi.nlm.nih.gov/37721734/","study_design":null,"title":"Care Ecosystem Collaborative Model and Health Care Costs in Medicare Beneficiaries With Dementia: A Secondary Analysis of a Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/the-use-of-telehealth-among-people-living-with-dementia-caregiver-37227755","doi":"10.2196/45045","journal":"Journal of medical Internet research","n_participants":24,"pmid":"37227755","source_url":"https://pubmed.ncbi.nlm.nih.gov/37227755/","study_design":"randomized controlled trial","title":"The Use of Telehealth Among People Living With Dementia-Caregiver Dyads During the COVID-19 Pandemic: Scoping Review","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/implications-of-the-covid-19-pandemic-on-adult-day-services-and-the-34647482","doi":"10.1177/15333175211050152","journal":"American journal of Alzheimer's disease and other dementias","n_participants":19,"pmid":"34647482","source_url":"https://pubmed.ncbi.nlm.nih.gov/34647482/","study_design":"randomized controlled trial","title":"Implications of the COVID-19 Pandemic on Adult Day Services and the Families They Serve","title_match":false,"year":2021},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/alzheimer-s-and-aducanumab-unjust-profits-and-false-hopes-34156732","doi":"10.1002/hast.1264","journal":"The Hastings Center report","n_participants":null,"pmid":"34156732","source_url":"https://pubmed.ncbi.nlm.nih.gov/34156732/","study_design":null,"title":"Alzheimer's and Aducanumab: Unjust Profits and False Hopes","title_match":false,"year":2021},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/smartphone-barrier-uncovering-the-digital-divide-in-mhealth-42712339","doi":"10.1136/bmjdhai-2025-000069","journal":"BMJ digital health & AI","n_participants":null,"pmid":"42712339","source_url":"https://pubmed.ncbi.nlm.nih.gov/42712339/","study_design":"randomized controlled trial","title":"Smartphone barrier: uncovering the digital divide in mHealth prevention among disadvantaged middle-aged and older-aged UK communities","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-diagnosis-of-mild-cognitive-impairment-due-to-alzheimer-s-disease-21514249","doi":"10.1016/j.jalz.2011.03.008","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"21514249","source_url":"https://pubmed.ncbi.nlm.nih.gov/21514249/","study_design":null,"title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging\u2010Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","title_match":false,"year":2011},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/the-diagnosis-of-mild-cognitive-impairment-due-to-alzheimers-disease-03675724","doi":"10.1176/appi.focus.11.1.96","journal":"FOCUS The Journal of Lifelong Learning in Psychiatry","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1176/appi.focus.11.1.96","study_design":null,"title":"The Diagnosis of Mild Cognitive Impairment due to Alzheimer\u2019s Disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease","title_match":false,"year":2013},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/phases-of-a-deposition-in-the-human-brain-and-its-relevance-for-the-12084879","doi":"10.1212/wnl.58.12.1791","journal":"Neurology","n_participants":null,"pmid":"12084879","source_url":"https://pubmed.ncbi.nlm.nih.gov/12084879/","study_design":"clinical trial","title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","title_match":false,"year":2002},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-neuroimaging-initiative-adni-mri-methods-18302232","doi":"10.1002/jmri.21049","journal":"Journal of Magnetic Resonance Imaging","n_participants":null,"pmid":"18302232","source_url":"https://pubmed.ncbi.nlm.nih.gov/18302232/","study_design":"longitudinal study","title":"The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods","title_match":false,"year":2008},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/benfotiamine-and-cognitive-decline-in-alzheimer-s-disease-results-of-33074237","doi":"10.3233/jad-200896","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"33074237","source_url":"https://pubmed.ncbi.nlm.nih.gov/33074237/","study_design":"randomized controlled trial","title":"Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial","title_match":true,"year":2020},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-phase-2-double-blind-placebo-controlled-24-week-treatment-clinical-34044875","doi":"10.1186/s13195-021-00843-2","journal":"Alzheimer's research & therapy","n_participants":464,"pmid":"34044875","source_url":"https://pubmed.ncbi.nlm.nih.gov/34044875/","study_design":"clinical trial","title":"A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease","title_match":true,"year":2021},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/safety-tolerability-and-efficacy-of-the-glutaminyl-cyclase-inhibitor-30309389","doi":"10.1186/s13195-018-0431-6","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"30309389","source_url":"https://pubmed.ncbi.nlm.nih.gov/30309389/","study_design":"randomized controlled trial","title":"Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study","title_match":true,"year":2018},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/souvenaid-reduces-behavioral-deficits-and-improves-social-cognition-25592742","doi":"10.1159/000369811","journal":"Neuro-degenerative diseases","n_participants":null,"pmid":"25592742","source_url":"https://pubmed.ncbi.nlm.nih.gov/25592742/","study_design":"randomized controlled trial","title":"Souvenaid reduces behavioral deficits and improves social cognition skills in frontotemporal dementia: a proof-of-concept study","title_match":false,"year":2015},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/resveratrol-attenuates-csf-markers-of-neurodegeneration-and-40507855","doi":"10.3390/ijms26115044","journal":"International journal of molecular sciences","n_participants":21,"pmid":"40507855","source_url":"https://pubmed.ncbi.nlm.nih.gov/40507855/","study_design":"clinical trial","title":"Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/inhibition-of-p38-mapk-increases-short-term-astrocyte-reactivity-the-41287056","doi":"10.1186/s12974-025-03625-x","journal":"Journal of neuroinflammation","n_participants":17,"pmid":"41287056","source_url":"https://pubmed.ncbi.nlm.nih.gov/41287056/","study_design":"randomized controlled trial","title":"Inhibition of p38\u03b1 MAPK increases short-term astrocyte reactivity: the exploratory VIP trial in early Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/location-of-pathogenic-variants-in-psen1-impacts-progression-of-37291760","doi":"10.1111/acel.13871","journal":"Aging cell","n_participants":null,"pmid":"37291760","source_url":"https://pubmed.ncbi.nlm.nih.gov/37291760/","study_design":"cross-sectional","title":"Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/17beta-estradiol-reduces-plasma-abeta40-for-hrt-naive-postmenopausal-12611754","doi":"10.1097/00019442-200303000-00015","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"12611754","source_url":"https://pubmed.ncbi.nlm.nih.gov/12611754/","study_design":"randomized controlled trial","title":"17beta-estradiol reduces plasma Abeta40 for HRT-na\u00efve postmenopausal women with Alzheimer disease: a preliminary study","title_match":false,"year":2003},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/does-inflammatory-bowel-disease-play-a-role-in-cognitive-decline-a-42172661","doi":"10.1093/ecco-jcc/jjag057","journal":"Journal of Crohn's & colitis","n_participants":null,"pmid":"42172661","source_url":"https://pubmed.ncbi.nlm.nih.gov/42172661/","study_design":"systematic review","title":"Does inflammatory bowel disease play a role in cognitive decline? A systematic review","title_match":false,"year":2026},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/phase-3-randomized-clinical-trials-of-simufilam-in-mild-to-moderate-41500915","doi":"10.1016/j.tjpad.2025.100469","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"41500915","source_url":"https://pubmed.ncbi.nlm.nih.gov/41500915/","study_design":"post-hoc analysis","title":"Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's disease","title_match":true,"year":2026},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/natural-compounds-as-multitarget-agents-in-alzheimer-s-diseases-41808871","doi":"10.3389/fphar.2026.1766470","journal":"Frontiers in pharmacology","n_participants":41,"pmid":"41808871","source_url":"https://pubmed.ncbi.nlm.nih.gov/41808871/","study_design":"systematic review","title":"Natural compounds as multitarget agents in Alzheimer's diseases: evidence from in vivo and in vitro models","title_match":false,"year":2026},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/evoke-and-evoke-design-of-two-large-scale-double-blind-placebo-39780249","doi":"10.1186/s13195-024-01666-7","journal":"Alzheimer's research & therapy","n_participants":210,"pmid":"39780249","source_url":"https://pubmed.ncbi.nlm.nih.gov/39780249/","study_design":"clinical trial","title":"evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/impact-of-zervimesine-on-the-neuroinflammatory-biomarker-gfap-and-41943055","doi":"10.1186/s13195-026-02025-4","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"41943055","source_url":"https://pubmed.ncbi.nlm.nih.gov/41943055/","study_design":"clinical trial","title":"Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer's disease","title_match":true,"year":2026},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/a-phase-2-open-label-study-of-anti-inflammatory-ne3107-in-patients-39058809","doi":"10.1097/md.0000000000039027","journal":"Medicine","n_participants":17,"pmid":"39058809","source_url":"https://pubmed.ncbi.nlm.nih.gov/39058809/","study_design":"clinical trial","title":"A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias","title_match":true,"year":2024},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/minocycline-for-sporadic-and-hereditary-cerebral-amyloid-angiopathy-37277877","doi":"10.1186/s13063-023-07371-4","journal":"Trials","n_participants":60,"pmid":"37277877","source_url":"https://pubmed.ncbi.nlm.nih.gov/37277877/","study_design":null,"title":"Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial","title_match":true,"year":2023},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/post-hoc-analysis-of-adamant-a-phase-2-clinical-trial-of-active-tau-39580468","doi":"10.1186/s13195-024-01620-7","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"39580468","source_url":"https://pubmed.ncbi.nlm.nih.gov/39580468/","study_design":"post-hoc analysis","title":"Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217","title_match":true,"year":2024},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/the-role-of-antidiabetic-drugs-in-the-treatment-of-alzheimer-s-37968954","doi":"10.14341/probl13183","journal":"Problemy endokrinologii","n_participants":null,"pmid":"37968954","source_url":"https://pubmed.ncbi.nlm.nih.gov/37968954/","study_design":"meta-analysis","title":"[The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review]","title_match":false,"year":2023},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/boswellic-acids-improve-clinical-cognitive-scores-and-reduce-systemic-37248896","doi":"10.3233/jad-221026","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"37248896","source_url":"https://pubmed.ncbi.nlm.nih.gov/37248896/","study_design":"randomized controlled trial","title":"Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/the-potential-role-of-nutritional-components-in-improving-brain-31982903","doi":"10.17712/nsj.2020.1.20190037","journal":"Neurosciences (Riyadh, Saudi Arabia)","n_participants":2297,"pmid":"31982903","source_url":"https://pubmed.ncbi.nlm.nih.gov/31982903/","study_design":"systematic review","title":"The potential role of nutritional components in improving brain function among patients with Alzheimers disease: a meta-analysis of RCT studies","title_match":false,"year":2020},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/a-randomized-open-label-clinical-trial-in-mild-cognitive-impairment-37012306","doi":"10.1038/s41598-023-32515-6","journal":"Scientific reports","n_participants":50,"pmid":"37012306","source_url":"https://pubmed.ncbi.nlm.nih.gov/37012306/","study_design":"open-label trial","title":"A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress","title_match":true,"year":2023},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/regulatory-role-of-the-endocannabinoid-system-on-glial-cells-toward-36959856","doi":"10.3389/fphar.2023.1053680","journal":"Frontiers in pharmacology","n_participants":26,"pmid":"36959856","source_url":"https://pubmed.ncbi.nlm.nih.gov/36959856/","study_design":"systematic review","title":"Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer's disease: A systematic review and meta-analysis of animal studies","title_match":false,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/pti-125-reduces-biomarkers-of-alzheimer-s-disease-in-patients-32920628","doi":"10.14283/jpad.2020.6","journal":"The journal of prevention of Alzheimer's disease","n_participants":13,"pmid":"32920628","source_url":"https://pubmed.ncbi.nlm.nih.gov/32920628/","study_design":"open-label trial","title":"PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients","title_match":false,"year":2020},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/chf5074-reduces-biomarkers-of-neuroinflammation-in-patients-with-mild-23968157","doi":"10.2174/13892037113149990144","journal":"Current Alzheimer research","n_participants":null,"pmid":"23968157","source_url":"https://pubmed.ncbi.nlm.nih.gov/23968157/","study_design":"randomized controlled trial","title":"CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study","title_match":true,"year":2013},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/immune-related-genetic-enrichment-in-frontotemporal-dementia-an-29315334","doi":"10.1371/journal.pmed.1002487","journal":"PLoS medicine","n_participants":192886,"pmid":"29315334","source_url":"https://pubmed.ncbi.nlm.nih.gov/29315334/","study_design":"meta-analysis","title":"Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies","title_match":false,"year":2018},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/the-post-anaesthesia-n-acetylcysteine-cognitive-evaluation-panacea-27502769","doi":"10.1186/s13063-016-1529-4","journal":"Trials","n_participants":null,"pmid":"27502769","source_url":"https://pubmed.ncbi.nlm.nih.gov/27502769/","study_design":"longitudinal study","title":"The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial","title_match":true,"year":2016},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/lecanemab-appropriate-use-recommendations-37357276","doi":"10.14283/jpad.2023.30","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":null,"pmid":"37357276","source_url":"https://pubmed.ncbi.nlm.nih.gov/37357276/","study_design":null,"title":"Lecanemab: Appropriate Use Recommendations","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-an-update-on-pathobiology-and-treatment-strategies-31564456","doi":"10.1016/j.cell.2019.09.001","journal":"Cell","n_participants":null,"pmid":"31564456","source_url":"https://pubmed.ncbi.nlm.nih.gov/31564456/","study_design":null,"title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","title_match":false,"year":2019},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/effect-of-long-term-omega-3-polyunsaturated-fatty-acid-28359749","doi":"10.1016/s1474-4422(17)30040-6","journal":"The Lancet Neurology","n_participants":null,"pmid":"28359749","source_url":"https://pubmed.ncbi.nlm.nih.gov/28359749/","study_design":null,"title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","title_match":true,"year":2017},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/validity-and-reliability-of-the-alzheimer-s-disease-cooperative-study-9236949","doi":"10.1097/00002093-199700112-00004","journal":"Alzheimer Disease & Associated Disorders","n_participants":null,"pmid":"9236949","source_url":"https://pubmed.ncbi.nlm.nih.gov/9236949/","study_design":null,"title":"Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study","title_match":false,"year":1997},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/development-of-cognitive-instruments-for-use-in-clinical-trials-of-37e2cc49","doi":"10.1097/00002093-199700112-00003","journal":"Alzheimer Disease & Associated Disorders","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1097/00002093-199700112-00003","study_design":null,"title":"Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs","title_match":true,"year":1997},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-in-amyloid-modifying-21784348","doi":"10.1016/j.jalz.2011.05.2351","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"21784348","source_url":"https://pubmed.ncbi.nlm.nih.gov/21784348/","study_design":null,"title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","title_match":false,"year":2011},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/phase-3-trials-of-solanezumab-for-mild-to-moderate-alzheimer-s-disease-24450890","doi":"10.1056/nejmoa1312889","journal":"New England Journal of Medicine","n_participants":null,"pmid":"24450890","source_url":"https://pubmed.ncbi.nlm.nih.gov/24450890/","study_design":null,"title":"Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease","title_match":true,"year":2014},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-ten-years-later-20008648","doi":"10.1001/archneurol.2009.266","journal":"Archives of Neurology","n_participants":null,"pmid":"20008648","source_url":"https://pubmed.ncbi.nlm.nih.gov/20008648/","study_design":null,"title":"Mild cognitive impairment: ten years later","title_match":false,"year":2009},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/a-controlled-trial-of-selegiline-alpha-tocopherol-or-both-as-9110909","doi":"10.1056/nejm199704243361704","journal":"New England Journal of Medicine","n_participants":null,"pmid":"9110909","source_url":"https://pubmed.ncbi.nlm.nih.gov/9110909/","study_design":null,"title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study","title_match":false,"year":1997},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/a-soluble-phosphorylated-tau-signature-links-tau-amyloid-and-the-32161412","doi":"10.1038/s41591-020-0781-z","journal":"Nature Medicine","n_participants":null,"pmid":"32161412","source_url":"https://pubmed.ncbi.nlm.nih.gov/32161412/","study_design":null,"title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer\u2019s disease","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/a-proportional-hazards-model-for-the-subdistribution-of-a-competing-cad7787c","doi":"10.1080/01621459.1999.10474144","journal":"Journal of the American Statistical Association","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1080/01621459.1999.10474144","study_design":null,"title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","title_match":false,"year":1999},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/subacute-meningoencephalitis-in-a-subset-of-patients-with-ad-after-12847155","doi":"10.1212/01.wnl.0000073623.84147.a8","journal":"Neurology","n_participants":null,"pmid":"12847155","source_url":"https://pubmed.ncbi.nlm.nih.gov/12847155/","study_design":null,"title":"Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization","title_match":false,"year":2003},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/11c-pib-pet-assessment-of-change-in-fibrillar-amyloid-load-in-20189881","doi":"10.1016/s1474-4422(10)70043-0","journal":"The Lancet Neurology","n_participants":null,"pmid":"20189881","source_url":"https://pubmed.ncbi.nlm.nih.gov/20189881/","study_design":null,"title":"11C-PiB PET assessment of change in fibrillar amyloid-\u03b2 load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","title_match":true,"year":2010},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/florbetaben-pet-imaging-to-detect-amyloid-beta-plaques-in-alzheimer-s-25824567","doi":"10.1016/j.jalz.2015.02.004","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"25824567","source_url":"https://pubmed.ncbi.nlm.nih.gov/25824567/","study_design":null,"title":"Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study","title_match":true,"year":2015},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/differential-roles-of-a42-40-p-tau231-and-p-tau217-for-alzheimers-36456833","doi":"10.1038/s41591-022-02074-w","journal":"Nature Medicine","n_participants":null,"pmid":"36456833","source_url":"https://pubmed.ncbi.nlm.nih.gov/36456833/","study_design":null,"title":"Differential roles of A\u03b242/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/meta-analysis-in-clinical-trials-3802833","doi":"10.1016/0197-2456(86)90046-2","journal":"Controlled Clinical Trials","n_participants":null,"pmid":"3802833","source_url":"https://pubmed.ncbi.nlm.nih.gov/3802833/","study_design":null,"title":"Meta-analysis in clinical trials","title_match":true,"year":1986},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/autosomal-dominant-alzheimer-s-disease-a-review-and-proposal-for-the-21a895c8","doi":"10.1186/alzrt59","journal":"Alzheimer s Research & Therapy","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1186/alzrt59","study_design":null,"title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/multisite-study-of-the-relationships-between-antemortem-11-c-pibpet-30347188","doi":"10.1016/j.jalz.2018.09.001","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"30347188","source_url":"https://pubmed.ncbi.nlm.nih.gov/30347188/","study_design":null,"title":"Multisite study of the relationships between antemortem [ 11 C]PIB\u2010PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology","title_match":false,"year":2018},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/a-phase-3-trial-of-semagacestat-for-treatment-of-alzheimer-s-disease-23883379","doi":"10.1056/nejmoa1210951","journal":"New England Journal of Medicine","n_participants":null,"pmid":"23883379","source_url":"https://pubmed.ncbi.nlm.nih.gov/23883379/","study_design":null,"title":"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease","title_match":true,"year":2013},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/quantitative-analysis-of-pib-pet-with-freesurfer-rois-24223109","doi":"10.1371/journal.pone.0073377","journal":"PLoS ONE","n_participants":null,"pmid":"24223109","source_url":"https://pubmed.ncbi.nlm.nih.gov/24223109/","study_design":null,"title":"Quantitative Analysis of PiB-PET with FreeSurfer ROIs","title_match":false,"year":2013},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/arthritis-and-anti-inflammatory-agents-as-possible-protective-factors-8757015","doi":"10.1212/wnl.47.2.425","journal":"Neurology","n_participants":null,"pmid":"8757015","source_url":"https://pubmed.ncbi.nlm.nih.gov/8757015/","study_design":null,"title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies","title_match":false,"year":1996},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-due-to-alzheimer-s-disease-16437430","doi":"10.1002/14651858.cd001190.pub2","journal":"The Cochrane database of systematic reviews","n_participants":5272,"pmid":"16437430","source_url":"https://pubmed.ncbi.nlm.nih.gov/16437430/","study_design":null,"title":"Donepezil for dementia due to Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/onset-of-alzheimer-disease-in-apolipoprotein-4-carriers-is-earlier-in-2fcd5460","doi":"10.1101/2024.01.02.24300718","journal":"BMC neurology","n_participants":33,"pmid":null,"source_url":"https://doi.org/10.1101/2024.01.02.24300718","study_design":null,"title":"Onset of Alzheimer disease in apolipoprotein \u025b4 carriers is earlier in butyrylcholinesterase K variant carriers","title_match":false,"year":2024},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/diagnostic-performance-and-prediction-of-clinical-progression-of-01fa071e","doi":"10.1101/2020.07.15.20154237","journal":"Molecular psychiatry","n_participants":1000,"pmid":null,"source_url":"https://doi.org/10.1101/2020.07.15.20154237","study_design":"longitudinal study","title":"Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer\u2019s Disease Neuroimaging Initiative","title_match":false,"year":2020},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/gantenerumab-reduces-brain-amyloid-proteoforms-biochemical-evaluation-09be60d1","doi":"10.64898/2026.09.22.26363432","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.22.26363432","study_design":null,"title":"Gantenerumab reduces brain amyloid-\u03b2 proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease","title_match":false,"year":2026},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/a-comparative-study-of-the-effects-of-aducanumab-and-scanning-a9983515","doi":"10.1101/2021.01.04.425327","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1101/2021.01.04.425327","study_design":null,"title":"A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease","title_match":false,"year":2021},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-due-to-alzheimer-s-disease-12917900","doi":"10.1002/14651858.cd001190","journal":"The Cochrane database of systematic reviews","n_participants":4365,"pmid":"12917900","source_url":"https://pubmed.ncbi.nlm.nih.gov/12917900/","study_design":null,"title":"Donepezil for dementia due to Alzheimer's disease","title_match":false,"year":2003},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-alzheimer-s-disease-11034705","doi":"10.1002/14651858.cd001191","journal":"The Cochrane database of systematic reviews","n_participants":3370,"pmid":"11034705","source_url":"https://pubmed.ncbi.nlm.nih.gov/11034705/","study_design":null,"title":"Rivastigmine for Alzheimer's disease","title_match":false,"year":2000},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/glial-dysfunction-in-the-pathogenesis-of-synucleinopathies-emerging-21562886","doi":"10.1007/s00401-011-0833-z","journal":"Acta neuropathologica","n_participants":null,"pmid":"21562886","source_url":"https://pubmed.ncbi.nlm.nih.gov/21562886/","study_design":null,"title":"Glial dysfunction in the pathogenesis of \u03b1-synucleinopathies: emerging concepts","title_match":false,"year":2011},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/developing-the-atx-n-classification-for-use-across-the-alzheimer-34239130","doi":"10.1038/s41582-021-00520-w","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"34239130","source_url":"https://pubmed.ncbi.nlm.nih.gov/34239130/","study_design":null,"title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-dementia-and-stem-cell-therapy-28494803","doi":"10.1186/s13287-017-0567-5","journal":"Stem cell research & therapy","n_participants":null,"pmid":"28494803","source_url":"https://pubmed.ncbi.nlm.nih.gov/28494803/","study_design":null,"title":"Alzheimer's disease, dementia, and stem cell therapy","title_match":false,"year":2017},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/current-pharmacotherapy-for-alzheimer-s-disease-16409164","doi":"10.1146/annurev.med.57.121304.131442","journal":"Annual review of medicine","n_participants":null,"pmid":"16409164","source_url":"https://pubmed.ncbi.nlm.nih.gov/16409164/","study_design":null,"title":"Current pharmacotherapy for Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/tau-based-therapies-in-neurodegeneration-opportunities-and-challenges-28983098","doi":"10.1038/nrd.2017.155","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"28983098","source_url":"https://pubmed.ncbi.nlm.nih.gov/28983098/","study_design":null,"title":"Tau-based therapies in neurodegeneration: opportunities and challenges","title_match":false,"year":2017},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/plasma-extracellular-vesicle-tau-and-tdp-43-as-diagnostic-biomarkers-38890531","doi":"10.1038/s41591-024-02937-4","journal":"Nature medicine","n_participants":704,"pmid":"38890531","source_url":"https://pubmed.ncbi.nlm.nih.gov/38890531/","study_design":null,"title":"Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS","title_match":false,"year":2024},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/prion-diseases-26633779","doi":"10.1212/con.0000000000000251","journal":"Continuum (Minneapolis, Minn.)","n_participants":null,"pmid":"26633779","source_url":"https://pubmed.ncbi.nlm.nih.gov/26633779/","study_design":null,"title":"Prion Diseases","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/tauopathy-like-abnormalities-and-neurologic-deficits-in-mice-17030663","doi":"10.1001/archneur.63.10.1459","journal":"Archives of neurology","n_participants":null,"pmid":"17030663","source_url":"https://pubmed.ncbi.nlm.nih.gov/17030663/","study_design":null,"title":"Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein","title_match":false,"year":2006},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-amyloid-beta-protein-and-synaptic-function-19757208","doi":"10.1007/s12017-009-8091-0","journal":"Neuromolecular medicine","n_participants":null,"pmid":"19757208","source_url":"https://pubmed.ncbi.nlm.nih.gov/19757208/","study_design":null,"title":"Alzheimer's disease amyloid beta-protein and synaptic function","title_match":false,"year":2010},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/dha-may-prevent-age-related-dementia-20181786","doi":"10.3945/jn.109.113910","journal":"The Journal of nutrition","n_participants":null,"pmid":"20181786","source_url":"https://pubmed.ncbi.nlm.nih.gov/20181786/","study_design":null,"title":"DHA may prevent age-related dementia","title_match":false,"year":2010},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/a-farnesyltransferase-inhibitor-activates-lysosomes-and-reduces-tau-30918111","doi":"10.1126/scitranslmed.aat3005","journal":"Science translational medicine","n_participants":null,"pmid":"30918111","source_url":"https://pubmed.ncbi.nlm.nih.gov/30918111/","study_design":null,"title":"A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-keystone-of-alzheimer-pathogenesis-might-be-sought-in-a-physiology-26314631","doi":"10.1016/j.neuroscience.2015.08.039","journal":"Neuroscience","n_participants":null,"pmid":"26314631","source_url":"https://pubmed.ncbi.nlm.nih.gov/26314631/","study_design":null,"title":"The keystone of Alzheimer pathogenesis might be sought in A\u03b2 physiology","title_match":false,"year":2015},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/diabetes-as-a-risk-factor-for-alzheimer-s-disease-in-the-middle-east-32210695","doi":"10.1016/j.sjbs.2019.12.028","journal":"Saudi journal of biological sciences","n_participants":null,"pmid":"32210695","source_url":"https://pubmed.ncbi.nlm.nih.gov/32210695/","study_design":null,"title":"Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators","title_match":false,"year":2020},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-biomarkers-for-understanding-multiple-aspects-of-30770953","doi":"10.1007/s00018-019-03040-5","journal":"Cellular and molecular life sciences : CMLS","n_participants":null,"pmid":"30770953","source_url":"https://pubmed.ncbi.nlm.nih.gov/30770953/","study_design":null,"title":"Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis","title_match":false,"year":2019},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/cxcr4-involvement-in-neurodegenerative-diseases-29636460","doi":"10.1038/s41398-017-0049-7","journal":"Translational psychiatry","n_participants":82337,"pmid":"29636460","source_url":"https://pubmed.ncbi.nlm.nih.gov/29636460/","study_design":null,"title":"CXCR4 involvement in neurodegenerative diseases","title_match":false,"year":2018},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/in-vivo-imaging-of-tau-pathology-using-multi-parametric-quantitative-25700953","doi":"10.1016/j.neuroimage.2015.02.023","journal":"NeuroImage","n_participants":null,"pmid":"25700953","source_url":"https://pubmed.ncbi.nlm.nih.gov/25700953/","study_design":null,"title":"In vivo imaging of tau pathology using multi-parametric quantitative MRI","title_match":false,"year":2015},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/stress-as-risk-factor-for-alzheimer-s-disease-29689315","doi":"10.1016/j.phrs.2018.04.017","journal":"Pharmacological research","n_participants":null,"pmid":"29689315","source_url":"https://pubmed.ncbi.nlm.nih.gov/29689315/","study_design":null,"title":"Stress as risk factor for Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/is-the-amyloid-hypothesis-of-alzheimer-s-disease-therapeutically-22891628","doi":"10.1042/bj20120653","journal":"The Biochemical journal","n_participants":null,"pmid":"22891628","source_url":"https://pubmed.ncbi.nlm.nih.gov/22891628/","study_design":null,"title":"Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?","title_match":false,"year":2012},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/biomarkers-for-alzheimer-s-disease-31099321","doi":"10.2174/1567205016666190517121140","journal":"Current Alzheimer research","n_participants":null,"pmid":"31099321","source_url":"https://pubmed.ncbi.nlm.nih.gov/31099321/","study_design":null,"title":"Biomarkers for Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effects-of-cognitive-training-interventions-with-older-adults-a-12425704","doi":"10.1001/jama.288.18.2271","journal":"JAMA","n_participants":711,"pmid":"12425704","source_url":"https://pubmed.ncbi.nlm.nih.gov/12425704/","study_design":null,"title":"Effects of cognitive training interventions with older adults: a randomized controlled trial","title_match":true,"year":2002},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/cognitive-impairment-in-multiple-sclerosis-clinical-management-mri-32949546","doi":"10.1016/s1474-4422(20)30277-5","journal":"The Lancet. Neurology","n_participants":null,"pmid":"32949546","source_url":"https://pubmed.ncbi.nlm.nih.gov/32949546/","study_design":null,"title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/the-mediterranean-diet-its-components-and-cardiovascular-disease-25447615","doi":"10.1016/j.amjmed.2014.10.014","journal":"The American journal of medicine","n_participants":null,"pmid":"25447615","source_url":"https://pubmed.ncbi.nlm.nih.gov/25447615/","study_design":"randomized controlled trial","title":"The Mediterranean diet, its components, and cardiovascular disease","title_match":false,"year":2015},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/computerized-cognitive-training-in-older-adults-with-mild-cognitive-27838936","doi":"10.1176/appi.ajp.2016.16030360","journal":"The American journal of psychiatry","n_participants":null,"pmid":"27838936","source_url":"https://pubmed.ncbi.nlm.nih.gov/27838936/","study_design":"meta-analysis","title":"Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis","title_match":false,"year":2017},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/combined-physical-and-cognitive-training-for-older-adults-with-and-33249177","doi":"10.1016/j.arr.2020.101232","journal":"Ageing research reviews","n_participants":null,"pmid":"33249177","source_url":"https://pubmed.ncbi.nlm.nih.gov/33249177/","study_design":"meta-analysis","title":"Combined physical and cognitive training for older adults with and without cognitive impairment: A systematic review and network meta-analysis of randomized controlled trials","title_match":true,"year":2021},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/cognitive-training-in-parkinson-disease-a-systematic-review-and-meta-26519540","doi":"10.1212/wnl.0000000000002145","journal":"Neurology","n_participants":272,"pmid":"26519540","source_url":"https://pubmed.ncbi.nlm.nih.gov/26519540/","study_design":null,"title":"Cognitive training in Parkinson disease: A systematic review and meta-analysis","title_match":false,"year":2015},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/the-efficacy-of-cognitive-intervention-in-mild-cognitive-impairment-29282641","doi":"10.1007/s11065-017-9363-3","journal":"Neuropsychology review","n_participants":null,"pmid":"29282641","source_url":"https://pubmed.ncbi.nlm.nih.gov/29282641/","study_design":"meta-analysis","title":"The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures","title_match":false,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/a-literature-overview-of-virtual-reality-vr-in-treatment-of-31379623","doi":"10.3389/fpsyt.2019.00505","journal":"Frontiers in psychiatry","n_participants":null,"pmid":"31379623","source_url":"https://pubmed.ncbi.nlm.nih.gov/31379623/","study_design":null,"title":"A Literature Overview of Virtual Reality (VR) in Treatment of Psychiatric Disorders: Recent Advances and Limitations","title_match":false,"year":2019},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/cognitive-intervention-programs-for-individuals-with-mild-cognitive-20220584","doi":"10.1097/jgp.0b013e3181c37ce9","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":193,"pmid":"20220584","source_url":"https://pubmed.ncbi.nlm.nih.gov/20220584/","study_design":null,"title":"Cognitive intervention programs for individuals with mild cognitive impairment: systematic review of the literature","title_match":false,"year":2010},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/the-potential-effects-of-meditation-on-age-related-cognitive-decline-24571182","doi":"10.1111/nyas.12348","journal":"Annals of the New York Academy of Sciences","n_participants":null,"pmid":"24571182","source_url":"https://pubmed.ncbi.nlm.nih.gov/24571182/","study_design":null,"title":"The potential effects of meditation on age-related cognitive decline: a systematic review","title_match":false,"year":2014},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/effect-of-computerised-cognitive-training-on-cognitive-outcomes-in-31427316","doi":"10.1136/bmjopen-2018-027062","journal":"BMJ open","n_participants":690,"pmid":"31427316","source_url":"https://pubmed.ncbi.nlm.nih.gov/31427316/","study_design":"systematic review","title":"Effect of computerised cognitive training on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis","title_match":false,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/plant-based-dietary-patterns-plant-foods-and-age-related-cognitive-31728502","doi":"10.1093/advances/nmz081","journal":"Advances in nutrition (Bethesda, Md.)","n_participants":null,"pmid":"31728502","source_url":"https://pubmed.ncbi.nlm.nih.gov/31728502/","study_design":null,"title":"Plant-Based Dietary Patterns, Plant Foods, and Age-Related Cognitive Decline","title_match":false,"year":2019},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-cognitive-training-using-a-visual-23650501","doi":"10.1371/journal.pone.0061624","journal":"PloS one","n_participants":681,"pmid":"23650501","source_url":"https://pubmed.ncbi.nlm.nih.gov/23650501/","study_design":null,"title":"A randomized controlled trial of cognitive training using a visual speed of processing intervention in middle aged and older adults","title_match":true,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/non-pharmacological-interventions-for-adults-with-mild-cognitive-26070444","doi":"10.1016/j.mam.2015.06.003","journal":"Molecular aspects of medicine","n_participants":null,"pmid":"26070444","source_url":"https://pubmed.ncbi.nlm.nih.gov/26070444/","study_design":null,"title":"Non-pharmacological interventions for adults with mild cognitive impairment and early stage dementia: An updated scoping review","title_match":false,"year":2015},{"alzhub_score":88,"alzhub_url":"https://alzhub.org/study/speed-of-processing-training-results-in-lower-risk-of-dementia-29201994","doi":"10.1016/j.trci.2017.09.002","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":2802,"pmid":"29201994","source_url":"https://pubmed.ncbi.nlm.nih.gov/29201994/","study_design":"randomized controlled trial","title":"Speed of processing training results in lower risk of dementia","title_match":false,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/nutrition-and-the-risk-of-alzheimer-s-disease-23865055","doi":"10.1155/2013/524820","journal":"BioMed research international","n_participants":null,"pmid":"23865055","source_url":"https://pubmed.ncbi.nlm.nih.gov/23865055/","study_design":null,"title":"Nutrition and the risk of Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/efficacy-of-multidomain-interventions-to-improve-physical-frailty-32134208","doi":"10.1002/jcsm.12534","journal":"Journal of cachexia, sarcopenia and muscle","n_participants":1082,"pmid":"32134208","source_url":"https://pubmed.ncbi.nlm.nih.gov/32134208/","study_design":null,"title":"Efficacy of multidomain interventions to improve physical frailty, depression and cognition: data from cluster-randomized controlled trials","title_match":true,"year":2020},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/high-monounsaturated-fatty-acids-intake-protects-against-age-related-10331679","doi":"10.1212/wnl.52.8.1563","journal":"Neurology","n_participants":704,"pmid":"10331679","source_url":"https://pubmed.ncbi.nlm.nih.gov/10331679/","study_design":"longitudinal study","title":"High monounsaturated fatty acids intake protects against age-related cognitive decline","title_match":false,"year":1999},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/mediterranean-dash-intervention-for-neurodegenerative-delay-mind-33434704","doi":"10.1016/j.cct.2021.106270","journal":"Contemporary clinical trials","n_participants":604,"pmid":"33434704","source_url":"https://pubmed.ncbi.nlm.nih.gov/33434704/","study_design":"randomized controlled trial","title":"Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: Rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline","title_match":false,"year":2021},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/brain-volumes-and-cortical-thickness-on-mri-in-the-finnish-geriatric-31164160","doi":"10.1186/s13195-019-0506-z","journal":"Alzheimer's research & therapy","n_participants":132,"pmid":"31164160","source_url":"https://pubmed.ncbi.nlm.nih.gov/31164160/","study_design":"randomized controlled trial","title":"Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)","title_match":false,"year":2019},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/interventions-for-subjective-cognitive-decline-systematic-review-and-30030318","doi":"10.1136/bmjopen-2018-021610","journal":"BMJ open","n_participants":null,"pmid":"30030318","source_url":"https://pubmed.ncbi.nlm.nih.gov/30030318/","study_design":"meta-analysis","title":"Interventions for subjective cognitive decline: systematic review and meta-analysis","title_match":false,"year":2018},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/designing-clinical-trials-for-assessing-the-effects-of-cognitive-21615936","doi":"10.1186/1471-2318-11-27","journal":"BMC geriatrics","n_participants":1000,"pmid":"21615936","source_url":"https://pubmed.ncbi.nlm.nih.gov/21615936/","study_design":null,"title":"Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: the Seniors Health and Activity Research Program Pilot (SHARP-P) study, a randomized controlled trial","title_match":true,"year":2011},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/effects-of-exercise-alone-or-combined-with-cognitive-training-and-37471089","doi":"10.1001/jamanetworkopen.2023.24465","journal":"JAMA network open","n_participants":null,"pmid":"37471089","source_url":"https://pubmed.ncbi.nlm.nih.gov/37471089/","study_design":null,"title":"Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment: A Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/effect-of-cognitive-training-in-fully-immersive-virtual-reality-on-33955835","doi":"10.2196/24526","journal":"Journal of medical Internet research","n_participants":23,"pmid":"33955835","source_url":"https://pubmed.ncbi.nlm.nih.gov/33955835/","study_design":null,"title":"Effect of Cognitive Training in Fully Immersive Virtual Reality on Visuospatial Function and Frontal-Occipital Functional Connectivity in Predementia: Randomized Controlled Trial","title_match":true,"year":2021},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-mediterranean-diet-and-cognitive-function-among-healthy-older-27657119","doi":"10.3390/nu8090579","journal":"Nutrients","n_participants":137,"pmid":"27657119","source_url":"https://pubmed.ncbi.nlm.nih.gov/27657119/","study_design":null,"title":"The Mediterranean Diet and Cognitive Function among Healthy Older Adults in a 6-Month Randomised Controlled Trial: The MedLey Study","title_match":true,"year":2016},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/japan-multimodal-intervention-trial-for-the-prevention-of-dementia-a-38646854","doi":"10.1002/alz.13838","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":531,"pmid":"38646854","source_url":"https://pubmed.ncbi.nlm.nih.gov/38646854/","study_design":null,"title":"Japan-Multimodal Intervention Trial for the Prevention of Dementia: A randomized controlled trial","title_match":true,"year":2024},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/lifestyle-related-factors-in-predementia-and-dementia-syndromes-18088206","doi":"10.1586/14737175.8.1.133","journal":"Expert review of neurotherapeutics","n_participants":null,"pmid":"18088206","source_url":"https://pubmed.ncbi.nlm.nih.gov/18088206/","study_design":"longitudinal study","title":"Lifestyle-related factors in predementia and dementia syndromes","title_match":false,"year":2008},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/cognitive-decline-in-normal-aging-and-its-prevention-a-review-on-non-28579767","doi":"10.2147/cia.s132963","journal":"Clinical interventions in aging","n_participants":null,"pmid":"28579767","source_url":"https://pubmed.ncbi.nlm.nih.gov/28579767/","study_design":"longitudinal study","title":"Cognitive decline in normal aging and its prevention: a review on non-pharmacological lifestyle strategies","title_match":false,"year":2017},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/computerized-cognitive-training-for-memory-functions-in-mild-38172429","doi":"10.1038/s41746-023-00987-5","journal":"NPJ digital medicine","n_participants":1489,"pmid":"38172429","source_url":"https://pubmed.ncbi.nlm.nih.gov/38172429/","study_design":"meta-analysis","title":"Computerized cognitive training for memory functions in mild cognitive impairment or dementia: a systematic review and meta-analysis","title_match":false,"year":2024},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/enhancing-cognitive-training-effects-in-alzheimer-s-disease-rtms-as-33002645","doi":"10.1016/j.brs.2020.09.010","journal":"Brain stimulation","n_participants":null,"pmid":"33002645","source_url":"https://pubmed.ncbi.nlm.nih.gov/33002645/","study_design":null,"title":"Enhancing cognitive training effects in Alzheimer's disease: rTMS as an add-on treatment","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/cognitive-training-for-freezing-of-gait-in-parkinson-s-disease-a-29796409","doi":"10.1038/s41531-018-0052-6","journal":"NPJ Parkinson's disease","n_participants":20,"pmid":"29796409","source_url":"https://pubmed.ncbi.nlm.nih.gov/29796409/","study_design":null,"title":"Cognitive training for freezing of gait in Parkinson's disease: a randomized controlled trial","title_match":true,"year":2018},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/tailored-and-adaptive-computerized-cognitive-training-in-older-adults-28922158","doi":"10.3233/jad-170404","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"28922158","source_url":"https://pubmed.ncbi.nlm.nih.gov/28922158/","study_design":null,"title":"Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial","title_match":true,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-on-sleep-a-health-alliance-35889954","doi":"10.3390/nu14142998","journal":"Nutrients","n_participants":null,"pmid":"35889954","source_url":"https://pubmed.ncbi.nlm.nih.gov/35889954/","study_design":null,"title":"Mediterranean Diet on Sleep: A Health Alliance","title_match":false,"year":2022},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/effectiveness-of-combined-cognitive-and-physical-interventions-to-31697831","doi":"10.1093/geront/gnz149","journal":"The Gerontologist","n_participants":null,"pmid":"31697831","source_url":"https://pubmed.ncbi.nlm.nih.gov/31697831/","study_design":"systematic review","title":"Effectiveness of Combined Cognitive and Physical Interventions to Enhance Functioning in Older Adults With Mild Cognitive Impairment: A Systematic Review of Randomized Controlled Trials","title_match":true,"year":2020},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/potentials-and-limits-to-enhance-cognitive-functions-in-healthy-and-26441526","doi":"10.3389/fncel.2015.00355","journal":"Frontiers in cellular neuroscience","n_participants":null,"pmid":"26441526","source_url":"https://pubmed.ncbi.nlm.nih.gov/26441526/","study_design":null,"title":"Potentials and limits to enhance cognitive functions in healthy and pathological aging by tDCS","title_match":false,"year":2015},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/the-effect-of-adherence-on-cognition-in-a-multidomain-lifestyle-34668644","doi":"10.1002/alz.12492","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1260,"pmid":"34668644","source_url":"https://pubmed.ncbi.nlm.nih.gov/34668644/","study_design":"randomized controlled trial","title":"The effect of adherence on cognition in a multidomain lifestyle intervention (FINGER)","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/effects-of-transcranial-direct-current-stimulation-paired-with-31998111","doi":"10.3389/fnagi.2019.00340","journal":"Frontiers in aging neuroscience","n_participants":28,"pmid":"31998111","source_url":"https://pubmed.ncbi.nlm.nih.gov/31998111/","study_design":null,"title":"Effects of Transcranial Direct Current Stimulation Paired With Cognitive Training on Functional Connectivity of the Working Memory Network in Older Adults","title_match":false,"year":2019},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/dietary-factors-and-cognitive-decline-26900574","doi":"10.14283/jpad.2015.71","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"26900574","source_url":"https://pubmed.ncbi.nlm.nih.gov/26900574/","study_design":null,"title":"Dietary Factors and Cognitive Decline","title_match":false,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/is-cognitive-training-an-effective-treatment-for-preclinical-and-25171716","doi":"10.3233/jad-141302","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"25171716","source_url":"https://pubmed.ncbi.nlm.nih.gov/25171716/","study_design":null,"title":"Is cognitive training an effective treatment for preclinical and early Alzheimer's disease?","title_match":false,"year":2014},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/association-between-the-mediterranean-diet-and-cognitive-health-among-35967772","doi":"10.3389/fnut.2022.946361","journal":"Frontiers in nutrition","n_participants":null,"pmid":"35967772","source_url":"https://pubmed.ncbi.nlm.nih.gov/35967772/","study_design":"systematic review","title":"Association between the mediterranean diet and cognitive health among healthy adults: A systematic review and meta-analysis","title_match":false,"year":2022},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/repetitive-transcranial-magnetic-stimulation-for-cognitive-impairment-31760522","doi":"10.1007/s00415-019-09644-y","journal":"Journal of neurology","n_participants":240,"pmid":"31760522","source_url":"https://pubmed.ncbi.nlm.nih.gov/31760522/","study_design":"meta-analysis","title":"Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials","title_match":true,"year":2020},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/healthy-ageing-through-internet-counselling-in-the-elderly-the-hatice-27288376","doi":"10.1136/bmjopen-2015-010806","journal":"BMJ open","n_participants":null,"pmid":"27288376","source_url":"https://pubmed.ncbi.nlm.nih.gov/27288376/","study_design":"open-label trial","title":"Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment","title_match":true,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/repetitive-transcranial-magnetic-stimulation-rtms-combined-with-27631152","doi":"10.1007/s00702-016-1606-6","journal":"Journal of neural transmission (Vienna, Austria : 1996)","n_participants":30,"pmid":"27631152","source_url":"https://pubmed.ncbi.nlm.nih.gov/27631152/","study_design":null,"title":"Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience","title_match":false,"year":2016},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/randomized-controlled-trial-of-a-healthy-brain-ageing-cognitive-25408218","doi":"10.3233/jad-142061","journal":"Journal of Alzheimer's disease : JAD","n_participants":64,"pmid":"25408218","source_url":"https://pubmed.ncbi.nlm.nih.gov/25408218/","study_design":null,"title":"Randomized controlled trial of a healthy brain ageing cognitive training program: effects on memory, mood, and sleep","title_match":true,"year":2015},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/effects-of-computerized-cognitive-training-on-neuroimaging-outcomes-28693437","doi":"10.1186/s12877-017-0529-x","journal":"BMC geriatrics","n_participants":null,"pmid":"28693437","source_url":"https://pubmed.ncbi.nlm.nih.gov/28693437/","study_design":"systematic review","title":"Effects of computerized cognitive training on neuroimaging outcomes in older adults: a systematic review","title_match":false,"year":2017},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/transcranial-direct-current-stimulation-combined-with-cognitive-30056141","doi":"10.1016/j.brs.2018.07.046","journal":"Brain stimulation","n_participants":null,"pmid":"30056141","source_url":"https://pubmed.ncbi.nlm.nih.gov/30056141/","study_design":null,"title":"Transcranial direct current stimulation combined with cognitive training for the treatment of Parkinson Disease: A randomized, placebo-controlled study","title_match":true,"year":2018},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/cognitive-training-and-noninvasive-brain-stimulation-for-cognition-in-28583011","doi":"10.1177/1545968317712468","journal":"Neurorehabilitation and neural repair","n_participants":null,"pmid":"28583011","source_url":"https://pubmed.ncbi.nlm.nih.gov/28583011/","study_design":"randomized controlled trial","title":"Cognitive Training and Noninvasive Brain Stimulation for Cognition in Parkinson's Disease: A Meta-analysis","title_match":false,"year":2017},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/individually-modifiable-risk-factors-to-ameliorate-cognitive-aging-a-26361790","doi":"10.3109/13697137.2015.1078106","journal":"Climacteric : the journal of the International Menopause Society","n_participants":null,"pmid":"26361790","source_url":"https://pubmed.ncbi.nlm.nih.gov/26361790/","study_design":"systematic review","title":"Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis","title_match":false,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/cognitive-training-program-to-improve-working-memory-in-older-adults-29471774","doi":"10.1080/07317115.2015.1120257","journal":"Clinical gerontologist","n_participants":68,"pmid":"29471774","source_url":"https://pubmed.ncbi.nlm.nih.gov/29471774/","study_design":null,"title":"Cognitive Training Program to Improve Working Memory in Older Adults with MCI","title_match":false,"year":2016},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/multimodal-cognitive-enhancement-therapy-for-patients-with-mild-27802233","doi":"10.3233/jad-160619","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"27802233","source_url":"https://pubmed.ncbi.nlm.nih.gov/27802233/","study_design":null,"title":"Multimodal Cognitive Enhancement Therapy for Patients with Mild Cognitive Impairment and Mild Dementia: A\u00a0Multi- Center, Randomized, Controlled, Double-Blind, Crossover Trial","title_match":true,"year":2017},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-and-cognitive-function-from-methodology-to-34562607","doi":"10.1016/j.freeradbiomed.2021.09.018","journal":"Free radical biology & medicine","n_participants":null,"pmid":"34562607","source_url":"https://pubmed.ncbi.nlm.nih.gov/34562607/","study_design":"longitudinal study","title":"Mediterranean diet and cognitive function: From methodology to mechanisms of action","title_match":false,"year":2021},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/cognitive-training-interventions-for-patients-with-alzheimer-s-28222505","doi":"10.3233/jad-160810","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"28222505","source_url":"https://pubmed.ncbi.nlm.nih.gov/28222505/","study_design":null,"title":"Cognitive Training Interventions for\u00a0Patients with Alzheimer's Disease: A\u00a0Systematic Review","title_match":false,"year":2017},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effects-of-computerised-cognitive-training-on-cognitive-impairment-a-31650255","doi":"10.1007/s00415-019-09522-7","journal":"Journal of neurology","n_participants":null,"pmid":"31650255","source_url":"https://pubmed.ncbi.nlm.nih.gov/31650255/","study_design":null,"title":"Effects of computerised cognitive training on cognitive impairment: a meta-analysis","title_match":false,"year":2021},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-brain-computer-interface-based-cognitive-training-system-for-24260218","doi":"10.1371/journal.pone.0079419","journal":"PloS one","n_participants":15,"pmid":"24260218","source_url":"https://pubmed.ncbi.nlm.nih.gov/24260218/","study_design":null,"title":"A brain-computer interface based cognitive training system for healthy elderly: a randomized control pilot study for usability and preliminary efficacy","title_match":false,"year":2013},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/use-of-immersive-virtual-reality-in-the-assessment-and-treatment-of-32280091","doi":"10.3233/jad-191218","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"32280091","source_url":"https://pubmed.ncbi.nlm.nih.gov/32280091/","study_design":"longitudinal study","title":"Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review","title_match":false,"year":2020},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/lifestyle-risk-factors-and-cognitive-outcomes-from-the-multidomain-32909259","doi":"10.1111/jgs.16762","journal":"Journal of the American Geriatrics Society","n_participants":57,"pmid":"32909259","source_url":"https://pubmed.ncbi.nlm.nih.gov/32909259/","study_design":"randomized controlled trial","title":"Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL-CD)","title_match":true,"year":2020},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/the-effect-of-multidomain-lifestyle-intervention-on-daily-functioning-30809801","doi":"10.1111/jgs.15837","journal":"Journal of the American Geriatrics Society","n_participants":1260,"pmid":"30809801","source_url":"https://pubmed.ncbi.nlm.nih.gov/30809801/","study_design":"randomized controlled trial","title":"The Effect of Multidomain Lifestyle Intervention on Daily Functioning in Older People","title_match":false,"year":2019},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/a-review-of-multidomain-interventions-to-support-healthy-cognitive-23459978","doi":"10.1007/s12603-012-0402-8","journal":"The journal of nutrition, health & aging","n_participants":null,"pmid":"23459978","source_url":"https://pubmed.ncbi.nlm.nih.gov/23459978/","study_design":null,"title":"A review of multidomain interventions to support healthy cognitive ageing","title_match":false,"year":2013},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/computerized-cognitive-training-in-multiple-sclerosis-a-systematic-31328637","doi":"10.1177/1545968319860490","journal":"Neurorehabilitation and neural repair","n_participants":982,"pmid":"31328637","source_url":"https://pubmed.ncbi.nlm.nih.gov/31328637/","study_design":null,"title":"Computerized Cognitive Training in Multiple Sclerosis: A Systematic Review and Meta-analysis","title_match":false,"year":2019},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/the-effects-of-7-week-cognitive-training-in-patients-with-vascular-30894299","doi":"10.1016/j.jalz.2019.01.009","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"30894299","source_url":"https://pubmed.ncbi.nlm.nih.gov/30894299/","study_design":null,"title":"The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): A randomized controlled trial","title_match":true,"year":2019},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/augmenting-cognitive-training-in-older-adults-the-act-study-design-29313802","doi":"10.1016/j.cct.2017.11.017","journal":"Contemporary clinical trials","n_participants":360,"pmid":"29313802","source_url":"https://pubmed.ncbi.nlm.nih.gov/29313802/","study_design":null,"title":"Augmenting cognitive training in older adults (The ACT Study): Design and Methods of a Phase III tDCS and cognitive training trial","title_match":true,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/targets-for-the-prevention-of-dementia-20413867","doi":"10.3233/jad-2010-091657","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"20413867","source_url":"https://pubmed.ncbi.nlm.nih.gov/20413867/","study_design":null,"title":"Targets for the prevention of dementia","title_match":false,"year":2010},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/agewell-de-study-protocol-of-a-pragmatic-multi-center-cluster-31370792","doi":"10.1186/s12877-019-1212-1","journal":"BMC geriatrics","n_participants":1152,"pmid":"31370792","source_url":"https://pubmed.ncbi.nlm.nih.gov/31370792/","study_design":null,"title":"AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients","title_match":true,"year":2019},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/synergic-trial-synchronizing-exercises-remedies-in-gait-and-cognition-29661156","doi":"10.1186/s12877-018-0782-7","journal":"BMC geriatrics","n_participants":null,"pmid":"29661156","source_url":"https://pubmed.ncbi.nlm.nih.gov/29661156/","study_design":null,"title":"SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment","title_match":true,"year":2018},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/computer-based-cognitive-intervention-for-dementia-preliminary-18575355","doi":null,"journal":"Giornale italiano di medicina del lavoro ed ergonomia","n_participants":null,"pmid":"18575355","source_url":"https://pubmed.ncbi.nlm.nih.gov/18575355/","study_design":null,"title":"Computer-based cognitive intervention for dementia: preliminary results of a randomized clinical trial","title_match":true,"year":2007},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/intradialytic-cognitive-and-exercise-training-may-preserve-cognitive-29340317","doi":"10.1016/j.ekir.2017.08.006","journal":"Kidney international reports","n_participants":null,"pmid":"29340317","source_url":"https://pubmed.ncbi.nlm.nih.gov/29340317/","study_design":"randomized controlled trial","title":"Intradialytic Cognitive and Exercise Training May Preserve Cognitive Function","title_match":false,"year":2018},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/effects-of-creative-expression-therapy-for-older-adults-with-mild-30087557","doi":"10.2147/cia.s161861","journal":"Clinical interventions in aging","n_participants":93,"pmid":"30087557","source_url":"https://pubmed.ncbi.nlm.nih.gov/30087557/","study_design":null,"title":"Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer's disease: a randomized controlled clinical trial","title_match":true,"year":2018},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-timecourse-of-global-cognitive-gains-from-supervised-computer-29261218","doi":"10.14283/jpad.2014.18","journal":"The journal of prevention of Alzheimer's disease","n_participants":80,"pmid":"29261218","source_url":"https://pubmed.ncbi.nlm.nih.gov/29261218/","study_design":"longitudinal study","title":"The Timecourse of Global Cognitive Gains from Supervised Computer-Assisted Cognitive Training: A Randomised, Active-Controlled Trial in Elderly with Multiple Dementia Risk Factors","title_match":false,"year":2014},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/a-multimodal-precision-prevention-approach-combining-lifestyle-38297399","doi":"10.1186/s13195-023-01355-x","journal":"Alzheimer's research & therapy","n_participants":600,"pmid":"38297399","source_url":"https://pubmed.ncbi.nlm.nih.gov/38297399/","study_design":null,"title":"A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol","title_match":true,"year":2024},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/multi-domain-interventions-for-dementia-prevention-a-systematic-review-38151879","doi":"10.1007/s12603-023-2046-2","journal":"The journal of nutrition, health & aging","n_participants":15,"pmid":"38151879","source_url":"https://pubmed.ncbi.nlm.nih.gov/38151879/","study_design":"systematic review","title":"Multi-Domain Interventions for Dementia Prevention - A Systematic Review","title_match":false,"year":2023},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/computerized-cognitive-training-in-parkinson-s-disease-a-systematic-35714854","doi":"10.1016/j.arr.2022.101671","journal":"Ageing research reviews","n_participants":679,"pmid":"35714854","source_url":"https://pubmed.ncbi.nlm.nih.gov/35714854/","study_design":"meta-analysis","title":"Computerized cognitive training in Parkinson's disease: A systematic review and meta-analysis","title_match":false,"year":2022},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/efficacy-of-a-web-app-for-cognitive-training-memo-regarding-cognitive-32159519","doi":"10.2196/17167","journal":"Journal of medical Internet research","n_participants":46,"pmid":"32159519","source_url":"https://pubmed.ncbi.nlm.nih.gov/32159519/","study_design":null,"title":"Efficacy of a Web App for Cognitive Training (MeMo) Regarding Cognitive and Behavioral Performance in People With Neurocognitive Disorders: Randomized Controlled Trial","title_match":true,"year":2020},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/serious-video-games-and-virtual-reality-for-prevention-and-32073439","doi":"10.1097/wco.0000000000000791","journal":"Current opinion in neurology","n_participants":null,"pmid":"32073439","source_url":"https://pubmed.ncbi.nlm.nih.gov/32073439/","study_design":null,"title":"Serious video games and virtual reality for prevention and neurorehabilitation of cognitive decline because of aging and neurodegeneration","title_match":false,"year":2020},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/effectiveness-of-computerized-cognitive-training-in-delaying-36301590","doi":"10.2196/38624","journal":"Journal of medical Internet research","n_participants":1059,"pmid":"36301590","source_url":"https://pubmed.ncbi.nlm.nih.gov/36301590/","study_design":"systematic review","title":"Effectiveness of Computerized Cognitive Training in Delaying Cognitive Function Decline in People With Mild Cognitive Impairment: Systematic Review and Meta-analysis","title_match":false,"year":2022},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/virtual-reality-based-cognitive-motor-training-for-middle-aged-adults-29955655","doi":"10.1016/j.trci.2018.02.005","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":125,"pmid":"29955655","source_url":"https://pubmed.ncbi.nlm.nih.gov/29955655/","study_design":"randomized controlled trial","title":"Virtual reality-based cognitive-motor training for middle-aged adults at high Alzheimer's disease risk: A randomized controlled trial","title_match":true,"year":2018},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/psychosocial-interventions-for-people-with-dementia-an-overview-and-27380931","doi":"10.1177/1471301216656096","journal":"Dementia (London, England)","n_participants":null,"pmid":"27380931","source_url":"https://pubmed.ncbi.nlm.nih.gov/27380931/","study_design":null,"title":"Psychosocial interventions for people with dementia: An overview and commentary on recent developments","title_match":false,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/the-link-between-physical-activity-and-cognitive-dysfunction-in-25573757","doi":"10.2522/ptj.20140212","journal":"Physical therapy","n_participants":394,"pmid":"25573757","source_url":"https://pubmed.ncbi.nlm.nih.gov/25573757/","study_design":null,"title":"The Link Between Physical Activity and Cognitive Dysfunction in Alzheimer Disease","title_match":false,"year":2015},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/methodology-of-china-s-national-study-on-the-evaluation-early-24991140","doi":"10.3969/j.issn.1002-0829.2013.02.005","journal":"Shanghai archives of psychiatry","n_participants":null,"pmid":"24991140","source_url":"https://pubmed.ncbi.nlm.nih.gov/24991140/","study_design":null,"title":"Methodology of China's national study on the evaluation, early recognition, and treatment of psychological problems in the elderly: the China Longitudinal Aging Study (CLAS)","title_match":false,"year":2013},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/cognitive-training-in-parkinson-s-disease-reduces-cognitive-decline-25534579","doi":"10.1111/ene.12621","journal":"European journal of neurology","n_participants":null,"pmid":"25534579","source_url":"https://pubmed.ncbi.nlm.nih.gov/25534579/","study_design":"randomized controlled trial","title":"Cognitive training in Parkinson's disease reduces cognitive decline in the long term","title_match":false,"year":2015},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/facility-based-and-home-based-multidomain-interventions-including-34148030","doi":"10.18632/aging.203213","journal":"Aging","n_participants":51,"pmid":"34148030","source_url":"https://pubmed.ncbi.nlm.nih.gov/34148030/","study_design":"randomized controlled trial","title":"Facility-based and home-based multidomain interventions including cognitive training, exercise, diet, vascular risk management, and motivation for older adults: a randomized controlled feasibility trial","title_match":true,"year":2021},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/the-effect-of-adherence-to-the-mediterranean-diet-on-late-life-32981667","doi":"10.1016/j.jamda.2020.08.020","journal":"Journal of the American Medical Directors Association","n_participants":null,"pmid":"32981667","source_url":"https://pubmed.ncbi.nlm.nih.gov/32981667/","study_design":"systematic review","title":"The Effect of Adherence to the Mediterranean Diet on Late-Life Cognitive Disorders: A Systematic Review","title_match":false,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/the-active-ingredient-of-cognitive-restoration-a-multicenter-30639273","doi":"10.1016/j.apmr.2018.12.020","journal":"Archives of physical medicine and rehabilitation","n_participants":30,"pmid":"30639273","source_url":"https://pubmed.ncbi.nlm.nih.gov/30639273/","study_design":"randomized controlled trial","title":"The Active Ingredient of Cognitive Restoration: A Multicenter Randomized Controlled Trial of Sequential Combination of Aerobic Exercise and Computer-Based Cognitive Training in Stroke Survivors With Cognitive Decline","title_match":true,"year":2019},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/a-mediterranean-diet-supplemented-with-dairy-foods-improves-mood-and-30409085","doi":"10.1080/1028415x.2018.1543148","journal":"Nutritional neuroscience","n_participants":null,"pmid":"30409085","source_url":"https://pubmed.ncbi.nlm.nih.gov/30409085/","study_design":null,"title":"A Mediterranean diet supplemented with dairy foods improves mood and processing speed in an Australian sample: results from the MedDairy randomized controlled trial","title_match":true,"year":2020},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/botanicals-and-phytochemicals-active-on-cognitive-decline-the-29289576","doi":"10.1016/j.phrs.2017.12.029","journal":"Pharmacological research","n_participants":null,"pmid":"29289576","source_url":"https://pubmed.ncbi.nlm.nih.gov/29289576/","study_design":"systematic review","title":"Botanicals and phytochemicals active on cognitive decline: The clinical evidence","title_match":false,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/physical-activity-and-lifestyle-modifications-in-the-treatment-of-37304072","doi":"10.3389/fnagi.2023.1185671","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"37304072","source_url":"https://pubmed.ncbi.nlm.nih.gov/37304072/","study_design":null,"title":"Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases","title_match":false,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/dietary-patterns-and-cognition-in-older-persons-29035971","doi":"10.1097/mco.0000000000000434","journal":"Current opinion in clinical nutrition and metabolic care","n_participants":null,"pmid":"29035971","source_url":"https://pubmed.ncbi.nlm.nih.gov/29035971/","study_design":null,"title":"Dietary patterns and cognition in older persons","title_match":false,"year":2018},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/effects-of-virtual-reality-motor-cognitive-training-for-older-people-39259959","doi":"10.2196/57809","journal":"Journal of medical Internet research","n_participants":null,"pmid":"39259959","source_url":"https://pubmed.ncbi.nlm.nih.gov/39259959/","study_design":"randomized controlled trial","title":"Effects of Virtual Reality Motor-Cognitive Training for Older People With Cognitive Frailty: Multicentered Randomized Controlled Trial","title_match":true,"year":2024},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/effects-of-functional-tasks-exercise-on-cognitive-functions-of-older-31801630","doi":"10.1186/s13195-019-0548-2","journal":"Alzheimer's research & therapy","n_participants":59,"pmid":"31801630","source_url":"https://pubmed.ncbi.nlm.nih.gov/31801630/","study_design":"randomized controlled trial","title":"Effects of functional tasks exercise on cognitive functions of older adults with mild cognitive impairment: a randomized controlled pilot trial","title_match":true,"year":2019},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-pilot-double-blind-randomized-controlled-trial-of-cognitive-31424410","doi":"10.3233/jad-190306","journal":"Journal of Alzheimer's disease : JAD","n_participants":68,"pmid":"31424410","source_url":"https://pubmed.ncbi.nlm.nih.gov/31424410/","study_design":null,"title":"A Pilot Double-Blind Randomized Controlled Trial of Cognitive Training Combined with Transcranial Direct Current Stimulation for Amnestic Mild Cognitive Impairment","title_match":true,"year":2019},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/cognitive-flexibility-training-a-large-scale-multimodal-adaptive-29209183","doi":"10.3389/fnhum.2017.00529","journal":"Frontiers in human neuroscience","n_participants":null,"pmid":"29209183","source_url":"https://pubmed.ncbi.nlm.nih.gov/29209183/","study_design":"randomized controlled trial","title":"Cognitive Flexibility Training: A Large-Scale Multimodal Adaptive Active-Control Intervention Study in Healthy Older Adults","title_match":false,"year":2017},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/study-of-mental-activity-and-regular-training-smart-in-at-risk-21510896","doi":"10.1186/1471-2318-11-19","journal":"BMC geriatrics","n_participants":null,"pmid":"21510896","source_url":"https://pubmed.ncbi.nlm.nih.gov/21510896/","study_design":null,"title":"Study of Mental Activity and Regular Training (SMART) in at risk individuals: a randomised double blind, sham controlled, longitudinal trial","title_match":false,"year":2011},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/lifespan-intellectual-factors-genetic-susceptibility-and-cognitive-31214016","doi":"10.3389/fnagi.2019.00129","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"31214016","source_url":"https://pubmed.ncbi.nlm.nih.gov/31214016/","study_design":"narrative review","title":"Lifespan Intellectual Factors, Genetic Susceptibility, and Cognitive Phenotypes in Aging: Implications for Interventions","title_match":false,"year":2019},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/nutrient-intake-and-dietary-changes-during-a-2-year-multi-domain-28875868","doi":"10.1017/s0007114517001982","journal":"The British journal of nutrition","n_participants":631,"pmid":"28875868","source_url":"https://pubmed.ncbi.nlm.nih.gov/28875868/","study_design":null,"title":"Nutrient intake and dietary changes during a 2-year multi-domain lifestyle intervention among older adults: secondary analysis of the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) randomised controlled trial","title_match":true,"year":2017},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/whole-dietary-patterns-cognitive-decline-and-cognitive-disorders-a-36678204","doi":"10.3390/nu15020333","journal":"Nutrients","n_participants":17,"pmid":"36678204","source_url":"https://pubmed.ncbi.nlm.nih.gov/36678204/","study_design":"systematic review","title":"Whole Dietary Patterns, Cognitive Decline and Cognitive Disorders: A Systematic Review of Prospective and Intervention Studies","title_match":false,"year":2023},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/home-based-transcranial-direct-current-stimulation-to-enhance-35975663","doi":"10.1161/strokeaha.121.037629","journal":"Stroke","n_participants":null,"pmid":"35975663","source_url":"https://pubmed.ncbi.nlm.nih.gov/35975663/","study_design":null,"title":"Home-Based Transcranial Direct Current Stimulation to Enhance Cognition in Stroke: Randomized Controlled Trial","title_match":true,"year":2022},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/the-healthy-mind-healthy-mobility-trial-a-novel-exercise-program-for-26285025","doi":"10.1249/mss.0000000000000758","journal":"Medicine and science in sports and exercise","n_participants":44,"pmid":"26285025","source_url":"https://pubmed.ncbi.nlm.nih.gov/26285025/","study_design":"randomized controlled trial","title":"The Healthy Mind, Healthy Mobility Trial: A Novel Exercise Program for Older Adults","title_match":false,"year":2016},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/virtual-reality-interventions-for-older-adults-with-mild-cognitive-39793970","doi":"10.2196/59195","journal":"Journal of medical Internet research","n_participants":18,"pmid":"39793970","source_url":"https://pubmed.ncbi.nlm.nih.gov/39793970/","study_design":"meta-analysis","title":"Virtual Reality Interventions for Older Adults With Mild Cognitive Impairment: Systematic Review and Meta-Analysis of Randomized Controlled Trials","title_match":true,"year":2025},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/cognitive-training-interventions-and-depression-in-mild-cognitive-32378715","doi":"10.1093/ageing/afaa063","journal":"Age and ageing","n_participants":2551,"pmid":"32378715","source_url":"https://pubmed.ncbi.nlm.nih.gov/32378715/","study_design":null,"title":"Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials","title_match":true,"year":2020},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/efficacy-of-multidomain-intervention-against-physio-cognitive-decline-33765656","doi":"10.1016/j.archger.2021.104392","journal":"Archives of gerontology and geriatrics","n_participants":733,"pmid":"33765656","source_url":"https://pubmed.ncbi.nlm.nih.gov/33765656/","study_design":"randomized controlled trial","title":"Efficacy of Multidomain Intervention Against Physio-cognitive Decline Syndrome: A Cluster-randomized Trial","title_match":false,"year":2021},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/a-computer-based-cognitive-training-in-mild-cognitive-impairment-in-31256092","doi":"10.3233/nre-192714","journal":"NeuroRehabilitation","n_participants":null,"pmid":"31256092","source_url":"https://pubmed.ncbi.nlm.nih.gov/31256092/","study_design":null,"title":"A computer-based cognitive training in Mild Cognitive Impairment in Parkinson's Disease","title_match":false,"year":2019},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/cognitive-effects-of-multi-domain-interventions-among-pre-frail-and-29069291","doi":"10.1093/gerona/glx207","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":49,"pmid":"29069291","source_url":"https://pubmed.ncbi.nlm.nih.gov/29069291/","study_design":null,"title":"Cognitive Effects of Multi-Domain Interventions Among Pre-Frail and Frail Community-Living Older Persons: Randomized Controlled Trial","title_match":true,"year":2018},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/can-mindfulness-based-interventions-influence-cognitive-functioning-27827541","doi":"10.1080/13607863.2016.1247423","journal":"Aging & mental health","n_participants":null,"pmid":"27827541","source_url":"https://pubmed.ncbi.nlm.nih.gov/27827541/","study_design":"cross-sectional","title":"Can mindfulness-based interventions influence cognitive functioning in older adults? A review and considerations for future research","title_match":false,"year":2017},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/a-double-blind-randomized-controlled-trial-of-the-efficacy-of-32895890","doi":"10.1007/s40520-020-01665-2","journal":"Aging clinical and experimental research","n_participants":53,"pmid":"32895890","source_url":"https://pubmed.ncbi.nlm.nih.gov/32895890/","study_design":"randomized controlled trial","title":"A double-blind randomized controlled trial of the efficacy of cognitive training delivered using two different methods in mild cognitive impairment in Parkinson's disease: preliminary report of benefits associated with the use of a computerized tool","title_match":true,"year":2021},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/the-japan-multimodal-intervention-trial-for-prevention-of-dementia-j-34585222","doi":"10.14283/jpad.2021.29","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"34585222","source_url":"https://pubmed.ncbi.nlm.nih.gov/34585222/","study_design":"randomized controlled trial","title":"The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial","title_match":true,"year":2021},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/a-web-based-multidomain-lifestyle-intervention-for-older-adults-the-33569560","doi":"10.14283/jpad.2020.70","journal":"The journal of prevention of Alzheimer's disease","n_participants":54,"pmid":"33569560","source_url":"https://pubmed.ncbi.nlm.nih.gov/33569560/","study_design":"randomized controlled trial","title":"A Web-Based Multidomain Lifestyle Intervention for Older Adults: The eMIND Randomized Controlled Trial","title_match":true,"year":2021},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/facilitators-and-barriers-to-implementing-lifestyle-intervention-34448856","doi":"10.1093/eurpub/ckab087","journal":"European journal of public health","n_participants":27,"pmid":"34448856","source_url":"https://pubmed.ncbi.nlm.nih.gov/34448856/","study_design":"randomized controlled trial","title":"Facilitators and barriers to implementing lifestyle intervention programme to prevent cognitive decline","title_match":false,"year":2021},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/dietary-patterns-in-middle-age-effects-on-concurrent-neurocognition-34392373","doi":"10.1093/nutrit/nuab047","journal":"Nutrition reviews","n_participants":null,"pmid":"34392373","source_url":"https://pubmed.ncbi.nlm.nih.gov/34392373/","study_design":"systematic review","title":"Dietary patterns in middle age: effects on concurrent neurocognition and risk of age-related cognitive decline","title_match":false,"year":2022},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/multidomain-intervention-for-reversal-of-cognitive-frailty-towards-a-34092633","doi":"10.3233/jad-201607","journal":"Journal of Alzheimer's disease : JAD","n_participants":165,"pmid":"34092633","source_url":"https://pubmed.ncbi.nlm.nih.gov/34092633/","study_design":"randomized controlled trial","title":"Multidomain Intervention for Reversal of Cognitive Frailty, Towards a Personalized Approach (AGELESS Trial): Study Design","title_match":false,"year":2021},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/a-multi-domain-intervention-protocol-for-the-potential-reversal-of-33014971","doi":"10.3389/fpubh.2020.00471","journal":"Frontiers in public health","n_participants":null,"pmid":"33014971","source_url":"https://pubmed.ncbi.nlm.nih.gov/33014971/","study_design":"randomized controlled trial","title":"A Multi-Domain Intervention Protocol for the Potential Reversal of Cognitive Frailty: \"WE-RISE\" Randomized Controlled Trial","title_match":true,"year":2020},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/psychosocial-interventions-for-alzheimer-s-disease-cognitive-symptoms-30086714","doi":"10.1186/s12877-018-0864-6","journal":"BMC geriatrics","n_participants":682,"pmid":"30086714","source_url":"https://pubmed.ncbi.nlm.nih.gov/30086714/","study_design":"meta-analysis","title":"Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis","title_match":false,"year":2018},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/designing-an-internet-based-multidomain-intervention-for-the-29480185","doi":"10.3233/jad-170858","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"29480185","source_url":"https://pubmed.ncbi.nlm.nih.gov/29480185/","study_design":"randomized controlled trial","title":"Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial","title_match":false,"year":2018},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-and-risk-of-dementia-26159192","doi":"10.2174/1567205012666150710114430","journal":"Current Alzheimer research","n_participants":null,"pmid":"26159192","source_url":"https://pubmed.ncbi.nlm.nih.gov/26159192/","study_design":"cross-sectional","title":"Mediterranean Diet and Risk of Dementia","title_match":false,"year":2015},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/the-humanoid-robot-sil-bot-in-a-cognitive-training-program-for-34360490","doi":"10.3390/ijerph18158198","journal":"International journal of environmental research and public health","n_participants":90,"pmid":"34360490","source_url":"https://pubmed.ncbi.nlm.nih.gov/34360490/","study_design":"randomized controlled trial","title":"The Humanoid Robot Sil-Bot in a Cognitive Training Program for Community-Dwelling Elderly People with Mild Cognitive Impairment during the COVID-19 Pandemic: A Randomized Controlled Trial","title_match":true,"year":2021},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/change-in-caide-dementia-risk-score-and-neuroimaging-biomarkers-33970268","doi":"10.1093/gerona/glab130","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":112,"pmid":"33970268","source_url":"https://pubmed.ncbi.nlm.nih.gov/33970268/","study_design":"post-hoc analysis","title":"Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis","title_match":true,"year":2021},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/27-hydroxycholesterol-cognition-and-brain-imaging-markers-in-the-33676572","doi":"10.1186/s13195-021-00790-y","journal":"Alzheimer's research & therapy","n_participants":47,"pmid":"33676572","source_url":"https://pubmed.ncbi.nlm.nih.gov/33676572/","study_design":"cross-sectional","title":"27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial","title_match":true,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/wine-an-aspiring-agent-in-promoting-longevity-and-preventing-chronic-30096779","doi":"10.3390/diseases6030073","journal":"Diseases (Basel, Switzerland)","n_participants":null,"pmid":"30096779","source_url":"https://pubmed.ncbi.nlm.nih.gov/30096779/","study_design":null,"title":"Wine: An Aspiring Agent in Promoting Longevity and Preventing Chronic Diseases","title_match":false,"year":2018},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/a-multidomain-lifestyle-intervention-to-maintain-optimal-cognitive-38872204","doi":"10.1186/s13195-024-01495-8","journal":"Alzheimer's research & therapy","n_participants":1210,"pmid":"38872204","source_url":"https://pubmed.ncbi.nlm.nih.gov/38872204/","study_design":null,"title":"A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial","title_match":true,"year":2024},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/combined-exercise-and-cognitive-interventions-for-adults-with-mild-37769394","doi":"10.1016/j.ijnurstu.2023.104592","journal":"International journal of nursing studies","n_participants":2910,"pmid":"37769394","source_url":"https://pubmed.ncbi.nlm.nih.gov/37769394/","study_design":"meta-analysis","title":"Combined exercise and cognitive interventions for adults with mild cognitive impairment and dementia: A systematic review and network meta-analysis","title_match":false,"year":2023},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/augmenting-computerized-cognitive-training-with-vortioxetine-for-age-32212856","doi":"10.1176/appi.ajp.2019.19050561","journal":"The American journal of psychiatry","n_participants":100,"pmid":"32212856","source_url":"https://pubmed.ncbi.nlm.nih.gov/32212856/","study_design":null,"title":"Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial","title_match":true,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/is-computerized-working-memory-training-effective-in-healthy-older-30103334","doi":"10.3233/jad-180455","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30103334","source_url":"https://pubmed.ncbi.nlm.nih.gov/30103334/","study_design":null,"title":"Is Computerized Working Memory Training Effective in Healthy Older Adults? Evidence from a Multi-Site, Randomized Controlled Trial","title_match":true,"year":2018},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/n-3-fatty-acids-mediterranean-diet-and-cognitive-function-in-normal-28213052","doi":"10.1016/j.exger.2017.02.008","journal":"Experimental gerontology","n_participants":null,"pmid":"28213052","source_url":"https://pubmed.ncbi.nlm.nih.gov/28213052/","study_design":"systematic review","title":"n-3 Fatty acids, Mediterranean diet and cognitive function in normal aging: A systematic review","title_match":false,"year":2017},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/a-double-blind-randomized-controlled-trial-combining-cognitive-34156651","doi":"10.1007/s40520-021-01912-0","journal":"Aging clinical and experimental research","n_participants":33,"pmid":"34156651","source_url":"https://pubmed.ncbi.nlm.nih.gov/34156651/","study_design":"randomized controlled trial","title":"A double-blind randomized controlled trial combining cognitive training (CoRe) and neurostimulation (tDCS) in the early stages of cognitive impairment","title_match":true,"year":2022},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/computerized-cognitive-training-for-older-adults-at-higher-dementia-30868154","doi":"10.1093/gerona/glz073","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":null,"pmid":"30868154","source_url":"https://pubmed.ncbi.nlm.nih.gov/30868154/","study_design":null,"title":"Computerized Cognitive Training for Older Adults at Higher Dementia Risk due to Diabetes: Findings From a Randomized Controlled Trial","title_match":true,"year":2020},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/a-comparison-of-the-effects-between-2-computerized-cognitive-training-30407291","doi":"10.1097/md.0000000000013007","journal":"Medicine","n_participants":null,"pmid":"30407291","source_url":"https://pubmed.ncbi.nlm.nih.gov/30407291/","study_design":null,"title":"A comparison of the effects between 2 computerized cognitive training programs, Bettercog and COMCOG, on elderly patients with MCI and mild dementia: A single-blind randomized controlled study","title_match":true,"year":2018},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/the-effects-of-an-8-week-computerized-cognitive-training-program-in-29378515","doi":"10.1186/s12877-018-0730-6","journal":"BMC geriatrics","n_participants":null,"pmid":"29378515","source_url":"https://pubmed.ncbi.nlm.nih.gov/29378515/","study_design":"randomized controlled trial","title":"The effects of an 8-week computerized cognitive training program in older adults: a study protocol for a randomized controlled trial","title_match":true,"year":2018},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/cognitive-change-is-more-positively-associated-with-an-active-27608620","doi":"10.1186/s12888-016-1018-z","journal":"BMC psychiatry","n_participants":null,"pmid":"27608620","source_url":"https://pubmed.ncbi.nlm.nih.gov/27608620/","study_design":null,"title":"Cognitive change is more positively associated with an active lifestyle than with training interventions in older adults at risk of dementia: a controlled interventional clinical trial","title_match":true,"year":2016},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/cognitive-intervention-through-a-training-program-for-picture-book-25416537","doi":"10.1186/1471-2318-14-122","journal":"BMC geriatrics","n_participants":29,"pmid":"25416537","source_url":"https://pubmed.ncbi.nlm.nih.gov/25416537/","study_design":null,"title":"Cognitive intervention through a training program for picture book reading in community-dwelling older adults: a randomized controlled trial","title_match":true,"year":2014},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/white-matter-changes-on-diffusion-tensor-imaging-in-the-finger-32925045","doi":"10.3233/jad-200423","journal":"Journal of Alzheimer's disease : JAD","n_participants":34,"pmid":"32925045","source_url":"https://pubmed.ncbi.nlm.nih.gov/32925045/","study_design":"randomized controlled trial","title":"White Matter Changes on Diffusion Tensor Imaging in the FINGER Randomized Controlled Trial","title_match":true,"year":2020},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/south-korean-study-to-prevent-cognitive-impairment-and-protect-brain-32319247","doi":"10.3988/jcn.2020.16.2.292","journal":"Journal of clinical neurology (Seoul, Korea)","n_participants":150,"pmid":"32319247","source_url":"https://pubmed.ncbi.nlm.nih.gov/32319247/","study_design":"randomized controlled trial","title":"South Korean Study to Prevent Cognitive Impairment and Protect Brain Health Through Lifestyle Intervention in At-Risk Elderly People: Protocol of a Multicenter, Randomized Controlled Feasibility Trial","title_match":true,"year":2020},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-multimodal-non-pharmacological-interventions-31634894","doi":"10.1159/000503445","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"31634894","source_url":"https://pubmed.ncbi.nlm.nih.gov/31634894/","study_design":"systematic review","title":"A Systematic Review of Multimodal Non-Pharmacological Interventions for Cognitive Function in Older People with Dementia in Nursing Homes","title_match":false,"year":2019},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/use-of-the-internet-as-a-prevention-tool-against-cognitive-decline-in-27672317","doi":"10.2147/cia.s113758","journal":"Clinical interventions in aging","n_participants":null,"pmid":"27672317","source_url":"https://pubmed.ncbi.nlm.nih.gov/27672317/","study_design":"longitudinal study","title":"Use of the Internet as a prevention tool against cognitive decline in normal aging","title_match":false,"year":2016},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/one-year-repeated-cycles-of-cognitive-training-ct-for-alzheimer-s-23784727","doi":"10.1007/s40520-013-0065-2","journal":"Aging clinical and experimental research","n_participants":16,"pmid":"23784727","source_url":"https://pubmed.ncbi.nlm.nih.gov/23784727/","study_design":"randomized controlled trial","title":"One-year repeated cycles of cognitive training (CT) for Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/body-brain-life-for-cognitive-decline-bbl-cd-protocol-for-a-30538436","doi":"10.2147/cia.s182046","journal":"Clinical interventions in aging","n_participants":null,"pmid":"30538436","source_url":"https://pubmed.ncbi.nlm.nih.gov/30538436/","study_design":"randomized controlled trial","title":"Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment","title_match":true,"year":2018},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/higher-circulating-carotene-was-associated-with-better-cognitive-34527222","doi":"10.1017/jns.2021.56","journal":"Journal of nutritional science","n_participants":null,"pmid":"34527222","source_url":"https://pubmed.ncbi.nlm.nih.gov/34527222/","study_design":null,"title":"Higher circulating \u03b1-carotene was associated with better cognitive function: an evaluation among the MIND trial participants","title_match":false,"year":2021},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/a-critical-review-of-the-study-of-neuroprotective-diets-to-reduce-34208980","doi":"10.3390/nu13072264","journal":"Nutrients","n_participants":null,"pmid":"34208980","source_url":"https://pubmed.ncbi.nlm.nih.gov/34208980/","study_design":null,"title":"A Critical Review of the Study of Neuroprotective Diets to Reduce Cognitive Decline","title_match":false,"year":2021},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/a-literature-review-of-spaced-retrieval-interventions-a-direct-memory-23886395","doi":"10.1017/s1041610213001233","journal":"International psychogeriatrics","n_participants":null,"pmid":"23886395","source_url":"https://pubmed.ncbi.nlm.nih.gov/23886395/","study_design":null,"title":"A literature review of spaced-retrieval interventions: a direct memory intervention for people with dementia","title_match":false,"year":2013},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effectiveness-of-cognitive-training-in-chinese-older-people-with-22528470","doi":"10.1002/gps.3812","journal":"International journal of geriatric psychiatry","n_participants":111,"pmid":"22528470","source_url":"https://pubmed.ncbi.nlm.nih.gov/22528470/","study_design":null,"title":"Effectiveness of cognitive training in Chinese older people with subjective cognitive complaints: a randomized placebo-controlled trial","title_match":true,"year":2013},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-a-review-on-the-current-trends-of-the-effective-39185459","doi":"10.3389/fnagi.2024.1429211","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"39185459","source_url":"https://pubmed.ncbi.nlm.nih.gov/39185459/","study_design":null,"title":"Alzheimer's disease: a review on the current trends of the effective diagnosis and therapeutics","title_match":false,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/a-randomised-controlled-trial-investigating-the-effects-of-26003546","doi":"10.1186/s12937-015-0042-z","journal":"Nutrition journal","n_participants":null,"pmid":"26003546","source_url":"https://pubmed.ncbi.nlm.nih.gov/26003546/","study_design":null,"title":"A randomised controlled trial investigating the effects of Mediterranean diet and aerobic exercise on cognition in cognitively healthy older people living independently within aged care facilities: the Lifestyle Intervention in Independent Living Aged Care (LIILAC) study protocol [ACTRN12614001133628]","title_match":true,"year":2015},{"alzhub_score":88,"alzhub_url":"https://alzhub.org/study/an-18-month-multimodal-intervention-trial-for-preventing-dementia-j-39229900","doi":"10.1002/alz.14170","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":203,"pmid":"39229900","source_url":"https://pubmed.ncbi.nlm.nih.gov/39229900/","study_design":"randomized controlled trial","title":"An 18-month multimodal intervention trial for preventing dementia: J-MINT PRIME Tamba","title_match":false,"year":2024},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/integrating-a-multimodal-lifestyle-intervention-with-medical-food-in-38812047","doi":"10.1186/s13195-024-01468-x","journal":"Alzheimer's research & therapy","n_participants":93,"pmid":"38812047","source_url":"https://pubmed.ncbi.nlm.nih.gov/38812047/","study_design":"randomized controlled trial","title":"Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-ADmini randomized controlled trial","title_match":true,"year":2024},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effects-of-postoperative-cognitive-training-on-neurocognitive-decline-35415742","doi":"10.1093/ejcts/ezac251","journal":"European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery","n_participants":37,"pmid":"35415742","source_url":"https://pubmed.ncbi.nlm.nih.gov/35415742/","study_design":null,"title":"Effects of postoperative cognitive training on neurocognitive decline after heart surgery: a randomized clinical trial","title_match":true,"year":2022},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-pilot-feasibility-randomized-controlled-trial-on-combining-mind-33194354","doi":"10.7717/peerj.9845","journal":"PeerJ","n_participants":null,"pmid":"33194354","source_url":"https://pubmed.ncbi.nlm.nih.gov/33194354/","study_design":"randomized controlled trial","title":"A pilot feasibility randomized controlled trial on combining mind-body physical exercise, cognitive training, and nurse-led risk factor modification to reduce cognitive decline among older adults with mild cognitive impairment in primary care","title_match":true,"year":2020},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/effects-of-cognitive-training-on-cognition-and-quality-of-life-of-29345724","doi":"10.1111/jgs.15196","journal":"Journal of the American Geriatrics Society","n_participants":147,"pmid":"29345724","source_url":"https://pubmed.ncbi.nlm.nih.gov/29345724/","study_design":"randomized controlled trial","title":"Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia","title_match":false,"year":2018},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/new-opportunities-for-the-early-detection-and-treatment-of-cognitive-40093660","doi":"10.1186/s44247-023-00008-1","journal":"BMC digital health","n_participants":null,"pmid":"40093660","source_url":"https://pubmed.ncbi.nlm.nih.gov/40093660/","study_design":null,"title":"New Opportunities for the Early Detection and Treatment of Cognitive Decline: Adherence Challenges and the Promise of Smart and Person-Centered Technologies","title_match":false,"year":2023},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effects-of-multi-component-non-pharmacological-interventions-on-35839574","doi":"10.1016/j.archger.2022.104751","journal":"Archives of gerontology and geriatrics","n_participants":null,"pmid":"35839574","source_url":"https://pubmed.ncbi.nlm.nih.gov/35839574/","study_design":"systematic review","title":"Effects of multi-component non-pharmacological interventions on cognition in participants with mild cognitive impairment: A systematic review and meta-analysis","title_match":false,"year":2022},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/impact-of-the-covid-19-pandemic-on-statistical-design-and-analysis-33738333","doi":"10.1002/trc2.12143","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"33738333","source_url":"https://pubmed.ncbi.nlm.nih.gov/33738333/","study_design":null,"title":"Impact of the COVID-19 pandemic on statistical design and analysis plans for multidomain intervention clinical trials: Experience from World-Wide FINGERS","title_match":true,"year":2021},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/advances-in-non-pharmacological-interventions-for-subjective-32741806","doi":"10.3233/jad-191295","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"32741806","source_url":"https://pubmed.ncbi.nlm.nih.gov/32741806/","study_design":"systematic review","title":"Advances in Non-Pharmacological Interventions for Subjective Cognitive Decline: A Systematic Review and Meta-Analysis","title_match":false,"year":2020},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/foreign-language-learning-in-older-age-does-not-improve-memory-or-32011156","doi":"10.1037/pag0000439","journal":"Psychology and aging","n_participants":null,"pmid":"32011156","source_url":"https://pubmed.ncbi.nlm.nih.gov/32011156/","study_design":null,"title":"Foreign language learning in older age does not improve memory or intelligence: Evidence from a randomized controlled study","title_match":true,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-role-of-cognitive-activity-in-cognition-protection-from-bedside-28360996","doi":"10.1186/s40035-017-0078-4","journal":"Translational neurodegeneration","n_participants":null,"pmid":"28360996","source_url":"https://pubmed.ncbi.nlm.nih.gov/28360996/","study_design":null,"title":"The role of cognitive activity in cognition protection: from Bedside to Bench","title_match":false,"year":2017},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/current-perspectives-on-postoperative-cognitive-dysfunction-in-39399113","doi":"10.3389/fmed.2024.1466681","journal":"Frontiers in medicine","n_participants":null,"pmid":"39399113","source_url":"https://pubmed.ncbi.nlm.nih.gov/39399113/","study_design":null,"title":"Current perspectives on postoperative cognitive dysfunction in geriatric patients: insights from clinical practice","title_match":false,"year":2024},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/dietary-pattern-food-and-nutritional-supplement-effects-on-cognitive-37027832","doi":"10.1093/nutrit/nuad013","journal":"Nutrition reviews","n_participants":500,"pmid":"37027832","source_url":"https://pubmed.ncbi.nlm.nih.gov/37027832/","study_design":"systematic review","title":"Dietary pattern, food, and nutritional supplement effects on cognitive outcomes in mild cognitive impairment: a systematic review of previous reviews","title_match":false,"year":2023},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/longitudinal-associations-of-pain-and-cognitive-decline-in-community-35901382","doi":"10.1037/pag0000699","journal":"Psychology and aging","n_participants":688,"pmid":"35901382","source_url":"https://pubmed.ncbi.nlm.nih.gov/35901382/","study_design":"randomized controlled trial","title":"Longitudinal associations of pain and cognitive decline in community-dwelling older adults","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/souvenaid-in-the-management-of-mild-cognitive-impairment-an-expert-31421681","doi":"10.1186/s13195-019-0528-6","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"31421681","source_url":"https://pubmed.ncbi.nlm.nih.gov/31421681/","study_design":null,"title":"Souvenaid in the management of mild cognitive impairment: an expert consensus opinion","title_match":false,"year":2019},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/building-research-in-diet-and-cognition-the-bridge-randomized-28600159","doi":"10.1016/j.cct.2017.06.003","journal":"Contemporary clinical trials","n_participants":180,"pmid":"28600159","source_url":"https://pubmed.ncbi.nlm.nih.gov/28600159/","study_design":"randomized controlled trial","title":"Building research in diet and cognition: The BRIDGE randomized controlled trial","title_match":true,"year":2017},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/determinants-of-dropout-and-nonadherence-in-a-dementia-prevention-28263374","doi":"10.1111/jgs.14834","journal":"Journal of the American Geriatrics Society","n_participants":2994,"pmid":"28263374","source_url":"https://pubmed.ncbi.nlm.nih.gov/28263374/","study_design":"randomized controlled trial","title":"Determinants of Dropout and Nonadherence in a Dementia Prevention Randomized Controlled Trial: The Prevention of Dementia by Intensive Vascular Care Trial","title_match":true,"year":2017},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/gait-and-cognition-a-complementary-approach-to-understanding-brain-23110433","doi":"10.1111/j.1532-5415.2012.04209.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"23110433","source_url":"https://pubmed.ncbi.nlm.nih.gov/23110433/","study_design":null,"title":"Gait and cognition: a complementary approach to understanding brain function and the risk of falling","title_match":false,"year":2012},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/efficacy-and-adverse-effects-of-atypical-antipsychotics-for-dementia-16505124","doi":"10.1097/01.jgp.0000200589.01396.6d","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":3353,"pmid":"16505124","source_url":"https://pubmed.ncbi.nlm.nih.gov/16505124/","study_design":"meta-analysis","title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","title_match":true,"year":2006},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/adverse-drug-reactions-in-special-populations-the-elderly-25619317","doi":"10.1111/bcp.12596","journal":"British journal of clinical pharmacology","n_participants":null,"pmid":"25619317","source_url":"https://pubmed.ncbi.nlm.nih.gov/25619317/","study_design":null,"title":"Adverse drug reactions in special populations - the elderly","title_match":false,"year":2015},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/caring-for-aged-dementia-care-resident-study-cadres-of-person-centred-19282246","doi":"10.1016/s1474-4422(09)70045-6","journal":"The Lancet. Neurology","n_participants":null,"pmid":"19282246","source_url":"https://pubmed.ncbi.nlm.nih.gov/19282246/","study_design":"randomized controlled trial","title":"Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial","title_match":false,"year":2009},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/sedation-depth-during-spinal-anesthesia-and-the-development-of-20042557","doi":"10.4065/mcp.2009.0469","journal":"Mayo Clinic proceedings","n_participants":114,"pmid":"20042557","source_url":"https://pubmed.ncbi.nlm.nih.gov/20042557/","study_design":"randomized controlled trial","title":"Sedation depth during spinal anesthesia and the development of postoperative delirium in elderly patients undergoing hip fracture repair","title_match":false,"year":2010},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/aerobic-exercise-for-alzheimer-s-disease-a-randomized-controlled-28187125","doi":"10.1371/journal.pone.0170547","journal":"PloS one","n_participants":68,"pmid":"28187125","source_url":"https://pubmed.ncbi.nlm.nih.gov/28187125/","study_design":"randomized controlled trial","title":"Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial","title_match":true,"year":2017},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/effect-of-dexmedetomidine-added-to-standard-care-on-ventilator-free-26975647","doi":"10.1001/jama.2016.2707","journal":"JAMA","n_participants":39,"pmid":"26975647","source_url":"https://pubmed.ncbi.nlm.nih.gov/26975647/","study_design":null,"title":"Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial","title_match":true,"year":2016},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/multifactorial-intervention-after-a-fall-in-older-people-with-12521968","doi":"10.1136/bmj.326.7380.73","journal":"BMJ (Clinical research ed.)","n_participants":null,"pmid":"12521968","source_url":"https://pubmed.ncbi.nlm.nih.gov/12521968/","study_design":"randomized controlled trial","title":"Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial","title_match":true,"year":2003},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-gait-stability-in-patients-with-parkinson-s-disease-26795874","doi":"10.1016/s1474-4422(15)00389-0","journal":"The Lancet. Neurology","n_participants":130,"pmid":"26795874","source_url":"https://pubmed.ncbi.nlm.nih.gov/26795874/","study_design":"clinical trial","title":"Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial","title_match":true,"year":2016},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/comparing-clinical-trial-population-representativeness-to-real-world-36150402","doi":"10.1016/s2666-7568(22)00186-6","journal":"The lancet. Healthy longevity","n_participants":null,"pmid":"36150402","source_url":"https://pubmed.ncbi.nlm.nih.gov/36150402/","study_design":"cohort study","title":"Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43\u2008895 trials and 5\u2008685\u2008738 individuals across 989 unique drugs and 286 conditions in England","title_match":true,"year":2022},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/melatonin-decreases-delirium-in-elderly-patients-a-randomized-placebo-20845391","doi":"10.1002/gps.2582","journal":"International journal of geriatric psychiatry","n_participants":145,"pmid":"20845391","source_url":"https://pubmed.ncbi.nlm.nih.gov/20845391/","study_design":null,"title":"Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial","title_match":true,"year":2011},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/physical-exercise-improves-strength-balance-mobility-and-endurance-in-29289581","doi":"10.1016/j.jphys.2017.12.001","journal":"Journal of physiotherapy","n_participants":3988,"pmid":"29289581","source_url":"https://pubmed.ncbi.nlm.nih.gov/29289581/","study_design":"systematic review","title":"Physical exercise improves strength, balance, mobility, and endurance in people with cognitive impairment and dementia: a systematic review","title_match":false,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/comparison-of-2-interventions-for-liquid-aspiration-on-pneumonia-18378947","doi":"10.7326/0003-4819-148-7-200804010-00007","journal":"Annals of internal medicine","n_participants":259,"pmid":"18378947","source_url":"https://pubmed.ncbi.nlm.nih.gov/18378947/","study_design":null,"title":"Comparison of 2 interventions for liquid aspiration on pneumonia incidence: a randomized trial","title_match":false,"year":2008},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/initiation-and-persistence-of-warfarin-or-aspirin-in-patients-with-18573187","doi":"10.1111/j.1538-7836.2008.03059.x","journal":"Journal of thrombosis and haemostasis : JTH","n_participants":41,"pmid":"18573187","source_url":"https://pubmed.ncbi.nlm.nih.gov/18573187/","study_design":null,"title":"Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?","title_match":false,"year":2008},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/stereotactic-brain-injection-of-human-umbilical-cord-blood-29854930","doi":"10.1016/j.trci.2015.06.007","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29854930","source_url":"https://pubmed.ncbi.nlm.nih.gov/29854930/","study_design":"clinical trial","title":"Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial","title_match":true,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/psychiatric-illness-predicts-poor-outcome-after-surgery-for-hip-11037100","doi":"10.1017/s0033291799002548","journal":"Psychological medicine","n_participants":731,"pmid":"11037100","source_url":"https://pubmed.ncbi.nlm.nih.gov/11037100/","study_design":null,"title":"Psychiatric illness predicts poor outcome after surgery for hip fracture: a prospective cohort study","title_match":false,"year":2000},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/biomarkers-associated-with-delirium-in-critically-ill-patients-and-22206727","doi":"10.1186/cc10598","journal":"Critical care (London, England)","n_participants":46,"pmid":"22206727","source_url":"https://pubmed.ncbi.nlm.nih.gov/22206727/","study_design":null,"title":"Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients","title_match":false,"year":2011},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/a-randomized-trial-of-comprehensive-geriatric-assessment-in-the-care-7715645","doi":"10.1056/nejm199505183322007","journal":"The New England journal of medicine","n_participants":1337,"pmid":"7715645","source_url":"https://pubmed.ncbi.nlm.nih.gov/7715645/","study_design":null,"title":"A randomized trial of comprehensive geriatric assessment in the care of hospitalized patients","title_match":false,"year":1995},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/exploring-the-effect-of-companion-robots-on-emotional-expression-in-23506125","doi":"10.3928/00989134-20130313-03","journal":"Journal of gerontological nursing","n_participants":null,"pmid":"23506125","source_url":"https://pubmed.ncbi.nlm.nih.gov/23506125/","study_design":null,"title":"Exploring the effect of companion robots on emotional expression in older adults with dementia: a pilot randomized controlled trial","title_match":true,"year":2013},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/effects-of-vivifrail-multicomponent-intervention-on-functional-35150086","doi":"10.1002/jcsm.12925","journal":"Journal of cachexia, sarcopenia and muscle","n_participants":88,"pmid":"35150086","source_url":"https://pubmed.ncbi.nlm.nih.gov/35150086/","study_design":"randomized controlled trial","title":"Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial","title_match":true,"year":2022},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/improving-decision-making-for-feeding-options-in-advanced-dementia-a-22091750","doi":"10.1111/j.1532-5415.2011.03629.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"22091750","source_url":"https://pubmed.ncbi.nlm.nih.gov/22091750/","study_design":"randomized controlled trial","title":"Improving decision-making for feeding options in advanced dementia: a randomized, controlled trial","title_match":true,"year":2011},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/donepezil-in-the-prevention-and-treatment-of-post-surgical-delirium-16319303","doi":"10.1176/appi.ajgp.13.12.1100","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":80,"pmid":"16319303","source_url":"https://pubmed.ncbi.nlm.nih.gov/16319303/","study_design":null,"title":"Donepezil in the prevention and treatment of post-surgical delirium","title_match":false,"year":2005},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/effect-of-depth-of-sedation-in-older-patients-undergoing-hip-fracture-30090923","doi":"10.1001/jamasurg.2018.2602","journal":"JAMA surgery","n_participants":73,"pmid":"30090923","source_url":"https://pubmed.ncbi.nlm.nih.gov/30090923/","study_design":null,"title":"Effect of Depth of Sedation in Older Patients Undergoing Hip Fracture Repair on Postoperative Delirium: The STRIDE Randomized Clinical Trial","title_match":true,"year":2018},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/current-evidence-for-a-role-of-the-kynurenine-pathway-of-tryptophan-27540379","doi":"10.3389/fimmu.2016.00246","journal":"Frontiers in immunology","n_participants":null,"pmid":"27540379","source_url":"https://pubmed.ncbi.nlm.nih.gov/27540379/","study_design":null,"title":"Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis","title_match":false,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/psychiatric-aspects-of-parkinson-s-disease-an-update-15258780","doi":"10.1007/s00415-004-0483-3","journal":"Journal of neurology","n_participants":null,"pmid":"15258780","source_url":"https://pubmed.ncbi.nlm.nih.gov/15258780/","study_design":null,"title":"Psychiatric aspects of Parkinson's disease--an update","title_match":false,"year":2004},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-trial-of-donepezil-17006875","doi":"10.1002/gps.1679","journal":"International journal of geriatric psychiatry","n_participants":95,"pmid":"17006875","source_url":"https://pubmed.ncbi.nlm.nih.gov/17006875/","study_design":"randomized controlled trial","title":"A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement","title_match":true,"year":2007},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/drug-induced-cognition-disorders-in-the-elderly-incidence-prevention-10456379","doi":"10.2165/00002018-199921020-00004","journal":"Drug safety","n_participants":null,"pmid":"10456379","source_url":"https://pubmed.ncbi.nlm.nih.gov/10456379/","study_design":null,"title":"Drug-induced cognition disorders in the elderly: incidence, prevention and management","title_match":false,"year":1999},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/atrial-fibrillation-and-stroke-prevention-with-warfarin-in-the-long-9140268","doi":"10.1001/archinte.1997.00440300080006","journal":"Archives of internal medicine","n_participants":null,"pmid":"9140268","source_url":"https://pubmed.ncbi.nlm.nih.gov/9140268/","study_design":null,"title":"Atrial fibrillation and stroke prevention with warfarin in the long-term care setting","title_match":false,"year":1997},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/healing-of-fracture-nonunions-treated-with-low-intensity-pulsed-28532896","doi":"10.1016/j.injury.2017.05.016","journal":"Injury","n_participants":null,"pmid":"28532896","source_url":"https://pubmed.ncbi.nlm.nih.gov/28532896/","study_design":"systematic review","title":"Healing of fracture nonunions treated with low-intensity pulsed ultrasound (LIPUS): A systematic review and meta-analysis","title_match":false,"year":2017},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effectiveness-of-exercise-programs-to-reduce-falls-in-older-people-25709416","doi":"10.2147/cia.s71691","journal":"Clinical interventions in aging","n_participants":null,"pmid":"25709416","source_url":"https://pubmed.ncbi.nlm.nih.gov/25709416/","study_design":"systematic review","title":"Effectiveness of exercise programs to reduce falls in older people with dementia living in the community: a systematic review and meta-analysis","title_match":false,"year":2015},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/effect-of-interventions-to-reduce-potentially-inappropriate-use-of-21496345","doi":"10.1186/1471-2318-11-16","journal":"BMC geriatrics","n_participants":null,"pmid":"21496345","source_url":"https://pubmed.ncbi.nlm.nih.gov/21496345/","study_design":"systematic review","title":"Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials","title_match":true,"year":2011},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-multidisciplinary-intervention-program-improved-the-outcome-after-21930310","doi":"10.1016/j.archger.2011.08.013","journal":"Archives of gerontology and geriatrics","n_participants":null,"pmid":"21930310","source_url":"https://pubmed.ncbi.nlm.nih.gov/21930310/","study_design":"randomized controlled trial","title":"A multidisciplinary intervention program improved the outcome after hip fracture for people with dementia--subgroup analyses of a randomized controlled trial","title_match":true,"year":2012},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/health-benefits-of-tai-chi-what-is-the-evidence-28661865","doi":null,"journal":"Canadian family physician Medecin de famille canadien","n_participants":null,"pmid":"28661865","source_url":"https://pubmed.ncbi.nlm.nih.gov/28661865/","study_design":"systematic review","title":"Health benefits of tai chi: What is the evidence?","title_match":false,"year":2016},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/representation-of-racial-and-ethnic-minority-populations-in-dementia-35098981","doi":"10.14283/jpad.2021.49","journal":"The journal of prevention of Alzheimer's disease","n_participants":100748,"pmid":"35098981","source_url":"https://pubmed.ncbi.nlm.nih.gov/35098981/","study_design":"systematic review","title":"Representation of Racial and Ethnic Minority Populations in Dementia Prevention Trials: A Systematic Review","title_match":false,"year":2022},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-comprehensive-database-of-published-tdcs-clinical-trials-2005-2016-27865707","doi":"10.1016/j.neucli.2016.10.002","journal":"Neurophysiologie clinique = Clinical neurophysiology","n_participants":null,"pmid":"27865707","source_url":"https://pubmed.ncbi.nlm.nih.gov/27865707/","study_design":"meta-analysis","title":"A comprehensive database of published tDCS clinical trials (2005-2016)","title_match":true,"year":2016},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/european-stroke-organisation-and-european-academy-of-neurology-joint-34746430","doi":"10.1177/23969873211042192","journal":"European stroke journal","n_participants":null,"pmid":"34746430","source_url":"https://pubmed.ncbi.nlm.nih.gov/34746430/","study_design":"randomized controlled trial","title":"European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment","title_match":false,"year":2021},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/care-in-specialist-medical-and-mental-health-unit-compared-with-23819964","doi":"10.1136/bmj.f4132","journal":"BMJ (Clinical research ed.)","n_participants":600,"pmid":"23819964","source_url":"https://pubmed.ncbi.nlm.nih.gov/23819964/","study_design":"randomized controlled trial","title":"Care in specialist medical and mental health unit compared with standard care for older people with cognitive impairment admitted to general hospital: randomised controlled trial (NIHR TEAM trial)","title_match":true,"year":2013},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/multicomponent-geriatric-intervention-for-elderly-inpatients-with-16510862","doi":"10.1093/gerona/61.2.176","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":87,"pmid":"16510862","source_url":"https://pubmed.ncbi.nlm.nih.gov/16510862/","study_design":null,"title":"Multicomponent geriatric intervention for elderly inpatients with delirium: a randomized, controlled trial","title_match":true,"year":2006},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/occupational-therapy-for-community-dwelling-elderly-people-a-15315918","doi":"10.1093/ageing/afh174","journal":"Age and ageing","n_participants":null,"pmid":"15315918","source_url":"https://pubmed.ncbi.nlm.nih.gov/15315918/","study_design":"systematic review","title":"Occupational therapy for community dwelling elderly people: a systematic review","title_match":false,"year":2004},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/processed-electroencephalogram-and-evoked-potential-techniques-for-29761891","doi":"10.1002/14651858.cd011283.pub2","journal":"The Cochrane database of systematic reviews","n_participants":2929,"pmid":"29761891","source_url":"https://pubmed.ncbi.nlm.nih.gov/29761891/","study_design":null,"title":"Processed electroencephalogram and evoked potential techniques for amelioration of postoperative delirium and cognitive dysfunction following non-cardiac and non-neurosurgical procedures in adults","title_match":false,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/extraskeletal-effects-of-vitamin-d-in-older-adults-cardiovascular-20226390","doi":"10.1016/j.amjopharm.2010.02.004","journal":"The American journal of geriatric pharmacotherapy","n_participants":null,"pmid":"20226390","source_url":"https://pubmed.ncbi.nlm.nih.gov/20226390/","study_design":"randomized controlled trial","title":"Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition","title_match":false,"year":2010},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/optimizing-function-and-physical-activity-among-nursing-home-24092822","doi":"10.1093/geront/gnt108","journal":"The Gerontologist","n_participants":103,"pmid":"24092822","source_url":"https://pubmed.ncbi.nlm.nih.gov/24092822/","study_design":"randomized controlled trial","title":"Optimizing function and physical activity among nursing home residents with dementia: testing the impact of function-focused care","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/heart-failure-and-cognitive-impairment-challenges-and-opportunities-18044137","doi":null,"journal":"Clinical interventions in aging","n_participants":null,"pmid":"18044137","source_url":"https://pubmed.ncbi.nlm.nih.gov/18044137/","study_design":null,"title":"Heart failure and cognitive impairment: challenges and opportunities","title_match":false,"year":2007},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/long-term-cognitive-outcome-of-delirium-in-elderly-hip-surgery-18562793","doi":"10.1159/000140611","journal":"Dementia and geriatric cognitive disorders","n_participants":112,"pmid":"18562793","source_url":"https://pubmed.ncbi.nlm.nih.gov/18562793/","study_design":"cohort study","title":"Long-term cognitive outcome of delirium in elderly hip surgery patients. A prospective matched controlled study over two and a half years","title_match":false,"year":2008},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/quetiapine-to-treat-agitation-in-dementia-a-randomized-double-blind-17316169","doi":"10.2174/156720507779939805","journal":"Current Alzheimer research","n_participants":117,"pmid":"17316169","source_url":"https://pubmed.ncbi.nlm.nih.gov/17316169/","study_design":null,"title":"Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study","title_match":true,"year":2007},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/dementia-medications-and-risk-of-falls-syncope-and-related-adverse-21649634","doi":"10.1111/j.1532-5415.2011.03450.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"21649634","source_url":"https://pubmed.ncbi.nlm.nih.gov/21649634/","study_design":"meta-analysis","title":"Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials","title_match":true,"year":2011},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/development-of-disease-modifying-drugs-for-frontotemporal-dementia-32203398","doi":"10.1038/s41582-020-0330-x","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"32203398","source_url":"https://pubmed.ncbi.nlm.nih.gov/32203398/","study_design":null,"title":"Development of disease-modifying drugs for frontotemporal dementia spectrum disorders","title_match":false,"year":2020},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/haloperidol-prophylaxis-in-critically-ill-patients-with-a-high-risk-23327295","doi":"10.1186/cc11933","journal":"Critical care (London, England)","n_participants":299,"pmid":"23327295","source_url":"https://pubmed.ncbi.nlm.nih.gov/23327295/","study_design":"randomized controlled trial","title":"Haloperidol prophylaxis in critically ill patients with a high risk for delirium","title_match":false,"year":2013},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/deconstructing-the-complexities-of-advance-care-planning-outcomes-32894787","doi":"10.1111/jgs.16801","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"32894787","source_url":"https://pubmed.ncbi.nlm.nih.gov/32894787/","study_design":"systematic review","title":"Deconstructing the Complexities of Advance Care Planning Outcomes: What Do We Know and Where Do We Go? A Scoping Review","title_match":false,"year":2021},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/tools-to-promote-shared-decision-making-in-serious-illness-a-25985438","doi":"10.1001/jamainternmed.2015.1679","journal":"JAMA internal medicine","n_participants":null,"pmid":"25985438","source_url":"https://pubmed.ncbi.nlm.nih.gov/25985438/","study_design":"systematic review","title":"Tools to Promote Shared Decision Making in Serious Illness: A Systematic Review","title_match":false,"year":2015},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/video-decision-support-tool-for-advance-care-planning-in-dementia-19477893","doi":"10.1136/bmj.b2159","journal":"BMJ (Clinical research ed.)","n_participants":106,"pmid":"19477893","source_url":"https://pubmed.ncbi.nlm.nih.gov/19477893/","study_design":"randomized controlled trial","title":"Video decision support tool for advance care planning in dementia: randomised controlled trial","title_match":true,"year":2009},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/effect-of-the-goals-of-care-intervention-for-advanced-dementia-a-27893884","doi":"10.1001/jamainternmed.2016.7031","journal":"JAMA internal medicine","n_participants":null,"pmid":"27893884","source_url":"https://pubmed.ncbi.nlm.nih.gov/27893884/","study_design":null,"title":"Effect of the Goals of Care Intervention for Advanced Dementia: A Randomized Clinical Trial","title_match":true,"year":2017},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyotrophic-lateral-sclerosis-an-update-for-2013-clinical-features-24124634","doi":"10.14336/ad.2013.0400295","journal":"Aging and disease","n_participants":null,"pmid":"24124634","source_url":"https://pubmed.ncbi.nlm.nih.gov/24124634/","study_design":null,"title":"Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials","title_match":false,"year":2013},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/the-effectiveness-of-advance-care-planning-in-improving-end-of-life-28827062","doi":"10.1016/j.jpainsymman.2017.04.009","journal":"Journal of pain and symptom management","n_participants":18,"pmid":"28827062","source_url":"https://pubmed.ncbi.nlm.nih.gov/28827062/","study_design":null,"title":"The Effectiveness of Advance Care Planning in Improving End-of-Life Outcomes for People With Dementia and Their Carers: A Systematic Review and Critical Discussion","title_match":false,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/populations-and-interventions-for-palliative-and-end-of-life-care-a-27533892","doi":"10.1089/jpm.2015.0367","journal":"Journal of palliative medicine","n_participants":null,"pmid":"27533892","source_url":"https://pubmed.ncbi.nlm.nih.gov/27533892/","study_design":null,"title":"Populations and Interventions for Palliative and End-of-Life Care: A Systematic Review","title_match":false,"year":2016},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/management-of-chronic-heart-failure-in-the-older-population-25593582","doi":"10.11909/j.issn.1671-5411.2014.04.008","journal":"Journal of geriatric cardiology : JGC","n_participants":null,"pmid":"25593582","source_url":"https://pubmed.ncbi.nlm.nih.gov/25593582/","study_design":null,"title":"Management of chronic heart failure in the older population","title_match":false,"year":2014},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/effectiveness-of-advance-care-planning-with-family-carers-in-dementia-28786323","doi":"10.1177/0269216317722413","journal":"Palliative medicine","n_participants":24,"pmid":"28786323","source_url":"https://pubmed.ncbi.nlm.nih.gov/28786323/","study_design":"randomized controlled trial","title":"Effectiveness of advance care planning with family carers in dementia nursing homes: A paired cluster randomized controlled trial","title_match":true,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-the-scientific-evidence-for-the-efficacy-of-a-15945590","doi":"10.1017/s1041610205001018","journal":"International psychogeriatrics","n_participants":null,"pmid":"15945590","source_url":"https://pubmed.ncbi.nlm.nih.gov/15945590/","study_design":"randomized controlled trial","title":"A systematic review of the scientific evidence for the efficacy of a palliative care approach in advanced dementia","title_match":false,"year":2005},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-barriers-and-facilitators-to-and-interventions-25870004","doi":"10.1017/s1041610215000411","journal":"International psychogeriatrics","n_participants":null,"pmid":"25870004","source_url":"https://pubmed.ncbi.nlm.nih.gov/25870004/","study_design":null,"title":"A systematic review of barriers and facilitators to and interventions for proxy decision-making by family carers of people with dementia","title_match":false,"year":2015},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/palliative-assessment-and-advance-care-planning-in-severe-dementia-an-21228087","doi":"10.1177/0269216310391691","journal":"Palliative medicine","n_participants":33,"pmid":"21228087","source_url":"https://pubmed.ncbi.nlm.nih.gov/21228087/","study_design":null,"title":"Palliative assessment and advance care planning in severe dementia: an exploratory randomized controlled trial of a complex intervention","title_match":true,"year":2011},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/palliative-care-to-support-the-needs-of-adults-with-neurological-37353280","doi":"10.1016/s1474-4422(23)00129-1","journal":"The Lancet. Neurology","n_participants":null,"pmid":"37353280","source_url":"https://pubmed.ncbi.nlm.nih.gov/37353280/","study_design":null,"title":"Palliative care to support the needs of adults with neurological disease","title_match":false,"year":2023},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/an-advance-care-planning-video-decision-support-tool-for-nursing-home-29868778","doi":"10.1001/jamainternmed.2018.1506","journal":"JAMA internal medicine","n_participants":212,"pmid":"29868778","source_url":"https://pubmed.ncbi.nlm.nih.gov/29868778/","study_design":null,"title":"An Advance Care Planning Video Decision Support Tool for Nursing Home Residents With Advanced Dementia: A Cluster Randomized Clinical Trial","title_match":true,"year":2018},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/evaluation-of-a-palliative-care-program-for-nursing-homes-in-7-31710345","doi":"10.1001/jamainternmed.2019.5349","journal":"JAMA internal medicine","n_participants":null,"pmid":"31710345","source_url":"https://pubmed.ncbi.nlm.nih.gov/31710345/","study_design":null,"title":"Evaluation of a Palliative Care Program for Nursing Homes in 7 Countries: The PACE Cluster-Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/palliative-care-in-advanced-dementia-a-randomized-controlled-trial-15859668","doi":"10.1089/jpm.2000.3.265","journal":"Journal of palliative medicine","n_participants":99,"pmid":"15859668","source_url":"https://pubmed.ncbi.nlm.nih.gov/15859668/","study_design":"randomized controlled trial","title":"Palliative care in advanced dementia: a randomized controlled trial and descriptive analysis","title_match":true,"year":2000},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/advance-care-planning-video-intervention-among-long-stay-nursing-home-32628258","doi":"10.1001/jamainternmed.2020.2366","journal":"JAMA internal medicine","n_participants":4171,"pmid":"32628258","source_url":"https://pubmed.ncbi.nlm.nih.gov/32628258/","study_design":null,"title":"Advance Care Planning Video Intervention Among Long-Stay Nursing Home Residents: A Pragmatic Cluster Randomized Clinical Trial","title_match":true,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/triggered-palliative-care-for-late-stage-dementia-a-pilot-randomized-30342242","doi":"10.1016/j.jpainsymman.2018.10.494","journal":"Journal of pain and symptom management","n_participants":62,"pmid":"30342242","source_url":"https://pubmed.ncbi.nlm.nih.gov/30342242/","study_design":"randomized controlled trial","title":"Triggered Palliative Care for Late-Stage Dementia: A Pilot Randomized Trial","title_match":false,"year":2019},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effects-of-facilitated-family-case-conferencing-for-advanced-dementia-28786995","doi":"10.1371/journal.pone.0181020","journal":"PloS one","n_participants":null,"pmid":"28786995","source_url":"https://pubmed.ncbi.nlm.nih.gov/28786995/","study_design":"randomized controlled trial","title":"Effects of facilitated family case conferencing for advanced dementia: A cluster randomised clinical trial","title_match":true,"year":2017},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/level-of-care-preferences-among-nursing-home-residents-with-advanced-28797857","doi":"10.1016/j.jpainsymman.2017.04.020","journal":"Journal of pain and symptom management","n_participants":402,"pmid":"28797857","source_url":"https://pubmed.ncbi.nlm.nih.gov/28797857/","study_design":null,"title":"Level of Care Preferences Among Nursing Home Residents With Advanced Dementia","title_match":false,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/development-and-testing-of-a-decision-aid-on-goals-of-care-for-24508326","doi":"10.1016/j.jamda.2013.11.020","journal":"Journal of the American Medical Directors Association","n_participants":null,"pmid":"24508326","source_url":"https://pubmed.ncbi.nlm.nih.gov/24508326/","study_design":null,"title":"Development and testing of a decision aid on goals of care for advanced dementia","title_match":false,"year":2014},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/concordance-between-proxy-level-of-care-preference-and-advance-30273717","doi":"10.1016/j.jpainsymman.2018.09.018","journal":"Journal of pain and symptom management","n_participants":328,"pmid":"30273717","source_url":"https://pubmed.ncbi.nlm.nih.gov/30273717/","study_design":null,"title":"Concordance Between Proxy Level of Care Preference and Advance Directives Among Nursing Home Residents With Advanced Dementia: A Cluster Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/advance-care-planning-in-nursing-homes-improving-the-communication-30564163","doi":"10.3389/fpsyg.2018.02284","journal":"Frontiers in psychology","n_participants":72,"pmid":"30564163","source_url":"https://pubmed.ncbi.nlm.nih.gov/30564163/","study_design":null,"title":"Advance Care Planning in Nursing Homes - Improving the Communication Among Patient, Family, and Staff: Results From a Cluster Randomized Controlled Trial (COSMOS)","title_match":true,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/cpap-adherence-may-slow-1-year-cognitive-decline-in-older-adults-with-30724333","doi":"10.1111/jgs.15758","journal":"Journal of the American Geriatrics Society","n_participants":29,"pmid":"30724333","source_url":"https://pubmed.ncbi.nlm.nih.gov/30724333/","study_design":null,"title":"CPAP Adherence May Slow 1-Year Cognitive Decline in Older Adults with Mild Cognitive Impairment and Apnea","title_match":false,"year":2019},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/educating-dutch-general-practitioners-in-dementia-advance-care-31759901","doi":"10.1016/j.jamda.2019.09.010","journal":"Journal of the American Medical Directors Association","n_participants":140,"pmid":"31759901","source_url":"https://pubmed.ncbi.nlm.nih.gov/31759901/","study_design":"randomized controlled trial","title":"Educating Dutch General Practitioners in Dementia Advance Care Planning: A Cluster Randomized Controlled Trial","title_match":true,"year":2020},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/a-group-intervention-to-improve-quality-of-life-for-people-with-31971506","doi":"10.3310/hta24060","journal":"Health technology assessment (Winchester, England)","n_participants":32,"pmid":"31971506","source_url":"https://pubmed.ncbi.nlm.nih.gov/31971506/","study_design":"randomized controlled trial","title":"A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-strategies-used-to-increase-recruitment-of-25546286","doi":"10.1016/j.jpainsymman.2014.09.018","journal":"Journal of pain and symptom management","n_participants":null,"pmid":"25546286","source_url":"https://pubmed.ncbi.nlm.nih.gov/25546286/","study_design":"systematic review","title":"A systematic review of strategies used to increase recruitment of people with cancer or organ failure into clinical trials: implications for palliative care research","title_match":true,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/does-case-conferencing-for-people-with-advanced-dementia-living-in-23200128","doi":"10.1016/j.ijnurstu.2012.11.001","journal":"International journal of nursing studies","n_participants":null,"pmid":"23200128","source_url":"https://pubmed.ncbi.nlm.nih.gov/23200128/","study_design":null,"title":"Does case conferencing for people with advanced dementia living in nursing homes improve care outcomes: evidence from an integrative review?","title_match":false,"year":2013},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/discontinuation-of-preventive-medicines-in-older-people-with-limited-28853000","doi":"10.1007/s40266-017-0487-1","journal":"Drugs & aging","n_participants":26854,"pmid":"28853000","source_url":"https://pubmed.ncbi.nlm.nih.gov/28853000/","study_design":"randomized controlled trial","title":"Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review","title_match":false,"year":2017},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/cannabis-in-palliative-care-a-systematic-review-of-current-evidence-35705116","doi":"10.1016/j.jpainsymman.2022.06.002","journal":"Journal of pain and symptom management","n_participants":4491,"pmid":"35705116","source_url":"https://pubmed.ncbi.nlm.nih.gov/35705116/","study_design":"meta-analysis","title":"Cannabis in Palliative Care: A Systematic Review of Current Evidence","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/signs-and-symptoms-of-low-intake-dehydration-do-not-work-in-older-30872081","doi":"10.1016/j.jamda.2019.01.122","journal":"Journal of the American Medical Directors Association","n_participants":null,"pmid":"30872081","source_url":"https://pubmed.ncbi.nlm.nih.gov/30872081/","study_design":null,"title":"Signs and Symptoms of Low-Intake Dehydration Do Not Work in Older Care Home Residents-DRIE Diagnostic Accuracy Study","title_match":false,"year":2019},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/assessment-of-quality-of-life-as-outcome-in-dementia-and-mci-17545745","doi":"10.1097/wad.0b013e318047df4c","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"17545745","source_url":"https://pubmed.ncbi.nlm.nih.gov/17545745/","study_design":"systematic review","title":"Assessment of quality of life as outcome in dementia and MCI intervention trials: a systematic review","title_match":false,"year":2007},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/emergency-medicine-palliative-care-access-empalla-protocol-for-a-30813112","doi":"10.1136/bmjopen-2018-025692","journal":"BMJ open","n_participants":1350,"pmid":"30813112","source_url":"https://pubmed.ncbi.nlm.nih.gov/30813112/","study_design":"randomized controlled trial","title":"Emergency Medicine Palliative Care Access (EMPallA): protocol for a multicentre randomised controlled trial comparing the effectiveness of specialty outpatient versus nurse-led telephonic palliative care of older adults with advanced illness","title_match":true,"year":2019},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/reliability-and-validity-of-the-resistiveness-to-care-scale-among-27776986","doi":"10.1016/j.jamda.2016.08.008","journal":"Journal of the American Medical Directors Association","n_participants":null,"pmid":"27776986","source_url":"https://pubmed.ncbi.nlm.nih.gov/27776986/","study_design":"randomized controlled trial","title":"Reliability and Validity of the Resistiveness to Care Scale Among Cognitively Impaired Older Adults","title_match":false,"year":2017},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/advance-care-planning-for-african-american-caregivers-of-relatives-32308012","doi":"10.1177/1049909120916127","journal":"The American journal of hospice & palliative care","n_participants":173,"pmid":"32308012","source_url":"https://pubmed.ncbi.nlm.nih.gov/32308012/","study_design":"randomized controlled trial","title":"Advance Care Planning for African American Caregivers of Relatives With Dementias: Cluster Randomized Controlled Trial","title_match":true,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/problem-solving-therapy-in-the-elderly-24729951","doi":"10.1007/s40501-013-0003-0","journal":"Current treatment options in psychiatry","n_participants":null,"pmid":"24729951","source_url":"https://pubmed.ncbi.nlm.nih.gov/24729951/","study_design":null,"title":"Problem-Solving Therapy in the Elderly","title_match":false,"year":2014},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/effects-of-the-namaste-care-family-programme-on-quality-of-life-of-30327407","doi":"10.1136/bmjopen-2018-025411","journal":"BMJ open","n_participants":null,"pmid":"30327407","source_url":"https://pubmed.ncbi.nlm.nih.gov/30327407/","study_design":"randomized controlled trial","title":"Effects of the Namaste Care Family programme on quality of life of nursing home residents with advanced dementia and on family caregiving experiences: study protocol of a cluster-randomised controlled trial","title_match":true,"year":2018},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/a-facilitated-approach-to-family-case-conferencing-for-people-with-28651659","doi":"10.1017/s1041610217000977","journal":"International psychogeriatrics","n_participants":null,"pmid":"28651659","source_url":"https://pubmed.ncbi.nlm.nih.gov/28651659/","study_design":"randomized controlled trial","title":"A facilitated approach to family case conferencing for people with advanced dementia living in nursing homes: perceptions of palliative care planning coordinators and other health professionals in the IDEAL study","title_match":false,"year":2017},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/improving-comfort-around-dying-in-elderly-people-a-cluster-randomised-28526493","doi":"10.1016/s0140-6736(17)31265-5","journal":"Lancet (London, England)","n_participants":118,"pmid":"28526493","source_url":"https://pubmed.ncbi.nlm.nih.gov/28526493/","study_design":"randomized controlled trial","title":"Improving comfort around dying in elderly people: a cluster randomised controlled trial","title_match":true,"year":2017},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/fidelity-to-a-behavioral-intervention-to-improve-goals-of-care-27271683","doi":"10.1177/1740774516650863","journal":"Clinical trials (London, England)","n_participants":151,"pmid":"27271683","source_url":"https://pubmed.ncbi.nlm.nih.gov/27271683/","study_design":"randomized controlled trial","title":"Fidelity to a behavioral intervention to improve goals of care decisions for nursing home residents with advanced dementia","title_match":false,"year":2016},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/advance-care-planning-in-neurodegenerative-disorders-a-scoping-review-35055625","doi":"10.3390/ijerph19020803","journal":"International journal of environmental research and public health","n_participants":53,"pmid":"35055625","source_url":"https://pubmed.ncbi.nlm.nih.gov/35055625/","study_design":null,"title":"Advance Care Planning in Neurodegenerative Disorders: A Scoping Review","title_match":false,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/barriers-to-obtaining-consent-in-dementia-research-implications-for-9514373","doi":"10.1111/j.1532-5415.1998.tb01039.x","journal":"Journal of the American Geriatrics Society","n_participants":68,"pmid":"9514373","source_url":"https://pubmed.ncbi.nlm.nih.gov/9514373/","study_design":null,"title":"Barriers to obtaining consent in dementia research: implications for surrogate decision-making","title_match":false,"year":1998},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-novel-screening-method-to-identify-late-stage-dementia-patients-for-29288881","doi":"10.1016/j.jpainsymman.2017.12.480","journal":"Journal of pain and symptom management","n_participants":null,"pmid":"29288881","source_url":"https://pubmed.ncbi.nlm.nih.gov/29288881/","study_design":null,"title":"A Novel Screening Method to Identify Late-Stage Dementia Patients for Palliative Care Research and Practice","title_match":false,"year":2018},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/palliative-care-in-advanced-dementia-a-mixed-methods-approach-for-the-18620567","doi":"10.1186/1472-684x-7-8","journal":"BMC palliative care","n_participants":40,"pmid":"18620567","source_url":"https://pubmed.ncbi.nlm.nih.gov/18620567/","study_design":"randomized controlled trial","title":"Palliative care in advanced dementia; A mixed methods approach for the development of a complex intervention","title_match":false,"year":2008},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/hippocampal-plasticity-in-response-to-exercise-in-schizophrenia-20124113","doi":"10.1001/archgenpsychiatry.2009.193","journal":"Archives of general psychiatry","n_participants":null,"pmid":"20124113","source_url":"https://pubmed.ncbi.nlm.nih.gov/20124113/","study_design":null,"title":"Hippocampal plasticity in response to exercise in schizophrenia","title_match":false,"year":2010},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/understanding-disease-progression-and-improving-alzheimer-s-disease-30321505","doi":"10.1016/j.jalz.2018.08.005","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"30321505","source_url":"https://pubmed.ncbi.nlm.nih.gov/30321505/","study_design":"longitudinal study","title":"Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative","title_match":true,"year":2019},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/the-dynamics-of-cortical-and-hippocampal-atrophy-in-alzheimer-disease-21825241","doi":"10.1001/archneurol.2011.167","journal":"Archives of neurology","n_participants":317,"pmid":"21825241","source_url":"https://pubmed.ncbi.nlm.nih.gov/21825241/","study_design":"case-control study","title":"The dynamics of cortical and hippocampal atrophy in Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/postmenopausal-hormone-therapy-and-regional-brain-volumes-the-whims-19139364","doi":"10.1212/01.wnl.0000339037.76336.cf","journal":"Neurology","n_participants":null,"pmid":"19139364","source_url":"https://pubmed.ncbi.nlm.nih.gov/19139364/","study_design":null,"title":"Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study","title_match":false,"year":2009},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/mri-as-a-biomarker-of-disease-progression-in-a-therapeutic-trial-of-12552040","doi":"10.1212/01.wnl.0000042480.86872.03","journal":"Neurology","n_participants":362,"pmid":"12552040","source_url":"https://pubmed.ncbi.nlm.nih.gov/12552040/","study_design":null,"title":"MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD","title_match":false,"year":2003},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/randomized-placebo-controlled-trial-of-the-effects-of-donepezil-on-14594748","doi":"10.1176/appi.ajp.160.11.2003","journal":"The American journal of psychiatry","n_participants":67,"pmid":"14594748","source_url":"https://pubmed.ncbi.nlm.nih.gov/14594748/","study_design":null,"title":"Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease","title_match":true,"year":2003},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/steps-similarity-and-truth-estimation-for-propagated-segmentations-23510558","doi":"10.1016/j.media.2013.02.006","journal":"Medical image analysis","n_participants":null,"pmid":"23510558","source_url":"https://pubmed.ncbi.nlm.nih.gov/23510558/","study_design":"cross-sectional","title":"STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation","title_match":false,"year":2013},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/not-only-cardiovascular-but-also-coordinative-exercise-increases-25165446","doi":"10.3389/fnagi.2014.00170","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"25165446","source_url":"https://pubmed.ncbi.nlm.nih.gov/25165446/","study_design":"randomized controlled trial","title":"Not only cardiovascular, but also coordinative exercise increases hippocampal volume in older adults","title_match":false,"year":2014},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/effects-of-mindfulness-training-and-exercise-on-cognitive-function-in-36511926","doi":"10.1001/jama.2022.21680","journal":"JAMA","n_participants":150,"pmid":"36511926","source_url":"https://pubmed.ncbi.nlm.nih.gov/36511926/","study_design":null,"title":"Effects of Mindfulness Training and Exercise on Cognitive Function in Older Adults: A Randomized Clinical Trial","title_match":true,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/clinical-safety-and-efficacy-of-allogenic-human-adipose-mesenchymal-37859748","doi":"10.1136/gpsych-2023-101143","journal":"General psychiatry","n_participants":null,"pmid":"37859748","source_url":"https://pubmed.ncbi.nlm.nih.gov/37859748/","study_design":null,"title":"Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer's disease: a phase I/II clinical trial","title_match":true,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/exercise-training-for-neural-recovery-in-a-restricted-sample-of-27555603","doi":"10.1093/neuonc/now177","journal":"Neuro-oncology","n_participants":16,"pmid":"27555603","source_url":"https://pubmed.ncbi.nlm.nih.gov/27555603/","study_design":null,"title":"Exercise training for neural recovery in a restricted sample of pediatric brain tumor survivors: a controlled clinical trial with crossover of training versus no training","title_match":true,"year":2017},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/brain-delivery-of-supplemental-docosahexaenoic-acid-dha-a-randomized-32690472","doi":"10.1016/j.ebiom.2020.102883","journal":"EBioMedicine","n_participants":33,"pmid":"32690472","source_url":"https://pubmed.ncbi.nlm.nih.gov/32690472/","study_design":null,"title":"Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial","title_match":true,"year":2020},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/exercise-therapy-cardiorespiratory-fitness-and-their-effect-on-brain-22981376","doi":"10.1016/j.euroneuro.2012.08.008","journal":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","n_participants":null,"pmid":"22981376","source_url":"https://pubmed.ncbi.nlm.nih.gov/22981376/","study_design":"randomized controlled trial","title":"Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: a randomised controlled trial in patients with schizophrenia and healthy controls","title_match":true,"year":2013},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/nilotinib-effects-on-safety-tolerability-and-biomarkers-in-alzheimer-32468646","doi":"10.1002/ana.25775","journal":"Annals of neurology","n_participants":37,"pmid":"32468646","source_url":"https://pubmed.ncbi.nlm.nih.gov/32468646/","study_design":"clinical trial","title":"Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease","title_match":false,"year":2020},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/effect-of-estrogen-plus-progestin-on-global-cognitive-function-in-12771113","doi":"10.1001/jama.289.20.2663","journal":"JAMA","n_participants":2145,"pmid":"12771113","source_url":"https://pubmed.ncbi.nlm.nih.gov/12771113/","study_design":null,"title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","title_match":true,"year":2003},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/oxidative-stress-in-brain-aging-implications-for-therapeutics-of-12392783","doi":"10.1016/s0197-4580(02)00019-2","journal":"Neurobiology of aging","n_participants":null,"pmid":"12392783","source_url":"https://pubmed.ncbi.nlm.nih.gov/12392783/","study_design":null,"title":"Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases","title_match":false,"year":2002},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-role-of-excitotoxicity-in-neurodegenerative-disease-implications-10334661","doi":"10.1016/s0163-7258(98)00042-4","journal":"Pharmacology & therapeutics","n_participants":null,"pmid":"10334661","source_url":"https://pubmed.ncbi.nlm.nih.gov/10334661/","study_design":null,"title":"The role of excitotoxicity in neurodegenerative disease: implications for therapy","title_match":false,"year":1999},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/shining-light-on-the-head-photobiomodulation-for-brain-disorders-27752476","doi":"10.1016/j.bbacli.2016.09.002","journal":"BBA clinical","n_participants":null,"pmid":"27752476","source_url":"https://pubmed.ncbi.nlm.nih.gov/27752476/","study_design":null,"title":"Shining light on the head: Photobiomodulation for brain disorders","title_match":false,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/therapeutic-modulation-of-notch-signalling-are-we-there-yet-24781550","doi":"10.1038/nrd4252","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"24781550","source_url":"https://pubmed.ncbi.nlm.nih.gov/24781550/","study_design":null,"title":"Therapeutic modulation of Notch signalling--are we there yet?","title_match":false,"year":2014},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/efficacy-and-comparative-effectiveness-of-atypical-antipsychotic-21954480","doi":"10.1001/jama.2011.1360","journal":"JAMA","n_participants":1000,"pmid":"21954480","source_url":"https://pubmed.ncbi.nlm.nih.gov/21954480/","study_design":"systematic review","title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis","title_match":false,"year":2011},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-mtor-signalling-cascade-paving-new-roads-to-cure-neurological-27340022","doi":"10.1038/nrneurol.2016.81","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"27340022","source_url":"https://pubmed.ncbi.nlm.nih.gov/27340022/","study_design":null,"title":"The mTOR signalling cascade: paving new roads to cure neurological disease","title_match":false,"year":2016},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/age-related-hearing-loss-and-dementia-31335455","doi":"10.1097/wad.0000000000000325","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"31335455","source_url":"https://pubmed.ncbi.nlm.nih.gov/31335455/","study_design":null,"title":"Age-related Hearing Loss and Dementia","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/failures-and-successes-of-nmda-receptor-antagonists-molecular-basis-15717010","doi":"10.1602/neurorx.1.1.101","journal":"NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"15717010","source_url":"https://pubmed.ncbi.nlm.nih.gov/15717010/","study_design":null,"title":"Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults","title_match":false,"year":2004},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/efficacy-of-non-invasive-brain-stimulation-on-cognitive-functioning-33070785","doi":"10.1017/s0033291720003670","journal":"Psychological medicine","n_participants":2784,"pmid":"33070785","source_url":"https://pubmed.ncbi.nlm.nih.gov/33070785/","study_design":"meta-analysis","title":"Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis","title_match":false,"year":2020},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/predicting-time-to-nursing-home-care-and-death-in-individuals-with-9052710","doi":"10.1001/jama.1997.03540340040030","journal":"JAMA","n_participants":236,"pmid":"9052710","source_url":"https://pubmed.ncbi.nlm.nih.gov/9052710/","study_design":"cohort study","title":"Predicting time to nursing home care and death in individuals with Alzheimer disease","title_match":false,"year":1997},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/glutamate-based-therapeutic-approaches-clinical-trials-with-nmda-16359918","doi":"10.1016/j.coph.2005.12.002","journal":"Current opinion in pharmacology","n_participants":9000,"pmid":"16359918","source_url":"https://pubmed.ncbi.nlm.nih.gov/16359918/","study_design":null,"title":"Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists","title_match":true,"year":2006},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/donepezil-in-vascular-dementia-a-randomized-placebo-controlled-study-12939421","doi":"10.1212/01.wnl.0000078943.50032.fc","journal":"Neurology","n_participants":616,"pmid":"12939421","source_url":"https://pubmed.ncbi.nlm.nih.gov/12939421/","study_design":null,"title":"Donepezil in vascular dementia: a randomized, placebo-controlled study","title_match":true,"year":2003},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/efficacy-and-tolerability-of-donepezil-in-vascular-dementia-positive-12970516","doi":"10.1161/01.str.0000091396.95360.e1","journal":"Stroke","n_participants":603,"pmid":"12970516","source_url":"https://pubmed.ncbi.nlm.nih.gov/12970516/","study_design":null,"title":"Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","title_match":true,"year":2003},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/wmh-and-long-term-outcomes-in-ischemic-stroke-a-systematic-review-and-30770431","doi":"10.1212/wnl.0000000000007142","journal":"Neurology","n_participants":104,"pmid":"30770431","source_url":"https://pubmed.ncbi.nlm.nih.gov/30770431/","study_design":"meta-analysis","title":"WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/vascular-cognitive-disorder-a-new-diagnostic-category-updating-15537526","doi":"10.1016/j.jns.2004.09.016","journal":"Journal of the neurological sciences","n_participants":null,"pmid":"15537526","source_url":"https://pubmed.ncbi.nlm.nih.gov/15537526/","study_design":null,"title":"Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia","title_match":false,"year":2004},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/progression-of-brain-atrophy-and-cognitive-decline-in-diabetes-20837967","doi":"10.1212/wnl.0b013e3181f25f06","journal":"Neurology","n_participants":89,"pmid":"20837967","source_url":"https://pubmed.ncbi.nlm.nih.gov/20837967/","study_design":"randomized controlled trial","title":"Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up","title_match":false,"year":2010},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/plasma-p-tau231-and-p-tau217-as-state-markers-of-amyloid-pathology-in-35953717","doi":"10.1038/s41591-022-01925-w","journal":"Nature medicine","n_participants":null,"pmid":"35953717","source_url":"https://pubmed.ncbi.nlm.nih.gov/35953717/","study_design":"longitudinal study","title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/modified-mediterranean-ketogenic-diet-modulates-gut-microbiome-and-31477562","doi":"10.1016/j.ebiom.2019.08.032","journal":"EBioMedicine","n_participants":17,"pmid":"31477562","source_url":"https://pubmed.ncbi.nlm.nih.gov/31477562/","study_design":null,"title":"Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment","title_match":false,"year":2019},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/oral-curcumin-for-alzheimer-s-disease-tolerability-and-efficacy-in-a-23107780","doi":"10.1186/alzrt146","journal":"Alzheimer's research & therapy","n_participants":30,"pmid":"23107780","source_url":"https://pubmed.ncbi.nlm.nih.gov/23107780/","study_design":"open-label trial","title":"Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study","title_match":true,"year":2012},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/total-and-phosphorylated-tau-protein-as-biological-markers-of-19853650","doi":"10.1016/j.exger.2009.10.010","journal":"Experimental gerontology","n_participants":null,"pmid":"19853650","source_url":"https://pubmed.ncbi.nlm.nih.gov/19853650/","study_design":null,"title":"Total and phosphorylated tau protein as biological markers of Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/decreased-cerebrospinal-fluid-abeta-42-correlates-with-brain-atrophy-19260027","doi":"10.1002/ana.21559","journal":"Annals of neurology","n_participants":29,"pmid":"19260027","source_url":"https://pubmed.ncbi.nlm.nih.gov/19260027/","study_design":null,"title":"Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly","title_match":false,"year":2009},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-biomarkers-of-alzheimer-s-disease-improve-prediction-of-34117234","doi":"10.1038/s41467-021-23746-0","journal":"Nature communications","n_participants":null,"pmid":"34117234","source_url":"https://pubmed.ncbi.nlm.nih.gov/34117234/","study_design":null,"title":"Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations","title_match":false,"year":2021},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/lecanemab-in-patients-with-early-alzheimer-s-disease-detailed-results-36544184","doi":"10.1186/s13195-022-01124-2","journal":"Alzheimer's research & therapy","n_participants":856,"pmid":"36544184","source_url":"https://pubmed.ncbi.nlm.nih.gov/36544184/","study_design":"open-label trial","title":"Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","title_match":true,"year":2022},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/lithium-as-a-treatment-for-alzheimer-s-disease-a-systematic-review-26402004","doi":"10.3233/jad-150437","journal":"Journal of Alzheimer's disease : JAD","n_participants":199,"pmid":"26402004","source_url":"https://pubmed.ncbi.nlm.nih.gov/26402004/","study_design":"meta-analysis","title":"Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis","title_match":false,"year":2015},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/an-accurate-fully-automated-panel-of-plasma-biomarkers-for-alzheimer-35950735","doi":"10.1002/alz.12751","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":920,"pmid":"35950735","source_url":"https://pubmed.ncbi.nlm.nih.gov/35950735/","study_design":null,"title":"An accurate fully automated panel of plasma biomarkers for Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/plasma-biomarkers-of-alzheimer-s-disease-a-review-of-available-assays-37220625","doi":"10.3233/adr-230029","journal":"Journal of Alzheimer's disease reports","n_participants":null,"pmid":"37220625","source_url":"https://pubmed.ncbi.nlm.nih.gov/37220625/","study_design":null,"title":"Plasma Biomarkers of Alzheimer's Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice","title_match":false,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/plasma-a42-a40-and-phospho-tau217-concentration-ratios-increase-the-37932961","doi":"10.1002/alz.13542","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"37932961","source_url":"https://pubmed.ncbi.nlm.nih.gov/37932961/","study_design":null,"title":"Plasma A\u03b242/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-clinical-performance-of-csf-phospho-tau-33252199","doi":"10.1002/alz.12236","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":503,"pmid":"33252199","source_url":"https://pubmed.ncbi.nlm.nih.gov/33252199/","study_design":null,"title":"Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/mass-spectrometric-simultaneous-quantification-of-tau-species-in-37198279","doi":"10.1038/s43587-023-00405-1","journal":"Nature aging","n_participants":214,"pmid":"37198279","source_url":"https://pubmed.ncbi.nlm.nih.gov/37198279/","study_design":null,"title":"Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies","title_match":false,"year":2023},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/the-fda-approved-anti-amyloid-monoclonal-antibodies-for-the-treatment-38017568","doi":"10.1186/s40001-023-01512-w","journal":"European journal of medical research","n_participants":4471,"pmid":"38017568","source_url":"https://pubmed.ncbi.nlm.nih.gov/38017568/","study_design":"systematic review","title":"The FDA-approved anti-amyloid-\u03b2 monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials","title_match":true,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/identification-of-longitudinally-dynamic-biomarkers-in-alzheimer-s-24902845","doi":"10.1186/1750-1326-9-22","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"24902845","source_url":"https://pubmed.ncbi.nlm.nih.gov/24902845/","study_design":"longitudinal study","title":"Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics","title_match":false,"year":2014},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-biomarkers-for-early-and-differential-alzheimer-s-29562530","doi":"10.3233/jad-170680","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"29562530","source_url":"https://pubmed.ncbi.nlm.nih.gov/29562530/","study_design":null,"title":"Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis","title_match":false,"year":2018},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/comparison-of-two-plasma-p-tau217-assays-to-detect-and-monitor-38471397","doi":"10.1016/j.ebiom.2024.105046","journal":"EBioMedicine","n_participants":294,"pmid":"38471397","source_url":"https://pubmed.ncbi.nlm.nih.gov/38471397/","study_design":null,"title":"Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer's pathology","title_match":false,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/the-cerebrospinal-fluid-a1-42-a1-40-ratio-improves-concordance-with-28869470","doi":"10.3233/jad-170327","journal":"Journal of Alzheimer's disease : JAD","n_participants":17,"pmid":"28869470","source_url":"https://pubmed.ncbi.nlm.nih.gov/28869470/","study_design":"longitudinal study","title":"The Cerebrospinal Fluid A\u03b21-42/A\u03b21-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting","title_match":false,"year":2017},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-bio-hermes-study-biomarker-database-developed-to-investigate-38415908","doi":"10.1002/alz.13722","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":417,"pmid":"38415908","source_url":"https://pubmed.ncbi.nlm.nih.gov/38415908/","study_design":null,"title":"The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2019-31334330","doi":"10.1016/j.trci.2019.05.008","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"31334330","source_url":"https://pubmed.ncbi.nlm.nih.gov/31334330/","study_design":"clinical trial","title":"Alzheimer's disease drug development pipeline: 2019","title_match":false,"year":2019},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/increased-neurofilament-light-chain-blood-levels-in-neurodegenerative-24073237","doi":"10.1371/journal.pone.0075091","journal":"PloS one","n_participants":20,"pmid":"24073237","source_url":"https://pubmed.ncbi.nlm.nih.gov/24073237/","study_design":"longitudinal study","title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","title_match":false,"year":2013},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/a-trial-of-gantenerumab-or-solanezumab-in-dominantly-inherited-34155411","doi":"10.1038/s41591-021-01369-8","journal":"Nature medicine","n_participants":null,"pmid":"34155411","source_url":"https://pubmed.ncbi.nlm.nih.gov/34155411/","study_design":null,"title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/blood-based-biomarkers-for-alzheimer-s-disease-34859598","doi":"10.15252/emmm.202114408","journal":"EMBO molecular medicine","n_participants":null,"pmid":"34859598","source_url":"https://pubmed.ncbi.nlm.nih.gov/34859598/","study_design":null,"title":"Blood-based biomarkers for Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/neurofilament-proteins-as-biomarkers-to-monitor-neurological-diseases-34646114","doi":"10.3389/fnins.2021.689938","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"34646114","source_url":"https://pubmed.ncbi.nlm.nih.gov/34646114/","study_design":null,"title":"Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/senolytic-therapy-in-mild-alzheimer-s-disease-a-phase-1-feasibility-37679434","doi":"10.1038/s41591-023-02543-w","journal":"Nature medicine","n_participants":null,"pmid":"37679434","source_url":"https://pubmed.ncbi.nlm.nih.gov/37679434/","study_design":"open-label trial","title":"Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial","title_match":true,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/a-fluid-biomarker-reveals-loss-of-tdp-43-splicing-repression-in-38278991","doi":"10.1038/s41591-023-02788-5","journal":"Nature medicine","n_participants":null,"pmid":"38278991","source_url":"https://pubmed.ncbi.nlm.nih.gov/38278991/","study_design":null,"title":"A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD","title_match":false,"year":2024},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/plasma-amyloid-42-40-ratios-as-biomarkers-for-amyloid-cerebral-28948206","doi":"10.1016/j.dadm.2017.07.004","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"28948206","source_url":"https://pubmed.ncbi.nlm.nih.gov/28948206/","study_design":"cross-sectional","title":"Plasma amyloid \u03b2 42/40 ratios as biomarkers for amyloid \u03b2 cerebral deposition in cognitively normal individuals","title_match":false,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-precivityadtm-test-accurate-and-reliable-lc-ms-ms-assays-for-34015303","doi":"10.1016/j.cca.2021.05.011","journal":"Clinica chimica acta; international journal of clinical chemistry","n_participants":null,"pmid":"34015303","source_url":"https://pubmed.ncbi.nlm.nih.gov/34015303/","study_design":null,"title":"The PrecivityAD\u2122 test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis","title_match":false,"year":2021},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/current-advances-in-plasma-and-cerebrospinal-fluid-biomarkers-in-33470669","doi":"10.1097/wco.0000000000000904","journal":"Current opinion in neurology","n_participants":null,"pmid":"33470669","source_url":"https://pubmed.ncbi.nlm.nih.gov/33470669/","study_design":null,"title":"Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/a-selected-reaction-monitoring-srm-based-method-for-absolute-23076076","doi":"10.3233/jad-2012-121471","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"23076076","source_url":"https://pubmed.ncbi.nlm.nih.gov/23076076/","study_design":null,"title":"A selected reaction monitoring (SRM)-based method for absolute quantification of A\u03b238, A\u03b240, and A\u03b242 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls","title_match":false,"year":2013},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/elecsys-csf-biomarker-immunoassays-demonstrate-concordance-with-32234072","doi":"10.1186/s13195-020-00595-5","journal":"Alzheimer's research & therapy","n_participants":202,"pmid":"32234072","source_url":"https://pubmed.ncbi.nlm.nih.gov/32234072/","study_design":null,"title":"Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging","title_match":false,"year":2020},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/novelty-related-fmri-responses-of-precuneus-and-medial-temporal-35995589","doi":"10.1212/wnl.0000000000200667","journal":"Neurology","n_participants":499,"pmid":"35995589","source_url":"https://pubmed.ncbi.nlm.nih.gov/35995589/","study_design":"longitudinal study","title":"Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease","title_match":false,"year":2022},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/the-effect-of-cognitive-motor-dual-task-training-on-cognitive-26018225","doi":"10.1186/s12877-015-0058-4","journal":"BMC geriatrics","n_participants":27,"pmid":"26018225","source_url":"https://pubmed.ncbi.nlm.nih.gov/26018225/","study_design":null,"title":"The effect of cognitive-motor dual-task training on cognitive function and plasma amyloid \u03b2 peptide 42/40 ratio in healthy elderly persons: a randomized controlled trial","title_match":true,"year":2015},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/blarcamesine-for-the-treatment-of-early-alzheimer-s-disease-results-39800452","doi":"10.1016/j.tjpad.2024.100016","journal":"The journal of prevention of Alzheimer's disease","n_participants":338,"pmid":"39800452","source_url":"https://pubmed.ncbi.nlm.nih.gov/39800452/","study_design":"open-label trial","title":"Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial","title_match":true,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-a42-40-ratio-alone-or-combined-with-fdg-pet-can-accurately-31787105","doi":"10.1186/s13195-019-0549-1","journal":"Alzheimer's research & therapy","n_participants":39,"pmid":"31787105","source_url":"https://pubmed.ncbi.nlm.nih.gov/31787105/","study_design":null,"title":"Plasma A\u03b242/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/sleep-deprivation-induced-plasma-amyloid-transport-disturbance-in-28304302","doi":"10.3233/jad-161213","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"28304302","source_url":"https://pubmed.ncbi.nlm.nih.gov/28304302/","study_design":null,"title":"Sleep Deprivation Induced Plasma Amyloid-\u03b2 Transport Disturbance in Healthy Young Adults","title_match":false,"year":2017},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/comparison-of-plasma-and-csf-biomarkers-in-predicting-cognitive-36183195","doi":"10.1002/acn3.51670","journal":"Annals of clinical and translational neurology","n_participants":371,"pmid":"36183195","source_url":"https://pubmed.ncbi.nlm.nih.gov/36183195/","study_design":null,"title":"Comparison of plasma and CSF biomarkers in predicting cognitive decline","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/therapeutic-inhibition-of-the-complement-system-in-diseases-of-the-30886620","doi":"10.3389/fimmu.2019.00362","journal":"Frontiers in immunology","n_participants":null,"pmid":"30886620","source_url":"https://pubmed.ncbi.nlm.nih.gov/30886620/","study_design":null,"title":"Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System","title_match":false,"year":2019},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/plasma-amyloid-beta-measurements-a-desired-but-elusive-alzheimer-s-23470128","doi":"10.1186/alzrt162","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"23470128","source_url":"https://pubmed.ncbi.nlm.nih.gov/23470128/","study_design":"cross-sectional","title":"Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker","title_match":false,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/blood-based-biomarkers-for-alzheimer-s-disease-diagnosis-and-35456047","doi":"10.3390/cells11081367","journal":"Cells","n_participants":null,"pmid":"35456047","source_url":"https://pubmed.ncbi.nlm.nih.gov/35456047/","study_design":"narrative review","title":"Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/a-decade-of-blood-biomarkers-for-alzheimer-s-disease-research-an-29562526","doi":"10.3233/jad-170531","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"29562526","source_url":"https://pubmed.ncbi.nlm.nih.gov/29562526/","study_design":null,"title":"A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication","title_match":false,"year":2018},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-sargramostim-gm-csf-in-the-treatment-of-33778150","doi":"10.1002/trc2.12158","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":20,"pmid":"33778150","source_url":"https://pubmed.ncbi.nlm.nih.gov/33778150/","study_design":null,"title":"Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/biomarker-potential-of-brain-secreted-extracellular-vesicles-in-blood-32211497","doi":"10.1002/dad2.12001","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"32211497","source_url":"https://pubmed.ncbi.nlm.nih.gov/32211497/","study_design":null,"title":"Biomarker potential of brain-secreted extracellular vesicles in blood in Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/raman-spectroscopy-to-diagnose-alzheimer-s-disease-and-dementia-with-29865787","doi":"10.1021/acschemneuro.8b00198","journal":"ACS chemical neuroscience","n_participants":null,"pmid":"29865787","source_url":"https://pubmed.ncbi.nlm.nih.gov/29865787/","study_design":null,"title":"Raman Spectroscopy to Diagnose Alzheimer's Disease and Dementia with Lewy Bodies in Blood","title_match":false,"year":2018},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-biomarkers-and-their-current-use-in-clinical-39232196","doi":"10.1038/s41380-024-02709-z","journal":"Molecular psychiatry","n_participants":null,"pmid":"39232196","source_url":"https://pubmed.ncbi.nlm.nih.gov/39232196/","study_design":null,"title":"Alzheimer's disease biomarkers and their current use in clinical research and practice","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/development-of-alzheimer-s-disease-biomarkers-from-csf-to-blood-based-35453600","doi":"10.3390/biomedicines10040850","journal":"Biomedicines","n_participants":null,"pmid":"35453600","source_url":"https://pubmed.ncbi.nlm.nih.gov/35453600/","study_design":null,"title":"Development of Alzheimer's Disease Biomarkers: From CSF- to Blood-Based Biomarkers","title_match":false,"year":2022},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/neurofilament-light-as-a-blood-biomarker-for-neurodegeneration-in-29631614","doi":"10.1186/s13195-018-0367-x","journal":"Alzheimer's research & therapy","n_participants":100,"pmid":"29631614","source_url":"https://pubmed.ncbi.nlm.nih.gov/29631614/","study_design":"cross-sectional","title":"Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome","title_match":false,"year":2018},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/dha-supplementation-improves-cognitive-function-via-enhancing-a-29142143","doi":"10.1136/jnnp-2017-316176","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":120,"pmid":"29142143","source_url":"https://pubmed.ncbi.nlm.nih.gov/29142143/","study_design":null,"title":"DHA supplementation improves cognitive function via enhancing A\u03b2-mediated autophagy in Chinese elderly with mild cognitive impairment: a randomised placebo-controlled trial","title_match":true,"year":2018},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/a-nanoplasmonic-biosensor-for-ultrasensitive-detection-of-alzheimer-s-30747516","doi":"10.1021/acssensors.8b01242","journal":"ACS sensors","n_participants":null,"pmid":"30747516","source_url":"https://pubmed.ncbi.nlm.nih.gov/30747516/","study_design":null,"title":"A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer's Disease Biomarker Using a Chaotropic Agent","title_match":false,"year":2019},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/blood-protein-markers-of-neocortical-amyloid-burden-a-candidate-study-25881911","doi":"10.3233/jad-150020","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"25881911","source_url":"https://pubmed.ncbi.nlm.nih.gov/25881911/","study_design":null,"title":"Blood Protein Markers of Neocortical Amyloid-\u03b2 Burden: A Candidate Study Using SOMAscan Technology","title_match":false,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/blood-based-biomarker-candidates-of-cerebral-amyloid-using-pib-pet-in-27031486","doi":"10.3233/jad-151155","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"27031486","source_url":"https://pubmed.ncbi.nlm.nih.gov/27031486/","study_design":"longitudinal study","title":"Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly","title_match":false,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/solanezumab-for-alzheimer-s-disease-21504387","doi":"10.1517/14712598.2011.578573","journal":"Expert opinion on biological therapy","n_participants":null,"pmid":"21504387","source_url":"https://pubmed.ncbi.nlm.nih.gov/21504387/","study_design":null,"title":"Solanezumab for Alzheimer's disease","title_match":false,"year":2011},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/blood-based-biomarkers-for-alzheimer-disease-mapping-the-road-to-the-30297701","doi":"10.1038/s41582-018-0079-7","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"30297701","source_url":"https://pubmed.ncbi.nlm.nih.gov/30297701/","study_design":null,"title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","title_match":false,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/clinical-core-of-the-alzheimer-s-disease-neuroimaging-initiative-20451872","doi":"10.1016/j.jalz.2010.03.006","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":800,"pmid":"20451872","source_url":"https://pubmed.ncbi.nlm.nih.gov/20451872/","study_design":"longitudinal study","title":"Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans","title_match":false,"year":2010},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/a-phase-ii-trial-of-tideglusib-in-alzheimer-s-disease-25537011","doi":"10.3233/jad-141959","journal":"Journal of Alzheimer's disease : JAD","n_participants":86,"pmid":"25537011","source_url":"https://pubmed.ncbi.nlm.nih.gov/25537011/","study_design":null,"title":"A phase II trial of tideglusib in Alzheimer's disease","title_match":true,"year":2015},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-biomarkers-in-alzheimer-s-disease-25840462","doi":"10.1016/j.tips.2015.03.002","journal":"Trends in pharmacological sciences","n_participants":null,"pmid":"25840462","source_url":"https://pubmed.ncbi.nlm.nih.gov/25840462/","study_design":null,"title":"Amyloid biomarkers in Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/increasing-participant-diversity-in-ad-research-plans-for-digital-36209495","doi":"10.1002/alz.12797","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":20000,"pmid":"36209495","source_url":"https://pubmed.ncbi.nlm.nih.gov/36209495/","study_design":"longitudinal study","title":"Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4","title_match":false,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-neuroimaging-initiative-2-clinical-core-progress-26194309","doi":"10.1016/j.jalz.2015.05.005","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"26194309","source_url":"https://pubmed.ncbi.nlm.nih.gov/26194309/","study_design":"longitudinal study","title":"Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans","title_match":false,"year":2015},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/benefits-of-rivastigmine-on-attention-in-dementia-associated-with-16301500","doi":"10.1212/01.wnl.0000184517.69816.e9","journal":"Neurology","n_participants":487,"pmid":"16301500","source_url":"https://pubmed.ncbi.nlm.nih.gov/16301500/","study_design":null,"title":"Benefits of rivastigmine on attention in dementia associated with Parkinson disease","title_match":false,"year":2005},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-mild-cognitive-impairment-in-parkinson-disease-a-25914281","doi":"10.1002/mds.26236","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":28,"pmid":"25914281","source_url":"https://pubmed.ncbi.nlm.nih.gov/25914281/","study_design":null,"title":"Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study","title_match":true,"year":2015},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/comparison-of-multiple-interventions-for-older-adults-with-alzheimer-29768349","doi":"10.1097/md.0000000000010744","journal":"Medicine","n_participants":1747,"pmid":"29768349","source_url":"https://pubmed.ncbi.nlm.nih.gov/29768349/","study_design":"meta-analysis","title":"Comparison of multiple interventions for older adults with Alzheimer disease or mild cognitive impairment: A PRISMA-compliant network meta-analysis","title_match":false,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/effects-of-tc-1734-azd3480-a-selective-neuronal-nicotinic-receptor-17225162","doi":"10.1007/s00213-006-0675-x","journal":"Psychopharmacology","n_participants":null,"pmid":"17225162","source_url":"https://pubmed.ncbi.nlm.nih.gov/17225162/","study_design":null,"title":"Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers","title_match":false,"year":2007},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/protecting-cognition-from-aging-and-alzheimer-s-disease-a-26205305","doi":"10.1002/gps.4328","journal":"International journal of geriatric psychiatry","n_participants":348,"pmid":"26205305","source_url":"https://pubmed.ncbi.nlm.nih.gov/26205305/","study_design":null,"title":"Protecting cognition from aging and Alzheimer's disease: a computerized cognitive training combined with reminiscence therapy","title_match":false,"year":2016},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/sharper-in-the-morning-cognitive-time-of-day-effects-revealed-with-35037593","doi":"10.1080/13803395.2021.2009447","journal":"Journal of clinical and experimental neuropsychology","n_participants":169,"pmid":"35037593","source_url":"https://pubmed.ncbi.nlm.nih.gov/35037593/","study_design":null,"title":"Sharper in the morning: Cognitive time of day effects revealed with high-frequency smartphone testing","title_match":false,"year":2021},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/corticomotor-plasticity-predicts-clinical-efficacy-of-combined-32733232","doi":"10.3389/fnagi.2020.00200","journal":"Frontiers in aging neuroscience","n_participants":16,"pmid":"32733232","source_url":"https://pubmed.ncbi.nlm.nih.gov/32733232/","study_design":null,"title":"Corticomotor Plasticity Predicts Clinical Efficacy of Combined Neuromodulation and Cognitive Training in Alzheimer's Disease","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-feasibility-of-at-home-ipad-cognitive-testing-for-use-in-clinical-26998469","doi":"10.14283/jpad.2015.78","journal":"The journal of prevention of Alzheimer's disease","n_participants":49,"pmid":"26998469","source_url":"https://pubmed.ncbi.nlm.nih.gov/26998469/","study_design":null,"title":"The Feasibility of At-Home iPad Cognitive Testing For Use in Clinical Trials","title_match":true,"year":2016},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/design-and-rationale-of-the-ebbinghaus-trial-a-phase-3-double-blind-28207168","doi":"10.1002/clc.22678","journal":"Clinical cardiology","n_participants":null,"pmid":"28207168","source_url":"https://pubmed.ncbi.nlm.nih.gov/28207168/","study_design":null,"title":"Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy-A cognitive study of patients enrolled in the FOURIER trial","title_match":true,"year":2017},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/a-scoping-review-of-remote-and-unsupervised-digital-cognitive-40348870","doi":"10.1038/s41746-025-01583-5","journal":"NPJ digital medicine","n_participants":null,"pmid":"40348870","source_url":"https://pubmed.ncbi.nlm.nih.gov/40348870/","study_design":"longitudinal study","title":"A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/comparative-effectiveness-of-behavioral-interventions-on-quality-of-31099860","doi":"10.1001/jamanetworkopen.2019.3016","journal":"JAMA network open","n_participants":272,"pmid":"31099860","source_url":"https://pubmed.ncbi.nlm.nih.gov/31099860/","study_design":null,"title":"Comparative Effectiveness of Behavioral Interventions on Quality of Life for Older Adults With Mild Cognitive Impairment: A Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/computerized-cognitive-testing-for-use-in-clinical-trials-a-29188853","doi":"10.14283/jpad.2017.1","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"29188853","source_url":"https://pubmed.ncbi.nlm.nih.gov/29188853/","study_design":"cross-sectional","title":"Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries","title_match":true,"year":2017},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/using-a-digital-neuro-signature-to-measure-longitudinal-individual-34168269","doi":"10.1038/s41746-021-00470-z","journal":"NPJ digital medicine","n_participants":525,"pmid":"34168269","source_url":"https://pubmed.ncbi.nlm.nih.gov/34168269/","study_design":"longitudinal study","title":"Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study","title_match":false,"year":2021},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/computerized-structured-cognitive-training-in-patients-affected-by-27600448","doi":"10.1093/arclin/acw072","journal":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","n_participants":null,"pmid":"27600448","source_url":"https://pubmed.ncbi.nlm.nih.gov/27600448/","study_design":null,"title":"Computerized Structured Cognitive Training in Patients Affected by Early-Stage Alzheimer's Disease is Feasible and Effective: A Randomized Controlled Study","title_match":true,"year":2016},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/telemedicine-for-neurological-diseases-a-systematic-review-and-meta-36256522","doi":"10.1111/ene.15599","journal":"European journal of neurology","n_participants":2335,"pmid":"36256522","source_url":"https://pubmed.ncbi.nlm.nih.gov/36256522/","study_design":null,"title":"Telemedicine for neurological diseases: A systematic review and meta-analysis","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/methodology-for-establishing-a-community-wide-life-laboratory-for-30102277","doi":"10.3791/56942","journal":"Journal of visualized experiments : JoVE","n_participants":null,"pmid":"30102277","source_url":"https://pubmed.ncbi.nlm.nih.gov/30102277/","study_design":null,"title":"Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data","title_match":false,"year":2018},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/efficacy-of-the-ubiquitous-spaced-retrieval-based-memory-advancement-28587629","doi":"10.1186/s13195-017-0264-8","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"28587629","source_url":"https://pubmed.ncbi.nlm.nih.gov/28587629/","study_design":"open-label trial","title":"Efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (USMART) program among patients with mild cognitive impairment: a randomized controlled crossover trial","title_match":true,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/ethical-issues-when-using-digital-biomarkers-and-artificial-38439952","doi":"10.1002/widm.1492","journal":"Wiley interdisciplinary reviews. Data mining and knowledge discovery","n_participants":null,"pmid":"38439952","source_url":"https://pubmed.ncbi.nlm.nih.gov/38439952/","study_design":null,"title":"Ethical issues when using digital biomarkers and artificial intelligence for the early detection of dementia","title_match":false,"year":2023},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/prevention-of-dementia-using-mobile-phone-applications-prodemos-34108173","doi":"10.1136/bmjopen-2021-049762","journal":"BMJ open","n_participants":2400,"pmid":"34108173","source_url":"https://pubmed.ncbi.nlm.nih.gov/34108173/","study_design":"randomized controlled trial","title":"Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial","title_match":true,"year":2021},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/the-cognitive-effects-of-recombinant-interleukin-2-ril-2-therapy-a-9038610","doi":"10.1016/s0959-8049(96)00300-0","journal":"European journal of cancer (Oxford, England : 1990)","n_participants":17,"pmid":"9038610","source_url":"https://pubmed.ncbi.nlm.nih.gov/9038610/","study_design":null,"title":"The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments","title_match":true,"year":1996},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/improvement-in-executive-function-for-older-adults-through-smartphone-34694201","doi":"10.1080/13825585.2021.1991262","journal":"Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition","n_participants":76,"pmid":"34694201","source_url":"https://pubmed.ncbi.nlm.nih.gov/34694201/","study_design":"randomized controlled trial","title":"Improvement in executive function for older adults through smartphone apps: a randomized clinical trial comparing language learning and brain training","title_match":true,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/patient-perspectives-of-the-experience-of-a-computerized-cognitive-30090850","doi":"10.1016/j.trci.2018.06.003","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"30090850","source_url":"https://pubmed.ncbi.nlm.nih.gov/30090850/","study_design":null,"title":"Patient perspectives of the experience of a computerized cognitive assessment in a clinical setting","title_match":false,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/deep-and-frequent-phenotyping-study-protocol-an-observational-study-30904851","doi":"10.1136/bmjopen-2018-024498","journal":"BMJ open","n_participants":null,"pmid":"30904851","source_url":"https://pubmed.ncbi.nlm.nih.gov/30904851/","study_design":null,"title":"Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/pain-and-decreased-cognitive-function-negatively-impact-physical-25040845","doi":"10.1111/pme.12483","journal":"Pain medicine (Malden, Mass.)","n_participants":null,"pmid":"25040845","source_url":"https://pubmed.ncbi.nlm.nih.gov/25040845/","study_design":null,"title":"Pain and decreased cognitive function negatively impact physical functioning in older adults with knee osteoarthritis","title_match":false,"year":2014},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/effectiveness-of-non-pharmacological-therapies-on-cognitive-function-36967820","doi":"10.3389/fnagi.2023.1131744","journal":"Frontiers in aging neuroscience","n_participants":38,"pmid":"36967820","source_url":"https://pubmed.ncbi.nlm.nih.gov/36967820/","study_design":"systematic review","title":"Effectiveness of non-pharmacological therapies on cognitive function in patients with dementia-A network meta-analysis of randomized controlled trials","title_match":true,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/validation-of-the-remote-automated-ki-e-speech-biomarker-for-36466952","doi":"10.1159/000526471","journal":"Digital biomarkers","n_participants":69,"pmid":"36466952","source_url":"https://pubmed.ncbi.nlm.nih.gov/36466952/","study_design":null,"title":"Validation of the Remote Automated ki:e Speech Biomarker for Cognition in Mild Cognitive Impairment: Verification and Validation following DiME V3 Framework","title_match":false,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/feasibility-and-acceptability-of-remote-smartphone-cognitive-testing-37180971","doi":"10.1002/dad2.12423","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":101,"pmid":"37180971","source_url":"https://pubmed.ncbi.nlm.nih.gov/37180971/","study_design":null,"title":"Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research","title_match":false,"year":2023},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/acu193-a-monoclonal-antibody-that-selectively-binds-soluble-a-36641606","doi":"10.14283/jpad.2022.93","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"36641606","source_url":"https://pubmed.ncbi.nlm.nih.gov/36641606/","study_design":"clinical trial","title":"ACU193, a Monoclonal Antibody that Selectively Binds Soluble A\u00df Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan","title_match":true,"year":2023},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/apoe-and-alzheimer-s-disease-advances-in-genetics-pathophysiology-and-33340485","doi":"10.1016/s1474-4422(20)30412-9","journal":"The Lancet. Neurology","n_participants":null,"pmid":"33340485","source_url":"https://pubmed.ncbi.nlm.nih.gov/33340485/","study_design":"meta-analysis","title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","title_match":false,"year":2021},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-the-cholesterol-connection-12658281","doi":"10.1038/nn0403-345","journal":"Nature neuroscience","n_participants":null,"pmid":"12658281","source_url":"https://pubmed.ncbi.nlm.nih.gov/12658281/","study_design":null,"title":"Alzheimer's disease: the cholesterol connection","title_match":false,"year":2003},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/a-1-year-randomized-placebo-controlled-study-of-donepezil-in-patients-11502918","doi":"10.1212/wnl.57.3.489","journal":"Neurology","n_participants":286,"pmid":"11502918","source_url":"https://pubmed.ncbi.nlm.nih.gov/11502918/","study_design":null,"title":"A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD","title_match":true,"year":2001},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-multiplex-model-of-the-genetics-of-alzheimer-s-disease-32112059","doi":"10.1038/s41593-020-0599-5","journal":"Nature neuroscience","n_participants":null,"pmid":"32112059","source_url":"https://pubmed.ncbi.nlm.nih.gov/32112059/","study_design":null,"title":"The multiplex model of the genetics of Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/common-polygenic-variation-enhances-risk-prediction-for-alzheimer-s-26490334","doi":"10.1093/brain/awv268","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"26490334","source_url":"https://pubmed.ncbi.nlm.nih.gov/26490334/","study_design":null,"title":"Common polygenic variation enhances risk prediction for Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-neuroimaging-initiative-biomarkers-as-20451875","doi":"10.1016/j.jalz.2010.03.013","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"20451875","source_url":"https://pubmed.ncbi.nlm.nih.gov/20451875/","study_design":"longitudinal study","title":"Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans","title_match":false,"year":2010},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/common-variants-in-alzheimer-s-disease-and-risk-stratification-by-34099642","doi":"10.1038/s41467-021-22491-8","journal":"Nature communications","n_participants":409435,"pmid":"34099642","source_url":"https://pubmed.ncbi.nlm.nih.gov/34099642/","study_design":"case-control study","title":"Common variants in Alzheimer's disease and risk stratification by polygenic risk scores","title_match":false,"year":2021},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/genetic-variants-and-functional-pathways-associated-with-resilience-32844198","doi":"10.1093/brain/awaa209","journal":"Brain : a journal of neurology","n_participants":5108,"pmid":"32844198","source_url":"https://pubmed.ncbi.nlm.nih.gov/32844198/","study_design":"cohort study","title":"Genetic variants and functional pathways associated with resilience to Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/new-insights-into-atypical-alzheimer-s-disease-in-the-era-of-33609479","doi":"10.1016/s1474-4422(20)30440-3","journal":"The Lancet. Neurology","n_participants":null,"pmid":"33609479","source_url":"https://pubmed.ncbi.nlm.nih.gov/33609479/","study_design":null,"title":"New insights into atypical Alzheimer's disease in the era of biomarkers","title_match":false,"year":2021},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-mitochondrial-cascade-hypothesis-progress-and-24071439","doi":"10.1016/j.bbadis.2013.09.010","journal":"Biochimica et biophysica acta","n_participants":null,"pmid":"24071439","source_url":"https://pubmed.ncbi.nlm.nih.gov/24071439/","study_design":null,"title":"The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-secretase-bace1-in-alzheimer-s-disease-32223911","doi":"10.1016/j.biopsych.2020.02.001","journal":"Biological psychiatry","n_participants":null,"pmid":"32223911","source_url":"https://pubmed.ncbi.nlm.nih.gov/32223911/","study_design":null,"title":"The \u03b2-Secretase BACE1 in Alzheimer's Disease","title_match":false,"year":2021},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-role-of-dna-methylation-in-aging-rejuvenation-and-age-related-23098078","doi":"10.1089/rej.2012.1324","journal":"Rejuvenation research","n_participants":null,"pmid":"23098078","source_url":"https://pubmed.ncbi.nlm.nih.gov/23098078/","study_design":null,"title":"The role of DNA methylation in aging, rejuvenation, and age-related disease","title_match":false,"year":2012},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/prospective-longitudinal-atrophy-in-alzheimer-s-disease-correlates-31894103","doi":"10.1126/scitranslmed.aau5732","journal":"Science translational medicine","n_participants":32,"pmid":"31894103","source_url":"https://pubmed.ncbi.nlm.nih.gov/31894103/","study_design":"longitudinal study","title":"Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/longitudinal-tau-pet-in-ageing-and-alzheimer-s-disease-29538647","doi":"10.1093/brain/awy059","journal":"Brain : a journal of neurology","n_participants":126,"pmid":"29538647","source_url":"https://pubmed.ncbi.nlm.nih.gov/29538647/","study_design":null,"title":"Longitudinal tau PET in ageing and Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-relationships-between-neuroinflammation-beta-amyloid-and-tau-32375809","doi":"10.1186/s12974-020-01820-6","journal":"Journal of neuroinflammation","n_participants":null,"pmid":"32375809","source_url":"https://pubmed.ncbi.nlm.nih.gov/32375809/","study_design":"longitudinal study","title":"The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/neuroimaging-biomarkers-for-alzheimer-s-disease-31174557","doi":"10.1186/s13024-019-0325-5","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"31174557","source_url":"https://pubmed.ncbi.nlm.nih.gov/31174557/","study_design":null,"title":"Neuroimaging Biomarkers for Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/accelerating-alzheimer-s-therapeutic-development-the-past-and-future-37848035","doi":"10.1016/j.cell.2023.09.023","journal":"Cell","n_participants":null,"pmid":"37848035","source_url":"https://pubmed.ncbi.nlm.nih.gov/37848035/","study_design":"clinical trial","title":"Accelerating Alzheimer's therapeutic development: The past and future of clinical trials","title_match":true,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/patient-centered-connectivity-based-prediction-of-tau-pathology-33246962","doi":"10.1126/sciadv.abd1327","journal":"Science advances","n_participants":null,"pmid":"33246962","source_url":"https://pubmed.ncbi.nlm.nih.gov/33246962/","study_design":"longitudinal study","title":"Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/mild-behavioral-impairment-is-associated-with-amyloid-but-not-tau-or-31914223","doi":"10.1002/alz.12007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"31914223","source_url":"https://pubmed.ncbi.nlm.nih.gov/31914223/","study_design":null,"title":"Mild behavioral impairment is associated with \u03b2-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals","title_match":false,"year":2020},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/biomarkers-for-the-early-detection-and-progression-of-alzheimer-s-27738903","doi":"10.1007/s13311-016-0481-z","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"27738903","source_url":"https://pubmed.ncbi.nlm.nih.gov/27738903/","study_design":null,"title":"Biomarkers for the Early Detection and Progression of Alzheimer's Disease","title_match":false,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-development-and-validation-of-tau-pet-tracers-current-status-and-30148121","doi":"10.1007/s40336-018-0290-y","journal":"Clinical and translational imaging","n_participants":null,"pmid":"30148121","source_url":"https://pubmed.ncbi.nlm.nih.gov/30148121/","study_design":null,"title":"The development and validation of tau PET tracers: current status and future directions","title_match":false,"year":2018},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/clinical-research-on-alzheimer-s-disease-progress-and-perspectives-29956105","doi":"10.1007/s12264-018-0249-z","journal":"Neuroscience bulletin","n_participants":null,"pmid":"29956105","source_url":"https://pubmed.ncbi.nlm.nih.gov/29956105/","study_design":null,"title":"Clinical Research on Alzheimer's Disease: Progress and Perspectives","title_match":false,"year":2018},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/tau-from-research-to-clinical-development-27154059","doi":"10.1016/j.jalz.2016.03.018","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"27154059","source_url":"https://pubmed.ncbi.nlm.nih.gov/27154059/","study_design":null,"title":"Tau: From research to clinical development","title_match":false,"year":2016},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/predicting-future-rates-of-tau-accumulation-on-pet-33094327","doi":"10.1093/brain/awaa248","journal":"Brain : a journal of neurology","n_participants":203,"pmid":"33094327","source_url":"https://pubmed.ncbi.nlm.nih.gov/33094327/","study_design":null,"title":"Predicting future rates of tau accumulation on PET","title_match":false,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/blood-brain-barrier-opening-in-alzheimer-s-disease-using-mr-guided-30046032","doi":"10.1038/s41467-018-04529-6","journal":"Nature communications","n_participants":null,"pmid":"30046032","source_url":"https://pubmed.ncbi.nlm.nih.gov/30046032/","study_design":null,"title":"Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound","title_match":false,"year":2018},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/trial-of-solanezumab-in-preclinical-alzheimer-s-disease-37458272","doi":"10.1056/nejmoa2305032","journal":"The New England journal of medicine","n_participants":1169,"pmid":"37458272","source_url":"https://pubmed.ncbi.nlm.nih.gov/37458272/","study_design":"clinical trial","title":"Trial of Solanezumab in Preclinical Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-tau-and-ptau-181-increase-with-cortical-amyloid-20049742","doi":"10.1002/emmm.200900048","journal":"EMBO molecular medicine","n_participants":null,"pmid":"20049742","source_url":"https://pubmed.ncbi.nlm.nih.gov/20049742/","study_design":null,"title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease","title_match":true,"year":2009},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/amyloid-pet-imaging-in-alzheimer-s-disease-a-comparison-of-three-24647577","doi":"10.1007/s00259-014-2753-3","journal":"European journal of nuclear medicine and molecular imaging","n_participants":40,"pmid":"24647577","source_url":"https://pubmed.ncbi.nlm.nih.gov/24647577/","study_design":null,"title":"Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers","title_match":false,"year":2014},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-neuroimaging-initiative-2-pet-core-2015-26194311","doi":"10.1016/j.jalz.2015.05.001","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"26194311","source_url":"https://pubmed.ncbi.nlm.nih.gov/26194311/","study_design":"cross-sectional","title":"The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015","title_match":false,"year":2015},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/phase-1-study-of-the-pittsburgh-compound-b-derivative-18f-19617318","doi":"10.2967/jnumed.109.063305","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"19617318","source_url":"https://pubmed.ncbi.nlm.nih.gov/19617318/","study_design":"clinical trial","title":"Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease","title_match":true,"year":2009},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/brain-atrophy-in-alzheimer-s-disease-and-aging-26827786","doi":"10.1016/j.arr.2016.01.002","journal":"Ageing research reviews","n_participants":null,"pmid":"26827786","source_url":"https://pubmed.ncbi.nlm.nih.gov/26827786/","study_design":null,"title":"Brain atrophy in Alzheimer's Disease and aging","title_match":false,"year":2016},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/a-phase-i-trial-of-deep-brain-stimulation-of-memory-circuits-in-20687206","doi":"10.1002/ana.22089","journal":"Annals of neurology","n_participants":null,"pmid":"20687206","source_url":"https://pubmed.ncbi.nlm.nih.gov/20687206/","study_design":null,"title":"A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease","title_match":true,"year":2010},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/accurate-automatic-estimation-of-total-intracranial-volume-a-nuisance-25255942","doi":"10.1016/j.neuroimage.2014.09.034","journal":"NeuroImage","n_participants":288,"pmid":"25255942","source_url":"https://pubmed.ncbi.nlm.nih.gov/25255942/","study_design":null,"title":"Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance","title_match":false,"year":2015},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/longitudinal-pet-evaluation-of-cerebral-metabolic-decline-in-dementia-11986126","doi":"10.1176/appi.ajp.159.5.738","journal":"The American journal of psychiatry","n_participants":14,"pmid":"11986126","source_url":"https://pubmed.ncbi.nlm.nih.gov/11986126/","study_design":"cross-sectional","title":"Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies","title_match":false,"year":2002},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/update-on-the-magnetic-resonance-imaging-core-of-the-alzheimer-s-20451869","doi":"10.1016/j.jalz.2010.03.004","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"20451869","source_url":"https://pubmed.ncbi.nlm.nih.gov/20451869/","study_design":null,"title":"Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative","title_match":false,"year":2010},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/senolytic-drugs-from-discovery-to-translation-32686219","doi":"10.1111/joim.13141","journal":"Journal of internal medicine","n_participants":null,"pmid":"32686219","source_url":"https://pubmed.ncbi.nlm.nih.gov/32686219/","study_design":null,"title":"Senolytic drugs: from discovery to translation","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/current-clinical-applications-of-in-vivo-gene-therapy-with-aavs-33309881","doi":"10.1016/j.ymthe.2020.12.007","journal":"Molecular therapy : the journal of the American Society of Gene Therapy","n_participants":null,"pmid":"33309881","source_url":"https://pubmed.ncbi.nlm.nih.gov/33309881/","study_design":null,"title":"Current Clinical Applications of In Vivo Gene Therapy with AAVs","title_match":false,"year":2021},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/nerve-growth-factor-from-the-early-discoveries-to-the-potential-23190582","doi":"10.1186/1479-5876-10-239","journal":"Journal of translational medicine","n_participants":null,"pmid":"23190582","source_url":"https://pubmed.ncbi.nlm.nih.gov/23190582/","study_design":null,"title":"Nerve growth factor: from the early discoveries to the potential clinical use","title_match":false,"year":2012},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/melatonin-antioxidative-defense-therapeutical-implications-for-aging-22739839","doi":"10.1007/s12640-012-9337-4","journal":"Neurotoxicity research","n_participants":null,"pmid":"22739839","source_url":"https://pubmed.ncbi.nlm.nih.gov/22739839/","study_design":null,"title":"Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/clinical-uses-of-melatonin-evaluation-of-human-trials-20423309","doi":"10.2174/092986710791233689","journal":"Current medicinal chemistry","n_participants":null,"pmid":"20423309","source_url":"https://pubmed.ncbi.nlm.nih.gov/20423309/","study_design":null,"title":"Clinical uses of melatonin: evaluation of human trials","title_match":false,"year":2010},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/recent-advances-in-alzheimer-s-disease-mechanisms-clinical-trials-and-39174535","doi":"10.1038/s41392-024-01911-3","journal":"Signal transduction and targeted therapy","n_participants":null,"pmid":"39174535","source_url":"https://pubmed.ncbi.nlm.nih.gov/39174535/","study_design":null,"title":"Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies","title_match":true,"year":2024},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-strategies-for-disease-modification-20431570","doi":"10.1038/nrd2896","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"20431570","source_url":"https://pubmed.ncbi.nlm.nih.gov/20431570/","study_design":null,"title":"Alzheimer's disease: strategies for disease modification","title_match":false,"year":2010},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/anti-amyloid-monoclonal-antibodies-for-alzheimer-s-disease-pitfalls-28967385","doi":"10.1016/j.biopsych.2017.08.010","journal":"Biological psychiatry","n_participants":null,"pmid":"28967385","source_url":"https://pubmed.ncbi.nlm.nih.gov/28967385/","study_design":null,"title":"Anti-Amyloid-\u03b2 Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise","title_match":false,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/biochemistry-of-amyloid-protein-and-amyloid-deposits-in-alzheimer-22675658","doi":"10.1101/cshperspect.a006262","journal":"Cold Spring Harbor perspectives in medicine","n_participants":null,"pmid":"22675658","source_url":"https://pubmed.ncbi.nlm.nih.gov/22675658/","study_design":null,"title":"Biochemistry of amyloid \u03b2-protein and amyloid deposits in Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/failure-to-demonstrate-efficacy-of-aducanumab-an-analysis-of-the-33135381","doi":"10.1002/alz.12213","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"33135381","source_url":"https://pubmed.ncbi.nlm.nih.gov/33135381/","study_design":null,"title":"Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/lecanemab-aducanumab-and-gantenerumab-binding-profiles-to-different-36253511","doi":"10.1007/s13311-022-01308-6","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"36253511","source_url":"https://pubmed.ncbi.nlm.nih.gov/36253511/","study_design":null,"title":"Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease","title_match":true,"year":2023},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/therapeutic-strategies-for-alzheimer-s-disease-in-clinical-trials-26721364","doi":"10.1016/j.pharep.2015.07.006","journal":"Pharmacological reports : PR","n_participants":null,"pmid":"26721364","source_url":"https://pubmed.ncbi.nlm.nih.gov/26721364/","study_design":null,"title":"Therapeutic strategies for Alzheimer's disease in clinical trials","title_match":true,"year":2016},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-in-cognitively-normal-individuals-at-risk-populations-24179789","doi":"10.1016/j.nicl.2013.02.006","journal":"NeuroImage. Clinical","n_participants":null,"pmid":"24179789","source_url":"https://pubmed.ncbi.nlm.nih.gov/24179789/","study_design":"longitudinal study","title":"Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/phase-3-solanezumab-trials-secondary-outcomes-in-mild-alzheimer-s-26238576","doi":"10.1016/j.jalz.2015.06.1893","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":659,"pmid":"26238576","source_url":"https://pubmed.ncbi.nlm.nih.gov/26238576/","study_design":"clinical trial","title":"Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients","title_match":true,"year":2016},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/structural-and-kinetic-basis-for-the-selectivity-of-aducanumab-for-29686315","doi":"10.1038/s41598-018-24501-0","journal":"Scientific reports","n_participants":null,"pmid":"29686315","source_url":"https://pubmed.ncbi.nlm.nih.gov/29686315/","study_design":"clinical trial","title":"Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2","title_match":false,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-amyloid-cascade-hypothesis-in-alzheimer-s-disease-it-s-time-to-28093977","doi":"10.2174/1570159x15666170116143743","journal":"Current neuropharmacology","n_participants":null,"pmid":"28093977","source_url":"https://pubmed.ncbi.nlm.nih.gov/28093977/","study_design":null,"title":"The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind","title_match":false,"year":2017},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/aducanumab-first-approval-34324167","doi":"10.1007/s40265-021-01569-z","journal":"Drugs","n_participants":null,"pmid":"34324167","source_url":"https://pubmed.ncbi.nlm.nih.gov/34324167/","study_design":null,"title":"Aducanumab: First Approval","title_match":false,"year":2021},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/past-present-and-future-of-therapeutic-strategies-against-amyloid-34687956","doi":"10.1016/j.arr.2021.101496","journal":"Ageing research reviews","n_participants":null,"pmid":"34687956","source_url":"https://pubmed.ncbi.nlm.nih.gov/34687956/","study_design":null,"title":"Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer's disease: a systematic review","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-path-forward-in-alzheimer-s-disease-therapeutics-reevaluating-the-31706733","doi":"10.1016/j.jalz.2019.09.075","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"31706733","source_url":"https://pubmed.ncbi.nlm.nih.gov/31706733/","study_design":"clinical trial","title":"The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis","title_match":false,"year":2020},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/safety-and-biomarker-effects-of-solanezumab-in-patients-with-22672770","doi":"10.1016/j.jalz.2011.09.224","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":52,"pmid":"22672770","source_url":"https://pubmed.ncbi.nlm.nih.gov/22672770/","study_design":"clinical trial","title":"Safety and biomarker effects of solanezumab in patients with Alzheimer's disease","title_match":false,"year":2012},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/inhibitors-of-nf-b-and-p2x7-nlrp3-caspase-1-pathway-in-microglia-30502599","doi":"10.1016/j.jneuroim.2018.11.010","journal":"Journal of neuroimmunology","n_participants":null,"pmid":"30502599","source_url":"https://pubmed.ncbi.nlm.nih.gov/30502599/","study_design":null,"title":"Inhibitors of NF-\u03baB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/impact-of-anti-amyloid-monoclonal-antibodies-on-the-pathology-and-35493943","doi":"10.3389/fnagi.2022.870517","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"35493943","source_url":"https://pubmed.ncbi.nlm.nih.gov/35493943/","study_design":null,"title":"Impact of Anti-amyloid-\u03b2 Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab","title_match":false,"year":2022},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/models-of-amyloid-induced-tau-pathology-the-long-and-folded-road-to-25407337","doi":"10.1186/1750-1326-9-51","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"25407337","source_url":"https://pubmed.ncbi.nlm.nih.gov/25407337/","study_design":null,"title":"Models of \u03b2-amyloid induced Tau-pathology: the long and \"folded\" road to understand the mechanism","title_match":false,"year":2014},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-amyloid-cascade-hypothesis-an-updated-critical-review-37183523","doi":"10.1093/brain/awad159","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"37183523","source_url":"https://pubmed.ncbi.nlm.nih.gov/37183523/","study_design":null,"title":"The amyloid cascade hypothesis: an updated critical review","title_match":false,"year":2023},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/effects-of-monoclonal-antibodies-against-amyloid-on-clinical-and-33831607","doi":"10.1016/j.arr.2021.101339","journal":"Ageing research reviews","n_participants":12585,"pmid":"33831607","source_url":"https://pubmed.ncbi.nlm.nih.gov/33831607/","study_design":"meta-analysis","title":"Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease","title_match":true,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-neuroprotective-effects-of-glucagon-like-peptide-1-in-alzheimer-s-36117625","doi":"10.3389/fnins.2022.970925","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"36117625","source_url":"https://pubmed.ncbi.nlm.nih.gov/36117625/","study_design":null,"title":"The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/immunotherapy-for-alzheimer-s-disease-targeting-amyloid-and-beyond-35300725","doi":"10.1186/s40035-022-00292-3","journal":"Translational neurodegeneration","n_participants":null,"pmid":"35300725","source_url":"https://pubmed.ncbi.nlm.nih.gov/35300725/","study_design":null,"title":"Immunotherapy for Alzheimer's disease: targeting \u03b2-amyloid and beyond","title_match":false,"year":2022},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-key-insights-from-two-decades-of-clinical-trial-35342092","doi":"10.3233/jad-215699","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"35342092","source_url":"https://pubmed.ncbi.nlm.nih.gov/35342092/","study_design":null,"title":"Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures","title_match":true,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/kinetic-fingerprints-differentiate-the-mechanisms-of-action-of-anti-a-32989305","doi":"10.1038/s41594-020-0505-6","journal":"Nature structural & molecular biology","n_participants":null,"pmid":"32989305","source_url":"https://pubmed.ncbi.nlm.nih.gov/32989305/","study_design":null,"title":"Kinetic fingerprints differentiate the mechanisms of action of anti-A\u03b2 antibodies","title_match":false,"year":2020},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/gantenerumab-reduces-amyloid-plaques-in-patients-with-prodromal-to-31831056","doi":"10.1186/s13195-019-0559-z","journal":"Alzheimer's research & therapy","n_participants":89,"pmid":"31831056","source_url":"https://pubmed.ncbi.nlm.nih.gov/31831056/","study_design":"clinical trial","title":"Gantenerumab reduces amyloid-\u03b2 plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis","title_match":false,"year":2019},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/ipsc-based-compound-screening-and-in-vitro-trials-identify-a-29166618","doi":"10.1016/j.celrep.2017.10.109","journal":"Cell reports","n_participants":null,"pmid":"29166618","source_url":"https://pubmed.ncbi.nlm.nih.gov/29166618/","study_design":null,"title":"iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid \u03b2 Combination for Alzheimer's Disease","title_match":false,"year":2017},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/melatonin-in-alzheimer-s-disease-23857055","doi":"10.3390/ijms140714575","journal":"International journal of molecular sciences","n_participants":null,"pmid":"23857055","source_url":"https://pubmed.ncbi.nlm.nih.gov/23857055/","study_design":null,"title":"Melatonin in Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-potent-bace1-inhibitor-ly2886721-elicits-robust-central-a-25609634","doi":"10.1523/jneurosci.4129-14.2015","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"25609634","source_url":"https://pubmed.ncbi.nlm.nih.gov/25609634/","study_design":"clinical trial","title":"The potent BACE1 inhibitor LY2886721 elicits robust central A\u03b2 pharmacodynamic responses in mice, dogs, and humans","title_match":false,"year":2015},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/disparities-by-race-and-ethnicity-among-adults-recruited-for-a-34228129","doi":"10.1001/jamanetworkopen.2021.14364","journal":"JAMA network open","n_participants":5945,"pmid":"34228129","source_url":"https://pubmed.ncbi.nlm.nih.gov/34228129/","study_design":"cross-sectional","title":"Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial","title_match":false,"year":2021},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/quantification-of-cerebral-amyloid-angiopathy-and-parenchymal-amyloid-17406451","doi":"10.1038/nprot.2006.277","journal":"Nature protocols","n_participants":null,"pmid":"17406451","source_url":"https://pubmed.ncbi.nlm.nih.gov/17406451/","study_design":null,"title":"Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain","title_match":false,"year":2006},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/clinical-amyloid-imaging-in-alzheimer-s-disease-21683932","doi":"10.1016/s1474-4422(11)70123-5","journal":"The Lancet. Neurology","n_participants":null,"pmid":"21683932","source_url":"https://pubmed.ncbi.nlm.nih.gov/21683932/","study_design":"longitudinal study","title":"Clinical amyloid imaging in Alzheimer's disease","title_match":false,"year":2011},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/aducanumab-evidence-from-clinical-trial-data-and-controversies-34650610","doi":"10.7573/dic.2021-7-3","journal":"Drugs in context","n_participants":null,"pmid":"34650610","source_url":"https://pubmed.ncbi.nlm.nih.gov/34650610/","study_design":null,"title":"Aducanumab: evidence from clinical trial data and controversies","title_match":true,"year":2021},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effect-of-reductions-in-amyloid-levels-on-cognitive-change-in-33632704","doi":"10.1136/bmj.n156","journal":"BMJ (Clinical research ed.)","n_participants":null,"pmid":"33632704","source_url":"https://pubmed.ncbi.nlm.nih.gov/33632704/","study_design":"meta-analysis","title":"Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis","title_match":false,"year":2021},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/fatal-iatrogenic-cerebral-amyloid-related-arteritis-in-a-woman-38086820","doi":"10.1038/s41467-023-43933-5","journal":"Nature communications","n_participants":null,"pmid":"38086820","source_url":"https://pubmed.ncbi.nlm.nih.gov/38086820/","study_design":"randomized controlled trial","title":"Fatal iatrogenic cerebral \u03b2-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/detection-and-management-of-amyloid-related-imaging-abnormalities-in-35542992","doi":"10.14283/jpad.2022.21","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"35542992","source_url":"https://pubmed.ncbi.nlm.nih.gov/35542992/","study_design":null,"title":"Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-targeting-the-glutamatergic-system-32048098","doi":"10.1007/s10522-020-09860-4","journal":"Biogerontology","n_participants":null,"pmid":"32048098","source_url":"https://pubmed.ncbi.nlm.nih.gov/32048098/","study_design":null,"title":"Alzheimer's disease: targeting the glutamatergic system","title_match":false,"year":2020},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/recent-advances-in-the-application-of-metabolomics-to-alzheimer-s-23816564","doi":"10.1016/j.bbadis.2013.06.014","journal":"Biochimica et biophysica acta","n_participants":null,"pmid":"23816564","source_url":"https://pubmed.ncbi.nlm.nih.gov/23816564/","study_design":null,"title":"Recent advances in the application of metabolomics to Alzheimer's Disease","title_match":false,"year":2014},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/role-of-aducanumab-in-the-treatment-of-alzheimer-s-disease-challenges-35611326","doi":"10.2147/cia.s325026","journal":"Clinical interventions in aging","n_participants":null,"pmid":"35611326","source_url":"https://pubmed.ncbi.nlm.nih.gov/35611326/","study_design":"clinical trial","title":"Role of Aducanumab in the Treatment of Alzheimer's Disease: Challenges and Opportunities","title_match":false,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/dominantly-inherited-alzheimer-network-facilitating-research-and-24131566","doi":"10.1186/alzrt213","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"24131566","source_url":"https://pubmed.ncbi.nlm.nih.gov/24131566/","study_design":"longitudinal study","title":"Dominantly Inherited Alzheimer Network: facilitating research and clinical trials","title_match":true,"year":2013},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/early-stage-alzheimer-disease-getting-trial-ready-35379951","doi":"10.1038/s41582-022-00645-6","journal":"Nature reviews. Neurology","n_participants":1169,"pmid":"35379951","source_url":"https://pubmed.ncbi.nlm.nih.gov/35379951/","study_design":null,"title":"Early-stage Alzheimer disease: getting trial-ready","title_match":false,"year":2022},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/first-in-human-double-blind-placebo-controlled-single-dose-escalation-29067304","doi":"10.1016/j.trci.2016.06.002","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29067304","source_url":"https://pubmed.ncbi.nlm.nih.gov/29067304/","study_design":null,"title":"First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease","title_match":true,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/delivery-of-the-brainshuttletm-amyloid-beta-antibody-fusion-37823690","doi":"10.1080/19420862.2023.2261509","journal":"mAbs","n_participants":null,"pmid":"37823690","source_url":"https://pubmed.ncbi.nlm.nih.gov/37823690/","study_design":null,"title":"Delivery of the Brainshuttle\u2122 amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/current-and-future-therapeutic-strategies-for-alzheimer-s-disease-an-37600514","doi":"10.3389/fnagi.2023.1206572","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"37600514","source_url":"https://pubmed.ncbi.nlm.nih.gov/37600514/","study_design":null,"title":"Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/beneficial-effect-of-human-anti-amyloid-beta-active-immunization-on-20360050","doi":"10.1093/brain/awq056","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"20360050","source_url":"https://pubmed.ncbi.nlm.nih.gov/20360050/","study_design":null,"title":"Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology","title_match":false,"year":2010},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/amyloid-associated-increases-in-soluble-tau-relate-to-tau-aggregation-36333294","doi":"10.1038/s41467-022-34129-4","journal":"Nature communications","n_participants":null,"pmid":"36333294","source_url":"https://pubmed.ncbi.nlm.nih.gov/36333294/","study_design":"cross-sectional","title":"Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/anti-amyloid-immunotherapies-for-alzheimer-s-disease-a-2023-clinical-37490245","doi":"10.1007/s13311-023-01405-0","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"37490245","source_url":"https://pubmed.ncbi.nlm.nih.gov/37490245/","study_design":"clinical trial","title":"Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/if-amyloid-drives-alzheimer-disease-why-have-anti-amyloid-therapies-35862308","doi":"10.1371/journal.pbio.3001694","journal":"PLoS biology","n_participants":null,"pmid":"35862308","source_url":"https://pubmed.ncbi.nlm.nih.gov/35862308/","study_design":null,"title":"If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?","title_match":false,"year":2022},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/detection-and-treatment-of-alzheimer-s-disease-in-its-preclinical-37202518","doi":"10.1038/s43587-023-00410-4","journal":"Nature aging","n_participants":null,"pmid":"37202518","source_url":"https://pubmed.ncbi.nlm.nih.gov/37202518/","study_design":"longitudinal study","title":"Detection and treatment of Alzheimer's disease in its preclinical stage","title_match":false,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/perspectives-on-future-alzheimer-therapies-amyloid-protofibrils-a-new-25031633","doi":"10.1186/alzrt246","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"25031633","source_url":"https://pubmed.ncbi.nlm.nih.gov/25031633/","study_design":"clinical trial","title":"Perspectives on future Alzheimer therapies: amyloid-\u03b2 protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/photobiomodulation-with-near-infrared-light-helmet-in-a-pilot-placebo-28593105","doi":"10.21767/2171-6625.1000176","journal":"Journal of neurology and neuroscience","n_participants":null,"pmid":"28593105","source_url":"https://pubmed.ncbi.nlm.nih.gov/28593105/","study_design":null,"title":"Photobiomodulation with Near Infrared Light Helmet in a Pilot, Placebo Controlled Clinical Trial in Dementia Patients Testing Memory and Cognition","title_match":true,"year":2017},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/designing-drug-trials-for-alzheimer-s-disease-what-we-have-learned-23809364","doi":"10.1016/j.jalz.2013.03.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"23809364","source_url":"https://pubmed.ncbi.nlm.nih.gov/23809364/","study_design":"clinical trial","title":"Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force","title_match":true,"year":2013},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/effects-of-several-quinones-on-insulin-aggregation-25008537","doi":"10.1038/srep05648","journal":"Scientific reports","n_participants":null,"pmid":"25008537","source_url":"https://pubmed.ncbi.nlm.nih.gov/25008537/","study_design":null,"title":"Effects of several quinones on insulin aggregation","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/lecanemab-first-approval-36856953","doi":"10.1007/s40265-023-01851-2","journal":"Drugs","n_participants":null,"pmid":"36856953","source_url":"https://pubmed.ncbi.nlm.nih.gov/36856953/","study_design":null,"title":"Lecanemab: First Approval","title_match":false,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/amyloid-directed-immunotherapy-for-alzheimer-s-disease-24605809","doi":"10.1111/joim.12168","journal":"Journal of internal medicine","n_participants":null,"pmid":"24605809","source_url":"https://pubmed.ncbi.nlm.nih.gov/24605809/","study_design":null,"title":"Amyloid-\u00df-directed immunotherapy for Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/nuclear-factor-kappa-b-and-alzheimer-disease-unifying-genetic-and-29312321","doi":"10.3389/fimmu.2017.01805","journal":"Frontiers in immunology","n_participants":null,"pmid":"29312321","source_url":"https://pubmed.ncbi.nlm.nih.gov/29312321/","study_design":null,"title":"Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans","title_match":false,"year":2017},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/second-generation-anti-amyloid-monoclonal-antibodies-for-alzheimer-s-39865265","doi":"10.1186/s40035-025-00465-w","journal":"Translational neurodegeneration","n_participants":null,"pmid":"39865265","source_url":"https://pubmed.ncbi.nlm.nih.gov/39865265/","study_design":null,"title":"Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/role-of-melatonin-in-alzheimer-like-neurodegeneration-16364209","doi":"10.1111/j.1745-7254.2006.00260.x","journal":"Acta pharmacologica Sinica","n_participants":null,"pmid":"16364209","source_url":"https://pubmed.ncbi.nlm.nih.gov/16364209/","study_design":null,"title":"Role of melatonin in Alzheimer-like neurodegeneration","title_match":false,"year":2006},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/risk-factors-in-developing-amyloid-related-imaging-abnormalities-aria-38312931","doi":"10.3389/fnins.2024.1326784","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"38312931","source_url":"https://pubmed.ncbi.nlm.nih.gov/38312931/","study_design":null,"title":"Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications","title_match":false,"year":2024},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/safety-and-tolerability-of-ban2401-a-clinical-study-in-alzheimer-s-27048170","doi":"10.1186/s13195-016-0181-2","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"27048170","source_url":"https://pubmed.ncbi.nlm.nih.gov/27048170/","study_design":null,"title":"Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective A\u03b2 antibody","title_match":false,"year":2016},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/aria-in-patients-treated-with-lecanemab-ban2401-in-a-phase-2-study-in-36949897","doi":"10.1002/trc2.12377","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"36949897","source_url":"https://pubmed.ncbi.nlm.nih.gov/36949897/","study_design":"clinical trial","title":"ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease","title_match":true,"year":2023},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/clinical-development-of-aducanumab-an-anti-a-human-monoclonal-29181491","doi":"10.14283/jpad.2017.39","journal":"The journal of prevention of Alzheimer's disease","n_participants":196,"pmid":"29181491","source_url":"https://pubmed.ncbi.nlm.nih.gov/29181491/","study_design":null,"title":"Clinical Development of Aducanumab, an Anti-A\u03b2 Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer's Disease","title_match":false,"year":2017},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-monoclonal-antibodies-for-alzheimer-s-disease-35275549","doi":"10.3233/jad-220046","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"35275549","source_url":"https://pubmed.ncbi.nlm.nih.gov/35275549/","study_design":"meta-analysis","title":"Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials","title_match":true,"year":2022},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/bapineuzumab-and-solanezumab-for-alzheimer-s-disease-is-the-amyloid-23574434","doi":"10.1517/14712598.2013.789856","journal":"Expert opinion on biological therapy","n_participants":null,"pmid":"23574434","source_url":"https://pubmed.ncbi.nlm.nih.gov/23574434/","study_design":null,"title":"Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive?","title_match":false,"year":2013},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-anti-amyloid-immunotherapy-for-alzheimer-s-29296624","doi":"10.1002/acn3.469","journal":"Annals of clinical and translational neurology","n_participants":5141,"pmid":"29296624","source_url":"https://pubmed.ncbi.nlm.nih.gov/29296624/","study_design":null,"title":"Efficacy and safety of anti-amyloid- \u03b2 immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis","title_match":false,"year":2017},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-anti-amyloid-monoclonal-antibodies-in-current-37423541","doi":"10.1016/j.arr.2023.102012","journal":"Ageing research reviews","n_participants":14980,"pmid":"37423541","source_url":"https://pubmed.ncbi.nlm.nih.gov/37423541/","study_design":"meta-analysis","title":"Efficacy and safety of anti-amyloid-\u03b2 monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis","title_match":true,"year":2023},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/high-clearance-anti-amyloid-immunotherapies-in-alzheimer-s-disease-36184326","doi":"10.1016/j.neurol.2022.06.012","journal":"Revue neurologique","n_participants":null,"pmid":"36184326","source_url":"https://pubmed.ncbi.nlm.nih.gov/36184326/","study_design":"meta-analysis","title":"High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects","title_match":false,"year":2022},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/anti-a-autoantibodies-in-amyloid-related-imaging-abnormalities-aria-26441825","doi":"10.3389/fneur.2015.00207","journal":"Frontiers in neurology","n_participants":null,"pmid":"26441825","source_url":"https://pubmed.ncbi.nlm.nih.gov/26441825/","study_design":null,"title":"Anti-A\u03b2 Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy","title_match":false,"year":2015},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/donanemab-for-alzheimer-s-disease-a-systematic-review-of-clinical-36611492","doi":"10.3390/healthcare11010032","journal":"Healthcare (Basel, Switzerland)","n_participants":396,"pmid":"36611492","source_url":"https://pubmed.ncbi.nlm.nih.gov/36611492/","study_design":"systematic review","title":"Donanemab for Alzheimer's Disease: A Systematic Review of Clinical Trials","title_match":true,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/donanemab-population-pharmacokinetics-amyloid-plaque-reduction-and-36805552","doi":"10.1002/cpt.2875","journal":"Clinical pharmacology and therapeutics","n_participants":null,"pmid":"36805552","source_url":"https://pubmed.ncbi.nlm.nih.gov/36805552/","study_design":null,"title":"Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-anti-amyloid-immunotherapy-in-alzheimer-s-28025724","doi":"10.1007/s11481-016-9722-5","journal":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","n_participants":5554,"pmid":"28025724","source_url":"https://pubmed.ncbi.nlm.nih.gov/28025724/","study_design":null,"title":"Safety and Efficacy of Anti-Amyloid-\u03b2 Immunotherapy in Alzheimer's Disease: A Systematic Review and Meta-Analysis","title_match":false,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-haemosiderin-aria-h-in-patients-25669746","doi":"10.1136/jnnp-2014-309493","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":262,"pmid":"25669746","source_url":"https://pubmed.ncbi.nlm.nih.gov/25669746/","study_design":"open-label trial","title":"Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis","title_match":false,"year":2016},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/three-major-effects-of-apoe-4-on-a-immunotherapy-induced-aria-38756535","doi":"10.3389/fnagi.2024.1412006","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"38756535","source_url":"https://pubmed.ncbi.nlm.nih.gov/38756535/","study_design":null,"title":"Three major effects of APOE \u03b54 on A\u03b2 immunotherapy induced ARIA","title_match":false,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/amyloid-beta-antibody-binding-to-cerebral-amyloid-angiopathy-fibrils-38740836","doi":"10.1038/s41598-024-61691-2","journal":"Scientific reports","n_participants":null,"pmid":"38740836","source_url":"https://pubmed.ncbi.nlm.nih.gov/38740836/","study_design":null,"title":"Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities","title_match":false,"year":2024},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/central-review-of-amyloid-related-imaging-abnormalities-in-two-phase-28269765","doi":"10.3233/jad-160216","journal":"Journal of Alzheimer's disease : JAD","n_participants":242,"pmid":"28269765","source_url":"https://pubmed.ncbi.nlm.nih.gov/28269765/","study_design":null,"title":"Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients","title_match":true,"year":2017},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/the-future-of-anti-amyloid-trials-32463066","doi":"10.14283/jpad.2020.24","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"32463066","source_url":"https://pubmed.ncbi.nlm.nih.gov/32463066/","study_design":null,"title":"The Future of Anti-Amyloid Trials","title_match":false,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/critical-assessment-of-anti-amyloid-monoclonal-antibodies-effects-in-39468148","doi":"10.1038/s41598-024-75204-8","journal":"Scientific reports","n_participants":null,"pmid":"39468148","source_url":"https://pubmed.ncbi.nlm.nih.gov/39468148/","study_design":"systematic review","title":"Critical assessment of anti-amyloid-\u03b2 monoclonal antibodies effects in Alzheimer's disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness","title_match":false,"year":2024},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/a-immunotherapy-for-alzheimer-s-disease-effects-on-apoe-and-cerebral-25195061","doi":"10.1007/s00401-014-1340-9","journal":"Acta neuropathologica","n_participants":null,"pmid":"25195061","source_url":"https://pubmed.ncbi.nlm.nih.gov/25195061/","study_design":null,"title":"A\u03b2 immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy","title_match":false,"year":2014},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/an-mri-rating-scale-for-amyloid-related-imaging-abnormalities-with-23436056","doi":"10.3174/ajnr.a3475","journal":"AJNR. American journal of neuroradiology","n_participants":20,"pmid":"23436056","source_url":"https://pubmed.ncbi.nlm.nih.gov/23436056/","study_design":null,"title":"An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion","title_match":false,"year":2013},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/safety-tolerability-and-pharmacokinetics-of-crenezumab-in-patients-32568196","doi":"10.3233/jad-200134","journal":"Journal of Alzheimer's disease : JAD","n_participants":21,"pmid":"32568196","source_url":"https://pubmed.ncbi.nlm.nih.gov/32568196/","study_design":"open-label trial","title":"Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks","title_match":false,"year":2020},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-from-trials-of-solanezumab-for-27239538","doi":"10.1016/j.dadm.2016.02.004","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":2042,"pmid":"27239538","source_url":"https://pubmed.ncbi.nlm.nih.gov/27239538/","study_design":"open-label trial","title":"Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-lecanemab-for-alzheimer-s-disease-a-systematic-37213538","doi":"10.3389/fnagi.2023.1169499","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"37213538","source_url":"https://pubmed.ncbi.nlm.nih.gov/37213538/","study_design":"systematic review","title":"Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials","title_match":true,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/lecanemab-for-early-alzheimer-s-disease-appropriate-use-40011173","doi":"10.1016/j.tjpad.2025.100094","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"40011173","source_url":"https://pubmed.ncbi.nlm.nih.gov/40011173/","study_design":null,"title":"Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-aria-in-immunotherapy-trials-27031492","doi":"10.3233/jad-160122","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"27031492","source_url":"https://pubmed.ncbi.nlm.nih.gov/27031492/","study_design":"clinical trial","title":"Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?","title_match":false,"year":2016},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/implications-of-the-approval-of-lecanemab-for-alzheimer-disease-37295957","doi":"10.1212/wnl.0000000000207438","journal":"Neurology","n_participants":null,"pmid":"37295957","source_url":"https://pubmed.ncbi.nlm.nih.gov/37295957/","study_design":"clinical trial","title":"Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift?","title_match":false,"year":2023},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/effects-of-oral-alz-801-valiltramiprosate-on-plasma-biomarkers-brain-38902571","doi":"10.1007/s40265-024-02067-8","journal":"Drugs","n_participants":80,"pmid":"38902571","source_url":"https://pubmed.ncbi.nlm.nih.gov/38902571/","study_design":"clinical trial","title":"Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease","title_match":true,"year":2024},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/comparative-efficacy-and-safety-of-monoclonal-antibodies-for-38429615","doi":"10.1007/s40263-024-01067-2","journal":"CNS drugs","n_participants":21087,"pmid":"38429615","source_url":"https://pubmed.ncbi.nlm.nih.gov/38429615/","study_design":"meta-analysis","title":"Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer's Disease: A Systematic Review and Network Meta-Analysis","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/clinical-evaluation-of-amyloid-related-imaging-abnormalities-in-30412493","doi":"10.3233/jad-180675","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30412493","source_url":"https://pubmed.ncbi.nlm.nih.gov/30412493/","study_design":null,"title":"Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies","title_match":true,"year":2018},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-active-and-passive-immunotherapy-in-mild-to-30904037","doi":"10.25011/cim.v42i1.32393","journal":"Clinical and investigative medicine. Medecine clinique et experimentale","n_participants":null,"pmid":"30904037","source_url":"https://pubmed.ncbi.nlm.nih.gov/30904037/","study_design":"systematic review","title":"Safety and efficacy of active and passive immunotherapy in mild-to-moderate Alzheimer's disease: A systematic review and network meta-analysis","title_match":false,"year":2019},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/monoclonal-therapy-with-lecanemab-in-the-treatment-of-mild-alzheimer-39638097","doi":"10.1016/j.arr.2024.102620","journal":"Ageing research reviews","n_participants":null,"pmid":"39638097","source_url":"https://pubmed.ncbi.nlm.nih.gov/39638097/","study_design":"systematic review","title":"Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis","title_match":false,"year":2025},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/first-administration-of-the-fc-attenuated-anti-amyloid-antibody-25789616","doi":"10.1371/journal.pone.0098153","journal":"PloS one","n_participants":18,"pmid":"25789616","source_url":"https://pubmed.ncbi.nlm.nih.gov/25789616/","study_design":"open-label trial","title":"First administration of the Fc-attenuated anti-\u03b2 amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study","title_match":true,"year":2015},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/chronic-verubecestat-treatment-suppresses-amyloid-accumulation-in-28800329","doi":"10.3233/jad-170056","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"28800329","source_url":"https://pubmed.ncbi.nlm.nih.gov/28800329/","study_design":"longitudinal study","title":"Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-A\u03b2PPswe Mice Without Inducing Microhemorrhage","title_match":false,"year":2017},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-in-an-aged-squirrel-monkey-with-28269776","doi":"10.3233/jad-160981","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"28269776","source_url":"https://pubmed.ncbi.nlm.nih.gov/28269776/","study_design":null,"title":"Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy","title_match":false,"year":2017},{"alzhub_score":88,"alzhub_url":"https://alzhub.org/study/trailblazer-alz-4-a-phase-3-trial-comparing-donanemab-with-aducanumab-40390253","doi":"10.1002/alz.70293","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":148,"pmid":"40390253","source_url":"https://pubmed.ncbi.nlm.nih.gov/40390253/","study_design":"clinical trial","title":"TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/results-from-the-long-term-extension-of-prime-a-randomized-phase-1b-38567735","doi":"10.1002/alz.13755","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38567735","source_url":"https://pubmed.ncbi.nlm.nih.gov/38567735/","study_design":null,"title":"Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab","title_match":true,"year":2024},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/long-term-safety-and-efficacy-of-bapineuzumab-in-patients-with-mild-30129411","doi":"10.2174/1567205015666180821114813","journal":"Current Alzheimer research","n_participants":85,"pmid":"30129411","source_url":"https://pubmed.ncbi.nlm.nih.gov/30129411/","study_design":"clinical trial","title":"Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension Study","title_match":true,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/a-combined-physiologically-based-pharmacokinetic-and-quantitative-36632701","doi":"10.1002/psp4.12912","journal":"CPT: pharmacometrics & systems pharmacology","n_participants":null,"pmid":"36632701","source_url":"https://pubmed.ncbi.nlm.nih.gov/36632701/","study_design":null,"title":"A combined physiologically-based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-phase-2-study-of-the-effects-of-the-vaccine-29199321","doi":"10.14283/jpad.2016.118","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"29199321","source_url":"https://pubmed.ncbi.nlm.nih.gov/29199321/","study_design":"clinical trial","title":"A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease","title_match":true,"year":2016},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/safety-and-effectiveness-of-the-anti-amyloid-monoclonal-antibody-mab-40051090","doi":"10.1002/bcp.70021","journal":"British journal of clinical pharmacology","n_participants":null,"pmid":"40051090","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051090/","study_design":"narrative review","title":"Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective","title_match":false,"year":2025},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/application-of-meta-analysis-to-evaluate-relationships-among-aria-e-35320578","doi":"10.1007/s43441-022-00390-4","journal":"Therapeutic innovation & regulatory science","n_participants":null,"pmid":"35320578","source_url":"https://pubmed.ncbi.nlm.nih.gov/35320578/","study_design":"meta-analysis","title":"Application of Meta-analysis to Evaluate Relationships Among ARIA-E Rate, Amyloid Reduction Rate, and Clinical Cognitive Response in Amyloid Therapeutic Clinical Trials for Early Alzheimer's Disease","title_match":true,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/population-pharmacokinetics-and-exposure-response-analyses-of-safety-39207112","doi":"10.1002/psp4.13224","journal":"CPT: pharmacometrics & systems pharmacology","n_participants":2641,"pmid":"39207112","source_url":"https://pubmed.ncbi.nlm.nih.gov/39207112/","study_design":null,"title":"Population pharmacokinetics and exposure-response analyses of safety (ARIA-E and isolated ARIA-H) of lecanemab in subjects with early Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/advances-in-amyloid-targeting-monoclonal-antibodies-for-alzheimer-s-37975226","doi":"10.1080/14737175.2023.2284305","journal":"Expert review of neurotherapeutics","n_participants":null,"pmid":"37975226","source_url":"https://pubmed.ncbi.nlm.nih.gov/37975226/","study_design":null,"title":"Advances in amyloid-targeting monoclonal antibodies for Alzheimer's disease: clinical and public health issues","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/disease-modeling-and-model-based-meta-analyses-to-define-a-new-35100444","doi":"10.1002/cpt.2535","journal":"Clinical pharmacology and therapeutics","n_participants":null,"pmid":"35100444","source_url":"https://pubmed.ncbi.nlm.nih.gov/35100444/","study_design":"open-label trial","title":"Disease Modeling and Model-Based Meta-Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's Disease","title_match":true,"year":2022},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/long-term-follow-up-of-patients-with-mild-to-moderate-alzheimer-s-29914022","doi":"10.3233/jad-171157","journal":"Journal of Alzheimer's disease : JAD","n_participants":1462,"pmid":"29914022","source_url":"https://pubmed.ncbi.nlm.nih.gov/29914022/","study_design":null,"title":"Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study","title_match":true,"year":2018},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/clinical-pharmacokinetics-of-oral-alz-801-valiltramiprosate-in-a-2-39907966","doi":"10.1007/s40262-025-01482-8","journal":"Clinical pharmacokinetics","n_participants":24,"pmid":"39907966","source_url":"https://pubmed.ncbi.nlm.nih.gov/39907966/","study_design":"longitudinal study","title":"Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer's Disease","title_match":true,"year":2025},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/the-efficacy-and-safety-of-lecanemab-10-mg-kg-biweekly-compared-to-a-38565747","doi":"10.1007/s10072-024-07477-w","journal":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","n_participants":null,"pmid":"38565747","source_url":"https://pubmed.ncbi.nlm.nih.gov/38565747/","study_design":"systematic review","title":"The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials","title_match":true,"year":2024},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/use-of-lecanemab-for-the-treatment-of-alzheimer-s-disease-a-38867460","doi":"10.1002/brb3.3592","journal":"Brain and behavior","n_participants":null,"pmid":"38867460","source_url":"https://pubmed.ncbi.nlm.nih.gov/38867460/","study_design":"meta-analysis","title":"Use of lecanemab for the treatment of Alzheimer's disease: A systematic review","title_match":false,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/lecanemab-a-second-in-class-therapy-for-the-management-of-early-38779110","doi":"10.24926/iip.v15i1.5787","journal":"Innovations in pharmacy","n_participants":null,"pmid":"38779110","source_url":"https://pubmed.ncbi.nlm.nih.gov/38779110/","study_design":null,"title":"Lecanemab: A Second in Class Therapy for the Management of Early Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-and-other-mri-findings-in-a-36281665","doi":"10.14283/jpad.2022.56","journal":"The journal of prevention of Alzheimer's disease","n_participants":1250,"pmid":"36281665","source_url":"https://pubmed.ncbi.nlm.nih.gov/36281665/","study_design":"cross-sectional","title":"Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid","title_match":false,"year":2022},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/aducanumab-for-alzheimer-s-disease-summarized-data-from-emerge-engage-35879846","doi":"10.4140/tcp.n.2022.329","journal":"The Senior care pharmacist","n_participants":null,"pmid":"35879846","source_url":"https://pubmed.ncbi.nlm.nih.gov/35879846/","study_design":"clinical trial","title":"Aducanumab for Alzheimer's Disease: Summarized Data From EMERGE, ENGAGE, and PRIME Studies","title_match":false,"year":2022},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-the-efficacy-and-safety-of-anti-amyloid-40621323","doi":"10.7759/cureus.85377","journal":"Cureus","n_participants":null,"pmid":"40621323","source_url":"https://pubmed.ncbi.nlm.nih.gov/40621323/","study_design":"systematic review","title":"A Systematic Review of the Efficacy and Safety of Anti-amyloid Monoclonal Antibodies in Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/greater-white-matter-hyperintensity-volume-is-associated-with-the-39044495","doi":"10.14283/jpad.2024.139","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"39044495","source_url":"https://pubmed.ncbi.nlm.nih.gov/39044495/","study_design":"longitudinal study","title":"Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/new-developments-of-clinical-trial-in-immunotherapy-for-alzheimer-s-25860060","doi":"10.2174/138920101606150407112319","journal":"Current pharmaceutical biotechnology","n_participants":null,"pmid":"25860060","source_url":"https://pubmed.ncbi.nlm.nih.gov/25860060/","study_design":"clinical trial","title":"New developments of clinical trial in immunotherapy for Alzheimer's disease","title_match":true,"year":2015},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/a-real-world-disproportionality-analysis-of-fda-adverse-event-40242445","doi":"10.3389/fphar.2025.1559447","journal":"Frontiers in pharmacology","n_participants":811,"pmid":"40242445","source_url":"https://pubmed.ncbi.nlm.nih.gov/40242445/","study_design":"clinical trial","title":"A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/quantitative-systems-pharmacology-based-exploration-of-relevant-anti-38774587","doi":"10.1002/trc2.12474","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"38774587","source_url":"https://pubmed.ncbi.nlm.nih.gov/38774587/","study_design":null,"title":"Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practice","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/more-failure-with-solanezumab-this-time-in-preclinical-alzheimer-s-38414336","doi":"10.1080/14712598.2024.2325551","journal":"Expert opinion on biological therapy","n_participants":null,"pmid":"38414336","source_url":"https://pubmed.ncbi.nlm.nih.gov/38414336/","study_design":"clinical trial","title":"More failure with solanezumab - this time in preclinical Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-and-epilepsy-shared-neuropathology-guides-current-37936917","doi":"10.3389/fneur.2023.1241339","journal":"Frontiers in neurology","n_participants":null,"pmid":"37936917","source_url":"https://pubmed.ncbi.nlm.nih.gov/37936917/","study_design":null,"title":"Alzheimer's disease and epilepsy: shared neuropathology guides current and future treatment strategies","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/review-of-anti-amyloid-beta-a-monoclonal-antibodies-for-the-treatment-40940304","doi":"10.1080/17512433.2025.2556122","journal":"Expert review of clinical pharmacology","n_participants":null,"pmid":"40940304","source_url":"https://pubmed.ncbi.nlm.nih.gov/40940304/","study_design":null,"title":"Review of anti-amyloid-beta (A\u03b2) monoclonal antibodies for the treatment of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/japanese-subgroup-analyses-from-emerge-and-engage-phase-3-clinical-39350371","doi":"10.14283/jpad.2024.106","journal":"The journal of prevention of Alzheimer's disease","n_participants":121,"pmid":"39350371","source_url":"https://pubmed.ncbi.nlm.nih.gov/39350371/","study_design":"clinical trial","title":"Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease","title_match":true,"year":2024},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/mri-in-the-new-era-of-antiamyloid-mabs-for-the-treatment-of-alzheimer-37382144","doi":"10.1097/wco.0000000000001177","journal":"Current opinion in neurology","n_participants":null,"pmid":"37382144","source_url":"https://pubmed.ncbi.nlm.nih.gov/37382144/","study_design":null,"title":"MRI in the new era of antiamyloid mAbs for the treatment of Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-value-of-subtraction-mri-in-detection-of-amyloid-related-imaging-28956123","doi":"10.1007/s00330-017-5022-6","journal":"European radiology","n_participants":75,"pmid":"28956123","source_url":"https://pubmed.ncbi.nlm.nih.gov/28956123/","study_design":null,"title":"The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study","title_match":false,"year":2018},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/efficacy-and-apoe-4-stratified-risk-of-donanemab-in-alzheimer-s-40692324","doi":"10.1177/13872877251361044","journal":"Journal of Alzheimer's disease : JAD","n_participants":2054,"pmid":"40692324","source_url":"https://pubmed.ncbi.nlm.nih.gov/40692324/","study_design":"systematic review","title":"Efficacy and APOE \u03b54-stratified risk of donanemab in Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials","title_match":true,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/pet-ct-mri-in-clinical-trials-of-alzheimer-s-disease-39422954","doi":"10.3233/jad-240206","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"39422954","source_url":"https://pubmed.ncbi.nlm.nih.gov/39422954/","study_design":null,"title":"PET/CT/MRI in Clinical Trials of Alzheimer's Disease","title_match":true,"year":2024},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/apoe-4-allele-s-associated-adverse-events-reported-from-placebo-arm-39081988","doi":"10.3389/frdem.2023.1320329","journal":"Frontiers in dementia","n_participants":6313,"pmid":"39081988","source_url":"https://pubmed.ncbi.nlm.nih.gov/39081988/","study_design":null,"title":"APOE -\u03b54 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy","title_match":true,"year":2023},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/fda-approved-passive-immunization-treatments-against-a-in-alzheimer-s-41596530","doi":"10.3390/ijms27020883","journal":"International journal of molecular sciences","n_participants":null,"pmid":"41596530","source_url":"https://pubmed.ncbi.nlm.nih.gov/41596530/","study_design":null,"title":"FDA-Approved Passive Immunization Treatments Against A\u03b2 in Alzheimer's Disease: Where Are We Now?","title_match":false,"year":2026},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/influence-of-patient-characteristics-on-efficacy-and-safety-of-anti-41352683","doi":"10.1016/j.arr.2025.102981","journal":"Ageing research reviews","n_participants":5633,"pmid":"41352683","source_url":"https://pubmed.ncbi.nlm.nih.gov/41352683/","study_design":"systematic review","title":"Influence of patient characteristics on efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer's disease: A systematic review and meta-analysis","title_match":false,"year":2026},{"alzhub_score":89,"alzhub_url":"https://alzhub.org/study/safety-tolerability-immunogenicity-and-efficacy-of-abvac40-active-41058018","doi":"10.1002/alz.70776","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":124,"pmid":"41058018","source_url":"https://pubmed.ncbi.nlm.nih.gov/41058018/","study_design":"clinical trial","title":"Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against A\u03b240 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study","title_match":true,"year":2025},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/oral-pri-002-treatment-in-patients-with-mci-or-mild-ad-a-randomized-40324978","doi":"10.1038/s41467-025-59295-z","journal":"Nature communications","n_participants":20,"pmid":"40324978","source_url":"https://pubmed.ncbi.nlm.nih.gov/40324978/","study_design":null,"title":"Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trial","title_match":true,"year":2025},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/exploring-the-efficacy-and-safety-of-lecanemab-in-the-management-of-40232258","doi":"10.1177/13872877251331640","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"40232258","source_url":"https://pubmed.ncbi.nlm.nih.gov/40232258/","study_design":"clinical trial","title":"Exploring the efficacy and safety of lecanemab in the management of early Alzheimer's disease: A systematic review of clinical evidence","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/profiling-aducanumab-as-a-treatment-option-for-alzheimer-s-disease-an-39291991","doi":"10.1080/14737175.2024.2402058","journal":"Expert review of neurotherapeutics","n_participants":null,"pmid":"39291991","source_url":"https://pubmed.ncbi.nlm.nih.gov/39291991/","study_design":null,"title":"Profiling aducanumab as a treatment option for Alzheimer's disease: an overview of efficacy, safety and tolerability","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/anti-amyloid-monoclonal-antibody-therapies-in-alzheimer-s-disease-a-41077117","doi":"10.1016/j.neuroscience.2025.10.011","journal":"Neuroscience","n_participants":null,"pmid":"41077117","source_url":"https://pubmed.ncbi.nlm.nih.gov/41077117/","study_design":null,"title":"Anti-amyloid monoclonal antibody therapies in Alzheimer's disease - a scoping review","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/practical-brain-mri-guidelines-for-anti-a-antibody-treatment-in-early-40266549","doi":"10.1007/s11604-025-01773-x","journal":"Japanese journal of radiology","n_participants":null,"pmid":"40266549","source_url":"https://pubmed.ncbi.nlm.nih.gov/40266549/","study_design":null,"title":"Practical brain MRI guidelines for anti-A\u03b2 antibody treatment in early symptomatic Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/long-term-safety-of-gantenerumab-in-participants-with-alzheimer-s-39177596","doi":"10.3233/jad-240221","journal":"Journal of Alzheimer's disease : JAD","n_participants":225,"pmid":"39177596","source_url":"https://pubmed.ncbi.nlm.nih.gov/39177596/","study_design":"open-label trial","title":"Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)","title_match":true,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-black-book-of-psychotropic-dosing-and-monitoring-38993656","doi":"10.64719/pb.4493","journal":"Psychopharmacology bulletin","n_participants":407,"pmid":"38993656","source_url":"https://pubmed.ncbi.nlm.nih.gov/38993656/","study_design":"clinical trial","title":"The Black Book of Psychotropic Dosing and Monitoring","title_match":false,"year":2024},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/real-world-experience-with-baseline-characteristics-and-safety-of-41396015","doi":"10.1177/13872877251406619","journal":"Journal of Alzheimer's disease : JAD","n_participants":190,"pmid":"41396015","source_url":"https://pubmed.ncbi.nlm.nih.gov/41396015/","study_design":null,"title":"Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China","title_match":false,"year":2026},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/higher-phosphorylated-tau-levels-predict-cognitive-decline-and-41276859","doi":"10.1186/s13195-025-01912-6","journal":"Alzheimer's research & therapy","n_participants":234,"pmid":"41276859","source_url":"https://pubmed.ncbi.nlm.nih.gov/41276859/","study_design":"longitudinal study","title":"Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/tau-targeting-therapies-for-alzheimer-disease-29895964","doi":"10.1038/s41582-018-0013-z","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"29895964","source_url":"https://pubmed.ncbi.nlm.nih.gov/29895964/","study_design":null,"title":"Tau-targeting therapies for Alzheimer disease","title_match":false,"year":2018},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-tau-aggregation-inhibitor-therapy-in-patients-27863809","doi":"10.1016/s0140-6736(16)31275-2","journal":"Lancet (London, England)","n_participants":354,"pmid":"27863809","source_url":"https://pubmed.ncbi.nlm.nih.gov/27863809/","study_design":null,"title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","title_match":true,"year":2016},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/tau-targeting-therapies-for-alzheimer-disease-current-status-and-37875627","doi":"10.1038/s41582-023-00883-2","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"37875627","source_url":"https://pubmed.ncbi.nlm.nih.gov/37875627/","study_design":null,"title":"Tau-targeting therapies for Alzheimer disease: current status and future directions","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/amyloid-beta-peptide-and-tau-protein-crosstalk-in-alzheimer-s-disease-35017413","doi":"10.4103/1673-5374.332127","journal":"Neural regeneration research","n_participants":null,"pmid":"35017413","source_url":"https://pubmed.ncbi.nlm.nih.gov/35017413/","study_design":null,"title":"Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/tau-immunotherapy-for-alzheimer-s-disease-25846560","doi":"10.1016/j.molmed.2015.03.003","journal":"Trends in molecular medicine","n_participants":null,"pmid":"25846560","source_url":"https://pubmed.ncbi.nlm.nih.gov/25846560/","study_design":null,"title":"Tau immunotherapy for Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/don-t-phos-over-tau-recent-developments-in-clinical-biomarkers-and-34090488","doi":"10.1186/s13024-021-00460-5","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"34090488","source_url":"https://pubmed.ncbi.nlm.nih.gov/34090488/","study_design":null,"title":"\"Don't Phos Over Tau\": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies","title_match":false,"year":2021},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/development-of-tau-aggregation-inhibitors-for-alzheimer-s-disease-19189357","doi":"10.1002/anie.200802621","journal":"Angewandte Chemie (International ed. in English)","n_participants":null,"pmid":"19189357","source_url":"https://pubmed.ncbi.nlm.nih.gov/19189357/","study_design":null,"title":"Development of tau aggregation inhibitors for Alzheimer's disease","title_match":false,"year":2009},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/tau-targeted-multifunctional-nanocomposite-for-combinational-therapy-29364648","doi":"10.1021/acsnano.7b07625","journal":"ACS nano","n_participants":null,"pmid":"29364648","source_url":"https://pubmed.ncbi.nlm.nih.gov/29364648/","study_design":null,"title":"Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer's Disease","title_match":false,"year":2018},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/suppression-of-mutant-c9orf72-expression-by-a-potent-mixed-backbone-34949835","doi":"10.1038/s41591-021-01557-6","journal":"Nature medicine","n_participants":null,"pmid":"34949835","source_url":"https://pubmed.ncbi.nlm.nih.gov/34949835/","study_design":null,"title":"Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide","title_match":false,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/from-the-prion-like-propagation-hypothesis-to-therapeutic-strategies-31686182","doi":"10.1007/s00401-019-02087-9","journal":"Acta neuropathologica","n_participants":null,"pmid":"31686182","source_url":"https://pubmed.ncbi.nlm.nih.gov/31686182/","study_design":null,"title":"From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy","title_match":false,"year":2020},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/tau-centric-targets-and-drugs-in-clinical-development-for-the-27429978","doi":"10.1155/2016/3245935","journal":"BioMed research international","n_participants":321,"pmid":"27429978","source_url":"https://pubmed.ncbi.nlm.nih.gov/27429978/","study_design":null,"title":"Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease","title_match":false,"year":2016},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/preclinical-and-clinical-development-of-abbv-8e12-a-humanized-anti-29181488","doi":"10.14283/jpad.2017.36","journal":"The journal of prevention of Alzheimer's disease","n_participants":30,"pmid":"29181488","source_url":"https://pubmed.ncbi.nlm.nih.gov/29181488/","study_design":"clinical trial","title":"Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies","title_match":false,"year":2017},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/complex-disposition-of-methylthioninium-redox-forms-determines-25320049","doi":"10.1124/jpet.114.219352","journal":"The Journal of pharmacology and experimental therapeutics","n_participants":null,"pmid":"25320049","source_url":"https://pubmed.ncbi.nlm.nih.gov/25320049/","study_design":"clinical trial","title":"Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/current-status-of-clinical-trials-on-tau-immunotherapies-34101156","doi":"10.1007/s40265-021-01546-6","journal":"Drugs","n_participants":null,"pmid":"34101156","source_url":"https://pubmed.ncbi.nlm.nih.gov/34101156/","study_design":null,"title":"Current Status of Clinical Trials on Tau Immunotherapies","title_match":true,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/acute-tau-knockdown-in-the-hippocampus-of-adult-mice-causes-learning-29749079","doi":"10.1111/acel.12775","journal":"Aging cell","n_participants":null,"pmid":"29749079","source_url":"https://pubmed.ncbi.nlm.nih.gov/29749079/","study_design":null,"title":"Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits","title_match":false,"year":2018},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/antibody-semorinemab-reduces-tau-pathology-in-a-transgenic-mouse-33980574","doi":"10.1126/scitranslmed.abb2639","journal":"Science translational medicine","n_participants":null,"pmid":"33980574","source_url":"https://pubmed.ncbi.nlm.nih.gov/33980574/","study_design":"clinical trial","title":"Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/amyloid-beta-aggregation-implicates-multiple-pathways-in-alzheimer-s-37113145","doi":"10.3389/fnins.2023.1081938","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"37113145","source_url":"https://pubmed.ncbi.nlm.nih.gov/37113145/","study_design":null,"title":"Amyloid-beta aggregation implicates multiple pathways in Alzheimer's disease: Understanding the mechanisms","title_match":false,"year":2023},{"alzhub_score":88,"alzhub_url":"https://alzhub.org/study/tango-a-placebo-controlled-randomized-phase-2-study-of-efficacy-and-38012285","doi":"10.1038/s43587-023-00523-w","journal":"Nature aging","n_participants":654,"pmid":"38012285","source_url":"https://pubmed.ncbi.nlm.nih.gov/38012285/","study_design":null,"title":"TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease","title_match":true,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/active-immunotherapy-options-for-alzheimer-s-disease-24476230","doi":"10.1186/alzrt237","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"24476230","source_url":"https://pubmed.ncbi.nlm.nih.gov/24476230/","study_design":null,"title":"Active immunotherapy options for Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/in-alzheimer-s-disease-6-month-treatment-with-glp-1-analog-prevents-27252647","doi":"10.3389/fnagi.2016.00108","journal":"Frontiers in aging neuroscience","n_participants":18,"pmid":"27252647","source_url":"https://pubmed.ncbi.nlm.nih.gov/27252647/","study_design":null,"title":"In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial","title_match":true,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-glucagon-like-peptide-1-glp-receptor-as-a-therapeutic-target-in-26851597","doi":"10.1016/j.drudis.2016.01.013","journal":"Drug discovery today","n_participants":null,"pmid":"26851597","source_url":"https://pubmed.ncbi.nlm.nih.gov/26851597/","study_design":"open-label trial","title":"The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action","title_match":false,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/protection-and-reversal-of-excitotoxic-neuronal-damage-by-glucagon-12183643","doi":"10.1124/jpet.102.037481","journal":"The Journal of pharmacology and experimental therapeutics","n_participants":null,"pmid":"12183643","source_url":"https://pubmed.ncbi.nlm.nih.gov/12183643/","study_design":null,"title":"Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4","title_match":false,"year":2002},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/liraglutide-can-reverse-memory-impairment-synaptic-loss-and-reduce-23973293","doi":"10.1016/j.neuropharm.2013.08.005","journal":"Neuropharmacology","n_participants":null,"pmid":"23973293","source_url":"https://pubmed.ncbi.nlm.nih.gov/23973293/","study_design":null,"title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/glucagon-like-peptide-1-glp-1-receptor-agonists-and-neuroinflammation-36372278","doi":"10.1016/j.phrs.2022.106550","journal":"Pharmacological research","n_participants":null,"pmid":"36372278","source_url":"https://pubmed.ncbi.nlm.nih.gov/36372278/","study_design":null,"title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment","title_match":false,"year":2022},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/central-effects-of-glp-1-new-opportunities-for-treatments-of-23999914","doi":"10.1530/joe-13-0221","journal":"The Journal of endocrinology","n_participants":null,"pmid":"23999914","source_url":"https://pubmed.ncbi.nlm.nih.gov/23999914/","study_design":null,"title":"Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases","title_match":false,"year":2014},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/a-novel-neurotrophic-property-of-glucagon-like-peptide-1-a-promoter-11861804","doi":"10.1124/jpet.300.3.958","journal":"The Journal of pharmacology and experimental therapeutics","n_participants":null,"pmid":"11861804","source_url":"https://pubmed.ncbi.nlm.nih.gov/11861804/","study_design":null,"title":"A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells","title_match":false,"year":2002},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/motor-and-cognitive-advantages-persist-12-months-after-exenatide-24662192","doi":"10.3233/jpd-140364","journal":"Journal of Parkinson's disease","n_participants":20,"pmid":"24662192","source_url":"https://pubmed.ncbi.nlm.nih.gov/24662192/","study_design":"randomized controlled trial","title":"Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/link-between-type-2-diabetes-and-alzheimer-s-disease-from-25792818","doi":"10.2147/cia.s74042","journal":"Clinical interventions in aging","n_participants":null,"pmid":"25792818","source_url":"https://pubmed.ncbi.nlm.nih.gov/25792818/","study_design":null,"title":"Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment","title_match":false,"year":2015},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/neuroprotective-effects-of-lixisenatide-and-liraglutide-in-the-1-26141845","doi":"10.1016/j.neuroscience.2015.06.054","journal":"Neuroscience","n_participants":null,"pmid":"26141845","source_url":"https://pubmed.ncbi.nlm.nih.gov/26141845/","study_design":null,"title":"Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","title_match":false,"year":2015},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/evaluating-the-effects-of-the-novel-glp-1-analogue-liraglutide-in-30944040","doi":"10.1186/s13063-019-3259-x","journal":"Trials","n_participants":206,"pmid":"30944040","source_url":"https://pubmed.ncbi.nlm.nih.gov/30944040/","study_design":null,"title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)","title_match":true,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/insulin-igf-1-and-glp-1-signaling-in-neurodegenerative-disorders-24582776","doi":"10.1016/j.pneurobio.2014.02.005","journal":"Progress in neurobiology","n_participants":null,"pmid":"24582776","source_url":"https://pubmed.ncbi.nlm.nih.gov/24582776/","study_design":null,"title":"Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?","title_match":false,"year":2014},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/treatment-with-glucagon-like-peptide-1-receptor-agonists-and-35229024","doi":"10.1002/trc2.12268","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":15820,"pmid":"35229024","source_url":"https://pubmed.ncbi.nlm.nih.gov/35229024/","study_design":null,"title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","title_match":true,"year":2022},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/potential-role-of-glucagon-like-peptide-1-glp-1-in-neuroprotection-22938097","doi":"10.2165/11635890-000000000-00000","journal":"CNS drugs","n_participants":null,"pmid":"22938097","source_url":"https://pubmed.ncbi.nlm.nih.gov/22938097/","study_design":null,"title":"Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection","title_match":false,"year":2012},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/novel-dual-glp-1-gip-receptor-agonists-show-neuroprotective-effects-29402504","doi":"10.1016/j.neuropharm.2018.01.040","journal":"Neuropharmacology","n_participants":null,"pmid":"29402504","source_url":"https://pubmed.ncbi.nlm.nih.gov/29402504/","study_design":null,"title":"Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models","title_match":false,"year":2018},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/brain-insulin-resistance-role-in-neurodegenerative-disease-and-32175781","doi":"10.1080/13543784.2020.1738383","journal":"Expert opinion on investigational drugs","n_participants":null,"pmid":"32175781","source_url":"https://pubmed.ncbi.nlm.nih.gov/32175781/","study_design":null,"title":"Brain insulin resistance: role in neurodegenerative disease and potential for targeting","title_match":false,"year":2020},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-pilot-study-of-exenatide-actions-in-alzheimer-s-disease-31518224","doi":"10.2174/1567205016666190913155950","journal":"Current Alzheimer research","n_participants":null,"pmid":"31518224","source_url":"https://pubmed.ncbi.nlm.nih.gov/31518224/","study_design":null,"title":"A Pilot Study of Exenatide Actions in Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/neuroprotective-and-anti-apoptotic-effects-of-liraglutide-on-sh-sy5y-24112036","doi":"10.1111/jnc.12469","journal":"Journal of neurochemistry","n_participants":null,"pmid":"24112036","source_url":"https://pubmed.ncbi.nlm.nih.gov/24112036/","study_design":null,"title":"Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress","title_match":false,"year":2014},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-extra-pancreatic-effects-of-glp-1-receptor-agonists-a-focus-on-24373150","doi":"10.1111/dom.12251","journal":"Diabetes, obesity & metabolism","n_participants":null,"pmid":"24373150","source_url":"https://pubmed.ncbi.nlm.nih.gov/24373150/","study_design":null,"title":"The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems","title_match":false,"year":2014},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/neural-correlates-of-liraglutide-effects-in-persons-at-risk-for-30099030","doi":"10.1016/j.bbr.2018.08.006","journal":"Behavioural brain research","n_participants":null,"pmid":"30099030","source_url":"https://pubmed.ncbi.nlm.nih.gov/30099030/","study_design":null,"title":"Neural correlates of liraglutide effects in persons at risk for Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/a-new-treatment-strategy-for-parkinson-s-disease-through-the-gut-29113464","doi":"10.1177/0963689717721234","journal":"Cell transplantation","n_participants":null,"pmid":"29113464","source_url":"https://pubmed.ncbi.nlm.nih.gov/29113464/","study_design":null,"title":"A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway","title_match":false,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/incretin-and-insulin-signaling-as-novel-therapeutic-targets-for-36258018","doi":"10.1038/s41380-022-01792-4","journal":"Molecular psychiatry","n_participants":null,"pmid":"36258018","source_url":"https://pubmed.ncbi.nlm.nih.gov/36258018/","study_design":"clinical trial","title":"Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease","title_match":false,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/protective-properties-of-glp-1-and-associated-peptide-hormones-in-33900631","doi":"10.1111/bph.15508","journal":"British journal of pharmacology","n_participants":null,"pmid":"33900631","source_url":"https://pubmed.ncbi.nlm.nih.gov/33900631/","study_design":null,"title":"Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders","title_match":false,"year":2022},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/diabetes-as-a-risk-factor-for-alzheimer-s-disease-insulin-signalling-21787319","doi":"10.1042/bst0390891","journal":"Biochemical Society transactions","n_participants":null,"pmid":"21787319","source_url":"https://pubmed.ncbi.nlm.nih.gov/21787319/","study_design":null,"title":"Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease","title_match":false,"year":2011},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/glp-1-s-role-in-neuroprotection-a-systematic-review-30938196","doi":"10.1080/02699052.2019.1587000","journal":"Brain injury","n_participants":null,"pmid":"30938196","source_url":"https://pubmed.ncbi.nlm.nih.gov/30938196/","study_design":"systematic review","title":"GLP-1's role in neuroprotection: a systematic review","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/prophylactic-liraglutide-treatment-prevents-amyloid-plaque-deposition-26205827","doi":"10.1016/j.bbr.2015.07.024","journal":"Behavioural brain research","n_participants":null,"pmid":"26205827","source_url":"https://pubmed.ncbi.nlm.nih.gov/26205827/","study_design":null,"title":"Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice","title_match":false,"year":2015},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/crosstalk-between-diabetes-and-brain-glucagon-like-peptide-1-mimetics-23314196","doi":"10.1016/j.bbadis.2013.01.008","journal":"Biochimica et biophysica acta","n_participants":null,"pmid":"23314196","source_url":"https://pubmed.ncbi.nlm.nih.gov/23314196/","study_design":null,"title":"Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration","title_match":false,"year":2013},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-incretin-hormones-glucagonlike-peptide-1-and-glucose-dependent-24529525","doi":"10.1016/j.jalz.2013.12.009","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"24529525","source_url":"https://pubmed.ncbi.nlm.nih.gov/24529525/","study_design":null,"title":"The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-mechanism-and-efficacy-of-glp-1-receptor-agonists-in-the-36465634","doi":"10.3389/fendo.2022.1033479","journal":"Frontiers in endocrinology","n_participants":null,"pmid":"36465634","source_url":"https://pubmed.ncbi.nlm.nih.gov/36465634/","study_design":null,"title":"The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/insulin-signaling-impairment-in-the-brain-as-a-risk-factor-in-31068799","doi":"10.3389/fnagi.2019.00088","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"31068799","source_url":"https://pubmed.ncbi.nlm.nih.gov/31068799/","study_design":null,"title":"Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/therapeutic-potential-of-semaglutide-a-newer-glp-1-receptor-agonist-35650449","doi":"10.1007/s11095-022-03302-1","journal":"Pharmaceutical research","n_participants":null,"pmid":"35650449","source_url":"https://pubmed.ncbi.nlm.nih.gov/35650449/","study_design":null,"title":"Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review","title_match":false,"year":2022},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/comparative-efficacy-and-acceptability-of-antidiabetic-agents-for-29790638","doi":"10.1111/dom.13373","journal":"Diabetes, obesity & metabolism","n_participants":4855,"pmid":"29790638","source_url":"https://pubmed.ncbi.nlm.nih.gov/29790638/","study_design":"meta-analysis","title":"Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis","title_match":false,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/insulin-resistance-and-exendin-4-treatment-for-multiple-system-atrophy-28334990","doi":"10.1093/brain/awx044","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"28334990","source_url":"https://pubmed.ncbi.nlm.nih.gov/28334990/","study_design":null,"title":"Insulin resistance and exendin-4 treatment for multiple system atrophy","title_match":false,"year":2017},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/liraglutide-improves-memory-in-obese-patients-with-prediabetes-or-31965072","doi":"10.1038/s41366-020-0535-5","journal":"International journal of obesity (2005)","n_participants":20,"pmid":"31965072","source_url":"https://pubmed.ncbi.nlm.nih.gov/31965072/","study_design":null,"title":"Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study","title_match":true,"year":2020},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/a-novel-dual-glp-1-and-gip-receptor-agonist-is-neuroprotective-in-the-26453833","doi":"10.1016/j.brainres.2015.09.035","journal":"Brain research","n_participants":null,"pmid":"26453833","source_url":"https://pubmed.ncbi.nlm.nih.gov/26453833/","study_design":null,"title":"A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF","title_match":false,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/incretin-analogues-that-have-been-developed-to-treat-type-2-diabetes-20337586","doi":"10.2174/157488910791213130","journal":"Recent patents on CNS drug discovery","n_participants":null,"pmid":"20337586","source_url":"https://pubmed.ncbi.nlm.nih.gov/20337586/","study_design":null,"title":"Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/gip-has-neuroprotective-effects-in-alzheimer-and-parkinson-s-disease-31705913","doi":"10.1016/j.peptides.2019.170184","journal":"Peptides","n_participants":null,"pmid":"31705913","source_url":"https://pubmed.ncbi.nlm.nih.gov/31705913/","study_design":null,"title":"GIP has neuroprotective effects in Alzheimer and Parkinson's disease models","title_match":false,"year":2020},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/insulin-incretins-and-other-growth-factors-as-potential-novel-24646283","doi":"10.1042/bst20140016","journal":"Biochemical Society transactions","n_participants":null,"pmid":"24646283","source_url":"https://pubmed.ncbi.nlm.nih.gov/24646283/","study_design":null,"title":"Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases","title_match":false,"year":2014},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/a-novel-glp-1-gip-dual-receptor-agonist-protects-from-6-ohda-lesion-28223210","doi":"10.1016/j.neuropharm.2017.02.013","journal":"Neuropharmacology","n_participants":null,"pmid":"28223210","source_url":"https://pubmed.ncbi.nlm.nih.gov/28223210/","study_design":null,"title":"A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease","title_match":false,"year":2017},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/role-of-glucagon-like-peptide-1-receptor-agonists-in-alzheimer-s-39501255","doi":"10.1186/s12929-024-01090-x","journal":"Journal of biomedical science","n_participants":null,"pmid":"39501255","source_url":"https://pubmed.ncbi.nlm.nih.gov/39501255/","study_design":null,"title":"Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/liraglutide-protects-against-brain-amyloid-1-42-accumulation-in-32143329","doi":"10.3390/ijms21051746","journal":"International journal of molecular sciences","n_participants":null,"pmid":"32143329","source_url":"https://pubmed.ncbi.nlm.nih.gov/32143329/","study_design":null,"title":"Liraglutide Protects Against Brain Amyloid-\u03b2 1-42 Accumulation in Female Mice with Early Alzheimer's Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation","title_match":false,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/comparison-on-cognitive-outcomes-of-antidiabetic-agents-for-type-2-37302139","doi":"10.1002/dmrr.3673","journal":"Diabetes/metabolism research and reviews","n_participants":null,"pmid":"37302139","source_url":"https://pubmed.ncbi.nlm.nih.gov/37302139/","study_design":"meta-analysis","title":"Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta-analysis","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/neuroprotective-actions-of-glucagon-like-peptide-1-glp-1-analogues-in-30511349","doi":"10.1007/s40263-018-0593-6","journal":"CNS drugs","n_participants":null,"pmid":"30511349","source_url":"https://pubmed.ncbi.nlm.nih.gov/30511349/","study_design":null,"title":"Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/neuroprotective-effects-of-glucose-dependent-insulinotropic-26351802","doi":"10.1515/revneuro-2015-0021","journal":"Reviews in the neurosciences","n_participants":null,"pmid":"26351802","source_url":"https://pubmed.ncbi.nlm.nih.gov/26351802/","study_design":null,"title":"Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/gut-brain-connection-the-neuroprotective-effects-of-the-anti-diabetic-26131323","doi":"10.4239/wjd.v6.i6.807","journal":"World journal of diabetes","n_participants":null,"pmid":"26131323","source_url":"https://pubmed.ncbi.nlm.nih.gov/26131323/","study_design":null,"title":"Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide","title_match":false,"year":2015},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/drug-development-for-alzheimer-s-disease-review-29732929","doi":"10.1080/1061186x.2018.1474361","journal":"Journal of drug targeting","n_participants":null,"pmid":"29732929","source_url":"https://pubmed.ncbi.nlm.nih.gov/29732929/","study_design":null,"title":"Drug development for Alzheimer's disease: review","title_match":false,"year":2019},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/genetic-variation-in-targets-of-antidiabetic-drugs-and-alzheimer-35654594","doi":"10.1212/wnl.0000000000200771","journal":"Neurology","n_participants":326885,"pmid":"35654594","source_url":"https://pubmed.ncbi.nlm.nih.gov/35654594/","study_design":null,"title":"Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study","title_match":false,"year":2022},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/drug-discovery-from-medicinal-plants-16198377","doi":"10.1016/j.lfs.2005.09.012","journal":"Life sciences","n_participants":null,"pmid":"16198377","source_url":"https://pubmed.ncbi.nlm.nih.gov/16198377/","study_design":null,"title":"Drug discovery from medicinal plants","title_match":false,"year":2005},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/paradigm-shift-in-neuroprotection-by-nmda-receptor-blockade-memantine-16424917","doi":"10.1038/nrd1958","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"16424917","source_url":"https://pubmed.ncbi.nlm.nih.gov/16424917/","study_design":null,"title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","title_match":false,"year":2006},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-rivastigmine-in-patients-with-alzheimer-s-10066203","doi":"10.1136/bmj.318.7184.633","journal":"BMJ (Clinical research ed.)","n_participants":725,"pmid":"10066203","source_url":"https://pubmed.ncbi.nlm.nih.gov/10066203/","study_design":null,"title":"Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial","title_match":true,"year":1999},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/safety-efficacy-and-biomarker-findings-of-pbt2-in-targeting-abeta-as-18672400","doi":"10.1016/s1474-4422(08)70167-4","journal":"The Lancet. Neurology","n_participants":78,"pmid":"18672400","source_url":"https://pubmed.ncbi.nlm.nih.gov/18672400/","study_design":"randomized controlled trial","title":"Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","title_match":true,"year":2008},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/long-term-donepezil-treatment-in-565-patients-with-alzheimer-s-15220031","doi":"10.1016/s0140-6736(04)16499-4","journal":"Lancet (London, England)","n_participants":null,"pmid":"15220031","source_url":"https://pubmed.ncbi.nlm.nih.gov/15220031/","study_design":null,"title":"Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial","title_match":true,"year":2004},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/the-efficacy-and-safety-of-donepezil-in-patients-with-alzheimer-s-8915035","doi":"10.1159/000106895","journal":"Dementia (Basel, Switzerland)","n_participants":161,"pmid":"8915035","source_url":"https://pubmed.ncbi.nlm.nih.gov/8915035/","study_design":null,"title":"The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group","title_match":true,"year":1996},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/donepezil-and-memantine-for-moderate-to-severe-alzheimer-s-disease-22397651","doi":"10.1056/nejmoa1106668","journal":"The New England journal of medicine","n_participants":null,"pmid":"22397651","source_url":"https://pubmed.ncbi.nlm.nih.gov/22397651/","study_design":null,"title":"Donepezil and memantine for moderate-to-severe Alzheimer's disease","title_match":false,"year":2012},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/current-and-future-treatments-for-alzheimer-s-disease-23277790","doi":"10.1177/1756285612461679","journal":"Therapeutic advances in neurological disorders","n_participants":null,"pmid":"23277790","source_url":"https://pubmed.ncbi.nlm.nih.gov/23277790/","study_design":null,"title":"Current and future treatments for Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-donepezil-galantamine-and-rivastigmine-for-the-18686744","doi":null,"journal":"Clinical interventions in aging","n_participants":null,"pmid":"18686744","source_url":"https://pubmed.ncbi.nlm.nih.gov/18686744/","study_design":"randomized controlled trial","title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","title_match":false,"year":2008},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/a-double-blind-placebo-controlled-multicenter-study-of-tacrine-for-1406817","doi":"10.1056/nejm199210293271801","journal":"The New England journal of medicine","n_participants":215,"pmid":"1406817","source_url":"https://pubmed.ncbi.nlm.nih.gov/1406817/","study_design":null,"title":"A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group","title_match":true,"year":1992},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-donepezil-galantamine-rivastigmine-and-24662102","doi":"10.3233/jad-132690","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"24662102","source_url":"https://pubmed.ncbi.nlm.nih.gov/24662102/","study_design":null,"title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","title_match":false,"year":2014},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/efficacy-of-cholinesterase-inhibitors-in-the-treatment-of-12517232","doi":"10.1001/jama.289.2.210","journal":"JAMA","n_participants":29,"pmid":"12517232","source_url":"https://pubmed.ncbi.nlm.nih.gov/12517232/","study_design":"systematic review","title":"Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis","title_match":false,"year":2003},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/neuropsychiatric-symptoms-in-patients-with-parkinson-s-disease-and-16820421","doi":"10.1136/jnnp.2005.083113","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":537,"pmid":"16820421","source_url":"https://pubmed.ncbi.nlm.nih.gov/16820421/","study_design":null,"title":"Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress","title_match":false,"year":2007},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-chemical-biology-of-clinically-tolerated-nmda-receptor-antagonists-16805772","doi":"10.1111/j.1471-4159.2006.03991.x","journal":"Journal of neurochemistry","n_participants":null,"pmid":"16805772","source_url":"https://pubmed.ncbi.nlm.nih.gov/16805772/","study_design":"clinical trial","title":"The chemical biology of clinically tolerated NMDA receptor antagonists","title_match":false,"year":2006},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-for-patients-with-alzheimer-s-disease-16081444","doi":"10.1136/bmj.331.7512.321","journal":"BMJ (Clinical research ed.)","n_participants":null,"pmid":"16081444","source_url":"https://pubmed.ncbi.nlm.nih.gov/16081444/","study_design":null,"title":"Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials","title_match":true,"year":2005},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/memantine-in-patients-with-parkinson-s-disease-dementia-or-dementia-19520613","doi":"10.1016/s1474-4422(09)70146-2","journal":"The Lancet. Neurology","n_participants":72,"pmid":"19520613","source_url":"https://pubmed.ncbi.nlm.nih.gov/19520613/","study_design":null,"title":"Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","title_match":true,"year":2009},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/rosiglitazone-monotherapy-in-mild-to-moderate-alzheimer-s-disease-20733306","doi":"10.1159/000318845","journal":"Dementia and geriatric cognitive disorders","n_participants":693,"pmid":"20733306","source_url":"https://pubmed.ncbi.nlm.nih.gov/20733306/","study_design":"open-label trial","title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study","title_match":true,"year":2010},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/efficacy-and-adverse-effects-of-cholinesterase-inhibitors-and-17689146","doi":"10.1016/s1474-4422(07)70195-3","journal":"The Lancet. Neurology","n_participants":3093,"pmid":"17689146","source_url":"https://pubmed.ncbi.nlm.nih.gov/17689146/","study_design":"systematic review","title":"Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials","title_match":true,"year":2007},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/open-label-multicenter-phase-3-extension-study-of-the-safety-and-11255446","doi":"10.1001/archneur.58.3.427","journal":"Archives of neurology","n_participants":763,"pmid":"11255446","source_url":"https://pubmed.ncbi.nlm.nih.gov/11255446/","study_design":"clinical trial","title":"Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease","title_match":true,"year":2001},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/donepezil-in-patients-with-severe-alzheimer-s-disease-double-blind-16581404","doi":"10.1016/s0140-6736(06)68350-5","journal":"Lancet (London, England)","n_participants":128,"pmid":"16581404","source_url":"https://pubmed.ncbi.nlm.nih.gov/16581404/","study_design":null,"title":"Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study","title_match":true,"year":2006},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/treatment-of-alzheimer-s-disease-with-the-gsk-3-inhibitor-tideglusib-22936007","doi":"10.3233/jad-2012-120805","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"22936007","source_url":"https://pubmed.ncbi.nlm.nih.gov/22936007/","study_design":null,"title":"Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study","title_match":false,"year":2013},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/an-overview-of-systematic-reviews-of-pharmacological-and-non-29143695","doi":"10.1017/s1041610217002344","journal":"International psychogeriatrics","n_participants":null,"pmid":"29143695","source_url":"https://pubmed.ncbi.nlm.nih.gov/29143695/","study_design":null,"title":"An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia","title_match":false,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/management-of-behavioral-problems-in-alzheimer-s-disease-20096151","doi":"10.1017/s1041610209991505","journal":"International psychogeriatrics","n_participants":null,"pmid":"20096151","source_url":"https://pubmed.ncbi.nlm.nih.gov/20096151/","study_design":null,"title":"Management of behavioral problems in Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-52-week-study-of-the-efficacy-of-rivastigmine-in-patients-with-mild-11096224","doi":"10.1159/000008243","journal":"European neurology","n_participants":null,"pmid":"11096224","source_url":"https://pubmed.ncbi.nlm.nih.gov/11096224/","study_design":"open-label trial","title":"A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease","title_match":false,"year":2000},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/outcomes-of-alzheimer-s-disease-therapy-with-acetylcholinesterase-24845946","doi":"10.1517/14740338.2014.914168","journal":"Expert opinion on drug safety","n_participants":null,"pmid":"24845946","source_url":"https://pubmed.ncbi.nlm.nih.gov/24845946/","study_design":null,"title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","title_match":false,"year":2014},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/clinical-pharmacology-of-rivastigmine-a-new-generation-9737824","doi":"10.1016/s0149-2918(98)80127-6","journal":"Clinical therapeutics","n_participants":null,"pmid":"9737824","source_url":"https://pubmed.ncbi.nlm.nih.gov/9737824/","study_design":null,"title":"Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease","title_match":false,"year":1998},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-cholinesterase-inhibitors-in-alzheimer-s-12975222","doi":null,"journal":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","n_participants":5159,"pmid":"12975222","source_url":"https://pubmed.ncbi.nlm.nih.gov/12975222/","study_design":"meta-analysis","title":"Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis","title_match":false,"year":2003},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/new-pharmacological-strategies-for-treatment-of-alzheimer-s-disease-22035455","doi":"10.1111/j.1365-2125.2011.04134.x","journal":"British journal of clinical pharmacology","n_participants":null,"pmid":"22035455","source_url":"https://pubmed.ncbi.nlm.nih.gov/22035455/","study_design":"clinical trial","title":"New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs","title_match":false,"year":2012},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/phase-ii-study-of-donepezil-in-irradiated-brain-tumor-patients-effect-16549835","doi":"10.1200/jco.2005.03.3001","journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","n_participants":35,"pmid":"16549835","source_url":"https://pubmed.ncbi.nlm.nih.gov/16549835/","study_design":"open-label trial","title":"Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life","title_match":true,"year":2006},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-six-month-double-blind-randomized-placebo-controlled-study-of-a-17380489","doi":"10.1002/gps.1788","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"17380489","source_url":"https://pubmed.ncbi.nlm.nih.gov/17380489/","study_design":null,"title":"A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule","title_match":true,"year":2007},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/memantine-monotherapy-for-alzheimer-s-disease-a-systematic-review-and-25860130","doi":"10.1371/journal.pone.0123289","journal":"PloS one","n_participants":2433,"pmid":"25860130","source_url":"https://pubmed.ncbi.nlm.nih.gov/25860130/","study_design":"meta-analysis","title":"Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis","title_match":false,"year":2015},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/a-review-of-butyrylcholinesterase-as-a-therapeutic-target-in-the-23930233","doi":"10.4088/pcc.12r01412","journal":"The primary care companion for CNS disorders","n_participants":null,"pmid":"23930233","source_url":"https://pubmed.ncbi.nlm.nih.gov/23930233/","study_design":null,"title":"A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-molecular-basis-of-memantine-action-in-alzheimer-s-disease-and-15974913","doi":"10.2174/1567205053585846","journal":"Current Alzheimer research","n_participants":null,"pmid":"15974913","source_url":"https://pubmed.ncbi.nlm.nih.gov/15974913/","study_design":"clinical trial","title":"The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism","title_match":false,"year":2005},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/current-and-future-treatments-in-alzheimer-s-disease-30925615","doi":"10.1055/s-0039-1678581","journal":"Seminars in neurology","n_participants":null,"pmid":"30925615","source_url":"https://pubmed.ncbi.nlm.nih.gov/30925615/","study_design":null,"title":"Current and Future Treatments in Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/memantine-for-alzheimer-s-disease-an-updated-systematic-review-and-28922160","doi":"10.3233/jad-170424","journal":"Journal of Alzheimer's disease : JAD","n_participants":7567,"pmid":"28922160","source_url":"https://pubmed.ncbi.nlm.nih.gov/28922160/","study_design":"systematic review","title":"Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis","title_match":false,"year":2017},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/memantine-a-review-of-its-use-in-alzheimer-s-disease-16906789","doi":"10.2165/00003495-200666110-00015","journal":"Drugs","n_participants":null,"pmid":"16906789","source_url":"https://pubmed.ncbi.nlm.nih.gov/16906789/","study_design":"meta-analysis","title":"Memantine: a review of its use in Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-a-flexible-galantamine-dose-in-alzheimer-s-disease-a-11606667","doi":"10.1136/jnnp.71.5.589","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":386,"pmid":"11606667","source_url":"https://pubmed.ncbi.nlm.nih.gov/11606667/","study_design":null,"title":"Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial","title_match":true,"year":2001},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/advances-in-the-treatment-of-alzheimer-s-disease-benefits-of-dual-11803198","doi":"10.1159/000047952","journal":"European neurology","n_participants":null,"pmid":"11803198","source_url":"https://pubmed.ncbi.nlm.nih.gov/11803198/","study_design":null,"title":"Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition","title_match":false,"year":2002},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-spectrum-of-behavioral-responses-to-cholinesterase-inhibitor-10555660","doi":"10.1001/archneur.56.11.1388","journal":"Archives of neurology","n_participants":86,"pmid":"10555660","source_url":"https://pubmed.ncbi.nlm.nih.gov/10555660/","study_design":"open-label trial","title":"The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease","title_match":false,"year":1999},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-galantamine-in-subjects-with-mild-cognitive-18322263","doi":"10.1212/01.wnl.0000303815.69777.26","journal":"Neurology","n_participants":2048,"pmid":"18322263","source_url":"https://pubmed.ncbi.nlm.nih.gov/18322263/","study_design":null,"title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","title_match":false,"year":2008},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/memantine-for-the-treatment-of-dementia-a-review-on-its-current-and-29254093","doi":"10.3233/jad-170672","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"29254093","source_url":"https://pubmed.ncbi.nlm.nih.gov/29254093/","study_design":null,"title":"Memantine for the Treatment of Dementia: A Review on its Current and Future Applications","title_match":false,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-novel-activities-of-old-molecules-15304241","doi":"10.1016/j.phrs.2003.12.027","journal":"Pharmacological research","n_participants":null,"pmid":"15304241","source_url":"https://pubmed.ncbi.nlm.nih.gov/15304241/","study_design":null,"title":"Acetylcholinesterase inhibitors: novel activities of old molecules","title_match":false,"year":2004},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/cost-effectiveness-of-donepezil-in-the-treatment-of-mild-or-moderate-10214734","doi":"10.1212/wnl.52.6.1138","journal":"Neurology","n_participants":null,"pmid":"10214734","source_url":"https://pubmed.ncbi.nlm.nih.gov/10214734/","study_design":"cross-sectional","title":"Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease","title_match":false,"year":1999},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2022-35516416","doi":"10.1002/trc2.12295","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":31,"pmid":"35516416","source_url":"https://pubmed.ncbi.nlm.nih.gov/35516416/","study_design":"clinical trial","title":"Alzheimer's disease drug development pipeline: 2022","title_match":false,"year":2022},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2020-32695874","doi":"10.1002/trc2.12050","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"32695874","source_url":"https://pubmed.ncbi.nlm.nih.gov/32695874/","study_design":"longitudinal study","title":"Alzheimer's disease drug development pipeline: 2020","title_match":false,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2021-34095440","doi":"10.1002/trc2.12179","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"34095440","source_url":"https://pubmed.ncbi.nlm.nih.gov/34095440/","study_design":"clinical trial","title":"Alzheimer's disease drug development pipeline: 2021","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2024-38659717","doi":"10.1002/trc2.12465","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":56,"pmid":"38659717","source_url":"https://pubmed.ncbi.nlm.nih.gov/38659717/","study_design":"clinical trial","title":"Alzheimer's disease drug development pipeline: 2024","title_match":false,"year":2024},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/treatment-with-simvastatin-in-normocholesterolemic-patients-with-12205648","doi":"10.1002/ana.10292","journal":"Annals of neurology","n_participants":44,"pmid":"12205648","source_url":"https://pubmed.ncbi.nlm.nih.gov/12205648/","study_design":null,"title":"Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial","title_match":true,"year":2002},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/disease-modifying-properties-of-long-term-lithium-treatment-for-21525519","doi":"10.1192/bjp.bp.110.080044","journal":"The British journal of psychiatry : the journal of mental science","n_participants":24,"pmid":"21525519","source_url":"https://pubmed.ncbi.nlm.nih.gov/21525519/","study_design":null,"title":"Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial","title_match":true,"year":2011},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/statin-associated-memory-loss-analysis-of-60-case-reports-and-review-12885101","doi":"10.1592/phco.23.7.871.32720","journal":"Pharmacotherapy","n_participants":60,"pmid":"12885101","source_url":"https://pubmed.ncbi.nlm.nih.gov/12885101/","study_design":"randomized controlled trial","title":"Statin-associated memory loss: analysis of 60 case reports and review of the literature","title_match":false,"year":2003},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/drug-repositioning-for-alzheimer-s-disease-23123941","doi":"10.1038/nrd3869","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"23123941","source_url":"https://pubmed.ncbi.nlm.nih.gov/23123941/","study_design":"systematic review","title":"Drug repositioning for Alzheimer's disease","title_match":false,"year":2012},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/metformin-in-amnestic-mild-cognitive-impairment-results-of-a-pilot-26890736","doi":"10.3233/jad-150493","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"26890736","source_url":"https://pubmed.ncbi.nlm.nih.gov/26890736/","study_design":null,"title":"Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial","title_match":true,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/therapy-insight-type-2-diabetes-mellitus-and-the-risk-of-late-onset-16932542","doi":"10.1038/ncpneuro0124","journal":"Nature clinical practice. Neurology","n_participants":null,"pmid":"16932542","source_url":"https://pubmed.ncbi.nlm.nih.gov/16932542/","study_design":null,"title":"Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/machine-learning-identifies-candidates-for-drug-repurposing-in-33589615","doi":"10.1038/s41467-021-21330-0","journal":"Nature communications","n_participants":null,"pmid":"33589615","source_url":"https://pubmed.ncbi.nlm.nih.gov/33589615/","study_design":null,"title":"Machine learning identifies candidates for drug repurposing in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/statins-and-cognitive-function-a-systematic-review-24247674","doi":"10.7326/0003-4819-159-10-201311190-00007","journal":"Annals of internal medicine","n_participants":null,"pmid":"24247674","source_url":"https://pubmed.ncbi.nlm.nih.gov/24247674/","study_design":"case-control study","title":"Statins and cognitive function: a systematic review","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/statins-mechanisms-of-neuroprotection-19428962","doi":"10.1016/j.pneurobio.2009.02.002","journal":"Progress in neurobiology","n_participants":null,"pmid":"19428962","source_url":"https://pubmed.ncbi.nlm.nih.gov/19428962/","study_design":null,"title":"Statins: mechanisms of neuroprotection","title_match":false,"year":2009},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/pravastatin-and-cognitive-function-in-the-elderly-results-of-the-19653027","doi":"10.1007/s00415-009-5271-7","journal":"Journal of neurology","n_participants":null,"pmid":"19653027","source_url":"https://pubmed.ncbi.nlm.nih.gov/19653027/","study_design":null,"title":"Pravastatin and cognitive function in the elderly. Results of the PROSPER study","title_match":false,"year":2010},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/the-role-of-statins-in-both-cognitive-impairment-and-protection-29507718","doi":"10.1186/s40035-018-0110-3","journal":"Translational neurodegeneration","n_participants":null,"pmid":"29507718","source_url":"https://pubmed.ncbi.nlm.nih.gov/29507718/","study_design":"narrative review","title":"The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms","title_match":false,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/review-of-lithium-effects-on-brain-and-blood-19523343","doi":"10.3727/096368909x471251","journal":"Cell transplantation","n_participants":null,"pmid":"19523343","source_url":"https://pubmed.ncbi.nlm.nih.gov/19523343/","study_design":null,"title":"Review of lithium effects on brain and blood","title_match":false,"year":2009},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/do-statins-impair-cognition-a-systematic-review-and-meta-analysis-of-25575908","doi":"10.1007/s11606-014-3115-3","journal":"Journal of general internal medicine","n_participants":46836,"pmid":"25575908","source_url":"https://pubmed.ncbi.nlm.nih.gov/25575908/","study_design":"meta-analysis","title":"Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials","title_match":true,"year":2015},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/molecular-actions-and-therapeutic-potential-of-lithium-in-preclinical-20705090","doi":"10.1016/j.pharmthera.2010.07.006","journal":"Pharmacology & therapeutics","n_participants":null,"pmid":"20705090","source_url":"https://pubmed.ncbi.nlm.nih.gov/20705090/","study_design":null,"title":"Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders","title_match":false,"year":2010},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cognitive-impairment-and-vitamin-b12-a-review-22221769","doi":"10.1017/s1041610211002511","journal":"International psychogeriatrics","n_participants":null,"pmid":"22221769","source_url":"https://pubmed.ncbi.nlm.nih.gov/22221769/","study_design":null,"title":"Cognitive impairment and vitamin B12: a review","title_match":false,"year":2012},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/endophenotype-based-in-silico-network-medicine-discovery-combined-35572351","doi":"10.1038/s43587-021-00138-z","journal":"Nature aging","n_participants":null,"pmid":"35572351","source_url":"https://pubmed.ncbi.nlm.nih.gov/35572351/","study_design":"case-control study","title":"Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/lithium-reduces-tau-phosphorylation-but-not-a-beta-or-working-memory-17456772","doi":"10.2353/ajpath.2007.061178","journal":"The American journal of pathology","n_participants":null,"pmid":"17456772","source_url":"https://pubmed.ncbi.nlm.nih.gov/17456772/","study_design":null,"title":"Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles","title_match":false,"year":2007},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/lithium-trial-in-alzheimer-s-disease-a-randomized-single-blind-19573486","doi":null,"journal":"The Journal of clinical psychiatry","n_participants":38,"pmid":"19573486","source_url":"https://pubmed.ncbi.nlm.nih.gov/19573486/","study_design":null,"title":"Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study","title_match":true,"year":2009},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/statins-and-cognition-a-systematic-review-and-meta-analysis-of-short-24095248","doi":"10.1016/j.mayocp.2013.07.013","journal":"Mayo Clinic proceedings","n_participants":23443,"pmid":"24095248","source_url":"https://pubmed.ncbi.nlm.nih.gov/24095248/","study_design":"cohort study","title":"Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects","title_match":false,"year":2013},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/evidence-for-benefit-of-statins-to-modify-cognitive-decline-and-risk-28212683","doi":"10.1186/s13195-017-0237-y","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"28212683","source_url":"https://pubmed.ncbi.nlm.nih.gov/28212683/","study_design":null,"title":"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/myricetin-bioactive-effects-moving-from-preclinical-evidence-to-32738903","doi":"10.1186/s12906-020-03033-z","journal":"BMC complementary medicine and therapies","n_participants":null,"pmid":"32738903","source_url":"https://pubmed.ncbi.nlm.nih.gov/32738903/","study_design":null,"title":"Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications","title_match":false,"year":2020},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/sex-and-race-differences-in-the-association-between-statin-use-and-27942728","doi":"10.1001/jamaneurol.2016.3783","journal":"JAMA neurology","n_participants":7794,"pmid":"27942728","source_url":"https://pubmed.ncbi.nlm.nih.gov/27942728/","study_design":null,"title":"Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease","title_match":false,"year":2017},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-amyloid-cascade-hypothesis-for-alzheimer-s-disease-an-appraisal-21852788","doi":"10.1038/nrd3505","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"21852788","source_url":"https://pubmed.ncbi.nlm.nih.gov/21852788/","study_design":null,"title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","title_match":false,"year":2011},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-few-candidates-frequent-25024750","doi":"10.1186/alzrt269","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"25024750","source_url":"https://pubmed.ncbi.nlm.nih.gov/25024750/","study_design":"clinical trial","title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","title_match":false,"year":2014},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/effectiveness-of-atypical-antipsychotic-drugs-in-patients-with-17035647","doi":"10.1056/nejmoa061240","journal":"The New England journal of medicine","n_participants":null,"pmid":"17035647","source_url":"https://pubmed.ncbi.nlm.nih.gov/17035647/","study_design":null,"title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/effect-of-probiotic-supplementation-on-cognitive-function-and-27891089","doi":"10.3389/fnagi.2016.00256","journal":"Frontiers in aging neuroscience","n_participants":30,"pmid":"27891089","source_url":"https://pubmed.ncbi.nlm.nih.gov/27891089/","study_design":null,"title":"Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial","title_match":true,"year":2016},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/oral-tetrahydroaminoacridine-in-long-term-treatment-of-senile-2430180","doi":"10.1056/nejm198611133152001","journal":"The New England journal of medicine","n_participants":17,"pmid":"2430180","source_url":"https://pubmed.ncbi.nlm.nih.gov/2430180/","study_design":null,"title":"Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type","title_match":false,"year":1986},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/clinical-trial-of-indomethacin-in-alzheimer-s-disease-8351023","doi":"10.1212/wnl.43.8.1609","journal":"Neurology","n_participants":null,"pmid":"8351023","source_url":"https://pubmed.ncbi.nlm.nih.gov/8351023/","study_design":null,"title":"Clinical trial of indomethacin in Alzheimer's disease","title_match":true,"year":1993},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/new-perspectives-on-the-role-of-melatonin-in-human-sleep-circadian-29318587","doi":"10.1111/bph.14116","journal":"British journal of pharmacology","n_participants":null,"pmid":"29318587","source_url":"https://pubmed.ncbi.nlm.nih.gov/29318587/","study_design":null,"title":"New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation","title_match":false,"year":2018},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/antibodies-against-beta-amyloid-slow-cognitive-decline-in-alzheimer-s-12765607","doi":"10.1016/s0896-6273(03)00294-0","journal":"Neuron","n_participants":30,"pmid":"12765607","source_url":"https://pubmed.ncbi.nlm.nih.gov/12765607/","study_design":"randomized controlled trial","title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease","title_match":false,"year":2003},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/a-30-week-randomized-controlled-trial-of-high-dose-tacrine-in-8139083","doi":"10.1001/jama.1994.03510370037029","journal":"JAMA","n_participants":663,"pmid":"8139083","source_url":"https://pubmed.ncbi.nlm.nih.gov/8139083/","study_design":null,"title":"A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group","title_match":true,"year":1994},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/oral-tolerance-16048553","doi":"10.1111/j.0105-2896.2005.00280.x","journal":"Immunological reviews","n_participants":null,"pmid":"16048553","source_url":"https://pubmed.ncbi.nlm.nih.gov/16048553/","study_design":null,"title":"Oral tolerance","title_match":false,"year":2005},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/robot-assisted-laparoscopic-prostatectomy-versus-open-radical-27474375","doi":"10.1016/s0140-6736(16)30592-x","journal":"Lancet (London, England)","n_participants":14,"pmid":"27474375","source_url":"https://pubmed.ncbi.nlm.nih.gov/27474375/","study_design":"clinical trial","title":"Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study","title_match":true,"year":2016},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/study-of-the-ketogenic-agent-ac-1202-in-mild-to-moderate-alzheimer-s-19664276","doi":"10.1186/1743-7075-6-31","journal":"Nutrition & metabolism","n_participants":55,"pmid":"19664276","source_url":"https://pubmed.ncbi.nlm.nih.gov/19664276/","study_design":null,"title":"Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial","title_match":true,"year":2009},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/exercise-program-for-nursing-home-residents-with-alzheimer-s-disease-17302650","doi":"10.1111/j.1532-5415.2007.01035.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"17302650","source_url":"https://pubmed.ncbi.nlm.nih.gov/17302650/","study_design":null,"title":"Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial","title_match":true,"year":2007},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/glutamate-as-a-therapeutic-target-in-psychiatric-disorders-15278097","doi":"10.1038/sj.mp.4001551","journal":"Molecular psychiatry","n_participants":null,"pmid":"15278097","source_url":"https://pubmed.ncbi.nlm.nih.gov/15278097/","study_design":null,"title":"Glutamate as a therapeutic target in psychiatric disorders","title_match":false,"year":2004},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/disclosure-of-apoe-genotype-for-risk-of-alzheimer-s-disease-19605829","doi":"10.1056/nejmoa0809578","journal":"The New England journal of medicine","n_participants":null,"pmid":"19605829","source_url":"https://pubmed.ncbi.nlm.nih.gov/19605829/","study_design":null,"title":"Disclosure of APOE genotype for risk of Alzheimer's disease","title_match":false,"year":2009},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/a-metaanalysis-of-controlled-trials-of-neuroleptic-treatment-in-1970586","doi":"10.1111/j.1532-5415.1990.tb02407.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"1970586","source_url":"https://pubmed.ncbi.nlm.nih.gov/1970586/","study_design":null,"title":"A metaanalysis of controlled trials of neuroleptic treatment in dementia","title_match":false,"year":1990},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/probiotic-supplementation-improves-cognitive-function-and-mood-with-32300799","doi":"10.1093/gerona/glaa090","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":null,"pmid":"32300799","source_url":"https://pubmed.ncbi.nlm.nih.gov/32300799/","study_design":null,"title":"Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial","title_match":true,"year":2021},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/a-controlled-trial-of-tacrine-in-alzheimer-s-disease-the-tacrine-1404819","doi":"10.1001/jama.1992.03490180055026","journal":"JAMA","n_participants":null,"pmid":"1404819","source_url":"https://pubmed.ncbi.nlm.nih.gov/1404819/","study_design":null,"title":"A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group","title_match":false,"year":1992},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/beneficial-effects-of-docosahexaenoic-acid-on-cognition-in-age-20434961","doi":"10.1016/j.jalz.2010.01.013","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":485,"pmid":"20434961","source_url":"https://pubmed.ncbi.nlm.nih.gov/20434961/","study_design":null,"title":"Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","title_match":false,"year":2010},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/behavioral-vs-drug-treatment-for-urge-urinary-incontinence-in-older-9863850","doi":"10.1001/jama.280.23.1995","journal":"JAMA","n_participants":null,"pmid":"9863850","source_url":"https://pubmed.ncbi.nlm.nih.gov/9863850/","study_design":null,"title":"Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial","title_match":true,"year":1998},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/the-dementia-antipsychotic-withdrawal-trial-dart-ad-long-term-follow-19138567","doi":"10.1016/s1474-4422(08)70295-3","journal":"The Lancet. Neurology","n_participants":165,"pmid":"19138567","source_url":"https://pubmed.ncbi.nlm.nih.gov/19138567/","study_design":null,"title":"The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial","title_match":true,"year":2009},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/randomized-trial-of-deep-brain-stimulation-for-parkinson-disease-22722632","doi":"10.1212/wnl.0b013e31825dcdc1","journal":"Neurology","n_participants":89,"pmid":"22722632","source_url":"https://pubmed.ncbi.nlm.nih.gov/22722632/","study_design":"randomized controlled trial","title":"Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes","title_match":false,"year":2012},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/advances-in-tau-focused-drug-discovery-for-alzheimer-s-disease-and-19794442","doi":"10.1038/nrd2959","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"19794442","source_url":"https://pubmed.ncbi.nlm.nih.gov/19794442/","study_design":null,"title":"Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies","title_match":false,"year":2009},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-prednisone-in-alzheimer-s-disease-10680787","doi":"10.1212/wnl.54.3.588","journal":"Neurology","n_participants":138,"pmid":"10680787","source_url":"https://pubmed.ncbi.nlm.nih.gov/10680787/","study_design":null,"title":"A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study","title_match":true,"year":2000},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/effect-of-enhanced-psychosocial-care-on-antipsychotic-use-in-nursing-16543297","doi":"10.1136/bmj.38782.575868.7c","journal":"BMJ (Clinical research ed.)","n_participants":null,"pmid":"16543297","source_url":"https://pubmed.ncbi.nlm.nih.gov/16543297/","study_design":"randomized controlled trial","title":"Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial","title_match":false,"year":2006},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/efficacy-of-treating-pain-to-reduce-behavioural-disturbances-in-21765198","doi":"10.1136/bmj.d4065","journal":"BMJ (Clinical research ed.)","n_participants":175,"pmid":"21765198","source_url":"https://pubmed.ncbi.nlm.nih.gov/21765198/","study_design":"randomized controlled trial","title":"Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial","title_match":true,"year":2011},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/probiotic-and-selenium-co-supplementation-and-the-effects-on-clinical-30642737","doi":"10.1016/j.clnu.2018.11.034","journal":"Clinical nutrition (Edinburgh, Scotland)","n_participants":27,"pmid":"30642737","source_url":"https://pubmed.ncbi.nlm.nih.gov/30642737/","study_design":null,"title":"Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial","title_match":true,"year":2019},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/effect-of-dimebon-on-cognition-activities-of-daily-living-behaviour-18640457","doi":"10.1016/s0140-6736(08)61074-0","journal":"Lancet (London, England)","n_participants":89,"pmid":"18640457","source_url":"https://pubmed.ncbi.nlm.nih.gov/18640457/","study_design":null,"title":"Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study","title_match":true,"year":2008},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/pbt2-rapidly-improves-cognition-in-alzheimer-s-disease-additional-20164561","doi":"10.3233/jad-2010-1390","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"20164561","source_url":"https://pubmed.ncbi.nlm.nih.gov/20164561/","study_design":"post-hoc analysis","title":"PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses","title_match":true,"year":2010},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effect-of-soy-protein-containing-isoflavones-on-cognitive-function-15238592","doi":"10.1001/jama.292.1.65","journal":"JAMA","n_participants":175,"pmid":"15238592","source_url":"https://pubmed.ncbi.nlm.nih.gov/15238592/","study_design":"randomized controlled trial","title":"Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial","title_match":true,"year":2004},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/effects-of-regular-and-long-acting-insulin-on-cognition-and-alzheimer-28372335","doi":"10.3233/jad-161256","journal":"Journal of Alzheimer's disease : JAD","n_participants":12,"pmid":"28372335","source_url":"https://pubmed.ncbi.nlm.nih.gov/28372335/","study_design":null,"title":"Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial","title_match":true,"year":2017},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/does-physical-activity-prevent-cognitive-decline-and-dementia-a-24885250","doi":"10.1186/1471-2458-14-510","journal":"BMC public health","n_participants":null,"pmid":"24885250","source_url":"https://pubmed.ncbi.nlm.nih.gov/24885250/","study_design":"meta-analysis","title":"Does physical activity prevent cognitive decline and dementia?: A systematic review and meta-analysis of longitudinal studies","title_match":false,"year":2014},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/exercise-cognition-and-the-aging-brain-16778001","doi":"10.1152/japplphysiol.00500.2006","journal":"Journal of applied physiology (Bethesda, Md. : 1985)","n_participants":null,"pmid":"16778001","source_url":"https://pubmed.ncbi.nlm.nih.gov/16778001/","study_design":null,"title":"Exercise, cognition, and the aging brain","title_match":false,"year":2006},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-physical-activity-and-quality-of-life-and-well-33044541","doi":"10.1093/tbm/ibz198","journal":"Translational behavioral medicine","n_participants":null,"pmid":"33044541","source_url":"https://pubmed.ncbi.nlm.nih.gov/33044541/","study_design":"systematic review","title":"A systematic review of physical activity and quality of life and well-being","title_match":false,"year":2020},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/positive-effects-of-combined-cognitive-and-physical-exercise-training-28912076","doi":"10.1016/j.arr.2017.09.003","journal":"Ageing research reviews","n_participants":null,"pmid":"28912076","source_url":"https://pubmed.ncbi.nlm.nih.gov/28912076/","study_design":"meta-analysis","title":"Positive effects of combined cognitive and physical exercise training on cognitive function in older adults with mild cognitive impairment or dementia: A meta-analysis","title_match":false,"year":2017},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/moderate-to-high-intensity-physical-exercise-in-patients-with-26682695","doi":"10.3233/jad-150817","journal":"Journal of Alzheimer's disease : JAD","n_participants":200,"pmid":"26682695","source_url":"https://pubmed.ncbi.nlm.nih.gov/26682695/","study_design":"randomized controlled trial","title":"Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial","title_match":true,"year":2016},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/the-effect-of-exercise-training-on-cognitive-function-in-older-adults-23831175","doi":"10.1016/j.jagp.2013.02.018","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":1695,"pmid":"23831175","source_url":"https://pubmed.ncbi.nlm.nih.gov/23831175/","study_design":"meta-analysis","title":"The effect of exercise training on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trials","title_match":true,"year":2013},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/risk-factors-and-preventive-interventions-for-alzheimer-disease-state-21555601","doi":"10.1001/archneurol.2011.100","journal":"Archives of neurology","n_participants":null,"pmid":"21555601","source_url":"https://pubmed.ncbi.nlm.nih.gov/21555601/","study_design":"cohort study","title":"Risk factors and preventive interventions for Alzheimer disease: state of the science","title_match":false,"year":2011},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/physical-activity-and-alzheimer-s-disease-from-prevention-to-18585641","doi":"10.1016/j.jamda.2008.02.007","journal":"Journal of the American Medical Directors Association","n_participants":null,"pmid":"18585641","source_url":"https://pubmed.ncbi.nlm.nih.gov/18585641/","study_design":null,"title":"Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives","title_match":false,"year":2008},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/association-between-circadian-rhythms-and-neurodegenerative-diseases-30784558","doi":"10.1016/s1474-4422(18)30461-7","journal":"The Lancet. Neurology","n_participants":null,"pmid":"30784558","source_url":"https://pubmed.ncbi.nlm.nih.gov/30784558/","study_design":"longitudinal study","title":"Association between circadian rhythms and neurodegenerative diseases","title_match":false,"year":2019},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/evidence-based-prevention-of-alzheimer-s-disease-systematic-review-32690803","doi":"10.1136/jnnp-2019-321913","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":44,"pmid":"32690803","source_url":"https://pubmed.ncbi.nlm.nih.gov/32690803/","study_design":"systematic review","title":"Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","title_match":true,"year":2020},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/a-multicenter-placebo-controlled-trial-of-melatonin-for-sleep-14655926","doi":"10.1093/sleep/26.7.893","journal":"Sleep","n_participants":157,"pmid":"14655926","source_url":"https://pubmed.ncbi.nlm.nih.gov/14655926/","study_design":null,"title":"A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease","title_match":true,"year":2003},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/herbal-medicines-for-diabetes-management-and-its-secondary-33143632","doi":"10.2174/1573399816666201103143225","journal":"Current diabetes reviews","n_participants":463,"pmid":"33143632","source_url":"https://pubmed.ncbi.nlm.nih.gov/33143632/","study_design":null,"title":"Herbal Medicines for Diabetes Management and its Secondary Complications","title_match":false,"year":2021},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-beyond-amyloid-can-the-repetitive-failures-of-32247851","doi":"10.1016/j.bcp.2020.113945","journal":"Biochemical pharmacology","n_participants":null,"pmid":"32247851","source_url":"https://pubmed.ncbi.nlm.nih.gov/32247851/","study_design":null,"title":"Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?","title_match":false,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/hearing-treatment-for-reducing-cognitive-decline-design-and-methods-30364572","doi":"10.1016/j.trci.2018.08.007","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"30364572","source_url":"https://pubmed.ncbi.nlm.nih.gov/30364572/","study_design":"randomized controlled trial","title":"Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial","title_match":true,"year":2018},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/healthy-aging-nutrition-matters-start-early-and-screen-often-33838032","doi":"10.1093/advances/nmab032","journal":"Advances in nutrition (Bethesda, Md.)","n_participants":null,"pmid":"33838032","source_url":"https://pubmed.ncbi.nlm.nih.gov/33838032/","study_design":"narrative review","title":"Healthy Aging-Nutrition Matters: Start Early and Screen Often","title_match":false,"year":2021},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/interventions-for-hearing-and-vision-impairment-to-improve-outcomes-30244688","doi":"10.1017/s1041610218000728","journal":"International psychogeriatrics","n_participants":null,"pmid":"30244688","source_url":"https://pubmed.ncbi.nlm.nih.gov/30244688/","study_design":"randomized controlled trial","title":"Interventions for hearing and vision impairment to improve outcomes for people with dementia: a scoping review","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/carbonic-anhydrases-novel-therapeutic-applications-for-inhibitors-and-18167490","doi":"10.1038/nrd2467","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"18167490","source_url":"https://pubmed.ncbi.nlm.nih.gov/18167490/","study_design":null,"title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","title_match":false,"year":2008},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/trends-in-gpcr-drug-discovery-new-agents-targets-and-indications-29075003","doi":"10.1038/nrd.2017.178","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"29075003","source_url":"https://pubmed.ncbi.nlm.nih.gov/29075003/","study_design":null,"title":"Trends in GPCR drug discovery: new agents, targets and indications","title_match":false,"year":2017},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/curcumin-as-curecumin-from-kitchen-to-clinic-17900536","doi":"10.1016/j.bcp.2007.08.016","journal":"Biochemical pharmacology","n_participants":null,"pmid":"17900536","source_url":"https://pubmed.ncbi.nlm.nih.gov/17900536/","study_design":null,"title":"Curcumin as \"Curecumin\": from kitchen to clinic","title_match":false,"year":2008},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/twenty-years-of-research-on-cytokine-induced-sickness-behavior-17088043","doi":"10.1016/j.bbi.2006.09.006","journal":"Brain, behavior, and immunity","n_participants":null,"pmid":"17088043","source_url":"https://pubmed.ncbi.nlm.nih.gov/17088043/","study_design":null,"title":"Twenty years of research on cytokine-induced sickness behavior","title_match":false,"year":2007},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/impact-of-intermittent-fasting-on-health-and-disease-processes-27810402","doi":"10.1016/j.arr.2016.10.005","journal":"Ageing research reviews","n_participants":null,"pmid":"27810402","source_url":"https://pubmed.ncbi.nlm.nih.gov/27810402/","study_design":null,"title":"Impact of intermittent fasting on health and disease processes","title_match":false,"year":2017},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/a-prospective-study-of-estrogen-replacement-therapy-and-the-risk-of-9191758","doi":"10.1212/wnl.48.6.1517","journal":"Neurology","n_participants":null,"pmid":"9191758","source_url":"https://pubmed.ncbi.nlm.nih.gov/9191758/","study_design":"longitudinal study","title":"A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging","title_match":false,"year":1997},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/assessment-of-pain-18487245","doi":"10.1093/bja/aen103","journal":"British journal of anaesthesia","n_participants":null,"pmid":"18487245","source_url":"https://pubmed.ncbi.nlm.nih.gov/18487245/","study_design":null,"title":"Assessment of pain","title_match":false,"year":2008},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/pm2-5-exposure-in-association-with-ad-related-neuropathology-and-34634399","doi":"10.1016/j.envpol.2021.118320","journal":"Environmental pollution (Barking, Essex : 1987)","n_participants":null,"pmid":"34634399","source_url":"https://pubmed.ncbi.nlm.nih.gov/34634399/","study_design":null,"title":"PM2.5 exposure in association with AD-related neuropathology and cognitive outcomes","title_match":false,"year":2022},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/anticholinesterases-medical-applications-of-neurochemical-principles-7722478","doi":"10.1046/j.1471-4159.1995.64051909.x","journal":"Journal of neurochemistry","n_participants":null,"pmid":"7722478","source_url":"https://pubmed.ncbi.nlm.nih.gov/7722478/","study_design":null,"title":"Anticholinesterases: medical applications of neurochemical principles","title_match":false,"year":1995},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/long-chain-omega-3-fatty-acids-and-the-brain-a-review-of-the-25954194","doi":"10.3389/fnagi.2015.00052","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"25954194","source_url":"https://pubmed.ncbi.nlm.nih.gov/25954194/","study_design":null,"title":"Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/role-of-neuroinflammation-in-neurodegeneration-development-37433768","doi":"10.1038/s41392-023-01486-5","journal":"Signal transduction and targeted therapy","n_participants":null,"pmid":"37433768","source_url":"https://pubmed.ncbi.nlm.nih.gov/37433768/","study_design":null,"title":"Role of neuroinflammation in neurodegeneration development","title_match":false,"year":2023},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-role-of-inflammation-in-cns-injury-and-disease-16402109","doi":"10.1038/sj.bjp.0706400","journal":"British journal of pharmacology","n_participants":null,"pmid":"16402109","source_url":"https://pubmed.ncbi.nlm.nih.gov/16402109/","study_design":null,"title":"The role of inflammation in CNS injury and disease","title_match":false,"year":2006},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/maternal-immune-activation-and-abnormal-brain-development-across-cns-25311587","doi":"10.1038/nrneurol.2014.187","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"25311587","source_url":"https://pubmed.ncbi.nlm.nih.gov/25311587/","study_design":null,"title":"Maternal immune activation and abnormal brain development across CNS disorders","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/tnf-signaling-inhibition-in-the-cns-implications-for-normal-brain-18925972","doi":"10.1186/1742-2094-5-45","journal":"Journal of neuroinflammation","n_participants":null,"pmid":"18925972","source_url":"https://pubmed.ncbi.nlm.nih.gov/18925972/","study_design":null,"title":"TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease","title_match":false,"year":2008},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-gut-microbiome-in-neurological-disorders-31753762","doi":"10.1016/s1474-4422(19)30356-4","journal":"The Lancet. Neurology","n_participants":null,"pmid":"31753762","source_url":"https://pubmed.ncbi.nlm.nih.gov/31753762/","study_design":"cross-sectional","title":"The gut microbiome in neurological disorders","title_match":false,"year":2020},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/fecal-microbiota-transplantation-in-neurological-disorders-32266160","doi":"10.3389/fcimb.2020.00098","journal":"Frontiers in cellular and infection microbiology","n_participants":null,"pmid":"32266160","source_url":"https://pubmed.ncbi.nlm.nih.gov/32266160/","study_design":null,"title":"Fecal Microbiota Transplantation in Neurological Disorders","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/gut-microbiome-and-human-health-exploring-how-the-probiotic-genus-36353491","doi":"10.3389/fphar.2022.1042189","journal":"Frontiers in pharmacology","n_participants":null,"pmid":"36353491","source_url":"https://pubmed.ncbi.nlm.nih.gov/36353491/","study_design":"narrative review","title":"Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/pharmaceutical-strategies-of-improving-oral-systemic-bioavailability-31682912","doi":"10.1016/j.jconrel.2019.10.053","journal":"Journal of controlled release : official journal of the Controlled Release Society","n_participants":null,"pmid":"31682912","source_url":"https://pubmed.ncbi.nlm.nih.gov/31682912/","study_design":null,"title":"Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application","title_match":false,"year":2019},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/does-severity-of-alzheimer-s-disease-contribute-to-its-responsiveness-30158897","doi":"10.3389/fneur.2018.00662","journal":"Frontiers in neurology","n_participants":null,"pmid":"30158897","source_url":"https://pubmed.ncbi.nlm.nih.gov/30158897/","study_design":null,"title":"Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial","title_match":true,"year":2018},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-pleiotropic-neuroprotective-effects-of-resveratrol-in-cognitive-33571701","doi":"10.1016/j.arr.2021.101271","journal":"Ageing research reviews","n_participants":null,"pmid":"33571701","source_url":"https://pubmed.ncbi.nlm.nih.gov/33571701/","study_design":null,"title":"The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy","title_match":false,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/gut-mycobiome-and-its-interaction-with-diet-gut-bacteria-and-32861197","doi":"10.1016/j.ebiom.2020.102950","journal":"EBioMedicine","n_participants":null,"pmid":"32861197","source_url":"https://pubmed.ncbi.nlm.nih.gov/32861197/","study_design":null,"title":"Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study","title_match":false,"year":2020},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/curcumin-inhibits-formation-of-amyloid-beta-oligomers-and-fibrils-15590663","doi":"10.1074/jbc.m404751200","journal":"The Journal of biological chemistry","n_participants":null,"pmid":"15590663","source_url":"https://pubmed.ncbi.nlm.nih.gov/15590663/","study_design":null,"title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","title_match":false,"year":2005},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/gdnf-ngf-and-bdnf-as-therapeutic-options-for-neurodegeneration-23348013","doi":"10.1016/j.pharmthera.2013.01.004","journal":"Pharmacology & therapeutics","n_participants":null,"pmid":"23348013","source_url":"https://pubmed.ncbi.nlm.nih.gov/23348013/","study_design":null,"title":"GDNF, NGF and BDNF as therapeutic options for neurodegeneration","title_match":false,"year":2013},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/a-review-inflammatory-process-in-alzheimer-s-disease-role-of-cytokines-22566778","doi":"10.1100/2012/756357","journal":"TheScientificWorldJournal","n_participants":null,"pmid":"22566778","source_url":"https://pubmed.ncbi.nlm.nih.gov/22566778/","study_design":null,"title":"A review: inflammatory process in Alzheimer's disease, role of cytokines","title_match":false,"year":2012},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/oxidative-stress-synaptic-dysfunction-and-alzheimer-s-disease-28059794","doi":"10.3233/jad-161088","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"28059794","source_url":"https://pubmed.ncbi.nlm.nih.gov/28059794/","study_design":null,"title":"Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease","title_match":false,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/targeting-oxidative-stress-in-disease-promise-and-limitations-of-34194012","doi":"10.1038/s41573-021-00233-1","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"34194012","source_url":"https://pubmed.ncbi.nlm.nih.gov/34194012/","study_design":null,"title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/molecular-mechanisms-of-cell-death-in-neurological-diseases-34099897","doi":"10.1038/s41418-021-00814-y","journal":"Cell death and differentiation","n_participants":null,"pmid":"34099897","source_url":"https://pubmed.ncbi.nlm.nih.gov/34099897/","study_design":null,"title":"Molecular mechanisms of cell death in neurological diseases","title_match":false,"year":2021},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/safety-and-immunogenicity-of-the-tau-vaccine-aadvac1-in-patients-with-27955995","doi":"10.1016/s1474-4422(16)30331-3","journal":"The Lancet. Neurology","n_participants":30,"pmid":"27955995","source_url":"https://pubmed.ncbi.nlm.nih.gov/27955995/","study_design":"clinical trial","title":"Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial","title_match":true,"year":2017},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/treatment-of-agitation-in-ad-a-randomized-placebo-controlled-clinical-11087767","doi":"10.1212/wnl.55.9.1271","journal":"Neurology","n_participants":149,"pmid":"11087767","source_url":"https://pubmed.ncbi.nlm.nih.gov/11087767/","study_design":null,"title":"Treatment of agitation in AD: a randomized, placebo-controlled clinical trial","title_match":true,"year":2000},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/systematic-review-of-information-and-support-interventions-for-17662119","doi":"10.1186/1471-2318-7-18","journal":"BMC geriatrics","n_participants":null,"pmid":"17662119","source_url":"https://pubmed.ncbi.nlm.nih.gov/17662119/","study_design":"systematic review","title":"Systematic review of information and support interventions for caregivers of people with dementia","title_match":false,"year":2007},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/community-occupational-therapy-for-older-patients-with-dementia-and-18171718","doi":"10.1136/bmj.39408.481898.be","journal":"BMJ (Clinical research ed.)","n_participants":135,"pmid":"18171718","source_url":"https://pubmed.ncbi.nlm.nih.gov/18171718/","study_design":"randomized controlled trial","title":"Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study","title_match":false,"year":2008},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/development-and-preliminary-validation-of-the-pain-assessment-14999652","doi":"10.1016/j.pmn.2003.10.001","journal":"Pain management nursing : official journal of the American Society of Pain Management Nurses","n_participants":null,"pmid":"14999652","source_url":"https://pubmed.ncbi.nlm.nih.gov/14999652/","study_design":"clinical trial","title":"Development and preliminary validation of the pain assessment checklist for seniors with limited ability to communicate (PACSLAC)","title_match":false,"year":2004},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/impact-of-person-centred-care-training-and-person-centred-activities-29408901","doi":"10.1371/journal.pmed.1002500","journal":"PLoS medicine","n_participants":847,"pmid":"29408901","source_url":"https://pubmed.ncbi.nlm.nih.gov/29408901/","study_design":"randomized controlled trial","title":"Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial","title_match":true,"year":2018},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-different-models-of-home-and-community-care-21549010","doi":"10.1186/1472-6963-11-93","journal":"BMC health services research","n_participants":null,"pmid":"21549010","source_url":"https://pubmed.ncbi.nlm.nih.gov/21549010/","study_design":"systematic review","title":"A systematic review of different models of home and community care services for older persons","title_match":false,"year":2011},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/18-f-flutemetamol-amyloid-positron-emission-tomography-in-preclinical-26141264","doi":"10.1016/j.jalz.2015.05.018","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":68,"pmid":"26141264","source_url":"https://pubmed.ncbi.nlm.nih.gov/26141264/","study_design":"clinical trial","title":"[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-\u03b2 pathology","title_match":false,"year":2015},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/the-use-of-cholinesterase-inhibitors-across-all-stages-of-alzheimer-s-26033268","doi":"10.1007/s40266-015-0273-x","journal":"Drugs & aging","n_participants":null,"pmid":"26033268","source_url":"https://pubmed.ncbi.nlm.nih.gov/26033268/","study_design":"meta-analysis","title":"The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-amnestic-mild-cognitive-impairment-and-age-18590347","doi":null,"journal":"Alternative medicine review : a journal of clinical therapeutic","n_participants":null,"pmid":"18590347","source_url":"https://pubmed.ncbi.nlm.nih.gov/18590347/","study_design":null,"title":"Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention","title_match":false,"year":2008},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/neurodegenerative-diseases-from-available-treatments-to-prospective-26550708","doi":"10.1016/j.neuint.2015.11.001","journal":"Neurochemistry international","n_participants":null,"pmid":"26550708","source_url":"https://pubmed.ncbi.nlm.nih.gov/26550708/","study_design":null,"title":"Neurodegenerative diseases: From available treatments to prospective herbal therapy","title_match":false,"year":2016},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/strategic-roadmap-for-an-early-diagnosis-of-alzheimer-s-disease-based-28721928","doi":"10.1016/s1474-4422(17)30159-x","journal":"The Lancet. Neurology","n_participants":null,"pmid":"28721928","source_url":"https://pubmed.ncbi.nlm.nih.gov/28721928/","study_design":"clinical trial","title":"Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers","title_match":false,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-and-blood-biomarkers-for-neurodegenerative-29076399","doi":"10.1080/15622975.2017.1375556","journal":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","n_participants":null,"pmid":"29076399","source_url":"https://pubmed.ncbi.nlm.nih.gov/29076399/","study_design":null,"title":"Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry","title_match":false,"year":2018},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/clinical-and-bacterial-markers-of-periodontitis-and-their-association-32280099","doi":"10.3233/jad-200064","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"32280099","source_url":"https://pubmed.ncbi.nlm.nih.gov/32280099/","study_design":null,"title":"Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer's Disease Dementia in a Large National Survey","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/neurotrophic-and-neuroregenerative-effects-of-gh-igf1-29149058","doi":"10.3390/ijms18112441","journal":"International journal of molecular sciences","n_participants":null,"pmid":"29149058","source_url":"https://pubmed.ncbi.nlm.nih.gov/29149058/","study_design":null,"title":"Neurotrophic and Neuroregenerative Effects of GH/IGF1","title_match":false,"year":2017},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/cognitive-stimulation-therapy-for-people-with-dementia-cost-16738349","doi":"10.1192/bjp.bp.105.010561","journal":"The British journal of psychiatry : the journal of mental science","n_participants":91,"pmid":"16738349","source_url":"https://pubmed.ncbi.nlm.nih.gov/16738349/","study_design":"randomized controlled trial","title":"Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis","title_match":false,"year":2006},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/recent-developments-in-alzheimer-s-disease-therapeutics-19228370","doi":"10.1186/1741-7015-7-7","journal":"BMC medicine","n_participants":null,"pmid":"19228370","source_url":"https://pubmed.ncbi.nlm.nih.gov/19228370/","study_design":null,"title":"Recent developments in Alzheimer's disease therapeutics","title_match":false,"year":2009},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/advances-in-progressive-supranuclear-palsy-new-diagnostic-criteria-28653647","doi":"10.1016/s1474-4422(17)30157-6","journal":"The Lancet. Neurology","n_participants":null,"pmid":"28653647","source_url":"https://pubmed.ncbi.nlm.nih.gov/28653647/","study_design":null,"title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","title_match":false,"year":2017},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/from-revolution-to-evolution-the-glutamate-hypothesis-of-21956446","doi":"10.1038/npp.2011.181","journal":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","n_participants":null,"pmid":"21956446","source_url":"https://pubmed.ncbi.nlm.nih.gov/21956446/","study_design":null,"title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","title_match":false,"year":2012},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/depression-and-postoperative-complications-an-overview-26830195","doi":"10.1186/s12893-016-0120-y","journal":"BMC surgery","n_participants":null,"pmid":"26830195","source_url":"https://pubmed.ncbi.nlm.nih.gov/26830195/","study_design":null,"title":"Depression and postoperative complications: an overview","title_match":false,"year":2016},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/gabaergic-inhibitory-interneuron-deficits-in-alzheimer-s-disease-32714136","doi":"10.3389/fnins.2020.00660","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"32714136","source_url":"https://pubmed.ncbi.nlm.nih.gov/32714136/","study_design":null,"title":"GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment","title_match":false,"year":2020},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/plasma-amyloid-40-42-ratio-predicts-cerebral-amyloidosis-in-31113759","doi":"10.1016/j.jalz.2019.03.009","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":276,"pmid":"31113759","source_url":"https://pubmed.ncbi.nlm.nih.gov/31113759/","study_design":"cohort study","title":"Plasma amyloid \u03b2 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/boosting-power-for-clinical-trials-using-classifiers-based-on-20541286","doi":"10.1016/j.neurobiolaging.2010.04.022","journal":"Neurobiology of aging","n_participants":null,"pmid":"20541286","source_url":"https://pubmed.ncbi.nlm.nih.gov/20541286/","study_design":null,"title":"Boosting power for clinical trials using classifiers based on multiple biomarkers","title_match":true,"year":2010},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/pragmatic-evaluation-of-events-and-benefits-of-lipid-lowering-in-37082807","doi":"10.1111/jgs.18312","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"37082807","source_url":"https://pubmed.ncbi.nlm.nih.gov/37082807/","study_design":null,"title":"Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale","title_match":false,"year":2023},{"alzhub_score":85,"alzhub_url":"https://alzhub.org/study/effectiveness-of-implementing-a-collaborative-chronic-care-model-for-30821830","doi":"10.1001/jamanetworkopen.2019.0230","journal":"JAMA network open","n_participants":5596,"pmid":"30821830","source_url":"https://pubmed.ncbi.nlm.nih.gov/30821830/","study_design":null,"title":"Effectiveness of Implementing a Collaborative Chronic Care Model for Clinician Teams on Patient Outcomes and Health Status in Mental Health: A Randomized Clinical Trial","title_match":true,"year":2019},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/causal-inference-in-medical-records-and-complementary-systems-36496454","doi":"10.1038/s41467-022-35157-w","journal":"Nature communications","n_participants":null,"pmid":"36496454","source_url":"https://pubmed.ncbi.nlm.nih.gov/36496454/","study_design":null,"title":"Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia","title_match":false,"year":2022},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/representation-of-patients-with-dementia-in-clinical-trials-of-15604527","doi":null,"journal":"The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique","n_participants":3423,"pmid":"15604527","source_url":"https://pubmed.ncbi.nlm.nih.gov/15604527/","study_design":"systematic review","title":"Representation of patients with dementia in clinical trials of donepezil","title_match":true,"year":2004},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/melatonin-and-bright-light-treatment-for-rest-activity-disruption-in-18070004","doi":"10.1111/j.1532-5415.2007.01543.x","journal":"Journal of the American Geriatrics Society","n_participants":16,"pmid":"18070004","source_url":"https://pubmed.ncbi.nlm.nih.gov/18070004/","study_design":null,"title":"Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease","title_match":false,"year":2008},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-natural-history-of-treated-parkinson-s-disease-in-an-incident-21593513","doi":"10.1136/jnnp.2011.240366","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"21593513","source_url":"https://pubmed.ncbi.nlm.nih.gov/21593513/","study_design":null,"title":"The natural history of treated Parkinson's disease in an incident, community based cohort","title_match":false,"year":2011},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/neurological-phenotypes-for-down-syndrome-across-the-life-span-22541290","doi":"10.1016/b978-0-444-54299-1.00006-6","journal":"Progress in brain research","n_participants":null,"pmid":"22541290","source_url":"https://pubmed.ncbi.nlm.nih.gov/22541290/","study_design":null,"title":"Neurological phenotypes for Down syndrome across the life span","title_match":false,"year":2012},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effects-of-resistance-exercise-training-on-cognitive-function-and-30272098","doi":"10.1007/s12603-018-1090-9","journal":"The journal of nutrition, health & aging","n_participants":30,"pmid":"30272098","source_url":"https://pubmed.ncbi.nlm.nih.gov/30272098/","study_design":"randomized controlled trial","title":"Effects of Resistance Exercise Training on Cognitive Function and Physical Performance in Cognitive Frailty: A Randomized Controlled Trial","title_match":true,"year":2018},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/down-syndrome-and-alzheimer-s-disease-common-pathways-common-goals-25510383","doi":"10.1016/j.jalz.2014.10.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":400000,"pmid":"25510383","source_url":"https://pubmed.ncbi.nlm.nih.gov/25510383/","study_design":null,"title":"Down syndrome and Alzheimer's disease: Common pathways, common goals","title_match":false,"year":2015},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/role-of-phosphodiesterases-in-the-pathophysiology-of-33414502","doi":"10.1038/s41380-020-00997-9","journal":"Molecular psychiatry","n_participants":null,"pmid":"33414502","source_url":"https://pubmed.ncbi.nlm.nih.gov/33414502/","study_design":null,"title":"Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders","title_match":false,"year":2021},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/a-phase-1-clinical-trial-of-nerve-growth-factor-gene-therapy-for-15852017","doi":"10.1038/nm1239","journal":"Nature medicine","n_participants":null,"pmid":"15852017","source_url":"https://pubmed.ncbi.nlm.nih.gov/15852017/","study_design":"clinical trial","title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","title_match":true,"year":2005},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/incidence-and-impact-of-subclinical-epileptiform-activity-in-27696483","doi":"10.1002/ana.24794","journal":"Annals of neurology","n_participants":33,"pmid":"27696483","source_url":"https://pubmed.ncbi.nlm.nih.gov/27696483/","study_design":null,"title":"Incidence and impact of subclinical epileptiform activity in Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/cross-cohort-validation-and-cutpoint-estimation-of-the-janssen-plasma-41273220","doi":"10.1002/alz.70916","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":441,"pmid":"41273220","source_url":"https://pubmed.ncbi.nlm.nih.gov/41273220/","study_design":"cohort study","title":"Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community studies","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/p-tau235-a-novel-biomarker-for-staging-preclinical-alzheimer-s-disease-34725927","doi":"10.15252/emmm.202115098","journal":"EMBO molecular medicine","n_participants":null,"pmid":"34725927","source_url":"https://pubmed.ncbi.nlm.nih.gov/34725927/","study_design":null,"title":"P-tau235: a novel biomarker for staging preclinical Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-p-tau212-identifies-cognitively-unimpaired-individuals-with-41447416","doi":"10.1007/s00415-025-13572-5","journal":"Journal of neurology","n_participants":317,"pmid":"41447416","source_url":"https://pubmed.ncbi.nlm.nih.gov/41447416/","study_design":null,"title":"Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-\u03b2 pathology","title_match":false,"year":2025},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/implementing-plasma-p-tau217-and-cognitive-testing-for-alzheimer-s-41804834","doi":"10.1002/alz.71251","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"41804834","source_url":"https://pubmed.ncbi.nlm.nih.gov/41804834/","study_design":"longitudinal study","title":"Implementing plasma p-tau217 and cognitive testing for Alzheimer's screening in low-education populations in central China","title_match":false,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/comparison-of-three-plasma-p-tau217-assays-to-detect-pet-confirmed-41788190","doi":"10.1002/dad2.70294","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":113,"pmid":"41788190","source_url":"https://pubmed.ncbi.nlm.nih.gov/41788190/","study_design":null,"title":"Comparison of three plasma p-tau217 assays to detect PET-confirmed Alzheimer's pathologies","title_match":false,"year":2026},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-predicting-brain-wide-tau-accumulation-in-preclinical-40544093","doi":"10.1016/j.tjpad.2025.100252","journal":"The journal of prevention of Alzheimer's disease","n_participants":333,"pmid":"40544093","source_url":"https://pubmed.ncbi.nlm.nih.gov/40544093/","study_design":"cross-sectional","title":"Plasma p-tau217 predicting brain-wide tau accumulation in preclinical AD","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/biomarker-treatment-effects-in-two-phase-3-trials-of-gantenerumab-39887500","doi":"10.1002/alz.14414","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39887500","source_url":"https://pubmed.ncbi.nlm.nih.gov/39887500/","study_design":"clinical trial","title":"Biomarker treatment effects in two phase 3 trials of gantenerumab","title_match":true,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/impact-of-racialization-on-neuroimaging-and-plasma-biomarkers-of-40631440","doi":"10.1002/alz.70463","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":260,"pmid":"40631440","source_url":"https://pubmed.ncbi.nlm.nih.gov/40631440/","study_design":null,"title":"Impact of racialization on neuroimaging and plasma biomarkers of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/temporal-order-of-clinical-and-biomarker-changes-in-familial-36138153","doi":"10.1038/s41591-022-01942-9","journal":"Nature medicine","n_participants":null,"pmid":"36138153","source_url":"https://pubmed.ncbi.nlm.nih.gov/36138153/","study_design":"longitudinal study","title":"Temporal order of clinical and biomarker changes in familial frontotemporal dementia","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/plasma-neurofilament-light-chain-predicts-cerebellar-atrophy-and-33636389","doi":"10.1016/j.nbd.2021.105311","journal":"Neurobiology of disease","n_participants":62,"pmid":"33636389","source_url":"https://pubmed.ncbi.nlm.nih.gov/33636389/","study_design":null,"title":"Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia","title_match":false,"year":2021},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/utility-of-plasma-neurofilament-light-and-total-tau-for-clinical-32995466","doi":"10.1002/dad2.12099","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"32995466","source_url":"https://pubmed.ncbi.nlm.nih.gov/32995466/","study_design":"cross-sectional","title":"Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease","title_match":true,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/comprehensive-cross-sectional-and-longitudinal-analyses-of-plasma-35492244","doi":"10.1016/j.xcrm.2022.100607","journal":"Cell reports. Medicine","n_participants":null,"pmid":"35492244","source_url":"https://pubmed.ncbi.nlm.nih.gov/35492244/","study_design":"longitudinal study","title":"Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/sex-differences-in-the-association-between-repetitive-negative-39528809","doi":"10.1038/s44184-024-00093-8","journal":"Npj mental health research","n_participants":null,"pmid":"39528809","source_url":"https://pubmed.ncbi.nlm.nih.gov/39528809/","study_design":null,"title":"Sex differences in the association between repetitive negative thinking and neurofilament light","title_match":false,"year":2024},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/plasma-biomarkers-and-cognitive-decline-in-hiv-findings-from-two-u-s-41847265","doi":"10.17925/id.2025.4.1.3","journal":"TouchREVIEWS in infectious diseases","n_participants":null,"pmid":"41847265","source_url":"https://pubmed.ncbi.nlm.nih.gov/41847265/","study_design":"cross-sectional","title":"Plasma Biomarkers and Cognitive Decline in HIV: Findings from Two U.S. Cohorts","title_match":false,"year":2025},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/presymptomatic-plasma-biomarkers-in-autosomal-dominant-alzheimer-s-42637536","doi":"10.1136/jnnp-2026-339037","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":113,"pmid":"42637536","source_url":"https://pubmed.ncbi.nlm.nih.gov/42637536/","study_design":"cohort study","title":"Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing","title_match":false,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/blood-biomarkers-in-alzheimer-s-disease-37878665","doi":"10.1021/acschemneuro.3c00641","journal":"ACS chemical neuroscience","n_participants":null,"pmid":"37878665","source_url":"https://pubmed.ncbi.nlm.nih.gov/37878665/","study_design":null,"title":"Blood Biomarkers in Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/predicting-cognitive-decline-with-amyloid-pet-plasma-p-tau217-a42-40-41117398","doi":"10.1002/alz.70802","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":225,"pmid":"41117398","source_url":"https://pubmed.ncbi.nlm.nih.gov/41117398/","study_design":null,"title":"Predicting cognitive decline with amyloid-PET, plasma p-tau217, A\u03b242/40, and p-tau217/A\u03b242 in a community-based cohort - relevance for clinical trial enrollment","title_match":true,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-biomarkers-in-the-longitudinal-early-onset-37491668","doi":"10.1002/alz.13399","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"37491668","source_url":"https://pubmed.ncbi.nlm.nih.gov/37491668/","study_design":"longitudinal study","title":"Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study","title_match":false,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/associations-of-csf-bace1-with-amyloid-pathology-neurodegeneration-38856925","doi":"10.1007/s00401-024-02750-w","journal":"Acta neuropathologica","n_participants":null,"pmid":"38856925","source_url":"https://pubmed.ncbi.nlm.nih.gov/38856925/","study_design":null,"title":"Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/preclinical-in-vivo-longitudinal-assessment-of-kg207-m-as-a-disease-34378436","doi":"10.1177/0271678x211035625","journal":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","n_participants":null,"pmid":"34378436","source_url":"https://pubmed.ncbi.nlm.nih.gov/34378436/","study_design":"longitudinal study","title":"Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/can-the-clinical-sign-head-turning-sign-and-simple-questions-in-39568089","doi":"10.1186/s13195-024-01605-6","journal":"Alzheimer's research & therapy","n_participants":155,"pmid":"39568089","source_url":"https://pubmed.ncbi.nlm.nih.gov/39568089/","study_design":null,"title":"Can the clinical sign \"head-turning sign\" and simple questions in \"Neucop-Q\" predict amyloid \u03b2 pathology?","title_match":false,"year":2024},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/interactions-between-weight-loss-and-plasma-neurodegenerative-markers-35034116","doi":"10.1093/gerona/glac015","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":470,"pmid":"35034116","source_url":"https://pubmed.ncbi.nlm.nih.gov/35034116/","study_design":null,"title":"Interactions Between Weight Loss and Plasma Neurodegenerative Markers for Determining Cognitive Decline Among Community-Dwelling Older Adults","title_match":false,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-amplified-plasmonic-exosome-a42-platform-33370497","doi":"10.1111/ene.14704","journal":"European journal of neurology","n_participants":68,"pmid":"33370497","source_url":"https://pubmed.ncbi.nlm.nih.gov/33370497/","study_design":null,"title":"Head-to-head comparison of amplified plasmonic exosome A\u03b242 platform and single-molecule array immunoassay in a memory clinic cohort","title_match":false,"year":2021},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/blood-biomarker-based-classification-study-for-neurodegenerative-37821485","doi":"10.1038/s41598-023-43956-4","journal":"Scientific reports","n_participants":null,"pmid":"37821485","source_url":"https://pubmed.ncbi.nlm.nih.gov/37821485/","study_design":null,"title":"Blood biomarker-based classification study for neurodegenerative diseases","title_match":false,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/a-possible-blood-plasma-biomarker-for-early-stage-alzheimer-s-disease-35446894","doi":"10.1371/journal.pone.0267407","journal":"PloS one","n_participants":25,"pmid":"35446894","source_url":"https://pubmed.ncbi.nlm.nih.gov/35446894/","study_design":null,"title":"A possible blood plasma biomarker for early-stage Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/plasma-neurofilament-l-to-amyloid-42-ratio-in-differentiating-34741884","doi":"10.1016/j.ajp.2021.102914","journal":"Asian journal of psychiatry","n_participants":null,"pmid":"34741884","source_url":"https://pubmed.ncbi.nlm.nih.gov/34741884/","study_design":null,"title":"Plasma neurofilament L to amyloid \u03b242 ratio in differentiating Alzheimer's type from non-Alzheimer's dementia: A cross-sectional pilot study from India","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/blood-based-systems-biology-biomarkers-for-next-generation-clinical-31636492","doi":"10.31887/dcns.2019.21.2/hhampel","journal":"Dialogues in clinical neuroscience","n_participants":null,"pmid":"31636492","source_url":"https://pubmed.ncbi.nlm.nih.gov/31636492/","study_design":null,"title":"Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease ","title_match":true,"year":2019},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/a-fragment-of-s38aa-is-a-novel-plasma-biomarker-of-alzheimer-s-disease-31524172","doi":"10.3233/jad-190700","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"31524172","source_url":"https://pubmed.ncbi.nlm.nih.gov/31524172/","study_design":null,"title":"A Fragment of S38AA is a Novel Plasma Biomarker of Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/targeted-mass-spectrometry-suggests-beta-synuclein-as-synaptic-blood-32101007","doi":"10.1021/acs.jproteome.9b00824","journal":"Journal of proteome research","n_participants":64,"pmid":"32101007","source_url":"https://pubmed.ncbi.nlm.nih.gov/32101007/","study_design":null,"title":"Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer's Disease","title_match":false,"year":2020},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/evaluation-of-blood-based-plasma-biomarkers-as-potential-markers-of-36710683","doi":"10.3233/jad-221118","journal":"Journal of Alzheimer's disease : JAD","n_participants":100,"pmid":"36710683","source_url":"https://pubmed.ncbi.nlm.nih.gov/36710683/","study_design":"cross-sectional","title":"Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/csf-proteome-profiling-reveals-biomarkers-to-discriminate-dementia-37704597","doi":"10.1038/s41467-023-41122-y","journal":"Nature communications","n_participants":109,"pmid":"37704597","source_url":"https://pubmed.ncbi.nlm.nih.gov/37704597/","study_design":null,"title":"CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer\u00b4s disease","title_match":false,"year":2023},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/novel-csf-tau-biomarkers-can-be-used-for-disease-staging-of-sporadic-37503281","doi":"10.1101/2023.07.14.23292650","journal":"medRxiv : the preprint server for health sciences","n_participants":426,"pmid":"37503281","source_url":"https://pubmed.ncbi.nlm.nih.gov/37503281/","study_design":"longitudinal study","title":"Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/neuropsychological-measures-that-detect-early-impairment-and-decline-28482211","doi":"10.1016/j.neurobiolaging.2017.04.004","journal":"Neurobiology of aging","n_participants":233,"pmid":"28482211","source_url":"https://pubmed.ncbi.nlm.nih.gov/28482211/","study_design":"longitudinal study","title":"Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease","title_match":false,"year":2017},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-beta-amyloid-and-dynabridging-in-alzheimer-s-20477709","doi":"10.2217/bmm.09.39","journal":"Biomarkers in medicine","n_participants":null,"pmid":"20477709","source_url":"https://pubmed.ncbi.nlm.nih.gov/20477709/","study_design":null,"title":"Cerebrospinal fluid beta-amyloid and dynabridging in Alzheimer's disease drug development","title_match":false,"year":2009},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/csf-biomarker-concordance-with-amyloid-pet-in-phase-3-studies-of-36795603","doi":"10.1002/alz.12919","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"36795603","source_url":"https://pubmed.ncbi.nlm.nih.gov/36795603/","study_design":"clinical trial","title":"CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab","title_match":true,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/ccog-web-based-cognitive-assessment-tool-38427202","doi":"10.1007/978-1-0716-3774-6_19","journal":"Methods in molecular biology (Clifton, N.J.)","n_participants":null,"pmid":"38427202","source_url":"https://pubmed.ncbi.nlm.nih.gov/38427202/","study_design":null,"title":"cCOG Web-Based Cognitive Assessment Tool","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/a-paradox-in-digital-memory-assessment-increased-sensitivity-with-34881380","doi":"10.3389/fdgth.2021.780303","journal":"Frontiers in digital health","n_participants":null,"pmid":"34881380","source_url":"https://pubmed.ncbi.nlm.nih.gov/34881380/","study_design":null,"title":"A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced Difficulty","title_match":false,"year":2021},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/virtual-reality-based-cognitive-stimulation-on-people-with-mild-to-34065698","doi":"10.3390/ijerph18105290","journal":"International journal of environmental research and public health","n_participants":17,"pmid":"34065698","source_url":"https://pubmed.ncbi.nlm.nih.gov/34065698/","study_design":"randomized controlled trial","title":"Virtual Reality-Based Cognitive Stimulation on People with Mild to Moderate Dementia due to Alzheimer's Disease: A Pilot Randomized Controlled Trial","title_match":true,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/smartphone-keystroke-based-cognitive-impairment-diagnostic-methodology-41337282","doi":"10.1109/embc58623.2025.11253467","journal":"Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference","n_participants":null,"pmid":"41337282","source_url":"https://pubmed.ncbi.nlm.nih.gov/41337282/","study_design":null,"title":"Smartphone Keystroke-based Cognitive Impairment Diagnostic Methodology","title_match":false,"year":2025},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/computerised-cognitive-training-in-parkinson-s-disease-a-protocol-for-33234647","doi":"10.1136/bmjopen-2020-040656","journal":"BMJ open","n_participants":null,"pmid":"33234647","source_url":"https://pubmed.ncbi.nlm.nih.gov/33234647/","study_design":"systematic review","title":"Computerised cognitive training in Parkinson's disease: a protocol for a systematic review and updated meta-analysis","title_match":false,"year":2020},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/computerised-cognitive-remediation-to-enhance-mobility-in-older-34522910","doi":"10.1016/s2666-7568(21)00173-2","journal":"The lancet. Healthy longevity","n_participants":383,"pmid":"34522910","source_url":"https://pubmed.ncbi.nlm.nih.gov/34522910/","study_design":"randomized controlled trial","title":"Computerised cognitive remediation to enhance mobility in older adults: a single-blind, single-centre, randomised trial","title_match":false,"year":2021},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/the-effect-of-tablet-based-multimodal-training-on-cognitive-40802794","doi":"10.1371/journal.pone.0329931","journal":"PloS one","n_participants":null,"pmid":"40802794","source_url":"https://pubmed.ncbi.nlm.nih.gov/40802794/","study_design":"randomized controlled trial","title":"The effect of tablet-based multimodal training on cognitive functioning in Alzheimer's disease: A randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/reproducibility-and-replicability-of-high-frequency-in-home-digital-35005204","doi":"10.1002/trc2.12220","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"35005204","source_url":"https://pubmed.ncbi.nlm.nih.gov/35005204/","study_design":null,"title":"Reproducibility and replicability of high-frequency, in-home digital biomarkers in reducing sample sizes for clinical trials","title_match":true,"year":2021},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-acupuncture-for-mild-cognitive-impairment-a-38560732","doi":"10.3389/fneur.2024.1346858","journal":"Frontiers in neurology","n_participants":32,"pmid":"38560732","source_url":"https://pubmed.ncbi.nlm.nih.gov/38560732/","study_design":null,"title":"Safety and efficacy of acupuncture for mild cognitive impairment: a study protocol for clinical study","title_match":false,"year":2024},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/a-tablet-based-intervention-for-activating-nursing-home-residents-34183087","doi":"10.1017/s1041610221000818","journal":"International psychogeriatrics","n_participants":162,"pmid":"34183087","source_url":"https://pubmed.ncbi.nlm.nih.gov/34183087/","study_design":"randomized controlled trial","title":"A tablet-based intervention for activating nursing home residents with dementia: results from a cluster-randomized controlled trial","title_match":true,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/digital-biomarkers-based-individualized-prognosis-for-people-at-risk-32468532","doi":"10.1007/978-3-030-32622-7_14","journal":"Advances in experimental medicine and biology","n_participants":null,"pmid":"32468532","source_url":"https://pubmed.ncbi.nlm.nih.gov/32468532/","study_design":null,"title":"Digital Biomarkers Based Individualized Prognosis for People at Risk of Dementia: the AltoidaML Multi-site External Validation Study","title_match":false,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/individualised-computerised-cognitive-training-for-community-dwelling-35513855","doi":"10.1186/s13063-022-06152-9","journal":"Trials","n_participants":null,"pmid":"35513855","source_url":"https://pubmed.ncbi.nlm.nih.gov/35513855/","study_design":null,"title":"Individualised computerised cognitive training for community-dwelling people with mild cognitive impairment: study protocol of a completely virtual, randomised, controlled trial","title_match":true,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-adni-administrative-core-ensuring-adni-s-success-and-informing-39535465","doi":"10.1002/alz.14311","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":500,"pmid":"39535465","source_url":"https://pubmed.ncbi.nlm.nih.gov/39535465/","study_design":null,"title":"The ADNI Administrative Core: Ensuring ADNI's success and informing future AD clinical trials","title_match":true,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/digital-computerised-cognitive-training-for-preventing-cognitive-38423771","doi":"10.1136/bmjopen-2023-079305","journal":"BMJ open","n_participants":null,"pmid":"38423771","source_url":"https://pubmed.ncbi.nlm.nih.gov/38423771/","study_design":null,"title":"Digital computerised cognitive training for preventing cognitive decline among hypertensive patients: a study protocol for a multicentre randomised controlled trial (DELIGHT trial)","title_match":true,"year":2024},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/can-a-serious-game-based-cognitive-training-attenuate-cognitive-35962371","doi":"10.1186/s12888-022-04131-7","journal":"BMC psychiatry","n_participants":162,"pmid":"35962371","source_url":"https://pubmed.ncbi.nlm.nih.gov/35962371/","study_design":"randomized controlled trial","title":"Can a serious game-based cognitive training attenuate cognitive decline related to Alzheimer's disease? Protocol for a randomized controlled trial","title_match":true,"year":2022},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/effect-of-computerized-cognitive-training-on-mood-cognition-and-serum-38298930","doi":"10.3389/fpsyt.2023.1287822","journal":"Frontiers in psychiatry","n_participants":28,"pmid":"38298930","source_url":"https://pubmed.ncbi.nlm.nih.gov/38298930/","study_design":"randomized controlled trial","title":"Effect of computerized cognitive training on mood, cognition, and serum brain-derived neurotrophic factor level in late-life depression - a pilot randomized controlled trial","title_match":true,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/computerized-cognitive-training-for-older-diabetic-adults-at-risk-of-29234725","doi":"10.1016/j.trci.2017.10.003","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29234725","source_url":"https://pubmed.ncbi.nlm.nih.gov/29234725/","study_design":null,"title":"Computerized cognitive training for older diabetic adults at risk of dementia: Study protocol for a randomized controlled trial","title_match":true,"year":2017},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/performance-and-validation-of-a-digital-memory-test-across-the-39886066","doi":"10.1093/braincomms/fcaf024","journal":"Brain communications","n_participants":325,"pmid":"39886066","source_url":"https://pubmed.ncbi.nlm.nih.gov/39886066/","study_design":null,"title":"Performance and validation of a digital memory test across the Alzheimer's disease continuum","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/apoe-in-the-bullseye-of-neurodegenerative-diseases-impact-of-the-apoe-36153580","doi":"10.1186/s13024-022-00566-4","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"36153580","source_url":"https://pubmed.ncbi.nlm.nih.gov/36153580/","study_design":null,"title":"APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/validation-of-a-novel-and-accurate-apoe4-assay-for-automated-32034174","doi":"10.1038/s41598-020-58841-7","journal":"Scientific reports","n_participants":null,"pmid":"32034174","source_url":"https://pubmed.ncbi.nlm.nih.gov/32034174/","study_design":null,"title":"Validation of a novel and accurate ApoE4 assay for automated chemistry analyzers","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/polygenic-risk-score-analysis-of-alzheimer-s-disease-in-cases-without-30569081","doi":"10.14283/jpad.2018.46","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"30569081","source_url":"https://pubmed.ncbi.nlm.nih.gov/30569081/","study_design":null,"title":"Polygenic Risk Score Analysis of Alzheimer's Disease in Cases without APOE4 or APOE2 Alleles","title_match":false,"year":2019},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/polygenic-effect-on-tau-pathology-progression-in-alzheimer-s-disease-36571564","doi":"10.1002/ana.26588","journal":"Annals of neurology","n_participants":85,"pmid":"36571564","source_url":"https://pubmed.ncbi.nlm.nih.gov/36571564/","study_design":"longitudinal study","title":"Polygenic Effect on Tau Pathology Progression in Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/a-genome-wide-association-study-in-human-lymphoblastoid-cells-33610756","doi":"10.1016/j.mito.2021.02.005","journal":"Mitochondrion","n_participants":null,"pmid":"33610756","source_url":"https://pubmed.ncbi.nlm.nih.gov/33610756/","study_design":null,"title":"A genome-wide association study in human lymphoblastoid cells supports safety of mitochondrial complex I inhibitor","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/triggering-receptor-expressed-on-myeloid-cells-2-trem2-a-potential-29889572","doi":"10.1080/14728222.2018.1486823","journal":"Expert opinion on therapeutic targets","n_participants":null,"pmid":"29889572","source_url":"https://pubmed.ncbi.nlm.nih.gov/29889572/","study_design":null,"title":"Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?","title_match":false,"year":2018},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/neuroimaging-biomarkers-and-csf-strem2-levels-in-alzheimer-s-disease-38961148","doi":"10.1038/s41598-024-66211-w","journal":"Scientific reports","n_participants":1001,"pmid":"38961148","source_url":"https://pubmed.ncbi.nlm.nih.gov/38961148/","study_design":"longitudinal study","title":"Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer's disease: a longitudinal study","title_match":false,"year":2024},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/potential-therapeutic-approaches-for-cerebral-amyloid-angiopathy-and-32183348","doi":"10.3390/ijms21061992","journal":"International journal of molecular sciences","n_participants":null,"pmid":"32183348","source_url":"https://pubmed.ncbi.nlm.nih.gov/32183348/","study_design":null,"title":"Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease","title_match":false,"year":2020},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/dian-dian-j-dian-tu-28739983","doi":"10.11477/mf.1416200811","journal":"Brain and nerve = Shinkei kenkyu no shinpo","n_participants":null,"pmid":"28739983","source_url":"https://pubmed.ncbi.nlm.nih.gov/28739983/","study_design":null,"title":"[DIAN/DIAN-J/DIAN-TU]","title_match":false,"year":2017},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/the-dian-study-24101429","doi":null,"journal":"Brain and nerve = Shinkei kenkyu no shinpo","n_participants":null,"pmid":"24101429","source_url":"https://pubmed.ncbi.nlm.nih.gov/24101429/","study_design":null,"title":"[The DIAN study]","title_match":false,"year":2013},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/systematic-validation-of-variants-of-unknown-significance-in-app-32087291","doi":"10.1016/j.nbd.2020.104817","journal":"Neurobiology of disease","n_participants":null,"pmid":"32087291","source_url":"https://pubmed.ncbi.nlm.nih.gov/32087291/","study_design":null,"title":"Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2","title_match":false,"year":2020},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/genetic-analyses-of-early-onset-alzheimer-s-disease-using-next-31182772","doi":"10.1038/s41598-019-44848-2","journal":"Scientific reports","n_participants":67,"pmid":"31182772","source_url":"https://pubmed.ncbi.nlm.nih.gov/31182772/","study_design":null,"title":"Genetic analyses of early-onset Alzheimer's disease using next generation sequencing","title_match":false,"year":2019},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/discovery-and-validation-of-autosomal-dominant-alzheimer-s-disease-30021643","doi":"10.1186/s13195-018-0392-9","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"30021643","source_url":"https://pubmed.ncbi.nlm.nih.gov/30021643/","study_design":null,"title":"Discovery and validation of autosomal dominant Alzheimer's disease mutations","title_match":false,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/familial-alzheimer-s-disease-presenilin-2-mutants-affect-ca2-31606858","doi":"10.1007/s40520-019-01341-0","journal":"Aging clinical and experimental research","n_participants":null,"pmid":"31606858","source_url":"https://pubmed.ncbi.nlm.nih.gov/31606858/","study_design":null,"title":"Familial Alzheimer's disease presenilin-2 mutants affect Ca2+ homeostasis and brain network excitability","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/discovery-and-validation-of-dominantly-inherited-alzheimer-s-disease-35932032","doi":"10.1186/s13195-022-01052-1","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"35932032","source_url":"https://pubmed.ncbi.nlm.nih.gov/35932032/","study_design":null,"title":"Discovery and validation of dominantly inherited Alzheimer's disease mutations in populations from Latin America","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/significance-and-progress-of-dian-a4-api-27025079","doi":null,"journal":"Nihon rinsho. Japanese journal of clinical medicine","n_participants":null,"pmid":"27025079","source_url":"https://pubmed.ncbi.nlm.nih.gov/27025079/","study_design":null,"title":"[Significance and progress of DIAN/A4/API]","title_match":false,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/evaluating-pathogenicity-of-variants-of-unknown-significance-in-app-39875235","doi":"10.1016/j.neurot.2025.e00527","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"39875235","source_url":"https://pubmed.ncbi.nlm.nih.gov/39875235/","study_design":null,"title":"Evaluating pathogenicity of variants of unknown significance in APP, PSEN1, and PSEN2","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/targeting-microglia-in-alzheimer-s-disease-pathogenesis-and-potential-39062547","doi":"10.3390/biom14070833","journal":"Biomolecules","n_participants":null,"pmid":"39062547","source_url":"https://pubmed.ncbi.nlm.nih.gov/39062547/","study_design":null,"title":"Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/single-nucleus-rna-sequencing-demonstrates-an-autosomal-dominant-38417436","doi":"10.1016/j.neuron.2024.02.009","journal":"Neuron","n_participants":null,"pmid":"38417436","source_url":"https://pubmed.ncbi.nlm.nih.gov/38417436/","study_design":null,"title":"Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protection","title_match":false,"year":2024},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/a-randomized-placebo-controlled-trial-of-nicotinamide-riboside-in-37994989","doi":"10.1007/s11357-023-00999-9","journal":"GeroScience","n_participants":null,"pmid":"37994989","source_url":"https://pubmed.ncbi.nlm.nih.gov/37994989/","study_design":null,"title":"A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment","title_match":true,"year":2024},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/association-of-a-pace-of-aging-epigenetic-clock-with-rate-of-39583644","doi":"10.1002/dad2.70038","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":2296,"pmid":"39583644","source_url":"https://pubmed.ncbi.nlm.nih.gov/39583644/","study_design":null,"title":"Association of a pace of aging epigenetic clock with rate of cognitive decline in the Framingham Heart Study Offspring Cohort","title_match":false,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/18f-mk-6240-tau-pet-in-patients-at-risk-for-chronic-traumatic-39994806","doi":"10.1186/s13024-025-00808-1","journal":"Molecular neurodegeneration","n_participants":39,"pmid":"39994806","source_url":"https://pubmed.ncbi.nlm.nih.gov/39994806/","study_design":"clinical trial","title":"18F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/evaluation-of-tau-deposition-using-18f-pi-2620-pet-in-mci-and-early-35897078","doi":"10.1186/s13195-022-01048-x","journal":"Alzheimer's research & therapy","n_participants":74,"pmid":"35897078","source_url":"https://pubmed.ncbi.nlm.nih.gov/35897078/","study_design":"clinical trial","title":"Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-proteomics-identification-of-biomarkers-for-40118053","doi":"10.1016/j.xcrm.2025.102031","journal":"Cell reports. Medicine","n_participants":136,"pmid":"40118053","source_url":"https://pubmed.ncbi.nlm.nih.gov/40118053/","study_design":null,"title":"Cerebrospinal fluid proteomics identification of biomarkers for amyloid and tau PET stages","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/combining-cerebrospinal-fluid-and-pi-2620-tau-pet-for-biomarker-based-39263969","doi":"10.1002/alz.14185","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":64,"pmid":"39263969","source_url":"https://pubmed.ncbi.nlm.nih.gov/39263969/","study_design":null,"title":"Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/a-practical-overview-of-the-use-of-amyloid-pet-centiloid-values-in-40101674","doi":"10.1016/j.nicl.2025.103765","journal":"NeuroImage. Clinical","n_participants":null,"pmid":"40101674","source_url":"https://pubmed.ncbi.nlm.nih.gov/40101674/","study_design":null,"title":"A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research","title_match":true,"year":2025},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/donanemab-ly3002813-phase-1b-study-in-alzheimer-s-disease-rapid-and-34585215","doi":"10.14283/jpad.2021.56","journal":"The journal of prevention of Alzheimer's disease","n_participants":18,"pmid":"34585215","source_url":"https://pubmed.ncbi.nlm.nih.gov/34585215/","study_design":null,"title":"Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging","title_match":true,"year":2021},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/18-f-florbetaben-a-review-in-amyloid-pet-imaging-in-cognitive-26175116","doi":"10.1007/s40263-015-0258-7","journal":"CNS drugs","n_participants":null,"pmid":"26175116","source_url":"https://pubmed.ncbi.nlm.nih.gov/26175116/","study_design":null,"title":"[(18)F]Florbetaben: a review in \u03b2-amyloid PET imaging in cognitive impairment","title_match":false,"year":2015},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/imaging-amyloid-using-18-f-flutemetamol-positron-emission-tomography-26440450","doi":"10.1007/s00259-015-3208-1","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"26440450","source_url":"https://pubmed.ncbi.nlm.nih.gov/26440450/","study_design":null,"title":"Imaging \u03b2-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis","title_match":false,"year":2016},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/early-detection-of-amyloid-load-using-18f-florbetaben-pet-33773598","doi":"10.1186/s13195-021-00807-6","journal":"Alzheimer's research & therapy","n_participants":287,"pmid":"33773598","source_url":"https://pubmed.ncbi.nlm.nih.gov/33773598/","study_design":null,"title":"Early detection of amyloid load using 18F-florbetaben PET","title_match":false,"year":2021},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/18f-florbetaben-pet-ct-to-assess-alzheimer-s-disease-a-new-analysis-30714241","doi":"10.1111/jon.12601","journal":"Journal of neuroimaging : official journal of the American Society of Neuroimaging","n_participants":44,"pmid":"30714241","source_url":"https://pubmed.ncbi.nlm.nih.gov/30714241/","study_design":null,"title":"18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification","title_match":false,"year":2019},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/post-mortem-histopathology-underlying-amyloid-pet-imaging-following-27955679","doi":"10.1186/s40478-016-0399-z","journal":"Acta neuropathologica communications","n_participants":null,"pmid":"27955679","source_url":"https://pubmed.ncbi.nlm.nih.gov/27955679/","study_design":null,"title":"Post-mortem histopathology underlying \u03b2-amyloid PET imaging following flutemetamol F 18 injection","title_match":false,"year":2016},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/medicare-and-amyloid-pet-imaging-the-battle-over-evidence-27285978","doi":"10.1080/08959420.2016.1198970","journal":"Journal of aging & social policy","n_participants":null,"pmid":"27285978","source_url":"https://pubmed.ncbi.nlm.nih.gov/27285978/","study_design":null,"title":"Medicare and Amyloid PET Imaging: The Battle Over Evidence","title_match":false,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/amypad-diagnostic-and-patient-management-study-rationale-and-design-30339801","doi":"10.1016/j.jalz.2018.09.003","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"30339801","source_url":"https://pubmed.ncbi.nlm.nih.gov/30339801/","study_design":null,"title":"AMYPAD Diagnostic and Patient Management Study: Rationale and design","title_match":false,"year":2019},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/prevalence-of-amyloid-positron-emission-tomographic-positivity-in-27539301","doi":"10.1161/strokeaha.116.013778","journal":"Stroke","n_participants":178,"pmid":"27539301","source_url":"https://pubmed.ncbi.nlm.nih.gov/27539301/","study_design":"prospective cohort","title":"Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment","title_match":false,"year":2016},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/electroacupuncture-improves-vascular-cognitive-impairment-no-dementia-38878393","doi":"10.1016/j.jstrokecerebrovasdis.2024.107788","journal":"Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","n_participants":70,"pmid":"38878393","source_url":"https://pubmed.ncbi.nlm.nih.gov/38878393/","study_design":"randomized controlled trial","title":"Electroacupuncture improves vascular cognitive impairment no dementia: A Randomized Clinical Trial","title_match":true,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/dysfunctional-resting-state-network-connectivity-predicts-41475933","doi":"10.1016/j.bja.2025.11.036","journal":"British journal of anaesthesia","n_participants":31,"pmid":"41475933","source_url":"https://pubmed.ncbi.nlm.nih.gov/41475933/","study_design":null,"title":"Dysfunctional resting state network connectivity predicts postoperative delirium after major surgery","title_match":false,"year":2026},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/structural-and-functional-brain-connectivity-in-presymptomatic-25002573","doi":"10.1212/wnl.0000000000000583","journal":"Neurology","n_participants":39,"pmid":"25002573","source_url":"https://pubmed.ncbi.nlm.nih.gov/25002573/","study_design":"case-control study","title":"Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia","title_match":false,"year":2014},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/four-distinct-subtypes-of-alzheimer-s-disease-based-on-resting-state-36137824","doi":"10.1016/j.biopsych.2022.06.019","journal":"Biological psychiatry","n_participants":809,"pmid":"36137824","source_url":"https://pubmed.ncbi.nlm.nih.gov/36137824/","study_design":null,"title":"Four Distinct Subtypes of Alzheimer's Disease Based on Resting-State Connectivity Biomarkers","title_match":false,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/imaging-of-the-optic-nerve-technological-advances-and-future-prospects-36155662","doi":"10.1016/s1474-4422(22)00173-9","journal":"The Lancet. Neurology","n_participants":null,"pmid":"36155662","source_url":"https://pubmed.ncbi.nlm.nih.gov/36155662/","study_design":null,"title":"Imaging of the optic nerve: technological advances and future prospects","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/octa-essential-or-gimmick-38970762","doi":"10.1007/s40123-024-00985-0","journal":"Ophthalmology and therapy","n_participants":null,"pmid":"38970762","source_url":"https://pubmed.ncbi.nlm.nih.gov/38970762/","study_design":null,"title":"OCTA: Essential or Gimmick?","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-from-immunotherapy-to-immunoprevention-37729908","doi":"10.1016/j.cell.2023.08.021","journal":"Cell","n_participants":null,"pmid":"37729908","source_url":"https://pubmed.ncbi.nlm.nih.gov/37729908/","study_design":null,"title":"Alzheimer's disease: From immunotherapy to immunoprevention","title_match":false,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/passive-anti-amyloid-immunotherapy-in-alzheimer-s-disease-39549715","doi":"10.1016/s0140-6736(24)01883-x","journal":"Lancet (London, England)","n_participants":null,"pmid":"39549715","source_url":"https://pubmed.ncbi.nlm.nih.gov/39549715/","study_design":null,"title":"Passive anti-amyloid \u03b2 immunotherapy in Alzheimer's disease-opportunities and challenges","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/treatment-of-alzheimer-disease-39620846","doi":"10.1212/con.0000000000001503","journal":"Continuum (Minneapolis, Minn.)","n_participants":null,"pmid":"39620846","source_url":"https://pubmed.ncbi.nlm.nih.gov/39620846/","study_design":null,"title":"Treatment of Alzheimer Disease","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/anti-amyloid-therapies-for-alzheimer-s-disease-and-the-amyloid-37833948","doi":"10.3390/ijms241914499","journal":"International journal of molecular sciences","n_participants":null,"pmid":"37833948","source_url":"https://pubmed.ncbi.nlm.nih.gov/37833948/","study_design":null,"title":"Anti-Amyloid Therapies for Alzheimer's Disease and the Amyloid Cascade Hypothesis","title_match":false,"year":2023},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/comparative-efficacy-tolerability-and-acceptability-of-donanemab-38253184","doi":"10.1016/j.arr.2024.102203","journal":"Ageing research reviews","n_participants":6547,"pmid":"38253184","source_url":"https://pubmed.ncbi.nlm.nih.gov/38253184/","study_design":"meta-analysis","title":"Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis","title_match":false,"year":2024},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/novel-anti-amyloid-beta-a-monoclonal-antibody-lecanemab-for-alzheimer-37902139","doi":"10.1177/03946320231209839","journal":"International journal of immunopathology and pharmacology","n_participants":2729,"pmid":"37902139","source_url":"https://pubmed.ncbi.nlm.nih.gov/37902139/","study_design":"systematic review","title":"Novel anti-amyloid-beta (A\u03b2) monoclonal antibody lecanemab for Alzheimer's disease: A systematic review","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/anti-amyloid-antibodies-and-anti-tau-therapies-for-alzheimer-s-38945936","doi":"10.1248/cpb.c24-00069","journal":"Chemical & pharmaceutical bulletin","n_participants":null,"pmid":"38945936","source_url":"https://pubmed.ncbi.nlm.nih.gov/38945936/","study_design":"clinical trial","title":"Anti-amyloid-\u03b2 Antibodies and Anti-tau Therapies for Alzheimer's Disease: Recent Advances and Perspectives","title_match":false,"year":2024},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/aducanumab-for-the-treatment-of-alzheimer-s-disease-a-systematic-36775284","doi":"10.1111/psyg.12944","journal":"Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society","n_participants":null,"pmid":"36775284","source_url":"https://pubmed.ncbi.nlm.nih.gov/36775284/","study_design":"meta-analysis","title":"Aducanumab for the treatment of Alzheimer's disease: a systematic review","title_match":false,"year":2023},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/overview-of-alzheimer-s-disease-neuroimaging-initiative-and-future-39711072","doi":"10.1002/alz.14321","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39711072","source_url":"https://pubmed.ncbi.nlm.nih.gov/39711072/","study_design":null,"title":"Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials","title_match":true,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/lecanemab-leqembi-is-not-the-right-drug-for-patients-with-alzheimer-s-37676096","doi":"10.17219/acem/171379","journal":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","n_participants":null,"pmid":"37676096","source_url":"https://pubmed.ncbi.nlm.nih.gov/37676096/","study_design":null,"title":"Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/comparisons-of-efficacy-and-safety-of-immunotherapies-for-alzheimer-s-40473116","doi":"10.1016/j.clinme.2025.100336","journal":"Clinical medicine (London, England)","n_participants":null,"pmid":"40473116","source_url":"https://pubmed.ncbi.nlm.nih.gov/40473116/","study_design":"meta-analysis","title":"Comparisons of efficacy and safety of immunotherapies for Alzheimer's disease treatment: A network meta-analysis of randomised controlled trials","title_match":true,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-studies-of-gantenerumab-in-patients-with-25081412","doi":"10.1586/14737175.2014.945522","journal":"Expert review of neurotherapeutics","n_participants":null,"pmid":"25081412","source_url":"https://pubmed.ncbi.nlm.nih.gov/25081412/","study_design":null,"title":"Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/the-potential-of-solanezumab-and-gantenerumab-to-prevent-alzheimer-s-29037101","doi":"10.1080/14712598.2018.1389885","journal":"Expert opinion on biological therapy","n_participants":null,"pmid":"29037101","source_url":"https://pubmed.ncbi.nlm.nih.gov/29037101/","study_design":null,"title":"The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset","title_match":false,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/anti-amyloid-antibody-therapies-for-alzheimer-s-disease-38932758","doi":"10.1007/s13139-024-00848-3","journal":"Nuclear medicine and molecular imaging","n_participants":null,"pmid":"38932758","source_url":"https://pubmed.ncbi.nlm.nih.gov/38932758/","study_design":"clinical trial","title":"Anti-amyloid Antibody Therapies for Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/monoclonal-antibody-treatments-for-alzheimer-s-disease-aducanumab-and-39726673","doi":"10.15190/d.2023.12","journal":"Discoveries (Craiova, Romania)","n_participants":null,"pmid":"39726673","source_url":"https://pubmed.ncbi.nlm.nih.gov/39726673/","study_design":null,"title":"Monoclonal Antibody Treatments for Alzheimer's Disease: Aducanumab and Lecanemab","title_match":false,"year":2023},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-long-term-gantenerumab-treatment-in-dominantly-40120616","doi":"10.1016/s1474-4422(25)00024-9","journal":"The Lancet. Neurology","n_participants":53,"pmid":"40120616","source_url":"https://pubmed.ncbi.nlm.nih.gov/40120616/","study_design":"clinical trial","title":"Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial","title_match":true,"year":2025},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/comparative-efficacy-tolerability-and-acceptability-of-aducanumab-40386876","doi":"10.1177/02698811251340901","journal":"Journal of psychopharmacology (Oxford, England)","n_participants":6918,"pmid":"40386876","source_url":"https://pubmed.ncbi.nlm.nih.gov/40386876/","study_design":"meta-analysis","title":"Comparative efficacy, tolerability, and acceptability of aducanumab, lecanemab, and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis","title_match":false,"year":2025},{"alzhub_score":89,"alzhub_url":"https://alzhub.org/study/japanese-participant-data-from-three-gantenerumab-trials-in-early-40302041","doi":"10.1002/alz.70192","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1965,"pmid":"40302041","source_url":"https://pubmed.ncbi.nlm.nih.gov/40302041/","study_design":"clinical trial","title":"Japanese participant data from three gantenerumab trials in early Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/profile-of-gantenerumab-and-its-potential-in-the-treatment-of-24255592","doi":"10.2147/dddt.s53401","journal":"Drug design, development and therapy","n_participants":null,"pmid":"24255592","source_url":"https://pubmed.ncbi.nlm.nih.gov/24255592/","study_design":null,"title":"Profile of gantenerumab and its potential in the treatment of Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/donanemab-not-two-without-a-third-37831471","doi":"10.17219/acem/172673","journal":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","n_participants":null,"pmid":"37831471","source_url":"https://pubmed.ncbi.nlm.nih.gov/37831471/","study_design":null,"title":"Donanemab: Not two without a third","title_match":false,"year":2023},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/identifying-genetic-risk-for-amyloid-related-imaging-abnormalities-38165303","doi":"10.1212/wnl.0000000000208096","journal":"Neurology","n_participants":null,"pmid":"38165303","source_url":"https://pubmed.ncbi.nlm.nih.gov/38165303/","study_design":null,"title":"Identifying Genetic Risk for Amyloid-Related Imaging Abnormalities","title_match":false,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/neuropathology-of-anti-amyloid-immunotherapy-a-case-report-37125554","doi":"10.3233/jad-221305","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"37125554","source_url":"https://pubmed.ncbi.nlm.nih.gov/37125554/","study_design":null,"title":"Neuropathology of Anti-Amyloid-\u03b2 Immunotherapy: A Case Report","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/gantenerumab-an-anti-amyloid-monoclonal-antibody-with-potential-36447240","doi":"10.1186/s13195-022-01110-8","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"36447240","source_url":"https://pubmed.ncbi.nlm.nih.gov/36447240/","study_design":"clinical trial","title":"Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/aducanumab-a-look-two-years-after-its-approval-39079148","doi":"10.7705/biomedica.6967","journal":"Biomedica : revista del Instituto Nacional de Salud","n_participants":null,"pmid":"39079148","source_url":"https://pubmed.ncbi.nlm.nih.gov/39079148/","study_design":null,"title":"Aducanumab: A look two years after its approval","title_match":false,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/optimal-anti-amyloid-beta-therapy-for-alzheimer-s-disease-via-a-36054214","doi":"10.1371/journal.pcbi.1010481","journal":"PLoS computational biology","n_participants":null,"pmid":"36054214","source_url":"https://pubmed.ncbi.nlm.nih.gov/36054214/","study_design":null,"title":"Optimal anti-amyloid-beta therapy for Alzheimer's disease via a personalized mathematical model","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/lecanemab-more-questions-than-answers-38095822","doi":"10.1007/s40261-023-01331-1","journal":"Clinical drug investigation","n_participants":null,"pmid":"38095822","source_url":"https://pubmed.ncbi.nlm.nih.gov/38095822/","study_design":null,"title":"Lecanemab: More Questions Than Answers!","title_match":false,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/an-anti-amyloid-therapy-works-for-alzheimer-s-disease-why-has-it-36797987","doi":"10.1093/brain/awad049","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"36797987","source_url":"https://pubmed.ncbi.nlm.nih.gov/36797987/","study_design":null,"title":"An anti-amyloid therapy works for Alzheimer's disease: why has it taken so long and what is next?","title_match":false,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/comparing-clinical-effect-sizes-of-souvenaidtm-lecanemab-and-41428477","doi":"10.1177/13872877251406221","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"41428477","source_url":"https://pubmed.ncbi.nlm.nih.gov/41428477/","study_design":null,"title":"Comparing clinical effect sizes of SouvenaidTM, lecanemab, and donanemab in early Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-anti-amyloid-monoclonal-antibody-lecanemab-16-cautionary-notes-37334596","doi":"10.3233/jad-230099","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"37334596","source_url":"https://pubmed.ncbi.nlm.nih.gov/37334596/","study_design":null,"title":"The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/therapeutic-news-in-alzheimer-s-disease-soon-a-disease-modifying-35489824","doi":"10.1016/j.neurol.2022.02.456","journal":"Revue neurologique","n_participants":null,"pmid":"35489824","source_url":"https://pubmed.ncbi.nlm.nih.gov/35489824/","study_design":null,"title":"Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?","title_match":false,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/systematic-in-silico-analysis-of-clinically-tested-drugs-for-reducing-33938131","doi":"10.1002/alz.12312","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"33938131","source_url":"https://pubmed.ncbi.nlm.nih.gov/33938131/","study_design":null,"title":"Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-s-amyloid-hypothesis-and-antibody-therapy-melting-glaciers-38612701","doi":"10.3390/ijms25073892","journal":"International journal of molecular sciences","n_participants":null,"pmid":"38612701","source_url":"https://pubmed.ncbi.nlm.nih.gov/38612701/","study_design":null,"title":"Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/anti-amyloid-antibody-therapy-for-alzheimer-s-disease-39370836","doi":"10.11477/mf.1416202747","journal":"Brain and nerve = Shinkei kenkyu no shinpo","n_participants":null,"pmid":"39370836","source_url":"https://pubmed.ncbi.nlm.nih.gov/39370836/","study_design":"clinical trial","title":"[Anti-Amyloid Antibody Therapy for Alzheimer's Disease]","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/viewpoint-clinicians-perspectives-on-how-disease-modifying-drugs-for-37357267","doi":"10.14283/jpad.2023.72","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"37357267","source_url":"https://pubmed.ncbi.nlm.nih.gov/37357267/","study_design":null,"title":"Viewpoint: Clinicians' Perspectives on How Disease Modifying Drugs for Alzheimer's Disease Impact Specialty Care","title_match":false,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/passive-alzheimer-s-immunotherapy-a-promising-or-uncertain-option-37414156","doi":"10.1016/j.arr.2023.101996","journal":"Ageing research reviews","n_participants":null,"pmid":"37414156","source_url":"https://pubmed.ncbi.nlm.nih.gov/37414156/","study_design":null,"title":"Passive Alzheimer's immunotherapy: A promising or uncertain option?","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/tau-immunotherapy-26551002","doi":"10.1159/000440842","journal":"Neuro-degenerative diseases","n_participants":null,"pmid":"26551002","source_url":"https://pubmed.ncbi.nlm.nih.gov/26551002/","study_design":null,"title":"Tau Immunotherapy","title_match":false,"year":2016},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/passive-tau-based-immunotherapy-for-tauopathies-37620094","doi":"10.1016/b978-0-323-98817-9.00029-6","journal":"Handbook of clinical neurology","n_participants":null,"pmid":"37620094","source_url":"https://pubmed.ncbi.nlm.nih.gov/37620094/","study_design":null,"title":"Passive tau-based immunotherapy for tauopathies","title_match":false,"year":2023},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/disease-modifying-therapy-for-proteinopathies-can-the-exception-31699321","doi":"10.1016/bs.pmbts.2019.07.010","journal":"Progress in molecular biology and translational science","n_participants":null,"pmid":"31699321","source_url":"https://pubmed.ncbi.nlm.nih.gov/31699321/","study_design":null,"title":"Disease-modifying therapy for proteinopathies: Can the exception become the rule?","title_match":false,"year":2019},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/pharmacodynamic-effects-of-semorinemab-on-plasma-and-csf-biomarkers-39513754","doi":"10.1002/alz.14346","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39513754","source_url":"https://pubmed.ncbi.nlm.nih.gov/39513754/","study_design":"clinical trial","title":"Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/nasal-tau-immunotherapy-clears-intracellular-tau-pathology-and-38959324","doi":"10.1126/scitranslmed.adj5958","journal":"Science translational medicine","n_participants":null,"pmid":"38959324","source_url":"https://pubmed.ncbi.nlm.nih.gov/38959324/","study_design":null,"title":"Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/clinical-trials-targeting-tau-should-be-halted-39908690","doi":"10.1016/j.jocn.2025.111101","journal":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","n_participants":null,"pmid":"39908690","source_url":"https://pubmed.ncbi.nlm.nih.gov/39908690/","study_design":null,"title":"Clinical trials targeting tau should be halted","title_match":true,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/formaldehyde-epigenetics-and-alzheimer-s-disease-30964647","doi":"10.1021/acs.chemrestox.9b00090","journal":"Chemical research in toxicology","n_participants":null,"pmid":"30964647","source_url":"https://pubmed.ncbi.nlm.nih.gov/30964647/","study_design":null,"title":"Formaldehyde, Epigenetics, and Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/anti-tau-vaccine-is-successful-in-clinical-trial-for-people-with-28560923","doi":"10.7748/nop.29.5.11.s12","journal":"Nursing older people","n_participants":null,"pmid":"28560923","source_url":"https://pubmed.ncbi.nlm.nih.gov/28560923/","study_design":null,"title":"Anti-tau vaccine is successful in clinical trial for people with Alzheimer's disease","title_match":true,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/tau-targeted-multifunctional-nanoinhibitor-for-alzheimer-s-disease-33999598","doi":"10.1021/acsami.1c00257","journal":"ACS applied materials & interfaces","n_participants":null,"pmid":"33999598","source_url":"https://pubmed.ncbi.nlm.nih.gov/33999598/","study_design":null,"title":"Tau-Targeted Multifunctional Nanoinhibitor for Alzheimer's Disease","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/clinical-development-of-passive-tau-based-immunotherapeutics-for-37405389","doi":"10.1080/13543784.2023.2233892","journal":"Expert opinion on investigational drugs","n_participants":null,"pmid":"37405389","source_url":"https://pubmed.ncbi.nlm.nih.gov/37405389/","study_design":null,"title":"Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies","title_match":false,"year":2023},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/csf-proteomics-of-semorinemab-alzheimer-s-disease-trials-identifies-40435316","doi":"10.1093/brain/awaf200","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"40435316","source_url":"https://pubmed.ncbi.nlm.nih.gov/40435316/","study_design":"clinical trial","title":"CSF proteomics of semorinemab Alzheimer's disease trials identifies cell-type specific signatures","title_match":false,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/targeting-endogenous-tau-in-seeded-tauopathy-models-inhibits-tau-39500576","doi":"10.1523/jneurosci.0877-24.2024","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"39500576","source_url":"https://pubmed.ncbi.nlm.nih.gov/39500576/","study_design":null,"title":"Targeting Endogenous Tau in Seeded Tauopathy Models Inhibits Tau Spread","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/a-review-of-recent-advances-in-the-management-of-alzheimer-s-disease-38756263","doi":"10.7759/cureus.58416","journal":"Cureus","n_participants":null,"pmid":"38756263","source_url":"https://pubmed.ncbi.nlm.nih.gov/38756263/","study_design":null,"title":"A Review of Recent Advances in the Management of Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/anti-alpha-synuclein-and-anti-tau-immunotherapies-can-a-cocktail-38508903","doi":"10.1016/j.parkreldis.2024.106080","journal":"Parkinsonism & related disorders","n_participants":null,"pmid":"38508903","source_url":"https://pubmed.ncbi.nlm.nih.gov/38508903/","study_design":null,"title":"Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?","title_match":false,"year":2024},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/chronic-pd-1-checkpoint-blockade-does-not-affect-cognition-or-promote-31992982","doi":"10.3389/fnagi.2019.00377","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"31992982","source_url":"https://pubmed.ncbi.nlm.nih.gov/31992982/","study_design":null,"title":"Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/tau-immunotherapy-in-alzheimer-s-disease-and-progressive-supranuclear-36410182","doi":"10.1016/j.intimp.2022.109445","journal":"International immunopharmacology","n_participants":null,"pmid":"36410182","source_url":"https://pubmed.ncbi.nlm.nih.gov/36410182/","study_design":null,"title":"Tau immunotherapy in Alzheimer's disease and progressive supranuclear palsy","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/anti-tau-trials-for-alzheimer-s-disease-a-report-from-the-eu-us-ctad-31062825","doi":"10.14283/jpad.2019.14","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"31062825","source_url":"https://pubmed.ncbi.nlm.nih.gov/31062825/","study_design":"clinical trial","title":"Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task Force","title_match":false,"year":2019},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/tau-immunotherapy-and-imaging-24029727","doi":"10.1159/000354491","journal":"Neuro-degenerative diseases","n_participants":null,"pmid":"24029727","source_url":"https://pubmed.ncbi.nlm.nih.gov/24029727/","study_design":null,"title":"Tau immunotherapy and imaging","title_match":false,"year":2014},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/emerging-drugs-for-progressive-supranuclear-palsy-31007097","doi":"10.1080/14728214.2019.1609450","journal":"Expert opinion on emerging drugs","n_participants":null,"pmid":"31007097","source_url":"https://pubmed.ncbi.nlm.nih.gov/31007097/","study_design":"clinical trial","title":"Emerging drugs for progressive supranuclear palsy","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/fungally-derived-isoquinoline-demonstrates-inducer-specific-tau-34009955","doi":"10.1021/acs.biochem.1c00111","journal":"Biochemistry","n_participants":null,"pmid":"34009955","source_url":"https://pubmed.ncbi.nlm.nih.gov/34009955/","study_design":null,"title":"Fungally Derived Isoquinoline Demonstrates Inducer-Specific Tau Aggregation Inhibition","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/pathogenic-mechanisms-and-therapy-development-for-c9orf72-amyotrophic-31667754","doi":"10.1007/s13311-019-00797-2","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"31667754","source_url":"https://pubmed.ncbi.nlm.nih.gov/31667754/","study_design":"clinical trial","title":"Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia","title_match":false,"year":2019},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/asos-are-an-effective-treatment-for-disease-associated-38429929","doi":"10.1016/j.ymthe.2024.02.033","journal":"Molecular therapy : the journal of the American Society of Gene Therapy","n_participants":null,"pmid":"38429929","source_url":"https://pubmed.ncbi.nlm.nih.gov/38429929/","study_design":null,"title":"ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice","title_match":false,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/messenger-rna-encoded-antibody-approach-for-targeting-extracellular-38585667","doi":"10.1093/braincomms/fcae100","journal":"Brain communications","n_participants":null,"pmid":"38585667","source_url":"https://pubmed.ncbi.nlm.nih.gov/38585667/","study_design":null,"title":"Messenger RNA-encoded antibody approach for targeting extracellular and intracellular tau","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/recent-trends-in-active-and-passive-immunotherapies-of-alzheimer-s-37366656","doi":"10.3390/antib12020041","journal":"Antibodies (Basel, Switzerland)","n_participants":null,"pmid":"37366656","source_url":"https://pubmed.ncbi.nlm.nih.gov/37366656/","study_design":null,"title":"Recent Trends in Active and Passive Immunotherapies of Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/emerging-amyloid-and-tau-targeting-treatments-for-alzheimer-s-disease-28490214","doi":"10.1080/14737175.2017.1326819","journal":"Expert review of neurotherapeutics","n_participants":null,"pmid":"28490214","source_url":"https://pubmed.ncbi.nlm.nih.gov/28490214/","study_design":null,"title":"Emerging amyloid and tau targeting treatments for Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/tau-directed-approaches-for-the-treatment-of-alzheimer-s-disease-26822031","doi":"10.1586/14737175.2016.1140039","journal":"Expert review of neurotherapeutics","n_participants":null,"pmid":"26822031","source_url":"https://pubmed.ncbi.nlm.nih.gov/26822031/","study_design":null,"title":"Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium","title_match":false,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-clinical-trials-to-watch-40782673","doi":"10.1016/j.medj.2025.100771","journal":"Med (New York, N.Y.)","n_participants":null,"pmid":"40782673","source_url":"https://pubmed.ncbi.nlm.nih.gov/40782673/","study_design":null,"title":"Alzheimer's disease: Clinical trials to watch","title_match":true,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/an-evaluation-of-hydromethylthionine-as-a-treatment-option-for-32037892","doi":"10.1080/14656566.2020.1719066","journal":"Expert opinion on pharmacotherapy","n_participants":null,"pmid":"32037892","source_url":"https://pubmed.ncbi.nlm.nih.gov/32037892/","study_design":null,"title":"An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/glucagon-like-peptide-1-receptor-agonists-in-neurodegenerative-40344943","doi":"10.1016/j.phrs.2025.107770","journal":"Pharmacological research","n_participants":null,"pmid":"40344943","source_url":"https://pubmed.ncbi.nlm.nih.gov/40344943/","study_design":null,"title":"Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-expanding-role-of-semaglutide-beyond-glycemic-control-40620322","doi":"10.1007/s40200-025-01663-z","journal":"Journal of diabetes and metabolic disorders","n_participants":null,"pmid":"40620322","source_url":"https://pubmed.ncbi.nlm.nih.gov/40620322/","study_design":null,"title":"The expanding role of semaglutide: beyond glycemic control","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/glp-1-and-the-degenerating-brain-exploring-mechanistic-insights-and-41226780","doi":"10.3390/ijms262110743","journal":"International journal of molecular sciences","n_participants":null,"pmid":"41226780","source_url":"https://pubmed.ncbi.nlm.nih.gov/41226780/","study_design":null,"title":"GLP-1 and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/from-metabolism-to-mind-the-expanding-role-of-the-glp-1-receptor-in-40738791","doi":"10.1016/j.neurot.2025.e00712","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"40738791","source_url":"https://pubmed.ncbi.nlm.nih.gov/40738791/","study_design":null,"title":"From metabolism to mind: The expanding role of the GLP-1 receptor in neurotherapeutics","title_match":false,"year":2025},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/12-month-neurological-and-psychiatric-outcomes-of-semaglutide-use-for-39764175","doi":"10.1016/j.eclinm.2024.102726","journal":"EClinicalMedicine","n_participants":23386,"pmid":"39764175","source_url":"https://pubmed.ncbi.nlm.nih.gov/39764175/","study_design":"cohort study","title":"12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/incretin-hormones-glp-1-and-gip-normalize-energy-utilization-and-40938528","doi":"10.1007/s40263-025-01226-z","journal":"CNS drugs","n_participants":null,"pmid":"40938528","source_url":"https://pubmed.ncbi.nlm.nih.gov/40938528/","study_design":null,"title":"Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer's Disease and Parkinson's Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies","title_match":false,"year":2025},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/effects-of-glp-1-receptor-agonists-on-neurological-complications-of-37231200","doi":"10.1007/s11154-023-09807-3","journal":"Reviews in endocrine & metabolic disorders","n_participants":19,"pmid":"37231200","source_url":"https://pubmed.ncbi.nlm.nih.gov/37231200/","study_design":"systematic review","title":"Effects of GLP-1 receptor agonists on neurological complications of diabetes","title_match":false,"year":2023},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/real-world-observations-of-glp-1-receptor-agonists-and-sglt-2-40898408","doi":"10.1002/alz.70639","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"40898408","source_url":"https://pubmed.ncbi.nlm.nih.gov/40898408/","study_design":null,"title":"Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/role-of-liraglutide-in-alzheimer-s-disease-pathology-34118986","doi":"10.1186/s13195-021-00853-0","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"34118986","source_url":"https://pubmed.ncbi.nlm.nih.gov/34118986/","study_design":null,"title":"Role of liraglutide in Alzheimer's disease pathology","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/cvot-summit-report-2023-new-cardiovascular-kidney-and-metabolic-38504284","doi":"10.1186/s12933-024-02180-8","journal":"Cardiovascular diabetology","n_participants":null,"pmid":"38504284","source_url":"https://pubmed.ncbi.nlm.nih.gov/38504284/","study_design":null,"title":"CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes","title_match":false,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/the-metabolic-brain-axis-glp-1-signaling-insulin-resistance-and-42962966","doi":"10.1016/j.metabol.2026.156810","journal":"Metabolism: clinical and experimental","n_participants":null,"pmid":"42962966","source_url":"https://pubmed.ncbi.nlm.nih.gov/42962966/","study_design":"clinical trial","title":"The metabolic-brain axis: GLP-1 signaling, insulin resistance, and obesity pharmacotherapy in neurodegeneration","title_match":false,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/glucagon-like-peptide-1-therapy-from-discovery-to-type-2-diabetes-and-36740965","doi":"10.3803/enm.2022.1642","journal":"Endocrinology and metabolism (Seoul, Korea)","n_participants":null,"pmid":"36740965","source_url":"https://pubmed.ncbi.nlm.nih.gov/36740965/","study_design":null,"title":"Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alternative-role-of-glucagon-like-peptide-1-receptor-agonists-in-36470445","doi":"10.1016/j.ejphar.2022.175439","journal":"European journal of pharmacology","n_participants":null,"pmid":"36470445","source_url":"https://pubmed.ncbi.nlm.nih.gov/36470445/","study_design":null,"title":"Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases","title_match":false,"year":2023},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/long-acting-exenatide-does-not-prevent-cognitive-decline-in-mild-38565814","doi":"10.1007/s40618-024-02320-7","journal":"Journal of endocrinological investigation","n_participants":17,"pmid":"38565814","source_url":"https://pubmed.ncbi.nlm.nih.gov/38565814/","study_design":null,"title":"Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial","title_match":true,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/glucagon-like-peptide-1-receptor-agonists-in-neurodegenerative-40964464","doi":"10.7759/cureus.92441","journal":"Cureus","n_participants":null,"pmid":"40964464","source_url":"https://pubmed.ncbi.nlm.nih.gov/40964464/","study_design":null,"title":"Glucagon-Like Peptide-1 Receptor Agonists in Neurodegenerative Diseases: A Comprehensive Review","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/diabetes-risk-factor-and-translational-therapeutic-implications-for-35128745","doi":"10.1111/ejn.15619","journal":"The European journal of neuroscience","n_participants":null,"pmid":"35128745","source_url":"https://pubmed.ncbi.nlm.nih.gov/35128745/","study_design":null,"title":"Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/neurodegeneration-onset-with-glucagon-like-peptide-1-receptor-41204243","doi":"10.1186/s12933-025-02962-8","journal":"Cardiovascular diabetology","n_participants":null,"pmid":"41204243","source_url":"https://pubmed.ncbi.nlm.nih.gov/41204243/","study_design":"cohort study","title":"Neurodegeneration onset with glucagon-like peptide-1 receptor agonists in people with type 2 diabetes: a real-world multinational cohort study","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/incretin-mimetics-as-potential-disease-modifying-treatment-for-39422964","doi":"10.3233/jad-240730","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"39422964","source_url":"https://pubmed.ncbi.nlm.nih.gov/39422964/","study_design":null,"title":"Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/protective-effects-of-incretin-against-age-related-diseases-31622202","doi":"10.2174/1567201816666191010145029","journal":"Current drug delivery","n_participants":null,"pmid":"31622202","source_url":"https://pubmed.ncbi.nlm.nih.gov/31622202/","study_design":null,"title":"Protective Effects of Incretin Against Age-Related Diseases","title_match":false,"year":2019},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/glucagon-like-peptide-1-receptor-agonists-and-mental-health-a-41025359","doi":"10.12701/jyms.2025.42.61","journal":"Journal of Yeungnam medical science","n_participants":null,"pmid":"41025359","source_url":"https://pubmed.ncbi.nlm.nih.gov/41025359/","study_design":"cohort study","title":"Glucagon-like peptide-1 receptor agonists and mental health: a narrative review of emerging benefits and risks","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/therapeutic-strategies-for-alzheimer-s-disease-in-the-view-of-31062332","doi":"10.1007/978-981-13-3540-2_11","journal":"Advances in experimental medicine and biology","n_participants":null,"pmid":"31062332","source_url":"https://pubmed.ncbi.nlm.nih.gov/31062332/","study_design":null,"title":"Therapeutic Strategies for Alzheimer's Disease in the View of Diabetes Mellitus","title_match":false,"year":2019},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-acetylcholinesterase-inhibitors-for-alzheimer-38439609","doi":"10.17219/acem/176051","journal":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","n_participants":null,"pmid":"38439609","source_url":"https://pubmed.ncbi.nlm.nih.gov/38439609/","study_design":"systematic review","title":"Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis","title_match":false,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/galantamine-memantine-combination-in-the-treatment-of-parkinson-s-39766362","doi":"10.3390/brainsci14121163","journal":"Brain sciences","n_participants":null,"pmid":"39766362","source_url":"https://pubmed.ncbi.nlm.nih.gov/39766362/","study_design":null,"title":"Galantamine-Memantine Combination in the Treatment of Parkinson's Disease Dementia","title_match":false,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/galantamine-memantine-combination-in-the-treatment-of-alzheimer-s-32829072","doi":"10.1016/j.psychres.2020.113409","journal":"Psychiatry research","n_participants":null,"pmid":"32829072","source_url":"https://pubmed.ncbi.nlm.nih.gov/32829072/","study_design":null,"title":"Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-enzyme-inhibitor-molecules-with-therapeutic-34602041","doi":"10.2174/1871527320666210928160159","journal":"CNS & neurological disorders drug targets","n_participants":null,"pmid":"34602041","source_url":"https://pubmed.ncbi.nlm.nih.gov/34602041/","study_design":null,"title":"Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-for-treating-dementia-symptoms-a-28678552","doi":"10.1080/14740338.2017.1351540","journal":"Expert opinion on drug safety","n_participants":null,"pmid":"28678552","source_url":"https://pubmed.ncbi.nlm.nih.gov/28678552/","study_design":null,"title":"Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation","title_match":false,"year":2017},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/memantine-er-donepezil-a-review-in-alzheimer-s-disease-26519339","doi":"10.1007/s40263-015-0287-2","journal":"CNS drugs","n_participants":null,"pmid":"26519339","source_url":"https://pubmed.ncbi.nlm.nih.gov/26519339/","study_design":null,"title":"Memantine ER/Donepezil: A Review in Alzheimer's Disease","title_match":false,"year":2015},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/the-efficacy-and-safety-of-memantine-for-the-treatment-of-alzheimer-s-30222469","doi":"10.1080/14740338.2018.1524870","journal":"Expert opinion on drug safety","n_participants":null,"pmid":"30222469","source_url":"https://pubmed.ncbi.nlm.nih.gov/30222469/","study_design":"meta-analysis","title":"The efficacy and safety of memantine for the treatment of Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/comparative-safety-of-cholinesterase-inhibitors-and-memantine-for-41188985","doi":"10.1186/s13643-025-02961-6","journal":"Systematic reviews","n_participants":null,"pmid":"41188985","source_url":"https://pubmed.ncbi.nlm.nih.gov/41188985/","study_design":"systematic review","title":"Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials","title_match":true,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/is-long-term-treatment-of-alzheimer-s-disease-with-cholinesterase-17953456","doi":"10.2165/00002512-200724110-00001","journal":"Drugs & aging","n_participants":null,"pmid":"17953456","source_url":"https://pubmed.ncbi.nlm.nih.gov/17953456/","study_design":"open-label trial","title":"Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?","title_match":false,"year":2007},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-and-sleep-architecture-in-patients-16872233","doi":"10.2165/00002512-200623060-00005","journal":"Drugs & aging","n_participants":41,"pmid":"16872233","source_url":"https://pubmed.ncbi.nlm.nih.gov/16872233/","study_design":null,"title":"Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/rivastigmine-a-brain-region-selective-acetylcholinesterase-inhibitor-11139819","doi":"10.1517/13543784.8.10.1673","journal":"Expert opinion on investigational drugs","n_participants":null,"pmid":"11139819","source_url":"https://pubmed.ncbi.nlm.nih.gov/11139819/","study_design":null,"title":"Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status","title_match":false,"year":1999},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/memantine-as-add-on-medication-to-acetylcholinesterase-inhibitor-27822591","doi":"10.1007/s00115-016-0237-3","journal":"Der Nervenarzt","n_participants":null,"pmid":"27822591","source_url":"https://pubmed.ncbi.nlm.nih.gov/27822591/","study_design":"meta-analysis","title":"[Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia]","title_match":false,"year":2017},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/donepezil-in-the-treatment-of-patients-with-alzheimer-s-disease-19811041","doi":"10.1586/14737175.1.1.11","journal":"Expert review of neurotherapeutics","n_participants":null,"pmid":"19811041","source_url":"https://pubmed.ncbi.nlm.nih.gov/19811041/","study_design":"open-label trial","title":"Donepezil in the treatment of patients with Alzheimer's disease","title_match":false,"year":2001},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/pharmacologic-treatments-of-dementia-12171061","doi":"10.1016/s0025-7125(02)00007-x","journal":"The Medical clinics of North America","n_participants":null,"pmid":"12171061","source_url":"https://pubmed.ncbi.nlm.nih.gov/12171061/","study_design":null,"title":"Pharmacologic treatments of dementia","title_match":false,"year":2002},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/systematic-review-of-sex-specific-reporting-of-data-cholinesterase-28832937","doi":"10.1111/jgs.15020","journal":"Journal of the American Geriatrics Society","n_participants":15971,"pmid":"28832937","source_url":"https://pubmed.ncbi.nlm.nih.gov/28832937/","study_design":null,"title":"Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example","title_match":false,"year":2017},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-and-memantine-for-neuroenhancement-in-20193764","doi":"10.1016/j.phrs.2010.02.009","journal":"Pharmacological research","n_participants":null,"pmid":"20193764","source_url":"https://pubmed.ncbi.nlm.nih.gov/20193764/","study_design":"systematic review","title":"Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review","title_match":false,"year":2010},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/rivastigmine-in-the-treatment-of-alzheimer-s-disease-an-update-18044073","doi":"10.2147/ciia.2007.2.1.17","journal":"Clinical interventions in aging","n_participants":null,"pmid":"18044073","source_url":"https://pubmed.ncbi.nlm.nih.gov/18044073/","study_design":null,"title":"Rivastigmine in the treatment of Alzheimer's disease: an update","title_match":false,"year":2007},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/rivastigmine-a-new-generation-cholinesterase-inhibitor-for-the-10641971","doi":"10.1592/phco.20.1.1.34664","journal":"Pharmacotherapy","n_participants":1324,"pmid":"10641971","source_url":"https://pubmed.ncbi.nlm.nih.gov/10641971/","study_design":null,"title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease","title_match":false,"year":2000},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/new-therapeutics-beyond-amyloid-and-tau-for-the-treatment-of-33268824","doi":"10.1038/s41401-020-00565-5","journal":"Acta pharmacologica Sinica","n_participants":null,"pmid":"33268824","source_url":"https://pubmed.ncbi.nlm.nih.gov/33268824/","study_design":null,"title":"New therapeutics beyond amyloid-\u03b2 and tau for the treatment of Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/galantamine-for-alzheimer-s-disease-20113148","doi":"10.1517/17425251003592137","journal":"Expert opinion on drug metabolism & toxicology","n_participants":null,"pmid":"20113148","source_url":"https://pubmed.ncbi.nlm.nih.gov/20113148/","study_design":"meta-analysis","title":"Galantamine for Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/pharmacotherapy-for-vascular-cognitive-impairment-28786085","doi":"10.1007/s40263-017-0459-3","journal":"CNS drugs","n_participants":null,"pmid":"28786085","source_url":"https://pubmed.ncbi.nlm.nih.gov/28786085/","study_design":null,"title":"Pharmacotherapy for Vascular Cognitive Impairment","title_match":false,"year":2017},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/effects-of-donepezil-galantamine-and-rivastigmine-in-938-italian-20088621","doi":"10.2165/11310960-000000000-00000","journal":"CNS drugs","n_participants":938,"pmid":"20088621","source_url":"https://pubmed.ncbi.nlm.nih.gov/20088621/","study_design":null,"title":"Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study","title_match":false,"year":2010},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/are-cholinesterase-inhibitors-effective-in-the-management-of-the-19538824","doi":"10.1017/s1041610209990354","journal":"International psychogeriatrics","n_participants":null,"pmid":"19538824","source_url":"https://pubmed.ncbi.nlm.nih.gov/19538824/","study_design":"systematic review","title":"Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine","title_match":true,"year":2009},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/clinical-efficacy-and-safety-of-donepezil-in-the-treatment-of-30349215","doi":"10.2147/cia.s159920","journal":"Clinical interventions in aging","n_participants":null,"pmid":"30349215","source_url":"https://pubmed.ncbi.nlm.nih.gov/30349215/","study_design":null,"title":"Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients","title_match":false,"year":2018},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/treatment-of-vascular-dementia-evidence-from-clinical-trials-with-15537522","doi":"10.1016/j.jns.2004.09.018","journal":"Journal of the neurological sciences","n_participants":null,"pmid":"15537522","source_url":"https://pubmed.ncbi.nlm.nih.gov/15537522/","study_design":null,"title":"Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors","title_match":true,"year":2004},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2025-40463637","doi":"10.1002/trc2.70098","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"40463637","source_url":"https://pubmed.ncbi.nlm.nih.gov/40463637/","study_design":null,"title":"Alzheimer's disease drug development pipeline: 2025","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/marine-natural-products-multitarget-therapy-and-repurposed-agents-in-32933034","doi":"10.3390/ph13090242","journal":"Pharmaceuticals (Basel, Switzerland)","n_participants":null,"pmid":"32933034","source_url":"https://pubmed.ncbi.nlm.nih.gov/32933034/","study_design":null,"title":"Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease","title_match":false,"year":2020},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/clinical-and-biological-effects-of-long-term-lithium-treatment-in-30947755","doi":"10.1192/bjp.2019.76","journal":"The British journal of psychiatry : the journal of mental science","n_participants":61,"pmid":"30947755","source_url":"https://pubmed.ncbi.nlm.nih.gov/30947755/","study_design":null,"title":"Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial","title_match":true,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/potential-repositioning-of-anti-cancer-egfr-inhibitors-in-alzheimer-s-34139302","doi":"10.1016/j.neuroscience.2021.06.013","journal":"Neuroscience","n_participants":null,"pmid":"34139302","source_url":"https://pubmed.ncbi.nlm.nih.gov/34139302/","study_design":null,"title":"Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer's Disease: Current Perspectives and Challenging Prospects","title_match":false,"year":2021},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/drug-repurposing-in-oncology-a-systematic-review-of-randomized-37296934","doi":"10.3390/cancers15112972","journal":"Cancers","n_participants":null,"pmid":"37296934","source_url":"https://pubmed.ncbi.nlm.nih.gov/37296934/","study_design":"systematic review","title":"Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials","title_match":true,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/network-based-stage-specific-drug-repurposing-for-alzheimer-s-disease-35386099","doi":"10.1016/j.csbj.2022.03.013","journal":"Computational and structural biotechnology journal","n_participants":null,"pmid":"35386099","source_url":"https://pubmed.ncbi.nlm.nih.gov/35386099/","study_design":null,"title":"Network-based stage-specific drug repurposing for Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/low-dose-lithium-treatment-of-behavioral-complications-in-alzheimer-s-34059401","doi":"10.1016/j.jagp.2021.04.014","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":77,"pmid":"34059401","source_url":"https://pubmed.ncbi.nlm.nih.gov/34059401/","study_design":null,"title":"Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial","title_match":true,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/dual-drug-repurposing-the-example-of-saracatinib-38674150","doi":"10.3390/ijms25084565","journal":"International journal of molecular sciences","n_participants":null,"pmid":"38674150","source_url":"https://pubmed.ncbi.nlm.nih.gov/38674150/","study_design":null,"title":"Dual Drug Repurposing: The Example of Saracatinib","title_match":false,"year":2024},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/drug-repositioning-for-alzheimer-s-disease-finding-hidden-clues-in-32144994","doi":"10.3233/jad-200049","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"32144994","source_url":"https://pubmed.ncbi.nlm.nih.gov/32144994/","study_design":null,"title":"Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs","title_match":false,"year":2020},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/trace-lithium-and-mental-health-29234900","doi":"10.1007/s00702-017-1824-6","journal":"Journal of neural transmission (Vienna, Austria : 1996)","n_participants":null,"pmid":"29234900","source_url":"https://pubmed.ncbi.nlm.nih.gov/29234900/","study_design":null,"title":"Trace lithium and mental health","title_match":false,"year":2018},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/repurposed-agents-in-the-alzheimer-s-disease-drug-development-pipeline-32807237","doi":"10.1186/s13195-020-00662-x","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"32807237","source_url":"https://pubmed.ncbi.nlm.nih.gov/32807237/","study_design":null,"title":"Repurposed agents in the Alzheimer's disease drug development pipeline","title_match":false,"year":2020},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/a-proteotranscriptomic-based-computational-drug-repositioning-method-32063857","doi":"10.3389/fphar.2019.01653","journal":"Frontiers in pharmacology","n_participants":null,"pmid":"32063857","source_url":"https://pubmed.ncbi.nlm.nih.gov/32063857/","study_design":null,"title":"A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/drug-repurposing-on-alzheimer-s-disease-through-modulation-of-nrf2-37696195","doi":"10.1016/j.redox.2023.102881","journal":"Redox biology","n_participants":null,"pmid":"37696195","source_url":"https://pubmed.ncbi.nlm.nih.gov/37696195/","study_design":"meta-analysis","title":"Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood","title_match":false,"year":2023},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/repositioning-of-immunomodulators-a-ray-of-hope-for-alzheimer-s-33343293","doi":"10.3389/fnins.2020.614643","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"33343293","source_url":"https://pubmed.ncbi.nlm.nih.gov/33343293/","study_design":null,"title":"Repositioning of Immunomodulators: A Ray of Hope for Alzheimer's Disease?","title_match":false,"year":2020},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/effects-of-the-sglt2-inhibitor-dapagliflozin-in-early-alzheimer-s-40566796","doi":"10.1002/alz.70416","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":32,"pmid":"40566796","source_url":"https://pubmed.ncbi.nlm.nih.gov/40566796/","study_design":null,"title":"Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/metformin-mitigates-dementia-risk-among-individuals-with-type-2-38725077","doi":"10.1186/s40842-024-00168-7","journal":"Clinical diabetes and endocrinology","n_participants":null,"pmid":"38725077","source_url":"https://pubmed.ncbi.nlm.nih.gov/38725077/","study_design":"longitudinal study","title":"Metformin mitigates dementia risk among individuals with type 2 diabetes","title_match":false,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-multicenter-randomized-placebo-controlled-trial-for-cilostazol-in-29067312","doi":"10.1016/j.trci.2016.10.001","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29067312","source_url":"https://pubmed.ncbi.nlm.nih.gov/29067312/","study_design":"cohort study","title":"A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol","title_match":true,"year":2016},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-25-year-evolution-of-lithium-as-a-disease-modifying-agent-in-42268602","doi":"10.1001/jamapsychiatry.2026.1296","journal":"JAMA psychiatry","n_participants":null,"pmid":"42268602","source_url":"https://pubmed.ncbi.nlm.nih.gov/42268602/","study_design":null,"title":"The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative Review","title_match":false,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/drug-repurposing-for-alzheimer-s-disease-and-other-neurodegenerative-39971900","doi":"10.1038/s41467-025-56690-4","journal":"Nature communications","n_participants":null,"pmid":"39971900","source_url":"https://pubmed.ncbi.nlm.nih.gov/39971900/","study_design":"clinical trial","title":"Drug repurposing for Alzheimer's disease and other neurodegenerative disorders","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/repurposing-proteostasis-modifying-drugs-to-prevent-or-treat-age-30425653","doi":"10.3389/fphys.2018.01520","journal":"Frontiers in physiology","n_participants":null,"pmid":"30425653","source_url":"https://pubmed.ncbi.nlm.nih.gov/30425653/","study_design":null,"title":"Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review","title_match":false,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pharmacological-approaches-using-diabetic-drugs-repurposed-for-38255204","doi":"10.3390/biomedicines12010099","journal":"Biomedicines","n_participants":null,"pmid":"38255204","source_url":"https://pubmed.ncbi.nlm.nih.gov/38255204/","study_design":null,"title":"Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/drug-repositioning-in-alzheimer-s-disease-25961694","doi":"10.2741/s432","journal":"Frontiers in bioscience (Scholar edition)","n_participants":null,"pmid":"25961694","source_url":"https://pubmed.ncbi.nlm.nih.gov/25961694/","study_design":null,"title":"Drug repositioning in Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/anticancer-drugs-repurposed-for-alzheimer-s-disease-a-systematic-33952306","doi":"10.1186/s13195-021-00831-6","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"33952306","source_url":"https://pubmed.ncbi.nlm.nih.gov/33952306/","study_design":"systematic review","title":"Anticancer drugs repurposed for Alzheimer's disease: a systematic review","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/long-term-use-of-metformin-and-alzheimer-s-disease-beneficial-or-36849855","doi":"10.1007/s10787-023-01163-7","journal":"Inflammopharmacology","n_participants":null,"pmid":"36849855","source_url":"https://pubmed.ncbi.nlm.nih.gov/36849855/","study_design":null,"title":"Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/a-drug-repositioning-algorithm-based-on-a-deep-autoencoder-and-34717542","doi":"10.1186/s12859-021-04406-y","journal":"BMC bioinformatics","n_participants":null,"pmid":"34717542","source_url":"https://pubmed.ncbi.nlm.nih.gov/34717542/","study_design":null,"title":"A drug repositioning algorithm based on a deep autoencoder and adaptive fusion","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/management-of-neuropsychiatric-symptoms-in-dementia-37639488","doi":"10.1097/wco.0000000000001199","journal":"Current opinion in neurology","n_participants":null,"pmid":"37639488","source_url":"https://pubmed.ncbi.nlm.nih.gov/37639488/","study_design":"clinical trial","title":"Management of neuropsychiatric symptoms in dementia","title_match":false,"year":2023},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/a-randomized-clinical-trial-of-low-dose-cannabis-extract-in-alzheimer-41160460","doi":"10.1177/13872877251389608","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"41160460","source_url":"https://pubmed.ncbi.nlm.nih.gov/41160460/","study_design":"clinical trial","title":"A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/dimebon-disappointment-20836898","doi":"10.1186/alzrt49","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"20836898","source_url":"https://pubmed.ncbi.nlm.nih.gov/20836898/","study_design":"clinical trial","title":"Dimebon disappointment","title_match":false,"year":2010},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/emerging-pharmacological-approaches-for-psychosis-and-agitation-in-39623197","doi":"10.1007/s40263-024-01133-9","journal":"CNS drugs","n_participants":null,"pmid":"39623197","source_url":"https://pubmed.ncbi.nlm.nih.gov/39623197/","study_design":"clinical trial","title":"Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/lecanemab-clarity-ad-quality-of-life-results-from-a-randomized-double-37874099","doi":"10.14283/jpad.2023.123","journal":"The journal of prevention of Alzheimer's disease","n_participants":1795,"pmid":"37874099","source_url":"https://pubmed.ncbi.nlm.nih.gov/37874099/","study_design":"clinical trial","title":"Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease","title_match":true,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/pimavanserin-26744739","doi":"10.1358/dot.2015.51.11.2404001","journal":"Drugs of today (Barcelona, Spain : 1998)","n_participants":null,"pmid":"26744739","source_url":"https://pubmed.ncbi.nlm.nih.gov/26744739/","study_design":null,"title":"Pimavanserin","title_match":false,"year":2015},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/bapineuzumab-20497044","doi":"10.1517/14712598.2010.493872","journal":"Expert opinion on biological therapy","n_participants":null,"pmid":"20497044","source_url":"https://pubmed.ncbi.nlm.nih.gov/20497044/","study_design":null,"title":"Bapineuzumab","title_match":false,"year":2010},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/omega-3-fatty-acid-carotenoid-and-vitamin-e-supplementation-improves-34999335","doi":"10.1016/j.clnu.2021.12.004","journal":"Clinical nutrition (Edinburgh, Scotland)","n_participants":30,"pmid":"34999335","source_url":"https://pubmed.ncbi.nlm.nih.gov/34999335/","study_design":null,"title":"Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial","title_match":true,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/mechanism-of-action-and-clinical-trial-results-of-lecanemab-leqembi-38692883","doi":"10.1254/fpj.24005","journal":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","n_participants":null,"pmid":"38692883","source_url":"https://pubmed.ncbi.nlm.nih.gov/38692883/","study_design":null,"title":"[Mechanism of action and clinical trial results of Lecanemab (Leqembi\u00ae 200 \u200dmg, 500 \u200dmg for Intravenous Infusion), a novel treatment for Alzheimer's disease]","title_match":true,"year":2024},{"alzhub_score":88,"alzhub_url":"https://alzhub.org/study/minocycline-to-reduce-inflammation-and-blood-brain-barrier-leakage-in-38629936","doi":"10.1002/alz.13830","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38629936","source_url":"https://pubmed.ncbi.nlm.nih.gov/38629936/","study_design":null,"title":"MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial","title_match":true,"year":2024},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/a-phase-2-randomized-placebo-controlled-study-on-the-efficacy-and-40912996","doi":"10.1016/j.tjpad.2025.100337","journal":"The journal of prevention of Alzheimer's disease","n_participants":210,"pmid":"40912996","source_url":"https://pubmed.ncbi.nlm.nih.gov/40912996/","study_design":"clinical trial","title":"A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/two-new-combination-pediatric-vaccines-advancing-to-use-in-infants-22914446","doi":"10.4161/hv.21700","journal":"Human vaccines & immunotherapeutics","n_participants":null,"pmid":"22914446","source_url":"https://pubmed.ncbi.nlm.nih.gov/22914446/","study_design":"clinical trial","title":"Two new combination pediatric vaccines advancing to use in infants","title_match":false,"year":2012},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/elevated-soluble-amyloid-beta-protofibrils-in-down-syndrome-and-34091073","doi":"10.1016/j.mcn.2021.103641","journal":"Molecular and cellular neurosciences","n_participants":null,"pmid":"34091073","source_url":"https://pubmed.ncbi.nlm.nih.gov/34091073/","study_design":"clinical trial","title":"Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/a-phase-3-trial-of-iv-immunoglobulin-for-alzheimer-disease-28381506","doi":"10.1212/wnl.0000000000003904","journal":"Neurology","n_participants":390,"pmid":"28381506","source_url":"https://pubmed.ncbi.nlm.nih.gov/28381506/","study_design":"clinical trial","title":"A phase 3 trial of IV immunoglobulin for Alzheimer disease","title_match":true,"year":2017},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-gv1001-in-patients-with-moderate-to-severe-33771205","doi":"10.1186/s13195-021-00803-w","journal":"Alzheimer's research & therapy","n_participants":31,"pmid":"33771205","source_url":"https://pubmed.ncbi.nlm.nih.gov/33771205/","study_design":"clinical trial","title":"Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial","title_match":true,"year":2021},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/protocol-of-a-phase-ii-randomized-multi-center-double-blind-placebo-37874102","doi":"10.14283/jpad.2023.55","journal":"The journal of prevention of Alzheimer's disease","n_participants":60,"pmid":"37874102","source_url":"https://pubmed.ncbi.nlm.nih.gov/37874102/","study_design":null,"title":"Protocol of a Phase II Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial of S-Adenosyl Methionine in Participants with Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease","title_match":true,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/a-pilot-randomized-controlled-trial-of-weinaokang-sailuotong-in-36606270","doi":"10.1002/agm2.12230","journal":"Aging medicine (Milton (N.S.W))","n_participants":null,"pmid":"36606270","source_url":"https://pubmed.ncbi.nlm.nih.gov/36606270/","study_design":null,"title":"A pilot randomized controlled trial of WeiNaoKang (SaiLuoTong) in treating vascular dementia","title_match":true,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/nefiracetam-daiichi-seiyaku-12090554","doi":null,"journal":"Current opinion in investigational drugs (London, England : 2000)","n_participants":null,"pmid":"12090554","source_url":"https://pubmed.ncbi.nlm.nih.gov/12090554/","study_design":null,"title":"Nefiracetam. Daiichi Seiyaku","title_match":false,"year":2002},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/ambroxol-as-a-disease-modifying-treatment-to-reduce-the-risk-of-38027469","doi":"10.1136/bmjno-2023-000535","journal":"BMJ neurology open","n_participants":null,"pmid":"38027469","source_url":"https://pubmed.ncbi.nlm.nih.gov/38027469/","study_design":"open-label trial","title":"Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol","title_match":true,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/oral-frailty-and-neurodegeneration-in-alzheimer-s-disease-33818486","doi":"10.4103/1673-5374.310672","journal":"Neural regeneration research","n_participants":null,"pmid":"33818486","source_url":"https://pubmed.ncbi.nlm.nih.gov/33818486/","study_design":null,"title":"Oral frailty and neurodegeneration in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/a-proof-of-concept-phase-ii-study-with-the-pde-4-inhibitor-38438923","doi":"10.1186/s13063-024-08001-3","journal":"Trials","n_participants":null,"pmid":"38438923","source_url":"https://pubmed.ncbi.nlm.nih.gov/38438923/","study_design":null,"title":"A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial","title_match":true,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/no-response-to-high-dose-muscarinic-agonist-therapy-in-alzheimer-s-3281057","doi":"10.1212/wnl.38.4.606","journal":"Neurology","n_participants":null,"pmid":"3281057","source_url":"https://pubmed.ncbi.nlm.nih.gov/3281057/","study_design":null,"title":"No response to high-dose muscarinic agonist therapy in Alzheimer's disease","title_match":false,"year":1988},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/a-phase-ii-randomized-trial-of-sodium-oligomannate-in-alzheimer-s-32928279","doi":"10.1186/s13195-020-00678-3","journal":"Alzheimer's research & therapy","n_participants":83,"pmid":"32928279","source_url":"https://pubmed.ncbi.nlm.nih.gov/32928279/","study_design":null,"title":"A phase II randomized trial of sodium oligomannate in Alzheimer's dementia","title_match":true,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/multicrossover-randomized-controlled-trial-designs-in-alzheimer-30014506","doi":"10.1002/ana.25280","journal":"Annals of neurology","n_participants":null,"pmid":"30014506","source_url":"https://pubmed.ncbi.nlm.nih.gov/30014506/","study_design":null,"title":"Multicrossover Randomized Controlled Trial Designs in Alzheimer Disease","title_match":true,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-s-drug-development-pipeline-2016-29067309","doi":"10.1016/j.trci.2016.07.001","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29067309","source_url":"https://pubmed.ncbi.nlm.nih.gov/29067309/","study_design":null,"title":"Alzheimer's drug-development pipeline: 2016","title_match":false,"year":2016},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/randomized-double-blind-placebo-controlled-multicenter-trial-of-26711658","doi":"10.1111/ggi.12696","journal":"Geriatrics & gerontology international","n_participants":12,"pmid":"26711658","source_url":"https://pubmed.ncbi.nlm.nih.gov/26711658/","study_design":null,"title":"Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease","title_match":true,"year":2017},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effectiveness-of-karxt-xanomeline-trospium-for-cognitive-impairment-36414626","doi":"10.1038/s41398-022-02254-9","journal":"Translational psychiatry","n_participants":60,"pmid":"36414626","source_url":"https://pubmed.ncbi.nlm.nih.gov/36414626/","study_design":"clinical trial","title":"Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study","title_match":true,"year":2022},{"alzhub_score":85,"alzhub_url":"https://alzhub.org/study/efficacy-assessment-of-an-active-tau-immunotherapy-in-alzheimer-s-38101301","doi":"10.1016/j.ebiom.2023.104923","journal":"EBioMedicine","n_participants":196,"pmid":"38101301","source_url":"https://pubmed.ncbi.nlm.nih.gov/38101301/","study_design":"post-hoc analysis","title":"Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the \"ADAMANT\" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial","title_match":true,"year":2024},{"alzhub_score":86,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-crenezumab-in-cognitively-unimpaired-carriers-41579901","doi":"10.1016/s1474-4422(25)00426-0","journal":"The Lancet. Neurology","n_participants":85,"pmid":"41579901","source_url":"https://pubmed.ncbi.nlm.nih.gov/41579901/","study_design":null,"title":"Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial","title_match":true,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/resveratrol-for-alzheimer-s-disease-28815614","doi":"10.1111/nyas.13431","journal":"Annals of the New York Academy of Sciences","n_participants":null,"pmid":"28815614","source_url":"https://pubmed.ncbi.nlm.nih.gov/28815614/","study_design":null,"title":"Resveratrol for Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/safety-and-tolerability-of-grf6019-infusions-in-severe-alzheimer-s-33967047","doi":"10.3233/jad-210011","journal":"Journal of Alzheimer's disease : JAD","n_participants":18,"pmid":"33967047","source_url":"https://pubmed.ncbi.nlm.nih.gov/33967047/","study_design":null,"title":"Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial","title_match":true,"year":2021},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/vortioxetine-treatment-for-depression-in-alzheimer-s-disease-a-35466102","doi":"10.9758/cpn.2022.20.2.311","journal":"Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology","n_participants":100,"pmid":"35466102","source_url":"https://pubmed.ncbi.nlm.nih.gov/35466102/","study_design":null,"title":"Vortioxetine Treatment for Depression in Alzheimer's Disease: A Randomized, Double-blind, Placebo-controlled Study","title_match":true,"year":2022},{"alzhub_score":85,"alzhub_url":"https://alzhub.org/study/a-phase-2-randomized-multicenter-double-blind-placebo-controlled-41980907","doi":"10.1002/alz.71381","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":63,"pmid":"41980907","source_url":"https://pubmed.ncbi.nlm.nih.gov/41980907/","study_design":"clinical trial","title":"A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease","title_match":true,"year":2026},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/economic-evaluations-during-early-phase-ii-drug-development-a-role-11735674","doi":"10.2165/00019053-200119110-00001","journal":"PharmacoEconomics","n_participants":null,"pmid":"11735674","source_url":"https://pubmed.ncbi.nlm.nih.gov/11735674/","study_design":null,"title":"Economic evaluations during early (phase II) drug development: a role for clinical trial simulations?","title_match":true,"year":2001},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/efficacy-of-probucol-on-cognitive-function-in-alzheimer-s-disease-35190446","doi":"10.1136/bmjopen-2021-058826","journal":"BMJ open","n_participants":314,"pmid":"35190446","source_url":"https://pubmed.ncbi.nlm.nih.gov/35190446/","study_design":null,"title":"Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study)","title_match":true,"year":2022},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-phase-ii-study-assessing-30530975","doi":"10.3233/jad-180759","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30530975","source_url":"https://pubmed.ncbi.nlm.nih.gov/30530975/","study_design":"post-hoc analysis","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease","title_match":true,"year":2019},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-losartan-for-the-reduction-of-brain-atrophy-in-34687634","doi":"10.1016/s1474-4422(21)00263-5","journal":"The Lancet. Neurology","n_participants":105,"pmid":"34687634","source_url":"https://pubmed.ncbi.nlm.nih.gov/34687634/","study_design":"randomized controlled trial","title":"Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial","title_match":true,"year":2021},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/huntington-s-disease-drug-development-a-phase-3-pipeline-analysis-38004378","doi":"10.3390/ph16111513","journal":"Pharmaceuticals (Basel, Switzerland)","n_participants":null,"pmid":"38004378","source_url":"https://pubmed.ncbi.nlm.nih.gov/38004378/","study_design":"systematic review","title":"Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis","title_match":true,"year":2023},{"alzhub_score":85,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-pioglitazone-for-the-delay-of-cognitive-34146512","doi":"10.1016/s1474-4422(21)00043-0","journal":"The Lancet. Neurology","n_participants":3494,"pmid":"34146512","source_url":"https://pubmed.ncbi.nlm.nih.gov/34146512/","study_design":"clinical trial","title":"Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial","title_match":true,"year":2021},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-the-35180125","doi":"10.3233/jad-215511","journal":"Journal of Alzheimer's disease : JAD","n_participants":48,"pmid":"35180125","source_url":"https://pubmed.ncbi.nlm.nih.gov/35180125/","study_design":null,"title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial","title_match":true,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/commentaries-lecanemab-pioneering-the-way-as-the-first-approved-drug-37682322","doi":"10.1007/s00011-023-01788-y","journal":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","n_participants":null,"pmid":"37682322","source_url":"https://pubmed.ncbi.nlm.nih.gov/37682322/","study_design":null,"title":"Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer's disease treatment","title_match":false,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/value-generating-exploratory-trials-in-neurodegenerative-dementias-33674360","doi":"10.1212/wnl.0000000000011774","journal":"Neurology","n_participants":null,"pmid":"33674360","source_url":"https://pubmed.ncbi.nlm.nih.gov/33674360/","study_design":"clinical trial","title":"Value-Generating Exploratory Trials in Neurodegenerative Dementias","title_match":false,"year":2021},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/investigating-partially-discordant-results-in-phase-3-studies-of-36946443","doi":"10.14283/jpad.2023.6","journal":"The journal of prevention of Alzheimer's disease","n_participants":1638,"pmid":"36946443","source_url":"https://pubmed.ncbi.nlm.nih.gov/36946443/","study_design":"post-hoc analysis","title":"Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab","title_match":true,"year":2023},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/the-integrated-alzheimer-s-disease-rating-scale-iadrs-findings-from-29616706","doi":"10.14283/jpad.2018.10","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"29616706","source_url":"https://pubmed.ncbi.nlm.nih.gov/29616706/","study_design":"clinical trial","title":"The Integrated Alzheimer's Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial","title_match":false,"year":2018},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/effects-of-kami-guibi-tang-in-patients-with-mild-cognitive-impairment-36461035","doi":"10.1186/s12906-022-03805-9","journal":"BMC complementary medicine and therapies","n_participants":84,"pmid":"36461035","source_url":"https://pubmed.ncbi.nlm.nih.gov/36461035/","study_design":null,"title":"Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial","title_match":true,"year":2022},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effects-of-an-essential-amino-acid-mixture-on-behavioral-and-35932158","doi":"10.1002/gps.5782","journal":"International journal of geriatric psychiatry","n_participants":36,"pmid":"35932158","source_url":"https://pubmed.ncbi.nlm.nih.gov/35932158/","study_design":null,"title":"Effects of an essential amino acid mixture on behavioral and psychological symptoms of dementia and executive function in patients with Alzheimer's disease: A double-blind, randomized, placebo-controlled exploratory clinical trial","title_match":true,"year":2022},{"alzhub_score":86,"alzhub_url":"https://alzhub.org/study/study-of-mirtazapine-for-agitated-behaviours-in-dementia-symbad-a-34688369","doi":"10.1016/s0140-6736(21)01210-1","journal":"Lancet (London, England)","n_participants":204,"pmid":"34688369","source_url":"https://pubmed.ncbi.nlm.nih.gov/34688369/","study_design":"post-hoc analysis","title":"Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial","title_match":true,"year":2021},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/safety-efficacy-and-tolerability-of-memantine-for-cognitive-and-34942135","doi":"10.1016/s1474-4422(21)00369-0","journal":"The Lancet. Neurology","n_participants":81,"pmid":"34942135","source_url":"https://pubmed.ncbi.nlm.nih.gov/34942135/","study_design":"clinical trial","title":"Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial","title_match":true,"year":2022},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/communication-bridge-2-randomized-controlled-trial-recruitment-and-39588869","doi":"10.1002/alz.14168","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39588869","source_url":"https://pubmed.ncbi.nlm.nih.gov/39588869/","study_design":"randomized controlled trial","title":"Communication Bridge-2 randomized controlled trial: Recruitment and baseline features","title_match":true,"year":2025},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-linopirdine-in-the-treatment-of-9164692","doi":"10.1017/s031716710002148x","journal":"The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","n_participants":382,"pmid":"9164692","source_url":"https://pubmed.ncbi.nlm.nih.gov/9164692/","study_design":null,"title":"A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease","title_match":true,"year":1997},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/egb-761-does-not-affect-blood-coagulation-and-bleeding-time-in-34946404","doi":"10.3390/healthcare9121678","journal":"Healthcare (Basel, Switzerland)","n_participants":169,"pmid":"34946404","source_url":"https://pubmed.ncbi.nlm.nih.gov/34946404/","study_design":null,"title":"EGb 761\u00ae Does Not Affect Blood Coagulation and Bleeding Time in Patients with Probable Alzheimer's Dementia-Secondary Analysis of a Randomized, Double-Blind Placebo-Controlled Trial","title_match":true,"year":2021},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/a-phase-ii-single-center-randomized-double-blind-placebo-controlled-33719017","doi":"10.1007/s40266-021-00845-7","journal":"Drugs & aging","n_participants":null,"pmid":"33719017","source_url":"https://pubmed.ncbi.nlm.nih.gov/33719017/","study_design":null,"title":"A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease","title_match":true,"year":2021},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/sembragiline-in-moderate-alzheimer-s-disease-results-of-a-randomized-28550255","doi":"10.3233/jad-161309","journal":"Journal of Alzheimer's disease : JAD","n_participants":542,"pmid":"28550255","source_url":"https://pubmed.ncbi.nlm.nih.gov/28550255/","study_design":null,"title":"Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)","title_match":true,"year":2017},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-behavioral-effects-of-combination-therapy-of-memantine-and-33685036","doi":"10.30773/pi.2020.0329","journal":"Psychiatry investigation","n_participants":148,"pmid":"33685036","source_url":"https://pubmed.ncbi.nlm.nih.gov/33685036/","study_design":null,"title":"The Behavioral Effects of Combination Therapy of Memantine and Acetylcholinesterase Inhibitors Compared with Acetylcholinesterase Inhibitors Alone in Patients with Moderate Alzheimer's Dementia: A Double-Blind Randomized Placebo-Controlled Trial","title_match":true,"year":2021},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/a-study-protocol-for-a-phase-ii-randomised-double-blind-placebo-33199422","doi":"10.1136/bmjopen-2020-040100","journal":"BMJ open","n_participants":null,"pmid":"33199422","source_url":"https://pubmed.ncbi.nlm.nih.gov/33199422/","study_design":null,"title":"A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia","title_match":true,"year":2020},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/a-double-blind-placebo-controlled-crossover-study-of-ganglioside-gm1-8267111","doi":"10.1176/ajp.151.1.126","journal":"The American journal of psychiatry","n_participants":12,"pmid":"8267111","source_url":"https://pubmed.ncbi.nlm.nih.gov/8267111/","study_design":null,"title":"A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease","title_match":true,"year":1994},{"alzhub_score":86,"alzhub_url":"https://alzhub.org/study/randomized-double-blind-study-of-zervimesine-in-mild-to-moderate-41930592","doi":"10.1177/13872877261437145","journal":"Journal of Alzheimer's disease : JAD","n_participants":153,"pmid":"41930592","source_url":"https://pubmed.ncbi.nlm.nih.gov/41930592/","study_design":"clinical trial","title":"Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease","title_match":true,"year":2026},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-progression-by-geographical-region-in-a-clinical-26120369","doi":"10.1186/s13195-015-0127-0","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"26120369","source_url":"https://pubmed.ncbi.nlm.nih.gov/26120369/","study_design":"clinical trial","title":"Alzheimer's disease progression by geographical region in a clinical trial setting","title_match":true,"year":2015},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/a-double-blind-placebo-controlled-study-of-clomipramine-in-depressed-8854297","doi":"10.1176/jnp.8.3.270","journal":"The Journal of neuropsychiatry and clinical neurosciences","n_participants":null,"pmid":"8854297","source_url":"https://pubmed.ncbi.nlm.nih.gov/8854297/","study_design":null,"title":"A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease","title_match":true,"year":1996},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/phase-ii-clinical-trials-of-anti-amyloid-antibodies-when-is-enough-29067346","doi":"10.1016/j.trci.2017.04.005","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"29067346","source_url":"https://pubmed.ncbi.nlm.nih.gov/29067346/","study_design":null,"title":"Phase II clinical trials of anti-amyloid \u03b2 antibodies: When is enough, enough?","title_match":true,"year":2017},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/pioglitazone-for-the-treatment-of-alzheimer-s-disease-27885860","doi":"10.1080/13543784.2017.1265504","journal":"Expert opinion on investigational drugs","n_participants":null,"pmid":"27885860","source_url":"https://pubmed.ncbi.nlm.nih.gov/27885860/","study_design":null,"title":"Pioglitazone for the treatment of Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/avp-786-for-the-treatment-of-agitation-in-dementia-of-the-alzheimer-s-27936965","doi":"10.1080/13543784.2017.1267726","journal":"Expert opinion on investigational drugs","n_participants":200,"pmid":"27936965","source_url":"https://pubmed.ncbi.nlm.nih.gov/27936965/","study_design":null,"title":"AVP-786 for the treatment of agitation in dementia of the Alzheimer's type","title_match":false,"year":2017},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/supplementation-with-dha-and-the-psychological-functioning-of-young-22715808","doi":"10.1017/s0007114512000566","journal":"The British journal of nutrition","n_participants":285,"pmid":"22715808","source_url":"https://pubmed.ncbi.nlm.nih.gov/22715808/","study_design":null,"title":"Supplementation with DHA and the psychological functioning of young adults","title_match":false,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/sulfopropanoic-acid-derivatives-for-treating-neurodegenerative-40828109","doi":"10.1080/20468954.2024.2363657","journal":"Pharmaceutical patent analyst","n_participants":null,"pmid":"40828109","source_url":"https://pubmed.ncbi.nlm.nih.gov/40828109/","study_design":null,"title":"Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight","title_match":false,"year":2024},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/dgavp-org-5667-in-early-alzheimer-s-disease-patients-an-international-2192301","doi":"10.1212/wnl.40.7.1099","journal":"Neurology","n_participants":115,"pmid":"2192301","source_url":"https://pubmed.ncbi.nlm.nih.gov/2192301/","study_design":null,"title":"DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial","title_match":true,"year":1990},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-therapeutic-landscape-of-tauopathies-challenges-and-prospects-37803386","doi":"10.1186/s13195-023-01321-7","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"37803386","source_url":"https://pubmed.ncbi.nlm.nih.gov/37803386/","study_design":null,"title":"The therapeutic landscape of tauopathies: challenges and prospects","title_match":false,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/bryostatin-placebo-controlled-trials-indicate-cognitive-restoration-35124654","doi":"10.3233/jad-215545","journal":"Journal of Alzheimer's disease : JAD","n_participants":95,"pmid":"35124654","source_url":"https://pubmed.ncbi.nlm.nih.gov/35124654/","study_design":null,"title":"Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer's Disease in the Absence of Memantine1","title_match":true,"year":2022},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/placebo-controlled-phase-ii-clinical-trial-safety-and-efficacy-of-33856613","doi":"10.1007/s11011-021-00727-2","journal":"Metabolic brain disease","n_participants":null,"pmid":"33856613","source_url":"https://pubmed.ncbi.nlm.nih.gov/33856613/","study_design":null,"title":"Placebo controlled phase II clinical trial: Safety and efficacy of combining intranasal insulin & acute exercise","title_match":true,"year":2021},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/homocysteine-vascular-dementia-and-alzheimer-s-disease-11592440","doi":"10.1515/cclm.2001.119","journal":"Clinical chemistry and laboratory medicine","n_participants":null,"pmid":"11592440","source_url":"https://pubmed.ncbi.nlm.nih.gov/11592440/","study_design":null,"title":"Homocysteine, vascular dementia and Alzheimer's disease","title_match":false,"year":2001},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/galantamine-a-randomized-double-blind-dose-comparison-in-patients-11571763","doi":"10.1002/gps.409","journal":"International journal of geriatric psychiatry","n_participants":285,"pmid":"11571763","source_url":"https://pubmed.ncbi.nlm.nih.gov/11571763/","study_design":null,"title":"Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease","title_match":true,"year":2001},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-idalopirdine-a-5-ht6-receptor-antagonist-in-25297016","doi":"10.1016/s1474-4422(14)70198-x","journal":"The Lancet. Neurology","n_participants":278,"pmid":"25297016","source_url":"https://pubmed.ncbi.nlm.nih.gov/25297016/","study_design":"clinical trial","title":"Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","title_match":true,"year":2014},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/olfactory-bulb-amyloid-correlates-with-brain-thal-amyloid-phase-and-35751438","doi":"10.1093/jnen/nlac042","journal":"Journal of neuropathology and experimental neurology","n_participants":null,"pmid":"35751438","source_url":"https://pubmed.ncbi.nlm.nih.gov/35751438/","study_design":"clinical trial","title":"Olfactory Bulb Amyloid-\u03b2 Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/clinical-experience-with-cerebrolysin-10961441","doi":null,"journal":"Journal of neural transmission. Supplementum","n_participants":null,"pmid":"10961441","source_url":"https://pubmed.ncbi.nlm.nih.gov/10961441/","study_design":null,"title":"Clinical experience with Cerebrolysin","title_match":false,"year":2000},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/a-phase-ii-randomized-controlled-pilot-study-of-nicotinamide-riboside-42478598","doi":"10.1002/alz.71605","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":42,"pmid":"42478598","source_url":"https://pubmed.ncbi.nlm.nih.gov/42478598/","study_design":null,"title":"A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment","title_match":true,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/randomized-controlled-trial-of-standardized-bacopa-monniera-extract-20703343","doi":"10.4103/0019-5545.31555","journal":"Indian journal of psychiatry","n_participants":null,"pmid":"20703343","source_url":"https://pubmed.ncbi.nlm.nih.gov/20703343/","study_design":null,"title":"Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment","title_match":true,"year":2006},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/exercise-interventions-in-alzheimer-s-disease-a-systematic-review-and-34601135","doi":"10.1016/j.arr.2021.101479","journal":"Ageing research reviews","n_participants":1337,"pmid":"34601135","source_url":"https://pubmed.ncbi.nlm.nih.gov/34601135/","study_design":"systematic review","title":"Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials","title_match":true,"year":2021},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/effect-of-a-multidomain-lifestyle-intervention-on-estimated-dementia-34151805","doi":"10.3233/jad-210331","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"34151805","source_url":"https://pubmed.ncbi.nlm.nih.gov/34151805/","study_design":"randomized controlled trial","title":"Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk","title_match":false,"year":2021},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/white-matter-plasticity-in-healthy-older-adults-the-effects-of-34174392","doi":"10.1016/j.neuroimage.2021.118305","journal":"NeuroImage","n_participants":180,"pmid":"34174392","source_url":"https://pubmed.ncbi.nlm.nih.gov/34174392/","study_design":null,"title":"White matter plasticity in healthy older adults: The effects of aerobic exercise","title_match":false,"year":2021},{"alzhub_score":93,"alzhub_url":"https://alzhub.org/study/an-online-multidomain-lifestyle-intervention-to-prevent-cognitive-39875685","doi":"10.1038/s41591-024-03351-6","journal":"Nature medicine","n_participants":6104,"pmid":"39875685","source_url":"https://pubmed.ncbi.nlm.nih.gov/39875685/","study_design":"randomized controlled trial","title":"An online multidomain lifestyle intervention to prevent cognitive decline in at-risk older adults: a randomized controlled trial","title_match":true,"year":2025},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/risk-reduction-and-precision-prevention-across-the-alzheimer-s-41145344","doi":"10.1016/j.tjpad.2025.100367","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"41145344","source_url":"https://pubmed.ncbi.nlm.nih.gov/41145344/","study_design":null,"title":"Risk reduction and precision prevention across the Alzheimer's disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches","title_match":true,"year":2025},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/exercise-dose-and-aerobic-fitness-response-in-alzheimer-s-dementia-34492709","doi":"10.1055/a-1639-2307","journal":"International journal of sports medicine","n_participants":16,"pmid":"34492709","source_url":"https://pubmed.ncbi.nlm.nih.gov/34492709/","study_design":"randomized controlled trial","title":"Exercise Dose and Aerobic Fitness Response in Alzheimer's Dementia: Findings from the FIT-AD Trial","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/dementia-risk-and-prevention-by-targeting-modifiable-vascular-risk-28734089","doi":"10.1111/jnc.14132","journal":"Journal of neurochemistry","n_participants":null,"pmid":"28734089","source_url":"https://pubmed.ncbi.nlm.nih.gov/28734089/","study_design":null,"title":"Dementia risk and prevention by targeting modifiable vascular risk factors","title_match":false,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/protocol-of-aerobic-exercise-and-cognitive-health-reach-a-pilot-study-32587945","doi":"10.3233/adr-200180","journal":"Journal of Alzheimer's disease reports","n_participants":null,"pmid":"32587945","source_url":"https://pubmed.ncbi.nlm.nih.gov/32587945/","study_design":null,"title":"Protocol of Aerobic Exercise and Cognitive Health (REACH): A Pilot Study","title_match":false,"year":2020},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/effectiveness-and-feasibility-of-a-theory-informed-intervention-to-39716203","doi":"10.1186/s12916-024-03815-z","journal":"BMC medicine","n_participants":104,"pmid":"39716203","source_url":"https://pubmed.ncbi.nlm.nih.gov/39716203/","study_design":null,"title":"Effectiveness and feasibility of a theory-informed intervention to improve Mediterranean diet adherence, physical activity and cognition in older adults at risk of dementia: the MedEx-UK randomised controlled trial","title_match":true,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/cognition-and-activity-of-daily-living-function-in-people-with-38976044","doi":"10.1007/s00702-024-02796-w","journal":"Journal of neural transmission (Vienna, Austria : 1996)","n_participants":null,"pmid":"38976044","source_url":"https://pubmed.ncbi.nlm.nih.gov/38976044/","study_design":"narrative review","title":"Cognition and Activity of Daily Living Function in people with Parkinson's disease","title_match":false,"year":2024},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/can-exercise-improve-cognitive-symptoms-of-alzheimer-s-disease-29363108","doi":"10.1111/jgs.15241","journal":"Journal of the American Geriatrics Society","n_participants":1145,"pmid":"29363108","source_url":"https://pubmed.ncbi.nlm.nih.gov/29363108/","study_design":"meta-analysis","title":"Can Exercise Improve Cognitive Symptoms of Alzheimer's Disease?","title_match":false,"year":2018},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/exercise-for-individuals-with-lewy-body-dementia-a-systematic-review-27258533","doi":"10.1371/journal.pone.0156520","journal":"PloS one","n_participants":16,"pmid":"27258533","source_url":"https://pubmed.ncbi.nlm.nih.gov/27258533/","study_design":"randomized controlled trial","title":"Exercise for Individuals with Lewy Body Dementia: A Systematic Review","title_match":false,"year":2016},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/the-impact-of-pandemic-related-restrictions-on-dementia-risk-factors-37930366","doi":"10.1177/07334648231210671","journal":"Journal of applied gerontology : the official journal of the Southern Gerontological Society","n_participants":156,"pmid":"37930366","source_url":"https://pubmed.ncbi.nlm.nih.gov/37930366/","study_design":"randomized controlled trial","title":"The Impact of Pandemic-Related Restrictions on Dementia Risk Factors in Older Adults","title_match":false,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/insomnia-phenotypes-cardiovascular-risk-and-their-link-to-brain-health-40811499","doi":"10.1161/circresaha.125.325686","journal":"Circulation research","n_participants":null,"pmid":"40811499","source_url":"https://pubmed.ncbi.nlm.nih.gov/40811499/","study_design":null,"title":"Insomnia Phenotypes, Cardiovascular Risk and Their Link to Brain Health","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/hearing-interventions-to-prevent-dementia-30767054","doi":"10.1007/s00106-019-0617-7","journal":"HNO","n_participants":null,"pmid":"30767054","source_url":"https://pubmed.ncbi.nlm.nih.gov/30767054/","study_design":null,"title":"Hearing interventions to prevent dementia","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/understanding-the-association-between-sensory-impairment-and-dementia-37458042","doi":"10.3233/jad-230472","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"37458042","source_url":"https://pubmed.ncbi.nlm.nih.gov/37458042/","study_design":null,"title":"Understanding the Association Between Sensory Impairment and Dementia: Toward Informing Future Research and Health Policy","title_match":false,"year":2023},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/enablers-and-barriers-to-hearing-aid-use-in-people-living-with-38235997","doi":"10.1177/07334648231225346","journal":"Journal of applied gerontology : the official journal of the Southern Gerontological Society","n_participants":null,"pmid":"38235997","source_url":"https://pubmed.ncbi.nlm.nih.gov/38235997/","study_design":"randomized controlled trial","title":"Enablers and Barriers to Hearing aid Use in People Living With Dementia","title_match":false,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/current-and-emerging-therapeutic-approaches-for-vascular-cognitive-41498480","doi":"10.1016/j.jacc.2025.09.1502","journal":"Journal of the American College of Cardiology","n_participants":null,"pmid":"41498480","source_url":"https://pubmed.ncbi.nlm.nih.gov/41498480/","study_design":null,"title":"Current and Emerging Therapeutic Approaches for Vascular Cognitive Impairment and Dementia","title_match":false,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/atrial-fibrillation-and-alzheimer-s-disease-a-conundrum-33219514","doi":"10.1111/eci.13451","journal":"European journal of clinical investigation","n_participants":null,"pmid":"33219514","source_url":"https://pubmed.ncbi.nlm.nih.gov/33219514/","study_design":null,"title":"Atrial fibrillation and Alzheimer's disease: A conundrum","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/influence-of-genetic-and-cardiometabolic-risk-factors-in-alzheimer-s-36038112","doi":"10.1016/j.arr.2022.101723","journal":"Ageing research reviews","n_participants":null,"pmid":"36038112","source_url":"https://pubmed.ncbi.nlm.nih.gov/36038112/","study_design":null,"title":"Influence of genetic and cardiometabolic risk factors in Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/linking-metabolic-syndrome-to-neurodegeneration-mechanisms-and-40272771","doi":"10.1007/s12035-025-04947-w","journal":"Molecular neurobiology","n_participants":null,"pmid":"40272771","source_url":"https://pubmed.ncbi.nlm.nih.gov/40272771/","study_design":"longitudinal study","title":"Linking Metabolic Syndrome to Neurodegeneration Mechanisms and Potential Treatments","title_match":false,"year":2025},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/molecular-basis-of-late-life-depression-34299040","doi":"10.3390/ijms22147421","journal":"International journal of molecular sciences","n_participants":null,"pmid":"34299040","source_url":"https://pubmed.ncbi.nlm.nih.gov/34299040/","study_design":"meta-analysis","title":"Molecular Basis of Late-Life Depression","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/vitamin-d-and-neurodegenerative-diseases-36820164","doi":"10.1016/j.heliyon.2023.e12877","journal":"Heliyon","n_participants":null,"pmid":"36820164","source_url":"https://pubmed.ncbi.nlm.nih.gov/36820164/","study_design":null,"title":"Vitamin D and neurodegenerative diseases","title_match":false,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/diet-and-alzheimer-s-disease-17764625","doi":"10.1007/s11910-007-0057-8","journal":"Current neurology and neuroscience reports","n_participants":null,"pmid":"17764625","source_url":"https://pubmed.ncbi.nlm.nih.gov/17764625/","study_design":null,"title":"Diet and Alzheimer's disease","title_match":false,"year":2007},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/navigating-prevention-a-systematic-review-of-strategies-for-alzheimer-39221402","doi":"10.7759/cureus.65972","journal":"Cureus","n_participants":null,"pmid":"39221402","source_url":"https://pubmed.ncbi.nlm.nih.gov/39221402/","study_design":null,"title":"Navigating Prevention: A Systematic Review of Strategies for Alzheimer's Disease in High-Risk and Affected Individuals","title_match":false,"year":2024},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-and-cognitive-health-an-update-of-available-25405316","doi":"10.1097/mco.0000000000000131","journal":"Current opinion in clinical nutrition and metabolic care","n_participants":null,"pmid":"25405316","source_url":"https://pubmed.ncbi.nlm.nih.gov/25405316/","study_design":"meta-analysis","title":"Mediterranean diet and cognitive health: an update of available knowledge","title_match":false,"year":2015},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/omega-3-fatty-acids-and-neurodegenerative-diseases-new-evidence-in-31480294","doi":"10.3390/ijms20174256","journal":"International journal of molecular sciences","n_participants":null,"pmid":"31480294","source_url":"https://pubmed.ncbi.nlm.nih.gov/31480294/","study_design":"systematic review","title":"Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials","title_match":true,"year":2019},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-in-preventing-neurodegenerative-diseases-29892785","doi":"10.1007/s13668-018-0222-5","journal":"Current nutrition reports","n_participants":null,"pmid":"29892785","source_url":"https://pubmed.ncbi.nlm.nih.gov/29892785/","study_design":null,"title":"Mediterranean Diet in Preventing Neurodegenerative Diseases","title_match":false,"year":2018},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/dietary-interventions-to-prevent-or-delay-alzheimer-s-disease-what-32681411","doi":"10.1007/s13668-020-00333-1","journal":"Current nutrition reports","n_participants":null,"pmid":"32681411","source_url":"https://pubmed.ncbi.nlm.nih.gov/32681411/","study_design":null,"title":"Dietary Interventions to Prevent or Delay Alzheimer's Disease: What the Evidence Shows","title_match":false,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-mediterranean-diet-a-powerful-defense-against-alzheimer-disease-a-39349103","doi":"10.1016/j.clnesp.2024.09.020","journal":"Clinical nutrition ESPEN","n_participants":null,"pmid":"39349103","source_url":"https://pubmed.ncbi.nlm.nih.gov/39349103/","study_design":null,"title":"The Mediterranean Diet: A powerful defense against Alzheimer disease-A comprehensive review","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/omega-3-polyunsaturated-fatty-acids-in-neurodegenerative-disorders-40976313","doi":"10.1016/j.plipres.2025.101356","journal":"Progress in lipid research","n_participants":null,"pmid":"40976313","source_url":"https://pubmed.ncbi.nlm.nih.gov/40976313/","study_design":null,"title":"Omega-3 polyunsaturated fatty acids in neurodegenerative disorders: Mixed designs = mixed results","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/diet-and-lifestyle-impact-the-development-and-progression-of-37457976","doi":"10.3389/fnut.2023.1213223","journal":"Frontiers in nutrition","n_participants":null,"pmid":"37457976","source_url":"https://pubmed.ncbi.nlm.nih.gov/37457976/","study_design":null,"title":"Diet and lifestyle impact the development and progression of Alzheimer's dementia","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/therapeutic-targets-in-innate-immunity-to-tackle-alzheimer-s-disease-39272998","doi":"10.3390/cells13171426","journal":"Cells","n_participants":null,"pmid":"39272998","source_url":"https://pubmed.ncbi.nlm.nih.gov/39272998/","study_design":null,"title":"Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/electroacupuncture-ameliorates-neuroinflammation-in-animal-models-35229660","doi":"10.1177/09645284221076515","journal":"Acupuncture in medicine : journal of the British Medical Acupuncture Society","n_participants":null,"pmid":"35229660","source_url":"https://pubmed.ncbi.nlm.nih.gov/35229660/","study_design":null,"title":"Electroacupuncture ameliorates neuroinflammation in animal models","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/microbiota-brain-gut-axis-and-neurodegenerative-diseases-29039142","doi":"10.1007/s11910-017-0802-6","journal":"Current neurology and neuroscience reports","n_participants":null,"pmid":"29039142","source_url":"https://pubmed.ncbi.nlm.nih.gov/29039142/","study_design":null,"title":"Microbiota-Brain-Gut Axis and Neurodegenerative Diseases","title_match":false,"year":2017},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/microbiota-gut-brain-axis-in-neurodegenerative-diseases-molecular-40952592","doi":"10.1186/s43556-025-00307-1","journal":"Molecular biomedicine","n_participants":null,"pmid":"40952592","source_url":"https://pubmed.ncbi.nlm.nih.gov/40952592/","study_design":"longitudinal study","title":"Microbiota-gut-brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-and-its-relationship-with-the-microbiota-gut-37194773","doi":"10.1590/s0004-2803.202301000-17","journal":"Arquivos de gastroenterologia","n_participants":null,"pmid":"37194773","source_url":"https://pubmed.ncbi.nlm.nih.gov/37194773/","study_design":"narrative review","title":"ALZHEIMER'S DISEASE AND ITS RELATIONSHIP WITH THE MICROBIOTA-GUT-BRAIN AXIS","title_match":false,"year":2023},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/the-intestinal-microbiota-as-an-ally-in-the-treatment-of-alzheimer-s-39295910","doi":"10.1017/gmb.2023.8","journal":"Gut microbiome (Cambridge, England)","n_participants":null,"pmid":"39295910","source_url":"https://pubmed.ncbi.nlm.nih.gov/39295910/","study_design":"systematic review","title":"The intestinal microbiota as an ally in the treatment of Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/microbiome-a-key-regulator-of-body-brain-interactions-40442386","doi":"10.1007/978-3-031-89525-8_6","journal":"Advances in experimental medicine and biology","n_participants":null,"pmid":"40442386","source_url":"https://pubmed.ncbi.nlm.nih.gov/40442386/","study_design":null,"title":"Microbiome: A Key Regulator of Body-Brain Interactions","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/modification-of-the-gut-microbiome-to-combat-neurodegeneration-31095511","doi":"10.1515/revneuro-2019-0005","journal":"Reviews in the neurosciences","n_participants":null,"pmid":"31095511","source_url":"https://pubmed.ncbi.nlm.nih.gov/31095511/","study_design":null,"title":"Modification of the gut microbiome to combat neurodegeneration","title_match":false,"year":2019},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/relationship-between-the-gut-microbiota-and-alzheimer-s-disease-a-35367961","doi":"10.3233/jad-215224","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"35367961","source_url":"https://pubmed.ncbi.nlm.nih.gov/35367961/","study_design":"narrative review","title":"Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/advanced-mri-in-cerebral-small-vessel-disease-35311609","doi":"10.1177/17474930221091879","journal":"International journal of stroke : official journal of the International Stroke Society","n_participants":null,"pmid":"35311609","source_url":"https://pubmed.ncbi.nlm.nih.gov/35311609/","study_design":null,"title":"Advanced MRI in cerebral small vessel disease","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/endothelial-cells-as-key-players-in-cerebral-small-vessel-disease-39743557","doi":"10.1038/s41583-024-00892-0","journal":"Nature reviews. Neuroscience","n_participants":null,"pmid":"39743557","source_url":"https://pubmed.ncbi.nlm.nih.gov/39743557/","study_design":null,"title":"Endothelial cells as key players in cerebral small vessel disease","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/advances-in-cerebral-amyloid-angiopathy-imaging-31105769","doi":"10.1177/1756286419844113","journal":"Therapeutic advances in neurological disorders","n_participants":null,"pmid":"31105769","source_url":"https://pubmed.ncbi.nlm.nih.gov/31105769/","study_design":null,"title":"Advances in cerebral amyloid angiopathy imaging","title_match":false,"year":2019},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/antiplatelets-and-vascular-dementia-a-systematic-review-36245899","doi":"10.1155/2022/9780067","journal":"Journal of aging research","n_participants":null,"pmid":"36245899","source_url":"https://pubmed.ncbi.nlm.nih.gov/36245899/","study_design":"systematic review","title":"Antiplatelets and Vascular Dementia: A Systematic Review","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-biomarkers-for-cerebral-amyloid-angiopathy-35527557","doi":"10.3233/jad-220133","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"35527557","source_url":"https://pubmed.ncbi.nlm.nih.gov/35527557/","study_design":null,"title":"Cerebrospinal Fluid Biomarkers for Cerebral Amyloid Angiopathy Diagnosis","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/hdl-from-an-alzheimer-s-disease-perspective-30946049","doi":"10.1097/mol.0000000000000604","journal":"Current opinion in lipidology","n_participants":null,"pmid":"30946049","source_url":"https://pubmed.ncbi.nlm.nih.gov/30946049/","study_design":null,"title":"HDL from an Alzheimer's disease perspective","title_match":false,"year":2019},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/the-evolving-therapeutic-landscape-of-dementia-with-lewy-bodies-41240919","doi":"10.1016/s1474-4422(25)00323-0","journal":"The Lancet. Neurology","n_participants":null,"pmid":"41240919","source_url":"https://pubmed.ncbi.nlm.nih.gov/41240919/","study_design":null,"title":"The evolving therapeutic landscape of dementia with Lewy bodies","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/tdp-43-proteinopathy-at-the-crossroads-of-tauopathy-on-copathology-41229731","doi":"10.3389/fncel.2025.1671419","journal":"Frontiers in cellular neuroscience","n_participants":null,"pmid":"41229731","source_url":"https://pubmed.ncbi.nlm.nih.gov/41229731/","study_design":null,"title":"TDP-43-proteinopathy at the crossroads of tauopathy: on copathology and current and prospective biomarkers","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/disease-modifying-drugs-for-non-alzheimer-dementias-39251226","doi":"10.11477/mf.1416202733","journal":"Brain and nerve = Shinkei kenkyu no shinpo","n_participants":null,"pmid":"39251226","source_url":"https://pubmed.ncbi.nlm.nih.gov/39251226/","study_design":"clinical trial","title":"[Disease-modifying Drugs for non-Alzheimer Dementias]","title_match":false,"year":2024},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/a-refined-concept-synuclein-dysregulation-disease-29305061","doi":"10.1016/j.neuint.2017.12.011","journal":"Neurochemistry international","n_participants":null,"pmid":"29305061","source_url":"https://pubmed.ncbi.nlm.nih.gov/29305061/","study_design":null,"title":"A refined concept: \u03b1-synuclein dysregulation disease","title_match":false,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/senescence-in-aging-and-alzheimer-s-disease-41296937","doi":"10.14336/ad.2025.1201","journal":"Aging and disease","n_participants":null,"pmid":"41296937","source_url":"https://pubmed.ncbi.nlm.nih.gov/41296937/","study_design":null,"title":"Senescence in Aging and Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/autophagy-dysfunction-in-alzheimer-s-disease-mechanistic-insights-and-31262433","doi":"10.1016/j.biopsych.2019.05.008","journal":"Biological psychiatry","n_participants":null,"pmid":"31262433","source_url":"https://pubmed.ncbi.nlm.nih.gov/31262433/","study_design":null,"title":"Autophagy Dysfunction in Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities","title_match":false,"year":2020},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/protein-quality-control-and-the-amyotrophic-lateral-sclerosis-28539871","doi":"10.3389/fnmol.2017.00119","journal":"Frontiers in molecular neuroscience","n_participants":null,"pmid":"28539871","source_url":"https://pubmed.ncbi.nlm.nih.gov/28539871/","study_design":null,"title":"Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum","title_match":false,"year":2017},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/a-randomized-controlled-trial-of-the-positive-diary-intervention-for-34951029","doi":"10.1111/ppc.13013","journal":"Perspectives in psychiatric care","n_participants":null,"pmid":"34951029","source_url":"https://pubmed.ncbi.nlm.nih.gov/34951029/","study_design":"randomized controlled trial","title":"A randomized controlled trial of the \"positive diary\" intervention for family caregivers of people with dementia","title_match":true,"year":2022},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/home-based-caregiver-training-benefits-differ-by-care-receivers-27291982","doi":"10.1016/j.gerinurse.2016.05.005","journal":"Geriatric nursing (New York, N.Y.)","n_participants":null,"pmid":"27291982","source_url":"https://pubmed.ncbi.nlm.nih.gov/27291982/","study_design":null,"title":"Home-based caregiver training: Benefits differ by care receivers' dementia diagnosis","title_match":false,"year":2016},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/multiphase-optimization-of-a-multicomponent-intervention-for-informal-38053147","doi":"10.1186/s13063-023-07801-3","journal":"Trials","n_participants":null,"pmid":"38053147","source_url":"https://pubmed.ncbi.nlm.nih.gov/38053147/","study_design":null,"title":"Multiphase optimization of a multicomponent intervention for informal dementia caregivers: a study protocol","title_match":false,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/documenting-the-need-for-teaching-resourcefulness-skills-to-family-36116865","doi":"10.1016/j.apnr.2022.151627","journal":"Applied nursing research : ANR","n_participants":null,"pmid":"36116865","source_url":"https://pubmed.ncbi.nlm.nih.gov/36116865/","study_design":"cross-sectional","title":"Documenting the need for teaching resourcefulness skills to family caregivers","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/a-national-program-to-advance-dementia-research-in-vietnam-38302993","doi":"10.1186/s12913-024-10608-w","journal":"BMC health services research","n_participants":null,"pmid":"38302993","source_url":"https://pubmed.ncbi.nlm.nih.gov/38302993/","study_design":null,"title":"A national program to advance dementia research in Vietnam","title_match":false,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/reality-of-family-caregiving-for-hispanics-with-alzheimer-s-disease-37311202","doi":"10.1089/jpm.2023.0008","journal":"Journal of palliative medicine","n_participants":null,"pmid":"37311202","source_url":"https://pubmed.ncbi.nlm.nih.gov/37311202/","study_design":null,"title":"Reality of Family Caregiving for Hispanics With Alzheimer's Disease and Related Dementias: A Qualitative Analysis","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/analgesic-prescribing-in-care-home-residents-how-epidemiological-27383004","doi":"10.2217/pmt-2016-0008","journal":"Pain management","n_participants":null,"pmid":"27383004","source_url":"https://pubmed.ncbi.nlm.nih.gov/27383004/","study_design":null,"title":"Analgesic prescribing in care home residents: how epidemiological studies may inform clinical practice","title_match":false,"year":2016},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/recognition-of-the-complexity-facing-residential-care-homes-a-29444736","doi":"10.1017/s1463423618000105","journal":"Primary health care research & development","n_participants":null,"pmid":"29444736","source_url":"https://pubmed.ncbi.nlm.nih.gov/29444736/","study_design":"clinical trial","title":"Recognition of the complexity facing residential care homes: a practitioner inquiry","title_match":false,"year":2018},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/me-my-wishes-concordance-of-end-of-life-preferences-between-residents-34962157","doi":"10.1089/jpm.2021.0111","journal":"Journal of palliative medicine","n_participants":50,"pmid":"34962157","source_url":"https://pubmed.ncbi.nlm.nih.gov/34962157/","study_design":null,"title":"Me & My Wishes: Concordance of End-of-Life Preferences between Residents with Dementia, Family, and Staff","title_match":false,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/urinary-and-fecal-incontinence-in-nursing-home-residents-18794004","doi":"10.1016/j.gtc.2008.06.005","journal":"Gastroenterology clinics of North America","n_participants":null,"pmid":"18794004","source_url":"https://pubmed.ncbi.nlm.nih.gov/18794004/","study_design":null,"title":"Urinary and fecal incontinence in nursing home residents","title_match":false,"year":2008},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/how-international-experts-would-define-advance-care-planning-a-39308165","doi":"10.21037/apm-24-57","journal":"Annals of palliative medicine","n_participants":131,"pmid":"39308165","source_url":"https://pubmed.ncbi.nlm.nih.gov/39308165/","study_design":null,"title":"How international experts would define advance care planning: a content analysis","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/racial-and-ethnic-disparities-in-neurological-care-in-the-united-38485124","doi":"10.1055/s-0043-1778639","journal":"Seminars in neurology","n_participants":null,"pmid":"38485124","source_url":"https://pubmed.ncbi.nlm.nih.gov/38485124/","study_design":null,"title":"Racial and Ethnic Disparities in Neurological Care in the United States","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/analysis-of-eligibility-criteria-in-alzheimer-s-and-related-dementias-38951633","doi":"10.1038/s41598-024-65767-x","journal":"Scientific reports","n_participants":null,"pmid":"38951633","source_url":"https://pubmed.ncbi.nlm.nih.gov/38951633/","study_design":null,"title":"Analysis of eligibility criteria in Alzheimer's and related dementias clinical trials","title_match":true,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/reasons-for-undergoing-amyloid-imaging-among-diverse-enrollees-in-the-39041310","doi":"10.1002/alz.14077","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39041310","source_url":"https://pubmed.ncbi.nlm.nih.gov/39041310/","study_design":null,"title":"Reasons for undergoing amyloid imaging among diverse enrollees in the A4 study","title_match":false,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/dyadic-enrollment-in-a-phase-3-mild-cognitive-impairment-clinical-35482891","doi":"10.1097/wad.0000000000000506","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"35482891","source_url":"https://pubmed.ncbi.nlm.nih.gov/35482891/","study_design":null,"title":"Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial","title_match":true,"year":2022},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/representativeness-of-participants-eligible-to-be-enrolled-in-34499725","doi":"10.1001/jama.2021.15286","journal":"JAMA","n_participants":null,"pmid":"34499725","source_url":"https://pubmed.ncbi.nlm.nih.gov/34499725/","study_design":null,"title":"Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment","title_match":true,"year":2021},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/plasma-neurofilament-light-chain-is-markedly-elevated-in-general-25f2d41d","doi":"10.64898/2026.10.18.26365854","journal":"medRxiv","n_participants":176,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.18.26365854","study_design":"cross-sectional","title":"Plasma Neurofilament Light Chain is Markedly Elevated in General Hospital Inpatients with Delirium","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/blood-biomarkers-of-alzheimers-disease-neuropathology-cognition-and-f728d2cc","doi":"10.64898/2026.10.02.26364486","journal":"medRxiv","n_participants":1260,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.02.26364486","study_design":null,"title":"Blood Biomarkers of Alzheimer\u2019s Disease Neuropathology, Cognition, and Response to a Multidomain Lifestyle Intervention: Secondary analysis of the FINGER Randomized Controlled Dementia Risk Reduction Trial","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/cannabidiol-for-chronic-neuroinflammation-clinical-pharmacology-and-f55806d2","doi":"10.22541/authorea.15009897/v1","journal":"Authorea Preprints","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.22541/authorea.15009897/v1","study_design":"narrative review","title":"Cannabidiol for chronic neuroinflammation: clinical pharmacology and what an interpretable trial will require","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/does-csf-testing-add-value-after-an-indeterminate-plasma-p-tau217-632475b0","doi":"10.21203/rs.3.rs-10754560/v1","journal":"Research Square","n_participants":283,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10754560/v1","study_design":null,"title":"Does CSF testing add value after an indeterminate plasma p-tau217 result?","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/quantitative-systems-pharmacology-analysis-of-amyloid-aggregation-and-a02492d7","doi":"10.21203/rs.3.rs-10570608/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10570608/v1","study_design":"clinical trial","title":"Quantitative Systems Pharmacology Analysis of Amyloid Aggregation and Hippocampal Atrophy Trajectories in Alzheimer\u2019s Disease by APOE4 Genotype and Valiltramiprosate/ALZ-801 Treatment","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/plasma-biomarker-profiles-in-a-colombian-cohort-of-heterozygous-apoe3-6c38e2c0","doi":"10.21203/rs.3.rs-10705602/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10705602/v1","study_design":"cross-sectional","title":"Plasma Biomarker Profiles in a Colombian Cohort of Heterozygous APOE3-Christchurch Carriers","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/test-retest-reliability-of-plasma-biomarkers-and-digital-cognitive-3b9d2254","doi":"10.21203/rs.3.rs-10016306/v1","journal":"Research Square","n_participants":92,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10016306/v1","study_design":null,"title":"Test-retest reliability of plasma biomarkers and digital cognitive metrics at clinically meaningful timescales","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/large-scale-cerebrospinal-fluid-proteomics-identifies-diagnostic-b2999acb","doi":"10.64898/2026.09.29.755483","journal":"bioRxiv","n_participants":566,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.29.755483","study_design":null,"title":"Large-scale cerebrospinal fluid proteomics identifies diagnostic biomarker candidates across the clinico-pathological continuum of frontotemporal lobar degeneration","title_match":false,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/remote-digital-cognitive-assessment-in-a-trial-ready-alzheimers-9ad4316a","doi":"10.31234/osf.io/mz62t_v2","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.31234/osf.io/mz62t_v2","study_design":null,"title":"Remote Digital Cognitive Assessment in a Trial-Ready Alzheimer\u2019s Cohort: A Scalable Approach for Early Intervention Studies","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/efficacy-of-care-management-in-reducing-needs-of-caregivers-of-people-dc67c10d","doi":"10.21203/rs.3.rs-10521194/v1","journal":"Research Square","n_participants":96,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10521194/v1","study_design":"randomized controlled trial","title":"Efficacy of care management in reducing needs of caregivers of people with dementia","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/living-arrangements-shape-the-determinants-of-life-sustaining-bc771d3f","doi":"10.21203/rs.3.rs-10441296/v1","journal":"Research Square","n_participants":3787,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10441296/v1","study_design":"longitudinal study","title":"Living arrangements shape the determinants of life-sustaining treatment preferences among Korean older adults","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/digitized-and-ai-assisted-scoring-of-cognitive-assessments-in-als-and-78e22c6f","doi":"10.31234/osf.io/a79u4_v2","journal":"PsyArXiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.31234/osf.io/a79u4_v2","study_design":"meta-analysis","title":"Digitized and AI-Assisted Scoring of Cognitive Assessments in ALS and Neurodegenerative Diseases: A Scoping Review of Consistency, Reliability, and Cross-Site Applicability","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/large-scale-head-to-head-comparison-of-on-and-off-target-profiles-of-2c13a0a9","doi":"10.21203/rs.3.rs-9987995/v1","journal":"Research Square","n_participants":681,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-9987995/v1","study_design":null,"title":"Large-scale head-to-head comparison of on- and off-target profiles of [18F]Tauvid and [18F]MK6240 tau-PET in aging and Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/when-is-amyloid-really-cleared-substantial-discordance-between-fc03ab7d","doi":"10.64898/2026.10.03.26364642","journal":"medRxiv","n_participants":15,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.03.26364642","study_design":null,"title":"When Is Amyloid Really Cleared? Substantial Discordance Between Centiloid Quantitation and Visual Reads of Amyloid PET after Amyloid-Targeting Therapy","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/deep-nanoparticle-protein-corona-plasma-proteomics-resolves-a-stage-7fb049ee","doi":"10.64898/2026.07.25.740710","journal":"bioRxiv","n_participants":90,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.25.740710","study_design":null,"title":"Deep nanoparticle protein corona plasma proteomics resolves a stage-specific peripheral signature of Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/biomarker-variability-limits-individualized-amyloid-time-estimation-d4682f47","doi":"10.64898/2026.07.08.737258","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.08.737258","study_design":null,"title":"Biomarker Variability Limits Individualized Amyloid Time Estimation in Alzheimer Disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/night-to-night-rem-sleep-variability-a-relevant-marker-of-early-7a89a129","doi":"10.64898/2025.12.19.25342684","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2025.12.19.25342684","study_design":"longitudinal study","title":"Night-to-night REM sleep variability: a relevant marker of early amyloid-\u03b2 deposition","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/apoe-4-carrier-status-and-cognitive-decline-in-mild-to-moderate-8aa9046f","doi":"10.64898/2026.09.27.26364131","journal":"medRxiv","n_participants":370,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.27.26364131","study_design":"clinical trial","title":"APOE \u03b54 Carrier Status and Cognitive Decline in Mild-to-Moderate Alzheimer\u2019s Disease: A Linear Mixed-Effects Analysis of the Placebo Arm of EXPEDITION 1","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/cognitive-screening-biases-in-a-secondary-prevention-alzheimers-a28a08bc","doi":"10.64898/2025.11.28.25341235","journal":"medRxiv","n_participants":6669,"pmid":null,"source_url":"https://doi.org/10.64898/2025.11.28.25341235","study_design":null,"title":"Cognitive screening biases in a secondary prevention Alzheimer\u2019s disease clinical trial","title_match":true,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/automated-quantification-of-cerebral-microbleeds-for-aria-h-23d6501e","doi":"10.64898/2026.05.19.26353364","journal":"medRxiv","n_participants":264,"pmid":null,"source_url":"https://doi.org/10.64898/2026.05.19.26353364","study_design":null,"title":"Automated quantification of cerebral microbleeds for ARIA-H monitoring in Aging and Alzheimer\u2019s Disease: A multicenter deep learning validation","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/scfv-h3d6-prevents-bapineuzumab-induced-hemorrhagic-events-in-the-343d96ed","doi":"10.20944/preprints202511.0180.v1","journal":"Preprints.org","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.20944/preprints202511.0180.v1","study_design":null,"title":"ScFv-h3D6 Prevents Bapineuzumab-Induced Hemorrhagic Events in the APP23 Mouse Model of Alzheimer\u2019s Disease","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/xpro1595-a-selective-soluble-tnf-neutralizer-in-early-alzheimers-377d6a5b","doi":"10.1101/2025.09.24.25336496","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1101/2025.09.24.25336496","study_design":"clinical trial","title":"XPro1595, a Selective Soluble TNF Neutralizer, in Early Alzheimer\u2019s Disease with Inflammation (ADi): Results from the Phase 2 MINDFuL Trial","title_match":true,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-as-the-result-of-aberrant-reactivation-of-830ed5a8","doi":"10.21203/rs.3.rs-10436661/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10436661/v1","study_design":null,"title":"Alzheimer's Disease as the Result of Aberrant Reactivation of Embryonic Brain Pathways Silenced Decades Earlier","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/plasma-ptau-181-exhibits-flat-longitudinal-trajectories-and-weak-eaeb6aee","doi":"10.21203/rs.3.rs-8204349/v1","journal":"Research Square","n_participants":2523,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-8204349/v1","study_design":"cross-sectional","title":"Plasma pTau-181 Exhibits Flat Longitudinal Trajectories and Weak Cognitive Correlation in UK Biobank: Implications for Anti-Tau Antibody Trial Failures","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/glp-1-receptor-agonists-vs-sglt2-inhibitors-for-alzheimers-disease-e092d390","doi":"10.64898/2026.07.22.26358702","journal":"medRxiv","n_participants":12,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.22.26358702","study_design":"cohort study","title":"GLP-1 Receptor Agonists vs SGLT2 Inhibitors for Alzheimer\u2019s Disease Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/reversibility-and-access-a-two-axis-framework-for-glucagon-like-7e0e4d07","doi":"10.20944/preprints202607.1279.v1","journal":"Preprints.org","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.20944/preprints202607.1279.v1","study_design":"clinical trial","title":"Reversibility and Access: A Two-Axis Framework for Glucagon-Like Peptide-1 Receptor Agonists Across the Neurological Spectrum, and a Falsifiable Analgesic Hypothesis for Chronic Migraine","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/glucagon-like-peptide-1-receptor-agonists-and-risk-of-parkinsonian-0839901b","doi":"10.64898/2025.11.24.25340763","journal":"medRxiv","n_participants":11683,"pmid":null,"source_url":"https://doi.org/10.64898/2025.11.24.25340763","study_design":"cohort study","title":"Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinsonian Disorders in Patients with Obesity","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/reducing-placebo-response-in-clinical-trials-of-agitation-in-59dea31b","doi":"10.64898/2026.06.03.26354808","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.06.03.26354808","study_design":null,"title":"Reducing placebo response in clinical trials of agitation in Alzheimer\u2019s disease","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/computational-screening-of-1-348-fda-approved-drugs-as-potential-5bb621f8","doi":"10.21203/rs.3.rs-10484841/v1","journal":"Research Square","n_participants":1348,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10484841/v1","study_design":null,"title":"Computational Screening of 1,348 FDA-Approved Drugs as Potential BACE1 Inhibitors for Alzheimer's Disease Drug Repurposing","title_match":false,"year":2026},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/evaluating-a-primary-care-pharmacist-led-intervention-to-reduce-6293a8b2","doi":"10.3310/nihropenres.13961.4","journal":"NIHR Open Res","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.3310/nihropenres.13961.4","study_design":"randomized controlled trial","title":"Evaluating a primary care pharmacist-led intervention to reduce opioid use for persistent non-cancer pain: the PROMPPT cluster randomised controlled trial protocol","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-effect-of-noncontingent-monetary-incentives-in-recruitment-01133a22","doi":"10.21203/rs.3.rs-10818940/v1","journal":"Research Square","n_participants":103,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10818940/v1","study_design":"randomized controlled trial","title":"The Effect of Noncontingent Monetary Incentives in Recruitment Letters on Research Enrollment of Alzheimer\u2019s Disease and Related Dementia Caregiving Dyads: A Study Within a Trial (SWAT) Randomized Controlled Trial","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-effects-of-virtual-reality-and-video-conferencing-on-personal-and-fb5f31f1","doi":"10.21203/rs.3.rs-10584186/v1","journal":"Research Square","n_participants":90,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10584186/v1","study_design":"randomized controlled trial","title":"The effects of virtual reality and video conferencing on personal and relational well-being among older adults with cognitive impairments and their adult children: The Thrive randomized controlled trial","title_match":true,"year":2026},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/efficacy-of-curcumin-in-neurodegenerative-diseases-from-8eff1361","doi":"10.20944/preprints202608.1026.v1","journal":"Pharmaceuticals (Basel, Switzerland)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.20944/preprints202608.1026.v1","study_design":"systematic review","title":"Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery Systems","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-effects-of-a-multidomain-lifestyle-intervention-on-brain-function-1fa09c34","doi":"10.64898/2026.07.28.26358647","journal":"medRxiv","n_participants":53,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.28.26358647","study_design":null,"title":"The Effects of a Multidomain Lifestyle Intervention on Brain Function and Its Relation with Immunometabolic Markers and Intestinal Health in Older Adults at Risk of Cognitive Decline: The HELI Randomised Controlled Trial","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/building-cognitive-lines-of-defense-a-life-course-prevention-strategy-9d3fb2a4","doi":"10.21203/rs.3.rs-10476642/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10476642/v1","study_design":null,"title":"Building Cognitive Lines of Defense: A Life-Course Prevention Strategy for Alzheimer's Disease\u2014An Evidence-Based Multi-Stage Intervention Protocol","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/new-alzheimers-disease-diagnostics-and-psychological-clinical-24e6bbda","doi":"10.31234/osf.io/sz4ay_v1","journal":"PsyArXiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.31234/osf.io/sz4ay_v1","study_design":"clinical trial","title":"New Alzheimer\u2019s Disease Diagnostics and Psychological Clinical Perspectives","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/effects-of-practice-testing-with-corrective-feedback-on-long-term-af6361e3","doi":"10.21203/rs.3.rs-10232266/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10232266/v1","study_design":null,"title":"Effects of Practice Testing with Corrective Feedback on Long-Term BPSD Knowledge in Dementia Caregivers: Randomized Controlled Trial","title_match":true,"year":2026},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/a-clustering-approach-based-on-neuropsychological-testing-to-detect-183d3fda","doi":"10.64898/2026.07.04.26357270","journal":"Frontiers in aging neuroscience","n_participants":161,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.04.26357270","study_design":"randomized controlled trial","title":"A clustering approach based on neuropsychological testing to detect early signs of probable MCI among community-dwelling older adults","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/effects-of-high-intensity-interval-training-with-or-without-525e1fdd","doi":"10.64898/2026.07.02.26357035","journal":"medRxiv","n_participants":105,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.02.26357035","study_design":"randomized controlled trial","title":"Effects of high-intensity interval training with or without resistance training on Alzheimer\u2019s disease brain signatures in individuals with coronary artery disease: the Heart-Brain randomized controlled trial","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/disproportionately-elevated-sulcal-index-desi-an-automatically-driven-4205cb47","doi":"10.64898/2025.12.01.25341388","journal":"medRxiv","n_participants":1032,"pmid":null,"source_url":"https://doi.org/10.64898/2025.12.01.25341388","study_design":"longitudinal study","title":"Disproportionately Elevated Sulcal Index (DESI): An automatically driven index representing disproportionate subarachnoid space enlargement in brain MRI scans","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-effects-of-vortioxetine-versus-placebo-on-cognitive-functioning-d7d29632","doi":"10.64898/2025.12.10.25341977","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2025.12.10.25341977","study_design":"randomized controlled trial","title":"The effects of vortioxetine versus placebo on cognitive functioning in mild cognitive impairment: a placebo-controlled, randomized, double-blind study","title_match":true,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-effectiveness-and-safety-of-high-intensity-interval-training-yoga-f7d2ca48","doi":"10.64898/2026.08.05.26359785","journal":"medRxiv","n_participants":100,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.05.26359785","study_design":null,"title":"The effectiveness and safety of high-intensity interval training, yoga and intermittent hypoxia-hyperoxia exposure on cognitive performance and health in individuals with mild cognitive impairment (KAYH): a study protocol for a randomized, sham-controlled trial","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/multidomain-lifestyle-interventions-for-the-risk-reduction-of-d985936c","doi":"10.64898/2026.07.12.26357861","journal":"medRxiv","n_participants":23209,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.12.26357861","study_design":"systematic review","title":"Multidomain lifestyle interventions for the risk reduction of cognitive impairment and dementia: A systematic review and meta-analysis","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/autophagy-stimulation-by-intermittent-fasting-and-its-potential-7ad35564","doi":"10.20944/preprints202608.1636.v1","journal":"Preprints.org","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.20944/preprints202608.1636.v1","study_design":null,"title":"Autophagy Stimulation by Intermittent Fasting and Its Potential Neuroprotective Role in Alzheimer\u2019s Disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/sleep-duration-and-mental-well-being-are-associated-with-delayed-76517e05","doi":"10.64898/2026.07.29.26359263","journal":"medRxiv","n_participants":329,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.29.26359263","study_design":"cross-sectional","title":"Sleep duration and mental well-being are associated with delayed memory in a 12-week digital and remote community-sample study","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/synergistic-interactions-of-midlife-multimorbidity-on-dementia-a-b0111b5c","doi":"10.21203/rs.3.rs-10402188/v1","journal":"Research Square","n_participants":2597,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10402188/v1","study_design":null,"title":"Synergistic Interactions of Midlife Multimorbidity on Dementia\uff1a A Stratified Analysis by Neuropsychiatric Subtypes","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/hypertension-is-associated-with-better-brain-health-outcomes-in-older-21596d92","doi":"10.21203/rs.3.rs-10731777/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10731777/v1","study_design":null,"title":"Hypertension is associated with better brain health outcomes in older-age asymptomatic carotid disease populations - A Multi-Cohort Study","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/a-binding-site-for-cvn293-reveals-a-mechanism-for-allosteric-control-50f6f595","doi":"10.64898/2026.10.27.761881","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.27.761881","study_design":null,"title":"A Binding Site for CVN293 Reveals a Mechanism for Allosteric Control of THIK-1 K2P Channel Gating","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-gut-brain-axis-mechanism-in-alzheimers-disease-from-animal-models-57ac176b","doi":"10.20944/preprints202607.2232.v1","journal":"Preprints.org","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.20944/preprints202607.2232.v1","study_design":null,"title":"The Gut-Brain Axis Mechanism in Alzheimer\u2019s Disease: From Animal Models to Clinical Translation and Innovative Treatment Strategies","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/gut-microbiota-mediates-the-association-between-aging-and-cognitive-d413d81c","doi":"10.21203/rs.3.rs-10040802/v1","journal":"Research Square","n_participants":578,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10040802/v1","study_design":"cross-sectional","title":"Gut microbiota mediates the association between aging and cognitive function: evidence from a population-based Kyotango study linking diet, Bifidobacterium, and Mini-Mental State Examination (MMSE) score","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/carbonic-anhydrase-inhibition-rescues-heart-function-in-the-tg2576-32eba34d","doi":"10.64898/2026.10.08.757731","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.08.757731","study_design":null,"title":"Carbonic anhydrase inhibition rescues heart function in the Tg2576 Alzheimer\u2019s mouse model by ameliorating cardiac amyloid-\u03b2 pathology and neurotrophic-signaling impairment","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/generalizing-amyloid-pathology-from-postmortem-human-brains-with-e5794f8d","doi":"10.64898/2026.10.05.26364184","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.05.26364184","study_design":"longitudinal study","title":"Generalizing Amyloid \u03b2 Pathology from Postmortem Human Brains with Vision Foundation Models for Lesion Quantification","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/research-trends-of-drama-therapy-in-mental-health-a-comprehensive-a7bfc0b6","doi":"10.21203/rs.3.rs-10691733/v1","journal":"Research Square","n_participants":785,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10691733/v1","study_design":null,"title":"Research Trends of Drama Therapy in Mental Health : A Comprehensive Bibliometric analysis","title_match":false,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/palmitoylethanolamide-and-luteolin-in-brain-aging-and-cognitive-d4144d2f","doi":"10.20944/preprints202607.2125.v1","journal":"Nutrients","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.20944/preprints202607.2125.v1","study_design":"narrative review","title":"Palmitoylethanolamide and Luteolin in Brain Aging and Cognitive Decline: Biological Rationale and Current Evidence","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/dementia-and-pde5-inhibitors-a-retrospective-cohort-study-of-veterans-628d86a7","doi":"10.21203/rs.3.rs-11010754/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-11010754/v1","study_design":"cohort study","title":"Dementia and PDE5 inhibitors: A retrospective cohort study of veterans","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-ywhag-nptx2-ratio-predicts-clinical-severity-and-4579e717","doi":"10.64898/2026.08.22.746470","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.22.746470","study_design":null,"title":"Cerebrospinal fluid YWHAG:NPTX2 ratio predicts clinical severity and future phenoconversion in frontotemporal lobar degeneration","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/exercise-effects-on-balance-confidence-and-concerns-about-falling-in-bb061755","doi":"10.21203/rs.3.rs-10741058/v1","journal":"Research Square","n_participants":327,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10741058/v1","study_design":null,"title":"Exercise effects on balance confidence and concerns about falling in older adults with cognitive impairment: a construct-stratified meta-analysis","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/a-biologically-constrained-continuous-time-framework-for-long-horizon-ae3097e3","doi":"10.64898/2026.08.07.26359964","journal":"medRxiv","n_participants":300,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.07.26359964","study_design":"longitudinal study","title":"A Biologically Constrained Continuous-Time Framework for Long-Horizon Cognition Forecasting in Alzheimer\u2019s Disease","title_match":false,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/idebenone-treatment-in-friedreich-patients-one-year-long-randomized-12771264","doi":"10.1212/01.wnl.0000055872.50364.fc","journal":"Neurology","n_participants":null,"pmid":"12771264","source_url":"https://pubmed.ncbi.nlm.nih.gov/12771264/","study_design":null,"title":"Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial","title_match":true,"year":2003},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/self-organizing-3d-human-neural-tissue-derived-from-induced-27622770","doi":"10.1371/journal.pone.0161969","journal":"PLoS ONE","n_participants":null,"pmid":"27622770","source_url":"https://pubmed.ncbi.nlm.nih.gov/27622770/","study_design":null,"title":"Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer\u2019s Disease Phenotypes","title_match":false,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/addneuromedthe-european-collaboration-for-the-discovery-of-novel-19906259","doi":"10.1111/j.1749-6632.2009.05064.x","journal":"Annals of the New York Academy of Sciences","n_participants":null,"pmid":"19906259","source_url":"https://pubmed.ncbi.nlm.nih.gov/19906259/","study_design":null,"title":"AddNeuroMed\u2014The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease","title_match":false,"year":2009},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/deep-learning-detection-of-informative-features-in-tau-pet-for-33371874","doi":"10.1186/s12859-020-03848-0","journal":"BMC Bioinformatics","n_participants":132,"pmid":"33371874","source_url":"https://pubmed.ncbi.nlm.nih.gov/33371874/","study_design":null,"title":"Deep learning detection of informative features in tau PET for Alzheimer\u2019s disease classification","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/open-peer-commentary-to-failure-to-demonstrate-efficacy-of-aducanumab-33135288","doi":"10.1002/alz.12235","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"33135288","source_url":"https://pubmed.ncbi.nlm.nih.gov/33135288/","study_design":"clinical trial","title":"Open Peer Commentary to \u201cFailure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019\u201d","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/o40405-aducanumab-biib037-an-antiamyloid-beta-monoclonal-antibody-in-204cb97e","doi":"10.1016/j.jalz.2015.07.367","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2015.07.367","study_design":null,"title":"O4\u201004\u201005: Aducanumab (BIIB037), an anti\u2010amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double\u2010blind, placebo\u2010controlled, phase 1b study","title_match":true,"year":2015},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/anti-amyloid-therapies-for-alzheimers-disease-progress-pitfalls-and-41096797","doi":"10.3390/ijms26199529","journal":"International Journal of Molecular Sciences","n_participants":null,"pmid":"41096797","source_url":"https://pubmed.ncbi.nlm.nih.gov/41096797/","study_design":null,"title":"Anti-Amyloid Therapies for Alzheimer\u2019s Disease: Progress, Pitfalls, and the Path Ahead","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/o41106-a-randomized-doubleblind-placebocontrolled-phase-2-study-to-a7c335d7","doi":"10.1016/j.jalz.2014.04.450","journal":"Alzheimer s & Dementia","n_participants":433,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2014.04.450","study_design":"clinical trial","title":"O4\u201011\u201006: A RANDOMIZED, DOUBLE\u2010BLIND, PLACEBO\u2010CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE","title_match":true,"year":2014},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/trailblazer-alz-4-topline-study-results-directly-comparing-donanemab-7521651f","doi":"10.1192/bjo.2023.227","journal":"BJPsych Open","n_participants":148,"pmid":null,"source_url":"https://doi.org/10.1192/bjo.2023.227","study_design":"clinical trial","title":"TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/dt0103-efficacy-and-safety-of-gantenerumab-in-prodromal-alzheimer-s-f0473682","doi":"10.1016/j.jalz.2015.08.153","journal":"Alzheimer s & Dementia","n_participants":312,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2015.08.153","study_design":"clinical trial","title":"DT\u201001\u201003: Efficacy and safety of gantenerumab in prodromal Alzheimer's disease: Results from scarlet road\u2014a global, multicenter trial","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/assessing-preparedness-for-alzheimer-diseasemodifying-therapies-in-36934371","doi":"10.5694/mja2.51880","journal":"The Medical Journal of Australia","n_participants":null,"pmid":"36934371","source_url":"https://pubmed.ncbi.nlm.nih.gov/36934371/","study_design":"clinical trial","title":"Assessing preparedness for Alzheimer disease\u2010modifying therapies in Australasian health care systems","title_match":false,"year":2023},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/intravenous-immunoglobulin-for-alzheimer-s-disease-25546751","doi":"10.1111/cei.12500","journal":"Clinical & Experimental Immunology","n_participants":16,"pmid":"25546751","source_url":"https://pubmed.ncbi.nlm.nih.gov/25546751/","study_design":"open-label trial","title":"Intravenous immunoglobulin for Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/p2003-clinical-trial-design-of-cread-a-randomized-doubleblind-916a25c5","doi":"10.1016/j.jalz.2016.06.1207","journal":"Alzheimer s & Dementia","n_participants":500,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2016.06.1207","study_design":"clinical trial","title":"P2\u2010003: Clinical Trial Design of Cread: A Randomized, Double\u2010Blind, Placebo\u2010Controlled, Parallel\u2010Group Phase 3 Study to Evaluate Crenezumab Treatment in Patients with Prodromal\u2010To\u2010Mild Alzheimer\u2019s Disease","title_match":true,"year":2016},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/donanemab-in-early-symptomatic-alzheimers-disease-efficacy-and-safety-3d9d0576","doi":"10.1002/alz.082733","journal":"Alzheimer s & Dementia","n_participants":1182,"pmid":null,"source_url":"https://doi.org/10.1002/alz.082733","study_design":null,"title":"Donanemab in Early Symptomatic Alzheimer\u2019s Disease: Efficacy and Safety in TRAILBLAZER\u2010ALZ 2, a Phase 3 Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/randomized-double-blind-placebo-controlled-studies-to-evaluate-5b6a5200","doi":"10.1212/wnl.86.16_supplement.s1.003","journal":"Neurology","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1212/wnl.86.16_supplement.s1.003","study_design":"clinical trial","title":"Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer\u2019s Disease: Phase 3 Study Design (S1.003)","title_match":true,"year":2016},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/aducanumab-36-month-data-from-prime-a-randomized-double-blind-placebo-12a02583","doi":"10.1212/wnl.90.15_supplement.s2.004","journal":"Neurology","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1212/wnl.90.15_supplement.s2.004","study_design":"clinical trial","title":"Aducanumab 36-month data from PRIME: a randomized, double-blind, placebo-controlled Phase 1b study in patients with prodromal or mild Alzheimer\u2019s disease (S2.004)","title_match":true,"year":2018},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/japanese-clinical-practice-guideline-for-diabetes-2019-7f71ce0b","doi":"10.1111/jdi.13306","journal":"Journal of Diabetes Investigation","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1111/jdi.13306","study_design":"randomized controlled trial","title":"Japanese Clinical Practice Guideline for Diabetes 2019","title_match":false,"year":2020},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/effect-of-liraglutide-on-cardiovascular-outcomes-in-elderly-patients-30508430","doi":"10.7326/m18-1569","journal":"Annals of Internal Medicine","n_participants":null,"pmid":"30508430","source_url":"https://pubmed.ncbi.nlm.nih.gov/30508430/","study_design":"randomized controlled trial","title":"Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial","title_match":true,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/liraglutide-restores-chronic-er-stress-autophagy-impairments-and-29170452","doi":"10.1038/s41598-017-16488-x","journal":"Scientific Reports","n_participants":null,"pmid":"29170452","source_url":"https://pubmed.ncbi.nlm.nih.gov/29170452/","study_design":null,"title":"Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells","title_match":false,"year":2017},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/comparative-effectiveness-of-glucagon-like-peptide-1-agonists-39429814","doi":"10.1016/j.eclinm.2024.102689","journal":"EClinicalMedicine","n_participants":12351,"pmid":"39429814","source_url":"https://pubmed.ncbi.nlm.nih.gov/39429814/","study_design":null,"title":"Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/liraglutide-reduces-vascular-damage-neuronal-loss-and-cognitive-34975451","doi":"10.3389/fnagi.2021.741923","journal":"Frontiers in Aging Neuroscience","n_participants":null,"pmid":"34975451","source_url":"https://pubmed.ncbi.nlm.nih.gov/34975451/","study_design":null,"title":"Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer\u2019s Disease and Type 2 Diabetes","title_match":false,"year":2021},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/glucagon-like-peptide-1-decreases-intracerebral-glucose-content-by-22929437","doi":"10.1038/jcbfm.2012.118","journal":"Journal of Cerebral Blood Flow & Metabolism","n_participants":null,"pmid":"22929437","source_url":"https://pubmed.ncbi.nlm.nih.gov/22929437/","study_design":null,"title":"Glucagon-Like Peptide-1 Decreases Intracerebral Glucose Content by Activating Hexokinase and Changing Glucose Clearance during Hyperglycemia","title_match":false,"year":2012},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/dt0104-the-efficacy-of-rvt101-a-5ht6-receptor-antagonist-as-an-d54d3985","doi":"10.1016/j.jalz.2015.08.154","journal":"Alzheimer s & Dementia","n_participants":684,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2015.08.154","study_design":"clinical trial","title":"DT\u201001\u201004: The efficacy of RVT\u2010101, a 5\u2010ht6 receptor antagonist, as an adjunct to donepezil in adults with mild\u2010to\u2010moderate Alzheimer's disease: Completer analysis of a phase 2b study","title_match":true,"year":2015},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/medicinal-plants-and-alzheimer-s-disease-from-ethnobotany-to-10411211","doi":"10.1211/0022357991772808","journal":"Journal of Pharmacy and Pharmacology","n_participants":null,"pmid":"10411211","source_url":"https://pubmed.ncbi.nlm.nih.gov/10411211/","study_design":null,"title":"Medicinal Plants and Alzheimer's Disease: from Ethnobotany to Phytotherapy","title_match":false,"year":1999},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/memantine-for-agitation-aggression-and-psychosis-in-moderately-severe-18294023","doi":"10.4088/jcp.v69n0302","journal":"The Journal of Clinical Psychiatry","n_participants":null,"pmid":"18294023","source_url":"https://pubmed.ncbi.nlm.nih.gov/18294023/","study_design":null,"title":"Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease","title_match":false,"year":2008},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/risk-factors-in-coronary-heart-disease-14233810","doi":"10.7326/0003-4819-61-5-888","journal":"Annals of Internal Medicine","n_participants":null,"pmid":"14233810","source_url":"https://pubmed.ncbi.nlm.nih.gov/14233810/","study_design":"cross-sectional","title":"Risk Factors in Coronary Heart Disease","title_match":false,"year":1964},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/sleep-epidemiology-a-rapidly-growing-field-22158659","doi":"10.1093/ije/dyr203","journal":"International Journal of Epidemiology","n_participants":null,"pmid":"22158659","source_url":"https://pubmed.ncbi.nlm.nih.gov/22158659/","study_design":"meta-analysis","title":"Sleep epidemiology--a rapidly growing field","title_match":false,"year":2011},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/promoting-successful-cognitive-aging-a-comprehensive-review-20308777","doi":"10.3233/jad-2010-1306","journal":"Journal of Alzheimer s Disease","n_participants":null,"pmid":"20308777","source_url":"https://pubmed.ncbi.nlm.nih.gov/20308777/","study_design":"cohort study","title":"Promoting Successful Cognitive Aging: A Comprehensive Review","title_match":false,"year":2010},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-cardiovascular-continuum-and-reninangiotensinaldosterone-system-15821452","doi":"10.1097/01.hjh.0000165623.72310.dd","journal":"Journal of Hypertension","n_participants":null,"pmid":"15821452","source_url":"https://pubmed.ncbi.nlm.nih.gov/15821452/","study_design":null,"title":"The cardiovascular continuum and renin\u2013angiotensin\u2013aldosterone system blockade","title_match":false,"year":2005},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/a-placebo-controlled-double-blind-randomized-trial-of-an-extract-of-f69c6c73","doi":"10.1001/jama.1997.03550160047037","journal":"JAMA","n_participants":309,"pmid":null,"source_url":"https://doi.org/10.1001/jama.1997.03550160047037","study_design":null,"title":"A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia","title_match":true,"year":1997},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/six-month-randomized-placebo-controlled-double-blind-pilot-clinical-18204357","doi":"10.1097/jcp.0b013e318160862c","journal":"Journal of Clinical Psychopharmacology","n_participants":null,"pmid":"18204357","source_url":"https://pubmed.ncbi.nlm.nih.gov/18204357/","study_design":null,"title":"Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease","title_match":true,"year":2008},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/a-double-blind-placebo-controlled-trial-of-diclofenac-misoprostol-in-10408559","doi":"10.1212/wnl.53.1.197","journal":"Neurology","n_participants":41,"pmid":"10408559","source_url":"https://pubmed.ncbi.nlm.nih.gov/10408559/","study_design":null,"title":"A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer\u2019s disease","title_match":true,"year":1999},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/frontotemporal-dementia-a-randomised-controlled-trial-with-trazodone-15178953","doi":"10.1159/000077171","journal":"Dementia and Geriatric Cognitive Disorders","n_participants":null,"pmid":"15178953","source_url":"https://pubmed.ncbi.nlm.nih.gov/15178953/","study_design":null,"title":"Frontotemporal Dementia: A Randomised, Controlled Trial with Trazodone","title_match":true,"year":2004},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/effect-of-fish-oil-on-cognitive-performance-in-older-subjects-18678826","doi":"10.1212/01.wnl.0000324268.45138.86","journal":"Neurology","n_participants":null,"pmid":"18678826","source_url":"https://pubmed.ncbi.nlm.nih.gov/18678826/","study_design":null,"title":"Effect of fish oil on cognitive performance in older subjects","title_match":false,"year":2008},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-clinical-efficacy-of-citalopram-in-treatment-of-emotional-1705151","doi":"10.1192/bjp.157.6.894","journal":"The British Journal of Psychiatry","n_participants":98,"pmid":"1705151","source_url":"https://pubmed.ncbi.nlm.nih.gov/1705151/","study_design":null,"title":"The Clinical Efficacy of Citalopram in Treatment of Emotional Disturbances in Dementia Disorders a Nordic Multicentre Study","title_match":false,"year":1990},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/proof-of-efficacy-of-the-ginkgo-biloba-special-extract-egb-761-in-8741021","doi":"10.1055/s-2007-979544","journal":"Pharmacopsychiatry","n_participants":216,"pmid":"8741021","source_url":"https://pubmed.ncbi.nlm.nih.gov/8741021/","study_design":null,"title":"Proof of Efficacy of the Ginkgo Biloba Special Extract EGb 761 in Outpatients Suffering from Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Multi-infarct Dementia","title_match":false,"year":1996},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/investigation-of-the-effects-of-solid-lipid-curcumin-on-cognition-and-25277322","doi":"10.1177/0269881114552744","journal":"Journal of Psychopharmacology","n_participants":null,"pmid":"25277322","source_url":"https://pubmed.ncbi.nlm.nih.gov/25277322/","study_design":null,"title":"Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population","title_match":false,"year":2014},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/effects-of-cannabidiol-in-the-treatment-of-patients-with-parkinsons-25237116","doi":"10.1177/0269881114550355","journal":"Journal of Psychopharmacology","n_participants":119,"pmid":"25237116","source_url":"https://pubmed.ncbi.nlm.nih.gov/25237116/","study_design":null,"title":"Effects of cannabidiol in the treatment of patients with Parkinson\u2019s disease: An exploratory double-blind trial","title_match":true,"year":2014},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/management-of-mild-cognitive-impairment-mci-the-need-for-national-and-32019392","doi":"10.1080/15622975.2019.1696473","journal":"The World Journal of Biological Psychiatry","n_participants":null,"pmid":"32019392","source_url":"https://pubmed.ncbi.nlm.nih.gov/32019392/","study_design":null,"title":"Management of mild cognitive impairment (MCI): The need for national and international guidelines","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cognitive-stimulation-in-patients-with-dementia-randomized-controlled-24052800","doi":"10.1159/000353457","journal":"Dementia and Geriatric Cognitive Disorders Extra","n_participants":null,"pmid":"24052800","source_url":"https://pubmed.ncbi.nlm.nih.gov/24052800/","study_design":null,"title":"Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial","title_match":true,"year":2013},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/guide-to-preventive-cardiology-for-women-10318674","doi":"10.1161/01.cir.99.18.2480","journal":"Circulation","n_participants":2763,"pmid":"10318674","source_url":"https://pubmed.ncbi.nlm.nih.gov/10318674/","study_design":null,"title":"Guide to Preventive Cardiology for Women","title_match":false,"year":1999},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/dysfunction-of-the-microbiota-gut-brain-axis-in-neurodegenerative-33092396","doi":"10.1177/2515690x20957225","journal":"Journal of Evidence-Based Integrative Medicine","n_participants":null,"pmid":"33092396","source_url":"https://pubmed.ncbi.nlm.nih.gov/33092396/","study_design":"longitudinal study","title":"Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics","title_match":false,"year":2020},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/study-of-the-use-of-antidepressants-for-depression-in-dementia-the-23438937","doi":"10.3310/hta17070","journal":"Health Technology Assessment","n_participants":326,"pmid":"23438937","source_url":"https://pubmed.ncbi.nlm.nih.gov/23438937/","study_design":"randomized controlled trial","title":"Study of the use of antidepressants for depression in dementia: the HTA-SADD trial \u2013 a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine","title_match":true,"year":2013},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/start-strategies-for-relatives-study-a-pragmatic-randomised-25300037","doi":"10.3310/hta18610","journal":"Health Technology Assessment","n_participants":null,"pmid":"25300037","source_url":"https://pubmed.ncbi.nlm.nih.gov/25300037/","study_design":null,"title":"START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia","title_match":true,"year":2014},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/adjusted-dose-warfarin-versus-aspirin-for-preventing-stroke-in-17938402","doi":"10.7326/0003-4819-147-8-200710160-00018","journal":"Annals of Internal Medicine","n_participants":973,"pmid":"17938402","source_url":"https://pubmed.ncbi.nlm.nih.gov/17938402/","study_design":"randomized controlled trial","title":"Adjusted-Dose Warfarin versus Aspirin for Preventing Stroke in Patients with Atrial Fibrillation","title_match":false,"year":2007},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/clinical-symptom-responses-to-atypical-antipsychotic-medications-in-18519523","doi":"10.1176/appi.ajp.2008.07111779","journal":"American Journal of Psychiatry","n_participants":421,"pmid":"18519523","source_url":"https://pubmed.ncbi.nlm.nih.gov/18519523/","study_design":"clinical trial","title":"Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer\u2019s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial","title_match":true,"year":2008},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/a-phase-2-trial-of-the-gsk3-inhibitor-tideglusib-in-progressive-24532007","doi":"10.1002/mds.25824","journal":"Movement Disorders","n_participants":146,"pmid":"24532007","source_url":"https://pubmed.ncbi.nlm.nih.gov/24532007/","study_design":"randomized controlled trial","title":"A phase 2 trial of the GSK\u20103 inhibitor tideglusib in progressive supranuclear palsy","title_match":true,"year":2014},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/analysis-of-spontaneous-conversational-speech-in-dementia-of-73274d36","doi":"10.1080/026870300401603","journal":"Aphasiology","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1080/026870300401603","study_design":null,"title":"Analysis of spontaneous, conversational speech in dementia of Alzheimer type: Evaluation of an objective technique for analysing lexical performance","title_match":false,"year":2000},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/hepatotoxic-effects-of-tacrine-administration-in-patients-with-8139084","doi":"10.1001/jama.1994.03510370044030","journal":"JAMA","n_participants":2446,"pmid":"8139084","source_url":"https://pubmed.ncbi.nlm.nih.gov/8139084/","study_design":"open-label trial","title":"Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease","title_match":false,"year":1994},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/effectiveness-of-regional-dti-measures-in-distinguishing-alzheimer-s-24179862","doi":"10.1016/j.nicl.2013.07.006","journal":"NeuroImage Clinical","n_participants":null,"pmid":"24179862","source_url":"https://pubmed.ncbi.nlm.nih.gov/24179862/","study_design":null,"title":"Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging","title_match":false,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/an-inventory-to-assess-activities-of-daily-living-for-clinical-trials-9305513","doi":"10.1097/00002093-199700112-00005","journal":"Alzheimer Disease & Associated Disorders","n_participants":45,"pmid":"9305513","source_url":"https://pubmed.ncbi.nlm.nih.gov/9305513/","study_design":null,"title":"An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer\u02bcs Disease","title_match":true,"year":1997},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/csf-biomarkers-and-plasma-ptau181-as-predictors-of-longitudinal-tau-b0535a07","doi":"10.1002/alz.12570","journal":"Alzheimer's & Dementia","n_participants":163,"pmid":null,"source_url":"https://doi.org/10.1002/alz.12570","study_design":null,"title":"CSF biomarkers and plasma p\u2010tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design","title_match":true,"year":2022},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/immunotherapy-with-aducanumab-restores-calcium-homeostasis-in-tg2576-aa97eb96","doi":"10.1523/jneurosci.2080-16.2016","journal":"The Journal of Neuroscience","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1523/jneurosci.2080-16.2016","study_design":null,"title":"Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice","title_match":false,"year":2016},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/donanemab-leads-to-less-decline-in-early-alzheimer-s-disease-38d83515","doi":"10.1002/pu.30739","journal":"The Brown University Psychopharmacology Update","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/pu.30739","study_design":"clinical trial","title":"Donanemab leads to less decline in early Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/aducanumab-and-disease-modifying-treatments-for-alzheimer-s-disease-6ea281e6","doi":"10.1002/pnp.711","journal":"Progress in Neurology and Psychiatry","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/pnp.711","study_design":null,"title":"Aducanumab and disease modifying treatments for Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/population-pharmacokinetics-and-standard-uptake-value-ratio-of-098ca6fa","doi":"10.1002/psp4.12728","journal":"CPT: Pharmacometrics & Systems Pharmacology","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/psp4.12728","study_design":null,"title":"Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque\u2013removing agent, in patients with Alzheimer\u2019s disease","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/computational-approaches-for-supporting-combination-therapy-in-the-80f66de5","doi":"10.3233/adr-210039","journal":"Journal of Alzheimer's Disease Reports","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.3233/adr-210039","study_design":null,"title":"Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer\u2019s Disease","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/new-drug-update-dostarlimab-loncastuximab-tesirine-and-aducanumab-c153db12","doi":"10.4140/tcp.n.2022.9","journal":"The Senior Care Pharmacist","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.4140/tcp.n.2022.9","study_design":null,"title":"New Drug Update: Dostarlimab, Loncastuximab Tesirine, and Aducanumab","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-with-lewy-bodies-a-randomized-placebo-044b4853","doi":"10.1186/s13195-014-0083-0","journal":"Alzheimer's Research & Therapy","n_participants":142,"pmid":null,"source_url":"https://doi.org/10.1186/s13195-014-0083-0","study_design":null,"title":"Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial","title_match":true,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/long-term-donepezil-use-for-dementia-with-lewy-bodies-results-from-an-88c17657","doi":"10.1186/s13195-014-0081-2","journal":"Alzheimer's Research & Therapy","n_participants":100,"pmid":null,"source_url":"https://doi.org/10.1186/s13195-014-0081-2","study_design":"clinical trial","title":"Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial","title_match":true,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pharmacokinetic-drugdrug-interaction-study-of-ranolazine-and-2d3045db","doi":"10.1002/cpdd.174","journal":"Clinical Pharmacology in Drug Development","n_participants":28,"pmid":null,"source_url":"https://doi.org/10.1002/cpdd.174","study_design":"clinical trial","title":"Pharmacokinetic drug\u2013drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus","title_match":false,"year":2015},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/cerebrolysin-asian-pacific-trial-in-acute-brain-injury-and-a031a0f8","doi":"10.1089/neu.2014.3558","journal":"Journal of Neurotrauma","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1089/neu.2014.3558","study_design":"meta-analysis","title":"Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery: Design and Methods","title_match":false,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/melatonin-for-sleep-disorders-and-cognition-in-dementia-6572f8e9","doi":"10.1177/1533317514568005","journal":"American Journal of Alzheimer's Disease & Other Dementias\u00ae","n_participants":520,"pmid":null,"source_url":"https://doi.org/10.1177/1533317514568005","study_design":null,"title":"Melatonin for Sleep Disorders and Cognition in Dementia","title_match":false,"year":2015},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/association-of-plasma-biomarkers-with-cognition-cognitive-decline-and-38105605","doi":"10.1002/alz.13560","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":480,"pmid":"38105605","source_url":"https://pubmed.ncbi.nlm.nih.gov/38105605/","study_design":null,"title":"Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative","title_match":false,"year":2024},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/longitudinal-phospho-tau217-predicts-amyloid-positron-emission-39044490","doi":"10.14283/jpad.2024.134","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"39044490","source_url":"https://pubmed.ncbi.nlm.nih.gov/39044490/","study_design":"longitudinal study","title":"Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/csf-biomarkers-and-plasma-p-tau181-as-predictors-of-longitudinal-tau-35226405","doi":"10.1002/alz.12570","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":163,"pmid":"35226405","source_url":"https://pubmed.ncbi.nlm.nih.gov/35226405/","study_design":null,"title":"CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design","title_match":true,"year":2022},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/validation-of-alzheimer-s-disease-csf-and-plasma-biological-markers-19539742","doi":"10.1016/j.exger.2009.06.003","journal":"Experimental gerontology","n_participants":49,"pmid":"19539742","source_url":"https://pubmed.ncbi.nlm.nih.gov/19539742/","study_design":null,"title":"Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI)","title_match":false,"year":2009},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/rapamycin-treatment-for-alzheimer-s-disease-and-related-dementias-a-40394335","doi":"10.1038/s43856-025-00904-9","journal":"Communications medicine","n_participants":null,"pmid":"40394335","source_url":"https://pubmed.ncbi.nlm.nih.gov/40394335/","study_design":"clinical trial","title":"Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial","title_match":true,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/csf-beta-amyloid-1-42-what-are-we-measuring-in-alzheimer-s-disease-25750918","doi":"10.1002/acn3.160","journal":"Annals of clinical and translational neurology","n_participants":69,"pmid":"25750918","source_url":"https://pubmed.ncbi.nlm.nih.gov/25750918/","study_design":null,"title":"CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?","title_match":false,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/p-tau217-and-other-blood-biomarkers-of-dementia-variation-with-time-39271655","doi":"10.1038/s41398-024-03084-7","journal":"Translational psychiatry","n_participants":38,"pmid":"39271655","source_url":"https://pubmed.ncbi.nlm.nih.gov/39271655/","study_design":null,"title":"P-tau217 and other blood biomarkers of dementia: variation with time of day","title_match":false,"year":2024},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/blood-phosphorylated-tau217-distinguishes-amyloid-positive-from-40047958","doi":"10.1007/s00415-025-12996-3","journal":"Journal of neurology","n_participants":null,"pmid":"40047958","source_url":"https://pubmed.ncbi.nlm.nih.gov/40047958/","study_design":"systematic review","title":"Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysis","title_match":false,"year":2025},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/plasma-ptau217-ratio-predicts-continuous-regional-brain-tau-39575854","doi":"10.1002/alz.14411","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39575854","source_url":"https://pubmed.ncbi.nlm.nih.gov/39575854/","study_design":null,"title":"Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/effect-of-the-histone-deacetylase-inhibitor-frm-0334-on-progranulin-34559230","doi":"10.1001/jamanetworkopen.2021.25584","journal":"JAMA network open","n_participants":27,"pmid":"34559230","source_url":"https://pubmed.ncbi.nlm.nih.gov/34559230/","study_design":"cross-sectional","title":"Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial","title_match":true,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/relationship-between-plasma-p-tau217-and-amyloid-pet-in-racial-and-39044491","doi":"10.14283/jpad.2024.124","journal":"The journal of prevention of Alzheimer's disease","n_participants":1018,"pmid":"39044491","source_url":"https://pubmed.ncbi.nlm.nih.gov/39044491/","study_design":null,"title":"Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4","title_match":false,"year":2024},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-tas-test-project-a-prospective-longitudinal-validation-of-new-35850660","doi":"10.1186/s12883-022-02772-5","journal":"BMC neurology","n_participants":300,"pmid":"35850660","source_url":"https://pubmed.ncbi.nlm.nih.gov/35850660/","study_design":"cohort study","title":"The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia","title_match":false,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/comparison-of-plasma-and-neuroimaging-biomarkers-to-predict-cognitive-38755703","doi":"10.1186/s13195-024-01478-9","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"38755703","source_url":"https://pubmed.ncbi.nlm.nih.gov/38755703/","study_design":null,"title":"Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients","title_match":false,"year":2024},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/potential-utility-of-plasma-p-tau-and-neurofilament-light-chain-as-36878697","doi":"10.1212/wnl.0000000000207115","journal":"Neurology","n_participants":257,"pmid":"36878697","source_url":"https://pubmed.ncbi.nlm.nih.gov/36878697/","study_design":"longitudinal study","title":"Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials","title_match":true,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/validation-of-elisa-methods-for-quantification-of-total-tau-and-21694458","doi":"10.3233/jad-2011-110296","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"21694458","source_url":"https://pubmed.ncbi.nlm.nih.gov/21694458/","study_design":"clinical trial","title":"Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studies","title_match":false,"year":2011},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/potential-utility-of-plasma-ptau217-for-assessing-amyloid-and-tau-40768095","doi":"10.1007/s00259-025-07457-y","journal":"European journal of nuclear medicine and molecular imaging","n_participants":2919,"pmid":"40768095","source_url":"https://pubmed.ncbi.nlm.nih.gov/40768095/","study_design":"longitudinal study","title":"Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles","title_match":false,"year":2025},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/blood-phosphorylated-tau181-reliably-differentiates-amyloid-positive-39822285","doi":"10.1002/dad2.70068","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"39822285","source_url":"https://pubmed.ncbi.nlm.nih.gov/39822285/","study_design":"systematic review","title":"Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum: A systematic review and meta-analysis","title_match":false,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/using-the-alzheimer-s-disease-neuroimaging-initiative-to-improve-34581485","doi":"10.1002/alz.12422","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"34581485","source_url":"https://pubmed.ncbi.nlm.nih.gov/34581485/","study_design":null,"title":"Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/clinical-value-of-neurofilament-and-phospho-tau-tau-ratio-in-the-29514947","doi":"10.1212/wnl.0000000000005261","journal":"Neurology","n_participants":361,"pmid":"29514947","source_url":"https://pubmed.ncbi.nlm.nih.gov/29514947/","study_design":null,"title":"Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum","title_match":false,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/targeted-delivery-of-nerve-growth-factor-to-the-cholinergic-basal-27389402","doi":"10.1186/s13195-016-0195-9","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"27389402","source_url":"https://pubmed.ncbi.nlm.nih.gov/27389402/","study_design":"open-label trial","title":"Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device","title_match":false,"year":2016},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/medical-comorbidities-and-ethnicity-impact-plasma-alzheimer-s-disease-35235702","doi":"10.1002/alz.12647","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":445,"pmid":"35235702","source_url":"https://pubmed.ncbi.nlm.nih.gov/35235702/","study_design":null,"title":"Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice","title_match":true,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/fluid-biomarkers-in-frontotemporal-dementia-past-present-and-future-33188134","doi":"10.1136/jnnp-2020-323520","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"33188134","source_url":"https://pubmed.ncbi.nlm.nih.gov/33188134/","study_design":null,"title":"Fluid biomarkers in frontotemporal dementia: past, present and future","title_match":false,"year":2021},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-dynamics-of-biomarkers-across-the-clinical-spectrum-of-alzheimer-32534594","doi":"10.1186/s13195-020-00636-z","journal":"Alzheimer's research & therapy","n_participants":2014,"pmid":"32534594","source_url":"https://pubmed.ncbi.nlm.nih.gov/32534594/","study_design":"longitudinal study","title":"The dynamics of biomarkers across the clinical spectrum of Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/correlations-between-plasma-and-pet-beta-amyloid-levels-in-30497535","doi":"10.1186/s13195-018-0444-1","journal":"Alzheimer's research & therapy","n_participants":200,"pmid":"30497535","source_url":"https://pubmed.ncbi.nlm.nih.gov/30497535/","study_design":null,"title":"Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundaci\u00f3 ACE Healthy Brain Initiative (FACEHBI)","title_match":false,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/deep-cervical-lymphovenous-anastomosis-lva-for-alzheimer-s-disease-40391969","doi":"10.1097/js9.0000000000002490","journal":"International journal of surgery (London, England)","n_participants":null,"pmid":"40391969","source_url":"https://pubmed.ncbi.nlm.nih.gov/40391969/","study_design":null,"title":"Deep cervical lymphovenous anastomosis (LVA) for Alzheimer's disease: microsurgical procedure in a prospective cohort study","title_match":false,"year":2025},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/clinical-performance-of-an-antibody-free-assay-for-plasma-a42-a40-to-36604729","doi":"10.1186/s13195-022-01143-z","journal":"Alzheimer's research & therapy","n_participants":200,"pmid":"36604729","source_url":"https://pubmed.ncbi.nlm.nih.gov/36604729/","study_design":"cohort study","title":"Clinical performance of an antibody-free assay for plasma A\u03b242/A\u03b240 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/fluid-biomarker-based-molecular-phenotyping-of-alzheimer-s-disease-31699324","doi":"10.1016/bs.pmbts.2019.07.006","journal":"Progress in molecular biology and translational science","n_participants":null,"pmid":"31699324","source_url":"https://pubmed.ncbi.nlm.nih.gov/31699324/","study_design":null,"title":"Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings","title_match":false,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/morphological-and-molecular-profiling-of-amyloid-species-in-alzheimer-39446217","doi":"10.1007/s12035-024-04543-4","journal":"Molecular neurobiology","n_participants":null,"pmid":"39446217","source_url":"https://pubmed.ncbi.nlm.nih.gov/39446217/","study_design":null,"title":"Morphological and Molecular Profiling of Amyloid-\u03b2 Species in Alzheimer's Pathogenesis","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/fully-automated-and-highly-specific-plasma-amyloid-immunoassays-35739591","doi":"10.1186/s13195-022-01029-0","journal":"Alzheimer's research & therapy","n_participants":197,"pmid":"35739591","source_url":"https://pubmed.ncbi.nlm.nih.gov/35739591/","study_design":"clinical trial","title":"Fully automated and highly specific plasma \u03b2-amyloid immunoassays predict \u03b2-amyloid status defined by amyloid positron emission tomography with high accuracy","title_match":false,"year":2022},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/bapineuzumab-alters-a-composition-implications-for-the-amyloid-23555764","doi":"10.1371/journal.pone.0059735","journal":"PloS one","n_participants":null,"pmid":"23555764","source_url":"https://pubmed.ncbi.nlm.nih.gov/23555764/","study_design":null,"title":"Bapineuzumab alters a\u03b2 composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy","title_match":false,"year":2013},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/blood-derived-amyloid-biomarkers-for-alzheimer-s-disease-prevention-35098969","doi":"10.14283/jpad.2021.70","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"35098969","source_url":"https://pubmed.ncbi.nlm.nih.gov/35098969/","study_design":"cross-sectional","title":"Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/novel-presenilin-1-and-2-double-knock-out-cell-line-for-in-vitro-32032730","doi":"10.1016/j.nbd.2020.104785","journal":"Neurobiology of disease","n_participants":null,"pmid":"32032730","source_url":"https://pubmed.ncbi.nlm.nih.gov/32032730/","study_design":null,"title":"Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations","title_match":false,"year":2020},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/concordance-between-cerebrospinal-fluid-biomarkers-with-alzheimer-s-29171991","doi":"10.3233/jad-170128","journal":"Journal of Alzheimer's disease : JAD","n_participants":77,"pmid":"29171991","source_url":"https://pubmed.ncbi.nlm.nih.gov/29171991/","study_design":null,"title":"Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms","title_match":false,"year":2018},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/new-insights-into-the-spontaneous-human-alzheimer-s-disease-like-30412496","doi":"10.3233/jad-180729","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30412496","source_url":"https://pubmed.ncbi.nlm.nih.gov/30412496/","study_design":null,"title":"New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-\u03b2 Peptide Aggregation and Age-Related Amyloid Pathology","title_match":false,"year":2018},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/definition-of-a-threshold-for-the-plasma-a42-a40-ratio-measured-by-38256246","doi":"10.3390/ijms25021173","journal":"International journal of molecular sciences","n_participants":88,"pmid":"38256246","source_url":"https://pubmed.ncbi.nlm.nih.gov/38256246/","study_design":null,"title":"Definition of a Threshold for the Plasma A\u03b242/A\u03b240 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia","title_match":false,"year":2024},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/association-between-modifiable-risk-factors-and-levels-of-blood-based-38204926","doi":"10.14283/jarlife.2024.1","journal":"JAR life","n_participants":779,"pmid":"38204926","source_url":"https://pubmed.ncbi.nlm.nih.gov/38204926/","study_design":null,"title":"Association between Modifiable Risk Factors and Levels of Blood-Based Biomarkers of Alzheimer's and Related Dementias in the Look AHEAD Cohort","title_match":false,"year":2024},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/apoe-4-modulates-the-association-among-plasma-a-lt-sub-gt-42-lt-sub-35351867","doi":"10.1038/s41398-022-01899-w","journal":"Translational psychiatry","n_participants":null,"pmid":"35351867","source_url":"https://pubmed.ncbi.nlm.nih.gov/35351867/","study_design":"longitudinal study","title":"APOE-\u03b54 modulates the association among plasma A\u03b242/A\u03b240, vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults","title_match":false,"year":2022},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-influence-of-baseline-alzheimer-s-disease-severity-on-cognitive-32210906","doi":"10.3389/fneur.2020.00149","journal":"Frontiers in neurology","n_participants":497,"pmid":"32210906","source_url":"https://pubmed.ncbi.nlm.nih.gov/32210906/","study_design":null,"title":"The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/plasma-amyloid-peptides-in-type-2-diabetes-a-matched-case-control-28106562","doi":"10.3233/jad-161050","journal":"Journal of Alzheimer's disease : JAD","n_participants":194,"pmid":"28106562","source_url":"https://pubmed.ncbi.nlm.nih.gov/28106562/","study_design":null,"title":"Plasma Amyloid-\u03b2 Peptides in Type 2 Diabetes: A Matched Case-Control Study","title_match":false,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/a-phase-iia-clinical-trial-to-evaluate-the-effects-of-anti-retroviral-40104524","doi":"10.1038/s44400-024-00001-z","journal":"NPJ dementia","n_participants":12,"pmid":"40104524","source_url":"https://pubmed.ncbi.nlm.nih.gov/40104524/","study_design":"open-label trial","title":"A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD)","title_match":true,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/cognitively-unimpaired-individuals-with-a-low-burden-of-a-pathology-34315519","doi":"10.1186/s13195-021-00863-y","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"34315519","source_url":"https://pubmed.ncbi.nlm.nih.gov/34315519/","study_design":"cross-sectional","title":"Cognitively unimpaired individuals with a low burden of A\u03b2 pathology have a distinct CSF biomarker profile","title_match":false,"year":2021},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/lecanemab-associated-amyloid-protofibril-in-cerebrospinal-fluid-39761671","doi":"10.1002/ana.27175","journal":"Annals of neurology","n_participants":163,"pmid":"39761671","source_url":"https://pubmed.ncbi.nlm.nih.gov/39761671/","study_design":null,"title":"Lecanemab-Associated Amyloid-\u03b2 Protofibril in Cerebrospinal Fluid Correlates with Biomarkers of Neurodegeneration in Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/a-multicenter-randomized-double-blind-placebo-controlled-ascending-38970127","doi":"10.1186/s13195-024-01490-z","journal":"Alzheimer's research & therapy","n_participants":19,"pmid":"38970127","source_url":"https://pubmed.ncbi.nlm.nih.gov/38970127/","study_design":null,"title":"A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease","title_match":true,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/prospective-analysis-of-plasma-amyloid-beta-and-postoperative-36842841","doi":"10.1016/j.bja.2023.01.020","journal":"British journal of anaesthesia","n_participants":100,"pmid":"36842841","source_url":"https://pubmed.ncbi.nlm.nih.gov/36842841/","study_design":"cohort study","title":"Prospective analysis of plasma amyloid beta and postoperative delirium in the Interventions for Postoperative Delirium: Biomarker-3 study","title_match":false,"year":2023},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/novel-ultrasensitive-detection-technologies-for-the-identification-of-35213367","doi":"10.3233/jad-215093","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"35213367","source_url":"https://pubmed.ncbi.nlm.nih.gov/35213367/","study_design":"systematic review","title":"Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers","title_match":false,"year":2022},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/accuracy-of-plasma-biomarkers-to-detect-alzheimer-s-disease-40108829","doi":"10.1002/alz.14570","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":304,"pmid":"40108829","source_url":"https://pubmed.ncbi.nlm.nih.gov/40108829/","study_design":"cohort study","title":"Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementia","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/biomarkers-of-inflammation-and-amyloid-beta-phagocytosis-in-patients-19699791","doi":"10.1016/j.exger.2009.08.003","journal":"Experimental gerontology","n_participants":null,"pmid":"19699791","source_url":"https://pubmed.ncbi.nlm.nih.gov/19699791/","study_design":null,"title":"Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease","title_match":false,"year":2010},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/diagnostic-utility-of-vegf-and-soluble-cd40l-levels-in-serum-of-26706786","doi":"10.1016/j.cca.2015.12.018","journal":"Clinica chimica acta; international journal of clinical chemistry","n_participants":90,"pmid":"26706786","source_url":"https://pubmed.ncbi.nlm.nih.gov/26706786/","study_design":null,"title":"Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients","title_match":false,"year":2016},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/utilization-of-fluid-based-biomarkers-as-endpoints-in-disease-38678292","doi":"10.1186/s13195-024-01456-1","journal":"Alzheimer's research & therapy","n_participants":121,"pmid":"38678292","source_url":"https://pubmed.ncbi.nlm.nih.gov/38678292/","study_design":null,"title":"Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review","title_match":true,"year":2024},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-kami-guibi-tang-for-mild-cognitive-impairment-34620151","doi":"10.1186/s12906-021-03428-6","journal":"BMC complementary medicine and therapies","n_participants":16,"pmid":"34620151","source_url":"https://pubmed.ncbi.nlm.nih.gov/34620151/","study_design":null,"title":"Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial","title_match":true,"year":2021},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/asian-cohort-for-alzheimer-s-disease-acad-pilot-study-on-genetic-and-38215053","doi":"10.1002/alz.13611","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":606,"pmid":"38215053","source_url":"https://pubmed.ncbi.nlm.nih.gov/38215053/","study_design":null,"title":"Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians","title_match":false,"year":2024},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/cis-p-tau-is-a-central-circulating-and-placental-etiologic-driver-and-37669931","doi":"10.1038/s41467-023-41144-6","journal":"Nature communications","n_participants":null,"pmid":"37669931","source_url":"https://pubmed.ncbi.nlm.nih.gov/37669931/","study_design":null,"title":"Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia","title_match":false,"year":2023},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/european-multicentre-double-blind-placebo-controlled-trial-of-27436668","doi":"10.1136/bmjopen-2016-011584","journal":"BMJ open","n_participants":null,"pmid":"27436668","source_url":"https://pubmed.ncbi.nlm.nih.gov/27436668/","study_design":null,"title":"European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow","title_match":true,"year":2016},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-potential-of-pathological-protein-fragmentation-in-blood-based-26029153","doi":"10.3389/fneur.2015.00090","journal":"Frontiers in neurology","n_participants":null,"pmid":"26029153","source_url":"https://pubmed.ncbi.nlm.nih.gov/26029153/","study_design":null,"title":"The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/acute-exercise-alters-brain-glucose-metabolism-in-aging-and-alzheimer-39258961","doi":"10.1113/jp286923","journal":"The Journal of physiology","n_participants":30,"pmid":"39258961","source_url":"https://pubmed.ncbi.nlm.nih.gov/39258961/","study_design":"randomized controlled trial","title":"Acute exercise alters brain glucose metabolism in aging and Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/exploring-the-association-between-mild-behavioral-impairment-and-40406748","doi":"10.1002/dad2.70119","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":101,"pmid":"40406748","source_url":"https://pubmed.ncbi.nlm.nih.gov/40406748/","study_design":null,"title":"Exploring the association between mild behavioral impairment and plasma p-tau217: Implications for early detection of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/white-matter-free-water-mediates-the-associations-between-placental-39692213","doi":"10.1002/alz.14408","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":370,"pmid":"39692213","source_url":"https://pubmed.ncbi.nlm.nih.gov/39692213/","study_design":null,"title":"White matter free water mediates the associations between placental growth factor, white matter hyperintensities, and cognitive status","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/comparing-the-effects-of-olfactory-based-sensory-stimulation-and-36204759","doi":"10.3389/fpsyg.2022.1003325","journal":"Frontiers in psychology","n_participants":30,"pmid":"36204759","source_url":"https://pubmed.ncbi.nlm.nih.gov/36204759/","study_design":null,"title":"Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial","title_match":true,"year":2022},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/population-pharmacokinetic-and-pharmacodynamic-analysis-of-plasma-a40-27129013","doi":"10.1002/cpdd.130","journal":"Clinical pharmacology in drug development","n_participants":null,"pmid":"27129013","source_url":"https://pubmed.ncbi.nlm.nih.gov/27129013/","study_design":null,"title":"Population pharmacokinetic and pharmacodynamic analysis of plasma A\u03b240 and A\u03b242 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers","title_match":false,"year":2014},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/biological-determinants-of-blood-based-biomarker-levels-in-alzheimer-41280310","doi":"10.3389/fnagi.2025.1614962","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"41280310","source_url":"https://pubmed.ncbi.nlm.nih.gov/41280310/","study_design":null,"title":"Biological determinants of blood-based biomarker levels in Alzheimer's disease: role of nutrition, inflammation, and metabolic factors","title_match":false,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/identifying-blood-biomarkers-for-dementia-using-machine-learning-35563811","doi":"10.3390/cells11091506","journal":"Cells","n_participants":1642,"pmid":"35563811","source_url":"https://pubmed.ncbi.nlm.nih.gov/35563811/","study_design":null,"title":"Identifying Blood Biomarkers for Dementia Using Machine Learning Methods in the Framingham Heart Study","title_match":false,"year":2022},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/prediction-of-amyloid-and-tau-brain-deposition-and-cognitive-decline-40541209","doi":"10.1016/s1474-4422(25)00158-9","journal":"The Lancet. Neurology","n_participants":220,"pmid":"40541209","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541209/","study_design":"cohort study","title":"Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study","title_match":false,"year":2025},{"alzhub_score":86,"alzhub_url":"https://alzhub.org/study/the-australian-multidomain-approach-to-reduce-dementia-risk-by-38596483","doi":"10.1002/trc2.12466","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":600,"pmid":"38596483","source_url":"https://pubmed.ncbi.nlm.nih.gov/38596483/","study_design":"randomized controlled trial","title":"The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial","title_match":true,"year":2024},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/an-exploration-of-the-oryza-sativa-l-cyanidin-3-glucoside-on-the-31558689","doi":"10.30773/pi.2019.06.17","journal":"Psychiatry investigation","n_participants":48,"pmid":"31558689","source_url":"https://pubmed.ncbi.nlm.nih.gov/31558689/","study_design":null,"title":"An Exploration of the Oryza sativa L. Cyanidin-3-glucoside on the Cognitive Function in Older Adults with Subjective Memory Impairment","title_match":false,"year":2019},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/the-alz-tau-biomarker-for-alzheimer-s-disease-study-in-a-caucasian-30775977","doi":"10.3233/jad-180637","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30775977","source_url":"https://pubmed.ncbi.nlm.nih.gov/30775977/","study_design":null,"title":"The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population","title_match":false,"year":2019},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/the-japan-multimodal-intervention-trial-for-prevention-of-dementia-36088747","doi":"10.1016/j.archger.2022.104803","journal":"Archives of gerontology and geriatrics","n_participants":200,"pmid":"36088747","source_url":"https://pubmed.ncbi.nlm.nih.gov/36088747/","study_design":"randomized controlled trial","title":"The Japan-Multimodal Intervention Trial for Prevention of Dementia PRIME Tamba (J-MINT PRIME Tamba): Study protocol of a randomised controlled multi-domain intervention trial","title_match":true,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/early-detection-of-alzheimer-s-disease-by-peptides-from-phage-display-31247207","doi":"10.1016/j.brainres.2019.146306","journal":"Brain research","n_participants":null,"pmid":"31247207","source_url":"https://pubmed.ncbi.nlm.nih.gov/31247207/","study_design":null,"title":"Early detection of Alzheimer's disease by peptides from phage display screening","title_match":false,"year":2019},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-impact-of-tau-pet-in-a-selected-memory-clinic-cohort-rationale-39427210","doi":"10.1186/s13195-024-01588-4","journal":"Alzheimer's research & therapy","n_participants":300,"pmid":"39427210","source_url":"https://pubmed.ncbi.nlm.nih.gov/39427210/","study_design":"longitudinal study","title":"The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study","title_match":false,"year":2024},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/the-alzmatch-pilot-study-feasibility-of-remote-blood-collection-of-39350391","doi":"10.14283/jpad.2024.101","journal":"The journal of prevention of Alzheimer's disease","n_participants":117,"pmid":"39350391","source_url":"https://pubmed.ncbi.nlm.nih.gov/39350391/","study_design":null,"title":"The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease Trials","title_match":false,"year":2024},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/intranasal-insulin-as-a-treatment-for-alzheimer-s-disease-a-review-of-23719722","doi":"10.1007/s40263-013-0076-8","journal":"CNS drugs","n_participants":null,"pmid":"23719722","source_url":"https://pubmed.ncbi.nlm.nih.gov/23719722/","study_design":null,"title":"Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-bace1-inhibitor-verubecestat-mk-8931-reduces-cns-amyloid-in-27807285","doi":"10.1126/scitranslmed.aad9704","journal":"Science translational medicine","n_participants":null,"pmid":"27807285","source_url":"https://pubmed.ncbi.nlm.nih.gov/27807285/","study_design":null,"title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer's disease patients","title_match":false,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/alzheimer-s-prevention-initiative-a-plan-to-accelerate-the-evaluation-21971471","doi":"10.3233/jad-2011-0059","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"21971471","source_url":"https://pubmed.ncbi.nlm.nih.gov/21971471/","study_design":null,"title":"Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments","title_match":false,"year":2011},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-clinical-promise-of-biomarkers-of-synapse-damage-or-loss-in-32122400","doi":"10.1186/s13195-020-00588-4","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"32122400","source_url":"https://pubmed.ncbi.nlm.nih.gov/32122400/","study_design":null,"title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/a-gamma-secretase-inhibitor-decreases-amyloid-beta-production-in-the-19360898","doi":"10.1002/ana.21623","journal":"Annals of neurology","n_participants":null,"pmid":"19360898","source_url":"https://pubmed.ncbi.nlm.nih.gov/19360898/","study_design":null,"title":"A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system","title_match":false,"year":2009},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/bapineuzumab-for-mild-to-moderate-alzheimer-s-disease-in-two-global-27176461","doi":"10.1186/s13195-016-0189-7","journal":"Alzheimer's research & therapy","n_participants":329,"pmid":"27176461","source_url":"https://pubmed.ncbi.nlm.nih.gov/27176461/","study_design":"clinical trial","title":"Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials","title_match":true,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-murine-version-of-ban2401-mab158-selectively-reduces-amyloid-25096615","doi":"10.3233/jad-140741","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"25096615","source_url":"https://pubmed.ncbi.nlm.nih.gov/25096615/","study_design":"clinical trial","title":"The murine version of BAN2401 (mAb158) selectively reduces amyloid-\u03b2 protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice","title_match":false,"year":2015},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/blood-based-molecular-biomarkers-for-alzheimer-s-disease-30922367","doi":"10.1186/s13041-019-0448-1","journal":"Molecular brain","n_participants":null,"pmid":"30922367","source_url":"https://pubmed.ncbi.nlm.nih.gov/30922367/","study_design":"narrative review","title":"Blood-based molecular biomarkers for Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-a-multifactorial-disorder-seeking-multitherapies-20813343","doi":"10.1016/j.jalz.2010.04.006","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"20813343","source_url":"https://pubmed.ncbi.nlm.nih.gov/20813343/","study_design":null,"title":"Alzheimer's disease, a multifactorial disorder seeking multitherapies","title_match":false,"year":2010},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/nilotinib-effects-in-parkinson-s-disease-and-dementia-with-lewy-bodies-27434297","doi":"10.3233/jpd-160867","journal":"Journal of Parkinson's disease","n_participants":null,"pmid":"27434297","source_url":"https://pubmed.ncbi.nlm.nih.gov/27434297/","study_design":null,"title":"Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies","title_match":false,"year":2016},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/csf-tau-abeta42-ratio-for-increased-risk-of-mild-cognitive-impairment-17698783","doi":"10.1212/01.wnl.0000267428.62582.aa","journal":"Neurology","n_participants":12,"pmid":"17698783","source_url":"https://pubmed.ncbi.nlm.nih.gov/17698783/","study_design":null,"title":"CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study","title_match":false,"year":2007},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/innovative-diagnostic-tools-for-early-detection-of-alzheimer-s-disease-25443858","doi":"10.1016/j.jalz.2014.06.004","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"25443858","source_url":"https://pubmed.ncbi.nlm.nih.gov/25443858/","study_design":null,"title":"Innovative diagnostic tools for early detection of Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/alterations-in-metabolic-pathways-and-networks-in-alzheimer-s-disease-23571809","doi":"10.1038/tp.2013.18","journal":"Translational psychiatry","n_participants":40,"pmid":"23571809","source_url":"https://pubmed.ncbi.nlm.nih.gov/23571809/","study_design":null,"title":"Alterations in metabolic pathways and networks in Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/cognitive-training-and-neuroplasticity-in-mild-cognitive-impairment-31471436","doi":"10.1136/bmjopen-2018-028536","journal":"BMJ open","n_participants":100,"pmid":"31471436","source_url":"https://pubmed.ncbi.nlm.nih.gov/31471436/","study_design":null,"title":"Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial","title_match":true,"year":2019},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/determinants-of-adherence-to-a-gradior-computer-based-cognitive-35330040","doi":"10.3390/jcm11061714","journal":"Journal of clinical medicine","n_participants":43,"pmid":"35330040","source_url":"https://pubmed.ncbi.nlm.nih.gov/35330040/","study_design":null,"title":"Determinants of Adherence to a \"GRADIOR\" Computer-Based Cognitive Training Program in People with Mild Cognitive Impairment (MCI) and Mild Dementia","title_match":false,"year":2022},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/implementation-and-evaluation-of-a-driving-cessation-intervention-to-30832581","doi":"10.1186/s12877-019-1074-6","journal":"BMC geriatrics","n_participants":null,"pmid":"30832581","source_url":"https://pubmed.ncbi.nlm.nih.gov/30832581/","study_design":"randomized controlled trial","title":"Implementation and evaluation of a driving cessation intervention to improve community mobility and wellbeing outcomes for people living with dementia: study protocol of the 'CarFreeMe' for people with dementia program","title_match":false,"year":2019},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/neuroaireh-b-an-artificial-intelligence-based-methodology-for-38322797","doi":"10.3389/fneur.2023.1258323","journal":"Frontiers in neurology","n_participants":null,"pmid":"38322797","source_url":"https://pubmed.ncbi.nlm.nih.gov/38322797/","study_design":null,"title":"NeuroAIreh@b: an artificial intelligence-based methodology for personalized and adaptive neurorehabilitation","title_match":false,"year":2023},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/screening-over-speech-in-unselected-populations-for-clinical-trials-36946458","doi":"10.14283/jpad.2023.11","journal":"The journal of prevention of Alzheimer's disease","n_participants":1000,"pmid":"36946458","source_url":"https://pubmed.ncbi.nlm.nih.gov/36946458/","study_design":"longitudinal study","title":"Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol","title_match":true,"year":2023},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/randomized-controlled-feasibility-study-of-findmyapps-first-32552074","doi":"10.1080/17483107.2020.1765420","journal":"Disability and rehabilitation. Assistive technology","n_participants":null,"pmid":"32552074","source_url":"https://pubmed.ncbi.nlm.nih.gov/32552074/","study_design":"randomized controlled trial","title":"Randomized controlled feasibility study of FindMyApps: first evaluation of a tablet-based intervention to promote self-management and meaningful activities in people with mild dementia","title_match":true,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/effects-of-the-online-computerized-cognitive-training-program-beynex-31887854","doi":"10.3906/sag-1905-244","journal":"Turkish journal of medical sciences","n_participants":60,"pmid":"31887854","source_url":"https://pubmed.ncbi.nlm.nih.gov/31887854/","study_design":null,"title":"Effects of the online computerized cognitive training program BEYNEX on the cognitive tests of individuals with subjective cognitive impairment and Alzheimer\u2019s disease on rivastigmine therapy","title_match":false,"year":2020},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/caring-for-me-and-you-the-co-production-of-a-computerised-cognitive-28691520","doi":"10.1080/13607863.2017.1348475","journal":"Aging & mental health","n_participants":null,"pmid":"28691520","source_url":"https://pubmed.ncbi.nlm.nih.gov/28691520/","study_design":"randomized controlled trial","title":"Caring For Me and You: the co-production of a computerised cognitive behavioural therapy (cCBT) package for carers of people with dementia","title_match":false,"year":2018},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/efficacy-of-digital-therapeutic-applications-for-cognitive-training-40073511","doi":"10.1016/j.psychres.2025.116426","journal":"Psychiatry research","n_participants":null,"pmid":"40073511","source_url":"https://pubmed.ncbi.nlm.nih.gov/40073511/","study_design":"meta-analysis","title":"Efficacy of digital therapeutic applications for cognitive training among older adults with mild cognitive impairment or dementia: A systematic review and network meta-analysis of randomized controlled trials","title_match":true,"year":2025},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/an-individual-cognitive-stimulation-therapy-app-for-people-with-35221680","doi":"10.2147/cia.s323994","journal":"Clinical interventions in aging","n_participants":31,"pmid":"35221680","source_url":"https://pubmed.ncbi.nlm.nih.gov/35221680/","study_design":"randomized controlled trial","title":"An Individual Cognitive Stimulation Therapy App for People with Dementia and Carers: Results from a Feasibility Randomized Controlled Trial (RCT)","title_match":true,"year":2021},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/nonimmersive-brain-gaming-for-older-adults-with-cognitive-impairment-30605502","doi":"10.1093/geront/gny164","journal":"The Gerontologist","n_participants":13,"pmid":"30605502","source_url":"https://pubmed.ncbi.nlm.nih.gov/30605502/","study_design":null,"title":"Nonimmersive Brain Gaming for Older Adults With Cognitive Impairment: A Scoping Review","title_match":false,"year":2019},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/findmyapps-compared-with-usual-tablet-use-to-promote-social-health-of-37680943","doi":"10.1016/j.eclinm.2023.102169","journal":"EClinicalMedicine","n_participants":76,"pmid":"37680943","source_url":"https://pubmed.ncbi.nlm.nih.gov/37680943/","study_design":"randomized controlled trial","title":"FindMyApps compared with usual tablet use to promote social health of community-dwelling people with mild dementia and their informal caregivers: a randomised controlled trial","title_match":true,"year":2023},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/user-preferences-and-usability-of-ivitality-optimizing-an-innovative-26170635","doi":"10.2147/ppa.s82510","journal":"Patient preference and adherence","n_participants":13,"pmid":"26170635","source_url":"https://pubmed.ncbi.nlm.nih.gov/26170635/","study_design":"clinical trial","title":"User preferences and usability of iVitality: optimizing an innovative online research platform for home-based health monitoring","title_match":false,"year":2015},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/impact-of-computerized-cognitive-training-on-default-mode-network-36442202","doi":"10.3233/jad-220946","journal":"Journal of Alzheimer's disease : JAD","n_participants":107,"pmid":"36442202","source_url":"https://pubmed.ncbi.nlm.nih.gov/36442202/","study_design":null,"title":"Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A\u00a078-week Randomized Controlled Trial","title_match":true,"year":2023},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/evaluation-of-findmyapps-protocol-for-a-randomized-controlled-trial-33627069","doi":"10.1186/s12877-021-02038-8","journal":"BMC geriatrics","n_participants":75,"pmid":"33627069","source_url":"https://pubmed.ncbi.nlm.nih.gov/33627069/","study_design":"randomized controlled trial","title":"Evaluation of FindMyApps: protocol for a randomized controlled trial of the effectiveness and cost-effectiveness of a tablet-based intervention to improve self-management and social participation of community-dwelling people with mild dementia, compared to usual tablet use","title_match":true,"year":2021},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/the-design-and-progress-of-a-multidomain-lifestyle-intervention-to-29854925","doi":"10.1016/j.trci.2015.05.001","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":104,"pmid":"29854925","source_url":"https://pubmed.ncbi.nlm.nih.gov/29854925/","study_design":"randomized controlled trial","title":"The design and progress of a multidomain lifestyle intervention to improve brain health in middle-aged persons to reduce later Alzheimer's disease risk: The Gray Matters randomized trial","title_match":false,"year":2015},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/study-protocol-of-a-comprehensive-activity-promotion-program-for-the-35543012","doi":"10.14283/jpad.2022.12","journal":"The journal of prevention of Alzheimer's disease","n_participants":1749,"pmid":"35543012","source_url":"https://pubmed.ncbi.nlm.nih.gov/35543012/","study_design":"randomized controlled trial","title":"Study Protocol of a Comprehensive Activity Promotion Program for the Prevention of Dementia: A Randomized Controlled Trial Protocol","title_match":true,"year":2022},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/diagnostic-test-accuracy-of-a-novel-smartphone-application-for-the-30223771","doi":"10.1186/s12877-018-0901-5","journal":"BMC geriatrics","n_participants":500,"pmid":"30223771","source_url":"https://pubmed.ncbi.nlm.nih.gov/30223771/","study_design":"case-control study","title":"Diagnostic test accuracy of a novel smartphone application for the assessment of attention deficits in delirium in older hospitalised patients: a prospective cohort study protocol","title_match":false,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/sex-differences-in-the-association-between-tau-pet-and-cognitive-37641484","doi":"10.1002/alz.13432","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":343,"pmid":"37641484","source_url":"https://pubmed.ncbi.nlm.nih.gov/37641484/","study_design":null,"title":"Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD","title_match":false,"year":2024},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/design-and-development-of-the-brain-training-system-for-the-digital-31518277","doi":"10.2196/13135","journal":"JMIR aging","n_participants":100,"pmid":"31518277","source_url":"https://pubmed.ncbi.nlm.nih.gov/31518277/","study_design":"randomized controlled trial","title":"Design and Development of the Brain Training System for the Digital \"Maintain Your Brain\" Dementia Prevention Trial","title_match":false,"year":2019},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/the-efficacy-of-cognitive-training-in-patients-with-vascular-27496126","doi":"10.1186/s13063-016-1523-x","journal":"Trials","n_participants":60,"pmid":"27496126","source_url":"https://pubmed.ncbi.nlm.nih.gov/27496126/","study_design":"randomized controlled trial","title":"The efficacy of Cognitive training in patients with VAsCular Cognitive Impairment, No dEmentia (the Cog-VACCINE study): study protocol for a randomized controlled trial","title_match":true,"year":2016},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/impact-of-short-term-computerized-cognitive-training-on-cognition-in-38642588","doi":"10.1016/j.jamda.2024.03.008","journal":"Journal of the American Medical Directors Association","n_participants":6544,"pmid":"38642588","source_url":"https://pubmed.ncbi.nlm.nih.gov/38642588/","study_design":"randomized controlled trial","title":"Impact of Short-Term Computerized Cognitive Training on Cognition in Older Adults With and Without Genetic Risk of Alzheimer's Disease: Outcomes From the START Randomized Controlled Trial","title_match":true,"year":2024},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/validation-study-of-sante-cerveau-a-digital-tool-for-early-cognitive-37013590","doi":"10.1186/s13195-023-01204-x","journal":"Alzheimer's research & therapy","n_participants":64,"pmid":"37013590","source_url":"https://pubmed.ncbi.nlm.nih.gov/37013590/","study_design":null,"title":"Validation study of \"Sant\u00e9-Cerveau\", a digital tool for early cognitive changes identification","title_match":false,"year":2023},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/psychosocial-effects-of-a-humanoid-robot-on-informal-caregivers-of-39700737","doi":"10.1016/j.ijnurstu.2024.104967","journal":"International journal of nursing studies","n_participants":16,"pmid":"39700737","source_url":"https://pubmed.ncbi.nlm.nih.gov/39700737/","study_design":null,"title":"Psychosocial effects of a humanoid robot on informal caregivers of people with dementia: A randomised controlled trial with nested interviews","title_match":true,"year":2025},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/development-of-a-cognitive-training-support-programme-for-prevention-39081598","doi":"10.3389/frdem.2024.1331741","journal":"Frontiers in dementia","n_participants":null,"pmid":"39081598","source_url":"https://pubmed.ncbi.nlm.nih.gov/39081598/","study_design":"meta-analysis","title":"Development of a Cognitive Training Support Programme for prevention of dementia and cognitive decline in at-risk older adults","title_match":false,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/effects-of-computerized-cognitive-training-on-biomarker-responses-in-38895550","doi":"10.1002/hsr2.2175","journal":"Health science reports","n_participants":null,"pmid":"38895550","source_url":"https://pubmed.ncbi.nlm.nih.gov/38895550/","study_design":null,"title":"Effects of computerized cognitive training on biomarker responses in older adults with mild cognitive impairment: A scoping review","title_match":false,"year":2024},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/randomized-controlled-trial-on-the-efficacy-of-a-multilevel-non-31749018","doi":"10.1007/s40520-019-01403-3","journal":"Aging clinical and experimental research","n_participants":40,"pmid":"31749018","source_url":"https://pubmed.ncbi.nlm.nih.gov/31749018/","study_design":"randomized controlled trial","title":"Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study","title_match":true,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/biomarkers-in-alzheimer-s-disease-clinical-trials-2025-41716297","doi":"10.1002/trc2.70217","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"41716297","source_url":"https://pubmed.ncbi.nlm.nih.gov/41716297/","study_design":"clinical trial","title":"Biomarkers in Alzheimer's disease clinical trials: 2025","title_match":true,"year":2026},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/comparison-of-the-effect-of-online-physical-exercise-and-computerized-38959564","doi":"10.1016/j.ctcp.2024.101881","journal":"Complementary therapies in clinical practice","n_participants":75,"pmid":"38959564","source_url":"https://pubmed.ncbi.nlm.nih.gov/38959564/","study_design":null,"title":"Comparison of the effect of online physical exercise and computerized cognitive stimulation in patients with Alzheimer's disease during the Covid-19 pandemic","title_match":false,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/cognitive-training-and-promoting-a-healthy-lifestyle-for-individuals-38943191","doi":"10.1186/s13063-024-08265-9","journal":"Trials","n_participants":null,"pmid":"38943191","source_url":"https://pubmed.ncbi.nlm.nih.gov/38943191/","study_design":"randomized controlled trial","title":"Cognitive training and promoting a healthy lifestyle for individuals with isolated REM sleep behavior disorder: study protocol of the delayed-start randomized controlled trial CogTrAiL-RBD","title_match":true,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/design-of-the-dutch-multicentre-study-on-opportunistic-screening-of-38619715","doi":"10.1007/s12471-024-01868-6","journal":"Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation","n_participants":null,"pmid":"38619715","source_url":"https://pubmed.ncbi.nlm.nih.gov/38619715/","study_design":null,"title":"Design of the Dutch multicentre study on opportunistic screening of geriatric patients for atrial fibrillation using a\u00a0smartphone PPG app: the Dutch-GERAF study","title_match":false,"year":2024},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/smartphone-app-based-intervention-for-reducing-stress-depression-and-36937692","doi":"10.1177/20552076231163786","journal":"Digital health","n_participants":null,"pmid":"36937692","source_url":"https://pubmed.ncbi.nlm.nih.gov/36937692/","study_design":"randomized controlled trial","title":"Smartphone app-based intervention for reducing stress, depression, and anxiety in caregivers of people with dementia in Vietnam: Study protocol for a pilot randomized controlled trial","title_match":true,"year":2023},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/the-effectiveness-of-a-motivational-enhancement-smartphone-35771740","doi":"10.1371/journal.pone.0267806","journal":"PloS one","n_participants":40,"pmid":"35771740","source_url":"https://pubmed.ncbi.nlm.nih.gov/35771740/","study_design":"randomized controlled trial","title":"The effectiveness of a motivational enhancement smartphone application promoting lifestyle improvement for brain health: A randomized controlled trial","title_match":true,"year":2022},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/shanghai-cognitive-intervention-of-mild-cognitive-impairment-for-30041656","doi":"10.1186/s12883-018-1100-x","journal":"BMC neurology","n_participants":800,"pmid":"30041656","source_url":"https://pubmed.ncbi.nlm.nih.gov/30041656/","study_design":null,"title":"Shanghai cognitive intervention of mild cognitive impairment for delaying progress with longitudinal evaluation-a prospective, randomized controlled study (SIMPLE): rationale, design, and methodology","title_match":true,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/support-for-patients-with-alzheimer-s-disease-and-their-caregivers-by-21586382","doi":"10.1684/pnv.2010.0248","journal":"Geriatrie et psychologie neuropsychiatrie du vieillissement","n_participants":null,"pmid":"21586382","source_url":"https://pubmed.ncbi.nlm.nih.gov/21586382/","study_design":null,"title":"[Support for patients with Alzheimer's disease and their caregivers by gerontechnology]","title_match":false,"year":2011},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/how-to-advance-the-pharmacological-management-of-cognitive-impairment-39973493","doi":"10.1177/1877718x251315645","journal":"Journal of Parkinson's disease","n_participants":null,"pmid":"39973493","source_url":"https://pubmed.ncbi.nlm.nih.gov/39973493/","study_design":"longitudinal study","title":"How to advance the pharmacological management of cognitive impairment in Parkinson's disease","title_match":false,"year":2026},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/a-feasibility-randomized-controlled-trial-of-a-community-level-39175624","doi":"10.3389/fragi.2024.1329177","journal":"Frontiers in aging","n_participants":79,"pmid":"39175624","source_url":"https://pubmed.ncbi.nlm.nih.gov/39175624/","study_design":"randomized controlled trial","title":"A feasibility randomized controlled trial of a community-level physical activity strategy for older adults with motoric cognitive risk syndrome","title_match":true,"year":2024},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/remote-data-collection-speech-analysis-in-people-at-risk-for-39081993","doi":"10.3389/frdem.2023.1271156","journal":"Frontiers in dementia","n_participants":68,"pmid":"39081993","source_url":"https://pubmed.ncbi.nlm.nih.gov/39081993/","study_design":null,"title":"Remote data collection speech analysis in people at risk for Alzheimer's disease dementia: usability and acceptability results","title_match":false,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/a-non-pharmacological-multi-modal-therapy-to-improve-sleep-and-37380020","doi":"10.1016/j.cct.2023.107275","journal":"Contemporary clinical trials","n_participants":100,"pmid":"37380020","source_url":"https://pubmed.ncbi.nlm.nih.gov/37380020/","study_design":null,"title":"A non-pharmacological multi-modal therapy to improve sleep and cognition and reduce mild cognitive impairment risk: Design and methodology of a randomized clinical trial","title_match":true,"year":2023},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/telephone-and-smartphone-based-interventions-for-cognitive-and-cardio-36393902","doi":"10.2147/cia.s352137","journal":"Clinical interventions in aging","n_participants":21,"pmid":"36393902","source_url":"https://pubmed.ncbi.nlm.nih.gov/36393902/","study_design":"systematic review","title":"Telephone and Smartphone-Based Interventions for Cognitive and Cardio-Metabolic Health in Middle-Aged and Older Adults: A Systematic Review","title_match":false,"year":2022},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/the-preventing-alzheimer-s-with-cognitive-training-pact-randomized-36341846","doi":"10.1016/j.cct.2022.106978","journal":"Contemporary clinical trials","n_participants":null,"pmid":"36341846","source_url":"https://pubmed.ncbi.nlm.nih.gov/36341846/","study_design":null,"title":"The Preventing Alzheimer's with Cognitive Training (PACT) randomized clinical trial","title_match":true,"year":2022},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/smarthealth-technology-study-protocol-to-improve-relationships-33576064","doi":"10.1111/jan.14714","journal":"Journal of advanced nursing","n_participants":30,"pmid":"33576064","source_url":"https://pubmed.ncbi.nlm.nih.gov/33576064/","study_design":"randomized controlled trial","title":"Smarthealth technology study protocol to improve relationships between older adults with dementia and family caregivers","title_match":false,"year":2021},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/effects-of-brain-training-on-brain-blood-flow-the-cognition-and-flow-31122994","doi":"10.1136/bmjopen-2018-027817","journal":"BMJ open","n_participants":60,"pmid":"31122994","source_url":"https://pubmed.ncbi.nlm.nih.gov/31122994/","study_design":"randomized controlled trial","title":"Effects of brain training on brain blood flow (The Cognition and Flow Study-CogFlowS): protocol for a feasibility randomised controlled trial of cognitive training in dementia","title_match":true,"year":2019},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/targeting-hiv-related-neurocognitive-impairments-with-cognitive-30710223","doi":"10.1007/7854_2018_80","journal":"Current topics in behavioral neurosciences","n_participants":null,"pmid":"30710223","source_url":"https://pubmed.ncbi.nlm.nih.gov/30710223/","study_design":null,"title":"Targeting HIV-Related Neurocognitive Impairments with Cognitive Training Strategies: Insights from the Cognitive Aging Literature","title_match":false,"year":2021},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/development-and-validation-of-the-tabcat-examiner-a-tablet-based-41165545","doi":"10.1017/s1355617725000177","journal":"Journal of the International Neuropsychological Society : JINS","n_participants":342,"pmid":"41165545","source_url":"https://pubmed.ncbi.nlm.nih.gov/41165545/","study_design":"cross-sectional","title":"Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials","title_match":true,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/mhealth-intervention-for-dementia-prevention-through-lifestyle-39900419","doi":"10.1136/bmjopen-2024-088324","journal":"BMJ open","n_participants":692,"pmid":"39900419","source_url":"https://pubmed.ncbi.nlm.nih.gov/39900419/","study_design":"open-label trial","title":"mHealth Intervention for Dementia Prevention through lifestyle Optimisation (MIND-PRO) in a primary care setting: protocol for a randomised controlled trial in people with low SES and/or migration background","title_match":true,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/usability-acceptability-and-preliminary-effectiveness-of-a-peer-38801660","doi":"10.2196/41202","journal":"JMIR human factors","n_participants":null,"pmid":"38801660","source_url":"https://pubmed.ncbi.nlm.nih.gov/38801660/","study_design":null,"title":"Usability, Acceptability, and Preliminary Effectiveness of a Peer-Delivered and Technology-Supported Mental Health Intervention for Family Caregivers of People With Dementia: Field Usability Study","title_match":false,"year":2024},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/findmyapps-ehealth-intervention-improves-quality-not-quantity-of-home-37324141","doi":"10.3389/fmed.2023.1152077","journal":"Frontiers in medicine","n_participants":null,"pmid":"37324141","source_url":"https://pubmed.ncbi.nlm.nih.gov/37324141/","study_design":"randomized controlled trial","title":"FindMyApps eHealth intervention improves quality, not quantity, of home tablet use by people with dementia","title_match":false,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/mentalizing-imagery-therapy-to-augment-skills-training-for-dementia-35331943","doi":"10.1016/j.cct.2022.106737","journal":"Contemporary clinical trials","n_participants":null,"pmid":"35331943","source_url":"https://pubmed.ncbi.nlm.nih.gov/35331943/","study_design":null,"title":"Mentalizing imagery therapy to augment skills training for dementia caregivers: Protocol for a randomized, controlled trial of a mobile application and digital phenotyping","title_match":true,"year":2022},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/unveiling-the-potential-of-the-digits-in-noise-test-as-a-hearing-40938770","doi":"10.1177/13872877251376949","journal":"Journal of Alzheimer's disease : JAD","n_participants":93,"pmid":"40938770","source_url":"https://pubmed.ncbi.nlm.nih.gov/40938770/","study_design":null,"title":"Unveiling the potential of the Digits-in-Noise test as a hearing screening tool for older adults with cognitive impairment","title_match":false,"year":2026},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/tablet-and-group-based-multicomponent-cognitive-stimulation-for-older-39983114","doi":"10.2196/64465","journal":"JMIR research protocols","n_participants":30,"pmid":"39983114","source_url":"https://pubmed.ncbi.nlm.nih.gov/39983114/","study_design":"randomized controlled trial","title":"Tablet- and Group-Based Multicomponent Cognitive Stimulation for Older Adults With Mild Cognitive Impairment: Single-Group Pilot Study and Protocol for Randomized Controlled Trial","title_match":true,"year":2025},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/a-novel-multidomain-primary-care-nurse-led-and-mhealth-assisted-38114278","doi":"10.1136/bmjopen-2023-073709","journal":"BMJ open","n_participants":15,"pmid":"38114278","source_url":"https://pubmed.ncbi.nlm.nih.gov/38114278/","study_design":"randomized controlled trial","title":"A novel, multidomain, primary care nurse-led and mHealth-assisted intervention for dementia risk reduction in middle-aged adults (HAPPI MIND): study protocol for a cluster randomised controlled trial","title_match":true,"year":2023},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effectiveness-of-a-tablet-based-intervention-for-people-living-with-38038608","doi":"10.1002/gps.6035","journal":"International journal of geriatric psychiatry","n_participants":28,"pmid":"38038608","source_url":"https://pubmed.ncbi.nlm.nih.gov/38038608/","study_design":"randomized controlled trial","title":"Effectiveness of a tablet-based intervention for people living with dementia in primary care-A cluster randomized controlled trial","title_match":true,"year":2023},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/integrated-therapist-and-online-cbt-for-depression-in-primary-care-37340500","doi":"10.1186/s13063-023-07396-9","journal":"Trials","n_participants":434,"pmid":"37340500","source_url":"https://pubmed.ncbi.nlm.nih.gov/37340500/","study_design":"randomized controlled trial","title":"Integrated therapist and online CBT for depression in primary care (INTERACT): study protocol for a multi-centre randomised controlled trial","title_match":true,"year":2023},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/tablet-based-sensorimotor-home-training-system-for-amnestic-mild-31377702","doi":"10.1136/bmjopen-2018-028632","journal":"BMJ open","n_participants":30,"pmid":"31377702","source_url":"https://pubmed.ncbi.nlm.nih.gov/31377702/","study_design":"randomized controlled trial","title":"Tablet-based sensorimotor home-training system for amnestic mild cognitive impairments in the elderly: design of a randomised clinical trial","title_match":true,"year":2019},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/recruitment-of-older-veterans-with-diabetes-risk-for-alzheimer-s-31006684","doi":"10.3233/jad-180952","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"31006684","source_url":"https://pubmed.ncbi.nlm.nih.gov/31006684/","study_design":"randomized controlled trial","title":"Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training","title_match":true,"year":2019},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-blood-biomarkers-measured-through-remote-42091863","doi":"10.1038/s41467-026-71448-2","journal":"Nature communications","n_participants":174,"pmid":"42091863","source_url":"https://pubmed.ncbi.nlm.nih.gov/42091863/","study_design":null,"title":"Alzheimer's Disease blood biomarkers measured through remote capillary sampling correlate with cognition in older adults","title_match":false,"year":2026},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/higher-amyloid-and-tau-burden-is-associated-with-faster-decline-on-a-41214447","doi":"10.1002/acn3.70233","journal":"Annals of clinical and translational neurology","n_participants":219,"pmid":"41214447","source_url":"https://pubmed.ncbi.nlm.nih.gov/41214447/","study_design":"cross-sectional","title":"Higher Amyloid and Tau Burden Is Associated With Faster Decline on a Digital Cognitive Test","title_match":false,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-mobile-toolbox-for-remote-self-administered-cognitive-assessment-40836942","doi":"10.1002/dad2.70160","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":100,"pmid":"40836942","source_url":"https://pubmed.ncbi.nlm.nih.gov/40836942/","study_design":null,"title":"The Mobile Toolbox for remote, self-administered cognitive assessment in older adults: associations with in-clinic cognitive testing and Alzheimer's disease biomarkers","title_match":false,"year":2025},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/effects-of-a-personalised-adapted-computerised-cognitive-stimulation-40326579","doi":"10.23938/assn.1118","journal":"Anales del sistema sanitario de Navarra","n_participants":null,"pmid":"40326579","source_url":"https://pubmed.ncbi.nlm.nih.gov/40326579/","study_design":"randomized controlled trial","title":"[Effects of a personalised, adapted computerised cognitive stimulation programme versus stimulating leisure activities in younger and older adults with mild or subjective cognitive impairment. Protocol for a randomised controlled trial]","title_match":true,"year":2025},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/prediction-of-mild-cognitive-impairment-status-pilot-study-of-machine-39024003","doi":"10.2196/55575","journal":"JMIR formative research","n_participants":20,"pmid":"39024003","source_url":"https://pubmed.ncbi.nlm.nih.gov/39024003/","study_design":"longitudinal study","title":"Prediction of Mild Cognitive Impairment Status: Pilot Study of Machine Learning Models Based on Longitudinal Data From Fitness Trackers","title_match":false,"year":2024},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effects-of-the-abacus-based-mental-calculation-training-application-38470885","doi":"10.1371/journal.pone.0299201","journal":"PloS one","n_participants":20,"pmid":"38470885","source_url":"https://pubmed.ncbi.nlm.nih.gov/38470885/","study_design":"randomized controlled trial","title":"Effects of the abacus-based mental calculation training application \"SoroTouch\" on cognitive functions: A randomized controlled trial","title_match":true,"year":2024},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/effect-of-cognitive-training-on-cognitive-function-in-community-38343201","doi":"10.1111/ajag.13283","journal":"Australasian journal on ageing","n_participants":31,"pmid":"38343201","source_url":"https://pubmed.ncbi.nlm.nih.gov/38343201/","study_design":"randomized controlled trial","title":"Effect of cognitive training on cognitive function in community-dwelling older people with mild-to-moderate dementia: A single-blind randomised controlled trial","title_match":true,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/computer-based-cognitive-interventions-for-mild-cognitive-impairment-31492180","doi":"10.1186/s13643-019-1146-x","journal":"Systematic reviews","n_participants":null,"pmid":"31492180","source_url":"https://pubmed.ncbi.nlm.nih.gov/31492180/","study_design":"systematic review","title":"Computer-based cognitive interventions for mild cognitive impairment and dementia in older adults: protocol for a systematic review of published studies and meta-analysis","title_match":false,"year":2019},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/remote-digital-cognitive-assessment-in-a-trial-ready-alzheimer-s-42719037","doi":"10.1002/trc2.70311","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"42719037","source_url":"https://pubmed.ncbi.nlm.nih.gov/42719037/","study_design":null,"title":"Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studies","title_match":false,"year":2026},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/mitochondrial-dysfunction-in-alzheimer-s-disease-role-in-pathogenesis-30675901","doi":"10.1111/bph.14585","journal":"British journal of pharmacology","n_participants":null,"pmid":"30675901","source_url":"https://pubmed.ncbi.nlm.nih.gov/30675901/","study_design":null,"title":"Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/100-years-and-counting-prospects-for-defeating-alzheimer-s-disease-17082448","doi":"10.1126/science.1132813","journal":"Science (New York, N.Y.)","n_participants":null,"pmid":"17082448","source_url":"https://pubmed.ncbi.nlm.nih.gov/17082448/","study_design":null,"title":"100 years and counting: prospects for defeating Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/role-of-inflammation-in-cognitive-impairment-results-of-observational-20955439","doi":"10.1111/j.1749-6632.2010.05726.x","journal":"Annals of the New York Academy of Sciences","n_participants":null,"pmid":"20955439","source_url":"https://pubmed.ncbi.nlm.nih.gov/20955439/","study_design":null,"title":"Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials","title_match":true,"year":2010},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/altered-lipid-metabolism-in-brain-injury-and-disorders-18751914","doi":"10.1007/978-1-4020-8831-5_9","journal":"Sub-cellular biochemistry","n_participants":null,"pmid":"18751914","source_url":"https://pubmed.ncbi.nlm.nih.gov/18751914/","study_design":null,"title":"Altered lipid metabolism in brain injury and disorders","title_match":false,"year":2008},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/an-effector-reduced-anti-amyloid-a-antibody-with-unique-a-binding-22787053","doi":"10.1523/jneurosci.4742-11.2012","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"22787053","source_url":"https://pubmed.ncbi.nlm.nih.gov/22787053/","study_design":null,"title":"An effector-reduced anti-\u03b2-amyloid (A\u03b2) antibody with unique a\u03b2 binding properties promotes neuroprotection and glial engulfment of A\u03b2","title_match":false,"year":2012},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/genome-wide-survival-study-identifies-a-novel-synaptic-locus-and-33958783","doi":"10.1038/s41588-021-00847-6","journal":"Nature genetics","n_participants":3821,"pmid":"33958783","source_url":"https://pubmed.ncbi.nlm.nih.gov/33958783/","study_design":"longitudinal study","title":"Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease","title_match":false,"year":2021},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/recent-updates-on-the-genetics-of-amyotrophic-lateral-sclerosis-and-35768750","doi":"10.1007/s12035-022-02934-z","journal":"Molecular neurobiology","n_participants":null,"pmid":"35768750","source_url":"https://pubmed.ncbi.nlm.nih.gov/35768750/","study_design":null,"title":"Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia","title_match":false,"year":2022},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/genetic-determinants-of-disease-progression-in-alzheimer-s-disease-25114068","doi":"10.3233/jad-140729","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"25114068","source_url":"https://pubmed.ncbi.nlm.nih.gov/25114068/","study_design":null,"title":"Genetic determinants of disease progression in Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/the-potential-and-challenges-of-trem2-targeted-therapy-in-alzheimer-s-40353063","doi":"10.3389/fnagi.2025.1576020","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"40353063","source_url":"https://pubmed.ncbi.nlm.nih.gov/40353063/","study_design":null,"title":"The potential and challenges of TREM2-targeted therapy in Alzheimer's disease: insights from the INVOKE-2 study","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/a-high-cerebrospinal-fluid-soluble-trem2-level-is-associated-with-33313376","doi":"10.1002/dad2.12128","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":231,"pmid":"33313376","source_url":"https://pubmed.ncbi.nlm.nih.gov/33313376/","study_design":null,"title":"A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/microglia-a-pharmacological-target-for-the-treatment-of-age-related-36969855","doi":"10.3389/fphar.2023.1125982","journal":"Frontiers in pharmacology","n_participants":null,"pmid":"36969855","source_url":"https://pubmed.ncbi.nlm.nih.gov/36969855/","study_design":null,"title":"Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/targeting-the-secretase-bace1-for-alzheimer-s-disease-therapy-24556009","doi":"10.1016/s1474-4422(13)70276-x","journal":"The Lancet. Neurology","n_participants":null,"pmid":"24556009","source_url":"https://pubmed.ncbi.nlm.nih.gov/24556009/","study_design":null,"title":"Targeting the \u03b2 secretase BACE1 for Alzheimer's disease therapy","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/autosomal-dominant-alzheimer-s-disease-a-review-and-proposal-for-the-21211070","doi":"10.1186/alzrt59","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"21211070","source_url":"https://pubmed.ncbi.nlm.nih.gov/21211070/","study_design":null,"title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","title_match":false,"year":2011},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/striking-while-the-iron-is-hot-iron-metabolism-and-ferroptosis-in-30266679","doi":"10.1016/j.freeradbiomed.2018.09.033","journal":"Free radical biology & medicine","n_participants":null,"pmid":"30266679","source_url":"https://pubmed.ncbi.nlm.nih.gov/30266679/","study_design":null,"title":"Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration","title_match":false,"year":2019}]}